0000764180-20-000048.txt : 20200430 0000764180-20-000048.hdr.sgml : 20200430 20200430111200 ACCESSION NUMBER: 0000764180-20-000048 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 101 CONFORMED PERIOD OF REPORT: 20200331 FILED AS OF DATE: 20200430 DATE AS OF CHANGE: 20200430 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ALTRIA GROUP, INC. CENTRAL INDEX KEY: 0000764180 STANDARD INDUSTRIAL CLASSIFICATION: CIGARETTES [2111] IRS NUMBER: 133260245 STATE OF INCORPORATION: VA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-08940 FILM NUMBER: 20833913 BUSINESS ADDRESS: STREET 1: 6601 WEST BROAD STREET CITY: RICHMOND STATE: VA ZIP: 23230 BUSINESS PHONE: (804) 274-2200 MAIL ADDRESS: STREET 1: 6601 WEST BROAD STREET CITY: RICHMOND STATE: VA ZIP: 23230 FORMER COMPANY: FORMER CONFORMED NAME: ALTRIA GROUP INC DATE OF NAME CHANGE: 20030127 FORMER COMPANY: FORMER CONFORMED NAME: PHILIP MORRIS COMPANIES INC DATE OF NAME CHANGE: 19920703 10-Q 1 a2020form10qq12020.htm FORM 10-Q Document
false--12-31Q12020000076418000P1Y0600000010000005000000200000080000002000000100000010000004000000100000010000001000000200000016000000800000010000001000000200000012000000300000050000005000000150000009000000300000030000002210000000050000000010000002000000016000000900000000200000001000000011000000740000001200000000.800.840.33330.333328059613172805961317P5Y1.673.181.602.932246000000100000000042050000006000000110000002100000001100000080000002000000300000040000002000000500000010000002600000010000001000000170000001000000947979763947593259 0000764180 2020-01-01 2020-03-31 0000764180 mo:CommonStock2.200NotesDue2027Member 2020-01-01 2020-03-31 0000764180 mo:CommonStock3.125NotesDue2031Member 2020-01-01 2020-03-31 0000764180 mo:CommonStock1.700NotesDue2025Member 2020-01-01 2020-03-31 0000764180 mo:CommonStock0.3313ParValueMember 2020-01-01 2020-03-31 0000764180 mo:CommonStock1.000NotesDue2023Member 2020-01-01 2020-03-31 0000764180 2020-04-21 0000764180 2019-12-31 0000764180 2020-03-31 0000764180 2019-01-01 2019-03-31 0000764180 us-gaap:TreasuryStockMember 2019-03-31 0000764180 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0000764180 us-gaap:RetainedEarningsMember 2019-03-31 0000764180 us-gaap:TreasuryStockMember 2019-01-01 2019-03-31 0000764180 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0000764180 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0000764180 us-gaap:CommonStockMember 2019-03-31 0000764180 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0000764180 2018-12-31 0000764180 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000764180 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000764180 us-gaap:RetainedEarningsMember 2018-12-31 0000764180 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0000764180 2019-03-31 0000764180 us-gaap:NoncontrollingInterestMember 2018-12-31 0000764180 us-gaap:CommonStockMember 2018-12-31 0000764180 us-gaap:NoncontrollingInterestMember 2019-03-31 0000764180 us-gaap:TreasuryStockMember 2018-12-31 0000764180 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000764180 us-gaap:CommonStockMember 2019-12-31 0000764180 us-gaap:RetainedEarningsMember 2020-03-31 0000764180 us-gaap:CommonStockMember 2020-03-31 0000764180 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0000764180 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000764180 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0000764180 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0000764180 us-gaap:NoncontrollingInterestMember 2019-12-31 0000764180 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-03-31 0000764180 us-gaap:TreasuryStockMember 2020-01-01 2020-03-31 0000764180 us-gaap:RetainedEarningsMember 2019-12-31 0000764180 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0000764180 us-gaap:NoncontrollingInterestMember 2020-03-31 0000764180 us-gaap:TreasuryStockMember 2019-12-31 0000764180 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0000764180 us-gaap:TreasuryStockMember 2020-03-31 0000764180 mo:January2018ShareRepurchaseProgramMember 2019-01-01 2019-03-31 0000764180 mo:CronosGroupInc.Member 2019-03-31 0000764180 mo:July2019ShareRepurchaseProgramMember 2019-07-31 0000764180 mo:January2018ShareRepurchaseProgramMember 2018-01-01 2019-06-30 0000764180 mo:HelixInnovationsLLCMember 2019-07-01 2019-09-30 0000764180 mo:CronosGroupInc.Member 2020-03-31 0000764180 mo:JUULMember 2020-03-31 0000764180 mo:July2019ShareRepurchaseProgramMember us-gaap:SubsequentEventMember 2020-04-30 0000764180 mo:HelixInnovationsLLCMember 2020-03-31 0000764180 mo:January2018ShareRepurchaseProgramMember 2018-05-31 0000764180 mo:July2019ShareRepurchaseProgramMember 2020-01-01 2020-03-31 0000764180 mo:January2018ShareRepurchaseProgramMember 2018-01-31 0000764180 mo:ABInBevMember 2020-03-31 0000764180 us-gaap:OperatingSegmentsMember mo:SmokeableProductsSegmentMember 2020-01-01 2020-03-31 0000764180 us-gaap:OperatingSegmentsMember mo:WineSegmentMember 2019-01-01 2019-03-31 0000764180 us-gaap:OperatingSegmentsMember mo:WineSegmentMember 2020-01-01 2020-03-31 0000764180 us-gaap:OperatingSegmentsMember mo:SmokeableProductsSegmentMember 2019-01-01 2019-03-31 0000764180 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2019-01-01 2019-03-31 0000764180 us-gaap:CorporateNonSegmentMember 2020-01-01 2020-03-31 0000764180 us-gaap:OperatingSegmentsMember mo:OralTobaccoSegmentMember 2020-01-01 2020-03-31 0000764180 us-gaap:OperatingSegmentsMember mo:OralTobaccoSegmentMember 2019-01-01 2019-03-31 0000764180 us-gaap:CorporateNonSegmentMember 2019-01-01 2019-03-31 0000764180 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2020-01-01 2020-03-31 0000764180 mo:InventoryWriteOffMember mo:WineBusinessStrategicResetMember 2020-01-01 2020-03-31 0000764180 mo:WineBusinessStrategicResetMember 2020-01-01 2020-03-31 0000764180 us-gaap:PurchaseCommitmentMember mo:WineBusinessStrategicResetMember 2020-01-01 2020-03-31 0000764180 srt:ScenarioForecastMember mo:WineBusinessStrategicResetMember 2020-04-01 2020-12-31 0000764180 mo:ABInBevMember 2019-01-01 2019-03-31 0000764180 mo:ABInBevMember 2020-01-01 2020-03-31 0000764180 mo:CronosGroupInc.Member 2019-01-01 2019-03-31 0000764180 mo:CronosGroupInc.Member 2020-01-01 2020-03-31 0000764180 mo:CronosGroupInc.Member us-gaap:CommonStockMember 2019-12-31 0000764180 mo:CronosGroupInc.Member mo:EquityContractPreemptiveRIghtsMember 2019-12-31 0000764180 mo:ABInBevMember 2019-12-31 0000764180 mo:ABInBevMember us-gaap:FairValueInputsLevel1Member 2019-12-31 0000764180 mo:CronosGroupInc.Member mo:EquityContractWarrantMember 2019-12-31 0000764180 mo:ABInBevMember us-gaap:FairValueInputsLevel1Member 2020-03-31 0000764180 mo:CronosGroupInc.Member mo:EquityContractWarrantMember 2020-03-31 0000764180 mo:ABInBevMember 2019-01-01 2019-12-31 0000764180 mo:CronosGroupInc.Member us-gaap:CommonStockMember 2020-03-31 0000764180 mo:CronosGroupInc.Member mo:EquityContractPreemptiveRIghtsMember 2020-03-31 0000764180 mo:CronosGroupInc.Member 2019-12-31 0000764180 mo:JUULMember 2019-12-31 0000764180 mo:JUULMember 2020-01-28 0000764180 mo:JUULMember 2018-12-01 2018-12-31 0000764180 mo:JUULMember 2020-01-28 2020-01-28 0000764180 mo:JUULMember 2019-01-01 2019-12-31 0000764180 mo:CronosGroupInc.Member us-gaap:FairValueInputsLevel1Member 2020-03-31 0000764180 mo:CronosGroupInc.Member 2019-03-31 2019-03-31 0000764180 mo:CronosGroupInc.Member mo:EquityContractWarrantMember 2019-03-31 0000764180 mo:CronosGroupInc.Member mo:EquityContractWarrantMember 2020-01-01 2020-03-31 0000764180 mo:CronosGroupInc.Member us-gaap:FairValueInputsLevel1Member 2019-12-31 0000764180 mo:CronosGroupInc.Member mo:EquityContractPreemptiveRIghtsMember 2019-03-31 2019-03-31 0000764180 mo:CronosGroupInc.Member mo:EquityContractPreemptiveRIghtsMember 2020-01-01 2020-03-31 0000764180 mo:CronosGroupInc.Member mo:EquityContractPreemptiveRIghtsMember 2019-03-31 0000764180 mo:CronosGroupInc.Member mo:EquityContractWarrantMember 2019-03-31 2019-03-31 0000764180 mo:CronosGroupInc.Member 2019-01-01 2019-09-30 0000764180 mo:CronosGroupInc.Member us-gaap:CommonStockMember 2020-01-01 2020-03-31 0000764180 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-03-31 0000764180 mo:ForeignCurrencyDenominatedDebtMember 2019-12-31 0000764180 mo:CronosGroupInc.Member 2019-03-07 2019-03-07 0000764180 mo:ForeignCurrencyDenominatedDebtMember 2020-03-31 0000764180 us-gaap:ForwardContractsMember us-gaap:NondesignatedMember 2019-01-01 2019-03-31 0000764180 srt:MaximumMember mo:EquityContractPreemptiveRIghtsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2020-03-31 0000764180 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-12-31 0000764180 srt:MaximumMember mo:EquityContractPreemptiveRIghtsMember mo:MeasurementInputWeightedAverageExpectedTermMember 2020-03-31 0000764180 srt:MinimumMember mo:EquityContractPreemptiveRIghtsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2019-12-31 0000764180 srt:MaximumMember mo:EquityContractPreemptiveRIghtsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2019-12-31 0000764180 srt:MinimumMember mo:EquityContractPreemptiveRIghtsMember mo:MeasurementInputWeightedAverageExpectedTermMember 2020-03-31 0000764180 us-gaap:ForwardContractsMember us-gaap:NondesignatedMember 2019-03-07 0000764180 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2020-03-31 0000764180 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-12-31 0000764180 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-03-31 0000764180 srt:MinimumMember mo:EquityContractPreemptiveRIghtsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2020-03-31 0000764180 mo:EquityContractPreemptiveRIghtsMember us-gaap:MeasurementInputPriceVolatilityMember 2019-12-31 0000764180 mo:EquityContractPreemptiveRIghtsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2019-12-31 0000764180 mo:EquityContractWarrantMember us-gaap:MeasurementInputExpectedDividendRateMember 2019-12-31 0000764180 mo:EquityContractWarrantMember us-gaap:MeasurementInputExpectedDividendRateMember 2020-03-31 0000764180 mo:EquityContractWarrantMember us-gaap:MeasurementInputSharePriceMember 2019-12-31 0000764180 mo:EquityContractPreemptiveRIghtsMember us-gaap:MeasurementInputSharePriceMember 2019-12-31 0000764180 mo:EquityContractPreemptiveRIghtsMember us-gaap:MeasurementInputSharePriceMember 2020-03-31 0000764180 mo:EquityContractPreemptiveRIghtsMember us-gaap:MeasurementInputPriceVolatilityMember 2020-03-31 0000764180 mo:EquityContractWarrantMember us-gaap:MeasurementInputSharePriceMember 2020-03-31 0000764180 mo:EquityContractPreemptiveRIghtsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2020-03-31 0000764180 mo:EquityContractWarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2019-12-31 0000764180 mo:EquityContractWarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2020-03-31 0000764180 mo:EquityContractWarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2019-12-31 0000764180 mo:EquityContractPreemptiveRIghtsMember us-gaap:MeasurementInputExpectedDividendRateMember 2020-03-31 0000764180 mo:EquityContractPreemptiveRIghtsMember us-gaap:MeasurementInputExpectedDividendRateMember 2019-12-31 0000764180 mo:EquityContractWarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2020-03-31 0000764180 us-gaap:NetInvestmentHedgingMember 2019-01-01 2019-03-31 0000764180 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2020-01-01 2020-03-31 0000764180 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2019-01-01 2019-03-31 0000764180 us-gaap:NetInvestmentHedgingMember 2020-01-01 2020-03-31 0000764180 mo:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember 2020-01-01 2020-03-31 0000764180 mo:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember 2019-01-01 2019-03-31 0000764180 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel3Member 2020-03-31 0000764180 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel3Member 2020-01-01 2020-03-31 0000764180 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel3Member 2019-12-31 0000764180 mo:EquityContractPreemptiveRIghtsMember 2019-01-01 2019-03-31 0000764180 mo:EquityContractWarrantMember 2020-01-01 2020-03-31 0000764180 mo:EquityContractWarrantMember 2019-01-01 2019-03-31 0000764180 mo:EquityContractPreemptiveRIghtsMember 2020-01-01 2020-03-31 0000764180 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000764180 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000764180 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000764180 us-gaap:EquityContractMember us-gaap:NetInvestmentHedgingMember us-gaap:NondesignatedMember 2019-12-31 0000764180 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000764180 us-gaap:NetInvestmentHedgingMember 2019-12-31 0000764180 us-gaap:OtherAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000764180 mo:InvestmentsInEquitySecuritiesMember mo:EquityContractWarrantMember us-gaap:NetInvestmentHedgingMember us-gaap:NondesignatedMember 2020-03-31 0000764180 mo:OtherAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000764180 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000764180 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000764180 us-gaap:NetInvestmentHedgingMember 2020-03-31 0000764180 us-gaap:OtherAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000764180 mo:InvestmentsInEquitySecuritiesMember mo:EquityContractPreemptiveRIghtsMember us-gaap:NetInvestmentHedgingMember us-gaap:NondesignatedMember 2020-03-31 0000764180 mo:InvestmentsInEquitySecuritiesMember mo:EquityContractPreemptiveRIghtsMember us-gaap:NetInvestmentHedgingMember us-gaap:NondesignatedMember 2019-12-31 0000764180 us-gaap:EquityContractMember us-gaap:NetInvestmentHedgingMember us-gaap:NondesignatedMember 2020-03-31 0000764180 mo:InvestmentsInEquitySecuritiesMember mo:EquityContractWarrantMember us-gaap:NetInvestmentHedgingMember us-gaap:NondesignatedMember 2019-12-31 0000764180 mo:OtherAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000764180 mo:EquityContractWarrantMember us-gaap:MeasurementInputExpectedTermMember 2020-03-31 0000764180 mo:EquityContractPreemptiveRIghtsMember us-gaap:MeasurementInputExpectedTermMember 2020-03-31 0000764180 mo:EquityContractWarrantMember us-gaap:MeasurementInputExpectedTermMember 2019-12-31 0000764180 mo:EquityContractPreemptiveRIghtsMember us-gaap:MeasurementInputExpectedTermMember 2019-12-31 0000764180 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2019-12-31 0000764180 srt:MaximumMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-03-31 0000764180 us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-03-31 0000764180 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-01-01 2020-03-31 0000764180 srt:MaximumMember us-gaap:PensionPlansDefinedBenefitMember 2020-03-31 0000764180 us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-03-31 0000764180 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-01-01 2019-03-31 0000764180 mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember 2020-01-01 2020-03-31 0000764180 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-12-31 0000764180 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-03-31 0000764180 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-03-31 0000764180 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-03-31 0000764180 mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember 2020-03-31 0000764180 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0000764180 us-gaap:AccumulatedTranslationAdjustmentMember 2020-03-31 0000764180 mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember 2019-12-31 0000764180 mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember 2018-12-31 0000764180 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-03-31 0000764180 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-03-31 0000764180 mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember 2019-01-01 2019-03-31 0000764180 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0000764180 mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember 2019-03-31 0000764180 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-03-31 0000764180 us-gaap:AccumulatedTranslationAdjustmentMember 2019-03-31 0000764180 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-31 0000764180 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2019-01-01 2019-03-31 0000764180 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0000764180 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2020-01-01 2020-03-31 0000764180 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-03-31 0000764180 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2020-01-01 2020-03-31 0000764180 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0000764180 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-03-31 0000764180 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2019-01-01 2019-03-31 0000764180 us-gaap:MaterialReconcilingItemsMember 2020-01-01 2020-03-31 0000764180 mo:OralTobaccoSegmentMember 2020-01-01 2020-03-31 0000764180 mo:WineSegmentMember 2019-01-01 2019-03-31 0000764180 mo:OralTobaccoSegmentMember 2019-01-01 2019-03-31 0000764180 us-gaap:AllOtherSegmentsMember 2020-01-01 2020-03-31 0000764180 mo:SmokeableProductsSegmentMember 2020-01-01 2020-03-31 0000764180 mo:SmokeableProductsSegmentMember 2019-01-01 2019-03-31 0000764180 mo:WineSegmentMember 2020-01-01 2020-03-31 0000764180 us-gaap:MaterialReconcilingItemsMember 2019-01-01 2019-03-31 0000764180 us-gaap:AllOtherSegmentsMember 2019-01-01 2019-03-31 0000764180 mo:TobaccoandHealthLitigationCasesMember 2019-01-01 2019-03-31 0000764180 mo:PhilipMorrisUSAMember us-gaap:OperatingSegmentsMember mo:TobaccoandHealthLitigationCasesMember mo:SmokeableProductsSegmentMember 2019-01-01 2019-03-31 0000764180 mo:PhilipMorrisUSAMember us-gaap:OperatingSegmentsMember mo:TobaccoandHealthLitigationCasesMember mo:SmokeableProductsSegmentMember 2020-01-01 2020-03-31 0000764180 us-gaap:MaterialReconcilingItemsMember mo:TobaccoandHealthLitigationCasesMember 2019-01-01 2019-03-31 0000764180 us-gaap:MaterialReconcilingItemsMember mo:TobaccoandHealthLitigationCasesMember 2020-01-01 2020-03-31 0000764180 mo:TobaccoandHealthLitigationCasesMember 2020-01-01 2020-03-31 0000764180 us-gaap:RevolvingCreditFacilityMember mo:RevolvingCreditFacilityDueAugust2023Member us-gaap:LineOfCreditMember 2020-03-31 0000764180 us-gaap:RevolvingCreditFacilityMember mo:RevolvingCreditFacilityDueAugust2023Member us-gaap:LineOfCreditMember 2018-08-01 0000764180 us-gaap:RevolvingCreditFacilityMember mo:RevolvingCreditFacilityDueAugust2023Member us-gaap:LineOfCreditMember 2020-01-01 2020-03-31 0000764180 us-gaap:SeniorNotesMember 2020-01-01 2020-03-31 0000764180 us-gaap:RevolvingCreditFacilityMember mo:RevolvingCreditFacilityDueAugust2023Member us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2020-01-01 2020-03-31 0000764180 us-gaap:RevolvingCreditFacilityMember mo:RevolvingCreditFacilityDueAugust2023Member us-gaap:LineOfCreditMember 2020-01-01 2020-03-31 0000764180 mo:EvaporLitigationMember us-gaap:SubsequentEventMember 2020-04-27 0000764180 mo:OtherTabaccoRelatedCasesMember us-gaap:SubsequentEventMember 2020-04-27 0000764180 mo:OtherTabaccoRelatedCasesMember 2018-04-23 0000764180 mo:EvaporLitigationMember 2019-04-22 0000764180 mo:IndividualSmokingAndHealthCasesMember us-gaap:SubsequentEventMember 2020-04-27 0000764180 mo:HealthCareCostRecoveryActionsMember 2018-04-23 0000764180 mo:OtherTabaccoRelatedCasesMember 2019-04-22 0000764180 mo:HealthCareCostRecoveryActionsMember us-gaap:SubsequentEventMember 2020-04-27 0000764180 mo:HealthCareCostRecoveryActionsMember 2019-04-22 0000764180 mo:EvaporLitigationMember 2018-04-23 0000764180 mo:IndividualSmokingAndHealthCasesMember 2019-04-22 0000764180 mo:IndividualSmokingAndHealthCasesMember 2018-04-23 0000764180 mo:InterestExpenseRelatedToLitigationMember 2019-01-01 2019-03-31 0000764180 mo:TobaccoandHealthJudgmentMember mo:LitigationCasesResultsMember 2019-01-01 2019-03-31 0000764180 mo:TobaccoandHealthJudgmentMember mo:LitigationCasesResultsMember 2020-01-01 2020-03-31 0000764180 mo:InterestExpenseRelatedToLitigationMember 2020-01-01 2020-03-31 0000764180 mo:ETSSmokingandHealthCaseFlightAttendantsMember us-gaap:PendingLitigationMember us-gaap:SubsequentEventMember 2020-04-27 2020-04-27 0000764180 mo:PhilipMorrisUSAMember mo:NonEngleProgenyCasesMember stpr:OH us-gaap:SubsequentEventMember 1999-01-01 2020-04-27 0000764180 mo:PhilipMorrisUSAMember mo:HealthCareCostRecoveryActionsMember us-gaap:SettledLitigationMember 2020-01-01 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesReiderandBanksMember us-gaap:SubsequentEventMember 2020-04-27 2020-04-27 0000764180 mo:PhilipMorrisUSAMember mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:MI 1996-05-01 2020-03-31 0000764180 mo:LightsUltraLightsClassActionsMember us-gaap:SubsequentEventMember 2020-04-27 0000764180 mo:EngleProgenyCasesStateMember 2008-01-31 0000764180 mo:PhilipMorrisUSAMember mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:IL 1996-05-01 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:HealthCareCostRecoveryActions2008NPMAdjustmentMember 2020-01-01 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:HealthCareCostRecoveryActions2003NPMAdjustmentMember us-gaap:PendingLitigationMember 2013-09-01 2013-09-30 0000764180 mo:PhilipMorrisUSAMember mo:NonEngleProgenyCasesMember us-gaap:SubsequentEventMember 1999-01-01 2020-04-27 0000764180 mo:PhilipMorrisUSAMember mo:NonEngleProgenyCasesMember stpr:MS us-gaap:SubsequentEventMember 1999-01-01 2020-04-27 0000764180 mo:PhilipMorrisUSAMember mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:LA 1996-05-01 2020-03-31 0000764180 2019-10-01 2019-12-31 0000764180 mo:PhilipMorrisUSAMember mo:HealthCareCostRecoveryActions20032015NPMAdjustmentsMember us-gaap:SettledLitigationMember 2018-12-31 0000764180 mo:PhilipMorrisUSAMember mo:HealthCareCostRecoveryActionsMember 2019-01-01 2019-03-31 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesMember us-gaap:SubsequentEventMember 2020-04-27 0000764180 mo:PhilipMorrisUSAMember mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:AR 1996-05-01 2020-03-31 0000764180 mo:USTLitigationMember mo:PendingIndividualLawsuitsMember us-gaap:SubsequentEventMember 2020-04-27 0000764180 mo:EvaporLitigationMember mo:PendingIndividualLawsuitsMember us-gaap:SubsequentEventMember 2020-04-27 0000764180 mo:PhilipMorrisUSAMember mo:NonEngleProgenyCasesMember stpr:TN us-gaap:SubsequentEventMember 1999-01-01 2020-04-27 0000764180 mo:PhilipMorrisUSAMember mo:HealthCareCostRecoveryActions2019NPMAdjustmentsMember 2020-01-01 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:HealthCareCostRecoveryActions20042017Member us-gaap:SettledLitigationMember 2018-04-01 2018-04-30 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesWeingartandHancockMember us-gaap:SubsequentEventMember 2020-04-27 2020-04-27 0000764180 mo:PhilipMorrisUSAMember mo:HealthCareCostRecoveryActionsMember 2020-01-01 2020-03-31 0000764180 mo:CanadianTobaccoManufacturersMember mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember country:CA 2019-03-31 0000764180 mo:IndividualSmokingAndHealthCasesMember stpr:MA us-gaap:PendingLitigationMember us-gaap:SubsequentEventMember 2020-04-27 0000764180 mo:PhilipMorrisUSAMember mo:HealthCareCostRecoveryActions2003NPMAdjustmentMember mo:MarylandMissouriNewMexicoandPennsylvaniaMember us-gaap:PendingLitigationMember 2013-09-01 2013-09-30 0000764180 mo:PhilipMorrisUSAMember mo:NonEngleProgenyCasesMember stpr:NH us-gaap:SubsequentEventMember 1999-01-01 2020-04-27 0000764180 mo:PhilipMorrisUSAMember mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:CA 1996-05-01 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:NonEngleProgenyCasesMember stpr:CT us-gaap:SubsequentEventMember 1999-01-01 2020-04-27 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesM.BrownMember 2018-04-01 2018-06-30 0000764180 mo:HealthCareCostRecoveryActionsMember 1998-11-01 1998-11-30 0000764180 mo:PhilipMorrisUSAMember us-gaap:AssetsMember us-gaap:PendingLitigationMember 2020-03-31 0000764180 us-gaap:SubsequentEventMember 2020-04-30 0000764180 mo:PhilipMorrisUSAMember mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:PA 1996-05-01 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:WI 1996-05-01 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:NonEngleProgenyCasesMember stpr:NY us-gaap:SubsequentEventMember 1999-01-01 2020-04-27 0000764180 mo:PhilipMorrisUSAandAltriaGroupMember mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember mo:BritishColumbiaSaskatchewanMember us-gaap:SubsequentEventMember 2020-04-27 0000764180 mo:PhilipMorrisUSAMember mo:HealthCareCostRecoveryActionsMember country:CA us-gaap:SubsequentEventMember 2020-04-27 0000764180 mo:PhilipMorrisUSAMember mo:HealthCareCostRecoveryActions2014NPMAdjustmentMember 2020-01-01 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:NonEngleProgenyCasesMember stpr:MA us-gaap:SubsequentEventMember 1999-01-01 2020-04-27 0000764180 mo:EvaporLitigationMember mo:PendingLawsuitsFiledByStateOrLocalGovernmentsMember us-gaap:SubsequentEventMember 2020-04-27 0000764180 mo:NonEngleProgenySmokingandHealthCaseGentileMember 2017-10-31 0000764180 mo:PhilipMorrisUSAandAltriaGroupMember mo:HealthCareCostRecoveryActionsMember country:CA us-gaap:SubsequentEventMember 2020-04-27 0000764180 us-gaap:LetterOfCreditMember 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:HealthCareCostRecoveryActions2007NPMAdjustmentMember 2020-01-01 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:HealthCareCostRecoveryActions2009NPMAdjustmentMember 2020-01-01 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:NonEngleProgenyCasesMember stpr:WV us-gaap:SubsequentEventMember 1999-01-01 2020-04-27 0000764180 mo:PhilipMorrisUSAMember mo:HealthCareCostRecoveryActions2005NPMAdjustmentMember 2020-01-01 2020-03-31 0000764180 mo:HealthCareCostRecoveryActionsMember 1998-11-30 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesStateMember us-gaap:SubsequentEventMember 2020-04-27 2020-04-27 0000764180 mo:PhilipMorrisUSAMember mo:HealthCareCostRecoveryActions20042017Member us-gaap:SettledLitigationMember 2018-01-01 2018-12-31 0000764180 mo:PhilipMorrisUSAMember mo:NonEngleProgenyCasesMember stpr:RI us-gaap:SubsequentEventMember 1999-01-01 2020-04-27 0000764180 mo:TobaccoandHealthJudgmentMember mo:PreTrialResolutionMember 2020-01-01 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:HealthCareCostRecoveryActions2004NPMAdjustmentMember 2020-01-01 2020-03-31 0000764180 mo:EngleProgenyCasesMember 2004-10-01 2020-03-31 0000764180 mo:FederalGovernmentsLawsuitMember mo:ImplementationofCorrectiveCommunicationsMember 2014-01-01 2014-12-31 0000764180 mo:PhilipMorrisUSAMember mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:SC 1996-05-01 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:NonEngleProgenySmokingandHealthCaseGentileMember 2017-10-31 0000764180 mo:PhilipMorrisUSAMember mo:HealthCareCostRecoveryActions20042017Member us-gaap:SettledLitigationMember 2020-01-01 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesFreemanMember us-gaap:SubsequentEventMember 2020-04-27 2020-04-27 0000764180 mo:PhilipMorrisUSAMember mo:NonEngleProgenyCasesMember stpr:CA us-gaap:SubsequentEventMember 1999-01-01 2020-04-27 0000764180 mo:PhilipMorrisUSAMember mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:KS 1996-05-01 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:HealthCareCostRecoveryActions20042017Member us-gaap:SettledLitigationMember us-gaap:SubsequentEventMember 2020-04-01 2020-04-30 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesMember us-gaap:SubsequentEventMember 2020-04-27 2020-04-27 0000764180 mo:PhilipMorrisUSAMember mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:OK 1996-05-01 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:HealthCareCostRecoveryActions2010NPMAdjustmentMember 2020-01-01 2020-03-31 0000764180 mo:EngleProgenyCasesStateMember us-gaap:SubsequentEventMember 2020-04-27 2020-04-27 0000764180 mo:PhilipMorrisUSAMember mo:HealthCareCostRecoveryActions2017NPMAdjustmentsMember 2020-01-01 2020-03-31 0000764180 mo:PreTrialResolutionMember 2020-01-01 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:OtherDisputesUndertheStateSettlementAgreementsMember 2018-08-01 2018-08-31 0000764180 mo:PhilipMorrisUSAMember mo:HealthCareCostRecoveryActions2006NPMAdjustmentMember 2020-01-01 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember 2020-01-01 2020-03-31 0000764180 mo:HealthCareCostRecoveryActionsMember 2020-01-01 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:HealthCareCostRecoveryActions20042017Member us-gaap:SettledLitigationMember 2019-04-01 2019-04-30 0000764180 mo:TobaccoandHealthJudgmentMember 2004-10-01 2020-03-31 0000764180 mo:PhilipMorrisUSAMember 2020-01-01 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:OR 1996-05-01 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:IndividualSmokingAndHealthCasesMember us-gaap:SubsequentEventMember 2020-04-27 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesNaugleMember 2020-01-01 2020-03-31 0000764180 mo:TobaccoandHealthJudgmentMember mo:PreTrialResolutionMember 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:HealthCareCostRecoveryActionsTransitionYears20042017Member stpr:NY us-gaap:SettledLitigationMember 2020-01-01 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesGlogerRintoulandDuignamMember us-gaap:SubsequentEventMember 2020-04-27 2020-04-27 0000764180 mo:PhilipMorrisUSAMember mo:NonEngleProgenyCasesMember stpr:NJ us-gaap:SubsequentEventMember 1999-01-01 2020-04-27 0000764180 mo:HealthCareCostRecoveryActionsMember 2019-01-01 2019-03-31 0000764180 mo:PhilipMorrisUSAMember mo:HealthCareCostRecoveryActions20032015NPMAdjustmentsMember us-gaap:SettledLitigationMember 2017-10-01 2017-10-31 0000764180 mo:PhilipMorrisUSAandAltriaGroupMember mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember country:CA us-gaap:SubsequentEventMember 2020-04-27 0000764180 mo:NonEngleProgenySmokingandHealthCaseLaramieMember 2019-08-31 0000764180 mo:EngleProgenyCasesStateMember us-gaap:SubsequentEventMember 2020-04-27 0000764180 mo:PhilipMorrisUSAMember mo:HealthCareCostRecoveryActions2013NPMAdjustmentMember 2020-01-01 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember 1996-05-01 2020-03-31 0000764180 mo:FederalGovernmentsLawsuitMember 2006-08-01 2006-08-31 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesFederalMember us-gaap:SubsequentEventMember 2020-04-27 0000764180 mo:EngleProgenyCasesStateMember stpr:FL 2009-06-30 0000764180 mo:NonEngleProgenySmokingAndHealthCasePrincipeMember 2020-02-29 0000764180 mo:PhilipMorrisUSAMember mo:NonEngleProgenyCasesMember stpr:LA us-gaap:SubsequentEventMember 1999-01-01 2020-04-27 0000764180 mo:PhilipMorrisUSAMember mo:HealthCareCostRecoveryActionsMember 2017-01-01 2017-12-31 0000764180 mo:PhilipMorrisUSAMember mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:TX 1996-05-01 2020-03-31 0000764180 mo:EngleProgenyCasesMember 2000-07-31 0000764180 mo:IndividualSmokingAndHealthCasesMember stpr:FL us-gaap:PendingLitigationMember us-gaap:SubsequentEventMember 2020-04-27 0000764180 mo:PhilipMorrisUSAMember mo:HealthCareCostRecoveryActions2018NPMAdjustmentsMember 2020-01-01 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:DC 1996-05-01 2020-03-31 0000764180 mo:HealthCareCostRecoveryActionsMember country:CA us-gaap:ThreatenedLitigationMember 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:HealthCareCostRecoveryActions2015NPMAdjustmentsMember 2020-01-01 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:NV 1996-05-01 2020-03-31 0000764180 mo:EvaporLitigationMember mo:PendingLawsuitFiledBySchoolDistrictMember us-gaap:SubsequentEventMember 2020-04-27 0000764180 mo:ETSSmokingandHealthCaseFlightAttendantsMember us-gaap:PendingLitigationMember 2018-03-01 2018-03-31 0000764180 mo:PhilipMorrisUSAMember mo:HealthCareCostRecoveryActionsMember 2018-01-01 2018-12-31 0000764180 mo:LightsMember us-gaap:SubsequentEventMember 2020-04-27 0000764180 mo:PhilipMorrisUSAMember mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:NY 1996-05-01 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesGoreMember 2020-01-01 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:LightsMember us-gaap:SubsequentEventMember 2020-04-27 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesMember 2006-07-01 2006-07-31 0000764180 mo:PhilipMorrisUSAMember mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:NJ 1996-05-01 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:NonEngleProgenyCasesMember stpr:PA us-gaap:SubsequentEventMember 1999-01-01 2020-04-27 0000764180 mo:PhilipMorrisUSAMember mo:NonEngleProgenyCasesMember stpr:AK us-gaap:SubsequentEventMember 1999-01-01 2020-04-27 0000764180 mo:PhilipMorrisUSAMember mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:DE 1996-05-01 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:NonEngleProgenyCasesMember stpr:MO us-gaap:SubsequentEventMember 1999-01-01 2020-04-27 0000764180 mo:PhilipMorrisUSAMember mo:NonEngleProgenyCasesMember stpr:FL us-gaap:SubsequentEventMember 1999-01-01 2020-04-27 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesJordanMember 2018-04-01 2018-06-30 0000764180 mo:NonEngleProgenySmokingandHealthCaseGreeneMember 2019-09-30 0000764180 mo:PhilipMorrisUSAMember mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:OH 1996-05-01 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:MN 1996-05-01 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesPearsonDCohenCollarChaconMemberMember us-gaap:SubsequentEventMember 2020-04-27 2020-04-27 0000764180 mo:PreTrialResolutionMember 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember country:PR 1996-05-01 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesMember 2000-07-31 0000764180 mo:PhilipMorrisUSAMember mo:HealthCareCostRecoveryActions2011NPMAdjustmentMember 2020-01-01 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:HealthCareCostRecoveryActions2003NPMAdjustmentMember us-gaap:CostOfSalesMember us-gaap:PendingLitigationMember 2013-09-01 2013-09-30 0000764180 mo:PhilipMorrisUSAMember mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:IA 1996-05-01 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:HealthCareCostRecoveryActions2012NPMAdjustmentMember 2020-01-01 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesPollariMember us-gaap:SubsequentEventMember 2020-04-27 2020-04-27 0000764180 mo:PhilipMorrisUSAMember mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:FL 1996-05-01 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:HealthCareCostRecoveryActions20042017Member us-gaap:SettledLitigationMember 2018-01-01 2018-03-31 0000764180 mo:FederalGovernmentsLawsuitMember mo:ImplementationofCorrectiveCommunicationsMember 2019-10-01 2019-12-31 0000764180 mo:PhilipMorrisUSAMember mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:MD 1996-05-01 2020-03-31 0000764180 mo:CanadianTobaccoManufacturersMember mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember country:CA 2019-03-01 2019-03-31 0000764180 mo:CreditAgreementMember us-gaap:RevolvingCreditFacilityMember 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:HealthCareCostRecoveryActions2003NPMAdjustmentMember us-gaap:SettledLitigationMember 2013-09-01 2013-09-30 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesJordanMember us-gaap:SettledLitigationMember 2018-04-01 2018-06-30 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesWallaceMember us-gaap:SettledLitigationMember 2019-04-01 2019-06-30 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesJ.BrownMember us-gaap:SettledLitigationMember 2019-01-01 2019-03-31 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesM.BrownMember us-gaap:SettledLitigationMember 2018-04-01 2018-06-30 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesDanielsonMember us-gaap:SettledLitigationMember 2019-01-01 2019-03-31 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesS.MartinMember us-gaap:SettledLitigationMember 2019-01-01 2019-03-31 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesPardueMember us-gaap:SettledLitigationMember 2018-04-01 2018-09-30 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesZingaroMember us-gaap:SettledLitigationMember 2019-07-01 2019-09-30 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesBoatrightMember us-gaap:SettledLitigationMember 2018-04-01 2018-06-30 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesBryantMember us-gaap:SettledLitigationMember 2019-04-01 2019-06-30 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesTheisMember us-gaap:SettledLitigationMember 2020-01-01 2020-03-31 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesSearcyMember us-gaap:SettledLitigationMember 2018-07-01 2018-09-30 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesAlvarezdelRealMember us-gaap:SettledLitigationMember 2019-10-01 2019-12-31 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesL.MartinMember us-gaap:SettledLitigationMember 2019-01-01 2019-03-31 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesMcKeeverMember us-gaap:SettledLitigationMember 2017-10-01 2017-12-31 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesRintoulMember us-gaap:PendingLitigationMember 2019-11-30 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesD.BrownMember us-gaap:PendingLitigationMember 2015-01-31 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesLandiMember us-gaap:PendingLitigationMember 2018-06-30 0000764180 mo:EngleProgenyCasesKerrivanMember us-gaap:PendingLitigationMember 2014-10-31 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesChadwellMember us-gaap:PendingLitigationMember 2018-09-30 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesCuddiheeMember us-gaap:PendingLitigationMember 2020-01-31 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesNeffMember us-gaap:PendingLitigationMember 2019-03-31 0000764180 mo:EngleProgenyCasesMcCallMember us-gaap:PendingLitigationMember 2019-03-31 0000764180 mo:EngleProgenyCasesHollimanMember us-gaap:PendingLitigationMember 2019-02-28 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesSantoroMember us-gaap:PendingLitigationMember 2017-03-31 0000764180 mo:EngleProgenyCasesHarrisMember us-gaap:PendingLitigationMember 2014-07-31 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesFrogelMember us-gaap:PendingLitigationMember 2019-03-31 0000764180 mo:EngleProgenyCasesCooperMember us-gaap:PendingLitigationMember 2015-09-30 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesHarrisMember us-gaap:PendingLitigationMember 2014-07-31 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesKerrivanMember us-gaap:PendingLitigationMember 2014-10-31 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesDuignanMember us-gaap:PendingLitigationMember 2020-02-29 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesR.DouglasMember us-gaap:PendingLitigationMember 2017-11-30 0000764180 mo:EngleProgenyCasesSommersMember us-gaap:PendingLitigationMember 2017-04-30 0000764180 mo:EngleProgenyCasesLandiMember us-gaap:PendingLitigationMember 2018-06-30 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesMahfuzMember us-gaap:PendingLitigationMember 2019-02-28 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesMcCallMember us-gaap:PendingLitigationMember 2019-03-31 0000764180 mo:EngleProgenyCasesSantoroMember us-gaap:PendingLitigationMember 2017-03-31 0000764180 mo:EngleProgenyCasesChadwellMember us-gaap:PendingLitigationMember 2018-09-30 0000764180 mo:EngleProgenyCasesGlogerMember us-gaap:PendingLitigationMember 2019-11-30 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesHollimanMember us-gaap:PendingLitigationMember 2019-02-28 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesKaplanMember us-gaap:PendingLitigationMember 2018-07-31 0000764180 mo:EngleProgenyCasesDuignanMember us-gaap:PendingLitigationMember 2020-02-29 0000764180 mo:EngleProgenyCasesR.DouglasMember us-gaap:PendingLitigationMember 2017-11-30 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesCooperMember us-gaap:PendingLitigationMember 2015-09-30 0000764180 mo:EngleProgenyCasesRintoulMember us-gaap:PendingLitigationMember 2019-11-30 0000764180 mo:EngleProgenyCasesFrogelMember us-gaap:PendingLitigationMember 2019-03-31 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesGlogerMember us-gaap:PendingLitigationMember 2019-11-30 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesSommersMember us-gaap:PendingLitigationMember 2017-04-30 0000764180 mo:EngleProgenyCasesCuddiheeMember us-gaap:PendingLitigationMember 2020-01-31 0000764180 mo:PhilipMorrisUSAMember mo:EngleProgenyCasesBergerMember us-gaap:PendingLitigationMember 2014-09-30 0000764180 mo:EngleProgenyCasesBergerMember us-gaap:PendingLitigationMember 2014-09-30 0000764180 mo:EngleProgenyCasesBergerMember us-gaap:PendingLitigationMember 2018-10-01 2018-12-31 0000764180 srt:GuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2019-12-31 0000764180 srt:ParentCompanyMember srt:ReportableLegalEntitiesMember 2019-12-31 0000764180 srt:ConsolidationEliminationsMember 2019-12-31 0000764180 srt:NonGuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2019-12-31 0000764180 srt:NonGuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2020-03-31 0000764180 srt:ConsolidationEliminationsMember 2020-03-31 0000764180 srt:GuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2020-03-31 0000764180 srt:ParentCompanyMember srt:ReportableLegalEntitiesMember 2020-03-31 0000764180 srt:ParentCompanyMember srt:ReportableLegalEntitiesMember 2019-01-01 2019-03-31 0000764180 srt:ConsolidationEliminationsMember 2019-01-01 2019-03-31 0000764180 srt:GuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2019-01-01 2019-03-31 0000764180 srt:NonGuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2019-01-01 2019-03-31 0000764180 srt:ParentCompanyMember srt:ReportableLegalEntitiesMember 2020-01-01 2020-03-31 0000764180 srt:NonGuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2020-01-01 2020-03-31 0000764180 srt:GuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2020-01-01 2020-03-31 0000764180 srt:ConsolidationEliminationsMember 2020-01-01 2020-03-31 0000764180 srt:GuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2018-12-31 0000764180 srt:NonGuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2018-12-31 0000764180 srt:ConsolidationEliminationsMember 2019-03-31 0000764180 srt:NonGuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2019-03-31 0000764180 srt:ConsolidationEliminationsMember 2018-12-31 0000764180 srt:ParentCompanyMember srt:ReportableLegalEntitiesMember 2018-12-31 0000764180 srt:GuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2019-03-31 0000764180 srt:ParentCompanyMember srt:ReportableLegalEntitiesMember 2019-03-31 mo:case mo:year iso4217:USD mo:director iso4217:CAD xbrli:shares iso4217:CAD mo:state mo:Extension mo:board_member iso4217:EUR xbrli:shares iso4217:USD xbrli:shares xbrli:shares mo:lawsuit xbrli:pure mo:ruling mo:settlement_development mo:manufacture mo:claim mo:shareholder mo:court mo:plantiff
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2020
OR
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                     to                    
Commission File Number 1-08940
Altria Group, Inc.
(Exact name of registrant as specified in its charter)
Virginia
 
 
13-3260245
 
(State or other jurisdiction of incorporation or organization)
 
 
(I.R.S. Employer
Identification No.)
 
 
 
 
6601 West Broad Street,
Richmond,
Virginia
23230
 
(Address of principal executive offices)
 
 
(Zip Code)
 
Registrant’s telephone number, including area code (804) 274-2200 
 Former name, former address and former fiscal year, if changed since last report
Securities registered pursuant to Section 12(b) of the Act:
               Title of each class               
Trading Symbols
Name of each exchange on which registered
Common Stock, $0.33 1/3 par value
MO
New York Stock Exchange
1.000% Notes due 2023
MO23A
New York Stock Exchange
1.700% Notes due 2025
MO25
New York Stock Exchange
2.200% Notes due 2027
MO27
New York Stock Exchange
3.125% Notes due 2031
MO31
New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes   þ     No   ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).     Yes   þ    No  ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
 
þ
 
Accelerated filer
 
☐
Non-accelerated filer
 
☐
  
Smaller reporting company
  
☐
 
 
 
 
Emerging growth company
  
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).     Yes  ☐  No   þ
At April 21, 2020, there were 1,858,368,058 shares outstanding of the registrant’s common stock, par value $0.33 1/3 per share.




ALTRIA GROUP, INC.
TABLE OF CONTENTS
 
 
 
 
 
 
 
  
 
  
Page No.
PART I -
  
FINANCIAL INFORMATION
  
 
 
 
 
 
Item 1.
  
Financial Statements (Unaudited)
  
 
 
 
 
 
 
  
  
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
  
  
 
 
 
 
 
 
  
  
 
 
 
 
Item 2.
  
  
 
 
 
 
 
Item 3.
  
  
 
 
 
 
Item 4.
  
  
 
 
 
 
PART II -
  
OTHER INFORMATION
  
 
 
 
 
 
Item 1.
  
  
 
 
 
 
Item 1A.
  
  
 
 
 
 
Item 2.
  
  
 
 
 
 
 
Item 6.
  
  
 
 
 
 
Signature
  
  


2

PART I - FINANCIAL INFORMATION
Item 1. Financial Statements.
Altria Group, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(in millions of dollars)
(Unaudited)
 
 
 
March 31, 2020
 
December 31, 2019
Assets
 
 
 
 
Cash and cash equivalents
 
$
5,616

 
$
2,117

Receivables
 
147

 
152

Inventories:
 

 

Leaf tobacco
 
895

 
874

Other raw materials
 
193

 
192

Work in process
 
467

 
696

Finished product
 
451

 
531

 
 
2,006

 
2,293

Other current assets
 
166

 
262

Total current assets
 
7,935

 
4,824

Property, plant and equipment, at cost
 
5,103

 
5,074

Less accumulated depreciation
 
3,106

 
3,075

 
 
1,997

 
1,999

Goodwill
 
5,177

 
5,177

Other intangible assets, net
 
12,668

 
12,687

Investments in equity securities
 
23,861

 
23,581

Other assets
 
980

 
1,003

Total Assets
 
$
52,618

 
$
49,271

 
See notes to condensed consolidated financial statements.

3

Altria Group, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets (Continued)
(in millions of dollars, except share and per share data)
(Unaudited)
 
 
 
March 31, 2020
 
December 31, 2019
Liabilities
 
 
 
 
Short-term borrowings
 
$
3,000

 
$
—

Current portion of long-term debt
 
—

 
1,000

Accounts payable
 
278

 
325

Accrued liabilities:
 
 
 
 
Marketing
 
467

 
393

Settlement charges
 
4,419

 
3,346

Other
 
1,032

 
1,533

Income taxes
 
393

 
12

Dividends payable
 
1,565

 
1,565

Total current liabilities
 
11,154

 
8,174

Long-term debt
 
26,971

 
27,042

Deferred income taxes
 
5,191

 
5,083

Accrued pension costs
 
427

 
473

Accrued postretirement health care costs
 
1,798

 
1,797

Other liabilities
 
402

 
345

Total liabilities
 
45,943

 
42,914

Contingencies (Note 11)
 

 

Redeemable noncontrolling interest
 
38

 
38

Stockholders’ Equity
 
 
 
 
Common stock, par value $0.33 1/3 per share
(2,805,961,317 shares issued)
 
935

 
935

Additional paid-in capital
 
5,959

 
5,970

Earnings reinvested in the business
 
36,528

 
36,539

Accumulated other comprehensive losses
 
(2,533
)
 
(2,864
)
Cost of repurchased stock
(947,593,259 shares at March 31, 2020 and
947,979,763 shares at December 31, 2019)
 
(34,346
)
 
(34,358
)
Total stockholders’ equity attributable to Altria
 
6,543

 
6,222

Noncontrolling interests
 
94

 
97

Total stockholders’ equity
 
6,637

 
6,319

Total Liabilities and Stockholders’ Equity
 
$
52,618

 
$
49,271

See notes to condensed consolidated financial statements.


4

Altria Group, Inc. and Subsidiaries
Condensed Consolidated Statements of Earnings
(in millions of dollars, except per share data)
(Unaudited)
 
 
 
For the Three Months Ended March 31,
 
 
2020
 
2019
Net revenues
 
$
6,359

 
$
5,628

Cost of sales
 
2,173

 
1,578

Excise taxes on products
 
1,313

 
1,239

Gross profit
 
2,873

 
2,811

Marketing, administration and research costs
 
537

 
533

Asset impairment and exit costs
 
—

 
40

Operating income
 
2,336

 
2,238

Interest and other debt expense, net
 
275

 
384

Net periodic benefit income, excluding service cost
 
(27
)
 
(1
)
Earnings from equity investments
 
(157
)
 
(86
)
Loss on Cronos-related financial instruments
 
137

 
425

Earnings before income taxes
 
2,108

 
1,516

Provision for income taxes
 
558

 
395

Net earnings
 
1,550

 
1,121

Net (earnings) losses attributable to noncontrolling interests
 
2

 
(1
)
Net earnings attributable to Altria
 
$
1,552

 
$
1,120

Per share data:
 
 
 
 
Basic and diluted earnings per share attributable to Altria
 
$
0.83

 
$
0.60

See notes to condensed consolidated financial statements.


5

Altria Group, Inc. and Subsidiaries
Condensed Consolidated Statements of Comprehensive Earnings
(in millions of dollars)
(Unaudited)

 
 
For the Three Months Ended March 31,
 
 
2020
 
2019
Net earnings
 
$
1,550

 
$
1,121

Other comprehensive earnings (losses), net of deferred income taxes:
 
 
 
 
Benefit plans
 
21

 
29

ABI
 
298

 
(199
)
Currency translation adjustments and other
 
12

 
—

Other comprehensive earnings (losses), net of deferred
income taxes
 
331

 
(170
)
 
 
 
 
 
Comprehensive earnings
 
1,881

 
951

Comprehensive (earnings) losses attributable to noncontrolling interests
 
2

 
(1
)
Comprehensive earnings attributable to Altria
 
$
1,883

 
$
950

See notes to condensed consolidated financial statements.

6

Altria Group, Inc. and Subsidiaries
Condensed Consolidated Statements of Stockholders’ Equity
for the Three Months Ended March 31, 2020 and 2019
(in millions of dollars, except per share data)
(Unaudited)
 

 
 
Attributable to Altria
 
 
 
 
 
 
Common
Stock
 
Additional
Paid-in
Capital
 
Earnings
Reinvested
in the
Business
 
Accumulated
Other
Comprehensive
Losses
 
Cost of
Repurchased
Stock
 
Non-controlling
Interests
 
Total
Stockholders’
Equity
Balances, December 31, 2019
 
$
935

 
$
5,970

 
$
36,539

 
$
(2,864
)
 
$
(34,358
)
 
$
97

 
$
6,319

Net earnings (1)
 
—

 
—

 
1,552

 
—

 
—

 
(3
)
 
1,549

Other comprehensive earnings (losses), net of deferred income taxes
 
—

 
—

 
—

 
331

 
—

 
—

 
331

Stock award activity
 
—

 
(11
)
 
—

 
—

 
12

 
—

 
1

Cash dividends declared ($0.84 per share)
 
—

 
—

 
(1,563
)
 
—

 
—

 
—

 
(1,563
)
Balances, March 31, 2020
 
$
935

 
$
5,959

 
$
36,528

 
$
(2,533
)
 
$
(34,346
)
 
$
94

 
$
6,637


 
 
Attributable to Altria
 
 
 
 
 
 
Common
Stock
 
Additional
Paid-in
Capital
 
Earnings
Reinvested
in the
Business
 
Accumulated
Other
Comprehensive
Losses
 
Cost of
Repurchased
Stock
 
Non-controlling
Interests
 
Total
Stockholders’
Equity
Balances, December 31, 2018
 
$
935

 
$
5,961

 
$
43,962

 
$
(2,547
)
 
$
(33,524
)
 
$
2

 
$
14,789

Net earnings (1)
 
—

 
—

 
1,120

 
—

 
—

 
—

 
1,120

Other comprehensive earnings (losses), net of deferred income taxes
 
—

 
—

 
—

 
(170
)
 
—

 
—

 
(170
)
Stock award activity
 
—

 
(18
)
 
—

 
—

 
11

 
—

 
(7
)
Cash dividends declared ($0.80 per share)
 
—

 
—

 
(1,500
)
 
—

 
—

 
—

 
(1,500
)
Repurchases of common stock
 
—

 
—

 
—

 
—

 
(151
)
 
—

 
(151
)
Balances, March 31, 2019
 
$
935

 
$
5,943

 
$
43,582

 
$
(2,717
)
 
$
(33,664
)
 
$
2

 
$
14,081


(1)
Amounts attributable to noncontrolling interests for the three months ended March 31, 2020 and 2019 exclude net earnings of $1 million due to the redeemable noncontrolling interest related to Stag’s Leap Wine Cellars, which is reported in the mezzanine equity section on the condensed consolidated balance sheets.

See notes to condensed consolidated financial statements.



7

Altria Group, Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows
(in millions of dollars)
(Unaudited)

 
 
For the Three Months Ended
March 31,
 
 
2020
 
2019
Cash Provided by (Used in) Operating Activities
 
 
 
 
Net earnings
 
$
1,550

 
$
1,121

Adjustments to reconcile net earnings to operating cash flows:
 
 
 
 
Depreciation and amortization
 
65

 
53

Deferred income tax provision (benefit)
 
26

 
(72
)
Earnings from equity investments
 
(157
)
 
(86
)
Loss on Cronos-related financial instruments
 
137

 
425

Asset impairment and exit costs, net of cash paid
 
(23
)
 
17

Cash effects of changes:
 
 
 
 
Receivables
 
5

 
(16
)
Inventories
 
(5
)
 
(25
)
Accounts payable
 
(45
)
 
(189
)
Income taxes
 
495

 
471

Accrued liabilities and other current assets
 
(421
)
 
(513
)
Accrued settlement charges
 
1,073

 
913

Pension plan contributions
 
(4
)
 
(3
)
Pension provisions and postretirement, net
 
(20
)
 
(8
)
Other, net
 
453

 
201

Net cash provided by (used in) operating activities
 
3,129

 
2,289

Cash Provided by (Used in) Investing Activities
 
 
 
 
Capital expenditures
 
(52
)
 
(38
)
Investment in Cronos
 
—

 
(1,831
)
Other, net
 
—

 
(81
)
Net cash provided by (used in) investing activities
 
$
(52
)
 
$
(1,950
)

See notes to condensed consolidated financial statements.


8

Altria Group, Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows (Continued)
(in millions of dollars)
(Unaudited)

 
 
For the Three Months Ended
March 31,
 
 
2020
 
2019
Cash Provided by (Used in) Financing Activities
 
 
 
 
Proceeds from short-term borrowings
 
$
3,000

 
$
—

Repayment of short-term borrowings
 
—

 
(12,800
)
Long-term debt issued
 
—

 
16,265

Long-term debt repaid
 
(1,000
)
 
—

Repurchases of common stock
 
—

 
(151
)
Dividends paid on common stock
 
(1,563
)
 
(1,502
)
Other, net
 
(10
)
 
(129
)
Net cash provided by (used in) financing activities
 
427

 
1,683

Cash, cash equivalents and restricted cash:
 
 
 
 
Increase (decrease)
 
3,504

 
2,022

Balance at beginning of period
 
2,160

 
1,433

Balance at end of period
 
$
5,664

 
$
3,455

 
 
 
 
 
The following table provides a reconciliation of cash, cash equivalents and restricted cash to the amounts reported on Altria’s condensed consolidated balance sheets:
 
 
At March 31, 2020
 
At December 31, 2019
Cash and cash equivalents
 
$
5,616

 
$
2,117

Restricted cash included in other current assets (1)
 
3

 
—

Restricted cash included in other assets (1)
 
45

 
43

Cash, cash equivalents and restricted cash
 
$
5,664

 
$
2,160

(1)
Restricted cash consisted of cash deposits collateralizing appeal bonds posted by PM USA to obtain stays of judgments pending appeals. See Note 11. Contingencies.

See notes to condensed consolidated financial statements.

9


Altria Group, Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)

Note 1. Background and Basis of Presentation:

Background

When used in these notes, the term "Altria” refers to Altria Group, Inc. and its subsidiaries, unless otherwise specified or unless otherwise required.

At March 31, 2020, Altria Group, Inc.’s wholly-owned subsidiaries included Philip Morris USA Inc. (“PM USA”), which is engaged in the manufacture and sale of cigarettes in the United States; John Middleton Co. (“Middleton”), which is engaged in the manufacture and sale of machine-made large cigars and pipe tobacco and is a wholly-owned subsidiary of PM USA; Sherman Group Holdings, LLC and its subsidiaries (“Nat Sherman”), which are engaged in the manufacture and sale of super premium cigarettes and the sale of premium cigars; UST LLC (“UST”), which through its wholly-owned subsidiaries, including U.S. Smokeless Tobacco Company LLC (“USSTC”) and Ste. Michelle Wine Estates Ltd. (“Ste. Michelle”), is engaged in the manufacture and sale of moist smokeless tobacco (“MST”) and snus products and wine; and Philip Morris Capital Corporation (“PMCC”), which maintains a portfolio of finance assets, substantially all of which are leveraged leases. In addition, Altria owned an 80% interest in Helix Innovations LLC (“Helix”), which is engaged in the manufacture and sale of oral nicotine pouches. Other Altria wholly-owned subsidiaries included Altria Group Distribution Company, which provides sales and distribution services to certain Altria operating subsidiaries, and Altria Client Services LLC, which provides various support services in areas such as legal, regulatory, consumer engagement, finance, human resources and external affairs to Altria and its subsidiaries. Altria’s access to the operating cash flows of its wholly-owned subsidiaries consists of cash received from the payment of dividends and distributions, and the payment of interest on intercompany loans by its subsidiaries. At March 31, 2020, Altria’s significant wholly-owned subsidiaries were not limited by long-term debt or other agreements in their ability to pay cash dividends or make other distributions with respect to their equity interests.

At March 31, 2020, Altria had a 10.1% ownership in Anheuser-Busch InBev SA/NV (“ABI”), which Altria accounts for under the equity method of accounting using a one-quarter lag. Altria receives cash dividends on its interest in ABI and will continue to do so as long as ABI pays dividends.

At March 31, 2020, Altria had a 35% economic interest in JUUL Labs, Inc. (“JUUL”), which Altria accounts for as an investment in an equity security. JUUL is engaged in the manufacture and sale of e-vapor products globally and is the U.S. leader in e-vapor.

During the third quarter of 2019, Helix acquired Burger Söhne Holding and its subsidiaries as well as certain affiliated companies (the “Burger Group”) that are engaged in the manufacture and sale of on! oral nicotine pouches. At closing, Altria indirectly owned an 80% interest in Helix, for which Altria paid $353 million in third quarter of 2019. The financial results of Helix are included in Altria’s condensed consolidated financial statements as part of its oral tobacco products segment (formerly smokeless products segment), with the 20% minority ownership interest in Helix (held by the former shareholders of the Burger Group) included as a noncontrolling interest. The final purchase price allocation, which is subject to post-closing adjustments, will be completed by the third quarter of 2020.

In March 2019, Altria completed its acquisition of a 45% ownership in Cronos Group Inc. (“Cronos”), a global cannabinoid company headquartered in Toronto, Canada. At March 31, 2020, Altria had a 45% ownership in Cronos, which Altria accounts for under the equity method of accounting using a one-quarter lag.

For further discussion of Altria’s investments in equity securities, see Note 4. Investments in Equity Securities.

Share Repurchases

In January 2018, Altria’s Board of Directors (the “Board of Directors”) authorized a new $1.0 billion share repurchase program that it expanded to $2.0 billion in May 2018 (as expanded, the “January 2018 share repurchase program”). In June 2019, Altria completed the January 2018 share repurchase program, under which it purchased a total of 34.0 million shares of its common stock at an average price of $58.86 per share.


10

In July 2019, the Board of Directors authorized a new $1.0 billion share repurchase program (the “July 2019 share repurchase program”). During the first quarter of 2020, there were no share repurchases made under the July 2019 share repurchase program. In April 2020, the Board of Directors rescinded the $500 million remaining in the July 2019 share repurchase program to strengthen Altria’s liquidity position amidst the COVID-19 pandemic.

Altria’s share repurchase activity for the three months ended March 31, 2019 was as follows:
(in millions, except per share data)
 
2019
Total number of shares repurchased
 
2.7

Aggregate cost of shares repurchased
 
$
151

Average price per share of shares repurchased
 
$
56.34



Basis of Presentation

The interim condensed consolidated financial statements of Altria are unaudited. It is the opinion of Altria’s management that all adjustments necessary for a fair statement of the interim results presented have been reflected in the interim condensed consolidated financial statements. All such adjustments were of a normal recurring nature. Net revenues and net earnings for any interim period are not necessarily indicative of results that may be expected for the entire year.

In the first quarter of 2020, Altria renamed its smokeless products segment as the oral tobacco products segment.

These statements should be read in conjunction with the audited consolidated financial statements and related notes, which appear in Altria’s Annual Report on Form 10-K for the year ended December 31, 2019.

On January 1, 2020, Altria adopted Accounting Standards Update (“ASU”) No. 2016-13, Measurement of Credit Losses on Financial Instruments and all related ASU amendments (collectively “ASU No. 2016-13”). This guidance replaces the current incurred loss impairment methodology for recognizing credit losses for financial assets with a methodology that reflects the entity’s current estimate of all expected credit losses and requires consideration of a broader range of reasonable and supportable information for estimating credit losses. The adoption of ASU No. 2016-13 did not have a material impact on Altria’s condensed consolidated financial statements.

Additionally, on January 1, 2020, Altria adopted ASU No. 2018-15, Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (“ASU No. 2018-15”). This guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The adoption of ASU No. 2018-15 did not have a material impact on Altria’s condensed consolidated financial statements.

For a description of issued accounting guidance applicable to, but not yet adopted by, Altria, see Note 13. New Accounting Guidance Not Yet Adopted.

Certain immaterial prior year amounts have been reclassified to conform with the current year’s presentation.

Note 2. Revenues from Contracts with Customers:

Altria disaggregates net revenues based on product type. For further discussion, see Note 9. Segment Reporting.

Altria’s businesses offer cash discounts to customers for prompt payment and calculate cash discounts as a percentage of the list price based on historical experience and agreed-upon payment terms. Altria’s businesses record an allowance for cash discounts, which is included as a contra-asset against receivables on Altria’s condensed consolidated balance sheets. Cash discounts at March 31, 2020 and December 31, 2019 were de minimis, and there were no differences between amounts recorded as an allowance for cash discounts and cash discounts subsequently given to customers.

Altria’s businesses that receive payments in advance of product shipment record such payments as deferred revenue. These payments are included in other accrued liabilities on Altria’s condensed consolidated balance sheets until control of such products is obtained by the customer. Deferred revenue was $219 million and $362 million at March 31, 2020 and December 31, 2019, respectively. When cash is received in advance of product shipment, Altria’s businesses satisfy their performance

11

obligations within three days of receiving payment. At March 31, 2020 and December 31, 2019, there were no differences between amounts recorded as deferred revenue and amounts subsequently recognized as revenue.

Receivables, which primarily reflect sales of wine produced and/or distributed by Ste. Michelle, were $147 million and $152 million at March 31, 2020 and December 31, 2019, respectively. At March 31, 2020 and December 31, 2019, there were no expected differences between amounts recorded and subsequently received, and Altria’s businesses did not record an allowance for doubtful accounts against these receivables.

Altria’s businesses record an allowance for returned goods, which is included in other accrued liabilities on Altria’s condensed consolidated balance sheets. While all of Altria’s tobacco operating companies sell tobacco products with dates relative to freshness as printed on product packaging, it is USSTC’s policy to accept authorized sales returns from its customers for products that have passed such dates due to the limited shelf life of USSTC’s MST and snus products. Altria’s businesses record estimated sales returns, which are based principally on historical volume and return rates, as a reduction to revenues. Actual sales returns will differ from estimated sales returns to the extent actual results differ from estimated assumptions. Altria’s businesses reflect differences between actual and estimated sales returns in the period in which the actual amounts become known. These differences, if any, have not had a material impact on Altria’s condensed consolidated financial statements. All returned goods are destroyed upon return and not included in inventory. Consequently, Altria’s businesses do not record an asset for their right to recover goods from customers upon return.

Sales incentives include variable payments related to goods sold by Altria’s businesses. Altria’s businesses include estimates of variable consideration as a reduction to revenues upon shipment of goods to customers. The sales incentives that require significant estimates and judgments are as follows:

Price promotion payments- Altria’s businesses make price promotion payments, substantially all of which are made to their retail partners, to incent the promotion of certain product offerings in select geographic areas.

Wholesale and retail participation payments- Altria’s businesses make payments to their wholesale and retail partners to incent merchandising and sharing of sales data in accordance with each business’s trade agreements.

These estimates primarily include estimated wholesale to retail sales volume and historical acceptance rates. Actual payments will differ from estimated payments to the extent actual results differ from estimated assumptions. Differences between actual and estimated payments are reflected in the period such information becomes available. These differences, if any, have not had a material impact on Altria’s condensed consolidated financial statements.

Note 3. Asset Impairment, Exit and Implementation Costs:

Pre-tax asset impairment, exit and implementation costs consisted of the following:
 
 
For the Three Months Ended March 31,
 
 
2020
 
2019
 
 
Implementation Costs (1)
 
Total
 
Asset Impairment and Exit Costs
 
Implementation Costs (1)
 
Total
 
(in millions)
Smokeable products
 
$
—

 
$
—

 
$
36

 
$
8

 
$
44

Oral tobacco products
 
—

 
—

 
8

 
1

 
9

Wine
 
392

 
392

 
—

 
—

 
—

All other
 
—

 
—

 
(5
)
 
—

 
(5
)
General corporate
 
—

 
—

 
1

 
—

 
1

Total
 
392

 
392

 
40

 
9

 
49

Plus amounts included in net periodic benefit income, excluding service cost (2)
 
—

 
—

 
12

 
—

 
12

Total
 
$
392

 
$
392

 
$
52

 
$
9

 
$
61

(1) Included in cost of sales for 2020 and marketing, administration and research costs for 2019 in Altria’s condensed consolidated statements of earnings.
(2) Represents curtailment costs. See Note 6. Benefit Plans.
 
 
 
 
 
 


12

Implementation costs for 2020 were related to Ste. Michelle’s inventory-related charges, as discussed below. The 2019 pre-tax asset impairment, exit and implementation costs were related to the cost reduction program, which was completed in 2019.

The movement in the restructuring liabilities, substantially all of which were severance liabilities, related to the cost reduction program was as follows:
 
(in millions)
Balances at December 31, 2019
$
67

Charges
—

Cash spent
(23
)
Balances at March 31, 2020
$
44



Wine Business Strategic Reset

Evolving adult consumer preferences have posed strategic challenges for Ste. Michelle, which has seen slowing growth in the wine category and increased inventory levels in recent periods. Against a backdrop of product volume demand uncertainty and long-term non-cancelable grape purchase commitments, which have been further negatively impacted by the economic uncertainty surrounding the COVID-19 pandemic, Ste. Michelle has experienced additional increases in inventory levels that at March 31, 2020 significantly exceed long-term forecasted demand.

As a result, in connection with the preparation of Altria’s first quarter financial statements, Ste. Michelle recorded pre-tax charges of $392 million, which were included in cost of sales in Altria’s condensed consolidated statement of earnings for the three months ended March 31, 2020. The charges consisted of the following: (i) write-off of inventory ($292 million) as Ste. Michelle no longer believes that the benefit of the blending and production plans for its inventory outweighs inventory carrying cost given the reduced product volume demand; and (ii) estimated losses on future non-cancelable grape purchase commitments that Ste. Michelle believes no longer have a future economic benefit ($100 million). Such commitments will continue to require cash payments as grape commitments are fulfilled over the next five years.

Given such uncertainty in economic conditions and product volume demand, as well as long-term supply-side contractual challenges, Altria and Ste. Michelle undertook a review of the wine business. As a result, Altria and Ste. Michelle implemented a strategic reset in order to maximize Ste. Michelle’s profitability and achieve improved long-term cash-flow generation. This strategic reset includes: (i) an updated approach to forecasting demand; (ii) supply chain optimization; (iii) SKU rationalization to reduce the number of products and eliminate underperforming brands; and (iv) streamlining operations by reducing future capital expenditures, working capital requirements and ongoing operating costs.

Additionally, Ste. Michelle expects to record additional charges of approximately $25 million during the remainder of 2020, consisting of inventory disposal costs and other charges.


Note 4. Investments in Equity Securities:

Altria’s investments consisted of the following:
 
 
Carrying Amount
 
 
March 31, 2020
 
December 31, 2019
 
 
(in millions)
ABI
 
$
18,453

 
$
18,071

JUUL
 
4,205

 
4,205

Cronos (1)
 
1,203

 
1,305

Total
 
$
23,861

 
$
23,581

(1) March 31, 2020 includes Altria’s equity method investment in Cronos ($1,037 million), the Cronos warrant ($132 million) and the Fixed-price Preemptive Rights ($34 million) and December 31, 2019 includes Altria’s equity method investment in Cronos ($1,002 million), the Cronos warrant ($234 million) and the Fixed -price Preemptive Rights ($69 million), as discussed further below.


13

Earnings from equity investments accounted for under the equity method of accounting consisted of the following:
 
 
For the Three Months Ended March 31,
 
 
2020
 
2019
 
 
(in millions)
ABI
 
$
134

 
$
86

Cronos (1)
 
23

 
—

Total
 
$
157

 
$
86

(1) Represents Altria’s share of Cronos’s earnings, which includes the change in fair value of Cronos’s derivative financial instruments associated with the issuance of additional shares. As a result of the acquisition of Cronos in March 2019 and Altria reporting its share of Cronos’s results using a one-quarter lag, no equity earnings from Altria’s investment in Cronos were recorded for the three months ended March 31, 2019.

Altria reviews its equity investments accounted for under the equity method of accounting (ABI and Cronos) for impairment on a quarterly basis in connection with the preparation of its financial statements by comparing the fair value of each of its investments to its respective carrying value. If the carrying value of an investment exceeds its fair value and the loss in value is other than temporary, the investment is considered impaired and reduced to fair value, and the impairment is recognized in the period identified. For further discussion, see Investment in ABI and Investment in Cronos below.

Investment in ABI

At March 31, 2020, Altria had a 10.1% ownership in ABI, consisting of 185 million restricted shares of ABI (the “Restricted Shares”) and 12 million ordinary shares of ABI. Altria accounts for its investment in ABI under the equity method of accounting because Altria has the ability to exercise significant influence over the operating and financial policies of ABI, including having active representation on ABI’s board of directors (“ABI Board”) and certain ABI Board committees. Through this representation, Altria participates in ABI policy making processes.

Altria reports its share of ABI’s results using a one-quarter lag because ABI’s results are not available in time for Altria to record them in the concurrent period.

The fair value of Altria’s equity investment in ABI is based on (i) unadjusted quoted prices in active markets for ABI’s ordinary shares and was classified in Level 1 of the fair value hierarchy and (ii) observable inputs other than Level 1 prices, such as quoted prices for similar assets for the Restricted Shares, and was classified in Level 2 of the fair value hierarchy. Altria may, in certain instances, pledge or otherwise grant a security interest in all or part of its Restricted Shares. In the event the pledgee or security interest holder forecloses on the Restricted Shares, the relevant Restricted Shares will be automatically converted, one-for-one, into ordinary shares. Therefore, the fair value of each Restricted Share is based on the value of an ordinary share.

The fair value of Altria’s equity investment in ABI at March 31, 2020 and December 31, 2019 was $8.8 billion (carrying value of $18.5 billion) and $16.1 billion (carrying value of $18.1 billion), respectively, which was less than its carrying by approximately 52% and 11%, respectively. As recently as September 30, 2019, the fair value of Altria’s equity investment in ABI exceeded its carrying value. In October 2019, the fair value of Altria’s equity investment in ABI declined below its carrying value and has not recovered. Altria has evaluated the factors related to the fair value decline, including the recent impact on the fair value of ABI’s shares amidst the COVID-19 pandemic, which has impacted the equity markets. Altria has also evaluated ABI’s financial condition and near-term prospects, and Altria’s intent and ability to hold its investment in ABI until recovery. Altria concluded at March 31, 2020 and December 31, 2019, the decline in fair value of its investment in ABI below its carrying value was temporary and, therefore, no impairment was recorded.

Consistent with the one-quarter lag for reporting ABI’s results in Altria’s financial results, in the second quarter of 2020 Altria will record its share of ABI’s first quarter 2020 net mark-to-market losses on certain ABI financial instruments associated with ABI’s share commitments, primarily related to ABI’s derivative financial instruments used to hedge exposure to approximately 100 million shares of ABI common stock. Such activity is primarily driven by the change in ABI’s share price, which decreased from €72.71 to €40.47 at December 31, 2019 and March 31, 2020, respectively.


14

Investment in JUUL

In December 2018, Altria made a minority investment in JUUL for $12.8 billion. In exchange for the investment, Altria received a 35% economic interest in JUUL through non-voting shares, which are convertible at Altria’s election into voting shares (“Share Conversion”), and for no additional payment, a security convertible into additional non-voting or voting shares, as applicable, upon settlement or exercise of certain JUUL convertible securities (the “JUUL Transaction”). During 2019, Altria recorded total pre-tax impairment charges of $8.6 billion related to its investment in JUUL resulting in a $4.2 billion carrying value of its investment in JUUL at December 31, 2019.

Altria received a broad preemptive right to purchase JUUL shares, exercisable each quarter upon dilution, to maintain its ownership percentage and is subject to a standstill restriction under which it may not acquire additional JUUL shares above its 35% interest. Furthermore, Altria agreed not to sell or transfer any of its JUUL shares until December 20, 2024.

On January 28, 2020, Altria and JUUL amended certain JUUL Transaction agreements and entered into a new cooperation agreement, which included the following provisions:
▪
Altria will continue to provide regulatory affairs support for JUUL’s pursuit of its pre-market tobacco applications (PMTA) and/or its modified risk tobacco products authorization (MRTP) and discontinued all other services as of March 31, 2020;
▪
Altria will have the option to be released from its non-compete obligation (i) in the event JUUL is prohibited by federal law from selling e-vapor products in the U.S. for a continuous period of at least 12 months (subject to tolling of this period in certain circumstances) or (ii) if the carrying value of Altria’s investment in JUUL is not more than 10% of its initial carrying value of $12.8 billion;
▪
Altria and JUUL agreed that for a period of one year they will not pursue any litigation against each other in connection with any conduct that occurred prior to the date of such cooperation agreement, with statutes of limitation being tolled during the one-year period;
▪
with respect to certain litigation in which Altria and JUUL are both defendants against third-party plaintiffs, Altria will not pursue any claims against JUUL for indemnification or reimbursement except for any non-contractual claims for contribution or indemnity where a judgment has been entered against Altria and JUUL; and
▪
upon Share Conversion, JUUL will:
▪
restructure JUUL’s current seven-member Board of Directors to a nine-member board that will include independent board members. The new structure will include: (i) three independent directors (one of whom will be designated by Altria and two of whom will be designated by JUUL stockholders other than Altria) unanimously certified as independent by a nominating committee, which will include at least one Altria designee, (ii) two directors designated by Altria, (iii) three directors designated by JUUL stockholders other than Altria, and (iv) the JUUL Chief Executive Officer; and
▪
create a Litigation Oversight Committee, which will include two Altria designated directors (one of whom will chair the Litigation Oversight Committee) that will have oversight authority and review of litigation management for matters in which JUUL and Altria are co-defendants and have or reasonably could have a written joint defense agreement in effect between them. Subject to certain limitations, the Litigation Oversight Committee will recommend to JUUL changes to outside counsel and litigation strategy by majority vote, with disagreements by JUUL’s management being resolved by majority vote of JUUL’s Board of Directors.

On April 1, 2020, the U.S. Federal Trade Commission (“FTC”) issued an administrative complaint challenging Altria’s investment in JUUL. The FTC has not sought to preliminarily enjoin Altria from converting its non-voting JUUL shares to voting shares. Altria has not converted its non-voting JUUL shares to voting shares and is considering whether to do so. For further discussion on the FTC litigation, see Note 11. Contingencies -  Antitrust Litigation.

At March 31, 2020 and December 31, 2019, Altria had a 35% economic interest in JUUL. Altria accounted for its investment in JUUL as an investment in an equity security as of March 31, 2020. Since the JUUL shares do not have a readily determinable fair value, Altria has elected to measure its investment in JUUL at its cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. There have been no upward or downward adjustments to the carrying value of Altria’s investment in JUUL resulting from observable price changes in orderly transactions since the JUUL Transaction through March 31, 2020.

Altria reviews its investment in JUUL for impairment by performing a qualitative assessment of impairment indicators on a quarterly basis in connection with the preparation of its financial statements. If this qualitative assessment indicates that

15

Altria’s investment in JUUL may be impaired, a quantitative assessment is performed. If the quantitative assessment indicates the fair value of the investment is less than its carrying value, the investment is written down to its fair value.

Altria performed its qualitative assessment of potential impairment indicators for its investment in JUUL, which included the consideration of potential impacts of COVID-19 on JUUL’s business, as part of the preparation of its financial statements for the period ended March 31, 2020. Altria’s assessment did not result in impairment at March 31, 2020. The carrying value of Altria’s investment in JUUL was $4.2 billion at March 31, 2020 and December 31, 2019.

Upon Share Conversion, Altria expects to account for its investment in JUUL under the fair value option. Under this option, Altria’s consolidated statement of earnings will include any cash dividends received from its investment in JUUL as well as any changes in the fair value of the investment, which will be calculated quarterly.

Investment in Cronos

In March 2019, Altria completed its acquisition of:
▪
149.8 million newly issued common shares of Cronos (“Acquired Common Shares”), which represented a 45% economic and voting interest and is accounted for under the equity method of accounting;
▪
anti-dilution protections to purchase Cronos common shares, exercisable each quarter upon dilution, to maintain its ownership percentage. Certain of the anti-dilution protections provide Altria the ability to purchase additional Cronos common shares at a per share exercise price of Canadian dollar (“CAD”) $16.25 upon the occurrence of specified events (“Fixed-price Preemptive Rights”). Based on Altria’s assumptions as of March 31, 2020, Altria estimates the Fixed-price Preemptive Rights allows Altria to purchase up to an additional approximately 37 million common shares of Cronos; and
▪
a warrant providing Altria the ability to purchase up to an additional 10% of common shares of Cronos (approximately 78 million common shares at March 31, 2020) at a per share exercise price of CAD $19.00, which expires on March 8, 2023.
The total purchase price for the Acquired Common Shares, Fixed-price Preemptive Rights and warrant (collectively, “Investment in Cronos”) was CAD $2.4 billion (U.S. dollar (“USD”) $1.8 billion). Upon full exercise of the Fixed-price Preemptive Rights, to the extent such rights become available, and the warrant, Altria would own a maximum of 55% of the outstanding common shares of Cronos.
In accounting for the acquisition of these assets as of the date of closing, the Fixed-price Preemptive Rights and warrant were recorded at each of their fair values using Black-Scholes option-pricing models, based on the assumptions described in Note 5. Financial Instruments. In addition, a deferred tax liability related to the Fixed-price Preemptive Rights and warrant was recorded. The residual of the purchase price was allocated to the Acquired Common Shares. Accordingly, the CAD $2.4 billion (USD $1.8 billion) purchase price was recorded in USD as follows:
▪
$1.2 billion to the warrant;
▪
$0.5 billion to the Fixed-price Preemptive Rights;
▪
$0.4 billion to the Acquired Common Shares; and
▪
$0.3 billion to a deferred tax liability.

If exercised in full, the exercise prices for the warrant and Fixed-price Preemptive Rights are approximately CAD $1.5 billion and CAD $0.6 billion (approximately USD $1.1 billion and $0.4 billion, respectively, based on the CAD to USD exchange rate on April 27, 2020).
For a discussion of derivatives related to Altria’s investment in Cronos, including Altria’s accounting for changes in the fair value of these derivatives, see Note 5. Financial Instruments.
At March 31, 2020, Altria had a 45% ownership in Cronos, which Altria accounts for under the equity method of accounting. Altria reports its share of Cronos’s results using a one-quarter lag because Cronos’s results are not available in time for Altria to record them in the concurrent period.

Altria nominated four directors, including one director who is independent from Altria, who serve on Cronos’s seven-member Board of Directors.

The fair value of Altria’s equity method investment in Cronos is based on unadjusted quoted prices in active markets for Cronos’s common shares and was classified in Level 1 of the fair value hierarchy. The fair value of Altria’s equity method investment in Cronos at March 31, 2020 and December 31, 2019 was $0.9 billion and $1.2 billion, respectively, compared with its carrying value of $1.0 billion at March 31, 2020 and December 31, 2019. At March 31, 2020, the fair value of Altria’s

16

equity method investment in Cronos was less than its carrying value by approximately 14%. Based on Altria’s evaluation of the duration and magnitude of the fair value decline, Altria’s evaluation of Cronos’s financial condition (including its strong cash position) and near-term prospects, and Altria’s intent and ability to hold its investment in Cronos until recovery, Altria concluded that the decline in fair value of its equity method investment in Cronos below its carrying value is temporary and, therefore, no impairment was recorded.

Note 5. Financial Instruments:

Altria enters into derivative financial instruments to mitigate the potential impact of certain market risks, including foreign currency exchange rate risk. Altria uses various types of derivative financial instruments, including forward contracts, options and swaps. Altria does not enter into or hold derivative financial instruments for trading or speculative purposes.

Altria’s investment in ABI, whose functional currency is the Euro, exposes Altria to foreign currency exchange risk on the carrying value of its investment. To manage this risk, Altria designates certain foreign exchange contracts, including cross-currency swap contracts and forward contracts (collectively “foreign currency contracts”), and Euro denominated unsecured long-term notes (“foreign currency denominated debt”) as net investment hedges of Altria’s investment in ABI.

At both March 31, 2020 and December 31, 2019, Altria had foreign currency contracts with aggregate notional amounts of $2,246 million. At March 31, 2020, Altria had foreign currency denominated debt with an aggregate fair value and carrying value of $4,595 million and $4,666 million, respectively. At December 31, 2019, Altria had foreign currency denominated debt with an aggregate fair value and carrying value of $5,057 million and $4,741 million, respectively.

Altria’s estimates of the fair values of its foreign currency contracts are determined using valuation models with significant inputs that are readily available in public markets, or can be derived from observable market transactions, and therefore are classified in Level 2 of the fair value hierarchy. An adjustment for credit risk and nonperformance risk is included in the fair values of foreign currency contracts.

Altria’s estimate of the fair value of its short-term borrowings is derived from discounted future cash flows based on the contractual terms of the Credit Agreement (see Note 10. Debt) and observable interest rates and is classified in Level 2 of the fair value hierarchy. The fair value of Altria’s short-term borrowings at March 31, 2020 approximated its carrying value. Altria had no short-term borrowings at December 31, 2019.

Altria’s estimate of the fair value of its total long-term debt is based on observable market information derived from a third-party pricing source and is classified in Level 2 of the fair value hierarchy. The aggregate fair value of Altria’s total long-term debt at March 31, 2020 and December 31, 2019 was $28.3 billion and $30.7 billion, respectively, as compared with its carrying value of $27.0 billion and $28.0 billion, respectively.


17

Altria’s Fixed-price Preemptive Rights and warrant related to its investment in Cronos, which is further discussed in Note 4. Investments in Equity Securities, are derivative financial instruments, which are required to be recorded at fair value. The fair values of the Fixed-price Preemptive Rights and Cronos warrant are estimated using Black-Scholes option-pricing models, adjusted for observable inputs (which are classified in Level 1 of the fair value hierarchy), including share price, and unobservable inputs, including probability factors and weighting of expected life, volatility levels and risk-free interest rates (which are classified in Level 3 of the fair value hierarchy) based on the following assumptions at:
 
 
March 31, 2020
 
December 31, 2019
 
March 31, 2020
 
December 31, 2019
 
 
Fixed-price Preemptive Rights
 
Cronos Warrant
Share price (1)
 
C$7.99
 
C$9.97
 
C$7.99
 
C$9.97
Expected life (2)
 
1.60 years
 
1.67 years
 
2.93 years
 
3.18 years
Expected volatility (3)
 
79.97%
 
81.61%
 
79.97%
 
81.61%
Risk-free interest rate (4)(5)
 
0.38%
 
1.71%
 
0.49%
 
1.69%
Expected dividend yield (6)
 
—%
 
—%
 
—%
 
—%
(1) Based on the closing market price for Cronos common stock on the Toronto Stock Exchange on the date indicated.
(2) Based on the weighted-average expected life of the Fixed-price Preemptive Rights (with a range from approximately 0.25 year to 6 years at March 31, 2020 and December 31, 2019) and the March 8, 2023 expiration date of the Cronos warrant.
(3) Based on a blend of historical volatility levels of the underlying equity security and peer companies.
(4) Based on the implied yield currently available on Canadian Treasury zero coupon issues (with a range from approximately 0.21% to 0.62% at March 31, 2020 and 1.66% to 1.74% at December 31, 2019) weighted for the remaining expected life of the Fixed-price Preemptive Rights.
(5) Based on the implied yield currently available on Canadian Treasury zero coupon issues and the expected life of the Cronos warrant.
(6) Based on Cronos’s expected dividend payments.

The following table provides a reconciliation of the beginning and ending balance of the Fixed-price Preemptive Rights and Cronos warrant, which are classified in Level 3 of the fair value hierarchy:
 
 
(in millions)
Balance at December 31, 2019
 
$
303

Pre-tax earnings (losses) recognized in net earnings
 
(137
)
Balance at March 31, 2020
 
$
166


Altria elects to record the gross assets and liabilities of derivative financial instruments executed with the same counterparty on its condensed consolidated balance sheets. The fair values of Altria’s derivative financial instruments on a gross basis included on the condensed consolidated balance sheets were as follows:
 
Fair Value of Assets
 
Fair Value of Liabilities
 
Balance Sheet Classification
 
March 31, 2020
 
December 31, 2019
 
Balance Sheet Classification
March 31, 2020
 
December 31, 2019
Derivatives designated as hedging instruments:
(in millions)
Foreign currency contracts
Other current assets
 
$
55

 
$
46

 
Other accrued liabilities
$
—

 
$
7

Foreign currency contracts
Other assets
 
19

 
—

 
Other liabilities
—

 
21

Total
 
$
74

 
$
46

 
 
$
—

 
$
28

 
 
 
 
 
 
 
 
 
 
 
Derivatives not designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
Cronos warrant
Investments in equity securities
 
$
132

 
$
234

 
 
 
 
 
Fixed-price
Preemptive Rights
Investments in equity securities
 
34

 
69

 
 
 
 
 
Total
 
 
$
166

 
$
303

 
 

 

 
 
 
 
 
 
 
 
 
 
 
Total derivatives
 
 
$
240

 
$
349

 
 
$
—

 
$
28



18

Altria records in its condensed consolidated statements of earnings any changes in the fair values of the Fixed-price Preemptive Rights and Cronos warrant as gains or losses on Cronos-related financial instruments in the periods in which the changes occur. For the three months ended March 31, 2020 and 2019, Altria recognized pre-tax unrealized losses, representing the changes in the fair values of the Fixed-price Preemptive Rights and Cronos warrant, as follows:
 
For the Three Months Ended March 31,
 
2020
 
2019
 
(in millions)
Fixed-price Preemptive Rights
$
(35
)
 
$
(132
)
Cronos warrant
(102
)
 
(262
)
 
(137
)
 
(394
)


Additionally, in January and February 2019, Altria entered into derivative financial instruments in the form of forward contracts, which were settled on March 7, 2019, to hedge Altria’s exposure to CAD to USD foreign currency exchange rate movements, in relation to the CAD $2.4 billion purchase price for the Cronos transaction. The aggregate notional amounts of the forward contracts were USD $1.8 billion (CAD $2.4 billion). The forward contracts did not qualify for hedge accounting; therefore, in the first quarter of 2019, pre-tax losses of USD $31 million representing changes in the fair values of the forward contracts were recorded in loss on Cronos-related financial instruments in Altria’s condensed consolidated statement of earnings.

Counterparties to Altria’s foreign currency contracts are domestic and international financial institutions. Altria is exposed to potential losses due to non-performance by these counterparties. Altria manages its credit risk by entering into transactions with counterparties with investment grade credit ratings, limiting the amount of exposure Altria has with each counterparty and monitoring the financial condition of each counterparty. The counterparty agreements also contain provisions that require Altria to maintain an investment grade credit rating. In the event Altria’s credit rating falls below investment grade, counterparties to Altria’s foreign currency contracts can require Altria to post collateral. No collateral was received or posted related to derivative assets and liabilities at March 31, 2020 and December 31, 2019.

Net Investment Hedging

The pre-tax effects of Altria’s net investment hedges on accumulated other comprehensive losses and the condensed consolidated statements of earnings were as follows:
 
 
Gain (Loss) Recognized in Accumulated Other Comprehensive Losses
 
Gain (Loss) Recognized in Net Earnings (1)
 
 
For the Three Months Ended March 31,
 
 
2020
 
2019
 
2020
 
2019
 
 
(in millions)
Foreign currency contracts
 
$
56

 
$
23

 
$
14

 
$
9

Foreign currency denominated debt
 
77

 
33

 
—

 
—

Total
 
$
133

 
$
56

 
$
14

 
$
9

(1) Related to amounts excluded from effectiveness testing.

The changes in the fair value of the foreign currency contracts and in the carrying value of the foreign currency denominated debt due to changes in the Euro to USD exchange rate were recognized in accumulated other comprehensive losses related to ABI. Gains on the foreign currency contracts arising from components excluded from effectiveness testing were recognized in interest and other debt expense, net in the condensed consolidated statements of earnings based on an amortization approach.


19

Note 6. Benefit Plans:

Components of Net Periodic Benefit (Income) Cost

Net periodic benefit (income) cost consisted of the following: 
 
For the Three Months Ended March 31,
 
Pension
 
Postretirement
 
2020
 
2019
 
2020
 
2019
 
(in millions)
Service cost
$
19

 
$
17

 
$
4

 
$
4

Interest cost
63

 
77

 
15

 
20

Expected return on plan assets
(126
)
 
(145
)
 
(3
)
 
(4
)
Amortization:
 
 
 
 
 
 
 
Net loss
27

 
42

 
3

 
3

Prior service cost (credit)
1

 
1

 
(7
)
 
(7
)
Curtailment
—

 
7

 
—

 
5

Net periodic benefit (income) cost
$
(16
)
 
$
(1
)
 
$
12

 
$
21



Curtailment costs shown in the table above were related to the cost reduction program discussed in Note 3. Asset Impairment, Exit and Implementation Costs.

Employer Contributions

Altria makes contributions to the pension plans to the extent that the contributions are tax deductible and pays benefits that relate to plans for salaried employees that cannot be funded under Internal Revenue Service regulations. Altria made employer contributions of $4 million to its pension plans during the three months ended March 31, 2020. Currently, Altria anticipates making additional employer contributions to its pension plans during the remainder of 2020 of up to approximately $25 million based on current tax law. Altria did not make any employer contributions to its postretirement plans during the three months ended March 31, 2020. Currently, Altria anticipates making employer contributions to its postretirement plans of up to approximately $60 million in 2020. However, these estimates may be subject to change as a result of changes in tax and other benefit laws, as well as asset performance significantly above or below the assumed long-term rate of return on assets, changes in interest rates or other considerations.

Note 7. Earnings Per Share:

Basic and diluted earnings per share (“EPS”) were calculated using the following:
 
 
For the Three Months Ended March 31,
 
 
2020
 
2019
 
 
(in millions)
Net earnings attributable to Altria
 
$
1,552

 
$
1,120

Less: Distributed and undistributed earnings attributable to share-based awards
 
(2
)
 
(2
)
Earnings for basic and diluted EPS
 
$
1,550

 
$
1,118

 
 
 
 
 
Weighted-average shares for basic and diluted EPS
 
1,858

 
1,874




20

Note 8. Other Comprehensive Earnings/Losses:

The following tables set forth the changes in each component of accumulated other comprehensive losses, net of deferred income taxes, attributable to Altria:
 
 
For the Three Months Ended March 31, 2020
 
 
Benefit Plans
 
ABI
 
Currency
Translation
Adjustments and Other
 
Accumulated
Other
Comprehensive
Losses
 
 
(in millions)
Balances, December 31, 2019
 
$
(2,192
)
 
$
(693
)
 
$
21

 
$
(2,864
)
 
 
 
 
 
 
 
 
 
Other comprehensive earnings (losses) before reclassifications
 
—

 
388

 
12

 
400

Deferred income taxes
 
—

 
(85
)
 
—

 
(85
)
Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes
 
—

 
303

 
12

 
315

 
 
 
 
 
 
 
 
 
Amounts reclassified to net earnings
 
28

 
(7
)
 
—

 
21

Deferred income taxes
 
(7
)
 
2

 
—

 
(5
)
Amounts reclassified to net earnings, net of deferred income taxes
 
21

 
(5
)
 
—

 
16

 
 
 
 
 
 
 
 
 
Other comprehensive earnings (losses), net of deferred income taxes
 
21

 
298

(1) 
12

 
331

 
 
 
 
 
 
 
 
 
Balances, March 31, 2020
 
$
(2,171
)
 
$
(395
)
 
$
33

 
$
(2,533
)


 
 
For the Three Months Ended March 31, 2019
 
 
Benefit Plans
 
ABI
 
Currency
Translation
Adjustments and Other
 
Accumulated
Other
Comprehensive
Losses
 
 
(in millions)
Balances, December 31, 2018
 
$
(2,168
)
 
$
(374
)
 
$
(5
)
 
$
(2,547
)
 
 
 
 
 
 
 
 
 
Other comprehensive earnings (losses) before reclassifications
 
—

 
(238
)
 
—

 
(238
)
Deferred income taxes
 
—

 
49

 
—

 
49

Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes
 
—

 
(189
)
 
—

 
(189
)
 
 
 
 
 
 
 
 
 
Amounts reclassified to net earnings
 
39

 
(12
)
 
—

 
27

Deferred income taxes
 
(10
)
 
2

 
—

 
(8
)
Amounts reclassified to net earnings, net of deferred income taxes
 
29

 
(10
)
 
—

 
19

 
 
 
 
 
 
 
 
 
Other comprehensive earnings (losses), net of deferred income taxes
 
29

 
(199
)
(1) 
—

 
(170
)
 
 
 
 
 
 
 
 
 
Balances, March 31, 2019
 
$
(2,139
)
 
$
(573
)
 
$
(5
)
 
$
(2,717
)

(1) Primarily reflects Altria’s share of ABI’s currency translation adjustments and the impact of Altria’s designated net investment hedges. For further discussion of designated net investment hedges, see Note 5. Financial Instruments.


21

The following table sets forth pre-tax amounts by component, reclassified from accumulated other comprehensive losses to net earnings:
 
 
For the Three Months Ended March 31,
 
 
2020
 
2019
 
 
(in millions)
Benefit Plans: (1)
 
 
 
 
Net loss
 
$
34

 
$
49

Prior service cost/credit
 
(6
)
 
(10
)
 
 
28

 
39

 
 
 
 
 
ABI (2)
 
(7
)
 
(12
)
 
 
 
 
 
Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings
 
$
21

 
$
27

(1) Amounts are included in net defined benefit plan costs. For further details, see Note 6. Benefit Plans.
(2) Amounts are included in earnings from equity investments. For further information, see Note 4. Investments in Equity Securities.

Note 9. Segment Reporting:


In the first quarter of 2020, Altria renamed its smokeless products segment as the oral tobacco products segment.

The products of Altria’s subsidiaries include smokeable tobacco products, consisting of combustible cigarettes manufactured and sold by PM USA and Nat Sherman, machine-made large cigars and pipe tobacco manufactured and sold by Middleton and premium cigars sold by Nat Sherman; oral tobacco products, consisting of MST and snus products manufactured and sold by USSTC and oral nicotine pouches manufactured and sold by Helix; and wine produced and/or distributed by Ste. Michelle. The products and services of these subsidiaries constitute Altria’s reportable segments of smokeable products, oral tobacco products (formerly smokeless products) and wine. The financial services and the innovative tobacco products businesses are included in all other.

Altria’s chief operating decision maker (the “CODM”) reviews operating companies income to evaluate the performance of, and allocate resources to, the segments. Operating companies income for the segments is defined as operating income before general corporate expenses and amortization of intangibles. Interest and other debt expense, net, net periodic benefit income/cost, excluding service cost, and provision for income taxes are centrally managed at the corporate level and, accordingly, such items are not presented by segment since they are excluded from the measure of segment profitability reviewed by the CODM.


22

Segment data were as follows: 
 
 
For the Three Months Ended March 31,
 
 
2020
 
2019
 
 
(in millions)
Net revenues:
 
 
 
 
Smokeable products
 
$
5,606

 
$
4,935

Oral tobacco products
 
601

 
540

Wine
 
146

 
151

All other
 
6

 
2

Net revenues
 
$
6,359

 
$
5,628

Earnings before income taxes:
 
 
 
 
Operating companies income (loss):
 
 
 
 
Smokeable products
 
$
2,370

 
$
1,932

Oral tobacco products
 
414

 
358

Wine
 
(379
)
 
15

All other
 
(5
)
 
(12
)
Amortization of intangibles
 
(19
)
 
(8
)
General corporate expenses
 
(45
)
 
(46
)
Corporate asset impairment and exit costs
 
—

 
(1
)
Operating income
 
2,336

 
2,238

Interest and other debt expense, net
 
(275
)
 
(384
)
Net periodic benefit income, excluding service cost
 
27

 
1

Earnings from equity investments
 
157

 
86

Loss on Cronos-related financial instruments
 
(137
)
 
(425
)
Earnings before income taxes
 
$
2,108

 
$
1,516



The comparability of operating companies income for the reportable segments was affected by the following:

Tobacco and Health Litigation Items - Pre-tax charges related to certain tobacco and health litigation items were recorded in Altria’s condensed consolidated statements of earnings as follows:
 
 
For the Three Months Ended March 31,
 
 
2020
 
2019
 
 
(in millions)
Smokeable products segment
 
$
22

 
$
15

Interest and other debt expense, net
 
2

 
2

Total
 
$
24

 
$
17



The amounts shown in the table above for the smokeable products segment were recorded in marketing, administration and research costs. For further discussion, see Note 11. Contingencies.

Asset Impairment, Exit and Implementation Costs - See Note 3. Asset Impairment, Exit and Implementation Costs for a breakdown of these costs by segment.


23

Note 10. Debt:

Short-term Borrowings and Borrowing Arrangements

Altria had $3.0 billion and no short-term borrowings at March 31, 2020 and December 31, 2019, respectively.

At March 31, 2020, Altria had a senior unsecured 5-year revolving credit agreement, dated August 1, 2018 (as amended, the “Credit Agreement”), that provides for borrowings up to an aggregate principal amount of $3.0 billion.

On March 23, 2020, Altria provided notice to JPMorgan Chase Bank, N.A., as administrative agent under the Credit Agreement, to borrow the entire available amount ($3.0 billion) under the Credit Agreement and, as of March 31, 2020, $3.0 billion was outstanding under the Credit Agreement. Altria typically accesses the commercial paper market early in the second quarter to help fund payments related to the 1998 Master Settlement Agreement (the “MSA”) and shareholder dividends. In light of the current uncertainty in the global capital markets, including the commercial paper markets, resulting from the COVID-19 pandemic, Altria elected to borrow the entire amount available under the Credit Agreement as a precautionary measure to increase its cash position and preserve financial flexibility. Altria used a portion of the proceeds from the borrowing under the Credit Agreement to help fund these payments and for other general corporate purposes.

All borrowings under the Credit Agreement mature on August 1, 2023, unless extended pursuant to the terms of the Credit Agreement. The Credit Agreement includes an option, subject to certain conditions, for Altria to extend the expiration date for two additional one-year periods. Altria may repay the borrowings under the Credit Agreement at any time without penalty. Altria has the intent and ability to repay the entire outstanding balance under the Credit Agreement within one year and believes it has adequate liquidity and access to financial resources to meet its anticipated obligations in the foreseeable future. As a result, Altria has classified the full amount of the borrowings as a current liability on its condensed consolidated balance sheet at March 31, 2020. Interest on the outstanding borrowings at March 31, 2020 was based on the three-month London Interbank Offered Rate (“LIBOR”) plus an applicable percentage based on the higher of the ratings of Altria’s long-term senior unsecured debt from Moody’s Investors Service, Inc. and Standard & Poor’s Ratings Services. The applicable percentage based on Altria’s long-term senior unsecured debt ratings at March 31, 2020 for borrowings under the Credit Agreement was 1.0%. At March 31, 2020, the interest rate for Altria’s current borrowings under the Credit Agreement was 2.23%. The Credit Agreement does not include any other rating triggers or any provisions that could require the posting of collateral.

The Credit Agreement includes various covenants, one of which requires Altria to maintain a ratio of consolidated earnings before interest, taxes, depreciation and amortization (“EBITDA”) to Consolidated Interest Expense of not less than 4.0 to 1.0, calculated as of the end of the applicable quarter on a rolling four quarters basis. At March 31, 2020, the ratio of consolidated EBITDA to Consolidated Interest Expense, calculated in accordance with the Credit Agreement, was 9.0 to 1.0. At March 31, 2020, Altria was in compliance with its covenants in the Credit Agreement. The terms “Consolidated EBITDA” and “Consolidated Interest Expense,” each as defined in the Credit Agreement, include certain adjustments.

At March 31, 2020, accrued interest on short-term borrowings under the Credit Agreement of $1 million was included in other accrued liabilities on Altria’s condensed consolidated balance sheet.

Any commercial paper issued by Altria and borrowings under the Credit Agreement are guaranteed by PM USA as further discussed in Note 12. Condensed Consolidating Financial Information.

For discussion of the fair value of Altria’s short-term borrowings, see Note 5. Financial Instruments.

Long-term Debt

During the first quarter of 2020, Altria repaid in full at maturity senior unsecured notes in the aggregate principal amount of $1,000 million.

At March 31, 2020 and December 31, 2019, accrued interest on long-term debt of $270 million and $470 million, respectively, was included in other accrued liabilities on Altria’s condensed consolidated balance sheets.

Altria designated its Euro denominated senior unsecured notes as a net investment hedge of its investment in ABI.

For discussion of Altria’s net investment hedge and the fair value of Altria’s long-term debt, see Note 5. Financial Instruments.


24

Note 11. Contingencies

Legal proceedings covering a wide range of matters are pending or threatened in various U.S. and foreign jurisdictions against Altria and its subsidiaries, including PM USA and USSTC, as well as their respective indemnitees and Altria’s investees. Various types of claims may be raised in these proceedings, including product liability, unfair trade practices, antitrust, tax, contraband shipments, patent infringement, employment matters, claims for contribution and claims of competitors, shareholders or distributors.

Litigation is subject to uncertainty and it is possible that there could be adverse developments in pending or future cases. An unfavorable outcome or settlement of pending tobacco-related or other litigation could encourage the commencement of additional litigation. Damages claimed in some tobacco-related and other litigation are or can be significant and, in certain cases, have ranged in the billions of dollars. The variability in pleadings in multiple jurisdictions, together with the actual experience of management in litigating claims, demonstrate that the monetary relief that may be specified in a lawsuit bears little relevance to the ultimate outcome. In certain cases, plaintiffs claim that defendants’ liability is joint and several. In such cases, Altria or its subsidiaries may face the risk that one or more co-defendants decline or otherwise fail to participate in the bonding required for an appeal or to pay their proportionate or jury-allocated share of a judgment. As a result, Altria or its subsidiaries under certain circumstances may have to pay more than their proportionate share of any bonding- or judgment-related amounts. Furthermore, in those cases where plaintiffs are successful, Altria or its subsidiaries may also be required to pay interest and attorneys’ fees.

Although PM USA has historically been able to obtain required bonds or relief from bonding requirements in order to prevent plaintiffs from seeking to collect judgments while adverse verdicts have been appealed, there remains a risk that such relief may not be obtainable in all cases. This risk has been substantially reduced given that 47 states and Puerto Rico limit the dollar amount of bonds or require no bond at all. As discussed below, however, tobacco litigation plaintiffs have challenged the constitutionality of Florida’s bond cap statute in several cases and plaintiffs may challenge state bond cap statutes in other jurisdictions as well. Such challenges may include the applicability of state bond caps in federal court. States, including Florida, may also seek to repeal or alter bond cap statutes through legislation. Although Altria cannot predict the outcome of such challenges, it is possible that the consolidated results of operations, cash flows or financial position of Altria, or one or more of its subsidiaries, could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome of one or more such challenges.

Altria and its subsidiaries record provisions in the condensed consolidated financial statements for pending litigation when they determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. At the present time, while it is reasonably possible that an unfavorable outcome in a case may occur, except to the extent discussed elsewhere in this Note 11. Contingencies: (i) management has concluded that it is not probable that a loss has been incurred in any of the pending cases; (ii) management is unable to estimate the possible loss or range of loss that could result from an unfavorable outcome in any of the pending cases; and (iii) accordingly, management has not provided any amounts in the condensed consolidated financial statements for unfavorable outcomes, if any. Litigation defense costs are expensed as incurred.

Altria and its subsidiaries have achieved substantial success in managing litigation. Nevertheless, litigation is subject to uncertainty and significant challenges remain. It is possible that the consolidated results of operations, cash flows or financial position of Altria, or one or more of its subsidiaries, could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome or settlement of certain pending litigation. Altria and each of its subsidiaries named as a defendant believe, and each has been so advised by counsel handling the respective cases, that it has valid defenses to the litigation pending against it, as well as valid bases for appeal of adverse verdicts. Each of the companies has defended, and will continue to defend, vigorously against litigation challenges. However, Altria and its subsidiaries may enter into settlement discussions in particular cases if they believe it is in the best interests of Altria to do so.

Overview of Altria and/or PM USA Tobacco-Related Litigation

Types and Number of U.S. Cases

Claims related to tobacco products generally fall within the following categories: (i) smoking and health cases alleging personal injury brought on behalf of individual plaintiffs; (ii) health care cost recovery cases brought by governmental (both domestic and foreign) plaintiffs seeking reimbursement for health care expenditures allegedly caused by cigarette smoking and/or disgorgement of profits; (iii) e-vapor cases alleging violation of the Racketeer Influenced and Corrupt Organizations Act (“RICO”), fraud, failure to warn, design defect, negligence and unfair trade practices; and (iv) other tobacco-related litigation described below. Plaintiffs’ theories of recovery and the defenses raised in tobacco-related litigation are discussed below.

25


The table below lists the number of certain tobacco-related cases pending in the U.S. against PM USA and, in some instances, Altria as of April 27, 2020, April 22, 2019 and April 23, 2018:
 
April 27, 2020
 
April 22, 2019
 
April 23, 2018
Individual Smoking and Health Cases (1)
109
 
98
 
102
Health Care Cost Recovery Actions (2)
—
 
1
 
1
E-vapor Cases(3)
202
 
2
 
3
Other Tobacco-Related Cases(4)
4
 
—
 
—
(1) Includes 22 cases filed in Massachusetts and 46 non-Engle cases filed in Florida. Does not include individual smoking and health cases brought by or on behalf of plaintiffs in Florida state and federal courts following the decertification of the Engle case (these Engle progeny cases are discussed below in Smoking and Health Litigation - Engle Class Action). Also does not include 1,472 cases brought by flight attendants seeking compensatory damages for personal injuries allegedly caused by exposure to environmental tobacco smoke (“ETS”). The flight attendants allege that they are members of an ETS smoking and health class action in Florida, which was settled in 1997 (Broin). The terms of the court-approved settlement in that case allowed class members to file individual lawsuits seeking compensatory damages, but prohibited them from seeking punitive damages. In March 2018, 923 of these cases were voluntarily dismissed without prejudice.
(2) See Health Care Cost Recovery Litigation - Federal Government’s Lawsuit below.
(3) Includes 24 class action lawsuits, 170 individual lawsuits, five state or local government lawsuits and three lawsuits filed by school districts relating to JUUL e-vapor products. JUUL is an additional named defendant in each of these lawsuits.
(4) For 2019 and 2020, includes two inactive smoking and health cases alleging personal injury or seeking court-supervised programs or ongoing medical monitoring and purporting to be brought on behalf of a class of individual plaintiffs, including one case in which the aggregated claims of a number of individual plaintiffs are to be tried in a single proceeding, and two inactive class action lawsuits alleging that use of the terms “Lights” and “Ultra Lights” constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO.

International Tobacco-Related Cases

As of April 27, 2020, PM USA is a named defendant in 10 health care cost recovery actions in Canada, eight of which also name Altria as a defendant. PM USA and Altria are also named defendants in seven smoking and health class actions filed in various Canadian provinces. See Guarantees and Other Similar Matters below for a discussion of the Distribution Agreement between Altria and Philip Morris International Inc. (“PMI”) that provides for indemnities for certain liabilities concerning tobacco products.

Tobacco-Related Cases Set for Trial

As of April 27, 2020, two Engle progeny cases are set for trial through June 30, 2020. In addition, there are no individual smoking and health cases against PM USA set for trial during this period. Cases against other companies in the tobacco industry may be scheduled for trial during this period. Trial dates are subject to change and some trials have been postponed due to the COVID-19 pandemic.

Trial Results

Since January 1999, excluding the Engle progeny cases (separately discussed below), verdicts have been returned in 69 tobacco-related cases in which PM USA was a defendant. Verdicts in favor of PM USA and other defendants were returned in 44 of the 69 cases. These 44 cases were tried in Alaska (1), California (7), Connecticut (1), Florida (10), Louisiana (1), Massachusetts (4), Mississippi (1), Missouri (4), New Hampshire (1), New Jersey (1), New York (5), Ohio (2), Pennsylvania (1), Rhode Island (1), Tennessee (2) and West Virginia (2).

Of the 25 non-Engle progeny cases in which verdicts were returned in favor of plaintiffs, 20 have reached final resolution, and one case (Gentile) that was initially returned in favor of plaintiff was reversed post-trial and remains pending.
See Smoking and Health Litigation - Engle Progeny Trial Results below for a discussion of verdicts in state and federal Engle progeny cases involving PM USA as of April 27, 2020.

Judgments Paid and Provisions for Tobacco and Health Litigation Items (Including Engle Progeny Litigation)

After exhausting all appeals in those cases resulting in adverse verdicts associated with tobacco-related litigation, since October 2004, PM USA has paid judgments and settlements (including related costs and fees) totaling approximately $748 million and interest totaling approximately $216 million as of March 31, 2020. These amounts include payments for Engle progeny

26

judgments (and related costs and fees) totaling approximately $327 million and related interest totaling approximately $54 million.

The changes in Altria’s accrued liability for tobacco and health litigation items, including related interest costs, for the periods specified below are as follows:
 
For the Three Months Ended March 31,
(in millions)
2020
 
2019
Accrued liability for tobacco and health litigation items at beginning of period (1)
$
14

 
$
112

Pre-tax charges for:
 
 
 
Tobacco and health litigation
22

(2) 
15

Related interest costs
2

 
2

Payments (1)
(28
)
(3) 
(109
)
Accrued liability for tobacco and health litigation items at end of period (1)
$
10

 
$
20

(1) Includes amounts related to the costs of implementing the corrective communications remedy related to the Federal Government’s Lawsuit discussed below.
(2) Includes approximately $7 million related to pre-trial resolution of approximately 100 tobacco and health cases.
(3) Includes approximately $7 million in payments related to above-mentioned pre-trial resolution of approximately 100 tobacco and health cases and $2 million for pre-trial resolution of other tobacco and health cases that was accrued in 2019 but not paid until 2020.

The accrued liability for tobacco and health litigation items, including related interest costs, was included in accrued liabilities on Altria’s condensed consolidated balance sheets. Pre-tax charges for tobacco and health litigation were included in marketing, administration and research costs on Altria’s condensed consolidated statements of earnings (losses). Pre-tax charges for related interest costs were included in interest and other debt expense, net on Altria’s condensed consolidated statements of earnings (losses).

Security for Judgments

To obtain stays of judgments pending appeal, PM USA has posted various forms of security. As of March 31, 2020, PM USA has posted appeal bonds totaling approximately $48 million, which have been collateralized with restricted cash that are included in assets on the condensed consolidated balance sheet.

Smoking and Health Litigation

Overview

Plaintiffs’ allegations of liability in smoking and health cases are based on various theories of recovery, including negligence, gross negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, nuisance, breach of express and implied warranties, breach of special duty, conspiracy, concert of action, violations of unfair trade practice laws and consumer protection statutes, and claims under the federal and state anti-racketeering statutes. Plaintiffs in the smoking and health cases seek various forms of relief, including compensatory and punitive damages, treble/multiple damages and other statutory damages and penalties, creation of medical monitoring and smoking cessation funds, disgorgement of profits, and injunctive and equitable relief. Defenses raised in these cases include lack of proximate cause, assumption of the risk, comparative fault and/or contributory negligence, statutes of limitations and preemption by the Federal Cigarette Labeling and Advertising Act.

Non-Engle Progeny Litigation

Summarized below are the non-Engle progeny smoking and health cases pending during 2020 in which a verdict was returned in favor of plaintiff and against PM USA. Charts listing certain verdicts for plaintiffs in the Engle progeny cases can be found in Smoking and Health Litigation - Engle Progeny Trial Results below.

Principe: In February 2020, a jury in a Florida state court returned a verdict in favor of plaintiff and against PM USA, awarding approximately $11 million in compensatory damages. There was no claim for punitive damages. PM USA’s post-trial motions are pending.

Greene: In September 2019, a jury in a Massachusetts state court returned a verdict in favor of plaintiffs and against PM USA, awarding approximately $10 million in compensatory damages. An additional claim by plaintiffs remains pending.

27


Laramie: In August 2019, a jury in a Massachusetts state court returned a verdict in favor of plaintiff, awarding $11 million in compensatory damages and $10 million in punitive damages. PM USA and plaintiff have appealed.

Gentile: In October 2017, a jury in a Florida state court returned a verdict in favor of plaintiff, awarding approximately $7.1 million in compensatory damages and allocating 75% of the fault to PM USA (an amount of approximately $5.3 million). PM USA appealed. In September 2019, the Florida Fourth District Court of Appeal reversed the judgment entered by the trial court, granted PM USA judgment on certain claims and remanded for a new trial on the remaining claims. Plaintiff has petitioned the Florida Supreme Court for further review.

Federal Government’s Lawsuit: See Health Care Cost Recovery Litigation - Federal Government’s Lawsuit below for a discussion of the verdict and post-trial developments in the United States of America health care cost recovery case.

Engle Class Action

In July 2000, in the second phase of the Engle smoking and health class action in Florida, a jury returned a verdict assessing punitive damages totaling approximately $145 billion against various defendants, including $74 billion against PM USA. Following entry of judgment, PM USA appealed. In May 2003, the Florida Third District Court of Appeal reversed the judgment entered by the trial court and instructed the trial court to order the decertification of the class. Plaintiffs petitioned the Florida Supreme Court for further review.

In July 2006, the Florida Supreme Court ordered that the punitive damages award be vacated, that the class approved by the trial court be decertified and that members of the decertified class could file individual actions against defendants within one year of issuance of the mandate. The court further declared the following Phase I findings are entitled to res judicata effect in such individual actions brought within one year of the issuance of the mandate: (i) that smoking causes various diseases; (ii) that nicotine in cigarettes is addictive; (iii) that defendants’ cigarettes were defective and unreasonably dangerous; (iv) that defendants concealed or omitted material information not otherwise known or available knowing that the material was false or misleading or failed to disclose a material fact concerning the health effects or addictive nature of smoking; (v) that defendants agreed to misrepresent information regarding the health effects or addictive nature of cigarettes with the intention of causing the public to rely on this information to their detriment; (vi) that defendants agreed to conceal or omit information regarding the health effects of cigarettes or their addictive nature with the intention that smokers would rely on the information to their detriment; (vii) that all defendants sold or supplied cigarettes that were defective; and (viii) that defendants were negligent.

In August 2006, PM USA and plaintiffs sought rehearing from the Florida Supreme Court on parts of its July 2006 opinion. In December 2006, the Florida Supreme Court refused to revise its July 2006 ruling, except that it revised the set of Phase I findings entitled to res judicata effect by excluding finding (v) listed above (relating to agreement to misrepresent information), and added the finding that defendants sold or supplied cigarettes that, at the time of sale or supply, did not conform to the representations of fact made by defendants. In February 2008, the trial court decertified the class.

Pending Engle Progeny Cases

The deadline for filing Engle progeny cases expired in January 2008, at which point a total of approximately 9,300 federal and state claims were pending. As of April 27, 2020, approximately 1,500 state court cases were pending against PM USA or Altria asserting individual claims by or on behalf of approximately 1,900 state court plaintiffs.  Because of a number of factors, including docketing delays, duplicated filings and overlapping dismissal orders, these numbers are estimates. While the Federal Engle Agreement (discussed below) resolved nearly all Engle progeny cases pending in federal court, as of April 27, 2020, four cases were pending against PM USA in federal court representing the cases excluded from that agreement.

Engle Progeny Trial Results

As of April 27, 2020, 134 federal and state Engle progeny cases involving PM USA have resulted in verdicts since the Florida Supreme Court Engle decision. Seventy-eight verdicts were returned in favor of plaintiffs and four verdicts (Skolnick, Calloway, Oshinsky-Blacker and Freeman) that were initially returned in favor of plaintiffs were reversed post-trial or on appeal and remain pending.

Forty-seven verdicts were returned in favor of PM USA, of which 42 were state cases. In addition, there have been a number of mistrials, only some of which have resulted in new trials as of April 27, 2020. Four verdicts (Pearson, D. Cohen, Collar and Chacon) that were returned in favor of PM USA were subsequently reversed for new trials. Juries in two cases (Reider and

28

Banks) returned zero damages verdicts in favor of PM USA. Juries in two other cases (Weingart and Hancock) returned verdicts against PM USA awarding no damages, but the trial court in each case decided to award plaintiffs damages. One case, Pollari, resulted in a verdict in favor of PM USA following a retrial of an initial verdict returned in favor of plaintiff. Appeals by plaintiff and defendants are pending. Three cases, Gloger, Rintoul (Caprio) and Duignan, resulted in verdicts in favor of plaintiffs following retrial of initial verdicts returned in favor of plaintiffs. Post-trial motions or appeals are pending. One case, Freeman, resulted in an appellate reversal of a jury verdict in favor of plaintiff and a judgment in favor of PM USA.

The charts below list the verdicts and post-trial developments in certain Engle progeny cases in which verdicts were returned in favor of plaintiffs. The first chart lists such cases that are pending as of April 27, 2020 where PM USA has recorded a provision in its consolidated financial statements because PM USA has determined that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated; the second chart lists other such cases that are pending as of April 27, 2020 but where PM USA has determined an unfavorable outcome is not probable and the amount of loss cannot be reasonably estimated; and the third chart lists other such cases that have concluded within the previous 12 months. Unless otherwise noted for a particular case, the jury’s award for compensatory damages will not be reduced by any finding of plaintiff’s comparative fault. Further, the damages noted reflect adjustments based on post-trial or appellate rulings.
Currently Pending Engle Cases with Accrued Liabilities
(rounded to nearest $ million)

Plaintiff
Verdict Date
Defendant(s)
Court
Compensatory Damages (All Defendants)
Punitive Damages (PM USA)
Appeal Status
Accrual (1)
Berger (Cote)
September 2014
PM USA
Federal Court - Middle District of Florida
$6 million
$21 million
The Eleventh Circuit Court of Appeals reinstated the punitive and compensatory damages awards and remanded the case to the district court. PM USA’s challenge to the punitive damages award was denied by the district court. PM USA’s appeal to the Eleventh Circuit Court of Appeals is pending.
$6 million accrual in the fourth quarter of 2018
(1) Accrual amounts include interest and associated costs, if applicable. For cases with multiple defendants, if any, accrual amounts reflect the portion of compensatory damages PM USA believes it will have to pay if the case is ultimately decided in plaintiff’s favor after taking into account any portion potentially payable by the other defendant(s).
Other Currently Pending Engle Cases with Verdicts Against PM USA
(rounded to nearest $ million)

Plaintiff
Verdict Date
Defendant(s)
Court
Compensatory Damages (1)
Punitive Damages
(PM USA)
Appeal Status
Duignan
February 2020(2)
PM USA and
R.J. Reynolds(3)
Pinellas
$3 million
$12 million
Defendants’ post-trial motions pending.
Cuddihee
January 2020
PM USA
Duval
$3 million
$0
Defendant’s post-trial motions pending.
Rintoul (Caprio)
November 2019(2)
PM USA and R.J. Reynolds
Broward
$9 million ($5 million PM USA)
$74 million
Defendants’ post-trial motion pending.
Gloger
November 2019(2)
PM USA and R.J. Reynolds
Miami-Dade
$15 million ($5 million PM USA)
$11 million
Appeal by defendants to Third District Court of Appeal pending.
McCall
March 2019
PM USA
Broward
<$1 million (<$1 million PM USA)
<$1 million
New trial ordered on punitive damages.
Neff
March 2019
PM USA and R.J. Reynolds
Broward
$4 million
$2 million
Appeals by plaintiff and defendants to Fourth District Court of Appeal pending.
Frogel
March 2019
PM USA
Palm Beach
<$1 million (<$1 million PM USA)
$0
Appeals by plaintiff and defendant to Fourth District Court of Appeal pending.

29

Other Currently Pending Engle Cases with Verdicts Against PM USA
(rounded to nearest $ million)

Plaintiff
Verdict Date
Defendant(s)
Court
Compensatory Damages (1)
Punitive Damages
(PM USA)
Appeal Status
Mahfuz
February 2019
PM USA and R.J. Reynolds
Broward
$12 million
$10 million
Appeals by plaintiff and defendants to Fourth District Court of Appeal pending.
Holliman
February 2019
PM USA
Miami-Dade
$3 million
$0
Defendant’s appeal to Third District Court of Appeal pending.
Chadwell
September 2018
PM USA
Miami-Dade
$2 million
$0
Appeals by defendant and plaintiff to Third District Court of Appeal pending.
Kaplan
July 2018
PM USA and R.J. Reynolds
Broward
$2 million
$2 million
Appeals by defendants and plaintiff to Fourth District Court of Appeal pending.
Landi
June 2018
PM USA and R.J. Reynolds
Broward
$8 million
$5 million
Appeals by plaintiff and defendants to Fourth District Court of Appeal pending.
R. Douglas
November 2017
PM USA
Duval
<$1 million
$0
Awaiting entry of final judgment by the trial court.
Sommers
April 2017
PM USA
Miami-Dade
$1 million
$0
Third District Court of Appeal affirmed compensatory damages award and granted new trial on punitive damages. Defendant petitioned Florida Supreme Court for review.
Santoro
March 2017
PM USA, R.J. Reynolds and Liggett Group(3)
Broward
$2 million
$0
Trial court set aside punitive damages award; appeals by plaintiff and defendants to Fourth District Court of Appeal pending.
Cooper (Blackwood)
September 2015
PM USA and R.J. Reynolds
Broward
$5 million
(<$1 million PM USA)
$0
Fourth District Court of Appeal affirmed judgment and granted a new trial on punitive damages.
D. Brown
January 2015
PM USA
Federal Court - Middle District of Florida
$8 million
$9 million
Appeal by defendant to U.S. Court of Appeals for the Eleventh Circuit pending.
Kerrivan
October 2014
PM USA and R.J. Reynolds
Federal Court - Middle District of Florida
$16 million
$16 million
U.S. Court of Appeals for the Eleventh Circuit affirmed the judgment. Defendants’ motion for rehearing pending.
Harris
July 2014
PM USA,
R.J. Reynolds and Lorillard(3)
Federal Court - Middle District of Florida
$2 million (<$ 1 million PM USA)
$0
Appeals by plaintiff and defendants to U.S. Court of Appeals for the Eleventh Circuit pending.
(1) PM USA’s portion of the compensatory damages award is noted parenthetically where the court has ruled that comparative fault applies.
(2) Plaintiff’s verdict following a retrial of an initial verdict in favor of plaintiff.
(3) References to “R.J. Reynolds,” “Liggett Group” and “Lorillard” are to R.J. Reynolds Tobacco Company, Liggett Group, LLC and Lorillard Tobacco Company, respectively.
 
 
 
 
 
 
 
Engle Cases Concluded Within Past 12 Months(1) 
(rounded to nearest $ million)
Plaintiff
Verdict Date
Defendant(s)
Court
Accrual Date
Payment Amount
(if any)
Payment Date
Theis(2)
May 2018
PM USA and
R.J. Reynolds
Sarasota
First quarter of 2020
$17 million
February 2020
Alvarez Del Real
September 2019
PM USA
Miami-Dade
Fourth quarter of 2019
<$1 million
October 2019

30

Engle Cases Concluded Within Past 12 Months(1) 
(rounded to nearest $ million)
Plaintiff
Verdict Date
Defendant(s)
Court
Accrual Date
Payment Amount
(if any)
Payment Date
Zingaro
May 2019
PM USA and
R.J. Reynolds
Broward
Third quarter of 2019
<$1 million
October 2019
Bryant
December 2017
PM USA
Escambia
Second quarter of 2019
<$1 million
July 2019
Wallace
October 2017
PM USA and
R.J. Reynolds
Brevard
Second quarter of 2019
$26 million
May 2019
J. Brown
February 2017
PM USA and
R.J. Reynolds
Pinellas
First quarter of 2019
$4 million
April 2019
L. Martin
May 2017
PM USA
Miami-Dade
First quarter of 2019
$2 million
April 2019
Danielson
November 2015
PM USA
Escambia
First quarter of 2019
$3 million
March 2019
S. Martin
November 2016
PM USA and
R.J. Reynolds
Broward
First quarter of 2019
$5 million
March 2019
Searcy
April 2013
PM USA and
R.J. Reynolds
Federal Court - Middle District of Florida
Third quarter of 2018
$2 million
March 2019
Boatright
November 2014
PM USA and Liggett Group
Polk
Second quarter of 2018
$42 million
March 2019
M. Brown(3)
May 2015
PM USA
Duval
Second quarter of 2018
$8 million
March 2019
Jordan(4)
August 2015
PM USA
Duval
Second quarter of 2018
$11 million
March 2019
Pardue
December 2016
PM USA and
R.J. Reynolds
Alachua
Second and Third quarters of 2018
$11 million
March 2019
McKeever
February 2015
PM USA
Broward
Fourth quarter of 2017
$21 million
March 2019
(1) In two cases in which PM USA paid the judgments more than a year ago, Naugle and Gore, plaintiffs were awarded approximately $8 million and approximately $2 million in fees and other costs, respectively.  In both cases, PM USA has appealed.
(2) In February 2020, the Florida Second District Court of Appeal denied PM USA’s petition for review.  As a result, in the first quarter of 2020, PM USA recorded a pre-tax provision of approximately $17 million for the judgment plus interest, which was subsequently paid in the first quarter of 2020.
(3) The trial court also awarded plaintiff approximately $9 million in fees, interest and costs.  PM USA and plaintiff have appealed.
(4) The trial court also awarded plaintiff approximately $4 million in fees and costs. PM USA and plaintiff have appealed.

Florida Bond Statute

In June 2009, Florida amended its existing bond cap statute by adding a $200 million bond cap that applies to all state Engle progeny lawsuits in the aggregate and establishes individual bond caps for individual Engle progeny cases in amounts that vary depending on the number of judgments in effect at a given time. Plaintiffs have been unsuccessful in various challenges to the bond cap statute in Florida state court.

No federal court has yet addressed the constitutionality of the bond cap statute or the applicability of the bond cap to Engle progeny cases tried in federal court.

From time to time, legislation has been presented to the Florida legislature that would repeal the bond cap statute; however to date, no legislation repealing the statute has passed.

Other Smoking and Health Class Actions

Since the dismissal in May 1996 of a purported nationwide class action brought on behalf of allegedly addicted smokers, plaintiffs have filed numerous putative smoking and health class action suits in various state and federal courts. In general, these cases purport to be brought on behalf of residents of a particular state or states (although a few cases purport to be nationwide in scope) and raise addiction claims and, in many cases, claims of physical injury as well.

Class certification has been denied or reversed by courts in 61 smoking and health class actions involving PM USA in Arkansas (1), California (1), Delaware (1), the District of Columbia (2), Florida (2), Illinois (3), Iowa (1), Kansas (1), Louisiana (1), Maryland (1), Michigan (1), Minnesota (1), Nevada (29), New Jersey (6), New York (2), Ohio (1), Oklahoma (1), Oregon (1), Pennsylvania (1), Puerto Rico (1), South Carolina (1), Texas (1) and Wisconsin (1). See Certain Other Tobacco-Related

31

Litigation below for a discussion of “Lights” and “Ultra Lights” class action cases and medical monitoring class action cases pending against PM USA.

As of April 27, 2020, PM USA and Altria are named as defendants, along with other cigarette manufacturers, in seven class actions filed in the Canadian provinces of Alberta, Manitoba, Nova Scotia, Saskatchewan, British Columbia and Ontario. In Saskatchewan, British Columbia (two separate cases) and Ontario, plaintiffs seek class certification on behalf of individuals who suffer or have suffered from various diseases, including chronic obstructive pulmonary disease, emphysema, heart disease or cancer, after smoking defendants’ cigarettes. In the actions filed in Alberta, Manitoba and Nova Scotia, plaintiffs seek certification of classes of all individuals who smoked defendants’ cigarettes. In March 2019, all of these class actions were stayed as a result of three Canadian tobacco manufacturers (none of which is related to Altria or its subsidiaries) seeking protection under Canada’s Companies’ Creditors Arrangement Act (which is similar to Chapter 11 bankruptcy in the U.S.). The companies entered into these proceedings following a Canadian appellate court upholding two smoking and health class action verdicts against those companies totaling approximately CAD $13 billion. See Guarantees and Other Similar Matters below for a discussion of the Distribution Agreement between Altria and PMI, which provides for indemnities for certain liabilities concerning tobacco products.

Health Care Cost Recovery Litigation

Overview

In the health care cost recovery litigation, governmental entities seek reimbursement of health care cost expenditures allegedly caused by tobacco products and, in some cases, of future expenditures and damages. Relief sought by some but not all plaintiffs includes punitive damages, multiple damages and other statutory damages and penalties, injunctions prohibiting alleged marketing and sales to minors, disclosure of research, disgorgement of profits, funding of anti-smoking programs, additional disclosure of nicotine yields, and payment of attorney and expert witness fees.

Although there have been some decisions to the contrary, most judicial decisions in the U.S. have dismissed all or most health care cost recovery claims against cigarette manufacturers. Nine federal circuit courts of appeals and eight state appellate courts, relying primarily on grounds that plaintiffs’ claims were too remote, have ordered or affirmed dismissals of health care cost recovery actions. The United States Supreme Court has refused to consider plaintiffs’ appeals from the cases decided by five federal circuit courts of appeal.

In addition to the cases brought in the U.S., health care cost recovery actions have also been brought against tobacco industry participants, including PM USA and Altria, in Canada (10 cases), and other entities have stated that they are considering filing such actions.

Since the beginning of 2008, the Canadian Provinces of British Columbia, New Brunswick, Ontario, Newfoundland and Labrador, Quebec, Alberta, Manitoba, Saskatchewan, Prince Edward Island and Nova Scotia have brought health care reimbursement claims against cigarette manufacturers. PM USA is named as a defendant in the British Columbia and Quebec cases, while both Altria and PM USA are named as defendants in the New Brunswick, Ontario, Newfoundland and Labrador, Alberta, Manitoba, Saskatchewan, Prince Edward Island and Nova Scotia cases. The Nunavut Territory and Northwest Territory have passed legislation permitting similar claims, but lawsuits based on this legislation have not been filed. All of these cases have been stayed pending resolution of proceedings in Canada involving three tobacco manufacturers (none of which are affiliated with Altria or its subsidiaries) under the Creditors Arrangement Act discussed above. See Smoking and Health Litigation - Other Smoking and Health Class Actions above for a discussion of these proceedings. See Guarantees and Other Similar Matters below for a discussion of the Distribution Agreement between Altria and PMI that provides for indemnities for certain liabilities concerning tobacco products.

Settlements of Health Care Cost Recovery Litigation

In November 1998, PM USA and certain other tobacco product manufacturers entered into the MSA with 46 states, the District of Columbia and certain U.S. territories to settle asserted and unasserted health care cost recovery and other claims. PM USA and certain other tobacco product manufacturers had previously entered into agreements to settle similar claims brought by Mississippi, Florida, Texas and Minnesota (together with the MSA, the “State Settlement Agreements”). The State Settlement Agreements require that the original participating manufacturers or “OPMs” (now PM USA and R.J. Reynolds and, with respect to certain brands, ITG Brands, LLC (“ITG”)) make annual payments of approximately $9.4 billion, subject to adjustments for several factors, including inflation, market share and industry volume. In addition, the OPMs are required to pay settling plaintiffs’ attorneys’ fees, subject to an annual cap of $500 million. For the three months ended March 31, 2020 and

32

2019, the aggregate amount recorded in cost of sales with respect to the State Settlement Agreements was approximately $1.1 billion and $0.9 billion, respectively. These amounts include PM USA’s estimate of amounts related to NPM Adjustments discussed below.

NPM Adjustment Disputes

PM USA is participating in proceedings regarding the NPM Adjustment for 2003-2019. The “NPM Adjustment” is a reduction in MSA payments made by the OPMs and those manufacturers that are subsequent signatories to the MSA (collectively, the “participating manufacturers” or “PMs”) that applies if the PMs collectively lose at least a specified level of market share to non-participating manufacturers since 1997, subject to certain conditions and defenses. The independent auditor (the “IA”) appointed under the MSA calculates the maximum amount of the NPM Adjustment, if any, for each year.

NPM Adjustment Disputes - Settlement with 36 States and Territories and Settlement with New York.

PM USA has entered into two settlements of NPM Adjustment disputes with a total of 37 states and territories, one with 36 states and territories (the “multi-state settlement”) and the other with the State of New York. In the multi-state settlement, PM USA, by the end of October 2017, had settled the NPM Adjustment disputes for 2003-2015 with 26 states in exchange for a total of $740 million. In 2018, there were two principal developments with respect to this settlement. First, PM USA agreed to settle the NPM Adjustment disputes for 2016 and 2017 with the 26 states mentioned above. Second, PM USA settled the NPM Adjustment disputes for 2004-2017 with ten additional states. As a result of these two developments, PM USA will receive approximately $248 million, $68 million of which it received in April 2018, $121 million of which it received in April 2019 and $47 million of which it received in April 2020. In connection with these two developments, PM USA recorded a reduction to cost of sales in the amount of $39 million in 2017 and in the amount of $209 million in 2018. In the first quarter of 2019, PM USA also recorded a reduction to cost of sales in the amount of $52 million for its estimate of the 2018 NPM Adjustment settlement credit it expects to receive under the multi-state settlement.

In the first quarter of 2020, the PMs agreed that certain conditions set forth in the multi-state settlement by the 10 states that settled the NPM Adjustment in 2018 had been met. As a result, PM USA’s and the other PMs’ settlement with Pennsylvania was extended to include NPM Adjustments for 2018-2024, and settlements with the other nine states were extended to include NPM Adjustments for 2018-2019. As a result of this development, PM USA will receive approximately $43 million in credits to offset PM USA’s MSA payments over nine years.

In the NPM Adjustment settlement with New York, which was entered into in 2015, PM USA has received approximately $317 million for 2004-2018. PM USA and the other participating manufacturers are involved in a proceeding pursuant to the New York settlement in which an independent investigator will determine the amounts due to the participating manufacturers from New York for 2019 and 2020. PM USA expects to receive such amounts in April 2021 and April 2022, respectively.
 
Both the New York settlement and the multi-state settlement also contain provisions resolving certain disputes regarding the application of the NPM Adjustment going forward.

2003 and Subsequent NPM Adjustments - Continuing Disputes with States that have not Settled.

▪
2003 NPM Adjustment. In September 2013, an arbitration panel issued rulings regarding the 15 states and territories that remained in the arbitration, ruling that six of them did not establish valid defenses to the NPM Adjustment for 2003. In June 2014, two of these six states joined the multi-state settlement discussed above. With respect to the remaining four states, following the outcome of challenges in state courts, PM USA ultimately recorded $74 million primarily as a reduction to cost of sales. Subsequently, another one of the six states joined the multi-state settlement. Two potential disputes remain outstanding regarding the amount of interest due to PM USA and there is no assurance that PM USA will prevail in either of these disputes.

▪
2004 and Subsequent NPM Adjustments. PM USA has continued to pursue the NPM Adjustments for 2004 and subsequent years in multi-state arbitrations against the states that did not join either of the settlements discussed above. In September 2019, a New Mexico state appellate court affirmed a trial court’s order compelling New Mexico to arbitrate the 2004 NPM Adjustment claims in the multi-state arbitration with the other states. In November 2019, the New Mexico Supreme Court declined to review that decision. The arbitration hearing has not yet been scheduled. The Montana state courts ruled that Montana may litigate its claims in state court, rather than participate in a multi-state arbitration and the PMs have agreed not to contest the applicability of the 2004 NPM Adjustment to Montana. In April 2020, the State of Montana filed a motion in Montana state court against the PMs, including PM USA and a Nat

33

Sherman affiliate, claiming that Montana’s share of the NPM Adjustment amounts should be paid to the state in advance of the resolution of disputes over the applicability of those adjustments. PM USA and the Nat Sherman affiliate have been placing the disputed NPM Adjustment amounts in the disputed payments account established pursuant to the terms of the MSA. Montana seeks a total of approximately $43 million in disputed payments from all defendants combined, as well as treble and punitive damages.

The hearings in a 2004 multi-state arbitration with all of the states that have not settled other than Montana and New Mexico concluded in July 2019. As of April 27, 2020, no decisions have resulted from the arbitration.

No assurance can be given as to when proceedings for 2005 and subsequent years will be scheduled or the precise form those proceedings will take.

The IA has calculated that PM USA’s share of the maximum potential NPM Adjustments for 2004-2018 is (exclusive of interest or earnings): $388 million for 2004; $181 million for 2005; $154 million for 2006; $185 million for 2007; $250 million for 2008; $211 million for 2009; $218 million for 2010; $166 million for 2011; $214 million for 2012; $224 million for 2013; $258 million for 2014; $313 million for 2015; $305 million for 2016; $297 million for 2017; $340 million for 2018 and $441 million for 2019. These maximum amounts will be reduced, likely substantially, to reflect the settlements with the signatory states and New York, and potentially for current and future calculation disputes and other developments. Finally, PM USA’s recovery of these amounts, even as reduced, is dependent upon subsequent determinations regarding state-specific defenses and disputes with other PMs.

Other Disputes Under the State Settlement Agreements

The payment obligations of the tobacco product manufacturers that are parties to the State Settlement Agreements, as well as the allocations of any NPM Adjustments and related settlements, have been and may continue to be affected by R.J. Reynolds’s acquisition of Lorillard and its related sale of certain cigarette brands to ITG (the “ITG brands”). In particular, R.J. Reynolds and ITG have asserted that they do not have to make payments on the ITG brands under the Florida, Minnesota and Texas State Settlement Agreements or include the ITG brands for purposes of certain calculations under the State Settlement Agreements. PM USA believes that R.J. Reynolds’s and ITG’s position violates the State Settlement Agreements and applicable law. PM USA further believes that these actions: (i) improperly increased PM USA’s payments for 2015-2019; (ii) may improperly increase PM USA’s payments for subsequent years; (iii) improperly decreased PM USA’s share of the 2015-2019 NPM Adjustments and of the settlements of related disputes; and (iv) may improperly decrease PM USA’s share of NPM Adjustments and related settlements for subsequent years.

In January 2017, PM USA and the State of Florida each filed a motion in Florida state court against R.J. Reynolds and ITG seeking to enforce the Florida State Settlement Agreement. In August 2018, the Florida trial court entered final judgment ruling that R.J. Reynolds (and not ITG) must make settlement payments under the Florida State Settlement Agreement on the ITG brands, and ordering R.J. Reynolds to pay PM USA approximately $9.8 million (inclusive of interest) for the 2015-2017 period. R.J. Reynolds and PM USA have each filed notices of appeal of the trial court’s decision, which proceedings may result in further modifications to PM USA’s settlement payments under the Florida State Settlement Agreement.

In March 2018, PM USA and the State of Minnesota filed pleadings in Minnesota state court asserting claims against R.J. Reynolds and ITG, similar to those made in Florida, and seeking to enforce the Minnesota State Settlement Agreement. In September 2019, the Minnesota court granted the State of Minnesota’s and PM USA’s motions to enforce the agreement against R.J. Reynolds. The Minnesota court concluded, however, that it could not yet resolve the question of ITG’s liability under the Minnesota State Settlement Agreement. An evidentiary hearing on the question of ITG’s potential liability is to be held in 2020.

In December 2018, PM USA filed a motion in Mississippi state court seeking to enforce the Mississippi State Settlement Agreement against R.J. Reynolds and ITG with respect to the accuracy of certain submissions made by R.J. Reynolds and ITG concerning the calculation of payments relating to the ITG brands. In December 2019, in a separate matter, the State of Mississippi filed a motion in Mississippi state court seeking to enforce the Mississippi State Settlement Agreement against PM USA, R.J. Reynolds and ITG concerning the calculation of the April 2019 payments.

In January 2019, PM USA and the State of Texas each filed a motion in federal court in the Eastern District of Texas asserting claims against R.J. Reynolds and ITG, similar to those made in Florida and Minnesota, seeking to enforce the Texas State Settlement Agreement. On February 25, 2020, the Texas court granted the State of Texas’ and PM USA’s motions to enforce the settlement agreement against R.J. Reynolds. The Texas court, however, deferred the ultimate resolution of the motions to

34

enforce against ITG, because it concluded that question was dependent upon the outcome of separate litigation pending between ITG and R.J. Reynolds in the Delaware Court of Chancery.

Federal Government’s Lawsuit

In 1999, the United States government filed a lawsuit in the U.S. District Court for the District of Columbia against various cigarette manufacturers, including PM USA, and others, including Altria, asserting claims under three federal statutes. The case ultimately proceeded only under the civil provisions of RICO. In August 2006, the district court held that certain defendants, including Altria and PM USA, violated RICO and engaged in seven of the eight “sub-schemes” to defraud that the government had alleged. Specifically, the court found that:

▪
defendants falsely denied, distorted and minimized the significant adverse health consequences of smoking;
▪
defendants hid from the public that cigarette smoking and nicotine are addictive;
▪
defendants falsely denied that they control the level of nicotine delivered to create and sustain addiction;
▪
defendants falsely marketed and promoted “low tar/light” cigarettes as less harmful than full-flavor cigarettes;
▪
defendants falsely denied that they intentionally marketed to youth;
▪
defendants publicly and falsely denied that ETS is hazardous to non-smokers; and
▪
defendants suppressed scientific research.

The court did not impose monetary penalties on defendants, but ordered the following relief: (i) an injunction against “committing any act of racketeering” relating to the manufacturing, marketing, promotion, health consequences or sale of cigarettes in the United States; (ii) an injunction against participating directly or indirectly in the management or control of the Council for Tobacco Research, the Tobacco Institute, or the Center for Indoor Air Research, or any successor or affiliated entities of each; (iii) an injunction against “making, or causing to be made in any way, any material false, misleading, or deceptive statement or representation or engaging in any public relations or marketing endeavor that is disseminated to the United States public and that misrepresents or suppresses information concerning cigarettes;” (iv) an injunction against conveying any express or implied health message or health descriptors on cigarette packaging or in cigarette advertising or promotional material, including “lights,” “ultra lights” and “low tar,” which the court found could cause consumers to believe one cigarette brand is less hazardous than another brand; (v) the issuance of “corrective statements” in various media regarding the adverse health effects of smoking, the addictiveness of smoking and nicotine, the lack of any significant health benefit from smoking “low tar” or “light” cigarettes, defendants’ manipulation of cigarette design to ensure optimum nicotine delivery and the adverse health effects of exposure to ETS; (vi) the disclosure on defendants’ public document websites and in the Minnesota document repository of all documents produced to the government in the lawsuit or produced in any future court or administrative action concerning smoking and health until 2021, with certain additional requirements as to documents withheld from production under a claim of privilege or confidentiality; (vii) the disclosure of disaggregated marketing data to the government in the same form and on the same schedule as defendants now follow in disclosing such data to the FTC for a period of 10 years; (viii) certain restrictions on the sale or transfer by defendants of any cigarette brands, brand names, formulas or cigarette businesses within the U.S.; and (ix) payment of the government’s costs in bringing the action.

Following several years of appeals relating to the content of the corrective statements remedy described above, in October 2017, the district court approved the parties’ proposed consent order implementing corrective statements in newspapers and on television. The corrective statements began appearing in newspapers and on television in the fourth quarter of 2017. In April 2018, the parties reached agreement on the implementation details of the corrective statements on websites and onserts. The corrective statements began appearing on websites in the second quarter of 2018 and the onserts began appearing in the fourth quarter of 2018.

In 2014, Altria and PM USA recorded provisions totaling $31 million for the estimated costs of implementing the corrective communications remedy. In the fourth quarter of 2019, PM USA updated its estimate and recorded approximately $5 million for additional costs to finish implementing the corrective communications remedy.

The requirements related to corrective statements at point-of-sale remain outstanding. In May 2014, the district court ordered further briefing on the issue, which was completed in June 2014. In May 2018, the parties submitted a joint status report and additional briefing on point-of-sale signage to the district court. In May 2019, the district court ordered a hearing on the point-of-sale signage issue.


35

E-vapor Product Litigation

As of April 27, 2020, Altria and/or its subsidiaries, including PM USA, were named as defendants in 24 class action lawsuits relating to JUUL e-vapor products. JUUL is an additional named defendant in each of these lawsuits. The theories of recovery include violation of RICO, fraud, failure to warn, design defect, negligence and unfair trade practices. Plaintiffs also are seeking to add antitrust claims due to the recent action by the FTC. See Antitrust Litigation below for further discussion. Plaintiffs seek various remedies, including compensatory and punitive damages and an injunction prohibiting product sales.

Altria and/or its subsidiaries, including PM USA, also have been named as defendants in other lawsuits involving JUUL e-vapor products, including 170 individual lawsuits, five lawsuits filed by state or local governments and three lawsuits filed by school districts. JUUL is an additional named defendant in each of these lawsuits.

The majority of the individual and class action lawsuits mentioned above were filed in federal court. In October 2019, the United States Judicial Panel on Multidistrict Litigation ordered the coordination or consolidation of these lawsuits in the U.S. District Court for the Northern District of California for pretrial purposes.

An additional group of cases is pending in California state courts. In January 2020, the Judicial Council of California determined that this group of cases was appropriate for coordination and assigned the group to the Superior Court of California, Los Angeles County, for pretrial purposes.

Neither Altria nor any of its subsidiaries has filed a response in any of these cases, and no case in which Altria or any of its subsidiaries is named has been set for trial.

JUUL also is named in a significant number of additional individual and class action lawsuits to which neither Altria nor any of its subsidiaries is currently named.

Certain Other Tobacco-Related Litigation

IQOS Litigation

In April 2020, RAI Strategic Holdings, Inc. and R.J. Reynolds Vapor Co., which are affiliates of R.J. Reynolds, filed a lawsuit against Altria, PM USA, Altria Client Services LLC, PMI and its affiliate Philip Morris Products S.A., in the United States District Court for the Eastern District of Virginia. The lawsuit asserts claims of patent infringement based on the sale of the IQOS electronic device and HeatSticks in the United States. Plaintiffs seek various remedies, including preliminary and permanent injunctive relief, treble damages and attorneys’ fees.

Also in April 2020, a related action was filed against the same defendants by the same plaintiffs, as well as R.J. Reynolds, with the United States International Trade Commission (“ITC”). There, the plaintiffs also allege patent infringement, but the remedies sought include a prohibition on the importation of the IQOS electronic device, HeatSticks and component parts into the United States. No damages are recoverable in the proceedings before the ITC.

“Lights/Ultra Lights” Cases and Other Smoking and Health Class Actions

Plaintiffs have sought certification of their cases as class actions, alleging among other things, that the uses of the terms “Lights” and/or “Ultra Lights” constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment or breach of warranty, and have sought injunctive and equitable relief, including restitution and, in certain cases, punitive damages. These class actions have been brought against PM USA and, in certain instances, Altria or its other subsidiaries, on behalf of individuals who purchased and consumed various brands of cigarettes. Defenses raised in these cases include lack of misrepresentation, lack of causation, injury and damages, the statute of limitations, non-liability under state statutory provisions exempting conduct that complies with federal regulatory directives, and the First Amendment. Twenty-one state courts in 23 “Lights” cases have refused to certify class actions, dismissed class action allegations, reversed prior class certification decisions or have entered judgment in favor of PM USA. As of April 27, 2020, two “Lights/Ultra Lights” class actions are pending in U.S. state court. Neither case is active.

As of April 27, 2020, two smoking and health cases alleging personal injury or seeking court-supervised programs or ongoing medical monitoring and purporting to be brought on behalf of a class of individual plaintiffs, are pending in their respective U.S. state courts. Neither case is active.


36

UST Litigation

UST and/or its tobacco subsidiaries have been named in a number of individual tobacco and health lawsuits over time. Plaintiffs’ allegations of liability in these cases have been based on various theories of recovery, such as negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, breach of implied warranty, addiction and breach of consumer protection statutes. Plaintiffs have typically sought various forms of relief, including compensatory and punitive damages, and certain equitable relief, including but not limited to disgorgement. Defenses raised in these cases include lack of causation, assumption of the risk, comparative fault and/or contributory negligence, and statutes of limitations. As of April 27, 2020, there is one case pending against USSTC.

Antitrust Litigation

In April 2020, the FTC issued an administrative complaint against Altria and JUUL alleging that Altria’s 35% investment in JUUL and the associated agreements constitute an unreasonable restraint of trade in violation of Section 1 of the Sherman Antitrust Act of 1890 (“Sherman Act”) and Section 5 of the Federal Trade Commission Act of 1914 (“FTC Act”), and substantially lessened competition in violation of Section 7 of the Clayton Antitrust Act (“Clayton Act”). If the FTC’s challenge is successful, the FTC may order a broad range of remedies, including divestiture of Altria’s minority investment in JUUL, rescission of the transaction and all associated agreements, and prohibition against any officer or director of either Altria or JUUL serving on the other party’s board of directors or attending meetings of the other party’s board of directors. The administrative trial will take place before an FTC administrative law judge and is currently scheduled to begin March 11, 2021. Any ruling by the FTC is subject to review by the FTC Commissioners and subsequently, by a federal appellate court.

Also as of April 27, 2020, three putative class action lawsuits were filed against Altria and JUUL in the United States District Court for the Northern District of California. The lawsuits cite the FTC administrative complaint and allege that Altria and JUUL violated Sections 1 and 2 of the Sherman Act and Section 7 of the Clayton Act by restraining trade and/or substantially lessening competition in the U.S. closed-system electronic cigarette market. Plaintiffs seek various remedies, including treble damages, attorneys’ fees, a declaration that the agreements between Altria and JUUL are invalid, divestiture of Altria’s minority investment in JUUL and rescission of the transaction.

Neither the FTC nor the private plaintiffs has sought to preliminarily enjoin Altria from converting Altria’s non-voting JUUL shares to voting shares or appointing directors to the JUUL board of directors. As of April 30, 2020, Altria has not exercised these rights.

Shareholder Class Actions

In October and December 2019, two purported Altria shareholders filed putative class action lawsuits against Altria, Howard A. Willard III, Altria’s former Chairman and Chief Executive Officer, and William F. Gifford, Jr., Altria’s former Vice Chairman and Chief Financial Officer and current Chief Executive Officer, in the United States District Court for the Eastern District of New York. In December 2019, the court consolidated the two lawsuits into a single proceeding. The consolidated lawsuit was subsequently transferred to the United States District Court for the Eastern District of Virginia. The lawsuit asserts claims under Sections 10(b) and 20(a) and under Rule 10b-5 of the Exchange Act. In April 2020, JUUL, its founders, and some of its current and former executives were added to the lawsuit. The claims involve allegedly false and misleading statements and omissions relating to Altria’s investment in JUUL. Plaintiffs seek various remedies, including damages and attorneys’ fees. A response to the lawsuit has not yet been filed.

Environmental Regulation

Altria and its subsidiaries (and former subsidiaries) are subject to various federal, state and local laws and regulations concerning the discharge of materials into the environment, or otherwise related to environmental protection, including, in the U.S.: the Clean Air Act, the Clean Water Act, the Resource Conservation and Recovery Act and the Comprehensive Environmental Response, Compensation and Liability Act (commonly known as “Superfund”), which can impose joint and several liability on each responsible party. Subsidiaries (and former subsidiaries) of Altria are involved in several matters subjecting them to potential costs of remediation and natural resource damages under Superfund or other laws and regulations. Altria’s subsidiaries expect to continue to make capital and other expenditures in connection with environmental laws and regulations.

Altria provides for expenses associated with environmental remediation obligations on an undiscounted basis when such amounts are probable and can be reasonably estimated. Such accruals are adjusted as new information develops or

37

circumstances change. Other than those amounts, it is not possible to reasonably estimate the cost of any environmental remediation and compliance efforts that subsidiaries of Altria may undertake in the future. In the opinion of management, however, compliance with environmental laws and regulations, including the payment of any remediation costs or damages and the making of related expenditures, has not had, and is not expected to have, a material adverse effect on Altria’s consolidated results of operations, capital expenditures, financial position or cash flows.

Guarantees and Other Similar Matters

In the ordinary course of business, certain subsidiaries of Altria have agreed to indemnify a limited number of third parties in the event of future litigation. At March 31, 2020, Altria and certain of its subsidiaries (i) had $50 million of unused letters of credit obtained in the ordinary course of business; (ii) were contingently liable for guarantees related to their own performance, including $27 million for surety bonds; and (iii) had a redeemable noncontrolling interest of $38 million recorded on its condensed consolidated balance sheet. In addition, from time to time, subsidiaries of Altria issue lines of credit to affiliated entities. These items have not had, and are not expected to have, a significant impact on Altria’s liquidity.

Under the terms of a distribution agreement between Altria and PMI (the “Distribution Agreement”), entered into as a result of Altria’s 2008 spin-off of its former subsidiary PMI, liabilities concerning tobacco products will be allocated based in substantial part on the manufacturer. PMI will indemnify Altria and PM USA for liabilities related to tobacco products manufactured by PMI or contract manufactured for PMI by PM USA, and PM USA will indemnify PMI for liabilities related to tobacco products manufactured by PM USA, excluding tobacco products contract manufactured for PMI. Altria does not have a related liability recorded on its condensed consolidated balance sheet at March 31, 2020 as the fair value of this indemnification is insignificant.

As more fully discussed in Note 12. Condensed Consolidating Financial Information, PM USA has issued guarantees relating to Altria’s obligations under its outstanding debt securities, borrowings under its $3.0 billion Credit Agreement and amounts outstanding under its commercial paper program.

Note 12. Condensed Consolidating Financial Information:

PM USA, which is a 100% owned subsidiary of Altria Group, Inc., has guaranteed Altria Group, Inc.’s obligations under its outstanding debt securities, borrowings under its Credit Agreement and amounts outstanding under its commercial paper program (the “Guarantees”). Pursuant to the Guarantees, PM USA fully and unconditionally guarantees, as primary obligor, the payment and performance of Altria Group, Inc.’s obligations under the guaranteed debt instruments (the “Obligations”), subject to release under certain customary circumstances as noted below.

The Guarantees provide that PM USA guarantees the punctual payment when due, whether at stated maturity, by acceleration or otherwise, of the Obligations. The liability of PM USA under the Guarantees is absolute and unconditional irrespective of: any lack of validity, enforceability or genuineness of any provision of any agreement or instrument relating thereto; any change in the time, manner or place of payment of, or in any other term of, all or any of the Obligations, or any other amendment or waiver of or any consent to departure from any agreement or instrument relating thereto; any exchange, release or non-perfection of any collateral, or any release or amendment or waiver of or consent to departure from any other guarantee, for all or any of the Obligations; or any other circumstance that might otherwise constitute a defense available to, or a discharge of, Altria Group, Inc. or PM USA.

The obligations of PM USA under the Guarantees are limited to the maximum amount as will not result in PM USA’s obligations under the Guarantees constituting a fraudulent transfer or conveyance, after giving effect to such maximum amount and all other contingent and fixed liabilities of PM USA that are relevant under Bankruptcy Law, the Uniform Fraudulent Conveyance Act, the Uniform Fraudulent Transfer Act or any similar federal or state law to the extent applicable to the Guarantees. For this purpose, “Bankruptcy Law” means Title 11, U.S. Code, or any similar federal or state law for the relief of debtors.


38

PM USA will be unconditionally released and discharged from the Obligations upon the earliest to occur of:

▪
the date, if any, on which PM USA consolidates with or merges into Altria Group, Inc. or any successor;
▪
the date, if any, on which Altria Group, Inc. or any successor consolidates with or merges into PM USA;
▪
the payment in full of the Obligations pertaining to such Guarantees; and
▪
the rating of Altria Group, Inc.’s long-term senior unsecured debt by Standard & Poor’s Ratings Services of A or higher.

At March 31, 2020, the respective principal 100% owned subsidiaries of Altria Group, Inc. and PM USA were not limited by long-term debt or other agreements in their ability to pay cash dividends or make other distributions with respect to their equity interests.

The following sets forth the condensed consolidating balance sheets as of March 31, 2020 and December 31, 2019, condensed consolidating statements of earnings and comprehensive earnings for the three months ended March 31, 2020 and 2019, and condensed consolidating statements of cash flows for the three months ended March 31, 2020 and 2019 for Altria Group, Inc., PM USA and, collectively, Altria Group, Inc.’s other subsidiaries that are not guarantors of Altria Group, Inc.’s debt instruments (the “Non-Guarantor Subsidiaries”).

The financial information may not necessarily be indicative of results of operations or financial position had PM USA and the Non-Guarantor Subsidiaries operated as independent entities. Altria Group, Inc. and PM USA account for investments in their subsidiaries under the equity method of accounting.


39

Condensed Consolidating Balance Sheets
March 31, 2020
(in millions of dollars)

 
 
Altria Group, Inc.

 
PM USA

 
Non-
Guarantor
Subsidiaries

 
Total
Consolidating
Adjustments

 
Consolidated

Assets
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
5,548

 
$
1

 
$
67

 
$
—

 
$
5,616

Receivables
 
—

 
17

 
130

 
—

 
147

Inventories:
 
 
 
 
 
 
 
 
 
 
Leaf tobacco
 
—

 
508

 
387

 
—

 
895

Other raw materials
 
—

 
123

 
70

 
—

 
193

Work in process
 
—

 
6

 
461

 
—

 
467

Finished product
 
—

 
87

 
364

 
—

 
451

 
 
—

 
724

 
1,282

 
—

 
2,006

Due from Altria Group, Inc. and subsidiaries
 
91

 
5,660

 
1,361

 
(7,112
)
 
—

Other current assets
 
301

 
23

 
68

 
(226
)
 
166

Total current assets
 
5,940

 
6,425

 
2,908

 
(7,338
)
 
7,935

Property, plant and equipment, at cost
 
—

 
2,970

 
2,133

 
—

 
5,103

Less accumulated depreciation
 
—

 
2,186

 
920

 
—

 
3,106

 
 
—

 
784

 
1,213

 
—

 
1,997

Goodwill
 
—

 
—

 
5,177

 
—

 
5,177

Other intangible assets, net
 
—

 
2

 
12,666

 
—

 
12,668

Investments in equity securities
 
18,453

 
—

 
5,408

 
—

 
23,861

Investment in consolidated subsidiaries
 
18,905

 
2,867

 
—

 
(21,772
)
 
—

Due from Altria Group, Inc. and subsidiaries
 
4,790

 
—

 
—

 
(4,790
)
 
—

Other assets
 
71

 
950

 
567

 
(608
)
 
980

Total Assets
 
$
48,159

 
$
11,028

 
$
27,939

 
$
(34,508
)
 
$
52,618


40

Condensed Consolidating Balance Sheets (Continued)
March 31, 2020
(in millions of dollars)

 
 
Altria Group, Inc.

 
PM USA

 
Non-
Guarantor
Subsidiaries

 
Total
Consolidating
Adjustments

 
Consolidated

Liabilities
 
 
 
 
 
 
 
 
 
 
Short-term borrowings
 
$
3,000

 
$
—

 
$
—

 
$
—

 
$
3,000

Accounts payable
 
1

 
136

 
141

 
—

 
278

Accrued liabilities:
 
 
 
 
 
 
 
 
 
 
Marketing
 
—

 
391

 
76

 
—

 
467

Settlement charges
 
—

 
4,410

 
9

 
—

 
4,419

Other
 
312

 
343

 
377

 
—

 
1,032

Income taxes
 
6

 
508

 
105

 
(226
)
 
393

Dividends payable
 
1,565

 
—

 
—

 
—

 
1,565

Due to Altria Group, Inc. and subsidiaries
 
6,278

 
587

 
247

 
(7,112
)
 
—

Total current liabilities
 
11,162

 
6,375

 
955

 
(7,338
)
 
11,154

Long-term debt
 
26,971

 
—

 
—

 
—

 
26,971

Deferred income taxes
 
3,228

 
—

 
2,571

 
(608
)
 
5,191

Accrued pension costs
 
196

 
—

 
231

 
—

 
427

Accrued postretirement health care costs
 
—

 
1,076

 
722

 
—

 
1,798

Due to Altria Group, Inc. and subsidiaries
 
—

 
—

 
4,790

 
(4,790
)
 
—

Other liabilities
 
59

 
90

 
253

 
—

 
402

Total liabilities
 
41,616

 
7,541

 
9,522

 
(12,736
)
 
45,943

Contingencies
 


 


 


 


 


Redeemable noncontrolling interest
 
—

 
—

 
38

 
—

 
38

Stockholders’ Equity
 
 
 
 
 
 
 
 
 
 
Common stock
 
935

 
—

 
9

 
(9
)
 
935

Additional paid-in capital
 
5,959

 
3,310

 
27,566

 
(30,876
)
 
5,959

Earnings reinvested in the business
 
36,528

 
393

 
(7,441
)
 
7,048

 
36,528

Accumulated other comprehensive losses
 
(2,533
)
 
(216
)
 
(1,849
)
 
2,065

 
(2,533
)
Cost of repurchased stock
 
(34,346
)
 
—

 
—

 
—

 
(34,346
)
Total stockholders’ equity attributable
 to Altria Group, Inc.
 
6,543

 
3,487

 
18,285

 
(21,772
)
 
6,543

Noncontrolling interests
 
—

 
—

 
94

 
—

 
94

Total stockholders’ equity
 
6,543

 
3,487

 
18,379

 
(21,772
)
 
6,637

Total Liabilities and Stockholders’ Equity
 
$
48,159

 
$
11,028

 
$
27,939

 
$
(34,508
)
 
$
52,618


41

Condensed Consolidating Balance Sheets
December 31, 2019
(in millions of dollars)

 
 
Altria Group, Inc.

 
PM USA

 
Non-
Guarantor
Subsidiaries

 
Total
Consolidating
Adjustments

 
Consolidated

Assets
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
2,022

 
$
—

 
$
95

 
$
—

 
$
2,117

Receivables
 
—

 
30

 
122

 
—

 
152

Inventories:
 
 
 
 
 
 
 
 
 
 
Leaf tobacco
 
—

 
494

 
380

 
—

 
874

Other raw materials
 
—

 
120

 
72

 
—

 
192

Work in process
 
—

 
4

 
692

 
—

 
696

Finished product
 
—

 
119

 
412

 
—

 
531

 
 
—

 
737

 
1,556

 
—

 
2,293

Due from Altria Group, Inc. and subsidiaries
 
88

 
4,005

 
1,359

 
(5,452
)
 
—

Other current assets
 
133

 
64

 
114

 
(49
)
 
262

Total current assets
 
2,243

 
4,836

 
3,246

 
(5,501
)
 
4,824

Property, plant and equipment, at cost
 
—

 
2,956

 
2,118

 
—

 
5,074

Less accumulated depreciation
 
—

 
2,166

 
909

 
—

 
3,075

 
 
—

 
790

 
1,209

 
—

 
1,999

Goodwill
 
—

 
—

 
5,177

 
—

 
5,177

Other intangible assets, net
 
—

 
2

 
12,685

 
—

 
12,687

Investments in equity securities
 
18,071

 
—

 
5,510

 
—

 
23,581

Investment in consolidated subsidiaries
 
19,312

 
2,831

 
—

 
(22,143
)
 
—

Due from Altria Group, Inc. and subsidiaries
 
4,790

 
—

 
—

 
(4,790
)
 
—

Other assets
 
58

 
951

 
603

 
(609
)
 
1,003

Total Assets
 
$
44,474

 
$
9,410

 
$
28,430

 
$
(33,043
)
 
$
49,271


42

Condensed Consolidating Balance Sheets (Continued)
December 31, 2019
(in millions of dollars)

 
 
Altria Group, Inc.

 
PM USA

 
Non-
Guarantor
Subsidiaries

 
Total
Consolidating
Adjustments

 
Consolidated

Liabilities
 
 
 
 
 
 
 
 
 
 
Current portion of long-term debt
 
$
1,000

 
$
—

 
$
—

 
$
—

 
$
1,000

Accounts payable
 
—

 
146

 
179

 
—

 
325

Accrued liabilities:
 
 
 
 
 
 
 
 
 
 
Marketing
 
—

 
320

 
73

 
—

 
393

Settlement charges
 
—

 
3,340

 
6

 
—

 
3,346

Other
 
570

 
482

 
481

 
—

 
1,533

Income taxes
 
6

 
—

 
55

 
(49
)
 
12

Dividends payable
 
1,565

 
—

 
—

 
—

 
1,565

Due to Altria Group, Inc. and subsidiaries
 
4,693

 
514

 
245

 
(5,452
)
 
—

Total current liabilities
 
7,834

 
4,802

 
1,039

 
(5,501
)
 
8,174

Long-term debt
 
27,042

 
—

 
—

 
—

 
27,042

Deferred income taxes
 
3,099

 
—

 
2,593

 
(609
)
 
5,083

Accrued pension costs
 
197

 
—

 
276

 
—

 
473

Accrued postretirement health care costs
 
—

 
1,078

 
719

 
—

 
1,797

Due to Altria Group, Inc. and subsidiaries
 
—

 
—

 
4,790

 
(4,790
)
 
—

Other liabilities
 
80

 
87

 
178

 
—

 
345

Total liabilities
 
38,252

 
5,967

 
9,595

 
(10,900
)
 
42,914

Contingencies
 


 


 


 


 


Redeemable noncontrolling interest
 
—

 
—

 
38

 
—

 
38

Stockholders’ Equity
 
 
 
 
 
 
 
 
 
 
Common stock
 
935

 
—

 
9

 
(9
)
 
935

Additional paid-in capital
 
5,970

 
3,310

 
27,565

 
(30,875
)
 
5,970

Earnings reinvested in the business
 
36,539

 
352

 
(6,997
)
 
6,645

 
36,539

Accumulated other comprehensive losses
 
(2,864
)
 
(219
)
 
(1,877
)
 
2,096

 
(2,864
)
Cost of repurchased stock
 
(34,358
)
 
—

 
—

 
—

 
(34,358
)
Total stockholders’ equity attributable
to Altria Group, Inc.
 
6,222

 
3,443

 
18,700

 
(22,143
)
 
6,222

Noncontrolling interests
 
—

 
—

 
97

 
—

 
97

Total stockholders’ equity
 
6,222

 
3,443

 
18,797

 
(22,143
)
 
6,319

Total Liabilities and Stockholders’ Equity
 
$
44,474

 
$
9,410

 
$
28,430

 
$
(33,043
)
 
$
49,271




43

Condensed Consolidating Statements of Earnings and Comprehensive Earnings
For the Three Months Ended March 31, 2020
(in millions of dollars)

 
 
Altria Group, Inc.

 
PM USA

 
Non-
Guarantor
Subsidiaries

 
Total
Consolidating
Adjustments

 
Consolidated

Net revenues
 
$
—

 
$
5,359

 
$
1,008

 
$
(8
)
 
$
6,359

Cost of sales
 
—

 
1,532

 
649

 
(8
)
 
2,173

Excise taxes on products
 
—

 
1,267

 
46

 
—

 
1,313

Gross profit
 
—

 
2,560

 
313

 
—

 
2,873

Marketing, administration and research costs
 
22

 
387

 
128

 
—

 
537

Operating income (expense)
 
(22
)
 
2,173

 
185

 
—

 
2,336

Interest and other debt expense (income), net
 
237

 
(18
)
 
56

 
—

 
275

Net periodic benefit (income) cost, excluding service cost
 
—

 
(22
)
 
(5
)
 
—

 
(27
)
Earnings from equity investments
 
(134
)
 
—

 
(23
)
 
—

 
(157
)
Loss on Cronos-related financial instruments
 
—

 
—

 
137

 
—

 
137

Earnings (losses) before income taxes and equity earnings of subsidiaries
 
(125
)
 
2,213


20


—


2,108

Provision (benefit) for income taxes
 
(32
)
 
550

 
40

 
—

 
558

Equity earnings of subsidiaries
 
1,645

 
126

 
—

 
(1,771
)
 
—

Net earnings
 
1,552

 
1,789

 
(20
)
 
(1,771
)
 
1,550

Net (earnings) losses attributable to noncontrolling interests
 
—

 
—

 
2

 
—

 
2

Net earnings attributable to Altria
 
$
1,552

 
$
1,789

 
$
(18
)
 
$
(1,771
)
 
$
1,552

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net earnings
 
$
1,552

 
$
1,789

 
$
(20
)
 
$
(1,771
)
 
$
1,550

Other comprehensive earnings (losses), net of deferred income taxes
 
331

 
3

 
28

 
(31
)
 
331

Comprehensive earnings
 
1,883

 
1,792

 
8

 
(1,802
)
 
1,881

Comprehensive (earnings) losses attributable to noncontrolling interests
 
—

 
—

 
2

 
—

 
2

Comprehensive earnings attributable to Altria
 
$
1,883

 
$
1,792

 
$
10

 
$
(1,802
)
 
$
1,883



44

Condensed Consolidating Statements of Earnings and Comprehensive Earnings
For the Three Months Ended March 31, 2019
(in millions of dollars)

 
 
Altria Group, Inc.

 
PM USA

 
Non-
Guarantor
Subsidiaries

 
Total
Consolidating
Adjustments

 
Consolidated

Net revenues
 
$
—

 
$
4,725

 
$
913

 
$
(10
)
 
$
5,628

Cost of sales
 
—

 
1,340

 
248

 
(10
)
 
1,578

Excise taxes on products
 
—

 
1,185

 
54

 
—

 
1,239

Gross profit
 
—

 
2,200

 
611

 
—

 
2,811

Marketing, administration and research costs
 
35

 
384

 
114

 
—

 
533

Asset impairment and exit costs
 
1

 
35

 
4

 
—

 
40

Operating income (expense)
 
(36
)
 
1,781

 
493

 
—

 
2,238

Interest and other debt expense (income), net
 
355

 
(25
)
 
54

 
—

 
384

Net periodic benefit (income) cost, excluding service cost
 
1

 
—

 
(2
)
 
—

 
(1
)
Earnings from equity investments
 
(86
)
 
—

 
—

 
—

 
(86
)
Loss on Cronos-related financial instruments
 
—

 
—

 
425

 
—

 
425

Earnings (losses) before income taxes and equity earnings of subsidiaries
 
(306
)
 
1,806

 
16

 
—

 
1,516

Provision (benefit) for income taxes
 
(75
)
 
459

 
11

 
—

 
395

Equity earnings of subsidiaries
 
1,351

 
95

 
—

 
(1,446
)
 
—

Net earnings
 
1,120

 
1,442

 
5

 
(1,446
)
 
1,121

Net (earnings) losses attributable to noncontrolling interests
 
—

 
—

 
(1
)
 
—

 
(1
)
Net earnings attributable to Altria
 
$
1,120

 
$
1,442

 
$
4

 
$
(1,446
)
 
$
1,120

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net earnings
 
$
1,120

 
$
1,442

 
$
5

 
$
(1,446
)
 
$
1,121

Other comprehensive earnings (losses), net of deferred income taxes
 
(170
)
 
5

 
23

 
(28
)
 
(170
)
Comprehensive earnings
 
950

 
1,447

 
28

 
(1,474
)
 
951

Comprehensive (earnings) losses attributable to noncontrolling interests
 
—

 
—

 
(1
)
 
—

 
(1
)
Comprehensive earnings attributable to Altria
 
$
950

 
$
1,447

 
$
27

 
$
(1,474
)
 
$
950



45

Condensed Consolidating Statements of Cash Flows
For the Three Months Ended March 31, 2020
(in millions of dollars)

 
 
Altria Group, Inc.

 
PM USA

 
Non-
Guarantor
Subsidiaries

 
Total
Consolidating
Adjustments

 
Consolidated

Cash Provided by (Used In) Operating Activities
 
 
 
 
 
 
 
 
 
 
Net cash provided by (used in) operating activities
 
$
1,515

 
$
3,351

 
$
437

 
$
(2,174
)
 
$
3,129

Cash Provided by (Used in) Investing Activities
 
 
 
 
 
 
 
 
 
 
Capital expenditures
 
—

 
(15
)
 
(37
)
 
—

 
(52
)
Investment in consolidated subsidiaries
 
(1
)
 
—

 
—

 
1

 
—

Other, net
 
—

 
—

 
—

 
—

 
—

Net cash provided by (used in) investing activities
 
(1
)
 
(15
)
 
(37
)
 
1

 
(52
)
Cash Provided by (Used in) Financing Activities
 
 
 
 
 
 
 
 
 
 
Proceeds from short-term borrowings
 
3,000

 
—

 
—

 
—

 
3,000

Long-term debt repaid
 
(1,000
)
 
—

 
—

 
—

 
(1,000
)
Dividends paid on common stock
 
(1,563
)
 
—

 
—

 
—

 
(1,563
)
Changes in amounts due to/from Altria Group, Inc.
and subsidiaries
 
1,584

 
(1,582
)
 
(1
)
 
(1
)
 
—

Cash dividends paid to parent
 
—

 
(1,748
)
 
(426
)
 
2,174

 
—

Other, net
 
(9
)
 
—

 
(1
)
 
—

 
(10
)
Net cash provided by (used in) financing activities
 
2,012

 
(3,330
)
 
(428
)
 
2,173

 
427

Cash, cash equivalents and restricted cash (1):
 
 
 
 
 
 
 
 
 
 
Increase (decrease)
 
3,526

 
6

 
(28
)
 
—

 
3,504

Balance at beginning of period
 
2,022

 
43

 
95

 
—

 
2,160

Balance at end of period
 
$
5,548

 
$
49

 
$
67

 
$
—

 
$
5,664

(1)
Restricted cash consisted of cash deposits collateralizing appeal bonds posted by PM USA to obtain stays of judgments pending appeals. See Note 11. Contingencies.

46

Condensed Consolidating Statements of Cash Flows
For the Three Months Ended March 31, 2019
(in millions of dollars)

 
 
Altria Group, Inc.

 
PM USA

 
Non-
Guarantor
Subsidiaries

 
Total
Consolidating
Adjustments

 
Consolidated

Cash Provided by (Used In) Operating Activities
 
 
 
 
 
 
 
 
 
 
Net cash provided by (used in) operating activities
 
$
1,642

 
$
2,520

 
$
166

 
$
(2,039
)
 
$
2,289

Cash Provided by (Used in) Investing Activities
 
 
 
 
 
 
 
 
 
 
Capital expenditures
 
—

 
(9
)
 
(29
)
 
—

 
(38
)
Investment in Cronos
 
—

 
—

 
(1,831
)
 
—

 
(1,831
)
Investment in consolidated subsidiaries
 
(1,947
)
 
—

 
—

 
1,947

 
—

Other, net
 
(3
)
 
—

 
(78
)
 
—

 
(81
)
Net cash provided by (used in) investing activities
 
(1,950
)
 
(9
)
 
(1,938
)
 
1,947

 
(1,950
)
Cash Provided by (Used in) Financing Activities
 
 
 
 
 
 
 
 
 
 
Repayment of short-term borrowings
 
(12,800
)
 
—

 
—

 
—

 
(12,800
)
Long-term debt issued
 
16,265

 
—

 
—

 
—

 
16,265

Repurchases of common stock
 
(151
)
 
—

 
—

 
—

 
(151
)
Dividends paid on common stock
 
(1,502
)
 
—

 
—

 
—

 
(1,502
)
Changes in amounts due to/from Altria Group, Inc.
and subsidiaries
 
657

 
(771
)
 
2,061

 
(1,947
)
 
—

Cash dividends paid to parent
 
—

 
(1,737
)
 
(302
)
 
2,039

 
—

Other
 
(120
)
 
—

 
(9
)
 
—

 
(129
)
Net cash provided by (used in) financing activities
 
2,349

 
(2,508
)
 
1,750

 
92

 
1,683

Cash, cash equivalents and restricted cash (1):
 
 
 
 
 
 
 
 
 
 
Increase (decrease)
 
2,041

 
3

 
(22
)
 
—

 
2,022

Balance at beginning of period
 
1,277

 
100

 
56

 
—

 
1,433

Balance at end of period
 
$
3,318

 
$
103

 
$
34

 
$
—

 
$
3,455

(1) Restricted cash consisted of cash deposits collateralizing appeal bonds posted by PM USA to obtain stays of judgments pending appeals. See Note 11. Contingencies.


47

Note 13. New Accounting Guidance Not Yet Adopted:

The following table provides a description of issued accounting guidance applicable to, but not yet adopted by, Altria:
Standards
Description
Effective Date for Public Entity
Effect on Financial Statements
ASU 2019-12 Simplifying the Accounting for Income Taxes (Topic 740)
The guidance removes certain exceptions for investments, intraperiod allocations and interim calculations, and adds guidance to reduce complexity in accounting for income taxes.
The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early application is permitted, including adoption in any interim period.
Altria is in the process of evaluating the impact of this guidance on its consolidated financial statements and related disclosures.
ASU 2020-01 Clarifying the Interactions between Topic 321, Topic 323, and Topic 815
The guidance provides clarification of the interaction of rules for equity securities, the equity method of accounting, and forward contracts and purchase options on certain types of securities.
The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early application is permitted, including adoption in any interim period.
Altria is in the process of evaluating the impact of this guidance on its consolidated financial statements and related disclosures.



48

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Description of the Company

When used in this Quarterly Report on Form 10-Q (“Form 10-Q”), the terms "Altria," "we," "us" and "our" refers to Altria Group, Inc. and its subsidiaries, unless otherwise specified or unless otherwise required.

For a description of Altria, see Background in Note 1. Background and Basis of Presentation to the condensed consolidated financial statements in Part I, Item 1. Financial Statements of this Form 10-Q (“Item 1”).

In the first quarter of 2020, Altria renamed its smokeless products segment as the oral tobacco products segment. Altria’s reportable segments are smokeable products, oral tobacco products and wine. The financial services and the innovative tobacco products businesses are included in an all other category due to the continued reduction of the lease portfolio of Philip Morris Capital Corporation and the relative financial contribution of Altria’s innovative tobacco products businesses to Altria’s consolidated results.
Executive Summary

In this Management’s Discussion and Analysis of Financial Condition and Results of Operations section, Altria refers to the following “adjusted” financial measures: adjusted operating companies income (loss); adjusted operating companies income margins; adjusted net earnings attributable to Altria and adjusted diluted earnings per share attributable to Altria (“EPS”). These adjusted financial measures are not required by, or calculated in accordance with, United States generally accepted accounting principles (“GAAP”) and may not be calculated the same as similarly titled measures used by other companies. These adjusted financial measures should thus be considered as supplemental in nature and not considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. Except as noted below, when Altria provides a non-GAAP measure in this Form 10-Q, it also provides a reconciliation of that non-GAAP financial measure to the most directly comparable GAAP financial measure. For a further description of these non-GAAP financial measures, see the Non-GAAP Financial Measures section below.

COVID-19

The recent outbreak of the novel coronavirus, COVID-19, which was declared a pandemic by the World Health Organization on March 11, 2020, has led to adverse impacts on the U.S. and global economies and created economic uncertainty. Although much uncertainty still surrounds the pandemic, including its duration and ultimate overall impact on U.S and global economies, our subsidiaries’ operations and those of our investees, Altria is carefully evaluating potential outcomes and working to mitigate risks. Specifically, Altria is focused on any potential impact to our liquidity, operations, supply and distribution chains and on economic conditions.

In terms of Altria’s liquidity, despite some volatility in the commercial paper market in March 2020, Altria believes it is in a solid financial position and, for the coming quarters, expects to maintain a higher cash balance than normal to preserve its financial flexibility. As a precautionary measure, in March 2020, Altria borrowed the entire $3.0 billion available under its senior unsecured 5-year revolving credit agreement, dated August 1, 2018 (as amended, the “Credit Agreement”). In addition, Altria did not repurchase any shares in the first quarter of 2020 under its current $1.0 billion share repurchase program, and in April 2020, Altria’s Board of Directors (the “Board of Directors”) rescinded the $500 million remaining in the share repurchase program.

As with so many other companies throughout the U.S. and globally, Altria’s operations have been affected by COVID-19. Altria has implemented remote working for many employees and aligned with the recommended social distancing protocols from public health authorities. To date, Altria believes it has experienced minimal impact to productivity due to the remote working and its critical information technology systems have remained operational. Although Altria temporarily suspended operations at Philip Morris USA Inc.’s (“PM USA”) Richmond, Virginia-area manufacturing facilities, John Middleton Co.’s (Middleton) King of Prussia, Pennsylvania manufacturing facility, as well as U.S. Smokeless Tobacco Company LLC’s (“USSTC”) Nashville, Tennessee-area manufacturing facilities in March 2020, Altria resumed operations at those facilities under enhanced safety protocols in April 2020 and all of Altria’s manufacturing facilities are currently operational. In addition, Helix Innovations LLC (“Helix”) continues to build domestic manufacturing capacity for on! in the Richmond Manufacturing Center. Currently, installed annualized capacity is approximately 25 million cans; however, due to the impacts of COVID-19, Helix expects potential delays in its ability to achieve annualized production capacity of 50 million cans by mid-year and 75

49

million cans by the end of 2020. Altria is continuing to monitor the risks associated with facility disruptions and workforce availability as a result of COVID-19 uncertainty.

Altria’s suppliers and those within its distribution chain also may be subject to government action requiring the closure of a facility and remote working protocols. To date, Altria has not experienced any material disruptions to its supply chains or distribution systems, nor has it experienced any material adverse effects associated with governmental actions to restrict consumer movement or business operations, but is continuing to monitor these factors. The majority of retail stores in which Altria’s products are sold, including convenience stores, have been deemed to be essential businesses by authorities and have remained open. Altria is continuing to monitor the risk that a supplier, distributor or any other entity within our supply and distribution chain closes temporarily or permanently.

In March 2020, PM USA temporarily closed its Atlanta and Richmond IQOS stores and paused its IQOS interactive marketing efforts. PM USA will consider guidance from public health authorities and consumer sentiment in deciding when to reopen the stores and resume its interactive marketing approach. HeatSticks remain available for sale in over 500 Atlanta and Richmond retail stores, and PM USA does not currently anticipate product availability issues. PM USA has also delayed the launch of IQOS in Charlotte due to COVID-19 concerns.

Although Altria’s core tobacco businesses have not been materially impacted to date by COVID-19, there is uncertainty as to how COVID-19 may impact the adult consumer. Altria is monitoring the macro-economic risks of COVID-19 and their effect on adult tobacco consumers, including impacts to unemployment rates, consumer confidence levels, number of housing starts and gasoline prices. Altria is also monitoring adult tobacco consumers purchasing behavior, including overall tobacco product expenditures, mix between premium and discount brand purchases (including a significant increase in deep discount category volumes in the first quarter of 2020 versus the prior quarter) and interest in noncombustible products.

While Altria’s core tobacco businesses have not been materially impacted to date by COVID-19, Altria has experienced some impacts to its alcohol assets. In the wine business, Ste. Michelle Wine Estates Ltd.’s (“Ste. Michelle”) on-premise wine sales in restaurants, bars, hospitality venues and cruise lines have been negatively affected by COVID-19 disruptions. In the first quarter of 2020, Ste. Michelle recorded pre-tax charges of $392 million consisting of (i) the write-off of inventory and (ii) estimated losses on future non-cancelable grape purchase commitments associated with product volume demand uncertainty, which has been further impacted by the economic uncertainty surrounding COVID-19. Altria and Ste. Michelle also undertook a review of the wine business resulting in a strategic reset. Ste. Michelle will continue to monitor the impact of COVID-19 associated risks to its business, results of operations, cash flows or financial position.

Anheuser-Busch InBev SA/NV (“ABI’) has also been impacted by COVID-19, recently announcing a 50% reduction to its upcoming dividend and the withdrawal of its earning guidance for 2020 due to the uncertainty, volatility and impact of COVID-19. As a result of these announcements, Altria has reduced expectations for equity earnings and cash dividends from ABI in 2020. In addition, the extreme market disruption and volatility associated with COVID-19 has resulted in a steep decline in ABI’s stock price, and the fair value of Altria’s investment in ABI is now well below the carrying value of its investment in ABI. While Altria believes that this decline is temporary, it will continue to monitor its investment in ABI and the impact of COVID-19 on ABI’s business and market valuation. If Altria were to conclude that the decline in fair value is other than temporary, Altria would determine and recognize, in the period identified, the impairment of its investment, which could be material. Altria has considered the impact of COVID-19 on the businesses of JUUL Labs, Inc. (“JUUL”) and Cronos Group Inc. (“Cronos”), including their sales, distribution, operations, supply chain and liquidity, and, at this time, Altria believes the impact of COVID-19 to these businesses is not material, and Altria’s assessment, which included the consideration of potential impacts of COVID-19 on the businesses, did not result in impairment at March 31, 2020.

In addition, due to the uncertainties related to the impact of COVID-19 and varying economic recovery scenarios, Altria withdrew its forecast for its full-year 2020 adjusted diluted EPS growth rate. For further discussion, see 2020 Forecasted Results below.

50

Consolidated Results of Operations for the Three Months Ended March 31, 2020: The changes in net earnings attributable to Altria and diluted EPS attributable to Altria for the three months ended March 31, 2020, from the three months ended March 31, 2019, were due primarily to the following:
 
Net Earnings
 
Diluted EPS
 
(in millions, except per share data)
For the three months ended March 31, 2019
$
1,120

 
$
0.60

 
 
 
 
2019 Asset impairment, exit, implementation and acquisition-related costs
125

 
0.06

2019 Tobacco and health litigation items
13

 
0.01

2019 ABI-related special items 1
129

 
0.07

2019 Cronos-related special items
328

 
0.17

2019 Tax items
19

 
0.01

Subtotal 2019 special items
614

 
0.32

 
 
 
 
2020 Implementation and acquisition-related costs
(300
)
 
(0.16
)
2020 Tobacco and health litigation items
(19
)
 
(0.01
)
2020 ABI-related special items
(44
)
 
(0.03
)
2020 Cronos-related special items
(95
)
 
(0.05
)
2020 Tax items
(24
)
 
(0.01
)
Subtotal 2020 special items
(482
)
 
(0.26
)
 
 
 
 
Fewer shares outstanding
—

 
0.01

Change in tax rate
(1
)
 
—

Operations
301

 
0.16

For the three months ended March 31, 2020
$
1,552

 
$
0.83

 
 
 
 
2020 Reported Net Earnings
$
1,552

 
$
0.83

2019 Reported Net Earnings
$
1,120

 
$
0.60

% Change
38.6
%
 
38.3
%
 
 
 
 
2020 Adjusted Net Earnings and Adjusted Diluted EPS
$
2,034

 
$
1.09

2019 Adjusted Net Earnings and Adjusted Diluted EPS 1
$
1,734

 
$
0.92

% Change
17.3
%
 
18.5
%
1 Prior period amounts have been recast to conform with current period presentation for certain ABI mark-to-market adjustments that were not previously identified as special items and that are now excluded from Altria’s adjusted financial measures. For further discussion, see below.

For a discussion of events affecting the comparability of statement of earnings amounts and reconciliations of adjusted earnings attributable to Altria and adjusted diluted EPS attributable to Altria, see the Consolidated Operating Results section below.

Fewer Shares Outstanding: Fewer shares outstanding during the three months ended March 31, 2020 compared with the prior-year period were due primarily to shares repurchased by Altria under its share repurchase programs.

Operations: The increase of $301 million in operations shown in the table above was due primarily to higher income from the smokeable products and oral tobacco products segments, partially offset by lower earnings from Altria’s equity investment in ABI.

For further details, see the Consolidated Operating Results and Operating Results by Business Segment sections below.

2020 Forecasted Results: Due to the uncertainties related to the impact of the COVID-19 pandemic and economic recovery scenarios, Altria withdrew its forecast for its full-year 2020 adjusted diluted EPS growth rate of 4% to 7% over its 2019 full-year adjusted diluted EPS base, which has been recast to $4.21 (from $4.22) for a change in ABI-related special items as shown

51

in the table below. In making the decision, Altria considered various factors, including uncertain contributions from its equity investment in ABI and the potential impacts of COVID-19 on the macro-economic environment and adult tobacco consumers. Altria is continuing to assess the COVID-19 situation and intends to reestablish guidance at the appropriate time.

Reconciliation of 2019 Reported Diluted EPS to 2019 Adjusted Diluted EPS
2019 Reported diluted EPS
$
(0.70
)
Asset impairment, exit, implementation and acquisition-related costs
0.15

Tobacco and health litigation items
0.03

Impairment of JUUL equity securities
4.60

ABI-related special items 1
(0.16
)
Cronos-related special items
0.34

Tax items
(0.05
)
2019 Adjusted diluted EPS
$
4.21

1 Beginning in the first quarter of 2020, Altria changed its treatment of Altria’s share of ABI’s mark-to-market activity relating to certain ABI financial instruments associated with its share-based compensation programs that were previously included in Altria’s adjusted results. These amounts will now be treated as special items and excluded from Altria’s adjusted results. The change is consistent with Altria’s treatment of its share of ABI’s mark-to-market activity on ABI’s financial instruments associated with its other share commitments. Altria has recast prior period results to conform with current period presentation.


Discussion and Analysis

Critical Accounting Policies and Estimates

Altria’s critical accounting policies and estimates are discussed in its Annual Report on Form 10-K for the year ended December 31, 2019 (the “2019 Form 10-K”); there have been no material changes to these critical accounting policies and estimates, except as noted below.
▪
Investments in ABI and Cronos:
Altria reviews its equity investments accounted for under the equity method of accounting (ABI and Cronos) for impairment on a quarterly basis in connection with the preparation of its financial statements by comparing the fair value of each of its investments to their carrying value. If the carrying value of an investment exceeds its fair value and the loss in value is other than temporary, the investment is considered impaired and reduced to fair value, and the impairment is recognized in the period identified.
Investment in ABI
At March 31, 2020, Altria’s investment in ABI consisted of 185 million restricted shares of ABI (the “Restricted Shares”) and 12 million ordinary shares of ABI. The fair value of Altria’s equity investment in ABI is based on: (i) unadjusted quoted prices in active markets for ABI’s ordinary shares and was classified in Level 1 of the fair value hierarchy and (ii) observable inputs other than Level 1 prices, such as quoted prices for similar assets, for the Restricted Shares, and was classified in Level 2 of the fair value hierarchy. Altria may, in certain instances, pledge or otherwise grant a security interest in all or part of its Restricted Shares. In the event the pledgee or security interest holder were to foreclose on the Restricted Shares, the encumbered Restricted Shares will be automatically converted, one-for-one, into ordinary shares. Therefore, the fair value of each Restricted Share is based on the value of an ordinary share.
The fair value of Altria’s equity investment in ABI at March 31, 2020 and December 31, 2019 was $8.8 billion (carrying value of $18.5 billion) and $16.1 billion (carrying value of $18.1 billion), respectively, which was less than its carrying value by approximately 52% and 11%, respectively. At April 27, 2020, the fair value of Altria’s investment was approximately $8.6 billion (approximately 53% below its carrying value). As recently as September 30, 2019, the fair value of Altria’s equity investment in ABI exceeded its carrying value. In October 2019, the fair value of Altria’s equity investment in ABI declined below its carrying value and has not recovered. Altria has evaluated the factors related to the fair value decline, including the recent impact on the fair value of ABI’s shares amidst the COVID-19 pandemic, which has impacted the equity markets. Altria has also evaluated ABI’s financial condition and near-term prospects, and Altria’s intent and ability to hold its investment in ABI until recovery. Altria concluded at March 31, 2020, the decline in fair value of its investment in ABI below its carrying value is temporary and, therefore, no impairment was recorded. This conclusion was based on the following factors:

52

▪
the fair value of Altria’s equity investment in ABI historically exceeding its carrying value since October 2016, when Altria obtained its ownership interest in ABI, with the exception of certain periods starting in September 2018;
▪
a history of significant recovery in stock price during 2019 which Altria believes indicates investor confidence in ABI’s ability to implement its business strategies and deleveraging plans;
▪
the relatively short period of time that ABI shares have traded below Altria’s carrying value;
▪
the extreme equity market disruption and volatility associated with the COVID-19 pandemic, resulting in stock prices across all markets that Altria does not believe are reflective of actual underlying equity values;
▪
ABI’s recent proactive actions to preserve financial flexibility through the period of significant financial market and operational volatility and uncertainty associated with the COVID-19 pandemic, including the following actions since December 31, 2019: (i) ABI’s April 2020 announcement of a 50% reduction to its upcoming dividend; (ii) ABI’s borrowing of the full $9 billion commitment under its revolving facility; (iii) ABI’s debt issuances of $6 billion and 4.5 billion euro denominated senior notes for general corporate purposes; and (iv) ABI’s reaffirmation that it expects to close the sale of its Australia subsidiary in the second quarter of 2020;
▪
ABI’s global platform (world’s largest brewer by volume and one of the world’s top ten consumer products companies by revenue) with strong market positions in key markets, geographic diversification, experienced management team, strict financial discipline (cost management and efficiency) and expected earnings and history of performance; and
▪
Altria’s ownership of restricted shares being subject to a five-year lock-up (subject to limited exceptions) ending October 10, 2021, which Altria believes provides sufficient time to allow for an anticipated recovery in the fair value of its investment in ABI.

Altria will continue to monitor its investment in ABI, including the impact of the COVID-19 pandemic on ABI’s business and market valuation. If Altria were to conclude that the decline in fair value is other than temporary, Altria would determine and recognize, in the period identified, the impairment of its investment, which could result in a material adverse effect on Altria’s consolidated financial position or earnings.

Investment in Cronos
The fair value of Altria’s equity method investment in Cronos is based on unadjusted quoted prices in active markets for Cronos’s common shares and was classified in Level 1 of the fair value hierarchy. The fair value of Altria’s equity method investment in Cronos at March 31, 2020 and December 31, 2019 was $0.9 billion and $1.2 billion, respectively, compared with its carrying value of $1.0 billion at March 31, 2020 and December 31, 2019. At March 31, 2020, the fair value of Altria’s equity method investment in Cronos was below its carrying value by 14%. Based on Altria’s evaluation of the duration and magnitude of the fair value decline at March 31, 2020, Altria’s evaluation of Cronos’s financial condition (including its strong cash position) and near-term prospects, and Altria’s intent and ability to hold its investment in Cronos until recovery, Altria concluded that the decline in fair value of its equity method investment in Cronos below its carrying value is temporary and, therefore, no impairment was recorded. At April 27, 2020, the fair value of Altria’s equity method investment in Cronos was approximately $1.0 billion (which approximates its carrying value). Altria will continue to assess the fair value of its equity method investment in Cronos to determine if any decline in fair value below its carrying value is other than temporary.
For further discussion of Altria’s investments in ABI and Cronos, see Note 4. Investments in Equity Securities to the condensed consolidated financial statements in Item 1.

53


Consolidated Operating Results
 
For the Three Months Ended
March 31,
 
2020
 
2019
 
(in millions)
Net revenues:
 
 
 
Smokeable products
$
5,606

 
$
4,935

Oral tobacco products
601

 
540

Wine
146

 
151

All other
6

 
2

Net revenues
$
6,359

 
$
5,628

 
 
 
 
Excise taxes on products:
 
 
 
Smokeable products
$
1,278

 
$
1,203

Oral tobacco products
31

 
31

Wine
4

 
5

Excise taxes on products
$
1,313

 
$
1,239

 
 
 
 
Operating income:
 
 
 
Operating companies income (loss):
 
 
 
Smokeable products
$
2,370

 
$
1,932

Oral tobacco products
414

 
358

Wine
(379
)
 
15

All other
(5
)
 
(12
)
Amortization of intangibles
(19
)
 
(8
)
General corporate expenses
(45
)
 
(46
)
Corporate asset impairment and exit costs
—

 
(1
)
Operating income
$
2,336

 
$
2,238


As discussed further in Note 9. Segment Reporting to the condensed consolidated financial statements in Item 1 (“Note 9”), Altria’s chief operating decision maker (“CODM”) reviews operating companies income (loss) (“OCI”) to evaluate the performance of, and allocate resources to, the segments. OCI for the segments is defined as operating income before general corporate expenses and amortization of intangibles.


54

The following table provides a reconciliation of adjusted net earnings attributable to Altria and adjusted diluted EPS attributable to Altria for the three months ended March 31:
(in millions of dollars, except per share data)
Earnings before Income Taxes
Provision for Income Taxes
Net Earnings
Net Earnings Attributable
to Altria
Diluted EPS
2020 Reported
$
2,108

$
558

$
1,550

$
1,552

$
0.83

ABI-related special items
56

12

44

44

0.03

Implementation and acquisition-related costs
395

95

300

300

0.16

Tobacco and health litigation items 
24

5

19

19

0.01

Cronos-related special items
89

(6
)
95

95

0.05

Tax items
—

(24
)
24

24

0.01

2020 Adjusted for Special Items
$
2,672

$
640

$
2,032

$
2,034

$
1.09

 
 
 
 
 
 
2019 Reported
$
1,516

$
395

$
1,121

$
1,120

$
0.60

ABI-related special items 1
163

34

129

129

0.07

Asset impairment, exit, implementation and acquisition-related costs
159

34

125

125

0.06

Tobacco and health litigation items
17

4

13

13

0.01

Cronos-related special items
425

97

328

328

0.17

Tax items
—

(19
)
19

19

0.01

2019 Adjusted for Special Items
$
2,280

$
545

$
1,735

$
1,734

$
0.92

1 Prior period amounts have been recast to conform with current period presentation for certain ABI mark-to-market adjustments not previously identified as special items and excluded from Altria’s adjusted financial measures. For further discussion, see Executive Summary - 2020 Forecast Results above.

The following events that occurred during the three months ended March 31, 2020 and 2019 affected the comparability of statement of earnings amounts:

▪
Tobacco and Health Litigation Items: For a discussion of tobacco and health litigation items and a breakdown of these costs by segment, see Note 11. Contingencies to the condensed consolidated financial statements in Item 1 (“Note 11”) and Tobacco and Health Litigation Items in Note 9, respectively.

▪
Asset Impairment, Exit, Implementation and Acquisition-Related Costs: Pre-tax asset impairment, exit, implementation and acquisition-related costs were $395 million and $159 million for the three months ended March 31, 2020 and 2019, respectively.

Ste. Michelle has been experiencing product volume demand uncertainty, which has been further negatively impacted in the first quarter by the economic uncertainty surrounding the COVID-19 pandemic as discussed in the Operating Results - Wine Segment - Business Environment. As a result of wine inventory levels significantly exceeding forecasted product volume demand as of March 31, 2020 and other factors, Ste. Michelle recorded pre-tax charges of $392 million, which were included in cost of sales in Altria’s condensed consolidated statement of earnings for the three months ended March 31, 2020. The charges consisted of the following: (i) write-off of inventory ($292 million) as Ste. Michelle no longer believes that the benefit of the blending and production plans for its inventory outweighs inventory carrying cost given the reduced product volume demand; and (ii) estimated losses on future non-cancelable grape purchase commitments that Ste. Michelle believes no longer have a future economic benefit ($100 million). In conjunction with Ste. Michelle’s examination of its inventory levels, Altria and Ste. Michelle undertook a review of Ste. Michelle’s wine business and have implemented a strategic reset in order to maximize Ste. Michelle’s profitability and achieve improved long-term cash-flow generation. Ste. Michelle expects to deliver pre-tax cost savings of approximately $15 million and pre-tax cash savings of approximately $40 million annually by 2021.

In December 2018, Altria announced a cost reduction program (which included workforce reductions and third-party spending across the businesses) that delivered approximately $600 million in annualized cost savings in 2019.


55

For further discussion on asset impairment, exit and implementation costs, including a breakdown of these costs by segment, see Note 3. Asset Impairment, Exit and Implementation Costs to the condensed consolidated financial statements in Item 1 (“Note 3”).

For the three months ended March 31, 2020 and 2019, Altria incurred pre-tax acquisition-related costs of $3 million and $98 million, respectively. Substantially all of the pre-tax acquisition-related costs for the three months ended March 31, 2019 were for the write-off of debt issuance costs related to Altria’s short-term borrowings under the term loan agreement that Altria entered into in connection with its investments in JUUL and Cronos.

▪
ABI-Related Special Items: Altria’s earnings from its equity investment in ABI for the three months ended March 31, 2020 included net pre-tax charges of $56 million, consisting primarily of Altria’s share of ABI’s net mark-to-market losses on certain ABI financial instruments associated with its share commitments, partially offset by an additional net gain related to the completion in October 2019 of ABI’s initial public offering of a minority stake of its Asia Pacific subsidiary, Budweiser Brewing Company APAC Limited.

Altria’s earnings from its equity investment in ABI for the three months ended March 31, 2019 included pre-tax charges of $163 million, consisting primarily of Altria’s share of ABI’s net mark-to-market losses on certain ABI financial instruments associated with its share commitments.

•
Cronos-Related Special Items: For the three months ended March 31, 2020 and 2019, Altria recorded net pre-tax losses of $89 million and $425 million, respectively, consisting of the following:
 
For the Three Months Ended March 31,
 
2020
 
2019
 
(in millions)
Loss on Cronos-related financial instruments(1)
$
137

 
$
425

Earnings from Equity Investments(2)
(48
)
 
—

      Total Cronos-related special items - (Income) Expense
$
89

 
$
425

(1)
The 2020 and substantially all of the 2019 amounts are related to the non-cash change in the fair value of the warrant and certain anti-dilution protections (the “Fixed-price Preemptive Rights”) acquired in the Cronos transaction.
(2)
Substantially all of these amounts represent Altria’s share of Cronos’s non-cash change in the fair value of Cronos’s derivative financial instruments associated with the issuance of additional shares.

For further discussion, see Note 5. Financial Instruments to the condensed consolidated financial statements in Item 1.


Consolidated Results of Operations for the Three Months Ended March 31, 2020 versus the Three Months Ended March 31, 2019

Net revenues, which include excise taxes billed to customers, increased $731 million (13.0%), due to higher net revenues in the smokeable products and oral tobacco products segments.

Cost of sales increased $595 million (37.7%), due primarily to the inventory-related charges in the wine segment in 2020 (as discussed above), higher per unit settlement charges and higher shipment volume in the smokeable products segment.

Excise taxes on products increased $74 million (6.0%), due primarily to higher smokeable products shipment volume.

Operating income increased $98 million (4.4%), due primarily to higher operating results from the smokeable products and oral tobacco products segments, partially offset by lower operating results from the wine segment.

Interest and other debt expense, net, decreased $109 million (28.4%), due primarily to debt issuance costs in 2019 for borrowings associated with the JUUL and Cronos transactions.

Earnings from Altria’s equity investments, increased $71 million (82.6%), due to higher earnings from Altria’s investment in ABI and earnings from Altria’s investment in Cronos in 2020 (which were both positively impacted by special items).


56

Reported net earnings attributable to Altria of $1,552 million increased $432 million (38.6%), due primarily to lower loss on Cronos-related financial instruments, higher operating income, debt issuance costs in 2019 and higher earnings from Altria’s equity investments. Reported diluted and basic EPS attributable to Altria of $0.83, each increased by 38.3%, due to higher net earnings attributable to Altria and fewer shares outstanding.

Adjusted net earnings attributable to Altria of $2,034 million increased $300 million (17.3%), due primarily to higher adjusted OCI from the smokeable products and oral tobacco products segments, partially offset by lower adjusted earnings from Altria’s equity investment in ABI. Adjusted diluted EPS attributable to Altria of $1.09 increased by 18.5%, due to higher adjusted net earnings attributable to Altria and fewer shares outstanding.

Non-GAAP Financial Measures

While Altria reports its financial results in accordance with GAAP, its management reviews certain financial results, including OCI, OCI margins, net earnings attributable to Altria and diluted EPS, on an adjusted basis, which excludes certain income and expense items that management believes are not part of underlying operations. These items may include, for example, restructuring charges, asset impairment charges, acquisition-related costs, equity investment-related special items (including any changes in fair value for the equity investment and any related warrants and preemptive rights), certain tax items, charges associated with tobacco and health litigation items, and resolutions of certain nonparticipating manufacturer (“NPM”) adjustment disputes under the 1998 Master Settlement Agreement (such dispute resolutions are referred to as “NPM Adjustment Items” and are more fully described in Health Care Cost Recovery Litigation - NPM Adjustment Disputes in Note 11. Altria’s management does not view any of these special items to be part of Altria’s underlying results as they may be highly variable, may be unusual or infrequent, are difficult to predict and can distort underlying business trends and results. Altria’s management also reviews income tax rates on an adjusted basis. Altria’s adjusted effective tax rate may exclude certain tax items from its reported effective tax rate.

Altria’s management believes that adjusted financial measures provide useful additional insight into underlying business trends and results, and provide a more meaningful comparison of year-over-year results. Adjusted financial measures are used by management and regularly provided to Altria’s CODM for planning, forecasting and evaluating business and financial performance, including allocating resources and evaluating results relative to employee compensation targets. These adjusted financial measures are not required by, or calculated in accordance with GAAP and may not be calculated the same as similarly titled measures used by other companies. These adjusted financial measures should thus be considered as supplemental in nature and not considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP.

Operating Results by Business Segment

Tobacco Space

Business Environment

Summary

The U.S. tobacco industry faces a number of business and legal challenges that have adversely affected and may adversely affect the business and sales volume of Altria’s tobacco subsidiaries and investees and Altria’s consolidated results of operations, cash flows or financial position. These challenges, some of which are discussed in more detail below, in Note 11 and in Part II, Item 1A., Risk Factors of this Form 10-Q (“Item 1A”) include:

▪
pending and threatened litigation and bonding requirements;
▪
restrictions and requirements imposed by the Family Smoking Prevention and Tobacco Control Act (“FSPTCA”), and restrictions and requirements (and related enforcement actions) that have been, and in the future will be, imposed by the Food and Drug Administration (“FDA”);
▪
actual and proposed excise tax increases, as well as changes in tax structures and tax stamping requirements;
▪
bans and restrictions on tobacco use imposed by governmental entities and private establishments and employers;
▪
other federal, state and local government actions, including:
▪
restrictions on the sale of certain tobacco products, the sale of tobacco products by certain retail establishments, the sale of certain tobacco products with certain characterizing flavors and the sale of tobacco products in certain package sizes;
▪
additional restrictions on the advertising and promotion of tobacco products;

57

▪
other actual and proposed tobacco product legislation and regulation; and
▪
governmental investigations;
▪
the diminishing prevalence of cigarette smoking;
▪
increased efforts by tobacco control advocates and other private sector entities (including retail establishments) to further restrict the availability and use of tobacco products;
▪
changes in adult tobacco consumer purchase behavior, which is influenced by various factors such as economic conditions, excise taxes and price gap relationships, may result in adult tobacco consumers switching to discount products or other lower-priced tobacco products;
▪
the highly competitive nature of the tobacco categories in which Altria’s tobacco subsidiaries operate, including competitive disadvantages related to cigarette price increases attributable to the settlement of certain litigation;
▪
illicit trade in tobacco products;
▪
potential adverse changes in prices, availability and quality of tobacco, other raw materials and components; and
▪
the COVID-19 pandemic.

In addition to and in connection with the foregoing, evolving adult tobacco consumer preferences pose challenges for Altria’s tobacco subsidiaries. Altria’s tobacco subsidiaries believe that a significant number of adult tobacco consumers switch among tobacco categories, use multiple forms of tobacco products and try innovative tobacco products, such as e-vapor products and oral nicotine pouches. In fact, a growing number of adult smokers are converting from cigarettes to exclusive use of non-combustible tobacco product alternatives. Up until the second half of 2019, the e-vapor category had experienced significant growth in recent years, and the number of adults who exclusively used e-vapor products also increased during that time which, along with growth in oral nicotine pouches, negatively impacted consumption levels and sales volume of cigarettes and moist smokeless tobacco (“MST”). Growth in the e-vapor category has been negatively impacted by legislative and regulatory activities discussed below. Based on the accelerated adult smoker movement across categories and the federal government raising the legal age to purchase tobacco products to 21, as discussed below under Federal, State and Local Legislation to Increase the Legal Age to Purchase Tobacco Products, Altria expects the U.S. adjusted cigarette industry volume for 2020 to decline by 4% - 6%. Due to the expected continued volatility across tobacco categories, Altria is no longer providing a multi-year forecast for U.S. cigarette industry volume decline. Altria and its tobacco subsidiaries believe the innovative tobacco product categories will continue to be dynamic as adult tobacco consumers explore a variety of tobacco product options and as the regulatory environment for these innovative tobacco products evolves.

Economic conditions also impact adult tobacco consumer purchase behavior. Prior economic downturns have resulted in adult tobacco consumers choosing discount products and other lower-priced tobacco products. If the COVID-19 pandemic results in an economic recession, adult tobacco consumers may increasingly choose these products. See Operating Results - Smokeable Products Segment in Item 2 for further discussion.

Altria and its tobacco subsidiaries work to meet these evolving adult tobacco consumer preferences over time by developing, manufacturing, marketing and distributing products both within and outside the U.S. through innovation and adjacency growth strategies (including, where appropriate, arrangements with, or investments in, third parties).

FSPTCA and FDA Regulation

The Regulatory Framework

The FSPTCA expressly establishes certain restrictions and prohibitions on our tobacco businesses and authorizes or requires further FDA action. Under the FSPTCA, the FDA has broad authority to (1) regulate the design, manufacture, packaging, advertising, promotion, sale and distribution of tobacco products; (2) require disclosures of related information; and (3) enforce the FSPTCA and related regulations. The FSPTCA applies to cigarettes, cigarette tobacco and smokeless tobacco(1) products, and as of 2016, Other Tobacco Products. See FDA Regulatory Actions - Deeming Regulations below.

Among other measures, the FSPTCA or its implementing regulations:

▪
imposes restrictions on the advertising, promotion, sale and distribution of tobacco products, including at retail;

___________________________
(1) “Smokeless tobacco,” as used in this section of this Form 10-Q, refers to smokeless tobacco products first regulated by the FDA in 2009, including MST. It excludes oral nicotine pouches, which were first regulated by the FDA in 2016.

58

▪
bans descriptors such as “light,” “mild” or “low” or similar descriptors when used as descriptors of modified risk unless expressly authorized by the FDA;
▪
requires extensive product disclosures to the FDA and may require public disclosures;
•
prohibits any express or implied claims that a tobacco product is or may be less harmful than other tobacco products without FDA authorization;
▪
imposes reporting obligations relating to contraband activity and grants the FDA authority to impose recordkeeping and other obligations to address illicit trade in tobacco products;
▪
changes the language of the cigarette and smokeless tobacco product health warnings, enlarges their size and requires the development by the FDA of graphic warnings for cigarettes, establishes warning requirements for Other Tobacco Products and gives the FDA the authority to require new warnings for any type of tobacco products (see FDA Regulatory Actions - Graphic Warnings below);
▪
authorizes the FDA to adopt product regulations and related actions, including imposing tobacco product standards that are appropriate for the protection of the public health and imposing manufacturing standards for tobacco products (see FDA’s Comprehensive Regulatory Plan for Tobacco and Nicotine Regulation and FDA Regulatory Actions - Potential Product Standards below);
▪
establishes pre-market review pathways for new and modified tobacco products for the FDA to follow (see Pre-Market Review Pathways Including Substantial Equivalence below); and
▪
equips the FDA with a variety of investigatory and enforcement tools, including the authority to inspect tobacco product manufacturing and other facilities.

Pre-Market Review Pathways for Tobacco Products, Including Substantial Equivalence

The FSPTCA permits the sale of tobacco products that were commercially marketed as of February 15, 2007, and for which no modifications have been made to the products since that date (“Grandfathered Products”). For new and modified tobacco products, however, the FSPTCA imposes restrictions on marketing, requiring FDA review and authorization before marketing a new or modified product. Specifically, cigarettes, cigarette tobacco and smokeless tobacco products modified or first introduced into the market after March 22, 2011, and Other Tobacco Products modified or first introduced into the market after August 8, 2016, are subject to new tobacco product application and pre-market review and authorization requirements unless a manufacturer can demonstrate they are “substantially equivalent” to products commercially marketed as of February 15, 2007. The FDA could deny any such new tobacco product application or determine lack of substantial equivalence, thereby preventing the distribution and sale of any product affected by such denial. A manufacturer is permitted, however, to introduce Grandfathered Products into the marketplace.

For cigarettes, cigarette tobacco and smokeless tobacco products modified or first introduced into the market between February 15, 2007 and March 22, 2011 (“Provisional Products”) for which a manufacturer submitted substantial equivalence reports, the FDA may determine that such products are not “substantially equivalent” to products commercially marketed as of February 15, 2007. In such cases, the FDA could require the removal of such products from the marketplace (see FDA Regulatory Actions - Substantial Equivalence and Other New Product Processes/Pathways - Cigarettes and Smokeless Tobacco Products below).

Similarly, the FDA could determine that Other Tobacco Products modified or first introduced into the market between February 15, 2007 and August 8, 2016 for which a manufacturer submits substantial equivalence reports, are not “substantially equivalent” to products commercially marketed as of February 15, 2007, or reject a new tobacco product application submitted by a manufacturer, both of which could require the removal of such products from the marketplace (see FDA’s Comprehensive Regulatory Plan for Tobacco and Nicotine Regulation, and FDA Regulatory Actions - Substantial Equivalence and Other New Product Processes/Pathways - Other Tobacco Products below).

Modifications to currently marketed products, including modifications that result from, for example, changes to the quantity of tobacco product(s) in a package, a manufacturer being unable to acquire ingredients or a supplier being unable to maintain the consistency required in ingredients, can trigger the FDA’s pre-market review process described above. As noted, adverse determinations by the FDA during that process could restrict a manufacturer’s ability to continue marketing such products.

FDA’s Comprehensive Regulatory Plan for Tobacco and Nicotine Regulation

In July 2017, the FDA announced a comprehensive plan for tobacco and nicotine regulation designed to strike a balance between regulation and encouraging the development of innovative tobacco products that may be less risky than combustible cigarettes. Since then, the FDA has issued additional information about its comprehensive plan in response to concerns associated with the rise in the use of e-vapor products by youth, and the potential youth appeal of flavored tobacco products.

59

The FDA said it is monitoring youth tobacco usage rates, particularly e-vapor product use, and exercised its regulatory authority by implementing measures designed to decrease youth tobacco use, including the removal of certain e-vapor products from the market (see FDA Regulatory Actions - Underage Access and Use of Certain Tobacco Products below).

Major components of the FDA’s comprehensive plan include the following:

▪
issuing advance notices of proposed rulemaking (“ANPRM”) relating to potential product standards for nicotine in cigarettes, flavors in all tobacco products (including menthol in cigarettes and characterizing flavors in all cigars); and, for e-vapor products, protection against known public health risks such as concerns about youth exposure to liquid nicotine;
▪
taking actions to restrict youth access to e-vapor products;
▪
establishing content requirements for “new tobacco product” and “modified risk tobacco product” applications;
▪
reconsidering the FDA review processes of substantial equivalence reports for Provisional Products and establishing review processes for e-vapor new product applications; and
▪
revisiting the timelines (previously extended by the FDA) to submit applications for Other Tobacco Products.

See FDA Regulatory Actions below for further discussion.

Rulemaking and Guidance

The provisions of the FSPTCA that require the FDA to take action through rulemaking generally involve consideration of public comment and, for some issues, scientific review. As required by the FSPTCA, the FDA has established a tobacco product scientific advisory committee (the “TPSAC”), which consists of voting and non-voting members, to provide advice, reports, information and recommendations to the FDA on certain scientific and health issues relating to tobacco products. TPSAC votes are considered by the FDA, but are not binding. From time to time, the FDA issues guidance, which may be issued in draft or final form, and generally involves public comment. Altria’s tobacco subsidiaries participate actively in processes established by the FDA to develop and implement the FSPTCA’s regulatory framework, including submission of comments to various FDA proposals and participation in public hearings and engagement sessions.

The implementation of the FSPTCA and related regulations and guidance also may have an impact on enforcement efforts by U.S. states, territories and localities of their laws and regulations as well as of the State Settlement Agreements discussed below (see State Settlement Agreements below).  Such enforcement efforts may adversely affect the ability of Altria’s tobacco subsidiaries and investees to market and sell regulated tobacco products in those states, territories and localities.

Impact on Our Business; Compliance Costs and User Fees

Regulations imposed and other regulatory actions taken by the FDA under the FSPTCA could have a material adverse effect on the business, consolidated results of operations, cash flows or financial position of Altria and its tobacco subsidiaries in a number of different ways. For example, actions by the FDA could:

▪
impact the consumer acceptability of tobacco products;
▪
delay, discontinue or prevent the sale or distribution of existing, new or modified tobacco products;
▪
limit adult tobacco consumer choices;
▪
impose restrictions on communications with adult tobacco consumers;
▪
create a competitive advantage or disadvantage for certain tobacco companies;
▪
impose additional manufacturing, labeling or packaging requirements;
▪
impose additional restrictions at retail;
▪
result in increased illicit trade in tobacco products; or
▪
otherwise significantly increase the cost of doing business.

The failure to comply with FDA regulatory requirements, even inadvertently, and FDA enforcement actions also could have a material adverse effect on the business, consolidated results of operations, cash flows or financial position of Altria and its tobacco subsidiaries, including adversely affecting the value of Altria’s investment in JUUL.


60

The FSPTCA imposes user fees on cigarette, cigarette tobacco, smokeless tobacco, cigar and pipe tobacco manufacturers and importers to pay for the cost of regulation and other matters. The FSPTCA does not impose user fees on e-vapor or oral nicotine pouch manufacturers. The cost of the FDA user fee is allocated first among tobacco product categories subject to FDA regulation and then among manufacturers and importers within each respective category based on their relative market shares, all as prescribed by the statute and FDA regulations. Payments for user fees are adjusted for several factors, including inflation, market share and industry volume. For a discussion of the impact of the FDA user fee payments on Altria, see Debt and Liquidity - Payments Under State Settlement Agreements and FDA Regulation below. In addition, compliance with the FSPTCA’s regulatory requirements has resulted and will continue to result in additional costs for Altria’s tobacco businesses. The amount of additional compliance and related costs has not been material in any given quarter or year to date period but could become material, either individually or in the aggregate, to one or more of Altria’s tobacco subsidiaries.

Investigation and Enforcement

The FDA has a number of investigatory and enforcement tools available to it, including document requests and other required information submissions, facility inspections, examinations and investigations, injunction proceedings, monetary penalties, product withdrawal and recall orders, and product seizures. The use of any of these investigatory or enforcement tools by the FDA could result in significant costs or otherwise have a material adverse effect on the business, consolidated results of operations, cash flows or financial position of Altria and its tobacco subsidiaries, including adversely affecting the value of Altria’s investment in JUUL.

Final Tobacco Marketing Rule

As required by the FSPTCA, the FDA re-promulgated in March 2010 a wide range of advertising and promotion restrictions in substantially the same form as regulations that were previously adopted in 1996 (but never imposed on tobacco manufacturers due to a United States Supreme Court ruling) (the “Final Tobacco Marketing Rule”). The May 2016 amendments to the Final Tobacco Marketing Rule apply certain provisions to certain “covered tobacco products,” which include cigars, e-vapor products containing nicotine or other tobacco derivatives, pipe tobacco and oral nicotine pouches, but do not include any component or part that is not made or derived from tobacco. The Final Tobacco Marketing Rule as so amended:

▪
bans the use of color and graphics in cigarette and smokeless tobacco product labeling and advertising;
▪
prohibits the sale of cigarettes, smokeless tobacco and covered tobacco products to persons under the age of 18 (See Federal, State and Local Legislation to Increase the Legal Age to Purchase Tobacco Products below for a discussion of more recent laws raising the minimum legal age to purchase tobacco products to 21);
▪
restricts the use of non-tobacco trade and brand names on cigarettes and smokeless tobacco products;
▪
requires the sale of cigarettes and smokeless tobacco in direct, face-to-face transactions;
▪
prohibits sampling of cigarettes and covered tobacco products and prohibits sampling of smokeless tobacco products except in qualified adult-only facilities;
▪
prohibits the sale or distribution of items such as hats and tee shirts with cigarette or smokeless tobacco brands or logos; and
▪
prohibits cigarettes and smokeless tobacco brand name sponsorship of any athletic, musical, artistic or other social or cultural event, or any entry or team in any event.

Subject to certain limitations arising from legal challenges, the Final Tobacco Marketing Rule took effect in June 2010 for cigarettes and smokeless tobacco products and in August 2016 for covered tobacco products. At the time of the re-promulgation of the Final Tobacco Marketing Rule, the FDA also issued an ANPRM regarding the so-called “1000 foot rule,” which would establish restrictions on the placement of outdoor tobacco advertising in relation to schools and playgrounds.

FDA Regulatory Actions

Graphic Warnings

In March 2020, the FDA issued a final rule requiring 11 textual warnings accompanied by color graphics depicting the negative health consequences of smoking. According to the final rule, the graphic health warnings will (i) be located beneath the cellophane, and comprise the top 50% of the front and rear panels of cigarette packages and (ii) occupy 20% of a cigarette advertisement and be located at the top of the advertisement. The final rule is effective as of June 18, 2021. Other tobacco manufacturers also filed a lawsuit challenging the final rule. In the preamble to the final rule, the FDA stated that it would not

61

exempt from the final rule HeatSticks, a heated tobacco product used with the IQOS electronic device, but would consider the HeatSticks market order, and similar market orders, on a case-by-case basis.

Substantial Equivalence and Other New Product Processes/Pathways

Cigarettes and Smokeless Tobacco Products: In general, in order to continue marketing Provisional Products, manufacturers of such products were required to submit to the FDA reports demonstrating substantial equivalence by March 22, 2011 for the FDA to determine if such tobacco products are “substantially equivalent” to products commercially available as of February 15, 2007.  Most cigarette and smokeless tobacco products currently marketed by PM USA and USSTC are Provisional Products, as are some of the products currently marketed by Sherman Group Holdings, LLC (“Nat Sherman”). Altria’s subsidiaries submitted timely substantial equivalence reports for these Provisional Products and can continue marketing these products unless the FDA makes a determination that a specific Provisional Product is not substantially equivalent. If the FDA ultimately makes such a determination, it could require the removal of such products from the marketplace, leaving Altria’s cigarette and smokeless tobacco subsidiaries with the option of marketing other products that have received FDA pre-market authorization or Grandfathered Products.

The FDA has communicated that it will not review a certain subset of Provisional Product substantial equivalence reports and that the products that are the subject of those reports can generally continue to be legally marketed without further FDA review. PM USA and USSTC have Provisional Products included in this subset of products, but also have a number of Provisional Products that will continue to be subject to the substantial equivalence review process. In addition, PM USA and USSTC have submitted, and continue to submit, substantial equivalence reports on products proposed to be marketed after March 22, 2011 (“Non-Provisional Products”).

PM USA and USSTC have received substantial equivalence determinations on certain Provisional and Non-Provisional Products. The Provisional Products that were found to be not substantially equivalent (certain smokeless tobacco products) had been discontinued for business reasons prior to the FDA’s determinations; therefore, the determinations did not impact business results.

While Altria’s cigarette and smokeless tobacco subsidiaries believe all of their current products meet the statutory requirements of the FSPTCA, they cannot predict whether, when or how the FDA ultimately will apply its guidance to their various respective substantial equivalence reports or seek to enforce the law and regulations. Should Altria’s cigarette and smokeless tobacco subsidiaries receive unfavorable determinations on any substantial equivalence reports currently pending with the FDA, they believe they have the ability to replace most of their respective product volumes that could be impacted by these determinations with other products that have received FDA pre-market authorization or with Grandfathered Products.

Other Tobacco Products: In 2016, the FDA said that it would permit manufacturers to continue marketing Other Tobacco Products modified or introduced into the market for the first time between February 15, 2007 and August 8, 2016, until the FDA rendered decisions on the applicable substantial equivalence reports and new tobacco product applications. A number of cigars were on the market as of February 15, 2007, including certain cigars manufactured by Middleton. Therefore, in addition to being able to file new tobacco product applications, certain cigar manufacturers, including Middleton, can file substantial equivalence reports with the FDA for products that were on the market as of August 8, 2016. Few if any e-vapor products or oral nicotine pouches, however, were on the market as of February 15, 2007. Therefore manufacturers of these products may not be able to file substantial equivalence reports with the FDA on e-vapor products or oral nicotine pouches that were on the market as of August 8, 2016. In such cases, manufacturers, including JUUL and Helix, have to file new tobacco product applications that, among other things, demonstrate that the marketing of the products would be appropriate for the protection of the public health.

Previously, the deadlines to file all substantial equivalence reports and new tobacco product applications for combustible Other Tobacco Products, such as cigars and pipe tobacco, and for non-combustible Other Tobacco Products, such as e-vapor products and oral nicotine pouches, were at various points in 2018. The FDA extended these deadlines to August 8, 2021 for combustible Other Tobacco Products and August 8, 2022 for non-combustible Other Tobacco Products through guidance rather than by providing notice and allowing for public comment. In May 2019, in a lawsuit filed by the American Academy of Pediatrics, among other plaintiffs, a federal district court in Maryland found that the FDA’s failure to engage in the notice and comment process violated the Administrative Procedures Act. In July 2019, the court ordered that: (1) the FDA require that for Other Tobacco Products on the market as of August 8, 2016, applications must be filed with the FDA by May 12, 2020; (2) at the FDA’s discretion, Other Tobacco Products for which applications are not timely filed will be subject to FDA enforcement action; (3) applications for Other Tobacco Products that are timely filed can remain on the market during FDA review without being subject to FDA enforcement action for up to one year from the date of the application; and (4) on a case-by-case basis,

62

the FDA can exempt Other Tobacco Products from filing requirements for good cause. The court’s ruling did not, however, prevent the FDA from taking enforcement action against Other Tobacco Products prior to the May 12, 2020 filing deadline. The FDA and other parties appealed the court’s ruling to the United States Court of Appeals for the Fourth Circuit. In April 2020, amid the COVID-19 pandemic, the federal district court extended the filing deadline to September 9, 2020.

If JUUL is unable to meet the court-ordered filing deadline, or if JUUL’s new tobacco product applications are timely filed but subsequently denied, it could adversely affect the value of Altria’s investment in JUUL and have a material adverse effect on Altria’s consolidated financial position or earnings.

Manufacturers of cigars and oral nicotine pouches also must file substantial equivalence reports or new tobacco product applications by the court-ordered filing deadline in order for their products to remain on the market. Middleton has received market authorizations from the FDA that cover a significant portion of its cigar product volume, and plans to file any required substantial equivalence reports with the FDA for its remaining cigar product volume by the court-ordered filing deadline. Helix also plans to file all required new tobacco product applications for its oral nicotine pouches by the court-ordered filing deadline.

Failure of Other Tobacco Product manufacturers, including Middleton, Helix and JUUL, to meet the court-ordered filing deadline for currently marketed products or to ultimately obtain market authorization from the FDA following proper submission, could result in Other Tobacco Products being removed from the market.

In January 2020, in an effort to address youth usage of certain Other Tobacco Products, the FDA issued final guidance (the “January 2020 Final Guidance”) in which it stated that certain cartridge-based, flavored e-vapor products (other than tobacco and menthol flavors) would be prioritized for FDA enforcement action beginning early February 2020, effectively requiring the removal of these products from the market unless these products receive FDA market authorization. E-vapor product manufacturers may still, however, file new tobacco product applications for these products. In its January 2020 Final Guidance, separate from the above-mentioned federal court order, the FDA adopted the filing deadline set by the court and stated that after that deadline, it would prioritize its enforcement against any e-vapor product (in any format or flavor) offered for sale but for which either no new tobacco product application has been filed or for which an application was timely filed but for which the FDA issued an adverse decision. See FDA Regulation - Underage Access and Use of Certain Tobacco Products below for further discussion. The effect of this guidance is to restrict the sale of certain flavored cartridge-based e-vapor products including those manufactured by JUUL, but permit the continued sale (subject to the exceptions discussed above) of other flavored e-vapor products, including flavored disposable e-vapor products. If these other flavored e-vapor products are sold in higher volumes than JUUL’s e-vapor products, it could adversely affect the value of Altria’s investment in JUUL and have a material adverse effect on Altria’s consolidated financial position or earnings.

All Tobacco Products: In March 2019, the FDA issued a proposed rule that would, if finalized, require that all substantial equivalence reports filed after the effective date of the final rule meet certain content and format requirements. Such requirements would not apply to substantial equivalence reports for Provisional Products or to any substantial equivalence report submitted to the FDA before this proposed rule becomes final. Various products marketed by Altria’s tobacco subsidiaries may fall within the scope of this proposed rule if finalized.

In September 2019, the FDA issued a proposed rule in which it set forth requirements for content, format and FDA’s procedures for reviewing new tobacco product applications. PM USA, Nat Sherman, Middleton, USSTC and Helix filed comments with the FDA. As of April 27, 2020, the FDA has not issued a final rule.

It is not possible to predict how long reviews by the FDA of substantial equivalence reports or new tobacco product applications for any tobacco product will take. A “not substantially equivalent” determination or denial of a new tobacco product application on one or more products could have a material adverse impact on the business, consolidated results of operations, cash flows or financial position of Altria and its tobacco subsidiaries, including adversely affecting the value of Altria’s investment in JUUL.

Deeming Regulations

As discussed above under FSPTCA and FDA Regulation - The Regulatory Framework, in 2016, the FDA issued final regulations for all Other Tobacco Products, imposing the FSPTCA regulatory framework on the cigar products manufactured, marketed and sold by Middleton and Nat Sherman. At the same time the FDA issued its final deeming regulations, it also amended the Final Tobacco Marketing Rule as described above in FSPTCA and FDA Regulation - Final Tobacco Marketing Rule.


63

Among the FSPTCA requirements that apply to Other Tobacco Products is a ban on descriptors, including “mild,” when used as descriptors of modified risk unless expressly authorized by the FDA. In connection with a 2016 lawsuit initiated by Middleton, the Department of Justice, on behalf of the FDA, informed Middleton that at present, the FDA does not intend to bring an enforcement action against Middleton for the use of the term “mild” in the trademark “Black & Mild.” Consequently, Middleton dismissed its lawsuit without prejudice. If the FDA were to change its position at some later date, Middleton would have the opportunity to make a submission to the FDA and ultimately, if necessary, to bring another lawsuit.

Underage Access and Use of Certain Tobacco Products

The FDA announced in September 2018 that it is using its regulatory authority to address underage access and use of e-vapor products. Altria engaged with the FDA on this topic in 2018 before discontinuing its Nu Mark LLC e-vapor business and also after acquiring a 35% economic interest in JUUL in December 2018. Altria reaffirmed to the FDA its ongoing and long-standing investment in underage tobacco use prevention efforts. For example, during 2019, Altria advocated raising the minimum legal age to purchase all tobacco products to 21 at the federal and state levels to further address underage tobacco use, which is now federal law. See Federal, State and Local Legislation to Increase the Legal Age to Purchase Tobacco Products below for further discussion.

In March 2019, the FDA issued draft guidance (the “March 2019 Draft Guidance”) further reflecting, among other things, its concerns about youth e-vapor use. The FDA finalized this guidance in the form of the January 2020 Final Guidance discussed above, which revises the FDA’s compliance policy and states that the FDA intends to prioritize enforcement action against:

▪
cartridge-based, flavored e-vapor products (other than tobacco and menthol flavors) unless such products have received market authorization from the FDA; and
▪
all e-vapor products (in any format or flavor):
▪
for which a manufacturer has failed or is failing to take adequate measures to prevent access by those under the age of 21 (referred to in the FDA guidance as “minors”);
▪
that are targeted to minors and the marketing for which is likely to promote use of such products by minors; or
▪
offered for sale after the court-ordered filing deadline and for which the manufacturer has either not submitted a pre-market application or for which an application was timely filed but an adverse decision on the application was issued by the FDA.

The January 2020 Final Guidance became effective in early February 2020. FDA enforcement action could result in tobacco products that are subject to such action being removed from the market unless and until these products receive pre-market authorization from the FDA. JUUL ceased its sales of all of its cartridge-based, flavored e-vapor products (other than tobacco and menthol) in 2019. If FDA enforcement action is taken against currently marketed JUUL e-vapor products, and a significant number of those products are removed from the market or if the FDA does not ultimately allow for the reintroduction of flavors other than tobacco and menthol, it could adversely affect the value of Altria’s investment in JUUL and have a material adverse effect on Altria’s consolidated financial position or earnings.

Potential Product Standards

▪
Nicotine in cigarettes and potentially other combustible tobacco products: In March 2018, the FDA issued an ANPRM through which it sought comments on the potential public health benefits and any possible adverse effects of lowering nicotine in combustible cigarettes to non-addictive or minimally addictive levels through achievable product standards. Specifically, the FDA sought comments on the consequences of such a product standard, including (i) smokers compensating by smoking more cigarettes to obtain the same level of nicotine as with their current product and (ii) the illicit trade of cigarettes containing nicotine at levels higher than a non-addictive threshold that may be established by the FDA. The FDA also sought comments on whether a nicotine product standard should apply to other combustible tobacco products, including cigars.

This ANPRM process may ultimately lead to the FDA’s development of product standards for nicotine in combustible tobacco products such as cigarettes and cigars. If such regulations were to become final and upheld in the courts, it could have a material adverse effect on the business, consolidated results of operations, cash flows or financial position of Altria and its tobacco subsidiaries.

▪
Flavors in tobacco products: In March 2018, the FDA issued an ANPRM seeking comments on the role that flavors (including menthol) in tobacco products play in attracting youth and may play in helping some smokers switch to

64

potentially less harmful forms of nicotine delivery. The FDA previously released its preliminary scientific evaluation on menthol, which states “that menthol cigarettes pose a public health risk above that seen with non-menthol cigarettes.” The FDA’s evaluation followed an earlier report to the FDA from TPSAC on the impact of the use of menthol in cigarettes on the public health and included a recommendation that the “[r]emoval of menthol cigarettes from the marketplace would benefit public health in the United States” and an observation that any ban on menthol cigarettes could lead to an increase in contraband cigarettes and other potential unintended consequences. As discussed above under FDA’s Comprehensive Regulatory Plan for Tobacco and Nicotine Regulation, the FDA indicated that it is considering proposing rulemaking for a product standard that would seek to ban menthol in combustible tobacco products, including cigarettes and cigars, and that it intends to propose a product standard that would ban characterizing flavors in all cigars. While the FDA has yet to define “characterizing flavors” with respect to cigars, most of Middleton’s cigar products contain added flavors and may be subject to any action by the FDA to ban flavors in cigars. No future action can be taken by the FDA to ban characterizing flavors in all cigars or regulate the manufacture, marketing or sale of menthol cigarettes (including a possible ban) until the completion of a full rulemaking process.

In the March 2019 Draft Guidance, noted above under FDA Regulatory Action - Underage Access and Use of Certain Tobacco Products, the FDA also proposed prioritizing enforcement action against flavored cigars (other than tobacco flavor) that either are not Grandfathered Products or have not received market authorization from the FDA to remain on the market. In the January 2020 Final Guidance, the FDA declined to prioritize enforcement action against such cigars before the court-ordered filing deadline. Instead, the FDA reiterated its intention to issue a proposed rule for a product standard banning all cigars with characterizing flavors. In its March 2019 Draft Guidance, the FDA indicated that such a rule would include Grandfathered Products and cigars that have received market authorization from the FDA.

Altria’s tobacco subsidiaries submitted public comments in response to the ANPRM regarding flavors in tobacco products and to the March 2019 Draft Guidance. Any proposed rules ultimately may lead to the FDA banning characterizing flavors in not only cigars, but in all tobacco products including oral nicotine pouches. If these regulations become final and are upheld in the courts, it could have a material adverse effect on the business, consolidated results of operations, cash flows or financial position of Altria and its tobacco subsidiaries, including adversely affecting the value of Altria’s investment in JUUL.

▪
NNN in Smokeless Tobacco: In January 2017, the FDA proposed a product standard for N-nitrosonornicotine (“NNN”) levels in finished smokeless tobacco products.  If the proposed rule, in present form, were to become final and upheld in the courts, it could have a material adverse effect on the business, consolidated results of operations, cash flows or financial position of Altria and USSTC.

Good Manufacturing Practices

The FSPTCA requires that the FDA promulgate good manufacturing practice regulations (referred to by the FDA as “Requirements for Tobacco Product Manufacturing Practice”) for tobacco product manufacturers, but does not specify a timeframe for such regulations.

Excise Taxes

Tobacco products are subject to substantial excise taxes in the U.S. Significant increases in tobacco-related taxes or fees have been proposed or enacted (including with respect to e-vapor products) and are likely to continue to be proposed or enacted at the federal, state and local levels within the U.S., including as a result of the COVID-19 pandemic as a way for governments to address potential budget shortfalls.

Federal, state and local cigarette excise taxes have increased substantially over the past two decades, far outpacing the rate of inflation. Between the end of 1998 and April 27, 2020, the weighted-average state cigarette excise tax increased from $0.36 to $1.82 per pack. As of April 27, 2020, no state has increased cigarette excise taxes in 2020, but various increases are under consideration or have been proposed.

A majority of states currently tax MST using an ad valorem method, which is calculated as a percentage of the price of the product, typically the wholesale price. This ad valorem method results in more tax being paid on premium products than is paid on lower-priced products of equal weight. Altria’s subsidiaries support legislation to convert ad valorem taxes on MST to a weight-based methodology because, unlike the ad valorem tax, a weight-based tax subjects cans of equal weight to the same tax. As of April 27, 2020, the federal government, 23 states, Puerto Rico, Philadelphia, Pennsylvania and Cook County, Illinois have adopted a weight-based tax methodology for MST.

65


An increasing number of states and localities also are imposing excise taxes on e-vapor and oral nicotine pouches. As of April 27, 2020, 23 states, the District of Columbia, Puerto Rico and a number of cities and counties have enacted legislation to tax e-vapor products. These taxes are calculated in varying ways and may differ based on the e-vapor product form. Similarly, ten states and the District of Columbia have enacted legislation to tax oral nicotine pouches. Tax increases could have an adverse impact on the sales of these products.

Tax increases are expected to continue to have an adverse impact on sales of cigarettes and MST products of Altria’s tobacco subsidiaries through lower consumption levels and the potential shift in adult consumer purchases from the premium to the non-premium or discount segments, or to counterfeit and contraband products. Such shifts may have an adverse impact on the sales volume and reported share performance of cigarettes and MST products of Altria’s tobacco subsidiaries.

International Treaty on Tobacco Control

The World Health Organization’s Framework Convention on Tobacco Control (the “FCTC”) entered into force in February 2005. As of April 27, 2020, 180 countries, as well as the European Community, have become parties to the FCTC. While the U.S. is a signatory of the FCTC, it is not currently a party to the agreement, as the agreement has not been submitted to, or ratified by, the United States Senate. The FCTC is the first international public health treaty and its objective is to establish a global agenda for tobacco regulation with the purpose of reducing initiation of tobacco use and encouraging cessation. The treaty recommends (and in certain instances, requires) signatory nations to enact legislation that would address various tobacco-related issues.

There are a number of proposals currently under consideration by the governing body of the FCTC, some of which call for substantial restrictions on the manufacture, marketing, distribution and sale of tobacco products. It is not possible to predict the outcome of these proposals or the impact of any FCTC actions on legislation or regulation in the U.S., either indirectly or as a result of the U.S. becoming a party to the FCTC, or whether or how these actions might indirectly influence FDA regulation and enforcement.

State Settlement Agreements

As discussed in Note 11, during 1997 and 1998, PM USA and other major domestic tobacco product manufacturers entered into the State Settlement Agreements. These settlements require participating manufacturers to make substantial annual payments, which are adjusted for several factors, including inflation, operating income, market share and industry volume. For a discussion of the impact of the State Settlement Agreements on Altria, see Debt and Liquidity - Payments Under State Settlement Agreements and FDA Regulation below and Note 11. The State Settlement Agreements also place numerous requirements and restrictions on participating manufacturers’ business operations, including prohibitions and restrictions on the advertising and marketing of cigarettes and smokeless tobacco products. Among these are prohibitions of outdoor and transit brand advertising, payments for product placement and free sampling (except in adult-only facilities). Restrictions are also placed on the use of brand name sponsorships and brand name non-tobacco products. The State Settlement Agreements also place prohibitions on targeting youth and the use of cartoon characters. In addition, the State Settlement Agreements require companies to affirm corporate principles directed at reducing underage use of cigarettes; impose requirements regarding lobbying activities; mandate public disclosure of certain industry documents; limit the industry’s ability to challenge certain tobacco control and underage use laws; and provide for the dissolution of certain tobacco-related organizations and place restrictions on the establishment of any replacement organizations.

In November 1998, USSTC entered into the Smokeless Tobacco Master Settlement Agreement (the “STMSA”) with the attorneys general of various states and U.S. territories to resolve the remaining health care cost reimbursement cases initiated against USSTC. The STMSA required USSTC to adopt various marketing and advertising restrictions. USSTC is the only smokeless tobacco manufacturer to sign the STMSA.

Other International, Federal, State and Local Regulation and Governmental and Private Activity

International, Federal, State and Local Regulation:

A number of states and localities have enacted or proposed legislation that imposes restrictions on tobacco products (including e-vapor and other innovative tobacco products), such as legislation that (1) prohibits the sale of tobacco product categories, such as e-vapor, and/or the sale of tobacco products with certain characterizing flavors, such as menthol cigarettes, (2) requires the disclosure of health information separate from or in addition to federally mandated health warnings and (3) restricts

66

commercial speech or imposes additional restrictions on the marketing or sale of tobacco products (including proposals to ban all tobacco product sales). The legislation varies in terms of the type of tobacco products, the conditions under which such products are or would be restricted or prohibited, and exceptions to the restrictions or prohibitions. For example, a number of proposals involving characterizing flavors would prohibit smokeless tobacco products with characterizing flavors without providing an exception for mint- or wintergreen-flavored products. As of April 27, 2020, 23 states and the District of Columbia have proposed legislation to ban flavors in one or more tobacco products, including e-vapor products, oral nicotine pouches and cigarettes and four states, Massachusetts, New Jersey, Utah and New York, have passed such legislation. Some of these states, such as New York and Utah, exempt certain products that have received FDA market authorization. Additionally, Massachusetts has passed legislation capping the amount of nicotine in e-vapor products. Similar legislation is pending in three other states.

In addition to legislation, some state governors had imposed restrictions on tobacco products through executive action. For example, in response to reports of lung injuries and deaths related to e-vapor product use, the governors of eight states exercised executive action to temporarily prohibit either the sale of all e-vapor products or e-vapor products with flavors other than tobacco. Some of those executive actions have been challenged in the courts and many of those executive actions have expired. Restrictions on e-vapor products also have been instituted or proposed internationally. For example, India and Singapore have instituted bans on e-vapor products.

Altria’s tobacco subsidiaries have challenged and will continue to challenge certain state and local legislation and other governmental action, including through litigation. It is possible, however, that legislation, regulation or other governmental action could be enacted or implemented that could have a material adverse impact on the business and volume of our tobacco subsidiaries and investees, and the consolidated results of operations, cash flows or financial position of Altria and its tobacco subsidiaries, including adversely affecting the value of Altria’s investment in JUUL.

Federal, State and Local Legislation to Increase the Legal Age to Purchase Tobacco Products

After a number of states and localities proposed and enacted legislation to increase the minimum age to purchase all tobacco products, including e-vapor products, in December 2019, the federal government passed legislation increasing the minimum age to purchase all tobacco products, including e-vapor products, to 21 nationwide. Although an increase in the minimum age to purchase tobacco products may have a negative impact on sales volume of our tobacco businesses, as discussed above under Underage Access and Use of Certain Tobacco Products, Altria supported raising the minimum legal age to purchase all tobacco products to 21 at the federal and state levels, reflecting its longstanding commitment to combat underage tobacco use.

Health Effects of Tobacco Products, Including E-vapor Products

Reports with respect to the health effects of smoking have been publicized for many years, including various reports by the U.S. Surgeon General. In 2019, there were public health advisories concerning vaping-related lung injuries and deaths and more recently, there have been health concerns raised about potential increased risks associated with COVID-19 among smokers and vapers. Altria and its tobacco subsidiaries believe that the public should be guided by the messages of the U.S. Surgeon General and public health authorities worldwide in making decisions concerning the use of tobacco products.

Most jurisdictions within the U.S. have restricted smoking in public places and some have restricted vaping in public places. Some public health groups have called for, and various jurisdictions have adopted or proposed, bans on smoking and vaping in outdoor places, in private apartments and in cars transporting children. It is not possible to predict the results of ongoing scientific research or the types of future scientific research into the health risks of tobacco exposure and the impact of such research on regulation.

Other Legislation or Governmental Initiatives

In addition to the actions discussed above, other regulatory initiatives affecting the tobacco industry have been adopted or are being considered at the federal level and in a number of state and local jurisdictions. For example, amid the COVID-19 pandemic, state and local governments have required additional health and safety requirements of all businesses, including tobacco manufacturing and other facilities. State and local governments also have mandated the temporary closure of some businesses. It is possible that tobacco manufacturing and other facilities could be subject to these government-mandated temporary closures. Additionally, in recent years, legislation has been introduced or enacted at the state or local level to subject tobacco products to various reporting requirements and performance standards; establish educational campaigns relating to tobacco consumption or tobacco control programs or provide additional funding for governmental tobacco control activities; restrict the sale of tobacco products in certain retail establishments and the sale of tobacco products in certain package sizes;

67

require tax stamping of smokeless tobacco products; require the use of state tax stamps using data encryption technology; and further restrict the sale, marketing and advertising of cigarettes and Other Tobacco Products. Such legislation may be subject to constitutional or other challenges on various grounds, which may or may not be successful.

It is not possible to predict what, if any, additional legislation, regulation or other governmental action will be enacted or implemented (and, if challenged, upheld) relating to the manufacturing, design, packaging, marketing, advertising, sale or use of tobacco products, or the tobacco industry generally. It is possible, however, that legislation, regulation or other governmental action could be enacted or implemented that could have a material adverse impact on the business and volume of our tobacco subsidiaries and investees, and the consolidated results of operations, cash flows or financial position of Altria and its tobacco subsidiaries, including adversely affecting the value of Altria’s investment in JUUL.

Governmental Investigations

From time to time, Altria, its subsidiaries and investees are subject to governmental investigations on a range of matters. For example, (i) the FTC issued a Civil Investigative Demand to Altria while conducting its antitrust review of Altria’s investment in JUUL seeking information regarding, among other things, Altria’s role in the resignation of JUUL’s former chief executive officer and the hiring by JUUL of any current or former Altria director, executive or employee and (ii) the SEC has commenced an investigation relating to Altria’s disclosures and controls in connection with the JUUL investment. Additionally, JUUL is currently under investigation by various federal and state agencies, including the FDA and the FTC, and state attorneys general. Such investigations vary in scope but at least some appear to include JUUL’s marketing practices, particularly as such practices relate to youth.

Private Sector Activity

A number of retailers, including national chains, have discontinued the sale of e-vapor products. Reasons for the discontinuation include reported illnesses related to e-vapor product use and the uncertain regulatory environment. It is possible that this private sector activity could adversely affect the value of Altria’s investment in JUUL and have a material adverse effect on Altria’s consolidated financial position or earnings.

Illicit Trade in Tobacco Products

Illicit trade in tobacco products can have an adverse impact on the businesses of Altria, its tobacco subsidiaries and investees. Illicit trade can take many forms, including the sale of counterfeit tobacco products; the sale of tobacco products in the U.S. that are intended for sale outside the country; the sale of untaxed tobacco products over the Internet and by other means designed to avoid the collection of applicable taxes; and diversion into one taxing jurisdiction of tobacco products intended for sale in another. Counterfeit tobacco products, for example, are manufactured by unknown third parties in unregulated environments. Counterfeit versions of our tobacco subsidiaries’ and investees’ products can negatively affect adult tobacco consumer experiences with and opinions of those brands. Illicit trade in tobacco products also harms law-abiding wholesalers and retailers by depriving them of lawful sales and undermines the significant investment Altria’s tobacco subsidiaries and investees have made in legitimate distribution channels. Moreover, illicit trade in tobacco products results in federal, state and local governments losing tax revenues. Losses in tax revenues can cause such governments to take various actions, including increasing excise taxes; imposing legislative or regulatory requirements that may adversely impact Altria’s consolidated results of operations and cash flows, including adversely affecting the value of Altria’s investment in JUUL, and the businesses of its tobacco subsidiaries and investees; or asserting claims against manufacturers of tobacco products or members of the trade channels through which such tobacco products are distributed and sold.

Altria’s tobacco subsidiaries communicate with wholesale and retail trade members regarding illicit trade in tobacco products and how they can help prevent such activities; enforce wholesale and retail trade programs and policies that address illicit trade in tobacco products and, when necessary, litigate to protect their trademarks.

Price, Availability and Quality of Tobacco, Other Raw Materials and Component Parts

Shifts in crops (such as those driven by economic conditions and adverse weather patterns), government restrictions and mandated prices, economic trade sanctions, import duties and tariffs, geopolitical instability and production control programs may increase or decrease the cost or reduce the supply or quality of tobacco and other raw materials or component parts used to manufacture our companies’ products. Any significant change in the price, quality or availability of tobacco, other raw materials or component parts used to manufacture our products could restrict our subsidiaries’ ability to continue marketing

68

existing products or impact adult consumer product acceptability and adversely affect our subsidiaries’ profitability and businesses.

With respect to tobacco, as with other agricultural commodities, crop quality and availability can be influenced by variations in weather patterns, including those caused by climate change. Additionally, the price of tobacco leaf can be influenced by economic conditions and imbalances in supply and demand. Economic conditions are increasingly unpredictable in light of the COVID-19 pandemic which, among other economic factors, may result in changes in the patterns of demand for agricultural products and the cost of tobacco production which could impact tobacco leaf prices and tobacco supply. Tobacco production in certain countries also is subject to a variety of controls, including government-mandated prices and production control programs.  Certain types of tobacco are only available in limited geographies, including geographies experiencing political instability, and loss of their availability could impair our subsidiaries’ ability to continue marketing existing products or impact adult tobacco consumer product acceptability.

The COVID-19 pandemic also may limit access to and increase the cost of raw materials, component parts and personal protective equipment as U.S. and global suppliers temporarily shut down facilities in order to address exposure to the virus or as a result of a government mandate.

Timing of Sales

In the ordinary course of business, our tobacco subsidiaries are subject to many influences that can impact the timing of sales to customers, including the timing of holidays and other annual or special events, the timing of promotions, customer incentive programs and customer inventory programs, as well as the actual or speculated timing of pricing actions and tax-driven price increases.


Operating Results
Smokeable products segment

The following table summarizes operating results, includes reported and adjusted OCI margins, and provides a reconciliation of reported OCI to adjusted OCI for the smokeable products segment:
Smokeable Products
 
For the Three Months Ended March 31,
 
2020
 
2019
 
Change
 
 
 
 
 
 
Net revenues
$
5,606

 
$
4,935

 
13.6
%
Excise taxes
(1,278
)
 
(1,203
)
 
 
Revenues net of excise taxes
$
4,328

 
$
3,732

 
 
 
 
 
 
 
 
Reported OCI
$
2,370

 
$
1,932

 
22.7
%
Asset impairment, exit and implementation costs
—

 
44

 
 
Tobacco and health litigation items
22

 
15

 
 
Adjusted OCI
$
2,392

 
$
1,991

 
20.1
%
 
 
 
 
 
 
Reported OCI margins 1
54.8
%
 
51.8
%
 
3.0 pp

Adjusted OCI margins 1
55.3
%
 
53.3
%
 
2.0 pp

1 Reported and adjusted OCI margins are calculated as reported and adjusted OCI, respectively, divided by revenues net of excise taxes.

Net revenues, which include excise taxes billed to customers, increased $671 million (13.6%), due primarily to higher shipment volume ($370 million) and higher pricing ($306 million), which includes higher promotional investments.


69

Reported OCI increased $438 million (22.7%), due primarily to higher pricing ($306 million), which includes higher promotional investments, higher shipment volume ($205 million), and asset impairment, exit and implementation costs in 2019 ($44 million), partially offset by higher per unit settlement charges. Reported OCI margins increased 3.0 percentage points to 54.8%.

Adjusted OCI increased $401 million (20.1%), due primarily to higher pricing ($306 million), which includes higher promotional investments, and higher shipment volume ($205 million), partially offset by higher per unit settlement charges. Adjusted OCI margins increased 2.0 percentage points to 55.3%.

The following table summarizes the smokeable products segment shipment volume performance:
 
Shipment Volume
 
For the Three Months Ended March 31,
 
2020
 
2019
 
Change
 
(sticks in millions)
Cigarettes:
 
 
 
 
 
     Marlboro
21,842

 
20,467

 
6.7
 %
     Other premium
1,137

 
1,165

 
(2.4
)%
     Discount
2,045

 
1,962

 
4.2
 %
Total cigarettes
25,024

 
23,594

 
6.1
 %
Cigars:
 
 
 
 
 
     Black & Mild
430

 
380

 
13.2
 %
     Other
2

 
2

 
—
 %
Total cigars
432

 
382

 
13.1
 %
Total smokeable products
25,456

 
23,976

 
6.2
 %

Cigarettes shipment volume includes Marlboro; Other premium brands, such as Virginia Slims, Parliament, Benson & Hedges and Nat’s; and Discount brands, which include L&M, Basic and Chesterfield. Cigarettes volume includes units sold as well as promotional units, but excludes units sold for distribution to Puerto Rico, and units sold in U.S. Territories, to overseas military and by Philip Morris Duty Free Inc., none of which, individually or in the aggregate, is material to the smokeable products segment.

The following table summarizes cigarettes retail share performance:
 
Retail Share
 
For the Three Months Ended March 31,
 
2020
 
2019
 
Percentage Point Change
Cigarettes:
 
 
 
 
 
     Marlboro
42.8
%
 
43.3
%
 
(0.5
)
     Other premium
2.4

 
2.5

 
(0.1
)
     Discount
4.0

 
4.1

 
(0.1
)
Total cigarettes
49.2
%
 
49.9
%
 
(0.7
)

Retail share results for cigarettes are based on data from IRI/Management Science Associates, Inc., a tracking service that uses a sample of stores and certain wholesale shipments to project market share and depict share trends. This service tracks sales in the food, drug, mass merchandisers, convenience, military, dollar store and club trade classes. For other trade classes selling cigarettes, retail share is based on shipments from wholesalers to retailers through the Store Tracking Analytical Reporting System (“STARS”). This service is not designed to capture sales through other channels, including the internet, direct mail and some illicitly tax-advantaged outlets. It is IRI’s standard practice to periodically refresh its services, which could restate retail share results that were previously released in this service.


70

For a discussion of volume trends and factors that impact volume and retail share performance, see Tobacco Space - Business Environment above.

The smokeable products segment’s reported domestic cigarettes shipment volume for the three months ended March 31, 2020 increased 6.1%, driven primarily by trade inventory movements, calendar differences and consumer pantry loading due to COVID-19, partially offset by the industry’s rate of decline, retail share losses and other factors. When adjusted for the traditional factors of trade inventory movements, calendar differences and other factors, the smokeable products segment’s domestic cigarettes shipment volume for the three months ended March 31, 2020 decreased by an estimated 3.5%. However, Altria believes that its preliminary estimates of consumer pantry loading due to COVID-19 should be an adjusting factor to reported volumes due to its high likelihood of near-term volume payback. When adjusted for trade inventory movements, calendar differences, Altria’s preliminary estimates of consumer pantry loading due to COVID-19 and other factors, the smokeable products segment’s domestic cigarettes shipment volume decreased by an estimated 5%. While it’s difficult to identify trends based on short time periods, especially in such a fluid environment, Altria will continue to monitor marketplace dynamics and will update its estimates as more data becomes available.
 
When adjusted for the traditional factors of trade inventory movements, calendar differences and other factors, total domestic cigarette industry volumes for the three months ended March 31, 2020 declined by an estimated 2%. When adjusted for trade inventory movements, calendar differences, Altria’s preliminary estimates of consumer pantry loading due to COVID-19 and other factors, total domestic cigarette industry volumes decreased by an estimated 3.5%.

Shipments of premium cigarettes accounted for 91.8% of smokeable products’ reported domestic cigarettes shipment volume for the three months ended March 31, 2020, versus 91.7% for the three months ended March 31, 2019.

Marlboro retail share of the total cigarette category declined 0.5 share points to 42.8% for the three months ended March 31, 2020, due to adult smoker movement across tobacco categories and dynamics within the discount cigarette category, each discussed above.

Total cigarettes industry discount category retail share increased 0.8 share points to 24.8% for the three months ended March 31, 2020, driven primarily by the deep discount category.

PM USA and Middleton executed the following pricing and promotional allowance actions during 2020 and 2019:

▪
Effective February 16, 2020, PM USA increased the list price on all of its cigarette brands by $0.08 per pack.

▪
Effective January 12, 2020, Middleton increased various list prices across substantially all of its cigar brands resulting in a weighted-average increase of approximately $0.08 per five-pack.

▪
Effective October 20, 2019, PM USA increased the list price on all of its cigarette brands by $0.08 per pack.

▪
Effective August 4, 2019, Middleton increased various list prices across substantially all of its cigar brands resulting in a weighted-average increase of approximately $0.04 per five-pack.

▪
Effective June 16, 2019, PM USA increased the list price on all of its cigarette brands by $0.06 per pack, except for L&M, which had no list price change.

▪
Effective February 24, 2019, PM USA increased the list price on Marlboro and L&M by $0.11 per pack and Parliament and Virginia Slims by $0.16 per pack. In addition, PM USA increased the list price on all of its other cigarette brands by $0.31 per pack.


71

Oral tobacco products segment

The following table summarizes operating results, includes reported and adjusted OCI margins, and provides a reconciliation of reported OCI to adjusted OCI for the oral tobacco products segment:
Oral Tobacco Products
 
For the Three Months Ended March 31,
 
2020
 
2019
 
Change
Net revenues
$
601

 
$
540

 
11.3
%
Excise taxes
(31
)
 
(31
)
 
 
Revenues net of excise taxes
$
570

 
$
509

 
 
 
 
 
 
 
 
Reported OCI
$
414

 
$
358

 
15.6
%
Asset impairment, exit, implementation and acquisition-related costs
2

 
9

 
 
Adjusted OCI
$
416

 
$
367

 
13.4
%
 
 
 
 
 
 
Reported OCI margins 1
72.6
%
 
70.3
%
 
2.3 pp

Adjusted OCI margins 1
73.0
%
 
72.1
%
 
0.9 pp

1 Reported and adjusted OCI margins are calculated as reported and adjusted OCI, respectively, divided by revenues net of excise taxes.

Net revenues, which include excise taxes billed to customers, increased $61 million (11.3%), due primarily to higher pricing ($43 million) and higher shipment volume ($20 million).

Reported OCI increased $56 million (15.6%), due primarily to higher pricing ($43 million), higher shipment volume ($19 million) and lower asset impairment, exit, implementation and acquisition-related costs, partially offset by increased costs associated with the expansion of on!. Reported OCI margins increased 2.3 percentage points to 72.6%.

Adjusted OCI increased $49 million (13.4%), due primarily to higher pricing ($43 million), higher shipment volume ($19 million), partially offset by increased costs associated with the expansion of on!. Adjusted OCI margins increased 0.9 percentage points to 73.0%.

The following table summarizes oral tobacco products segment shipment volume performance:
 
Shipment Volume
 
For the Three Months Ended March 31,
 
2020
 
2019
 
Change
 
(cans and packs in millions)
Copenhagen
125.0

 
125.2

 
(0.2
)%
Skoal
51.3

 
50.3

 
2.0
 %
Other1
20.4

 
15.9

 
28.3
 %
Total oral tobacco products
196.7

 
191.4

 
2.8
 %
1 Other includes Red Seal and on!.

Oral tobacco products shipment volume includes cans and packs sold, as well as promotional units, but excludes international volume, which is currently not material to the oral tobacco products segment. New types of oral tobacco products, as well as new packaging configurations of existing oral tobacco products, may or may not be equivalent to existing MST products on a can-for-can basis. To calculate volumes of cans and packs shipped, one pack of snus or one can of oral nicotine pouches, irrespective of the number of pouches in the pack or can, is assumed to be equivalent to one can of MST.

72

The following table summarizes oral tobacco products segment retail share performance (excluding international volume):
 
Retail Share
 
For the Three Months Ended March 31,
 
2020
 
2019
 
Percentage Point Change
Copenhagen
32.4
%
 
34.6
%
 
(2.2
)
Skoal
14.3

 
15.1

 
(0.8
)
Other
3.7

 
3.5

 
0.2

Total oral tobacco products
50.4
%
 
53.2
%
 
(2.8
)

Retail share results for oral tobacco products are based on data from IRI InfoScan, a tracking service that uses a sample of stores to project market share and depict share trends.  This service tracks sales in the food, drug, mass merchandisers, convenience, military, dollar store and club trade classes on the number of cans and packs sold.  Oral tobacco products is defined by IRI as MST, snus and oral nicotine pouches. New types of oral tobacco products, as well as new packaging configurations of existing oral tobacco products, may or may not be equivalent to existing MST products on a can-for-can basis. For example, one pack of snus or one can of oral nicotine pouches, irrespective of the number of pouches in the pack or can, is assumed to be equivalent to one can of MST. Because this service represents retail share performance only in key trade channels, it should not be considered a precise measurement of actual retail share.  It is IRI’s standard practice to periodically refresh its InfoScan services, which could restate retail share results that were previously released in this service.

As discussed above, in the first quarter of 2020, Altria’s smokeless products segment was renamed as the oral tobacco products segment. Prior to 2020, the smokeless products segment retail share performance and category industry volume estimates included MST and snus products, but excluded oral nicotine pouch products. Altria has restated prior period retail share performance data and estimated category industry volume to reflect the inclusion of oral tobacco products. The quarterly and year-to-date retail share results for the oral tobacco products segment, which are summarized below, have been restated to reflect this change.
 
Restated Retail Share
 
For the Three Months Ended
 
12/31/19
 
9/30/19
 
6/30/19
 
3/31/19
Copenhagen
33.2
%
 
33.8
%
 
34.1
%
 
34.6
%
Skoal
14.6

 
15.0

 
15.4

 
15.1

Other
3.6

 
3.5

 
3.5

 
3.5

Total oral tobacco products
51.4
%
 
52.3
%
 
53.0
%
 
53.2
%

 
Restated Retail Share
 
For the Year Ended
 
For the Nine Months Ended
 
For the Six Months Ended
 
For the Year Ended
 
12/31/19
 
9/30/19
 
6/30/19
 
12/31/18
Copenhagen
33.9
%
 
34.2
%
 
34.4
%
 
34.4
%
Skoal
15.0

 
15.2

 
15.2

 
15.9

Other
3.6

 
3.4

 
3.5

 
3.4

Total oral tobacco products
52.5
%
 
52.8
%
 
53.1
%
 
53.7
%
For a discussion of volume trends and factors that impact volume and retail share performance, see Tobacco Space - Business Environment above.

The oral tobacco products segment’s reported domestic shipment volume increased 2.8% for the three months ended March 31, 2020, driven primarily by the industry’s growth rate, calendar differences and retail and consumer pantry loading due to COVID-19, partially offset by retail share losses (primarily due to the rapid growth of oral nicotine pouches) and wholesale trade inventory movements. When adjusted for traditional factors of wholesale trade inventory movements, calendar differences and other factors, the oral tobacco products segment’s domestic shipment volume increased by an estimated 1% for

73

the three months ended March 31, 2020. However, Altria believes that its preliminary estimates of retail and consumer pantry loading due to COVID-19 should be an adjusting factor to reported volumes due to its high likelihood of near-term volume payback. When adjusted for wholesale trade inventory movements, Altria’s preliminary estimates of retail and consumer pantry loading due to COVID-19, calendar differences and other factors, the oral tobacco products segment’s shipment volume decreased by an estimated 0.5%.

The oral tobacco products category industry volume increased by an estimated 6% over the six months ended March 31, 2020, as the growth in oral nicotine pouches more than offset the volume decline in MST and snus. When adjusted for Altria’s preliminary estimates of retail and consumer pantry loading due to COVID-19, the oral tobacco products category industry volume increased by an estimated 5% over the six months ended March 31, 2020.

Oral tobacco products segment retail share of 50.4% declined for the three months ended March 31, 2020, due to the rapid growth of oral nicotine pouches and the associated volume declines in MST and snus.

Copenhagen continued to be the leading oral tobacco brand with a retail share of 32.4%.

USSTC executed the following pricing actions during 2020 and 2019:

▪
Effective February 18, 2020, USSTC increased the list price on its Skoal X-TRA products by $0.56 per can. USSTC also increased the list price on its Skoal Blend products by $0.16 cents per can and increased the list price on its Husky, Red Seal and Copenhagen brands and the balance of its Skoal products by $0.07 per can.

▪
Effective October 22, 2019, USSTC increased the list price on its Skoal X-TRA products and select Copenhagen products by $0.09 per can. USSTC also increased the list price on its Husky and Red Seal brands and the balance of its Copenhagen and Skoal products by $0.04 per can.

▪
Effective July 23, 2019, USSTC increased the list price on its Skoal X-TRA products and select Copenhagen products by $0.08 per can. USSTC also increased the list price on its Husky and Red Seal brands and the balance of its Copenhagen and Skoal products by $0.03 per can.

▪
Effective April 30, 2019, USSTC increased the list price on its Skoal X-TRA products and select Copenhagen products by $0.17 per can.  USSTC also increased the list price on its Husky and Red Seal brands and its Copenhagen and Skoal popular price products by $0.12 per can.  In addition, USSTC increased the list price on the balance of its Copenhagen and Skoal products by $0.07 per can.


Wine Segment

Business Environment

Ste. Michelle is a leading producer of Washington state wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other domestic and foreign wine regions. Ste. Michelle holds an 85% ownership interest in Michelle-Antinori, LLC, which owns Stag’s Leap Wine Cellars in Napa Valley. Ste. Michelle also owns Conn Creek in Napa Valley, Patz & Hall in Sonoma and Erath in Oregon. In addition, Ste. Michelle imports and markets Antinori and Villa Maria Estate wines and Champagne Nicolas Feuillatte in the United States. Ste. Michelle works to meet evolving adult consumer preferences over time by developing, marketing and distributing products through innovation.

Ste. Michelle’s business is subject to significant competition, including competition from many larger, well-established domestic and international companies, as well as from many smaller wine producers. Wine segment competition is primarily based on quality, price, consumer and trade wine tastings, competitive wine judging, third-party acclaim and advertising. Substantially all of Ste. Michelle’s sales occur in the United States through state-licensed distributors. Ste. Michelle also sells to domestic consumers through retail and e-commerce channels and exports wines to international distributors.

Adult consumer preferences among alcohol categories and within the wine category can shift due to a variety of factors, including changes in taste preferences, demographics or social trends, and changes in leisure, dining and beverage consumption patterns and economic conditions. Evolving adult consumer preferences pose challenges to the wine category, which has seen slowing volume growth and increases in inventory levels. Ste. Michelle has been experiencing product volume demand uncertainty, which has been further negatively impacted in the first quarter by the economic uncertainty surrounding the

74

COVID-19 pandemic. Ste. Michelle’s on-premise sales in restaurants, bars, hospitality venues and on cruise lines have been negatively impacted by disruptions arising from the COVID-19 pandemic. As a result of wine inventory levels significantly exceeding forecasted product volume demand as of March 31, 2020, Ste. Michelle recorded pre-tax charges of $392 million in cost of sales, including a $292 million inventory write off and $100 million in estimated losses on future non-cancelable grape purchase commitments. Ste. Michelle expects to record additional charges up to approximately $25 million during the remainder of 2020, consisting of inventory disposal costs and other charges. For further discussion see Asset Impairment, Exit and Implementation Costs in Note 3. In addition, Ste. Michelle also temporarily suspended operations at an operating facility as a result of the COVID-19 pandemic. Evolving adult consumer preferences, an economic downturn or recession, an extended disruption in on-premise sales or facility shutdowns, either voluntary or government-mandated, could result in a further slowdown in the wine category and otherwise have a material adverse effect on Ste. Michelle’s wine business, the consolidated results of operations, cash flows or financial position of Ste. Michelle.

As with other agricultural commodities, grape quality and availability can be influenced by plant disease and infestation, as well as by variations in weather patterns, such as fires and smoke damage from fires, including those caused by climate change. For example, in 2019, freezing temperatures reduced grape production and resulted in fewer grapes being available to Ste. Michelle.

Federal, state and local governmental agencies regulate the beverage alcohol industry through various means, including licensing requirements, pricing rules, labeling and advertising restrictions, and distribution and production policies. Further regulatory restrictions or additional excise or other taxes on the manufacture and sale of alcoholic beverages could have an adverse effect on Ste. Michelle’s wine business.

Operating Results

The following table summarizes operating results, includes reported and adjusted OCI margins, and provides a reconciliation of reported OCI to adjusted OCI for the wine segment:
Wine
 
For the Three Months Ended March 31,
 
2020
 
2019
 
Change
Net revenues
$
146

 
$
151

 
(3.3
)%
Excise taxes
(4
)
 
(5
)
 
 
Revenues net of excise taxes
$
142

 
$
146

 
 
 
 
 
 
 
 
Reported OCI
$
(379
)
 
$
15

 
(100.0)%+

Implementation costs
392

 
$
—

 
 
Adjusted OCI
13

 
15

 
(13.3
)%
 
 
 
 
 
 
Reported OCI margins 1
(100.0)%+

 
10.3
%
 
(100.0)%+

Adjusted OCI margins 1
9.2
%
 
10.3
%
 
(1.1) pp

1 Reported and adjusted OCI margins are calculated as reported and adjusted OCI, respectively, divided by revenues net of excise taxes.

Net revenues, which include excise taxes billed to customers, decreased $5 million (3.3%), due primarily to lower shipment volume, partially offset by higher pricing, which includes lower promotional investments, and favorable mix.

Reported OCI decreased $394 million (100.0%+), due primarily to the inventory-related charges discussed above (included in implementation costs and charged to cost of sales) , lower shipment volume and higher costs, partially offset by higher pricing, which includes lower promotional investments, and favorable mix. Reported OCI margins decreased in excess of 100.0 percentage points.

Adjusted OCI decreased $2 million (13.3%), due primarily to lower shipment volume and higher costs, partially offset by higher pricing, which includes lower promotional investments, and favorable mix. Adjusted OCI margins decreased 1.1 percentage points to 9.2%


75

For the three months ended March 31, 2020, Ste. Michelle’s reported wine shipment volume of 1,715 thousand cases, decreased 10.2%.

Financial Review

Cash Provided by/Used in Operating Activities

During the first three months of 2020, net cash provided by operating activities was $3,129 million compared with $2,289 million during the first three months of 2019. This increase was due primarily to higher net revenues in the smokable products and oral tobacco products segments and lower payments as a result of savings from the cost reduction program announced in December 2018, partially offset by higher long-term debt interest payments.

Altria had a working capital deficit at March 31, 2020 and December 31, 2019. Altria’s management believes that Altria has the ability to fund working capital deficits with cash provided by operating activities and borrowings through its access to credit and capital markets as discussed in the Debt and Liquidity section below.

Cash Provided by/Used in Investing Activities

During the first three months of 2020, net cash used in investing activities was $52 million compared with $1,950 million during the first three months of 2019. This decrease was due primarily to the investment in Cronos in 2019.

Cash Provided by/Used in Financing Activities

During the first three months of 2020, net cash provided by financing activities was $427 million compared with $1,683 million during the first three months of 2019. This decrease was due primarily to the following:
•
proceeds of $16.3 billion from the issuance of long-term senior unsecured notes in 2019; and
•
repayment of $1.0 billion in full of Altria senior unsecured notes at scheduled maturity in January 2020;

partially offset by:
•
repayments of $12.8 billion of short-term borrowings in 2019; and
•
proceeds of $3.0 billion from short-term borrowings in 2020.

Debt and Liquidity

Credit Ratings - Altria’s cost and terms of financing and its access to commercial paper markets may be impacted by applicable credit ratings. The impact of credit ratings on the cost of borrowings under the Credit Agreement is discussed below.

At March 31, 2020, the credit ratings and outlook for Altria’s indebtedness by major credit rating agencies were:
 
Short-term Debt
 
Long-term Debt
 
Outlook
Moody’s Investors Service, Inc. (“Moody’s”)
 P-2
 
 A3
 
Negative
Standard & Poor’s Ratings Services (“Standard & Poor’s”)
 A-2
 
BBB
 
 Stable
Fitch Ratings Ltd.
 F2
 
BBB
 
 Stable

Credit Lines - From time to time, Altria has short-term borrowing needs to meet its working capital requirements and generally uses its commercial paper program to meet those needs.

The Credit Agreement provides for borrowings up to an aggregate principal amount of $3.0 billion.

On March 23, 2020, Altria provided notice to JPMorgan Chase Bank, N.A., as administrative agent under the Credit Agreement, to borrow the entire available amount ($3.0 billion) under the Credit Agreement and, as of March 31, 2020, $3.0 billion was outstanding under the Credit Agreement. Altria typically accesses the commercial paper market early in the second quarter to help fund payments related to the 1998 Master Settlement Agreement (the “MSA”) and shareholder dividends. In light of the current uncertainty in the global capital markets, including the commercial paper markets, resulting from the COVID-19 pandemic, Altria elected to borrow the entire amount available under the Credit Agreement as a precautionary measure to increase its cash position and preserve financial flexibility. Altria used a portion of the proceeds from the borrowing under the Credit Agreement to help fund these payments and for other general corporate purposes.


76

All borrowings under the Credit Agreement mature on August 1, 2023, unless extended. The Credit Agreement includes an option, subject to certain conditions, for Altria to extend the expiration date for two additional one-year periods. Altria may repay the borrowings under the Credit Agreement at any time without penalty. Altria has the intent and ability to repay the entire outstanding balance under the Credit Agreement within one year and believes it has adequate liquidity and access to financial resources to meet its anticipated obligations in the foreseeable future. As a result, Altria has classified the full amount of the borrowings as a current liability on its condensed consolidated balance sheet at March 31, 2020. For further discussion, including interest and covenants in the Credit Agreement, see Note 10. Debt to the condensed consolidated financial statements in Item 1 (“Note 10”).

Any commercial paper issued by Altria and borrowings under the Credit Agreement are guaranteed by PM USA as further discussed in Note 12. Condensed Consolidating Financial Information to the condensed consolidated financial statements in Item 1 (“Note 12”).

Financial Market Environment - Altria believes it has adequate liquidity and access to financial resources to meet its anticipated obligations and ongoing business needs in the foreseeable future. Altria monitors the credit quality of its bank group and is not aware of any potential non-performing credit provider in that group.

COVID-19
Due to the uncertainty surrounding the COVID-19 pandemic, including its duration and ultimate overall impact, Altria expects to maintain a higher than normal cash balance in order to preserve its financial flexibility. As a result, Altria took the following actions to increase its cash position:
•
borrowed the full $3.0 billion available under the Credit Agreement as discussed above;
•
did not repurchase any shares during the first quarter of 2020 under its current $1.0 billion share repurchase program, and in April 2020, the Board of Directors rescinded the $500 million remaining in the share repurchase program;
•
as permitted under recent federal government COVID-19 tax relief, deferred approximately $450 million of estimated federal income tax payments from April 2020 to July 2020 and will defer an additional $475 million from June 2020 to July 2020;
•
as permitted under recent state governments COVID-19 tax relief, deferred approximately $65 million of estimated state income tax payments from April 2020 to July 2020 and will defer future payments as allowable; and
•
deferred federal excise tax payments of approximately $450 million from April 2020 to July 2020 and will continue to defer payments previously due in May 2020 and June 2020 by 90 days to August 2020 and September 2020, respectively.

At March 31, 2020, Altria’s receivables primarily reflect sales of wine produced and/or distributed by Ste. Michelle. Altria’s businesses anticipate that the COVID-19 pandemic may present challenges in ensuring timely payment and collection of accounts receivable for some of its customers. Altria will closely monitor these situations and will record an allowance for doubtful accounts against such receivables, if such conditions arise. As of the date of this filing, Altria was not aware of any such conditions.

In addition, in April 2020, ABI announced that it would reduce its next dividend payment by 50% to preserve financial flexibility during this period of significant volatility and uncertainty. This action will result in a reduction to Altria’s cash dividends received from ABI of approximately $100 million in the second quarter of 2020.

Debt - At March 31, 2020 and December 31, 2019, Altria’s total debt was $30.0 billion and $28.0 billion, respectively. The increase in debt was due to Altria’s borrowings of $3.0 billion under the Credit Agreement discussed above, partially offset by the repayment in full of $1.0 billion of Altria senior unsecured notes at scheduled maturity in January 2020.

For further details on short-term borrowings and long-term debt, see Note 10.

Guarantees and Other Similar Matters - As discussed in Note 11, Altria and certain of its subsidiaries had unused letters of credit obtained in the ordinary course of business, guarantees (including third-party guarantees) and a redeemable noncontrolling interest outstanding at March 31, 2020. From time to time, subsidiaries of Altria also issue lines of credit to affiliated entities. In addition, as discussed in Note 12, PM USA has issued guarantees relating to Altria’s obligations under its outstanding debt securities, borrowings under its Credit Agreement and amounts outstanding under its commercial paper program. These items have not had, and are not expected to have, a significant impact on Altria’s liquidity. For further discussion regarding Altria’s liquidity, see the Debt and Liquidity section above.


77

Payments Under State Settlement Agreements and FDA Regulation - As discussed previously and in Note 11, PM USA and Nat Sherman have entered into State Settlement Agreements with the states and territories of the United States that call for certain payments. In addition, PM USA, Middleton, Nat Sherman and USSTC are subject to quarterly user fees imposed by the FDA as a result of the FSPTCA. Altria’s subsidiaries recorded $1.1 billion and $1.0 billion of charges to cost of sales for the three months ended March 31, 2020 and 2019, respectively, in connection with the State Settlement Agreements and FDA user fees. For further discussion of the resolutions of certain disputes with states and territories related to the NPM adjustment provision under the MSA, see Health Care Cost Recovery Litigation - NPM Adjustment Disputes in Note 11.

Based on current agreements, 2019 market share and estimated annual industry volume decline rates, the estimated amounts that Altria’s subsidiaries may charge to cost of sales for payments related to State Settlement Agreements and FDA user fees approximate $4.5 billion in 2020 and $4.4 billion each year thereafter. These amounts exclude the potential impact of any NPM Adjustment Items.

The estimated amounts due under the State Settlement Agreements charged to cost of sales in each year would generally be paid in the following year. The amounts charged to cost of sales for FDA user fees are generally paid in the quarter in which the fees are incurred. As previously stated, the payments due under the terms of the State Settlement Agreements and FDA user fees are subject to adjustment for several factors, including volume, operating income, inflation and certain contingent events and, in general, are allocated based on each manufacturer’s market share. The future payment amounts discussed above are estimates, and actual payment amounts will differ to the extent underlying assumptions differ from actual future results.

Litigation-Related Deposits and Payments - With respect to certain adverse verdicts currently on appeal, to obtain stays of judgments pending appeals, as of March 31, 2020, PM USA had posted appeal bonds totaling $48 million, which have been collateralized with restricted cash that is included in assets on the condensed consolidated balance sheet.

Although litigation is subject to uncertainty and an adverse outcome or settlement of litigation could have a material adverse effect on the financial position, cash flows or results of operations of PM USA, UST LLC (“UST”) or Altria in a particular fiscal quarter or fiscal year, as more fully disclosed in Note 11 and in Cautionary Factors That May Affect Future Results, management expects cash flow from operations, together with Altria’s access to capital markets, to provide sufficient liquidity to meet ongoing business needs.

Equity and Dividends

On February 26, 2020, Altria granted an aggregate of 0.9 million restricted stock units “(“RSUs”) and 0.2 million performance stock units (“PSUs”) to eligible employees. The service restrictions for the RSUs and the PSUs lapse in the first quarter of 2023. In addition, the vesting of the PSUs depends first on Altria’s performance on certain financial metrics over the three-year vesting period. The payout resulting from the performance metrics is then scaled up or down by a total shareholder return (“TSR”) performance multiplier, which depends on Altria’s relative TSR against a predetermined peer group. The market value per share of the RSUs and the PSUs granted on February 26, 2020 was $42.61 and $43.28, respectively, on the date of grant.

During the three months ended March 31, 2020, 0.5 million shares of RSUs vested. The total fair value of RSUs that vested during the three months ended March 31, 2020 was $23 million. The weighted-average grant date fair value per share of these awards was $66.76.

Dividends paid during the first three months of 2020 and 2019 were $1,563 million and $1,502 million, respectively, an increase of 4.1%, reflecting a higher dividend rate, partially offset by fewer shares outstanding as a result of shares repurchased by Altria under its share repurchase programs. The current annualized dividend rate is $3.36 per share of Altria common stock. In 2020, Altria expects to recommend a quarterly dividend rate to the Board of Directors that reflects, among other things, its strong cash generation and the strength of its balance sheet. Altria’s objective remains a dividend payout ratio target of approximately 80% of its adjusted diluted EPS. Future dividend payments remain subject to the discretion of the Board of Directors.

For a discussion of Altria’s share repurchase programs, see Note 1. Background and Basis of Presentation to the condensed consolidated financial statements in Item 1 and Part II, Item 2. Unregistered Sales of Equity Securities and Use of Proceeds of this Form 10-Q.

78

New Accounting Guidance Not Yet Adopted

See Note 13. New Accounting Guidance Not Yet Adopted to the condensed consolidated financial statements in Item 1 for a discussion of issued accounting guidance applicable to, but not yet adopted by, Altria.

Contingencies

See Note 11 for a discussion of contingencies.


79

Cautionary Factors That May Affect Future Results

Forward-Looking and Cautionary Statements

We may from time to time make written or oral forward-looking statements, including earnings guidance and other statements contained in filings with the SEC, reports to security holders, press releases and investor webcasts. You can identify these forward-looking statements by use of words such as “strategy,” “expects,” “continues,” “plans,” “anticipates,” “believes,” “will,” “estimates,” “forecasts,” “intends,” “projects,” “goals,” “objectives,” “guidance,” “targets” and other words of similar meaning. You can also identify them by the fact that they do not relate strictly to historical or current facts.

We cannot guarantee that any forward-looking statement will be realized, although we believe we have been prudent in our plans, estimates and assumptions. Achievement of future results is subject to risks, uncertainties and assumptions that may prove to be inaccurate. Should known or unknown risks or uncertainties materialize, or should underlying estimates or assumptions prove inaccurate, actual results could differ materially from those anticipated, estimated or projected. You should bear this in mind as you consider forward-looking statements and whether to invest in or remain invested in Altria’s securities. In connection with the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, we are identifying important factors that, individually or in the aggregate, could cause actual results and outcomes to differ materially from those contained in, or implied by, any forward-looking statements made by us; any such statement is qualified by reference to the following cautionary statements. We elaborate on these important factors and the risks we face throughout this Form 10-Q, particularly in Item 1A and in the “Business Environment” sections preceding our discussion of the operating results of our subsidiaries’ businesses, and in our publicly filed reports, including our 2019 Form 10-K. These factors include the following:
▪
the risks associated with health epidemics and pandemics, including the COVID-19 pandemic and similar outbreaks, such as their impact on our financial performance and financial condition and on our subsidiaries’ and investees’ ability to continue manufacturing and distributing products, and the impact of health epidemics and pandemics on general economic conditions, including any resulting recession;
▪
unfavorable litigation outcomes, including risks associated with adverse jury and judicial determinations, courts and arbitrators reaching conclusions at variance with our, our subsidiaries’ or our investees’ understanding of applicable law, bonding requirements in the jurisdictions that do not limit the dollar amount of appeal bonds, and certain challenges to bond cap statutes;
▪
government (including FDA) and private sector actions that impact adult tobacco consumer acceptability of, or access to, tobacco products;
▪
the growth of the e-vapor category and other innovative tobacco products contributing to reductions in cigarette and MST consumption levels and sales volume;
▪
tobacco product taxation, including lower tobacco product consumption levels and potential shifts in adult consumer purchases as a result of federal, state and local excise tax increases;
▪
the failure by our tobacco and wine subsidiaries to compete effectively in their respective markets;
▪
our tobacco and wine subsidiaries’ continued ability to promote brand equity successfully; to anticipate and respond to evolving adult consumer preferences; to develop, manufacture, market and distribute products that appeal to adult consumers (including, where appropriate, through arrangements with, and investments in third parties); to improve productivity; and to protect or enhance margins through cost savings and price increases;
▪
changes, including in economic conditions, that result in adult consumers choosing lower-priced brands including discount brands;
▪
the unsuccessful commercialization of adjacent products or processes by our tobacco subsidiaries and investees, including innovative tobacco products that may reduce the health risks associated with cigarettes and other traditional tobacco products, and that appeal to adult tobacco consumers;
▪
significant changes in price, availability or quality of tobacco, other raw materials or component parts, including as a result of the COVID-19 pandemic;
▪
the risks related to the reliance by our tobacco and wine subsidiaries on a few significant facilities and a small number of key suppliers, and the risk of an extended disruption at a facility or of service by a supplier of our tobacco or wine subsidiaries or investees including as a result of the COVID-19 pandemic;
▪
required or voluntary product recalls as a result of various circumstances such as product contamination or FDA or other regulatory action;
▪
the failure of our information systems or service providers’ information systems to function as intended, or cyber-attacks or security breaches;
▪
unfavorable outcomes of any government investigations of Altria, our subsidiaries or investees;

80

▪
a successful challenge to our tax positions;
▪
the risks related to our and our investees’ international business operations, including failure to prevent violations of various U.S. and foreign laws and regulations such as laws prohibiting bribery and corruption;
▪
our inability to attract and retain the best talent due to the impact of decreasing social acceptance of tobacco usage and tobacco control actions;
▪
the adverse effect of acquisitions, investments, dispositions or other events on our credit rating;
▪
our inability to acquire attractive businesses or make attractive investments on favorable terms, or at all, or to realize the anticipated benefits from an acquisition or investment and our inability to dispose of businesses or investments on favorable terms or at all;
▪
the risks related to disruption and uncertainty in the credit and capital markets, including risk of access to these markets both generally and at current prevailing rates which may adversely affect our earnings or dividend rate or both;
▪
impairment losses as a result of the write down of intangible assets, including goodwill;
▪
the risks related to Ste. Michelle’s wine business, including competition, unfavorable changes in grape supply, and changes in adult consumer preferences that have resulted and may continue to result in increased inventory levels and inventory write offs, and governmental regulations;
▪
the risk that any challenge to our investment in JUUL, if successful, could result in a broad range of resolutions such as divestiture of the investment or rescission of the transaction;
▪
the risks generally related to our investments in JUUL and Cronos, including our inability to realize the expected benefits of our investments in the expected time frames, or at all, due to the risks encountered by our investees in their businesses, such as operational, compliance and regulatory risks at the international, federal, state and local levels, including actions by the FDA, and adverse publicity; potential disruptions to our investees’ management or current or future plans and operations; domestic or international litigation developments, government investigations, tax disputes or otherwise; and impairment of our investments;
▪
the risks related to our inability to acquire a controlling interest in JUUL as a result of standstill restrictions or to control the material decisions of JUUL, restrictions on our ability to sell or otherwise transfer our shares of JUUL until December 20, 2024, and non-competition restrictions for the same time period subject to certain exceptions;
▪
the adverse effects of risks encountered by ABI in its business, including effects of the COVID-19 pandemic, foreign currency exchange rates and the impact of movements in ABI’s stock price on our equity investment in ABI, including on our reported earnings from and carrying value of our investment in ABI, which could result in impairment of our investment, and the dividends paid by ABI on the shares we own;
▪
the risks related to our inability to transfer our equity securities in ABI until October 10, 2021, and, if our ownership percentage decreases below certain levels, the adverse effects of additional tax liabilities, a reduction in the number of directors that we have the right to have appointed to the ABI board of directors, and our potential inability to use the equity method of accounting for our investment in ABI;
▪
the risk of challenges to the tax treatment of the consideration we received in the ABI/SABMiller business combination and the tax treatment of our equity investment; and
▪
the risks, including criminal, civil or tax liability for Altria, related to Cronos’s or Altria’s failure to comply with applicable laws, including cannabis laws.

You should understand that it is not possible to predict or identify all factors and risks. Consequently, you should not consider the foregoing list to be complete. We do not undertake to update any forward-looking statement that we may make from time to time except as required by applicable law.


81

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Interest Rates

At March 31, 2020 and December 31, 2019, the fair value of Altria’s long-term debt, all of which is fixed-rate debt, was $28.3 billion and $30.7 billion, respectively. The fair value of Altria’s long-term debt is subject to fluctuations resulting from changes in market interest rates. A 1% increase in market interest rates at March 31, 2020 and December 31, 2019 would decrease the fair value of Altria’s long-term debt by $2.2 billion and $2.4 billion, respectively. A 1% decrease in market interest rates at March 31, 2020 and December 31, 2019 would increase the fair value of Altria’s long-term debt by $2.5 billion and $2.7 billion, respectively.

At March 31, 2020, the fair value of Altria’s short-term borrowings under the Credit Agreement was $3.0 billion. Altria had no short-term borrowings at December 31, 2019. Interest on the outstanding borrowings under the Credit Agreement at March 31, 2020 was based on London Interbank Offered Rate (“LIBOR”) plus a percentage based on the higher of the ratings of Altria’s long-term senior unsecured debt from Moody’s and Standard & Poor’s. The applicable percentage based on Altria’s long-term senior unsecured debt ratings at March 31, 2020 for borrowings under the Credit Agreement was 1.0%. At March 31, 2020, the interest rate for Altria’s current borrowing under the Credit Agreement was 2.23%.

Equity Price Risk

The estimated fair values of the Fixed-price Preemptive Rights and the Cronos warrant are subject to equity price risk. The Fixed-price Preemptive Rights and warrant are recorded at fair value, which is estimated using Black-Scholes option-pricing models. The fair values of the Fixed-price Preemptive Rights and Cronos warrant are subject to fluctuations resulting from changes in the quoted market price of Cronos shares, the underlying equity security.

At March 31, 2020, the fair values of the Fixed-price Preemptive Rights and Cronos warrant were $34 million and $132 million, respectively. A 10% increase or decrease in the quoted market price of Cronos shares at March 31, 2020 would increase or decrease the fair values of the Fixed-price Preemptive Rights and Cronos warrant by approximately $7 million and $23 million, respectively.

Item 4. Controls and Procedures.

Altria carried out an evaluation, with the participation of Altria’s management, including its Chief Executive Officer and Chief Financial Officer, of the effectiveness of its disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended, as of the end of the period covered by this Form 10-Q. Based upon that evaluation, Altria’s Chief Executive Officer and Chief Financial Officer concluded that Altria’s disclosure controls and procedures are effective.

There have been no changes in Altria’s internal control over financial reporting during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, its internal control over financial reporting.

Part II – OTHER INFORMATION

Item 1. Legal Proceedings.

See Note 11 for a discussion of legal proceedings pending against Altria and its subsidiaries. See also Exhibits 99.1 and 99.2 to this Form 10-Q.

Item 1A. Risk Factors.

Information regarding Risk Factors appears in Part I, Item 1A. Risk Factors of the 2019 Form 10-K. Except as set forth below, there have been no material changes to the risk factors previously disclosed in the 2019 Form 10-K:

Altria, its subsidiaries and its investees face various risks related to health epidemics and pandemics, including the COVID-19 pandemic and similar outbreaks, which could have a material adverse effect on the business, consolidated results of operations, cash flows or financial position of Altria and its subsidiaries and investees.


82

Altria’s, its subsidiaries’ and its investees’ business and financial results, consolidated results of operations, cash flows or financial position could be negatively impacted by health epidemics, pandemics and similar outbreaks. The recent and rapidly spreading COVID-19 pandemic could have negative impacts, such as (i) a global or U.S. recession or other economic crisis including a financial crisis, (ii) credit and capital markets volatility (and access to these markets, including by those in the distribution and supply chains), (iii) significant volatility in demand for our tobacco and wine subsidiaries’ and investees’ products, (iv) changes in adult consumer accessibility to those products including due to government action; (v) changes in adult consumer behavior and preferences, including trading down to lower-priced products or cessation of product use due to public health actions or concerns and (vi) extended or multiple disruptions in our subsidiaries’ or investees’ manufacturing operations, or in their distribution and supply chains. In addition, our subsidiaries’ and investees’ operations may incur increased costs and otherwise be negatively affected if significant portions of their respective workforces (or the workforces within their respective distribution or supply chains) are unable to work or work effectively, including because of illness, unavailability of personal protective equipment, quarantines, government actions, facility closures or other restrictions.

The impact of the COVID-19 pandemic depends on factors beyond our knowledge or control, including the duration and severity of the outbreak and actions taken to contain its spread and mitigate the public health effects. In the first quarter of 2020, due to these uncertainties, and the potential adverse impact of an economic downturn or recession due to the pandemic, including on our earnings from ABI, we withdrew our 2020 full-year adjusted diluted EPS guidance and our three-year adjusted diluted EPS growth objective. We cannot at this time predict the impact of the COVID-19 pandemic on our or our investees’ future financial or operational results, but the impact could be material over time. See the third risk factor below for risks related to extended disruptions at a facility, of a distributor or in service by a service provider and the sixth risk factor below for risks related to our investment in ABI and the earnings from and carrying value of that investment. For further discussion on the impact of the COVID-19 pandemic on the tobacco and wine businesses, see Tobacco Segment - Business Environment and Wine Segment - Business Environment in Item 2.

Significant changes in price, availability or quality of tobacco, other raw materials or component parts could have an adverse effect on the profitability and business of Altria’s tobacco subsidiaries and investees.

Any significant change in prices, quality or availability of tobacco, other raw materials or component parts, particularly as a result of the COVID-19 pandemic, could adversely affect our tobacco subsidiaries’ and our investees’ profitability and business. The COVID-19 pandemic also may impact the availability of direct materials necessary for our tobacco subsidiaries and JUUL to remain compliant with FDA and other regulatory requirements for tobacco products. For further discussion, see Tobacco Space - Business Environment - Price, Availability and Quality of Tobacco, Other Raw Materials and Component Parts in Item 2.

Altria’s subsidiaries rely on a few significant facilities and a small number of key suppliers, distributors and distribution chain service providers. An extended disruption at a facility or in service by a supplier, distributor or distribution chain service provider could have a material adverse effect on the business, the consolidated results of operations, cash flows or financial position of Altria and its tobacco and wine subsidiaries and investees.

Altria’s subsidiaries face risks inherent in reliance on a few significant manufacturing facilities and a small number of key suppliers, distributors and distribution chain service providers. A natural or man-made disaster or other disruption that affects the manufacturing operations of any of Altria’s tobacco or wine subsidiaries or investees, the operations of any key supplier, distributor or distribution chain service provider of any of Altria’s tobacco or wine subsidiaries or investees or any other disruption in the supply or distribution of goods or services (including a key supplier’s inability to comply with government regulations or unwillingness to supply goods or services to a tobacco company) could adversely impact the operations of the affected subsidiaries and investees. For example, in March 2020, the COVID-19 pandemic resulted in a temporary suspension of operations at PM USA’s Richmond, Virginia manufacturing facility, which is the primary facility for manufacturing PM USA cigarettes. Some state governors also have issued executive orders requiring that certain businesses temporarily suspend operations for varying periods of time while the COVID-19 pandemic persists. Operations of our subsidiaries, suppliers, distributors and distribution chain service providers and those of our investees could be suspended temporarily once or multiple times, or closed permanently, depending on various factors, including how long the COVID-19 pandemic persists and the extent to which state, local and federal governments, as well as foreign countries, impose restrictions on the operation of facilities or otherwise place limits on the supply and distribution chains. An extended disruption in operations experienced by one or more of Altria’s subsidiaries, investees or in the supply or distribution of goods or services by one or more key suppliers, distributors or distribution chain service providers could have a material adverse effect on the business, the consolidated results of operations, cash flows or financial position of Altria and its tobacco and wine subsidiaries and investees.


83

Competition, changes in adult consumer preferences, unfavorable changes in grape supply and new governmental regulations or revisions to existing governmental regulations could adversely affect Ste. Michelle’s wine business.

Ste. Michelle’s business is impacted by evolving adult consumer preferences. Shifts away from the wine category to other alcohol categories or shifts to lower-priced wines have resulted, and could continue to result, in slowing growth in Ste. Michelle’s sales and increased inventory levels and have an adverse effect on Ste. Michelle’s wine business. As discussed in Asset Impairment, Exit and Implementation Costs in Note 3, in the first quarter of 2020, Ste. Michelle recorded pre-tax charges of $392 million in cost of sales, including a $292 million inventory write off and $100 million in estimated losses on future non-cancelable grape purchase commitments as a result of inventory levels significantly exceeding long-term forecasted demand. Ste. Michelle expects to record additional charges up to approximately $25 million during the remainder of 2020, consisting of inventory disposal costs and other charges. Evolving adult consumer preferences, an economic downturn or recession or other factors could result in a further slowdown in the wine category and otherwise have a material adverse effect on Ste. Michelle’s wine business. The adequacy of Ste. Michelle’s grape supply is influenced by consumer demand for wine in relation to industry-wide production levels as well as by weather and crop conditions, particularly in eastern Washington. Supply shortages or surpluses related to any one or more of these factors could impact production costs and wine prices, which ultimately may have a negative impact on Ste. Michelle’s sales. In addition, Ste. Michelle’s business is subject to significant competition, including from many large, well-established domestic and international companies. Federal, state and local governmental agencies also regulate the alcohol beverage industry through various means, including licensing requirements, pricing, labeling and advertising restrictions, and distribution and production policies. New regulations or revisions to existing regulations, resulting in further restrictions or taxes on the manufacture and sale of alcoholic beverages may have an adverse effect on Ste. Michelle’s wine business. For further discussion see Wine Segment - Business Environment in Item 2.

A challenge to our investment in JUUL, if successful, could result in a broad range of resolutions such as divestiture of the investment or rescission of the transaction.

A challenge to our investment in JUUL, if successful, could result in a broad range of resolutions such as divestiture of the investment or rescission of the transaction. In April 2020, the FTC issued an administrative complaint against Altria and JUUL alleging that Altria’s 35% investment in JUUL and the associated agreements constitute an unreasonable restraint of trade in violation of Section 1 of the Sherman Act and Section 5 of the FTC Act, and substantially lessened competition in violation of Section 7 of the Clayton Act. The FTC seeks a broad range of remedies including divestiture of Altria’s minority investment in JUUL, rescission of the transaction and prohibition against any officer or director of either Altria or JUUL serving on the other’s board of directors or attending meetings. The administrative trial will take place before an FTC administrative law judge and is currently scheduled to begin March 11, 2021. Any ruling by the FTC is subject to review by the FTC Commissioners and subsequently, by a federal appellate court.

Additionally, on October 1, 2019, the FTC issued a Civil Investigative Demand to Altria seeking information regarding, among other things, Altria’s role in the resignation of JUUL’s former chief executive officer and the hiring by JUUL of any current or former Altria director, executive or employee. The FTC administrative complaint, referenced above, contains no allegations relating to this issue and the FTC has raised no further questions about it.

Also as of April 27, 2020, three putative class action lawsuits were filed against Altria and JUUL in the United States District Court for the Northern District of California. The lawsuits cite the FTC administrative complaint referenced above and allege claims similar to those made by the FTC. For further discussion see Note 11.

Neither the FTC nor the private plaintiffs has sought to preliminarily enjoin Altria from converting Altria’s non-voting JUUL shares to voting shares or appointing directors to the JUUL board of directors.

A successful challenge by the FTC or the plaintiffs in the lawsuits to the investment would adversely affect us, including by substantially limiting our rights with respect to our investment in JUUL.

Altria’s reported earnings from and carrying value of its equity investment in ABI and the dividends paid by ABI on shares owned by Altria may be adversely affected by various factors, including foreign currency exchange rates and ABI’s business results, including as a result of the COVID-19 pandemic, and stock price.

For purposes of financial reporting, the earnings from and carrying value of our equity investment in ABI are translated into U.S. dollars (“USD”) from various local currencies. In addition, ABI pays dividends in euros, which we convert into USD. During times of a strengthening USD against these currencies, our reported earnings from and carrying value of our equity investment in ABI will be reduced because these currencies will translate into fewer USD and the dividends that we receive

84

from ABI will convert into fewer USD. Dividends and earnings from and carrying value of our equity investment in ABI are also subject to the risks encountered by ABI in its business, its business outlook, cash flow requirements and financial performance, the state of the market and the general economic climate, including the impact of the COVID-19 pandemic. For example, in April 2020, as a result of the uncertainty, volatility and impact of the COVID-19 pandemic on ABI’s business, ABI announced a proposed 50% reduction to its upcoming dividend, which would result in a reduction of cash dividends Altria will receive from ABI. ABI previously announced a 50% rebase to its dividends in October 2018. In addition, if the carrying value of our investment in ABI exceeds its fair value and the loss in value is other than temporary, the investment is considered impaired, which would result in impairment losses and could have a material adverse effect on Altria’s consolidated financial position or earnings. We cannot provide any assurance that ABI will successfully execute its business plans and strategies. Earnings from and carrying value of our equity investment in ABI are also subject to fluctuations in ABI’s stock price.


Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

In July 2019, the Board of Directors authorized a new $1.0 billion share repurchase program (the “July 2019 share repurchase program”). In April 2020, the Board of Directors rescinded the $500 million remaining in the July 2019 share repurchase program.

Altria’s share repurchase activity for each of the three months in the period ended March 31, 2020, was as follows:
Period
 
Total Number of Shares Purchased (1) 
 
Average Price Paid Per Share
 
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
 
Approximate Dollar Value of Shares that May Yet be Purchased Under the Plans or Programs
 
 
 
 
 
 
 
 
 
January 1 - 31, 2020
 
—

 
$
—

 
—

 
$
500,000,064

February 1 - 29, 2020
 
192,652

 
$
46.18

 
—

 
$
500,000,064

March 1 - 31, 2020
 
—

 
$
—

 
—

 
$
500,000,064

For the Quarter Ended March 31, 2020
 
192,652

 
$
—

 
—

 
 
(1)
The total number of shares purchased represents shares withheld by Altria in an amount equal to the statutory withholding taxes for holders who vested in stock-based awards.


85

Item 6. Exhibits.

2.1

2.2

3.1

10.1

10.2

31.1

31.2

32.1

32.2

99.1

99.2
101.INS XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH XBRL Taxonomy Extension Schema.
101.CAL XBRL Taxonomy Extension Calculation Linkbase.
101.DEF XBRL Taxonomy Extension Definition Linkbase.
101.LAB XBRL Taxonomy Extension Label Linkbase.
101.PRE XBRL Taxonomy Extension Presentation Linkbase.
104 Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).



86


Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
ALTRIA GROUP, INC.

/s/ SALVATORE MANCUSO
Salvatore Mancuso
Executive Vice President and
Chief Financial Officer
April 30, 2020

87
 EX-10.1 2 exhibit101restrictedst.htm FORM OF RESTRICTED STOCK AGREEMENT (2020) Exhibit

Exhibit 10.1


THE ALTRIA GROUP, INC.
2015 PERFORMANCE INCENTIVE PLAN

RESTRICTED STOCK UNIT AGREEMENT
(____, 2020)


ALTRIA GROUP, INC. (“Company”), a Virginia corporation, hereby grants to the employee identified in the 2020 Stock Award section of the Award Statement (“Employee”) under the Altria Group, Inc. 2015 Performance Incentive Plan (“Plan”) a restricted stock unit award (“Award”) with respect to the number of shares of Common Stock of the Company (“Common Stock”) set forth in the 2020 Stock Award section of the Award Statement (“RSUs”), all in accordance with and subject to the following terms and conditions of this Restricted Stock Unit Agreement (“Agreement”).

1.    Definitions. Whenever the following terms are used in this Agreement, they will have the meanings set forth below. Capitalized terms not otherwise defined herein will have the same meanings as in the Plan.

(a)
“Award Date” means ___, 2020, the date on which the Award is granted to the Employee.

(b)
“Award Statement” means the written notice of a restricted stock unit award provided to the Employee by the Company.

(c)
“Compensation and Talent Development Committee” means the Compensation and Talent Development Committee of the Board of Directors of Altria Group, Inc.

(d)
“Disability” means a disability that entitles the Employee to benefits under the applicable long-term disability insurance program of the Company or any of its Subsidiaries.

(e)
“Normal Retirement” means retirement from active employment with the Company and its Subsidiaries following both attainment of age 65 and completion of five years of service with the Company and its Subsidiaries.

(f)
“Retirement” means retirement from active employment with the Company and its Subsidiaries following both attainment of age 50 and completion of five years of service with the Company and its Subsidiaries.

(g)
“Subsidiary” means any company in which the Company, directly or indirectly, has a beneficial ownership interest of greater than 50 percent.

(h)
“Termination of Employment” means a separation from service within the meaning of Code section 409A with the Company and all of its Subsidiaries, which includes circumstances in which the Employee is reasonably anticipated not to perform further services with the Company and its Subsidiaries.

(i)
“Vesting Date” means the date set forth in the Award Statement upon which the Award is generally no longer subject to forfeiture.

2.Condition to Award. The Company or its delegate, in its sole discretion, may require the Employee to execute a Confidentiality and Non-Competition Agreement in consideration of the Award by notifying the Employee of such requirement as soon as practicable after the Award Date. In such instance, the Award


is consideration for and contingent on the Employee’s execution of the Confidentiality and Non-Competition Agreement. The Employee’s failure to execute the Confidentiality and Non-Competition Agreement within a reasonable time after receipt, as specified by the Company or its delegate, but in no event later than 90 days after the Company or its delegate provides the Employee with the Confidentiality and Non-Competition Agreement, will result in complete nullification of the Agreement, and the Employee will forfeit any and all rights to the Award.

3.Normal Vesting. The RSUs will vest on the Vesting Date, provided that the Employee remains an employee of the Company or a Subsidiary from the Award Date through the Vesting Date and otherwise satisfies the terms of this Agreement and the Plan. The Employee will have no rights to the shares of Common Stock or cash equivalent until the RSUs have vested.

4.Accelerated Vesting. In the event that the Employee experiences a Termination of Employment with the Company and all of its Subsidiaries prior to the Vesting Date due to death, Disability, or Normal Retirement, the RSUs will become fully vested on the date of such Termination of Employment. In addition, in the event of a “Change in Control” within the meaning of the Plan, the RSUs will become vested and payable in the circumstances and in the manner specified in section 6(a) of the Plan and Section 11 below.

5.Forfeiture. If the Employee experiences a Termination of Employment with the Company and all of its Subsidiaries for any reason other than death, Disability, or Normal Retirement prior to the Vesting Date, the Employee will forfeit all rights to the RSUs immediately after Termination of Employment. For purposes of this paragraph, the sale of a Subsidiary that employs the Employee will be considered a Termination of Employment with respect to such Employee. Notwithstanding the foregoing, upon a Termination of Employment described in this paragraph, the Compensation and Talent Development Committee may, in its sole discretion, vest some or all of the RSUs.

6.Payment of RSUs. The RSUs will become payable upon the normal or accelerated vesting date described in Section 3 or 4 or following any later payment date described in Section 11, if applicable (“Payment Date”). Payment, in the form of issuance of shares of Common Stock and/or cash, will be made as soon as practicable following the Payment Date. However, in all cases payment will be made by the later of (a) December 31 of the year of the Payment Date or (b) two and a half months after the Payment Date. Upon such payment, the Company will issue and deliver to the Employee the number of shares of Common Stock equal to the number of vested RSUs or, if the Compensation and Talent Development Committee so determines in its sole discretion, the cash equivalent value of such shares of Common Stock, as determined by the Compensation and Talent Development Committee, in either case subject to satisfaction of applicable tax and/or other obligations as described in Section 9.

7. Voting and Dividend Rights. Unless and until the RSUs vest and the underlying Common Stock has been delivered to the Employee, the Employee will not have a right to vote the RSUs or receive dividends associated with shares of Common Stock underlying the RSUs. However, from the Award Date until the Vesting Date, the Employee will have the right to receive, free of vesting conditions (but subject to applicable withholding taxes), dividend equivalent cash payments in lieu of the dividends that the Employee would have received had the Employee held such shares of Common Stock, unless otherwise determined by the Compensation and Talent Development Committee.

8.Unfunded Award and Transfer Restrictions. Prior to settlement, the RSUs represent an unfunded and unsecured obligation of the Company. This Award and the RSUs are non-transferable and may not be sold, conveyed, assigned, transferred, pledged, or otherwise disposed of or encumbered at any time prior to vesting and settlement of the RSUs. If the Employee attempts to violate this Section 8, such action will be null and void, the Award will immediately become null and void, and the RSUs granted under the Award will be forfeited. These restrictions will not apply, however, to any shares of Common Stock or cash

2

payments that the Employee has received pursuant to Section 6. If the Employee is a resident of Canada, the Employee acknowledges that the shares of Common Stock that the Employee receives pursuant to Section 6 are subject to a restriction on the first trade under Canadian securities laws.  As a result, the Employee acknowledges that any first trade of such shares of Common Stock must be made (a) through an exchange, or a market, outside of Canada, (b) to a person or company outside of Canada, or (c) otherwise in compliance with applicable Canadian securities laws.

9.Taxes and Withholding Taxes. The Company is authorized to satisfy any withholding taxes arising in connection with this Award by (a) deducting the number of RSUs having an aggregate value equal to the amount of withholding taxes due, or (b) the remittance of the required amounts from any proceeds realized upon the open-market sale of the Common Stock received in payment of vested RSUs by the Employee. The Company is authorized to satisfy any withholding taxes arising from the payment of cash in lieu of dividends pursuant to Section 7 by withholding the required amounts from such cash payment. The Company is also authorized to satisfy any withholding taxes referred to in this Section 9 by requiring a cash payment from the Employee or by withholding from other payments due to the Employee. If the Employee is covered by a Company tax equalization policy, the Employee also agrees to pay to the Company any additional hypothetical tax obligation calculated and paid under the terms and conditions of such tax equalization policy. The Employee agrees that he or she is responsible for, and the Company and its Subsidiaries are not responsible for, any personal tax consequences in connection with the RSUs.

10.Beneficiary for Payments Upon Death. Upon the death of the Employee, any Common Stock or cash amounts paid in connection with the RSUs will be paid to the Employee’s estate. Notwithstanding the foregoing, the Compensation and Talent Development Committee may elect to permit the Employee to designate a beneficiary other than the Employee’s estate, and if the Compensation and Talent Development Committee so permits, then the proceeds will be paid to such beneficiary.

11.Code Section 409A Special Payment Provisions. This Agreement will be construed in a manner consistent with section 409A of the Internal Revenue Code and the regulations thereunder (“Code section 409A”). Special payment provisions apply under this Section 11 in two situations: (a) for RSUs with a Vesting Date between January 1 and March 15, if the Employee will become eligible for Retirement before the calendar year preceding the Vesting Date and (b) for RSUs with a Vesting Date after March 15, if the Employee will become eligible for Retirement before the calendar year in which the Vesting Date occurs. If the special payment provisions apply, then notwithstanding anything in this Agreement to the contrary:

(i) If the Employee is a “specified employee” within the meaning of Code section 409A, any payment of RSUs under Section 6 that is on account of his or her Termination of Employment will be delayed until the earlier of six months following such Termination of Employment or the Employee’s death.

(ii) In the event of a “Change in Control” under section 6(b) of the Plan that is not also a “change in control event” with the meaning of Treas. Reg. §1.409A-3(i)(5)(i), any RSUs that would otherwise become vested and paid pursuant to section 6(a) of the Plan upon such Change in Control will become vested, but will not be paid upon such Change in Control, and will instead be paid at the time the RSUs would otherwise be paid pursuant to this Agreement.

(iii) This Section 11(iii) applies in the event of a sale of a Subsidiary that is treated as a Termination of Employment under Section 5, but that does not result in a “separation from service” within the meaning of Code section 409A. In such event, any RSUs that become vested pursuant to Section 5 upon such sale will not be paid upon the accelerated vesting date, but will instead be paid upon the earlier of (A) the normal vesting date under Section 3 or (B) the Employee’s separation from service (within the meaning of Code section 409A) from the sold Subsidiary, including by reason of death or Disability.


3

12.Financial Restatement. Notwithstanding anything in this Agreement to the contrary, if the Board of Directors of the Company (“Board”) or an appropriate Committee of the Board determines that, as a result of a restatement of the Company’s financial statements, the Employee has received greater compensation in connection with the Award than would have been received absent the incorrect financial statements, the Board or Committee, in its discretion, may take such action with respect to this Award as it deems necessary or appropriate to address the events that gave rise to the restatement and to prevent its recurrence. Such action may include, to the extent permitted by applicable law, causing the full or partial cancellation of this Award and, with respect to RSUs that have vested, requiring the Employee to repay to the Company the full or partial Fair Market Value of the Award determined at the time of vesting, and the Employee agrees by accepting this Award that the Board or Committee may make such a cancellation, impose such a repayment obligation, or take other necessary or appropriate actions in such circumstances.

13.Employment Relationship. Nothing in this Agreement or in the Plan shall confer upon the Employee any right to continue in the employ of the Company or any Subsidiary for any period of specific duration or interfere with or restrict in any way the right of the Company or any Subsidiary, which is hereby expressly reserved, to remove, terminate or discharge the Employee at any time for any reason whatsoever, with or without cause and with or without advance notice.

14.Entire Agreement; Severability. This Agreement and the Plan, along with the referenced information in the Award Statement, represents the entire agreement between the parties regarding the subject matter of this Agreement. The terms and provisions of the Plan are incorporated into and made a part of this Agreement. To the extent any provision of this Agreement is inconsistent or in conflict with any term or provision of the Plan, the Plan will govern. The provisions of this Agreement are severable, and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.


IN WITNESS WHEREOF, this Restricted Stock Unit Agreement has been duly executed as of the date first written above.


 
ALTRIA GROUP, INC.
 
 
 
 
By:
W. Hildebrandt Surgner, Jr.
Corporate Secretary


4
 EX-10.2 3 exhibit102performacest.htm FORM OF PERFORMANCE STOCK UNIT AGREEMENT (2020) Exhibit

Exhibit 10.2


THE ALTRIA GROUP, INC.
2015 PERFORMANCE INCENTIVE PLAN

PERFORMANCE STOCK UNIT AGREEMENT
(____, 2020)


ALTRIA GROUP, INC. (“Company”), a Virginia corporation, hereby grants to the employee identified in the 2020 Stock Award section of the Award Statement (“Employee”) under the Altria Group, Inc. 2015 Performance Incentive Plan (“Plan”) a performance stock unit award (“Award”) with respect to the target number of shares of Common Stock of the Company (“Common Stock”) set forth in the 2020 Stock Award section of the Award Statement (“PSUs”), all in accordance with and subject to the following terms and conditions of this Performance Stock Unit Agreement (“Agreement”).

1.Definitions. Whenever the following terms are used in this Agreement, they will have the meanings set forth below. Capitalized terms not otherwise defined herein will have the same meanings as in the Plan.

(a)
“Award Date” means ____, 2020, the date on which the Award is granted to the Employee.

(b)
“Award Statement” means the written notice of a performance stock unit award provided to the Employee by the Company.

(c)
“Compensation and Talent Development Committee” means the Compensation and Talent Development Committee of the Board of Directors of Altria Group, Inc.

(d)
“Disability” means a disability that entitles the Employee to benefits under the applicable long-term disability insurance program of the Company or any of its Subsidiaries.

(e)
“Normal Retirement” means retirement from active employment with the Company and its Subsidiaries following both attainment of age 65 and completion of five years of service with the Company and its Subsidiaries.

(f)
“Performance Percentage” means a percentage that is determined based on the Company’s performance during the applicable PSU performance period against performance goals pre-determined by the Compensation and Talent Development Committee.

(g)
“Retirement” means retirement from active employment with the Company and its Subsidiaries following both attainment of age 50 and completion of five years of service with the Company and its Subsidiaries.

(h)
“Subsidiary” means any company in which the Company, directly or indirectly, has a beneficial ownership interest of greater than 50 percent.

(i)
“Termination of Employment” means a separation from service within the meaning of Code section 409A with the Company and all of its Subsidiaries, which includes circumstances in which the Employee is reasonably anticipated not to perform further services with the Company and its Subsidiaries.

(j)
“Vesting Date” means the date set forth in the Award Statement upon which the Award is generally no longer subject to forfeiture.




2.Condition to Award. The Company or its delegate, in its sole discretion, may require the Employee to execute a Confidentiality and Non-Competition Agreement in consideration of the Award by notifying the Employee of such requirement as soon as practicable after the Award Date. In such instance, the Award is consideration for and contingent on the Employee’s execution of the Confidentiality and Non-Competition Agreement. The Employee’s failure to execute the Confidentiality and Non-Competition Agreement within a reasonable time after receipt, as specified by the Company or its delegate, but in no event later than 90 days after the Company or its delegate provides the Employee with the Confidentiality and Non-Competition Agreement, will result in complete nullification of the Agreement, and the Employee will forfeit any and all rights to the Award.

3.Normal Vesting.

(a) The PSUs will vest on the Vesting Date, provided that the Employee remains an employee of the Company or a Subsidiary from the Award Date through the Vesting Date and otherwise satisfies the terms of this Agreement and the Plan. The Employee will have no rights to the shares of Common Stock or cash equivalent until the PSUs have vested.

(b) The number of PSUs that become vested on the Vesting Date will be equal to the target number of PSUs multiplied by the Performance Percentage. The Performance Percentage will be determined by the Compensation and Talent Development Committee. Notwithstanding the foregoing, if the date on which the Compensation and Talent Development Committee makes a final determination of the Performance Percentage is after the Vesting Date, then the date of the final determination will be treated as the Vesting Date for purposes of determining the number of PSUs that become vested and for purposes of Section 6. The Compensation and Talent Development Committee will make a final determination of the Performance Percentage no later than July 1 of the year in which the Vesting Date occurs.

4.Accelerated Vesting. In the event that the Employee experiences a Termination of Employment with the Company and all of its Subsidiaries prior to the Vesting Date due to death, Disability, or Normal Retirement, the target number of PSUs will become vested on the date of such Termination of Employment. In addition, in the event of a “Change in Control” within the meaning of the Plan, the PSUs will become vested and payable in the circumstances and in the manner specified in section 6(a) of the Plan and Section 11 below.

5.Forfeiture. If the Employee experiences a Termination of Employment with the Company and all of its Subsidiaries for any reason other than death, Disability, or Normal Retirement prior to the Vesting Date, the Employee will forfeit all rights to the PSUs immediately after Termination of Employment. For purposes of this paragraph, the sale of a Subsidiary that employs the Employee will be considered a Termination of Employment with respect to such Employee. Notwithstanding the foregoing, upon a Termination of Employment described in this paragraph, the Compensation and Talent Development Committee may, in its sole discretion, vest some or all of the PSUs and specify the manner in which the Performance Percentage is determined.

6.Payment of PSUs. The PSUs will become payable upon the normal or accelerated vesting date described in Section 3 or 4 or following any later payment date described in Section 11, if applicable (“Payment Date”). Payment, in the form of issuance of shares of Common Stock and/or cash, will be made as soon as practicable following the Payment Date. However, in all cases payment will be made by the later of (a) December 31 of the year of the Payment Date or (b) two and a half months after the Payment Date. Upon such payment, the Company will (i) issue and deliver to the Employee the number of shares of Common Stock equal to the number of vested PSUs or, if the Compensation and Talent Development

2

Committee so determines in its sole discretion, the cash equivalent value of such shares of Common Stock, as determined by the Compensation and Talent Development Committee, and (ii) pay to the Employee in a single lump sum any cash amount accrued with respect to dividends. Payment of such shares of Common Stock and cash amounts will be subject to satisfaction of applicable tax and/or other obligations as described in Section 9.

7. Voting and Dividend Rights. Unless and until the PSUs vest and the underlying Common Stock has been delivered to the Employee, the Employee will not have a right to vote the PSUs or receive dividends associated with shares of Common Stock underlying the PSUs. However, the Employee will accrue under the PSUs a cash amount in lieu of the dividends that the Employee would have received had the Employee held, from the Award Date to the date of payment, the number of shares of Common Stock that become issuable pursuant to this Agreement, unless otherwise determined by the Compensation and Talent Development Committee.

8.Unfunded Award and Transfer Restrictions. Prior to settlement, the PSUs represent an unfunded and unsecured obligation of the Company. This Award and the PSUs are non-transferable and may not be sold, conveyed, assigned, transferred, pledged, or otherwise disposed of or encumbered at any time prior to vesting and settlement of the PSUs. If the Employee attempts to violate this Section 8, such action will be null and void, the Award will immediately become null and void, and the PSUs granted under the Award will be forfeited. These restrictions will not apply, however, to any shares of Common Stock or cash payments that the Employee has received pursuant to Section 6. If the Employee is a resident of Canada, the Employee acknowledges that the shares of Common Stock that the Employee receives pursuant to Section 6 are subject to a restriction on the first trade under Canadian securities laws.  As a result, the Employee acknowledges that any first trade of such shares of Common Stock must be made (a) through an exchange, or a market, outside of Canada, (b) to a person or company outside of Canada, or (c) otherwise in compliance with applicable Canadian securities laws.

9.Taxes and Withholding Taxes. The Company is authorized to satisfy any withholding taxes arising in connection with this Award by (a) deducting the number of PSUs having an aggregate value equal to the amount of withholding taxes due, or (b) the remittance of the required amounts from any proceeds realized upon the open-market sale of the Common Stock received in payment of vested PSUs by the Employee. The Company is authorized to satisfy any withholding taxes arising from the payment of cash in lieu of dividends pursuant to Section 7 by withholding the required amounts from such cash payment. The Company is also authorized to satisfy any withholding taxes referred to in this Section 9 by requiring a cash payment from the Employee or by withholding from other payments due to the Employee. If the Employee is covered by a Company tax equalization policy, the Employee also agrees to pay to the Company any additional hypothetical tax obligation calculated and paid under the terms and conditions of such tax equalization policy. The Employee agrees that he or she is responsible for, and the Company and its Subsidiaries are not responsible for, any personal tax consequences in connection with the PSUs.

10.Beneficiary for Payments Upon Death. Upon the death of the Employee, any Common Stock or cash amounts paid in connection with the PSUs will be paid to the Employee’s estate. Notwithstanding the foregoing, the Compensation and Talent Development Committee may elect to permit the Employee to designate a beneficiary other than the Employee’s estate, and if the Compensation and Talent Development Committee so permits, then the proceeds will be paid to such beneficiary.

11.Code Section 409A Special Payment Provisions. This Agreement will be construed in a manner consistent with section 409A of the Internal Revenue Code and the regulations thereunder (“Code section 409A”). Special payment provisions apply under this Section 11 in two situations: (a) for PSUs with a Vesting Date between January 1 and March 15, if the Employee will become eligible for Retirement before the calendar year preceding the Vesting Date and (b) for PSUs with a Vesting Date after March 15, if the

3

Employee will become eligible for Retirement before the calendar year in which the Vesting Date occurs. If the special payment provisions apply, then notwithstanding anything in this Agreement to the contrary:

(i) If the Employee is a “specified employee” within the meaning of Code section 409A, any payment of PSUs under Section 6 that is on account of his or her Termination of Employment will be delayed until the earlier of six months following such Termination of Employment or the Employee’s death.

(ii) In the event of a “Change in Control” under section 6(b) of the Plan that is not also a “change in control event” with the meaning of Treas. Reg. §1.409A-3(i)(5)(i), any PSUs that would otherwise become vested and paid pursuant to section 6(a) of the Plan upon such Change in Control will become vested, but will not be paid upon such Change in Control, and will instead be paid at the time the PSUs would otherwise be paid pursuant to this Agreement.

(iii) This Section 11(iii) applies in the event of a sale of a Subsidiary that is treated as a Termination of Employment under Section 5, but that does not result in a “separation from service” within the meaning of Code section 409A. In such event, any PSUs that become vested pursuant to Section 5 upon such sale will not be paid upon the accelerated vesting date, but will instead be paid upon the earlier of (A) the normal vesting date under Section 3 or (B) the Employee’s separation from service (within the meaning of Code section 409A) from the sold Subsidiary, including by reason of death or Disability.

12.Financial Restatement. Notwithstanding anything in this Agreement to the contrary, if the Board of Directors of the Company (“Board”) or an appropriate Committee of the Board determines that, as a result of a restatement of the Company’s financial statements, the Employee has received greater compensation in connection with the Award than would have been received absent the incorrect financial statements, the Board or Committee, in its discretion, may take such action with respect to this Award as it deems necessary or appropriate to address the events that gave rise to the restatement and to prevent its recurrence. Such action may include, to the extent permitted by applicable law, causing the full or partial cancellation of this Award and, with respect to PSUs that have vested, requiring the Employee to repay to the Company the full or partial Fair Market Value of the Award determined at the time of vesting, and the Employee agrees by accepting this Award that the Board or Committee may make such a cancellation, impose such a repayment obligation, or take other necessary or appropriate actions in such circumstances.

13.Employment Relationship. Nothing in this Agreement or in the Plan shall confer upon the Employee any right to continue in the employ of the Company or any Subsidiary for any period of specific duration or interfere with or restrict in any way the right of the Company or any Subsidiary, which is hereby expressly reserved, to remove, terminate or discharge the Employee at any time for any reason whatsoever, with or without cause and with or without advance notice.

14.Entire Agreement; Severability. This Agreement and the Plan, along with the referenced information in the Award Statement, represents the entire agreement between the parties regarding the subject matter of this Agreement. The terms and provisions of the Plan are incorporated into and made a part of this Agreement. To the extent any provision of this Agreement is inconsistent or in conflict with any term or provision of the Plan, the Plan will govern. The provisions of this Agreement are severable, and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.


IN WITNESS WHEREOF, this Performance Stock Unit Agreement has been duly executed as of the date first written above.



4


 
ALTRIA GROUP, INC.
 
 
 
 
 
By:
W. Hildebrandt Surgner, Jr.
Corporate Secretary





5
 EX-31.1 4 exhibit311q12020.htm CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A) Exhibit


Exhibit 31.1

Certifications
 
I, William F. Gifford, Jr., certify that:

1.
I have reviewed this quarterly report on Form 10-Q of Altria Group, Inc.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: April 30, 2020
 
/s/ WILLIAM F. GIFFORD, JR.
 
William F. Gifford, Jr.
 
Chief Executive Officer
                                

 EX-31.2 5 exhibit312q12020.htm CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A) Exhibit


Exhibit 31.2

Certifications
 
I, Salvatore Mancuso, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of Altria Group, Inc.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: April 30, 2020
 
/s/ SALVATORE MANCUSO
 
Salvatore Mancuso
 
Executive Vice President and
Chief Financial Officer

                                

 EX-32.1 6 exhibit321q12020.htm CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. 1350 Exhibit


Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Altria Group, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, William F. Gifford, Jr., Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)    the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)    the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



/s/ WILLIAM F. GIFFORD, JR.
William F. Gifford, Jr.
Chief Executive Officer
April 30, 2020





 EX-32.2 7 exhibit322q12020.htm CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. 1350 Exhibit


Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Altria Group, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Salvatore Mancuso, Executive Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)    the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)    the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



/s/ SALVATORE MANCUSO
Salvatore Mancuso
Executive Vice President and
Chief Financial Officer
April 30, 2020



 EX-99.1 8 exhibit991q12020.htm CERTAIN LITIGATION MATTERS Exhibit
Exhibit 99.1


CERTAIN LITIGATION MATTERS

As described in Note 11. Contingencies to Altria Group, Inc.’s (“Altria”) condensed consolidated financial statements in Part 1, Item 1 of the Quarterly Report on Form 10-Q to which this Exhibit 99.1 is attached (“Note 11”), there are legal proceedings covering a wide range of matters pending or threatened in various United States and foreign jurisdictions against Altria, its subsidiaries, including Philip Morris USA Inc. (“PM USA”), and their respective indemnitees. Various types of claims may be raised in these proceedings, including product liability, unfair trade practices, antitrust, tax, contraband shipments, patent infringement, employment matters, claims for contribution and claims of competitors, shareholders or distributors. Claims related to tobacco products generally fall within the following categories: (i) smoking and health cases alleging personal injury brought on behalf of individual plaintiffs, (ii) smoking and health cases primarily alleging personal injury or seeking court-supervised programs for ongoing medical monitoring and purporting to be brought on behalf of a class of individual plaintiffs, including cases in which the aggregated claims of a number of individual plaintiffs are to be tried in a single proceeding, (iii) health care cost recovery cases brought by governmental (both domestic and foreign) plaintiffs seeking reimbursement for health care expenditures allegedly caused by cigarette smoking and/or disgorgement of profits, (iv) class action suits alleging that the use of the terms “Lights” and “Ultra Lights” constitute deceptive and unfair trade practices, common law fraud or statutory fraud, unjust enrichment, breach of warranty, or violations of the Racketeer Influenced and Corrupt Organizations Act, (v) class action suits involving e-vapor products and (vi) international cases. The following lists certain of the pending claims against Altria and PM USA included in these and other categories.

SMOKING AND HEALTH LITIGATION

The following lists the consolidated individual smoking and health cases as well as smoking and health class actions pending against PM USA and, in some cases, Altria and/or its other subsidiaries and affiliates, as of April 27, 2020. See International Cases below for a list of smoking and health class actions pending in Canada.

Flight Attendant Litigation

The settlement agreement entered into in 1997 in the case of Broin, et al. v. Philip Morris Companies Inc., et al., which was brought by flight attendants seeking damages for personal injuries allegedly caused by environmental tobacco smoke, allowed members of the Broin class to file individual lawsuits seeking compensatory damages, but prohibited them from seeking punitive damages. See Note 11 for a discussion of this litigation.

Domestic Class Actions

Engle, et al. v. R.J. Reynolds Tobacco Co., et al., Circuit Court, Eleventh Judicial Circuit, Dade County, Florida, filed May 5, 1994. See Note 11 for a discussion of this case (which has concluded) and the Engle progeny litigation.

Young, et al. v. The American Tobacco Company, et al., Civil District Court, Orleans Parish, Louisiana, filed November 12, 1997.

Cypret, et al. v. The American Tobacco Company, et al., Circuit Court, Jackson County, Missouri, filed December 22, 1998.

HEALTH CARE COST RECOVERY LITIGATION

The following lists a health care cost recovery action pending against PM USA and Altria as of April 27, 2020. See International Cases below for a list of international health care cost recovery actions.

Department of Justice Case

The United States of America v. Philip Morris Incorporated, et al., United States District Court, District of Columbia, filed September 22, 1999. See Note 11 for a discussion of this case.

“LIGHTS/ULTRA LIGHTS” CASES

The following lists the “Lights/Ultra Lights” class actions pending against Altria and/or its various subsidiaries and others as of April 27, 2020.

1


Moore, et al. v. Philip Morris Incorporated, et al., Circuit Court, Marshall County, West Virginia, filed September 17, 2001.

Virden v. Altria Group, Inc., et al., Circuit Court, Hancock County, West Virginia, filed March 28, 2003.

CLASS ACTION LAWSUITS INVOLVING E-VAPOR PRODUCTS

The following lists class action lawsuits relating to e-vapor products that are pending against Altria and/or its various subsidiaries and others as of April 27, 2020.

NesSmith, et al. v. JUUL Labs Inc., et al., United States District Court, Middle District of Florida, filed April 15, 2019.

Peavy (formerly Swearingen), et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of Alabama, filed May 31, 2019.

R.E., et al. v. JUUL Labs, Inc., et al., United States District Court, Southern District of West Virginia, filed August 13, 2019.

M.D., et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of Mississippi, filed August 15, 2019.

Phillips, et al. v. JUUL Labs, Inc., et al., United States District Court, Western District of Missouri, filed August 21, 2019.

C.B., et al. v. JUUL Labs, Inc., et al., United States District Court, Middle District of Louisiana, filed September 11, 2019.

J.G., et al. v. JUUL Labs, Inc., et al., United States District Court, District of New Jersey, filed September 10, 2019.

Oberhauser, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of California, filed September 12, 2019.

Hochhauser, et al. v. JUUL Labs, Inc., et al., United States District Court, Eastern District of New York, filed October 1, 2019.

Emidy et al. v. JUUL Labs, Inc., et al., United States District Court, Western District of Tennessee, filed October 2, 2019.

La Conner School District, et al. v. JUUL Labs, Inc., et al., United States District Court, Western District of Washington, filed October 7, 2019.

Montgomery County, Maryland, et al. v. JUUL Labs, Inc., et al., United States District Court, District of Maryland, filed October 11, 2019.

King County, Washington, et al. v. JUUL Labs, Inc., et al., United States District Court, Western District of Washington, filed October 16, 2019.

City of Rochester, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of California, filed November 6, 2019.

Jefferson County School District, et al. v. JUUL Labs, Inc., et al., United States District Court, Southern District of Mississippi, filed December 5, 2019.

Ledbetter, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of Alabama, filed December 12, 2019.

Escambia County School District, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of Florida, filed December 18, 2019.

School Board of Miami-Dade County, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of California, filed December 19, 2019.

The School Board of Broward County, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of California, filed December 19, 2019.


2

Frederick County, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of California, filed December 19, 2019.

Imani, et al. v. JUUL Labs, Inc., et al., United States District Court, District of Oregon, filed December 20, 2019.

Cooper, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of Texas, filed January 9, 2020.

O’Reilly, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of California, filed January 13, 2020.

Gabbard, et al. v. JUUL Labs, Inc., et al., United States District Court, Eastern District of Kentucky, filed February 21, 2020.

See Note 11 for a discussion of these cases.

IQOS LITIGATION

RAI Strategic Holdings, Inc., et al. v. Altria Client Services, LLC, et al., United States District Court, Eastern District of Virginia, filed April 9, 2020.

Certain Tobacco Heating Articles and Components Thereof, United States International Trade Commission, filed April 9, 2020.

ANTITRUST LITIGATION

In re Altria Group, Inc., et al., United States of America Before the Federal Trade Commission, filed April 1, 2020.

Reece, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed April 7, 2020.

Blomquist, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed April 13, 2020.

Deadwyler, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed April 20, 2020.

SHAREHOLDER CLASS ACTION

Klein, et al. v. Altria Group, Inc., et al., United States District Court, Eastern District of Virginia, filed October 2, 2019. See Note 11 for a discussion of this case.

INTERNATIONAL CASES

The following lists cases pending against Altria and/or its subsidiaries in foreign jurisdictions as of April 27, 2020.

Canada

Her Majesty the Queen in Right of British Columbia v. Imperial Tobacco Limited, et al., Supreme Court, British Columbia, Vancouver Registry, Canada, filed January 24, 2001. Health care cost recovery action. See Note 11 for a discussion of this case.

Her Majesty the Queen in Right of the Province of New Brunswick v. Rothmans, Inc., et al., Court of Queen’s Bench of New Brunswick Judicial District of Fredericton, Canada, filed March 13, 2008. Health care cost recovery action. See Note 11 for a discussion of this case.

Dorion v. Canadian Tobacco Manufacturers’ Council, et al., Court of Queen’s Bench of Alberta, Judicial District of Calgary, Canada, filed on or about June 17, 2009. Smoking and health class action. See Note 11 for a discussion of this case.

Semple v. Canadian Tobacco Manufacturers’ Council, et al., Supreme Court of Nova Scotia, Canada, filed on or about June 18, 2009. Smoking and health class action. See Note 11 for a discussion of this case.

Kunta v. Canadian Tobacco Manufacturers’ Council, et al., Court of Queen’s Bench of Manitoba, Winnipeg Judicial Centre, Canada, filed on an unknown date in June 2009. Smoking and health class action. See Note 11 for a discussion of this case.


3

Adams v. Canadian Tobacco Manufacturers’ Council, et al., Court of Queen’s Bench for Saskatchewan, Judicial Centre of Regina, Canada, filed on or about July 10, 2009. Smoking and health class action. See Note 11 for a discussion of this case.

Her Majesty the Queen in Right of Ontario v. Rothmans Inc., et al., Superior Court of Justice of Ontario, Canada, filed on or about September 30, 2009. Health care cost recovery action. See Note 11 for a discussion of this case.

Bourassa v. Imperial Tobacco Canada Limited, et al., Supreme Court of British Columbia, Victoria Registry, Canada, filed on or about June 25, 2010. Smoking and health class action. See Note 11 for a discussion of this case.

McDermid v. Imperial Tobacco Canada Limited, et al., Supreme Court of British Columbia, Victoria Registry, Canada, filed on or about June 25, 2010. Smoking and health class action. See Note 11 for a discussion of this case.

Attorney General of Newfoundland and Labrador v. Rothmans Inc., et al., Supreme Court of Newfoundland and Labrador, Trial Division, Canada, filed February 8, 2011. Health care cost recovery action. See Note 11 for a discussion of this case.

Attorney General of Quebec v. Imperial Tobacco Canada Limited, et al., Superior Court of Quebec, Montreal District, Canada, filed June 8, 2012. Health care cost recovery action. See Note 11 for a discussion of this case.

Her Majesty in Right of Alberta v. Altria Group, Inc., et al., Court of Queen’s Bench of Alberta, Judicial District of Calgary, Canada, filed June 8, 2012. Health care cost recovery action. See Note 11 for a discussion of this case.

Her Majesty the Queen in the Right of Manitoba v. Rothmans, Benson & Hedges Inc., et al., Court of Queen’s Bench of Manitoba, Winnipeg Judicial Centre, Canada, filed May 31, 2012. Health care cost recovery action. See Note 11 for a discussion of this case.

Her Majesty the Queen in Right of Saskatchewan v. Rothmans, Benson & Hedges Inc., et al., Court of Queen’s Bench of Saskatchewan, Judicial Centre of Saskatoon, Canada, filed on June 8, 2012. Health care cost recovery action. See Note 11 for a discussion of this case.

Her Majesty in the Right of the Province of Prince Edward Island v. Rothmans, Benson & Hedges, Inc., et al., Supreme Court of Prince Edward Island, filed on September 10, 2012. Health care cost recovery action. See Note 11 for a discussion of this case.

Her Majesty the Queen in Right of the Province of Nova Scotia v. Benson & Hedges, Inc., et al., Supreme Court of Nova Scotia, filed on January 2, 2015. Health care cost recovery action. See Note 11 for a discussion of this case.

Jacklin v. Canadian Tobacco Manufacturers’ Council et al., Ontario Superior Court of Justice, Case No. 5379412, Ontario, Canada, filed on or about June 27, 2012. Smoking and health class action. See Note 11 for a discussion of this case.





4
 EX-99.2 9 exhibit992q12020.htm TRIAL SCHEDULE FOR CERTAIN CASES Exhibit

Exhibit 99.2



TRIAL SCHEDULE FOR CERTAIN CASES

Below is a schedule, as of April 27, 2020 setting forth by month the number of individual smoking and health cases against Philip Morris USA Inc. that are scheduled for but not in trial through June 30, 2020.

2020

Engle progeny                        
April
 0
 
 
May
0
 
 
June
 2

As of April 27, 2020, there are no Engle progeny cases in trial.

Other Individual Smoking & Health
April
   0
 
 
May
   0
 
 
June
   0

As of April 27, 2020, there are no non-Engle progeny cases in trial.





 EX-101.SCH 10 mo-20200331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2106100 - Disclosure - Asset Impairment, Exit and Implementation Costs link:presentationLink link:calculationLink link:definitionLink 2406403 - Disclosure - Asset Impairment, Exit and Implementation Costs (Movement in Restructuring Liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 2406404 - Disclosure - Asset Impairment, Exit and Implementation Costs (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Asset Impairment, Exit and Implementation Costs (Pre-tax Asset Impairment, Exit and Implementation Costs) (Details) link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Asset Impairment, Exit and Implementation Costs (Pre-tax Asset Impairment, Exit and Implementation Costs) (Details) link:presentationLink link:calculationLink link:definitionLink 2306301 - Disclosure - Asset Impairment, Exit and Implementation Costs (Tables) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - Background and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 2401403 - Disclosure - Background and Basis of Presentation (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2201201 - Disclosure - Background and Basis of Presentation (Policies) link:presentationLink link:calculationLink link:definitionLink 2401404 - Disclosure - Background and Basis of Presentation (Share Repurchase Table) (Details) link:presentationLink link:calculationLink link:definitionLink 2301302 - Disclosure - Background and Basis of Presentation (Tables) link:presentationLink link:calculationLink link:definitionLink 2112100 - Disclosure - Benefit Plans link:presentationLink link:calculationLink link:definitionLink 2412403 - Disclosure - Benefit Plans (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2412402 - Disclosure - Benefit Plans (Schedule Of Components Of Net Periodic Benefit Cost (Income)) (Details) link:presentationLink link:calculationLink link:definitionLink 2312301 - Disclosure - Benefit Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1001501 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 106000 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - Condensed Consolidated Statements of Comprehensive Earnings link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - Condensed Consolidated Statements of Earnings link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - Condensed Consolidated Statements of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 1004501 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 2121100 - Disclosure - Condensed Consolidating Financial Information link:presentationLink link:calculationLink link:definitionLink 2421402 - Disclosure - Condensed Consolidating Financial Information (Condensed Consolidating Balance Sheets) (Details) link:presentationLink link:calculationLink link:definitionLink 2421404 - Disclosure - Condensed Consolidating Financial Information (Condensed Consolidating Statements of Cash Flows) (Details) link:presentationLink link:calculationLink link:definitionLink 2421403 - Disclosure - Condensed Consolidating Financial Information (Condensed Consolidating Statements of Earnings and Comprehensive Earnings) (Details) link:presentationLink link:calculationLink link:definitionLink 2321301 - Disclosure - Condensed Consolidating Financial Information (Tables) link:presentationLink link:calculationLink link:definitionLink 2120100 - Disclosure - Contingencies link:presentationLink link:calculationLink link:definitionLink 2420418 - Disclosure - Contingencies (Antitrust Litigation) (Details) link:presentationLink link:calculationLink link:definitionLink 2420415 - Disclosure - Contingencies (E-vapor Product Litigation) (Details) link:presentationLink link:calculationLink link:definitionLink 2420407 - Disclosure - Contingencies (Engle Class Action And Engle Progeny Trial Results) (Details) link:presentationLink link:calculationLink link:definitionLink 2420408 - Disclosure - Contingencies (Engle Progeny Cases Trial Results - Pending and Concluded) (Details) link:presentationLink link:calculationLink link:definitionLink 2420414 - Disclosure - Contingencies (Federal Government's Lawsuit) (Details) link:presentationLink link:calculationLink link:definitionLink 2420409 - Disclosure - Contingencies (Florida Bond Statute) (Details) link:presentationLink link:calculationLink link:definitionLink 2420402 - Disclosure - Contingencies (General Information) (Details) link:presentationLink link:calculationLink link:definitionLink 2420419 - Disclosure - Contingencies (Guarantees and Other Similar Matters Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2420411 - Disclosure - Contingencies (Health Care Cost Recovery Litigation) (Details) link:presentationLink link:calculationLink link:definitionLink 2420405 - Disclosure - Contingencies (Judgments Paid and Provisions for Tobacco and Health Litigation) (Details) link:presentationLink link:calculationLink link:definitionLink 2420416 - Disclosure - Contingencies (Lights/Ultra Lights Cases) (Details) link:presentationLink link:calculationLink link:definitionLink 2420406 - Disclosure - Contingencies (Non-Engle Progeny Litigation) (Details) link:presentationLink link:calculationLink link:definitionLink 2420412 - Disclosure - Contingencies (NPM Adjustment Disputes - Settlement with 20 States and Territories and Settlement with New York) (Details) link:presentationLink link:calculationLink link:definitionLink 2420413 - Disclosure - Contingencies (Other Disputes Under the State Settlement Agreements) (Details) link:presentationLink link:calculationLink link:definitionLink 2420410 - Disclosure - Contingencies (Other Smoking and Health Class Actions) (Details) link:presentationLink link:calculationLink link:definitionLink 2420404 - Disclosure - Contingencies (Overview of Altria and/or PM USA Tobacco-Related Litigation Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2420403 - Disclosure - Contingencies (Schedule of Pending Cases) (Details) link:presentationLink link:calculationLink link:definitionLink 2320301 - Disclosure - Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 2420417 - Disclosure - Contingencies (UST Litigations Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink 2118100 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 2418401 - Disclosure - Debt (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2113100 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 2413402 - Disclosure - Earnings Per Share (Basic and Diluted Earnings Per Share) (Details) link:presentationLink link:calculationLink link:definitionLink 2313301 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2109100 - Disclosure - Financial Instruments link:presentationLink link:calculationLink link:definitionLink 2409404 - Disclosure - Financial Instruments (Beginning and Ending Balances of Fixed-price Preemptive Rights and Warrants) (Details) link:presentationLink link:calculationLink link:definitionLink 2409407 - Disclosure - Financial Instruments (Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses) (Details) link:presentationLink link:calculationLink link:definitionLink 2409405 - Disclosure - Financial Instruments (Fair Value Derivative Financial Instruments) (Details) link:presentationLink link:calculationLink link:definitionLink 2409403 - Disclosure - Financial Instruments (Fair Value Using Black-Scholes Option-Pricing Model) (Details) link:presentationLink link:calculationLink link:definitionLink 2409402 - Disclosure - Financial Instruments (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2409406 - Disclosure - Financial Instruments (Pre-tax Unrealized Gains (Losses)) (Details) link:presentationLink link:calculationLink link:definitionLink 2309301 - Disclosure - Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - Investments in Equity Securities link:presentationLink link:calculationLink link:definitionLink 2408403 - Disclosure - Investments in Equity Securities (Earnings in Equity Securities) (Details) link:presentationLink link:calculationLink link:definitionLink 2408404 - Disclosure - Investments in Equity Securities (Investment in ABI Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2408406 - Disclosure - Investments in Equity Securities (Investment in Cronos Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2408405 - Disclosure - Investments in Equity Securities (Investment in JUUL Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - Investments in Equity Securities Investments in Equity Securities (Tables) link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - Investments in Equity Securities (Summary of Investments) (Details) link:presentationLink link:calculationLink link:definitionLink 2122100 - Disclosure - New Accounting Guidance Not Yet Adopted link:presentationLink link:calculationLink link:definitionLink 2322301 - Disclosure - New Accounting Guidance Not Yet Adopted (Tables) link:presentationLink link:calculationLink link:definitionLink 2116100 - Disclosure - Other Comprehensive Earnings/Losses link:presentationLink link:calculationLink link:definitionLink 2416402 - Disclosure - Other Comprehensive Earnings/Losses (Changes in Each Component of Accumulated Other Comprehensive Losses) (Details) link:presentationLink link:calculationLink link:definitionLink 2416403 - Disclosure - Other Comprehensive Earnings/Losses (Reclassifications) (Details) link:presentationLink link:calculationLink link:definitionLink 2316301 - Disclosure - Other Comprehensive Earnings/Losses (Tables) link:presentationLink link:calculationLink link:definitionLink 2103100 - Disclosure - Revenues from Contracts with Customers link:presentationLink link:calculationLink link:definitionLink 2403401 - Disclosure - Revenues from Contracts with Customers (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2117100 - Disclosure - Segment Reporting link:presentationLink link:calculationLink link:definitionLink 2417403 - Disclosure - Segment Reporting (Schedule of Tobacco and Health Litigation Items) (Details) link:presentationLink link:calculationLink link:definitionLink 2417402 - Disclosure - Segment Reporting (Segment Data Schedule) (Details) link:presentationLink link:calculationLink link:definitionLink 2317301 - Disclosure - Segment Reporting (Tables) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 11 mo-20200331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 12 mo-20200331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 13 mo-20200331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative [Table] Derivative [Table] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 2 [Member] Measurement Basis [Axis] Measurement Basis [Axis] Fair Value Measurement [Domain] Fair Value Measurement [Domain] Portion at Fair Value Measurement [Member] Portion at Fair Value Measurement [Member] Estimate of Fair Value Measurement [Member] Estimate of Fair Value Measurement [Member] Reported Value Measurement [Member] Reported Value Measurement [Member] Hedging Relationship [Axis] Hedging Relationship [Axis] Hedging Relationship [Domain] Hedging Relationship [Domain] Net Investment Hedging [Member] Net Investment Hedging [Member] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Foreign Currency Denominated Debt [Member] Foreign Currency Denominated Debt [Member] Foreign Currency Denominated Debt [Member] Investment, Name [Axis] Investment, Name [Axis] Investment, Name [Domain] Investment, Name [Domain] Cronos Group Inc. [Member] Cronos Group Inc. [Member] Cronos Group Inc. [Member] Hedging Designation [Axis] Hedging Designation [Axis] Hedging Designation [Domain] Hedging Designation [Domain] Not Designated as Hedging Instrument [Member] Not Designated as Hedging Instrument [Member] Derivative Instrument [Axis] Derivative Instrument [Axis] Derivative Contract [Domain] Derivative Contract [Domain] Foreign currency contracts [Member] Foreign Exchange Contract [Member] Forward Contracts [Member] Forward Contracts [Member] Derivative [Line Items] Derivative [Line Items] Derivative, notional amount Derivative, Notional Amount Debt instrument, fair value disclosure Debt Instrument, Fair Value Disclosure Long-term debt Long-term Debt Short-term borrowings Short-term Debt Long-term debt, fair value Long-term Debt, Fair Value Equity method investments, purchase price Payments to Acquire Equity Method Investments and Derivative Instruments, Investing Payments to Acquire Equity Method Investments and Derivative Instruments, Investing Derivative asset, notional amount Derivative Asset, Notional Amount Derivative, gain (loss) on derivative, net Derivative, Gain (Loss) on Derivative, Net Statement of Financial Position [Abstract] Assets Assets [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Receivables Receivables, Net, Current Inventories: Inventory, Net [Abstract] Leaf tobacco Inventory, Raw Materials, Plant Material, Net of Reserves Carrying amount as of the balance sheet date of products consisting of plant matter that is not used in the growth of plant goods Other raw materials Other Inventory, Raw Materials, Net of Reserves Other Inventory, Raw Materials, Net of Reserves Work in process Inventory, Work in Process, Net of Reserves Finished product Inventory, Finished Goods, Net of Reserves Inventory, net Inventory, Net Other current assets Other Assets, Current Total current assets Assets, Current Property, plant and equipment, at cost Property, Plant and Equipment, Gross Less accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Property, plant and equipment, net Property, Plant and Equipment, Net Goodwill Goodwill Other intangible assets, net Intangible Assets, Net (Excluding Goodwill) Investments in equity securities Equity Security Investments Equity Security Investments Other assets Other Assets, Noncurrent Total Assets Assets Liabilities Liabilities [Abstract] Current portion of long-term debt Long-term Debt, Current Maturities Accounts payable Accounts Payable, Current Accrued liabilities: Accrued Liabilities, Current [Abstract] Marketing Accrued Marketing Costs, Current Settlement charges Accrued Settlement Liability, Current Accrued Settlement Liability, Current Other Other Accrued Liabilities, Current Income taxes Accrued Income Taxes, Current Dividends payable Dividends Payable, Current Total current liabilities Liabilities, Current Long-term debt Long-term Debt, Excluding Current Maturities Deferred income taxes Deferred Income Tax Liabilities, Net Accrued pension costs Liability, Defined Benefit Pension Plan, Noncurrent Accrued postretirement health care costs Liability, Other Postretirement Defined Benefit Plan, Noncurrent Other liabilities Other Liabilities, Noncurrent Total liabilities Liabilities Contingencies (Note 11) Commitments and Contingencies Redeemable noncontrolling interest Redeemable Noncontrolling Interest, Equity, Carrying Amount Stockholders’ Equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Common stock, par value $0.33 1/3 per share (2,805,961,317 shares issued) Common Stock, Value, Issued Additional paid-in capital Additional Paid in Capital, Common Stock Earnings reinvested in the business Retained Earnings (Accumulated Deficit) Accumulated other comprehensive losses Accumulated Other Comprehensive Income (Loss), Net of Tax Cost of repurchased stock (947,593,259 shares at March 31, 2020 and 947,979,763 shares at December 31, 2019) Treasury Stock, Value Total stockholders’ equity attributable to Altria Stockholders' Equity Attributable to Parent Noncontrolling interests Stockholders' Equity Attributable to Noncontrolling Interest Total stockholders’ equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Total Liabilities and Stockholders’ Equity Liabilities and Equity Restructuring and Related Activities [Abstract] Restructuring and Related Costs Restructuring and Related Costs [Table Text Block] Schedule of Restructuring Reserve by Type of Cost Schedule of Restructuring Reserve by Type of Cost [Table Text Block] Organization, Consolidation and Presentation of Financial Statements [Abstract] Schedule of Share Repurchase Activity Class of Treasury Stock [Table Text Block] Debt Disclosure [Abstract] Debt Debt Disclosure [Text Block] Commitments and Contingencies Disclosure [Abstract] Loss Contingencies [Table] Loss Contingencies [Table] Litigation Case [Axis] Litigation Case [Axis] Litigation Case [Domain] Litigation Case [Domain] Non-Engle Progeny Smoking And Health Case, Principe [Member] Non-Engle Progeny Smoking And Health Case, Principe [Member] Non-Engle Progeny Smoking And Health Case, Principe Non-Engle Progeny Smoking and Health Case, Greene [Member] Non-Engle Progeny Smoking and Health Case, Greene [Member] Non-Engle Progeny Smoking and Health Case, Greene [Member] Non-Engle Progeny Smoking and Health Case, Laramie [Member] Non-Engle Progeny Smoking and Health Case, Laramie [Member] Non-Engle Progeny Smoking and Health Case, Laramie [Member] [Member] Non-Engle Progeny Smoking and Health Case, Gentile [Member] Non-Engle Progeny Smoking and Health Case, Gentile [Member] Non-Engle Progeny Smoking and Health Case, Gentile Legal Entity [Axis] Legal Entity [Axis] Entity [Domain] Entity [Domain] PM USA [Member] Philip Morris USA [Member] Philip Morris USA [Member] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Compensatory damages awarded Loss Contingency, Compensatory Damages Awarded, Value Loss Contingency, Compensatory Damages Awarded, Value Punitive damages awarded Loss Contingency, Punitive Damages Awarded, Value Loss Contingency, Punitive Damages Awarded, Value Compensatory damages award, allocation percentage Loss Contingency, Compensatory Damages Awarded, Allocation Percentage Loss Contingency, Compensatory Damages Awarded, Allocation Percentage Loss Contingency Nature [Axis] Loss Contingency Nature [Axis] Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Implementation of Corrective Communications [Member] Implementation of Corrective Communications [Member] Implementation of Corrective Communications [Member] Federal Governments Lawsuit [Member] Federal Governments Lawsuit [Member] Federal Government's Lawsuit [Member] Disclosure period Federal Trade Commission, Disclosure Period Federal Trade Commission, Disclosure Period Provision related to litigation recorded Loss Contingency Accrual, Provision Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent Event [Member] Subsequent Event [Member] Geographical [Axis] Geographical [Axis] Geographical [Domain] Geographical [Domain] New York [Member] NEW YORK Maryland, Missouri, New Mexico and Pennsylvania [Member] Maryland, Missouri, New Mexico and Pennsylvania [Member] Maryland, Missouri, New Mexico and Pennsylvania [Member] Health Care Cost Recovery Actions [Member] Health Care Cost Recovery Actions [Member] Health Care Cost Recovery Actions [Member] Health Care Cost Recovery Actions, 2003-2015 NPM Adjustments [Member] Health Care Cost Recovery Actions, 2003-2015 NPM Adjustments [Member] Health Care Cost Recovery Actions, 2003-2015 NPM Adjustments [Member] Health Care Cost Recovery Actions, 2004-2017 [Member] Health Care Cost Recovery Actions, 2004-2017 [Member] Health Care Cost Recovery Actions, 2004-2017 [Member] Health Care Cost Recovery Actions, Transition Years 2004-2017 [Member] Health Care Cost Recovery Actions, Transition Years 2004-2017 [Member] Health Care Cost Recovery Actions, Transition Years 2004-2017 [Member] Health Care Cost Recovery Actions, 2003 NPM Adjustment [Member] Health Care Cost Recovery Actions, 2003 NPM Adjustment [Member] Health Care Cost Recovery Actions, 2003 NPM Adjustment [Member] Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member] Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member] Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member] Health Care Cost Recovery Actions, 2005 NPM Adjustment [Member] Health Care Cost Recovery Actions, 2005 NPM Adjustment [Member] Health Care Cost Recovery Actions, 2005 NPM Adjustment [Member] Health Care Cost Recovery Actions, 2006 NPM Adjustment [Member] Health Care Cost Recovery Actions, 2006 NPM Adjustment [Member] Health Care Cost Recovery Actions, 2006 NPM Adjustment [Member] Health Care Cost Recovery Actions, 2007 NPM Adjustment [Member] Health Care Cost Recovery Actions, 2007 NPM Adjustment [Member] Health Care Cost Recovery Actions, 2007 NPM Adjustment [Member] Health Care Cost Recovery Actions, 2008 NPM Adjustment [Member] Health Care Cost Recovery Actions, 2008 NPM Adjustment [Member] Health Care Cost Recovery Actions, 2008 NPM Adjustment [Member] Health Care Cost Recovery Actions, 2009 NPM Adjustment [Member] Health Care Cost Recovery Actions, 2009 NPM Adjustment [Member] Health Care Cost Recovery Actions, 2009 NPM Adjustment [Member] Health Care Cost Recovery Actions, 2010 NPM Adjustment [Member] Health Care Cost Recovery Actions, 2010 NPM Adjustment [Member] Health Care Cost Recovery Actions, 2010 NPM Adjustment [Member] Health Care Cost Recovery Actions, 2011 NPM Adjustment [Member] Health Care Cost Recovery Actions, 2011 NPM Adjustment [Member] Health Care Cost Recovery Actions, 2011 NPM Adjustment [Member] Health Care Cost Recovery Actions, 2012 NPM Adjustment [Member] Health Care Cost Recovery Actions, 2012 NPM Adjustment [Member] Health Care Cost Recovery Actions, 2012 NPM Adjustment [Member] Health Care Cost Recovery Actions, 2013 NPM Adjustment [Member] Health Care Cost Recovery Actions, 2013 NPM Adjustment [Member] Health Care Cost Recovery Actions, 2013 NPM Adjustment [Member] Health Care Cost Recovery Actions, 2014 NPM Adjustment [Member] Health Care Cost Recovery Actions, 2014 NPM Adjustment [Member] Health Care Cost Recovery Actions, 2014 NPM Adjustment [Member] Health Care Cost Recovery Actions, 2015 NPM Adjustments [Member] Health Care Cost Recovery Actions, 2015 NPM Adjustments [Member] Health Care Cost Recovery Actions, 2015 NPM Adjustments [Member] Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member] Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member] [Member] Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member] Health Care Cost Recovery Actions, 2017 NPM Adjustments [Member] Health Care Cost Recovery Actions, 2017 NPM Adjustments [Member] Health Care Cost Recovery Actions, 2017 NPM Adjustments [Member] Health Care Cost Recovery Actions, 2018 NPM Adjustments [Member] Health Care Cost Recovery Actions, 2018 NPM Adjustments [Member] Health Care Cost Recovery Actions, 2018 NPM Adjustments [Member] Health Care Cost Recovery Actions, 2019 NPM Adjustments [Member] Health Care Cost Recovery Actions, 2019 NPM Adjustments [Member] Health Care Cost Recovery Actions, 2019 NPM Adjustments [Member] Litigation Status [Axis] Litigation Status [Axis] Litigation Status [Domain] Litigation Status [Domain] Settled Litigation [Member] Settled Litigation [Member] Pending Litigation [Member] Pending Litigation [Member] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Cost of Sales [Member] Cost of Sales [Member] Loss contingency, number of states with settled litigation including New York, subsequent expansion Loss Contingency, Number of States with Settled Litigation, Settlement One Loss Contingency, Number of States with Settled Litigation, Settlement One Settlement agreements, number Loss Contingency, Settlement Agreements, Number Loss Contingency, Settlement Agreements, Number Number of states with settled litigation Loss Contingency, Number of States with Settled Litigation Loss Contingency, Number of States with Settled Litigation ​Proceeds from legal settlements Loss Contingency, ​Proceeds from Legal Settlements Loss Contingency, ​Proceeds from Legal Settlements Loss contingency, number of settlement developments Loss Contingency, Number of Settlement Developments Loss Contingency, Number of Settlement Developments Loss contingency, number of additional states added Loss Contingency, Number of Additional States with Settled Litigation Loss Contingency, Number of Additional States with Settled Litigation Loss contingency, number of additional states extended with settled litigation Loss Contingency, Number of Additional States Extended with Settled Litigation Loss Contingency, Number of Additional States Extended with Settled Litigation Payments received from litigation settlement Proceeds from Legal Settlements Loss contingency, reduction to cost of sales Loss Contingency, Reduction To Cost Of Sales Loss Contingency, Reduction To Cost Of Sales Loss contingency, credits to offset payments Litigation Settlement, Amount Awarded from Other Party Loss contingency, settlement agreement, payment period Loss Contingency, Settlement Agreement, Payment Period Loss Contingency, Settlement Agreement, Payment Period Loss contingency, number of states Loss Contingency, Number of States Loss Contingency, Number of States Number of states without defense Loss Contingency, Number of States Without Defense Loss Contingency, Number of States Without Defense Loss contingency, number of states remaining Loss Contingency, Number of States Remaining Loss Contingency, Number of States Remaining Loss contingency, number of disputes outstanding Loss Contingency, Number Of Disputes Outstanding Loss Contingency, Number Of Disputes Outstanding Estimate of possible gain Litigation Settlement, Estimate of Possible Gain Litigation Settlement, Estimate of Possible Gain Condensed Balance Sheet Statement [Table] Condensed Balance Sheet Statement [Table] Consolidation Items [Axis] Consolidation Items [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Reportable Legal Entities [Member] Reportable Legal Entities [Member] Total Consolidating Adjustments [Member] Consolidation, Eliminations [Member] Consolidated Entities [Axis] Consolidated Entities [Axis] Consolidated Entities [Domain] Consolidated Entities [Domain] Altria Group, Inc. [Member] Parent Company [Member] PM USA [Member] Guarantor Subsidiaries [Member] Non-Guarantor Subsidiaries [Member] Non-Guarantor Subsidiaries [Member] Condensed Balance Sheet Statements, Captions [Line Items] Condensed Balance Sheet Statements, Captions [Line Items] Due from Altria Group, Inc. and subsidiaries Due from Affiliate, Current Investment in consolidated subsidiaries Investment in Consolidated Subsidiaries Investment in Consolidated Subsidiaries Due from Altria Group, Inc. and subsidiaries Due from Affiliate, Noncurrent Due to Altria Group, Inc. and subsidiaries Due to Affiliate, Current Deferred income taxes Due to Altria Group, Inc. and subsidiaries Due to Affiliate, Noncurrent Contingencies Common stock Cost of repurchased stock Measurement Input Type [Axis] Measurement Input Type [Axis] Measurement Input Type [Domain] Measurement Input Type [Domain] Share price [Member] Measurement Input, Share Price [Member] Expected Life [Member] Measurement Input, Expected Term [Member] Expected Volatility [Member] Measurement Input, Price Volatility [Member] Risk Free Interest Rate [Member] Measurement Input, Risk Free Interest Rate [Member] Expected Dividend Yield [Member] Measurement Input, Expected Dividend Rate [Member] Weighted Average Expected Term [Member] Measurement Input, Weighted Average Expected Term [Member] Measurement Input, Weighted Average Expected Term [Member] Fixed-price Preemptive Rights [Member] Equity Contract, Preemptive RIghts [Member] Equity Contract, Preemptive RIghts [Member] Cronos Warrant [Member] Equity Contract, Warrant [Member] Equity Contract, Warrant [Member] Statistical Measurement [Axis] Statistical Measurement [Axis] Statistical Measurement [Domain] Statistical Measurement [Domain] Minimum [Member] Minimum [Member] Maximum [Member] Maximum [Member] Derivative asset, measurement input Derivative Asset, Measurement Input Investments [Abstract] Investments [Table] Investments [Table] Investments [Table] Financial Instrument [Axis] Financial Instrument [Axis] Financial Instruments [Domain] Financial Instruments [Domain] Common Stock [Member] Common Stock [Member] Equity Contract, Warrant [Member] Equity Contract, Preemptive Rights [Member] ABI [Member] AB InBev [Member] AB InBev [Member] JUUL [Member] JUUL [Member] JUUL [Member] Cronos [Member] Investments [Line Items] Investments [Line Items] [Line Items] for Investments [Table] Investments in equity securities Equity Method Investments Equity securities without readily determinable fair value, amount Equity Securities without Readily Determinable Fair Value, Amount Investments Investments Derivative asset, fair value, gross asset Derivative Asset, Fair Value, Gross Asset Condensed Consolidating Financial Information Condensed Financial Statements [Text Block] New Accounting Pronouncements and Changes in Accounting Principles [Abstract] New Accounting Guidance Not Yet Adopted Description of New Accounting Pronouncements Not yet Adopted [Text Block] Earnings Per Share [Abstract] Earnings Per Share Earnings Per Share [Text Block] Background and Basis of Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Segment Reporting [Abstract] Segment Reporting Segment Reporting Disclosure [Text Block] Retirement Benefits [Abstract] Schedule of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Retirement Plan Type [Axis] Retirement Plan Type [Axis] Retirement Plan Type [Domain] Retirement Plan Type [Domain] Pension [Member] Pension Plan [Member] Postretirement [Member] Other Postretirement Benefits Plan [Member] Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Defined benefit plan, plan assets, contributions by employer Defined Benefit Plan, Plan Assets, Contributions by Employer Anticipated additional employer contributions Defined Benefit Plan, Expected Future Employer Contributions, Remainder of Fiscal Year Schedule of Net Periodic Benefit (Income) Cost Schedule of Net Benefit Costs [Table Text Block] Condensed Income Statement [Table] Condensed Income Statement [Table] Condensed Income Statements, Captions [Line Items] Condensed Income Statements, Captions [Line Items] Net revenues Revenue from Contract with Customer, Excluding Assessed Tax Cost of sales Cost of Goods and Services Sold Excise taxes on products Excise and Sales Taxes Gross profit Gross Profit Marketing, administration and research costs Marketing, Administration and Research Costs The aggregate total costs related to selling a firm's product and services, as well as research and development costs and all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. Research and development costs represent the aggregate costs incurred during an accounting period to research and develop new products/technologies when the technological feasibility has not been reached. General and administrative expenses include salaries of nonsales personnel, rent, utilities, communication, etc. Asset impairment and exit costs Asset Impairment and Business Exit Costs, Excluding Net Pension Cost (Credit) Asset Impairment and Business Exit Costs, Excluding Net Pension Cost (Credit) Operating income (expense) Operating Income (Loss) Interest and other debt expense (income), net Interest Income (Expense), Net Net periodic benefit (income) cost, excluding service cost Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component Earnings from equity investments Income (Loss) from Equity Method Investments Loss on Cronos-related financial instruments Earnings (losses) before income taxes and equity earnings of subsidiaries Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Provision (benefit) for income taxes Income Tax Expense (Benefit) Equity earnings of subsidiaries Income (Loss) from Subsidiaries, Net of Tax Net earnings Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net (earnings) losses attributable to noncontrolling interests Net Income (Loss) Attributable to Noncontrolling Interest Net earnings attributable to Altria Net Income (Loss) Attributable to Parent Net earnings Other comprehensive earnings (losses), net of deferred income taxes Other Comprehensive Income (Loss), Net of Tax Comprehensive earnings Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Comprehensive earnings attributable to noncontrolling interests Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Comprehensive earnings attributable to Altria Comprehensive Income (Loss), Net of Tax, Attributable to Parent Income Statement [Abstract] Interest and other debt expense, net Net periodic benefit income, excluding service cost Provision for income taxes Per share data: Basic and diluted earnings per share attributable to Altria (in usd per share) Earnings Per Share, Basic and Diluted Statement of Cash Flows [Abstract] Cash Provided by (Used in) Operating Activities Net Cash Provided by (Used in) Operating Activities [Abstract] Net earnings Adjustments to reconcile net earnings to operating cash flows: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation and amortization Depreciation, Depletion and Amortization Deferred income tax provision (benefit) Deferred Income Tax Expense (Benefit) Loss on Cronos-related financial instruments Asset impairment and exit costs, net of cash paid Restructuring Costs Cash effects of changes: Increase (Decrease) in Operating Capital [Abstract] Receivables Increase (Decrease) in Receivables Inventories Increase (Decrease) in Inventories Accounts payable Increase (Decrease) in Accounts Payable Income taxes Increase (Decrease) in Income Taxes Payable Accrued liabilities and other current assets Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net Accrued settlement charges Increase (Decrease) In Settlement Payable The net change during the period in Settlement payable. Pension plan contributions Payment for Pension and Other Postretirement Benefits Pension provisions and postretirement, net Increase (Decrease) in Obligation, Pension and Other Postretirement Benefits Other, net Increase (Decrease) in Other Operating Assets and Liabilities, Net Net cash provided by (used in) operating activities Net Cash Provided by (Used in) Operating Activities Cash Provided by (Used in) Investing Activities Net Cash Provided by (Used in) Investing Activities [Abstract] Capital expenditures Payments to Acquire Property, Plant, and Equipment Investment in Cronos Payments To Acquire Equity Method Investments And Derivative Instruments, Investing Activities Payments To Acquire Equity Method Investments And Derivative Instruments, Investing Activities Other, net Payments for (Proceeds from) Other Investing Activities Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Cash Provided by (Used in) Financing Activities Net Cash Provided by (Used in) Financing Activities [Abstract] Proceeds from short-term borrowings Proceeds from Short-term Debt Repayment of short-term borrowings Repayments of Short-term Debt Long-term debt issued Proceeds from Issuance of Long-term Debt Long-term debt repaid Repayments of Long-term Debt Repurchases of common stock Payments for Repurchase of Common Stock Dividends paid on common stock Payments of Ordinary Dividends, Common Stock Other, net Proceeds from (Payments for) Other Financing Activities Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Cash, cash equivalents and restricted cash: Cash and Cash Equivalents, Period Increase (Decrease) [Abstract] Increase (decrease) Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Balance at beginning of period Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Balance at end of period Cash and cash equivalents Restricted cash included in other current assets Restricted Cash, Current Restricted cash included in other assets Restricted Cash, Noncurrent Cash, cash equivalents and restricted cash Investments in Equity Securities Investment [Text Block] Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Line Items] Schedule of Equity Method Investments [Line Items] Payments to acquire equity securities Payments to Acquire Equity Securities Without Readily Determinable Fair Value Payments to Acquire Equity Securities Without Readily Determinable Fair Value Equity securities, ownership percentage Equity Securities Without Readily Determinable Fair Value, Ownership Percentage Equity Securities Without Readily Determinable Fair Value, Ownership Percentage Equity securities without readily determinable fair value, impairment loss, annual amount Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount Equity securities without readily determinable fair value, no litigation period Equity Securities Without Readily Determinable Fair Value, No Litigation Period Equity Securities Without Readily Determinable Fair Value, No Litigation Period Equity securities without readily determinable fair value, non-compete release trigger period Equity Securities Without Readily Determinable Fair Value, Non-Compete Release Trigger Period Equity Securities Without Readily Determinable Fair Value, Non-Compete Release Trigger Period Equity securities without readily determinable fair value, non-compete release trigger percentage of investment carrying value Equity Securities Without Readily Determinable Fair Value, Non-Compete Release Trigger Percentage Of Investment Carrying Value Equity Securities Without Readily Determinable Fair Value, Non-Compete Release Trigger Percentage Of Investment Carrying Value Equity securities without readily determinable fair value, quantitative assessment adjustment, annual amount Equity Securities Without Readily Determinable Fair Value, Quantitative Assessment Adjustment, Annual Amount Equity Securities Without Readily Determinable Fair Value, Quantitative Assessment Adjustment, Annual Amount Equity securities without readily determinable fair value, number of board members Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Equity securities without readily determinable fair value, number of board members upon share conversion Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Upon Share Conversion Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Upon Share Conversion Equity securities without readily determinable fair value, number of independent board members upon share conversion Equity Securities Without Readily Determinable Fair Value, Number Of Independent Board Members Upon Share Conversion Equity Securities Without Readily Determinable Fair Value, Number Of Independent Board Members Upon Share Conversion Equity securities without readily determinable fair value, number of board members appointed by investor upon share conversion Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Appointed By Investor Upon Share Conversion Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Appointed By Investor Upon Share Conversion Equity securities without readily determinable fair value, number of board members appointed by investee stockholders upon share conversion Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Appointed By Investee Stockholders Upon Share Conversion Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Appointed By Investee Stockholders Upon Share Conversion Equity securities without readily determinable fair value, number of investor nominating committee designees upon share conversion Equity Securities Without Readily Determinable Fair Value, Number Of Investor Nominating Committee Designees Upon Share Conversion Equity Securities Without Readily Determinable Fair Value, Number Of Investor Nominating Committee Designees Upon Share Conversion Equity securities without readily determinable fair value, number of directors designated by investor upon share conversion Equity Securities Without Readily Determinable Fair Value, Number Of Directors Designated By Investor Upon Share Conversion Equity Securities Without Readily Determinable Fair Value, Number Of Directors Designated By Investor Upon Share Conversion Equity securities without readily determinable fair value, number of nominating committee directors designated by investee upon share conversion Equity Securities Without Readily Determinable Fair Value, Number Of Nominating Committee Directors Designated By Investee Upon Share Conversion Equity Securities Without Readily Determinable Fair Value, Number Of Nominating Committee Directors Designated By Investee Upon Share Conversion Equity securities without readily determinable fair value, number of oversight committee directors designated by investor upon share conversion Equity Securities Without Readily Determinable Fair Value, Number Of Oversight Committee Directors Designated By Investor Upon Share Conversion Equity Securities Without Readily Determinable Fair Value, Number Of Oversight Committee Directors Designated By Investor Upon Share Conversion Equity securities without readily determinable fair value, number of oversight committee chair directors designated by investor upon share conversion Equity Securities Without Readily Determinable Fair Value, Number Of Oversight Committee Chair Directors Designated By Investor Upon Share Conversion Equity Securities Without Readily Determinable Fair Value, Number Of Oversight Committee Chair Directors Designated By Investor Upon Share Conversion Equity securities without readily determinable fair value, upward price adjustment, cumulative amount Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount Florida [Member] FLORIDA Engle Progeny Cases, State [Member] Engle Progeny Cases, State [Member] Engle Progeny Cases, State [Member] Maximum bond for all defendants Maximum Bond For All Defendants Maximum Bond For All Defendants Philip Morris USA and Altria Group [Member] Philip Morris USA and Altria Group [Member] Philip Morris USA and Altria Group [Member] Other Tabacco-Related Cases [Member] Other Tabacco-Related Cases [Member] Other Tabacco-Related Cases [Member] Smoking and Health Class Actions and Aggregated Claims Litigation [Member] Smoking And Health Class Actions And Aggregated Claims Litigation [Member] Smoking and Health Class Actions and Aggregated Claims Litigation [Member] Engle Progeny Cases [Member] Engle Progeny Cases [Member] Engle Progeny Cases [Member] Individual Smoking and Health Cases [Member] Individual Smoking And Health Cases [Member] Individual Smoking and Health Cases [Member] Non Engle Progeny Cases [Member] Non Engle Progeny Cases [Member] Non Engle Progeny Cases [Member] Canada [Member] CANADA Alaska [Member] ALASKA California [Member] CALIFORNIA Connecticut [Member] CONNECTICUT Louisiana [Member] LOUISIANA Massachusetts [Member] MASSACHUSETTS Mississippi [Member] MISSISSIPPI Missouri [Member] MISSOURI New Hampshire [Member] NEW HAMPSHIRE New Jersey [Member] NEW JERSEY Ohio [Member] OHIO Pennsylvania [Member] PENNSYLVANIA Rhode Island [Member] RHODE ISLAND Tennessee [Member] TENNESSEE West Virginia [Member] WEST VIRGINIA Loss contingency, number of inactive cases Loss Contingency, Number Of Inactive Cases Loss Contingency, Number Of Inactive Cases Number of cases pending Loss Contingency, Pending Claims, Number Number of cases set for trial Loss Contingency, Number of Cases Set for Trial Loss Contingency, Number of Cases Set for Trial Number of verdicts returned Loss Contingency, Claims Decided Loss Contingency, Claims Decided Number of favorable verdicts Loss Contingency, Claims Decided Favorable, Number Loss Contingency, Claims Decided Favorable, Number Number of unfavorable verdicts Loss Contingency, Claims Decided Unfavorable, Number Loss Contingency, Claims Decided Unfavorable, Number Number of claims resolved Loss Contingency, Claims Resolved, Number Loss Contingency, Claims Resolved, Number Number of verdicts reversed Loss Contingency, Verdict Reversed, Number Loss Contingency, Verdict Reversed, Number Statement of Stockholders' Equity [Abstract] Statement [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Additional Paid-in Capital [Member] Additional Paid-in Capital [Member] Earnings Reinvested in the Business [Member] Retained Earnings [Member] Accumulated Other Comprehensive Losses [Member] AOCI Attributable to Parent [Member] Cost of Repurchased Stock [Member] Treasury Stock [Member] Non-controlling Interests [Member] Noncontrolling Interest [Member] Statement [Line Items] Statement [Line Items] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Beginning balance Net earnings Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest Other comprehensive earnings (losses), net of deferred income taxes Stock award activity Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition and Income Tax Effect, Net Adjustment To Additional Paid In Capital, Share Based Compensation, Restricted And Deferred Stock Awards and the tax benefits associated with vestings of prior period restricted and deferred stock awards Cash dividends declared Dividends, Common Stock, Cash Repurchases of common stock Treasury Stock, Value, Acquired, Cost Method Ending balance Net earnings attributable to noncontrolling interests Net Income (Loss) Attributable to Redeemable Noncontrolling Interest Dividends declared (usd per share) Common Stock, Dividends, Per Share, Declared Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Variable Rate [Axis] Variable Rate [Axis] Variable Rate [Domain] Variable Rate [Domain] London Interbank Offered Rate (LIBOR) [Member] London Interbank Offered Rate (LIBOR) [Member] Short-term Debt, Type [Axis] Short-term Debt, Type [Axis] Short-term Debt, Type [Domain] Short-term Debt, Type [Domain] Line of Credit [Member] Line of Credit [Member] Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] Revolving Credit Facility [Member] Revolving Credit Facility [Member] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Senior Notes [Member] Senior Notes [Member] Revolving Credit Facility Due August 2023 [Member] Revolving Credit Facility Due August 2023 [Member] Revolving Credit Facility Due August 2023 [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Short-term borrowings Face amount Debt Instrument, Face Amount Debt instrument, term Debt Instrument, Term Debt instrument, number of extensions Debt Instrument, Number of Extensions Debt Instrument, Number of Extensions Debt instrument, expected repayment period Debt Instrument, Expected Repayment Period Debt Instrument, Expected Repayment Period Debt instrument, extension term Debt Instrument, Extension Term Debt Instrument, Extension Term Debt instrument, basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Debt instrument, interest rate during period Debt Instrument, Interest Rate During Period Debt instrument, covenant, consolidated EBITDA to interest expense ratio, minimum Debt Instrument, Covenant, Consolidated EBITDA to Interest Expense Ratio, Minimum Debt Instrument, Covenant, Consolidated EBITDA to Interest Expense Ratio, Minimum Debt instrument, consolidated EBITDA to interest expense ratio Debt Instrument, Consolidated EBITDA to Interest Expense Ratio Debt Instrument, Consolidated EBITDA to Interest Expense Ratio Interest payable, short-term borrowings Interest Payable, Current Long-term debt repaid Accrued interest on long-term debt Interest Payable Investment Investment [Table Text Block] Equity Method Investments Equity Method Investments [Table Text Block] Equity [Abstract] Reclassification out of Accumulated Other Comprehensive Income [Table] Reclassification out of Accumulated Other Comprehensive Income [Table] Equity Components [Axis] Benefit Plans [Member] Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Net loss [Member] Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member] Prior service cost/credit [Member] Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent [Member] Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income [Member] Reclassification out of Accumulated Other Comprehensive Income [Member] Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] ABI Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 1 [Member] Number of ordinary shares owned (approximately) (in shares) Equity Method Investment, Number of Shares Owned, Common Equity Method Investment, Number of Shares Owned, Common Ownership percentage (approximately) Equity Method Investment, Ownership Percentage Equity method investment, shares purchased, (CAD per share) Equity Method Investment, Price Per Share If Exercised Equity Method Investment, Price Per Share If Exercised Equity method investment, number of shares eligible for purchase (in shares) Equity Method Investment, Number of Shares Eligible For Purchase Equity Method Investment, Number of Shares Eligible For Purchase Equity method investment, percentage of shares eligible for purchase Equity Method Investment, Percentage of Shares Eligible For Purchase Equity Method Investment, Percentage of Shares Eligible For Purchase Equity method investment, warrant exercised, ownership percentage (approximately) Equity Method Investment, Warrant Exercised, Ownership Percentage Equity Method Investment, Warrant Exercised, Ownership Percentage Payments for derivative instrument, investing activities Payments for Derivative Instrument, Investing Activities Payments to acquire equity method investments Payments to Acquire Equity Method Investments Payments for deferred tax liability Deferred Tax Liabilities, Investments Equity method investment, aggregate exercise price Equity Method Investment, Aggregate Exercise Price Equity Method Investment, Aggregate Exercise Price Number of directors nominated Number of Directors Nominated Number of Directors Nominated Equity method investment, number of independent directors nominated Equity Method Investment, Number of Independent Directors Nominated Equity Method Investment, Number of Independent Directors Nominated Number of members on the Board of Directors Number of Members On the Board of Directors Number of Members On the Board of Directors Fair value of equity investment Equity Method Investments, Fair Value Disclosure Equity method investments Equity method investment, difference between carrying amount and fair value, percentage (approximately) Equity Method Investment, Difference Between Carrying Amount and Fair Value, Percentage Equity Method Investment, Difference Between Carrying Amount and Fair Value, Percentage Equity method investment, impairment Equity Method Investment, Other than Temporary Impairment Financial Instruments Derivative Instruments and Hedging Activities Disclosure [Text Block] Fair Value, Inputs, Level 3 [Member] Fair Value, Inputs, Level 3 [Member] Equity Contract [Member] Equity Contract [Member] Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward] Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward] Balance at begging of period Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs Pre-tax earnings (losses) recognized in net earnings Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Earnings Balance at end of period Earnings from equity investments Net earnings attributable to Altria Less: Distributed and undistributed earnings attributable to share-based awards Participating Securities, Distributed and Undistributed Earnings (Loss), Basic and Diluted Participating Securities, Distributed and Undistributed Earnings (Loss), Basic and Diluted Earnings for basic and diluted EPS Net Income (Loss) Available to Common Stockholders, Basic and Diluted Net Income (Loss) Available to Common Stockholders, Basic and Diluted Weighted-average shares for basic and diluted EPS (in shares) Weighted Average Number of Shares Outstanding, Basic and Diluted Schedule of Pre-tax Tobacco and Health Litigation Charges [Table] Schedule of Pre-tax Tobacco and Health Litigation Charges [Table] Schedule of Pre-tax Tobacco and Health Litigation Charges [Table] Tobacco and Health Litigation Cases [Member] Tobacco and Health Litigation Cases [Member] Tobacco and Health Litigation Cases [Member] Operating Segments [Member] Operating Segments [Member] Segment Reconciling Items [Member] Segment Reconciling Items [Member] Segments [Axis] Segments [Axis] Segments [Domain] Segments [Domain] Smokeable Products Segment [Member] Smokeable Products Segment [Member] Smokeable Products Segment [Member] Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items] Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items] [Line Items] for Schedule of Pre-tax Tobacco and Health Litigation Charges [Table] Litigation Case [Domain] Engle Progeny Cases, Berger [Member] Engle Progeny Cases, Berger [Member] Engle Progeny Cases, Berger [Member] Engle Progeny Cases, Duignan [Member] Engle Progeny Cases, Duignan [Member] Engle Progeny Cases, Duignan [Member] Engle Progeny Cases, Cuddihee [Member] Engle Progeny Cases, Cuddihee [Member] Engle Progeny Cases, Cuddihee Engle Progeny Cases, Rintoul [Member] Engle Progeny Cases, Rintoul [Member] Engle Progeny Cases, Rintoul Engle Progeny Cases, Gloger [Member] Engle Progeny Cases, Gloger [Member] Engle Progeny Cases, Gloger [Member] Engle Progeny Cases, McCall [Member] Engle Progeny Cases, McCall [Member] Engle Progeny Cases, McCall [Member] Engle Progeny Cases, Neff [Member] Engle Progeny Cases, Neff [Member] Engle Progeny Cases, Neff [Member] Engle Progeny Cases, Frogel [Member] Engle Progeny Cases, Frogel [Member] Engle Progeny Cases, Frogel [Member] Engle Progeny Cases, Mahfuz [Member] Engle Progeny Cases, Mahfuz [Member] Engle Progeny Cases, Mahfuz [Member] Engle Progeny Cases, Holliman [Member] Engle Progeny Cases, Holliman [Member] Engle Progeny Cases, Holliman [Member] Engle Progeny Cases, Chadwell [Member] Engle Progeny Cases, Chadwell [Member] Engle Progeny Cases, Chadwell [Member] [Member] Engle Progeny Cases, Kaplan [Member] Engle Progeny Cases, Kaplan [Member] Engle Progeny Cases, Kaplan [Member] Engle Progeny Cases, Landi [Member] Engle Progeny Cases, Landi [Member] Engle Progeny Cases, Landi [Member] Engle Progeny Cases, R. Douglas [Member] Engle Progeny Cases, R. Douglas [Member] Engle Progeny Cases, R. Douglas [Member] Engle Progeny Cases, Sommers [Member] Engle Progeny Cases, Sommers [Member] Engle Progeny Cases, Sommers [Member] Engle Progeny Cases, Santoro [Member] Engle Progeny Cases, Santoro [Member] Engle Progeny Cases, Santoro [Member] Engle Progeny Cases, Cooper [Member] Engle Progeny Cases, Cooper [Member] Engle Progeny Cases, Cooper [Member] Engle Progeny Cases, D. Brown [Member] Engle Progeny Cases, D. Brown [Member] Engle Progeny Cases, D. Brown [Member] Engle Progeny Cases, Kerrivan [Member] Engle Progeny Cases, Kerrivan [Member] Engle Progeny Cases, Kerrivan [Member] Engle Progeny Cases, Harris [Member] Engle Progeny Cases, Harris [Member] Engle Progeny Cases, Harris [Member] Engle Progeny Cases, Theis [Member] Engle Progeny Cases, Theis [Member] Engle Progeny Cases, Theis [Member] Engle Progeny Cases, Alvarez del Real [Member] Engle Progeny Cases, Alvarez del Real [Member] Engle Progeny Cases, Alvarez del Real [Member] Engle Progeny Cases, Zingaro [Member] Engle Progeny Cases, Zingaro [Member] Engle Progeny Cases, Zingaro [Member] Engle Progeny Cases, Bryant [Member] Engle Progeny Cases, Bryant [Member] Engle Progeny Cases, Bryant [Member] Engle Progeny Cases, Wallace [Member] Engle Progeny Cases, Wallace [Member] Engle Progeny Cases, Wallace [Member] Engle Progeny Cases, J. Brown [Member] Engle Progeny Cases, J. Brown [Member] Engle Progeny Cases, J. Brown [Member] Engle Progeny Cases, L. Martin [Member] Engle Progeny Cases, L. Martin [Member] Engle Progeny Cases, L. Martin [Member] Engle Progeny Cases, Danielson [Member] Engle Progeny Cases, Danielson [Member] Engle Progeny Cases, Danielson [Member] Engle Progeny Cases, S. Martin [Member] Engle Progeny Cases, S. Martin [Member] Engle Progeny Cases, S. Martin [Member] Engle Progeny Cases, Searcy [Member] Engle Progeny Cases, Searcy [Member] Engle Progeny Cases, Searcy [Member] Engle Progeny Cases, Boatright [Member] Engle Progeny Cases, Boatright [Member] Engle Progeny Cases, Boatright [Member] Engle Progeny Cases, M. Brown [Member] Engle Progeny Cases, M. Brown [Member] Engle Progeny Cases, M. Brown [Member] Engle Progeny Cases, Jordan [Member] Engle Progeny Cases, Jordan [Member] Engle Progeny Cases, Jordan [Member] Engle Progeny Cases, Pardue [Member] Engle Progeny Cases, Pardue [Member] Engle Progeny Cases, Pardue [Member] Engle Progeny Cases, McKeever [Member] Engle Progeny Cases, McKeever [Member] Engle Progeny Cases, McKeever [Member] Engle Progeny Cases, Naugle [Member] Engle Progeny Cases, Naugle [Member] Engle Progeny Cases, Naugle [Member] Engle Progeny Cases, Gore [Member] Engle Progeny Cases, Gore [Member] Engle Progeny Cases, Gore [Member] Damages awarded, value Loss Contingency, Damages Awarded, Value Pre-tax charges (gain) included in net earning Pre-Tax Charges (Gain) Included in Net Earning Pre-Tax Charges (Gain) Included in Net Earning Class of Treasury Stock [Table] Class of Treasury Stock [Table] Ownership [Axis] Ownership [Axis] Ownership [Domain] Ownership [Domain] Helix Innovations LLC [Member] Helix Innovations LLC [Member] Helix Innovations LLC [Member] Share Repurchase Program [Axis] Share Repurchase Program [Axis] Share Repurchase Program [Domain] Share Repurchase Program [Domain] January 2018 Share Repurchase Program [Member] January 2018 Share Repurchase Program [Member] January 2018 Share Repurchase Program [Member] July 2019 Share Repurchase Program [Member] July 2019 Share Repurchase Program [Member] July 2019 Share Repurchase Program [Member] Investment, Name [Axis] Investment, Name [Domain] Equity, Class of Treasury Stock [Line Items] Equity, Class of Treasury Stock [Line Items] Noncontrolling interest, ownership percentage by parent Noncontrolling Interest, Ownership Percentage by Parent Business Combination, Consideration Transferred Business Combination, Consideration Transferred Equity method investment, ownership percentage Noncontrolling interest, ownership percentage by noncontrolling owners Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners Planned share repurchase program Stock Repurchase Program, Authorized Amount Repurchase of common stock (shares) Treasury Stock, Shares, Acquired Average price of repurchased shares, per share (usd per share) Treasury Stock Acquired, Average Cost Per Share Stock repurchase program, remaining authorized repurchase amount Stock Repurchase Program, Rescinded Authorized Repurchase Amount Stock Repurchase Program, Rescinded Authorized Repurchase Amount Total number of shares repurchased (shares) Aggregate cost of shares repurchased Average price per share of shares repurchased (usd per share) Engle Progeny Cases, Federal [Member] Engle Progeny Cases, Federal [Member] Engle Progeny Cases, Federal [Member] Engle Progeny Cases, D Cohen, Collar, Chacon [Member] Engle Progeny Cases, Pearson, D Cohen, Collar, Chacon [Member] [Member] Engle Progeny Cases, Pearson, D Cohen, Collar, Chacon [Member] [Member] Engle Progeny Cases, Reider and Banks [Member] Engle Progeny Cases, Reider and Banks [Member] Engle Progeny Cases, Reider and Banks [Member] Engle Progeny Cases, Weingart and Hancock [Member] Engle Progeny Cases, Weingart and Hancock [Member] Engle Progeny Cases, Weingart and Hancock [Member] Engle Progeny Cases, Pollari [Member] Engle Progeny Cases, Pollari [Member] Engle Progeny Cases, Pollari [Member] Engle Progeny Cases, Gloger, Rintoul and Duignam [Member] Engle Progeny Cases, Gloger, Rintoul and Duignam [Member] Engle Progeny Cases, Gloger, Rintoul and Duignam [Member] Engle Progeny Cases, Freeman [Member] Engle Progeny Cases, Freeman [Member] Engle Progeny Cases, Freeman [Member] Period for decertified class members could file individual actions Loss Contingency, Period for Decertified Class Members to File Individual Actions Against Defendants Loss Contingency, Period for Decertified Class Members to File Individual Actions Against Defendants Number of plaintiffs Loss Contingency, Number of Plaintiffs Number of claims with unfavorable verdicts pending/reversed Loss Contingency, Unfavorable Verdicts Pending/Reversed Loss Contingency, Unfavorable Verdicts Pending/Reversed Zero damages verdicts Loss Contingency, Zero Damages Verdicts Loss Contingency, Zero Damages Verdicts Zero damages verdict modified Loss Contingency, Zero Damages Verdict Modified Loss Contingency, Zero Damages Verdict Modified Schedule of Segment Reporting Information, by Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of Pre-tax Tobacco and Health Litigation Items Schedule of Pre-tax Tobacco and Health Litigation Charges [Table Text Block] [Table Text Block] for Schedule of Pre-tax Tobacco and Health Litigation Charges [Table] Asset Impairment, Exit and Implementation Costs Restructuring and Related Activities Disclosure [Text Block] Lights Ultra Lights Class Actions [Member] Lights Ultra Lights Class Actions [Member] Lights/Ultra Lights Class Actions [Member] Lights [Member] Lights [Member] Lights [Member] Number of state courts Loss Contingency, State Courts, Number Loss Contingency, State Courts, Number Claims not certified, number Loss Contingency, Claims Not Certified, Number Loss Contingency, Claims Not Certified, Number Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] General corporate [Member] Corporate, Non-Segment [Member] Reporting Segment [Domain] Oral Tobacco Segment [Member] Oral Tobacco Segment [Member] Oral Tobacco Segment [Member] Wine Segment [Member] Wine Segment [Member] Wine Segment [Member] All Other [Member] Other Segments [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Operating income Amortization of intangibles Amortization of Intangible Assets General corporate expenses General and Administrative Expense Corporate asset impairment and exit costs Asset Impairment and Business Exit Costs Asset Impairment and Business Exit Costs Interest and other debt expense, net Net periodic benefit income, excluding service cost Loss on Cronos-related financial instruments Benefit Plans Pension and Other Postretirement Benefits Disclosure [Text Block] Recent Accounting Guidance Not Yet Adopted Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block] Fair Value Measurement Inputs and Valuation Techniques Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Schedule of Derivative Liabilities at Fair Value Schedule of Net Investment Hedges, Statements of Financial Performance and Financial Position, Location [Table Text Block] Pre-tax Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses Derivative Instruments, Gain (Loss) [Table Text Block] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Corporate, Non-Segment [Member] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Plus amounts included in net periodic benefit income, excluding service cost, Asset Impairment and Exit Costs Net Periodic Defined Benefits Income (Reversal of Income), Excluding Service Cost Component, Asset Impairment And Business Exit Costs Net Periodic Defined Benefits Income (Reversal of Income), Excluding Service Cost Component, Asset Impairment And Business Exit Costs Asset Impairment and Exit Costs Total, Implementation Costs Other Restructuring Costs, Including Net Pension Cost (Credit) Other Restructuring Costs, Including Net Pension Cost (Credit) Plus amounts included in net period benefit income, excluding service cost, Implementation Costs Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component, Implementation Costs Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component, Implementation Costs Implementation Costs Other Restructuring Costs Total restructuring Restructuring Charges, Including Net Pension Cost (Credit) Restructuring Charges, Including Net Pension Cost (Credit) Plus amounts included in net periodic benefit income, excluding service cost, Total Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component, Restructuring Charges Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component, Restructuring Charges Total Restructuring Charges Contingencies Legal Matters and Contingencies [Text Block] Revenue from Contract with Customer [Abstract] Allowance for sales discounts, goods Allowance For Sales Discounts, Goods Allowance For Sales Discounts, Goods Deferred revenue Contract with Customer, Liability Expected period for satisfaction of performance obligation Revenue, Performance Obligation, Description of Timing Condensed Consolidating Balance Sheet Condensed Balance Sheet [Table Text Block] Condensed Consolidating Statements of Earnings and Comprehensive Earnings Condensed Income Statement [Table Text Block] Condensed Consolidating Statements of Cash Flows Condensed Cash Flow Statement [Table Text Block] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] ABI [Member] Accumulated Equity Method Investments Attributable To Parent [Member] Accumulated Equity Method Investments Attributable To Parent [Member] Currency Translation Adjustments and Other [Member] Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income [Roll Forward] AOCI Attributable to Parent, Net of Tax [Roll Forward] Other comprehensive earnings (losses) before reclassifications Other Comprehensive Income (Loss), before Reclassifications, before Tax Deferred income taxes Other Comprehensive Income (Loss) before Reclassifications, Tax Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Amounts reclassified to net earnings Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax Deferred income taxes Reclassification from AOCI, Current Period, Tax Amounts reclassified to net earnings, net of deferred income taxes Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Other comprehensive earnings (losses), net of deferred income taxes Other Comprehensive Earnings/Losses Comprehensive Income (Loss) Note [Text Block] Credit Agreement [Member] Credit Agreement [Member] Credit Agreement [Member] Letter of Credit [Member] Letter of Credit [Member] Credit line available under the agreement Line of Credit Facility, Maximum Borrowing Capacity Contingent liability related to performance surety bonds Guarantor Obligations, Maximum Exposure, Undiscounted Arkansas [Member] ARKANSAS Delaware [Member] DELAWARE District of Columbia [Member] DISTRICT OF COLUMBIA Illinois [Member] ILLINOIS Iowa [Member] IOWA Kansas [Member] KANSAS Maryland [Member] MARYLAND Michigan [Member] MICHIGAN Minnesota [Member] MINNESOTA Nevada [Member] NEVADA Oklahoma [Member] OKLAHOMA Oregon [Member] OREGON Puerto Rico [Member] PUERTO RICO South Carolina [Member] SOUTH CAROLINA Texas [Member] TEXAS Wisconsin [Member] WISCONSIN British Columbia and Saskatchewan [Member] British Columbia, Saskatchewan [Member] British Columbia, Saskatchewan [Member] Canadian Tobacco Manufacturers [Member] Canadian Tobacco Manufacturers [Member] Canadian Tobacco Manufacturers [Member] Class not certified Loss Contingency, Class Not Certified, Number Loss Contingency, Class Not Certified, Number Number of manufacturers Loss Contingency, Number of Manufacturers Loss Contingency, Number of Manufacturers Number of verdicts upheld Loss Contingency, Verdicts Upheld Loss Contingency, Verdicts Upheld Amount awarded to other party Amount Awarded to Other Party Amount Awarded to Other Party Schedule of Contingencies Schedule of Loss Contingencies by Contingency [Table Text Block] Unrealized gain (loss) on derivatives Unrealized Gain (Loss) on Derivatives Number of restricted shares owned (in shares) Equity Method Investment, Number of Shares Owned, Restricted Equity Method Investment, Number of Shares Owned, Restricted Number of ordinary shares owned (in shares) Difference between carrying amount and fair value, percentage (approximately) Equity method investment, impairment Equity Method Investment, Impairment Equity Method Investment, Impairment Derivative instrument, number of shares hedged (in shares) Derivative Instrument, Number Of Shares Hedged Derivative Instrument, Number Of Shares Hedged Derivative instrument, shares hedged, price per share (in eur per share) Derivative Instrument, Shares Hedged, Price Per Share Derivative Instrument, Shares Hedged, Price Per Share Number of states that cap bond or require no bond Loss Contingency, Number of States That Cap Bond or Require No Bond Loss Contingency, Number of States That Cap Bond or Require No Bond Condensed Cash Flow Statement [Table] Condensed Cash Flow Statement [Table] PM USA [Member] Condensed Cash Flow Statements, Captions [Line Items] Condensed Cash Flow Statements, Captions [Line Items] Cash Provided by (Used In) Operating Activities Net cash provided by (used in) operating activities Cash Provided by (Used in) Investing Activities Investment in consolidated subsidiaries Investments in Consolidated Subsidiaries Investments in Consolidated Subsidiaries Cash Provided by (Used in) Financing Activities Proceeds from short-term borrowings Changes in amounts due to/from Altria Group, Inc. and subsidiaries Proceeds from (Repayments of) Related Party Debt Cash dividends paid to parent SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Consolidated Subsidiaries Scenario [Axis] Scenario [Axis] Scenario [Domain] Scenario [Domain] Forecast [Member] Forecast [Member] Restructuring Type [Axis] Restructuring Type [Axis] Type of Restructuring [Domain] Type of Restructuring [Domain] Inventory Write-Off [Member] Inventory Write-Off [Member] Inventory Write-Off [Member] Purchase Commitment [Member] Purchase Commitment [Member] Restructuring Plan [Axis] Restructuring Plan [Axis] Restructuring Plan [Domain] Restructuring Plan [Domain] Wine Business Strategic Reset [Member] Wine Business Strategic Reset [Member] Wine Business Strategic Reset [Member] Restructuring charges Fulfillment term Long-term Purchase Commitment, Period Common stock, par value (usd per share) Common Stock, Par or Stated Value Per Share Common stock, shares issued (shares) Common Stock, Shares, Issued Shares repurchased (shares) Treasury Stock, Shares Schedule of Accumulated Other Comprehensive Income (Loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Reclassification out of Accumulated Other Comprehensive Income Reclassification out of Accumulated Other Comprehensive Income [Table Text Block] Pending Individual Lawsuits [Member] Pending Individual Lawsuits [Member] Pending Individual Lawsuits [Member] E-vapor Litigation [Member] E-vapor Litigation [Member] E-vapor Litigation [Member] UST Litigation [Member] UST Litigation [Member] UST Litigation [Member] Claims filed, number Loss contingency, number of shareholders filing class action lawsuits Loss Contingency, Number Of Shareholders Filing Class Action Lawsuits Loss Contingency, Number Of Shareholders Filing Class Action Lawsuits Threatened Litigation [Member] Threatened Litigation [Member] State settlement agreements annual payments Litigation Settlement, Annual Payment Amount Litigation Settlement, Annual Payment Amount State settlement agreements attorney fees annual cap Litigation Settlement, Annual Legal Fees Payable, Maximum Litigation Settlement, Annual Legal Fees Payable, Maximum Litigation settlement Litigation Settlement, Amount Awarded to Other Party Other Disputes Under the State Settlement Agreements [Member] Other Disputes Under the State Settlement Agreements [Member] Other Disputes Under the State Settlement Agreements [Member] Amount ordered to be paid from other party Loss contingency, class action lawsuit Loss Contingency, Class Action Lawsuit Loss Contingency, Class Action Lawsuit New Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Equity Method Investments Equity Method Investments [Policy Text Block] Equity Securities Without Readily Determinable Fair Value Equity Securities without Readily Determinable Fair Value [Policy Text Block] Pension [Member] Service cost Defined Benefit Plan, Service Cost Interest cost Defined Benefit Plan, Interest Cost Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Amortization: Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract] Net loss Defined Benefit Plan, Amortization of Gain (Loss) Prior service cost (credit) Defined Benefit Plan, Amortization of Prior Service Cost (Credit) Curtailment Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment Net periodic benefit (income) cost Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Statement of Comprehensive Income [Abstract] Other comprehensive earnings (losses), net of deferred income taxes: Other Comprehensive Income (Loss), Net of Tax [Abstract] Benefit plans Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax ABI Other Comprehensive Income (Loss) From Equity Method Investment, Adjustment, Net Of Tax Other Comprehensive Income (Loss) From Equity Method Investment, Adjustment Currency translation adjustments and other Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Comprehensive (earnings) losses attributable to noncontrolling interests ETS Smoking and Health Case, Flight Attendants [Member] ETS Smoking and Health Case, Flight Attendants [Member] ETS Smoking and Health Case, Flight Attendants [Member] Pending Lawsuits Filed By State Or Local Governments [Member] Pending Lawsuits Filed By State Or Local Governments [Member] Pending Lawsuits Filed By State Or Local Governments [Member] Pending Lawsuit Filed By School District [Member] Pending Lawsuit Filed By School District [Member] Pending Lawsuit Filed By School District [Member] Number of cases Loss Contingency, Number Of Cases Loss Contingency, Number Of Cases Number of claims dismissed Loss Contingency, Claims Dismissed, Number Loss contingency, number of cases tried in a single proceeding Loss Contingency, Number Of Cases Tried in A Single Proceeding Loss Contingency, Number Of Cases Tried in A Single Proceeding Loss contingency, number of inactive class action lawsuits Loss Contingency, Number Of Inactive Class Action Lawsuits Loss Contingency, Number Of Inactive Class Action Lawsuits Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Restructuring reserve, beginning of period Restructuring Reserve Charges Restructuring and Related Cost, Incurred Cost Cash spent Payments for Restructuring Restructuring reserve, end of period Revenues from Contracts with Customers Revenue from Contract with Customer [Text Block] Earnings Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Assets [Member] Assets [Member] Tobacco and Health Judgment [Member] Tobacco and Health Judgment [Member] Tobacco and Health Judgment [Member] Pre-Trial Resolution [Member] Pre-Trial Resolution [Member] Pre-Trial Resolution [Member] Litigation Cases Results [Member] Litigation Cases Results [Member] Litigation Cases Results [Member] Interest Expense Related to Litigation [Member] Interest Expense Related To Litigation [Member] Interest Expense Related To Litigation [Member] Judgments paid (approximately) Loss Contingency, Damages Paid, Value Litigation settlement interest expense (income) Litigation Settlement Interest Loss Contingency Accrual [Roll Forward] Loss Contingency Accrual [Roll Forward] Accrued liability for tobacco and health litigation items at beginning of period Loss Contingency Accrual Payments Loss Contingency Accrual, Payments Accrued liability for tobacco and health litigation items at end of period Loss contingency, number of pre-trial resolution cases Loss Contingency, Number Of Pre-Trial Resolution Cases Loss Contingency, Number Of Pre-Trial Resolution Cases Security posted for appeal of judgments Litigation Escrow Deposit Litigation Escrow Deposit Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Foreign currency denominated debt [Member] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Gain (Loss) Recognized in Accumulated Other Comprehensive Losses Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax Gain (Loss) Recognized in Net Earnings Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Designated as Hedging Instrument [Member] Designated as Hedging Instrument [Member] Other Current Assets [Member] Other Current Assets [Member] Other Assets [Member] Other Assets [Member] Other Accrued Liabilities [Member] Other Accrued Liabilities [Member] Other Accrued Liabilities [Member] Other Liabilities [Member] Other Liabilities [Member] Investments In Equity Securities [Member] Investments In Equity Securities [Member] Investments In Equity Securities [Member] Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Fair Value of Assets Fair Value of Liabilities Derivative Liability, Fair Value, Gross Liability Cover [Abstract] Entities [Table] Entities [Table] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Common Stock, $0.33 1/3 par value [Member] Common Stock, 0.33 1/3 Par Value [Member] Common Stock, 0.33 1/3 Par Value [Member] 1.000% Notes due 2023 [Member] Common Stock, 1.000% Notes Due 2023 [Member] Common Stock, 1.000% Notes Due 2023 [Member] 1.700% Notes due 2025 [Member] Common Stock, 1.700% Notes Due 2025 [Member] Common Stock, 1.700% Notes Due 2025 [Member] 2.200% Notes due 2027 [Member] Common Stock, 2.200% Notes Due 2027 [Member] Common Stock, 2.200% Notes Due 2027 [Member] 3.125% Notes due 2031 [Member] Common Stock, 3.125% Notes Due 2031 [Member] Common Stock, 3.125% Notes Due 2031 [Member] Entity Information [Line Items] Entity Information [Line Items] Document Type Document Type Document Quarterly Report Document Quarterly Report Document Period End Date Document Period End Date Document Transition Report Document Transition Report Entity File Number Entity File Number Entity Registrant Name Entity Registrant Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Title of 12(b) Security Title of 12(b) Security Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Current Reporting Status Entity Current Reporting Status Entity Interactive Data Current Entity Interactive Data Current Entity Filer Category Entity Filer Category Entity Small Business Entity Small Business Emerging Growth Company Entity Emerging Growth Company Entity Shell Company Entity Shell Company Entity Common Stock, Shares Outstanding (in shares) Entity Common Stock, Shares Outstanding Amendment Flag Amendment Flag Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date EX-101.PRE 14 mo-20200331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 15 R28.htm IDEA: XBRL DOCUMENT v3.20.1
Earnings Per Share (Tables)
 3 Months Ended
Mar. 31, 2020
Earnings Per Share [Abstract]  
Earnings Per Share

Basic and diluted earnings per share (“EPS”) were calculated using the following:
 
 
For the Three Months Ended March 31,
 
 
2020
 
2019
 
 
(in millions)
Net earnings attributable to Altria
 
$
1,552

 
$
1,120

Less: Distributed and undistributed earnings attributable to share-based awards
 
(2
)
 
(2
)
Earnings for basic and diluted EPS
 
$
1,550

 
$
1,118

 
 
 
 
 
Weighted-average shares for basic and diluted EPS
 
1,858

 
1,874
XML 17 R24.htm IDEA: XBRL DOCUMENT v3.20.1
Asset Impairment, Exit and Implementation Costs (Tables)
 3 Months Ended
Mar. 31, 2020
Restructuring and Related Activities [Abstract]  
Restructuring and Related Costs

Pre-tax asset impairment, exit and implementation costs consisted of the following:
 
 
For the Three Months Ended March 31,
 
 
2020
 
2019
 
 
Implementation Costs (1)
 
Total
 
Asset Impairment and Exit Costs
 
Implementation Costs (1)
 
Total
 
(in millions)
Smokeable products
 
$
—

 
$
—

 
$
36

 
$
8

 
$
44

Oral tobacco products
 
—

 
—

 
8

 
1

 
9

Wine
 
392

 
392

 
—

 
—

 
—

All other
 
—

 
—

 
(5
)
 
—

 
(5
)
General corporate
 
—

 
—

 
1

 
—

 
1

Total
 
392

 
392

 
40

 
9

 
49

Plus amounts included in net periodic benefit income, excluding service cost (2)
 
—

 
—

 
12

 
—

 
12

Total
 
$
392

 
$
392

 
$
52

 
$
9

 
$
61

(1) Included in cost of sales for 2020 and marketing, administration and research costs for 2019 in Altria’s condensed consolidated statements of earnings.
(2) Represents curtailment costs. See Note 6. Benefit Plans.
Schedule of Restructuring Reserve by Type of Cost
The movement in the restructuring liabilities, substantially all of which were severance liabilities, related to the cost reduction program was as follows:
 
(in millions)
Balances at December 31, 2019
$
67

Charges
—

Cash spent
(23
)
Balances at March 31, 2020
$
44
XML 18 R20.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidating Financial Information
 3 Months Ended
Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Condensed Consolidating Financial Information Condensed Consolidating Financial Information:

PM USA, which is a 100% owned subsidiary of Altria Group, Inc., has guaranteed Altria Group, Inc.’s obligations under its outstanding debt securities, borrowings under its Credit Agreement and amounts outstanding under its commercial paper program (the “Guarantees”). Pursuant to the Guarantees, PM USA fully and unconditionally guarantees, as primary obligor, the payment and performance of Altria Group, Inc.’s obligations under the guaranteed debt instruments (the “Obligations”), subject to release under certain customary circumstances as noted below.

The Guarantees provide that PM USA guarantees the punctual payment when due, whether at stated maturity, by acceleration or otherwise, of the Obligations. The liability of PM USA under the Guarantees is absolute and unconditional irrespective of: any lack of validity, enforceability or genuineness of any provision of any agreement or instrument relating thereto; any change in the time, manner or place of payment of, or in any other term of, all or any of the Obligations, or any other amendment or waiver of or any consent to departure from any agreement or instrument relating thereto; any exchange, release or non-perfection of any collateral, or any release or amendment or waiver of or consent to departure from any other guarantee, for all or any of the Obligations; or any other circumstance that might otherwise constitute a defense available to, or a discharge of, Altria Group, Inc. or PM USA.

The obligations of PM USA under the Guarantees are limited to the maximum amount as will not result in PM USA’s obligations under the Guarantees constituting a fraudulent transfer or conveyance, after giving effect to such maximum amount and all other contingent and fixed liabilities of PM USA that are relevant under Bankruptcy Law, the Uniform Fraudulent Conveyance Act, the Uniform Fraudulent Transfer Act or any similar federal or state law to the extent applicable to the Guarantees. For this purpose, “Bankruptcy Law” means Title 11, U.S. Code, or any similar federal or state law for the relief of debtors.

PM USA will be unconditionally released and discharged from the Obligations upon the earliest to occur of:

▪
the date, if any, on which PM USA consolidates with or merges into Altria Group, Inc. or any successor;
▪
the date, if any, on which Altria Group, Inc. or any successor consolidates with or merges into PM USA;
▪
the payment in full of the Obligations pertaining to such Guarantees; and
▪
the rating of Altria Group, Inc.’s long-term senior unsecured debt by Standard & Poor’s Ratings Services of A or higher.

At March 31, 2020, the respective principal 100% owned subsidiaries of Altria Group, Inc. and PM USA were not limited by long-term debt or other agreements in their ability to pay cash dividends or make other distributions with respect to their equity interests.

The following sets forth the condensed consolidating balance sheets as of March 31, 2020 and December 31, 2019, condensed consolidating statements of earnings and comprehensive earnings for the three months ended March 31, 2020 and 2019, and condensed consolidating statements of cash flows for the three months ended March 31, 2020 and 2019 for Altria Group, Inc., PM USA and, collectively, Altria Group, Inc.’s other subsidiaries that are not guarantors of Altria Group, Inc.’s debt instruments (the “Non-Guarantor Subsidiaries”).

The financial information may not necessarily be indicative of results of operations or financial position had PM USA and the Non-Guarantor Subsidiaries operated as independent entities. Altria Group, Inc. and PM USA account for investments in their subsidiaries under the equity method of accounting.
Condensed Consolidating Balance Sheets
March 31, 2020
(in millions of dollars)

 
 
Altria Group, Inc.

 
PM USA

 
Non-
Guarantor
Subsidiaries

 
Total
Consolidating
Adjustments

 
Consolidated

Assets
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
5,548

 
$
1

 
$
67

 
$
—

 
$
5,616

Receivables
 
—

 
17

 
130

 
—

 
147

Inventories:
 
 
 
 
 
 
 
 
 
 
Leaf tobacco
 
—

 
508

 
387

 
—

 
895

Other raw materials
 
—

 
123

 
70

 
—

 
193

Work in process
 
—

 
6

 
461

 
—

 
467

Finished product
 
—

 
87

 
364

 
—

 
451

 
 
—

 
724

 
1,282

 
—

 
2,006

Due from Altria Group, Inc. and subsidiaries
 
91

 
5,660

 
1,361

 
(7,112
)
 
—

Other current assets
 
301

 
23

 
68

 
(226
)
 
166

Total current assets
 
5,940

 
6,425

 
2,908

 
(7,338
)
 
7,935

Property, plant and equipment, at cost
 
—

 
2,970

 
2,133

 
—

 
5,103

Less accumulated depreciation
 
—

 
2,186

 
920

 
—

 
3,106

 
 
—

 
784

 
1,213

 
—

 
1,997

Goodwill
 
—

 
—

 
5,177

 
—

 
5,177

Other intangible assets, net
 
—

 
2

 
12,666

 
—

 
12,668

Investments in equity securities
 
18,453

 
—

 
5,408

 
—

 
23,861

Investment in consolidated subsidiaries
 
18,905

 
2,867

 
—

 
(21,772
)
 
—

Due from Altria Group, Inc. and subsidiaries
 
4,790

 
—

 
—

 
(4,790
)
 
—

Other assets
 
71

 
950

 
567

 
(608
)
 
980

Total Assets
 
$
48,159

 
$
11,028

 
$
27,939

 
$
(34,508
)
 
$
52,618

Condensed Consolidating Balance Sheets (Continued)
March 31, 2020
(in millions of dollars)

 
 
Altria Group, Inc.

 
PM USA

 
Non-
Guarantor
Subsidiaries

 
Total
Consolidating
Adjustments

 
Consolidated

Liabilities
 
 
 
 
 
 
 
 
 
 
Short-term borrowings
 
$
3,000

 
$
—

 
$
—

 
$
—

 
$
3,000

Accounts payable
 
1

 
136

 
141

 
—

 
278

Accrued liabilities:
 
 
 
 
 
 
 
 
 
 
Marketing
 
—

 
391

 
76

 
—

 
467

Settlement charges
 
—

 
4,410

 
9

 
—

 
4,419

Other
 
312

 
343

 
377

 
—

 
1,032

Income taxes
 
6

 
508

 
105

 
(226
)
 
393

Dividends payable
 
1,565

 
—

 
—

 
—

 
1,565

Due to Altria Group, Inc. and subsidiaries
 
6,278

 
587

 
247

 
(7,112
)
 
—

Total current liabilities
 
11,162

 
6,375

 
955

 
(7,338
)
 
11,154

Long-term debt
 
26,971

 
—

 
—

 
—

 
26,971

Deferred income taxes
 
3,228

 
—

 
2,571

 
(608
)
 
5,191

Accrued pension costs
 
196

 
—

 
231

 
—

 
427

Accrued postretirement health care costs
 
—

 
1,076

 
722

 
—

 
1,798

Due to Altria Group, Inc. and subsidiaries
 
—

 
—

 
4,790

 
(4,790
)
 
—

Other liabilities
 
59

 
90

 
253

 
—

 
402

Total liabilities
 
41,616

 
7,541

 
9,522

 
(12,736
)
 
45,943

Contingencies
 


 


 


 


 


Redeemable noncontrolling interest
 
—

 
—

 
38

 
—

 
38

Stockholders’ Equity
 
 
 
 
 
 
 
 
 
 
Common stock
 
935

 
—

 
9

 
(9
)
 
935

Additional paid-in capital
 
5,959

 
3,310

 
27,566

 
(30,876
)
 
5,959

Earnings reinvested in the business
 
36,528

 
393

 
(7,441
)
 
7,048

 
36,528

Accumulated other comprehensive losses
 
(2,533
)
 
(216
)
 
(1,849
)
 
2,065

 
(2,533
)
Cost of repurchased stock
 
(34,346
)
 
—

 
—

 
—

 
(34,346
)
Total stockholders’ equity attributable
 to Altria Group, Inc.
 
6,543

 
3,487

 
18,285

 
(21,772
)
 
6,543

Noncontrolling interests
 
—

 
—

 
94

 
—

 
94

Total stockholders’ equity
 
6,543

 
3,487

 
18,379

 
(21,772
)
 
6,637

Total Liabilities and Stockholders’ Equity
 
$
48,159

 
$
11,028

 
$
27,939

 
$
(34,508
)
 
$
52,618

Condensed Consolidating Balance Sheets
December 31, 2019
(in millions of dollars)

 
 
Altria Group, Inc.

 
PM USA

 
Non-
Guarantor
Subsidiaries

 
Total
Consolidating
Adjustments

 
Consolidated

Assets
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
2,022

 
$
—

 
$
95

 
$
—

 
$
2,117

Receivables
 
—

 
30

 
122

 
—

 
152

Inventories:
 
 
 
 
 
 
 
 
 
 
Leaf tobacco
 
—

 
494

 
380

 
—

 
874

Other raw materials
 
—

 
120

 
72

 
—

 
192

Work in process
 
—

 
4

 
692

 
—

 
696

Finished product
 
—

 
119

 
412

 
—

 
531

 
 
—

 
737

 
1,556

 
—

 
2,293

Due from Altria Group, Inc. and subsidiaries
 
88

 
4,005

 
1,359

 
(5,452
)
 
—

Other current assets
 
133

 
64

 
114

 
(49
)
 
262

Total current assets
 
2,243

 
4,836

 
3,246

 
(5,501
)
 
4,824

Property, plant and equipment, at cost
 
—

 
2,956

 
2,118

 
—

 
5,074

Less accumulated depreciation
 
—

 
2,166

 
909

 
—

 
3,075

 
 
—

 
790

 
1,209

 
—

 
1,999

Goodwill
 
—

 
—

 
5,177

 
—

 
5,177

Other intangible assets, net
 
—

 
2

 
12,685

 
—

 
12,687

Investments in equity securities
 
18,071

 
—

 
5,510

 
—

 
23,581

Investment in consolidated subsidiaries
 
19,312

 
2,831

 
—

 
(22,143
)
 
—

Due from Altria Group, Inc. and subsidiaries
 
4,790

 
—

 
—

 
(4,790
)
 
—

Other assets
 
58

 
951

 
603

 
(609
)
 
1,003

Total Assets
 
$
44,474

 
$
9,410

 
$
28,430

 
$
(33,043
)
 
$
49,271

Condensed Consolidating Balance Sheets (Continued)
December 31, 2019
(in millions of dollars)

 
 
Altria Group, Inc.

 
PM USA

 
Non-
Guarantor
Subsidiaries

 
Total
Consolidating
Adjustments

 
Consolidated

Liabilities
 
 
 
 
 
 
 
 
 
 
Current portion of long-term debt
 
$
1,000

 
$
—

 
$
—

 
$
—

 
$
1,000

Accounts payable
 
—

 
146

 
179

 
—

 
325

Accrued liabilities:
 
 
 
 
 
 
 
 
 
 
Marketing
 
—

 
320

 
73

 
—

 
393

Settlement charges
 
—

 
3,340

 
6

 
—

 
3,346

Other
 
570

 
482

 
481

 
—

 
1,533

Income taxes
 
6

 
—

 
55

 
(49
)
 
12

Dividends payable
 
1,565

 
—

 
—

 
—

 
1,565

Due to Altria Group, Inc. and subsidiaries
 
4,693

 
514

 
245

 
(5,452
)
 
—

Total current liabilities
 
7,834

 
4,802

 
1,039

 
(5,501
)
 
8,174

Long-term debt
 
27,042

 
—

 
—

 
—

 
27,042

Deferred income taxes
 
3,099

 
—

 
2,593

 
(609
)
 
5,083

Accrued pension costs
 
197

 
—

 
276

 
—

 
473

Accrued postretirement health care costs
 
—

 
1,078

 
719

 
—

 
1,797

Due to Altria Group, Inc. and subsidiaries
 
—

 
—

 
4,790

 
(4,790
)
 
—

Other liabilities
 
80

 
87

 
178

 
—

 
345

Total liabilities
 
38,252

 
5,967

 
9,595

 
(10,900
)
 
42,914

Contingencies
 


 


 


 


 


Redeemable noncontrolling interest
 
—

 
—

 
38

 
—

 
38

Stockholders’ Equity
 
 
 
 
 
 
 
 
 
 
Common stock
 
935

 
—

 
9

 
(9
)
 
935

Additional paid-in capital
 
5,970

 
3,310

 
27,565

 
(30,875
)
 
5,970

Earnings reinvested in the business
 
36,539

 
352

 
(6,997
)
 
6,645

 
36,539

Accumulated other comprehensive losses
 
(2,864
)
 
(219
)
 
(1,877
)
 
2,096

 
(2,864
)
Cost of repurchased stock
 
(34,358
)
 
—

 
—

 
—

 
(34,358
)
Total stockholders’ equity attributable
to Altria Group, Inc.
 
6,222

 
3,443

 
18,700

 
(22,143
)
 
6,222

Noncontrolling interests
 
—

 
—

 
97

 
—

 
97

Total stockholders’ equity
 
6,222

 
3,443

 
18,797

 
(22,143
)
 
6,319

Total Liabilities and Stockholders’ Equity
 
$
44,474

 
$
9,410

 
$
28,430

 
$
(33,043
)
 
$
49,271


Condensed Consolidating Statements of Earnings and Comprehensive Earnings
For the Three Months Ended March 31, 2020
(in millions of dollars)

 
 
Altria Group, Inc.

 
PM USA

 
Non-
Guarantor
Subsidiaries

 
Total
Consolidating
Adjustments

 
Consolidated

Net revenues
 
$
—

 
$
5,359

 
$
1,008

 
$
(8
)
 
$
6,359

Cost of sales
 
—

 
1,532

 
649

 
(8
)
 
2,173

Excise taxes on products
 
—

 
1,267

 
46

 
—

 
1,313

Gross profit
 
—

 
2,560

 
313

 
—

 
2,873

Marketing, administration and research costs
 
22

 
387

 
128

 
—

 
537

Operating income (expense)
 
(22
)
 
2,173

 
185

 
—

 
2,336

Interest and other debt expense (income), net
 
237

 
(18
)
 
56

 
—

 
275

Net periodic benefit (income) cost, excluding service cost
 
—

 
(22
)
 
(5
)
 
—

 
(27
)
Earnings from equity investments
 
(134
)
 
—

 
(23
)
 
—

 
(157
)
Loss on Cronos-related financial instruments
 
—

 
—

 
137

 
—

 
137

Earnings (losses) before income taxes and equity earnings of subsidiaries
 
(125
)
 
2,213


20


—


2,108

Provision (benefit) for income taxes
 
(32
)
 
550

 
40

 
—

 
558

Equity earnings of subsidiaries
 
1,645

 
126

 
—

 
(1,771
)
 
—

Net earnings
 
1,552

 
1,789

 
(20
)
 
(1,771
)
 
1,550

Net (earnings) losses attributable to noncontrolling interests
 
—

 
—

 
2

 
—

 
2

Net earnings attributable to Altria
 
$
1,552

 
$
1,789

 
$
(18
)
 
$
(1,771
)
 
$
1,552

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net earnings
 
$
1,552

 
$
1,789

 
$
(20
)
 
$
(1,771
)
 
$
1,550

Other comprehensive earnings (losses), net of deferred income taxes
 
331

 
3

 
28

 
(31
)
 
331

Comprehensive earnings
 
1,883

 
1,792

 
8

 
(1,802
)
 
1,881

Comprehensive (earnings) losses attributable to noncontrolling interests
 
—

 
—

 
2

 
—

 
2

Comprehensive earnings attributable to Altria
 
$
1,883

 
$
1,792

 
$
10

 
$
(1,802
)
 
$
1,883


Condensed Consolidating Statements of Earnings and Comprehensive Earnings
For the Three Months Ended March 31, 2019
(in millions of dollars)

 
 
Altria Group, Inc.

 
PM USA

 
Non-
Guarantor
Subsidiaries

 
Total
Consolidating
Adjustments

 
Consolidated

Net revenues
 
$
—

 
$
4,725

 
$
913

 
$
(10
)
 
$
5,628

Cost of sales
 
—

 
1,340

 
248

 
(10
)
 
1,578

Excise taxes on products
 
—

 
1,185

 
54

 
—

 
1,239

Gross profit
 
—

 
2,200

 
611

 
—

 
2,811

Marketing, administration and research costs
 
35

 
384

 
114

 
—

 
533

Asset impairment and exit costs
 
1

 
35

 
4

 
—

 
40

Operating income (expense)
 
(36
)
 
1,781

 
493

 
—

 
2,238

Interest and other debt expense (income), net
 
355

 
(25
)
 
54

 
—

 
384

Net periodic benefit (income) cost, excluding service cost
 
1

 
—

 
(2
)
 
—

 
(1
)
Earnings from equity investments
 
(86
)
 
—

 
—

 
—

 
(86
)
Loss on Cronos-related financial instruments
 
—

 
—

 
425

 
—

 
425

Earnings (losses) before income taxes and equity earnings of subsidiaries
 
(306
)
 
1,806

 
16

 
—

 
1,516

Provision (benefit) for income taxes
 
(75
)
 
459

 
11

 
—

 
395

Equity earnings of subsidiaries
 
1,351

 
95

 
—

 
(1,446
)
 
—

Net earnings
 
1,120

 
1,442

 
5

 
(1,446
)
 
1,121

Net (earnings) losses attributable to noncontrolling interests
 
—

 
—

 
(1
)
 
—

 
(1
)
Net earnings attributable to Altria
 
$
1,120

 
$
1,442

 
$
4

 
$
(1,446
)
 
$
1,120

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net earnings
 
$
1,120

 
$
1,442

 
$
5

 
$
(1,446
)
 
$
1,121

Other comprehensive earnings (losses), net of deferred income taxes
 
(170
)
 
5

 
23

 
(28
)
 
(170
)
Comprehensive earnings
 
950

 
1,447

 
28

 
(1,474
)
 
951

Comprehensive (earnings) losses attributable to noncontrolling interests
 
—

 
—

 
(1
)
 
—

 
(1
)
Comprehensive earnings attributable to Altria
 
$
950

 
$
1,447

 
$
27

 
$
(1,474
)
 
$
950


Condensed Consolidating Statements of Cash Flows
For the Three Months Ended March 31, 2020
(in millions of dollars)

 
 
Altria Group, Inc.

 
PM USA

 
Non-
Guarantor
Subsidiaries

 
Total
Consolidating
Adjustments

 
Consolidated

Cash Provided by (Used In) Operating Activities
 
 
 
 
 
 
 
 
 
 
Net cash provided by (used in) operating activities
 
$
1,515

 
$
3,351

 
$
437

 
$
(2,174
)
 
$
3,129

Cash Provided by (Used in) Investing Activities
 
 
 
 
 
 
 
 
 
 
Capital expenditures
 
—

 
(15
)
 
(37
)
 
—

 
(52
)
Investment in consolidated subsidiaries
 
(1
)
 
—

 
—

 
1

 
—

Other, net
 
—

 
—

 
—

 
—

 
—

Net cash provided by (used in) investing activities
 
(1
)
 
(15
)
 
(37
)
 
1

 
(52
)
Cash Provided by (Used in) Financing Activities
 
 
 
 
 
 
 
 
 
 
Proceeds from short-term borrowings
 
3,000

 
—

 
—

 
—

 
3,000

Long-term debt repaid
 
(1,000
)
 
—

 
—

 
—

 
(1,000
)
Dividends paid on common stock
 
(1,563
)
 
—

 
—

 
—

 
(1,563
)
Changes in amounts due to/from Altria Group, Inc.
and subsidiaries
 
1,584

 
(1,582
)
 
(1
)
 
(1
)
 
—

Cash dividends paid to parent
 
—

 
(1,748
)
 
(426
)
 
2,174

 
—

Other, net
 
(9
)
 
—

 
(1
)
 
—

 
(10
)
Net cash provided by (used in) financing activities
 
2,012

 
(3,330
)
 
(428
)
 
2,173

 
427

Cash, cash equivalents and restricted cash (1):
 
 
 
 
 
 
 
 
 
 
Increase (decrease)
 
3,526

 
6

 
(28
)
 
—

 
3,504

Balance at beginning of period
 
2,022

 
43

 
95

 
—

 
2,160

Balance at end of period
 
$
5,548

 
$
49

 
$
67

 
$
—

 
$
5,664

(1)
Restricted cash consisted of cash deposits collateralizing appeal bonds posted by PM USA to obtain stays of judgments pending appeals. See Note 11. Contingencies.
Condensed Consolidating Statements of Cash Flows
For the Three Months Ended March 31, 2019
(in millions of dollars)

 
 
Altria Group, Inc.

 
PM USA

 
Non-
Guarantor
Subsidiaries

 
Total
Consolidating
Adjustments

 
Consolidated

Cash Provided by (Used In) Operating Activities
 
 
 
 
 
 
 
 
 
 
Net cash provided by (used in) operating activities
 
$
1,642

 
$
2,520

 
$
166

 
$
(2,039
)
 
$
2,289

Cash Provided by (Used in) Investing Activities
 
 
 
 
 
 
 
 
 
 
Capital expenditures
 
—

 
(9
)
 
(29
)
 
—

 
(38
)
Investment in Cronos
 
—

 
—

 
(1,831
)
 
—

 
(1,831
)
Investment in consolidated subsidiaries
 
(1,947
)
 
—

 
—

 
1,947

 
—

Other, net
 
(3
)
 
—

 
(78
)
 
—

 
(81
)
Net cash provided by (used in) investing activities
 
(1,950
)
 
(9
)
 
(1,938
)
 
1,947

 
(1,950
)
Cash Provided by (Used in) Financing Activities
 
 
 
 
 
 
 
 
 
 
Repayment of short-term borrowings
 
(12,800
)
 
—

 
—

 
—

 
(12,800
)
Long-term debt issued
 
16,265

 
—

 
—

 
—

 
16,265

Repurchases of common stock
 
(151
)
 
—

 
—

 
—

 
(151
)
Dividends paid on common stock
 
(1,502
)
 
—

 
—

 
—

 
(1,502
)
Changes in amounts due to/from Altria Group, Inc.
and subsidiaries
 
657

 
(771
)
 
2,061

 
(1,947
)
 
—

Cash dividends paid to parent
 
—

 
(1,737
)
 
(302
)
 
2,039

 
—

Other
 
(120
)
 
—

 
(9
)
 
—

 
(129
)
Net cash provided by (used in) financing activities
 
2,349

 
(2,508
)
 
1,750

 
92

 
1,683

Cash, cash equivalents and restricted cash (1):
 
 
 
 
 
 
 
 
 
 
Increase (decrease)
 
2,041

 
3

 
(22
)
 
—

 
2,022

Balance at beginning of period
 
1,277

 
100

 
56

 
—

 
1,433

Balance at end of period
 
$
3,318

 
$
103

 
$
34

 
$
—

 
$
3,455

(1) Restricted cash consisted of cash deposits collateralizing appeal bonds posted by PM USA to obtain stays of judgments pending appeals. See Note 11. Contingencies.
XML 19 R41.htm IDEA: XBRL DOCUMENT v3.20.1
Investments in Equity Securities (Earnings in Equity Securities) (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Schedule of Equity Method Investments [Line Items]    
Earnings from equity investments $ 157 $ 86
ABI [Member]    
Schedule of Equity Method Investments [Line Items]    
Earnings from equity investments 134 86
Cronos Group Inc. [Member]    
Schedule of Equity Method Investments [Line Items]    
Earnings from equity investments $ 23 $ 0
XML 20 R45.htm IDEA: XBRL DOCUMENT v3.20.1
Financial Instruments (Narrative) (Details)
$ in Billions
 3 Months Ended
Mar. 31, 2019
USD ($)
Mar. 31, 2019
CAD ($)
Mar. 07, 2019
CAD ($)
Mar. 31, 2020
USD ($)
Mar. 31, 2019
USD ($)
Dec. 31, 2019
USD ($)
Mar. 07, 2019
USD ($)
Mar. 07, 2019
CAD ($)
Derivative [Line Items]                
Short-term borrowings       $ 3,000,000,000.0   $ 0    
Derivative, gain (loss) on derivative, net       (137,000,000) $ (425,000,000)      
Not Designated as Hedging Instrument [Member] | Forward Contracts [Member]                
Derivative [Line Items]                
Derivative asset, notional amount             $ 1,800,000,000 $ 2.4
Derivative, gain (loss) on derivative, net         $ 31,000,000      
Cronos Group Inc. [Member]                
Derivative [Line Items]                
Equity method investments, purchase price $ 1,800,000,000 $ 2.4 $ 2.4          
Foreign Currency Denominated Debt [Member]                
Derivative [Line Items]                
Debt instrument, fair value disclosure       4,595,000,000   5,057,000,000    
Long-term debt       4,666,000,000   4,741,000,000    
Net Investment Hedging [Member] | Foreign currency contracts [Member]                
Derivative [Line Items]                
Derivative, notional amount       2,246,000,000   2,246,000,000    
Reported Value Measurement [Member]                
Derivative [Line Items]                
Long-term debt, fair value       27,000,000,000.0   28,000,000,000.0    
Fair Value, Inputs, Level 2 [Member] | Estimate of Fair Value Measurement [Member]                
Derivative [Line Items]                
Long-term debt, fair value       $ 28,300,000,000   $ 30,700,000,000    
XML 21 R49.htm IDEA: XBRL DOCUMENT v3.20.1
Financial Instruments (Pre-tax Unrealized Gains (Losses)) (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Derivative [Line Items]    
Unrealized gain (loss) on derivatives $ (137) $ (394)
Fixed-price Preemptive Rights [Member]    
Derivative [Line Items]    
Unrealized gain (loss) on derivatives (35) (132)
Cronos Warrant [Member]    
Derivative [Line Items]    
Unrealized gain (loss) on derivatives $ (102) $ (262)
XML 22 R66.htm IDEA: XBRL DOCUMENT v3.20.1
Contingencies (Florida Bond Statute) (Details)
$ in Millions
Jun. 30, 2009
USD ($)
Florida [Member] | Engle Progeny Cases, State [Member]  
Loss Contingencies [Line Items]  
Maximum bond for all defendants $ 200
XML 23 R62.htm IDEA: XBRL DOCUMENT v3.20.1
Contingencies (Judgments Paid and Provisions for Tobacco and Health Litigation) (Details)
$ in Millions
 3 Months Ended 186 Months Ended
Mar. 31, 2020
USD ($)
case
Mar. 31, 2019
USD ($)
Mar. 31, 2020
USD ($)
case
Loss Contingency Accrual [Roll Forward]      
Accrued liability for tobacco and health litigation items at beginning of period $ 14 $ 112  
Payments (28) (109)  
Accrued liability for tobacco and health litigation items at end of period 10 20 $ 10
Pre-Trial Resolution [Member]      
Loss Contingency Accrual [Roll Forward]      
Payments (7)    
Accrued liability for tobacco and health litigation items at end of period 2   2
Interest Expense Related to Litigation [Member]      
Loss Contingency Accrual [Roll Forward]      
Provision related to litigation recorded 2 2  
Tobacco and Health Judgment [Member]      
Loss Contingencies [Line Items]      
Judgments paid (approximately)     748
Litigation settlement interest expense (income)     $ 216
Tobacco and Health Judgment [Member] | Pre-Trial Resolution [Member]      
Loss Contingency Accrual [Roll Forward]      
Provision related to litigation recorded $ 7    
Loss contingency, number of pre-trial resolution cases | case 100   100
Tobacco and Health Judgment [Member] | Litigation Cases Results [Member]      
Loss Contingency Accrual [Roll Forward]      
Provision related to litigation recorded $ 22 $ 15  
Engle Progeny Cases [Member]      
Loss Contingencies [Line Items]      
Judgments paid (approximately)     $ 327
Litigation settlement interest expense (income)     54
Assets [Member] | Pending Litigation [Member] | PM USA [Member]      
Loss Contingency Accrual [Roll Forward]      
Security posted for appeal of judgments $ 48   $ 48
XML 24 R58.htm IDEA: XBRL DOCUMENT v3.20.1
Debt (Narrative) (Details)
 3 Months Ended
Mar. 31, 2020
USD ($)
Mar. 31, 2019
USD ($)
Dec. 31, 2019
USD ($)
Aug. 01, 2018
Extension
Debt Instrument [Line Items]        
Short-term borrowings $ 3,000,000,000.0   $ 0  
Face amount     0  
Debt instrument, covenant, consolidated EBITDA to interest expense ratio, minimum 4.0      
Debt instrument, consolidated EBITDA to interest expense ratio 9.0      
Interest payable, short-term borrowings $ 1,000,000      
Long-term debt repaid 1,000,000,000 $ 0    
Accrued interest on long-term debt 270,000,000   $ 470,000,000  
Senior Notes [Member]        
Debt Instrument [Line Items]        
Long-term debt repaid $ 1,000,000,000      
Revolving Credit Facility [Member] | Line of Credit [Member] | Revolving Credit Facility Due August 2023 [Member]        
Debt Instrument [Line Items]        
Debt instrument, number of extensions | Extension       2
Debt instrument, expected repayment period 1 year      
Debt instrument, extension term 1 year      
Debt instrument, interest rate during period 2.23%      
Line of Credit [Member] | Revolving Credit Facility [Member] | Revolving Credit Facility Due August 2023 [Member]        
Debt Instrument [Line Items]        
Face amount $ 3,000,000,000.0      
Debt instrument, term 5 years      
London Interbank Offered Rate (LIBOR) [Member] | Revolving Credit Facility [Member] | Line of Credit [Member] | Revolving Credit Facility Due August 2023 [Member]        
Debt Instrument [Line Items]        
Debt instrument, basis spread on variable rate 1.00%      
XML 25 R9.htm IDEA: XBRL DOCUMENT v3.20.1
Background and Basis of Presentation
 3 Months Ended
Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Background and Basis of Presentation Background and Basis of Presentation:

Background

When used in these notes, the term "Altria” refers to Altria Group, Inc. and its subsidiaries, unless otherwise specified or unless otherwise required.

At March 31, 2020, Altria Group, Inc.’s wholly-owned subsidiaries included Philip Morris USA Inc. (“PM USA”), which is engaged in the manufacture and sale of cigarettes in the United States; John Middleton Co. (“Middleton”), which is engaged in the manufacture and sale of machine-made large cigars and pipe tobacco and is a wholly-owned subsidiary of PM USA; Sherman Group Holdings, LLC and its subsidiaries (“Nat Sherman”), which are engaged in the manufacture and sale of super premium cigarettes and the sale of premium cigars; UST LLC (“UST”), which through its wholly-owned subsidiaries, including U.S. Smokeless Tobacco Company LLC (“USSTC”) and Ste. Michelle Wine Estates Ltd. (“Ste. Michelle”), is engaged in the manufacture and sale of moist smokeless tobacco (“MST”) and snus products and wine; and Philip Morris Capital Corporation (“PMCC”), which maintains a portfolio of finance assets, substantially all of which are leveraged leases. In addition, Altria owned an 80% interest in Helix Innovations LLC (“Helix”), which is engaged in the manufacture and sale of oral nicotine pouches. Other Altria wholly-owned subsidiaries included Altria Group Distribution Company, which provides sales and distribution services to certain Altria operating subsidiaries, and Altria Client Services LLC, which provides various support services in areas such as legal, regulatory, consumer engagement, finance, human resources and external affairs to Altria and its subsidiaries. Altria’s access to the operating cash flows of its wholly-owned subsidiaries consists of cash received from the payment of dividends and distributions, and the payment of interest on intercompany loans by its subsidiaries. At March 31, 2020, Altria’s significant wholly-owned subsidiaries were not limited by long-term debt or other agreements in their ability to pay cash dividends or make other distributions with respect to their equity interests.

At March 31, 2020, Altria had a 10.1% ownership in Anheuser-Busch InBev SA/NV (“ABI”), which Altria accounts for under the equity method of accounting using a one-quarter lag. Altria receives cash dividends on its interest in ABI and will continue to do so as long as ABI pays dividends.

At March 31, 2020, Altria had a 35% economic interest in JUUL Labs, Inc. (“JUUL”), which Altria accounts for as an investment in an equity security. JUUL is engaged in the manufacture and sale of e-vapor products globally and is the U.S. leader in e-vapor.

During the third quarter of 2019, Helix acquired Burger Söhne Holding and its subsidiaries as well as certain affiliated companies (the “Burger Group”) that are engaged in the manufacture and sale of on! oral nicotine pouches. At closing, Altria indirectly owned an 80% interest in Helix, for which Altria paid $353 million in third quarter of 2019. The financial results of Helix are included in Altria’s condensed consolidated financial statements as part of its oral tobacco products segment (formerly smokeless products segment), with the 20% minority ownership interest in Helix (held by the former shareholders of the Burger Group) included as a noncontrolling interest. The final purchase price allocation, which is subject to post-closing adjustments, will be completed by the third quarter of 2020.

In March 2019, Altria completed its acquisition of a 45% ownership in Cronos Group Inc. (“Cronos”), a global cannabinoid company headquartered in Toronto, Canada. At March 31, 2020, Altria had a 45% ownership in Cronos, which Altria accounts for under the equity method of accounting using a one-quarter lag.

For further discussion of Altria’s investments in equity securities, see Note 4. Investments in Equity Securities.

Share Repurchases

In January 2018, Altria’s Board of Directors (the “Board of Directors”) authorized a new $1.0 billion share repurchase program that it expanded to $2.0 billion in May 2018 (as expanded, the “January 2018 share repurchase program”). In June 2019, Altria completed the January 2018 share repurchase program, under which it purchased a total of 34.0 million shares of its common stock at an average price of $58.86 per share.

In July 2019, the Board of Directors authorized a new $1.0 billion share repurchase program (the “July 2019 share repurchase program”). During the first quarter of 2020, there were no share repurchases made under the July 2019 share repurchase program. In April 2020, the Board of Directors rescinded the $500 million remaining in the July 2019 share repurchase program to strengthen Altria’s liquidity position amidst the COVID-19 pandemic.

Altria’s share repurchase activity for the three months ended March 31, 2019 was as follows:
(in millions, except per share data)
 
2019
Total number of shares repurchased
 
2.7

Aggregate cost of shares repurchased
 
$
151

Average price per share of shares repurchased
 
$
56.34



Basis of Presentation

The interim condensed consolidated financial statements of Altria are unaudited. It is the opinion of Altria’s management that all adjustments necessary for a fair statement of the interim results presented have been reflected in the interim condensed consolidated financial statements. All such adjustments were of a normal recurring nature. Net revenues and net earnings for any interim period are not necessarily indicative of results that may be expected for the entire year.

In the first quarter of 2020, Altria renamed its smokeless products segment as the oral tobacco products segment.

These statements should be read in conjunction with the audited consolidated financial statements and related notes, which appear in Altria’s Annual Report on Form 10-K for the year ended December 31, 2019.

On January 1, 2020, Altria adopted Accounting Standards Update (“ASU”) No. 2016-13, Measurement of Credit Losses on Financial Instruments and all related ASU amendments (collectively “ASU No. 2016-13”). This guidance replaces the current incurred loss impairment methodology for recognizing credit losses for financial assets with a methodology that reflects the entity’s current estimate of all expected credit losses and requires consideration of a broader range of reasonable and supportable information for estimating credit losses. The adoption of ASU No. 2016-13 did not have a material impact on Altria’s condensed consolidated financial statements.

Additionally, on January 1, 2020, Altria adopted ASU No. 2018-15, Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (“ASU No. 2018-15”). This guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The adoption of ASU No. 2018-15 did not have a material impact on Altria’s condensed consolidated financial statements.

For a description of issued accounting guidance applicable to, but not yet adopted by, Altria, see Note 13. New Accounting Guidance Not Yet Adopted.

Certain immaterial prior year amounts have been reclassified to conform with the current year’s presentation.
XML 26 R54.htm IDEA: XBRL DOCUMENT v3.20.1
Other Comprehensive Earnings/Losses (Changes in Each Component of Accumulated Other Comprehensive Losses) (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Accumulated Other Comprehensive Income [Roll Forward]    
Beginning balance $ 6,319 $ 14,789
Other comprehensive earnings (losses), net of deferred income taxes 331 (170)
Ending balance 6,637 14,081
Accumulated Other Comprehensive Losses [Member]    
Accumulated Other Comprehensive Income [Roll Forward]    
Beginning balance (2,864) (2,547)
Other comprehensive earnings (losses) before reclassifications 400 (238)
Deferred income taxes (85) 49
Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes 315 (189)
Amounts reclassified to net earnings 21 27
Deferred income taxes (5) (8)
Amounts reclassified to net earnings, net of deferred income taxes 16 19
Other comprehensive earnings (losses), net of deferred income taxes 331 (170)
Ending balance (2,533) (2,717)
Benefit Plans [Member]    
Accumulated Other Comprehensive Income [Roll Forward]    
Beginning balance (2,192) (2,168)
Other comprehensive earnings (losses) before reclassifications 0 0
Deferred income taxes 0 0
Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes 0 0
Amounts reclassified to net earnings 28 39
Deferred income taxes (7) (10)
Amounts reclassified to net earnings, net of deferred income taxes 21 29
Other comprehensive earnings (losses), net of deferred income taxes 21 29
Ending balance (2,171) (2,139)
ABI [Member]    
Accumulated Other Comprehensive Income [Roll Forward]    
Beginning balance (693) (374)
Other comprehensive earnings (losses) before reclassifications 388 (238)
Deferred income taxes (85) 49
Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes 303 (189)
Amounts reclassified to net earnings (7) (12)
Deferred income taxes 2 2
Amounts reclassified to net earnings, net of deferred income taxes (5) (10)
Other comprehensive earnings (losses), net of deferred income taxes 298 (199)
Ending balance (395) (573)
Currency Translation Adjustments and Other [Member]    
Accumulated Other Comprehensive Income [Roll Forward]    
Beginning balance 21 (5)
Other comprehensive earnings (losses) before reclassifications 12 0
Deferred income taxes 0 0
Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes 12 0
Amounts reclassified to net earnings 0 0
Deferred income taxes 0 0
Amounts reclassified to net earnings, net of deferred income taxes 0 0
Other comprehensive earnings (losses), net of deferred income taxes 12 0
Ending balance $ 33 $ (5)
XML 27 R1.htm IDEA: XBRL DOCUMENT v3.20.1
Cover Page - shares
 3 Months Ended
Mar. 31, 2020
Apr. 21, 2020
Entity Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2020  
Document Transition Report false  
Entity File Number 1-08940  
Entity Registrant Name Altria Group, Inc.  
Entity Incorporation, State or Country Code VA  
Entity Tax Identification Number 13-3260245  
Entity Address, Address Line One 6601 West Broad Street,  
Entity Address, City or Town Richmond,  
Entity Address, State or Province VA  
Entity Address, Postal Zip Code 23230  
City Area Code 804  
Local Phone Number 274-2200  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding (in shares)   1,858,368,058
Amendment Flag false  
Document Fiscal Year Focus 2020  
Document Fiscal Period Focus Q1  
Entity Central Index Key 0000764180  
Current Fiscal Year End Date --12-31  
Common Stock, $0.33 1/3 par value [Member]    
Entity Information [Line Items]    
Title of 12(b) Security Common Stock, $0.33 1/3 par value  
Trading Symbol MO  
Security Exchange Name NYSE  
1.000% Notes due 2023 [Member]    
Entity Information [Line Items]    
Title of 12(b) Security 1.000% Notes due 2023  
Trading Symbol MO23A  
Security Exchange Name NYSE  
1.700% Notes due 2025 [Member]    
Entity Information [Line Items]    
Title of 12(b) Security 1.700% Notes due 2025  
Trading Symbol MO25  
Security Exchange Name NYSE  
2.200% Notes due 2027 [Member]    
Entity Information [Line Items]    
Title of 12(b) Security 2.200% Notes due 2027  
Trading Symbol MO27  
Security Exchange Name NYSE  
3.125% Notes due 2031 [Member]    
Entity Information [Line Items]    
Title of 12(b) Security 3.125% Notes due 2031  
Trading Symbol MO31  
Security Exchange Name NYSE  
XML 28 R5.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Comprehensive Earnings - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Statement of Comprehensive Income [Abstract]    
Net earnings $ 1,550 $ 1,121
Other comprehensive earnings (losses), net of deferred income taxes:    
Benefit plans 21 29
ABI 298 (199)
Currency translation adjustments and other 12 0
Other comprehensive earnings (losses), net of deferred income taxes 331 (170)
Comprehensive earnings 1,881 951
Comprehensive (earnings) losses attributable to noncontrolling interests 2 (1)
Comprehensive earnings attributable to Altria $ 1,883 $ 950
XML 29 R50.htm IDEA: XBRL DOCUMENT v3.20.1
Financial Instruments (Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses) (Details) - Net Investment Hedging [Member] - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (Loss) Recognized in Accumulated Other Comprehensive Losses $ 133 $ 56
Gain (Loss) Recognized in Net Earnings 14 9
Foreign currency contracts [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (Loss) Recognized in Accumulated Other Comprehensive Losses 56 23
Gain (Loss) Recognized in Net Earnings 14 9
Foreign currency denominated debt [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (Loss) Recognized in Accumulated Other Comprehensive Losses 77 33
Gain (Loss) Recognized in Net Earnings $ 0 $ 0
XML 30 R73.htm IDEA: XBRL DOCUMENT v3.20.1
Contingencies (Lights/Ultra Lights Cases) (Details) - Subsequent Event [Member]
Apr. 27, 2020
case
court
Lights Ultra Lights Class Actions [Member]  
Loss Contingencies [Line Items]  
Number of cases pending | case 2
Lights [Member]  
Loss Contingencies [Line Items]  
Claims not certified, number | case 23
Number of cases pending | court 2
Lights [Member] | PM USA [Member]  
Loss Contingencies [Line Items]  
Number of state courts | court 21
XML 31 R77.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidating Financial Information (Condensed Consolidating Balance Sheets) (Details) - USD ($)
Mar. 31, 2020
Dec. 31, 2019
Mar. 31, 2019
Dec. 31, 2018
Assets        
Cash and cash equivalents $ 5,616,000,000 $ 2,117,000,000    
Receivables 147,000,000 152,000,000    
Inventories:        
Leaf tobacco 895,000,000 874,000,000    
Other raw materials 193,000,000 192,000,000    
Work in process 467,000,000 696,000,000    
Finished product 451,000,000 531,000,000    
Inventory, net 2,006,000,000 2,293,000,000    
Due from Altria Group, Inc. and subsidiaries 0 0    
Other current assets 166,000,000 262,000,000    
Total current assets 7,935,000,000 4,824,000,000    
Property, plant and equipment, at cost 5,103,000,000 5,074,000,000    
Less accumulated depreciation 3,106,000,000 3,075,000,000    
Property, plant and equipment, net 1,997,000,000 1,999,000,000    
Goodwill 5,177,000,000 5,177,000,000    
Other intangible assets, net 12,668,000,000 12,687,000,000    
Investments in equity securities 23,861,000,000 23,581,000,000    
Investment in consolidated subsidiaries 0 0    
Due from Altria Group, Inc. and subsidiaries 0 0    
Other assets 980,000,000 1,003,000,000    
Total Assets 52,618,000,000 49,271,000,000    
Liabilities        
Short-term borrowings 3,000,000,000.0 0    
Current portion of long-term debt 0 1,000,000,000    
Accounts payable 278,000,000 325,000,000    
Accrued liabilities:        
Marketing 467,000,000 393,000,000    
Settlement charges 4,419,000,000 3,346,000,000    
Other 1,032,000,000 1,533,000,000    
Income taxes 393,000,000 12,000,000    
Dividends payable 1,565,000,000 1,565,000,000    
Due to Altria Group, Inc. and subsidiaries 0 0    
Total current liabilities 11,154,000,000 8,174,000,000    
Long-term debt 26,971,000,000 27,042,000,000    
Deferred income taxes 5,191,000,000 5,083,000,000    
Accrued pension costs 427,000,000 473,000,000    
Accrued postretirement health care costs 1,798,000,000 1,797,000,000    
Due to Altria Group, Inc. and subsidiaries 0 0    
Other liabilities 402,000,000 345,000,000    
Total liabilities 45,943,000,000 42,914,000,000    
Contingencies    
Redeemable noncontrolling interest 38,000,000 38,000,000    
Stockholders’ Equity        
Common stock 935,000,000 935,000,000    
Additional paid-in capital 5,959,000,000 5,970,000,000    
Earnings reinvested in the business 36,528,000,000 36,539,000,000    
Accumulated other comprehensive losses (2,533,000,000) (2,864,000,000)    
Cost of repurchased stock (34,346,000,000) (34,358,000,000)    
Total stockholders’ equity attributable to Altria 6,543,000,000 6,222,000,000    
Noncontrolling interests 94,000,000 97,000,000    
Total stockholders’ equity 6,637,000,000 6,319,000,000 $ 14,081,000,000 $ 14,789,000,000
Total Liabilities and Stockholders’ Equity 52,618,000,000 49,271,000,000    
Reportable Legal Entities [Member] | Altria Group, Inc. [Member]        
Assets        
Cash and cash equivalents 5,548,000,000 2,022,000,000    
Receivables 0 0    
Inventories:        
Leaf tobacco 0 0    
Other raw materials 0 0    
Work in process 0 0    
Finished product 0 0    
Inventory, net 0 0    
Due from Altria Group, Inc. and subsidiaries 91,000,000 88,000,000    
Other current assets 301,000,000 133,000,000    
Total current assets 5,940,000,000 2,243,000,000    
Property, plant and equipment, at cost 0 0    
Less accumulated depreciation 0 0    
Property, plant and equipment, net 0 0    
Goodwill 0 0    
Other intangible assets, net 0 0    
Investments in equity securities 18,453,000,000 18,071,000,000    
Investment in consolidated subsidiaries 18,905,000,000 19,312,000,000    
Due from Altria Group, Inc. and subsidiaries 4,790,000,000 4,790,000,000    
Other assets 71,000,000 58,000,000    
Total Assets 48,159,000,000 44,474,000,000    
Liabilities        
Short-term borrowings 3,000,000,000      
Current portion of long-term debt   1,000,000,000    
Accounts payable 1,000,000 0    
Accrued liabilities:        
Marketing 0 0    
Settlement charges 0 0    
Other 312,000,000 570,000,000    
Income taxes 6,000,000 6,000,000    
Dividends payable 1,565,000,000 1,565,000,000    
Due to Altria Group, Inc. and subsidiaries 6,278,000,000 4,693,000,000    
Total current liabilities 11,162,000,000 7,834,000,000    
Long-term debt 26,971,000,000 27,042,000,000    
Deferred income taxes 3,228,000,000 3,099,000,000    
Accrued pension costs 196,000,000 197,000,000    
Accrued postretirement health care costs 0 0    
Due to Altria Group, Inc. and subsidiaries 0 0    
Other liabilities 59,000,000 80,000,000    
Total liabilities 41,616,000,000 38,252,000,000    
Contingencies    
Redeemable noncontrolling interest 0 0    
Stockholders’ Equity        
Common stock 935,000,000 935,000,000    
Additional paid-in capital 5,959,000,000 5,970,000,000    
Earnings reinvested in the business 36,528,000,000 36,539,000,000    
Accumulated other comprehensive losses (2,533,000,000) (2,864,000,000)    
Cost of repurchased stock (34,346,000,000) (34,358,000,000)    
Total stockholders’ equity attributable to Altria 6,543,000,000 6,222,000,000    
Noncontrolling interests 0 0    
Total stockholders’ equity 6,543,000,000 6,222,000,000    
Total Liabilities and Stockholders’ Equity 48,159,000,000 44,474,000,000    
Reportable Legal Entities [Member] | PM USA [Member]        
Assets        
Cash and cash equivalents 1,000,000 0    
Receivables 17,000,000 30,000,000    
Inventories:        
Leaf tobacco 508,000,000 494,000,000    
Other raw materials 123,000,000 120,000,000    
Work in process 6,000,000 4,000,000    
Finished product 87,000,000 119,000,000    
Inventory, net 724,000,000 737,000,000    
Due from Altria Group, Inc. and subsidiaries 5,660,000,000 4,005,000,000    
Other current assets 23,000,000 64,000,000    
Total current assets 6,425,000,000 4,836,000,000    
Property, plant and equipment, at cost 2,970,000,000 2,956,000,000    
Less accumulated depreciation 2,186,000,000 2,166,000,000    
Property, plant and equipment, net 784,000,000 790,000,000    
Goodwill 0 0    
Other intangible assets, net 2,000,000 2,000,000    
Investments in equity securities 0 0    
Investment in consolidated subsidiaries 2,867,000,000 2,831,000,000    
Due from Altria Group, Inc. and subsidiaries 0 0    
Other assets 950,000,000 951,000,000    
Total Assets 11,028,000,000 9,410,000,000    
Liabilities        
Short-term borrowings 0      
Current portion of long-term debt   0    
Accounts payable 136,000,000 146,000,000    
Accrued liabilities:        
Marketing 391,000,000 320,000,000    
Settlement charges 4,410,000,000 3,340,000,000    
Other 343,000,000 482,000,000    
Income taxes 508,000,000 0    
Dividends payable 0 0    
Due to Altria Group, Inc. and subsidiaries 587,000,000 514,000,000    
Total current liabilities 6,375,000,000 4,802,000,000    
Long-term debt 0 0    
Deferred income taxes 0 0    
Accrued pension costs 0 0    
Accrued postretirement health care costs 1,076,000,000 1,078,000,000    
Due to Altria Group, Inc. and subsidiaries 0 0    
Other liabilities 90,000,000 87,000,000    
Total liabilities 7,541,000,000 5,967,000,000    
Contingencies    
Redeemable noncontrolling interest 0 0    
Stockholders’ Equity        
Common stock 0 0    
Additional paid-in capital 3,310,000,000 3,310,000,000    
Earnings reinvested in the business 393,000,000 352,000,000    
Accumulated other comprehensive losses (216,000,000) (219,000,000)    
Cost of repurchased stock 0 0    
Total stockholders’ equity attributable to Altria 3,487,000,000 3,443,000,000    
Noncontrolling interests 0 0    
Total stockholders’ equity 3,487,000,000 3,443,000,000    
Total Liabilities and Stockholders’ Equity 11,028,000,000 9,410,000,000    
Reportable Legal Entities [Member] | Non-Guarantor Subsidiaries [Member]        
Assets        
Cash and cash equivalents 67,000,000 95,000,000    
Receivables 130,000,000 122,000,000    
Inventories:        
Leaf tobacco 387,000,000 380,000,000    
Other raw materials 70,000,000 72,000,000    
Work in process 461,000,000 692,000,000    
Finished product 364,000,000 412,000,000    
Inventory, net 1,282,000,000 1,556,000,000    
Due from Altria Group, Inc. and subsidiaries 1,361,000,000 1,359,000,000    
Other current assets 68,000,000 114,000,000    
Total current assets 2,908,000,000 3,246,000,000    
Property, plant and equipment, at cost 2,133,000,000 2,118,000,000    
Less accumulated depreciation 920,000,000 909,000,000    
Property, plant and equipment, net 1,213,000,000 1,209,000,000    
Goodwill 5,177,000,000 5,177,000,000    
Other intangible assets, net 12,666,000,000 12,685,000,000    
Investments in equity securities 5,408,000,000 5,510,000,000    
Investment in consolidated subsidiaries 0 0    
Due from Altria Group, Inc. and subsidiaries 0 0    
Other assets 567,000,000 603,000,000    
Total Assets 27,939,000,000 28,430,000,000    
Liabilities        
Short-term borrowings 0      
Current portion of long-term debt   0    
Accounts payable 141,000,000 179,000,000    
Accrued liabilities:        
Marketing 76,000,000 73,000,000    
Settlement charges 9,000,000 6,000,000    
Other 377,000,000 481,000,000    
Income taxes 105,000,000 55,000,000    
Dividends payable 0 0    
Due to Altria Group, Inc. and subsidiaries 247,000,000 245,000,000    
Total current liabilities 955,000,000 1,039,000,000    
Long-term debt 0 0    
Deferred income taxes 2,571,000,000 2,593,000,000    
Accrued pension costs 231,000,000 276,000,000    
Accrued postretirement health care costs 722,000,000 719,000,000    
Due to Altria Group, Inc. and subsidiaries 4,790,000,000 4,790,000,000    
Other liabilities 253,000,000 178,000,000    
Total liabilities 9,522,000,000 9,595,000,000    
Contingencies    
Redeemable noncontrolling interest 38,000,000 38,000,000    
Stockholders’ Equity        
Common stock 9,000,000 9,000,000    
Additional paid-in capital 27,566,000,000 27,565,000,000    
Earnings reinvested in the business (7,441,000,000) (6,997,000,000)    
Accumulated other comprehensive losses (1,849,000,000) (1,877,000,000)    
Cost of repurchased stock 0 0    
Total stockholders’ equity attributable to Altria 18,285,000,000 18,700,000,000    
Noncontrolling interests 94,000,000 97,000,000    
Total stockholders’ equity 18,379,000,000 18,797,000,000    
Total Liabilities and Stockholders’ Equity 27,939,000,000 28,430,000,000    
Total Consolidating Adjustments [Member]        
Assets        
Cash and cash equivalents 0 0    
Receivables 0 0    
Inventories:        
Leaf tobacco 0 0    
Other raw materials 0 0    
Work in process 0 0    
Finished product 0 0    
Inventory, net 0 0    
Due from Altria Group, Inc. and subsidiaries (7,112,000,000) (5,452,000,000)    
Other current assets (226,000,000) (49,000,000)    
Total current assets (7,338,000,000) (5,501,000,000)    
Property, plant and equipment, at cost 0 0    
Less accumulated depreciation 0 0    
Property, plant and equipment, net 0 0    
Goodwill 0 0    
Other intangible assets, net 0 0    
Investments in equity securities 0 0    
Investment in consolidated subsidiaries (21,772,000,000) (22,143,000,000)    
Due from Altria Group, Inc. and subsidiaries (4,790,000,000) (4,790,000,000)    
Other assets (608,000,000) (609,000,000)    
Total Assets (34,508,000,000) (33,043,000,000)    
Liabilities        
Short-term borrowings 0      
Current portion of long-term debt   0    
Accounts payable 0 0    
Accrued liabilities:        
Marketing 0 0    
Settlement charges 0 0    
Other 0 0    
Income taxes (226,000,000) (49,000,000)    
Dividends payable 0 0    
Due to Altria Group, Inc. and subsidiaries (7,112,000,000) (5,452,000,000)    
Total current liabilities (7,338,000,000) (5,501,000,000)    
Long-term debt 0 0    
Deferred income taxes (608,000,000) (609,000,000)    
Accrued pension costs 0 0    
Accrued postretirement health care costs 0 0    
Due to Altria Group, Inc. and subsidiaries (4,790,000,000) (4,790,000,000)    
Other liabilities 0 0    
Total liabilities (12,736,000,000) (10,900,000,000)    
Contingencies    
Redeemable noncontrolling interest 0 0    
Stockholders’ Equity        
Common stock (9,000,000) (9,000,000)    
Additional paid-in capital (30,876,000,000) (30,875,000,000)    
Earnings reinvested in the business 7,048,000,000 6,645,000,000    
Accumulated other comprehensive losses 2,065,000,000 2,096,000,000    
Cost of repurchased stock 0 0    
Total stockholders’ equity attributable to Altria (21,772,000,000) (22,143,000,000)    
Noncontrolling interests 0 0    
Total stockholders’ equity (21,772,000,000) (22,143,000,000)    
Total Liabilities and Stockholders’ Equity $ (34,508,000,000) $ (33,043,000,000)    
XML 32 R16.htm IDEA: XBRL DOCUMENT v3.20.1
Other Comprehensive Earnings/Losses
 3 Months Ended
Mar. 31, 2020
Equity [Abstract]  
Other Comprehensive Earnings/Losses Other Comprehensive Earnings/Losses:

The following tables set forth the changes in each component of accumulated other comprehensive losses, net of deferred income taxes, attributable to Altria:
 
 
For the Three Months Ended March 31, 2020
 
 
Benefit Plans
 
ABI
 
Currency
Translation
Adjustments and Other
 
Accumulated
Other
Comprehensive
Losses
 
 
(in millions)
Balances, December 31, 2019
 
$
(2,192
)
 
$
(693
)
 
$
21

 
$
(2,864
)
 
 
 
 
 
 
 
 
 
Other comprehensive earnings (losses) before reclassifications
 
—

 
388

 
12

 
400

Deferred income taxes
 
—

 
(85
)
 
—

 
(85
)
Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes
 
—

 
303

 
12

 
315

 
 
 
 
 
 
 
 
 
Amounts reclassified to net earnings
 
28

 
(7
)
 
—

 
21

Deferred income taxes
 
(7
)
 
2

 
—

 
(5
)
Amounts reclassified to net earnings, net of deferred income taxes
 
21

 
(5
)
 
—

 
16

 
 
 
 
 
 
 
 
 
Other comprehensive earnings (losses), net of deferred income taxes
 
21

 
298

(1) 
12

 
331

 
 
 
 
 
 
 
 
 
Balances, March 31, 2020
 
$
(2,171
)
 
$
(395
)
 
$
33

 
$
(2,533
)

 
 
For the Three Months Ended March 31, 2019
 
 
Benefit Plans
 
ABI
 
Currency
Translation
Adjustments and Other
 
Accumulated
Other
Comprehensive
Losses
 
 
(in millions)
Balances, December 31, 2018
 
$
(2,168
)
 
$
(374
)
 
$
(5
)
 
$
(2,547
)
 
 
 
 
 
 
 
 
 
Other comprehensive earnings (losses) before reclassifications
 
—

 
(238
)
 
—

 
(238
)
Deferred income taxes
 
—

 
49

 
—

 
49

Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes
 
—

 
(189
)
 
—

 
(189
)
 
 
 
 
 
 
 
 
 
Amounts reclassified to net earnings
 
39

 
(12
)
 
—

 
27

Deferred income taxes
 
(10
)
 
2

 
—

 
(8
)
Amounts reclassified to net earnings, net of deferred income taxes
 
29

 
(10
)
 
—

 
19

 
 
 
 
 
 
 
 
 
Other comprehensive earnings (losses), net of deferred income taxes
 
29

 
(199
)
(1) 
—

 
(170
)
 
 
 
 
 
 
 
 
 
Balances, March 31, 2019
 
$
(2,139
)
 
$
(573
)
 
$
(5
)
 
$
(2,717
)

(1) Primarily reflects Altria’s share of ABI’s currency translation adjustments and the impact of Altria’s designated net investment hedges. For further discussion of designated net investment hedges, see Note 5. Financial Instruments.
The following table sets forth pre-tax amounts by component, reclassified from accumulated other comprehensive losses to net earnings:
 
 
For the Three Months Ended March 31,
 
 
2020
 
2019
 
 
(in millions)
Benefit Plans: (1)
 
 
 
 
Net loss
 
$
34

 
$
49

Prior service cost/credit
 
(6
)
 
(10
)
 
 
28

 
39

 
 
 
 
 
ABI (2)
 
(7
)
 
(12
)
 
 
 
 
 
Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings
 
$
21

 
$
27

(1) Amounts are included in net defined benefit plan costs. For further details, see Note 6. Benefit Plans.
(2) Amounts are included in earnings from equity investments. For further information, see Note 4. Investments in Equity Securities.
XML 33 R12.htm IDEA: XBRL DOCUMENT v3.20.1
Investments in Equity Securities
 3 Months Ended
Mar. 31, 2020
Investments [Abstract]  
Investments in Equity Securities Investments in Equity Securities:

Altria’s investments consisted of the following:
 
 
Carrying Amount
 
 
March 31, 2020
 
December 31, 2019
 
 
(in millions)
ABI
 
$
18,453

 
$
18,071

JUUL
 
4,205

 
4,205

Cronos (1)
 
1,203

 
1,305

Total
 
$
23,861

 
$
23,581

(1) March 31, 2020 includes Altria’s equity method investment in Cronos ($1,037 million), the Cronos warrant ($132 million) and the Fixed-price Preemptive Rights ($34 million) and December 31, 2019 includes Altria’s equity method investment in Cronos ($1,002 million), the Cronos warrant ($234 million) and the Fixed -price Preemptive Rights ($69 million), as discussed further below.

Earnings from equity investments accounted for under the equity method of accounting consisted of the following:
 
 
For the Three Months Ended March 31,
 
 
2020
 
2019
 
 
(in millions)
ABI
 
$
134

 
$
86

Cronos (1)
 
23

 
—

Total
 
$
157

 
$
86

(1) Represents Altria’s share of Cronos’s earnings, which includes the change in fair value of Cronos’s derivative financial instruments associated with the issuance of additional shares. As a result of the acquisition of Cronos in March 2019 and Altria reporting its share of Cronos’s results using a one-quarter lag, no equity earnings from Altria’s investment in Cronos were recorded for the three months ended March 31, 2019.

Altria reviews its equity investments accounted for under the equity method of accounting (ABI and Cronos) for impairment on a quarterly basis in connection with the preparation of its financial statements by comparing the fair value of each of its investments to its respective carrying value. If the carrying value of an investment exceeds its fair value and the loss in value is other than temporary, the investment is considered impaired and reduced to fair value, and the impairment is recognized in the period identified. For further discussion, see Investment in ABI and Investment in Cronos below.

Investment in ABI

At March 31, 2020, Altria had a 10.1% ownership in ABI, consisting of 185 million restricted shares of ABI (the “Restricted Shares”) and 12 million ordinary shares of ABI. Altria accounts for its investment in ABI under the equity method of accounting because Altria has the ability to exercise significant influence over the operating and financial policies of ABI, including having active representation on ABI’s board of directors (“ABI Board”) and certain ABI Board committees. Through this representation, Altria participates in ABI policy making processes.

Altria reports its share of ABI’s results using a one-quarter lag because ABI’s results are not available in time for Altria to record them in the concurrent period.

The fair value of Altria’s equity investment in ABI is based on (i) unadjusted quoted prices in active markets for ABI’s ordinary shares and was classified in Level 1 of the fair value hierarchy and (ii) observable inputs other than Level 1 prices, such as quoted prices for similar assets for the Restricted Shares, and was classified in Level 2 of the fair value hierarchy. Altria may, in certain instances, pledge or otherwise grant a security interest in all or part of its Restricted Shares. In the event the pledgee or security interest holder forecloses on the Restricted Shares, the relevant Restricted Shares will be automatically converted, one-for-one, into ordinary shares. Therefore, the fair value of each Restricted Share is based on the value of an ordinary share.

The fair value of Altria’s equity investment in ABI at March 31, 2020 and December 31, 2019 was $8.8 billion (carrying value of $18.5 billion) and $16.1 billion (carrying value of $18.1 billion), respectively, which was less than its carrying by approximately 52% and 11%, respectively. As recently as September 30, 2019, the fair value of Altria’s equity investment in ABI exceeded its carrying value. In October 2019, the fair value of Altria’s equity investment in ABI declined below its carrying value and has not recovered. Altria has evaluated the factors related to the fair value decline, including the recent impact on the fair value of ABI’s shares amidst the COVID-19 pandemic, which has impacted the equity markets. Altria has also evaluated ABI’s financial condition and near-term prospects, and Altria’s intent and ability to hold its investment in ABI until recovery. Altria concluded at March 31, 2020 and December 31, 2019, the decline in fair value of its investment in ABI below its carrying value was temporary and, therefore, no impairment was recorded.

Consistent with the one-quarter lag for reporting ABI’s results in Altria’s financial results, in the second quarter of 2020 Altria will record its share of ABI’s first quarter 2020 net mark-to-market losses on certain ABI financial instruments associated with ABI’s share commitments, primarily related to ABI’s derivative financial instruments used to hedge exposure to approximately 100 million shares of ABI common stock. Such activity is primarily driven by the change in ABI’s share price, which decreased from €72.71 to €40.47 at December 31, 2019 and March 31, 2020, respectively.
Investment in JUUL

In December 2018, Altria made a minority investment in JUUL for $12.8 billion. In exchange for the investment, Altria received a 35% economic interest in JUUL through non-voting shares, which are convertible at Altria’s election into voting shares (“Share Conversion”), and for no additional payment, a security convertible into additional non-voting or voting shares, as applicable, upon settlement or exercise of certain JUUL convertible securities (the “JUUL Transaction”). During 2019, Altria recorded total pre-tax impairment charges of $8.6 billion related to its investment in JUUL resulting in a $4.2 billion carrying value of its investment in JUUL at December 31, 2019.

Altria received a broad preemptive right to purchase JUUL shares, exercisable each quarter upon dilution, to maintain its ownership percentage and is subject to a standstill restriction under which it may not acquire additional JUUL shares above its 35% interest. Furthermore, Altria agreed not to sell or transfer any of its JUUL shares until December 20, 2024.

On January 28, 2020, Altria and JUUL amended certain JUUL Transaction agreements and entered into a new cooperation agreement, which included the following provisions:
▪
Altria will continue to provide regulatory affairs support for JUUL’s pursuit of its pre-market tobacco applications (PMTA) and/or its modified risk tobacco products authorization (MRTP) and discontinued all other services as of March 31, 2020;
▪
Altria will have the option to be released from its non-compete obligation (i) in the event JUUL is prohibited by federal law from selling e-vapor products in the U.S. for a continuous period of at least 12 months (subject to tolling of this period in certain circumstances) or (ii) if the carrying value of Altria’s investment in JUUL is not more than 10% of its initial carrying value of $12.8 billion;
▪
Altria and JUUL agreed that for a period of one year they will not pursue any litigation against each other in connection with any conduct that occurred prior to the date of such cooperation agreement, with statutes of limitation being tolled during the one-year period;
▪
with respect to certain litigation in which Altria and JUUL are both defendants against third-party plaintiffs, Altria will not pursue any claims against JUUL for indemnification or reimbursement except for any non-contractual claims for contribution or indemnity where a judgment has been entered against Altria and JUUL; and
▪
upon Share Conversion, JUUL will:
▪
restructure JUUL’s current seven-member Board of Directors to a nine-member board that will include independent board members. The new structure will include: (i) three independent directors (one of whom will be designated by Altria and two of whom will be designated by JUUL stockholders other than Altria) unanimously certified as independent by a nominating committee, which will include at least one Altria designee, (ii) two directors designated by Altria, (iii) three directors designated by JUUL stockholders other than Altria, and (iv) the JUUL Chief Executive Officer; and
▪
create a Litigation Oversight Committee, which will include two Altria designated directors (one of whom will chair the Litigation Oversight Committee) that will have oversight authority and review of litigation management for matters in which JUUL and Altria are co-defendants and have or reasonably could have a written joint defense agreement in effect between them. Subject to certain limitations, the Litigation Oversight Committee will recommend to JUUL changes to outside counsel and litigation strategy by majority vote, with disagreements by JUUL’s management being resolved by majority vote of JUUL’s Board of Directors.

On April 1, 2020, the U.S. Federal Trade Commission (“FTC”) issued an administrative complaint challenging Altria’s investment in JUUL. The FTC has not sought to preliminarily enjoin Altria from converting its non-voting JUUL shares to voting shares. Altria has not converted its non-voting JUUL shares to voting shares and is considering whether to do so. For further discussion on the FTC litigation, see Note 11. Contingencies -  Antitrust Litigation.

At March 31, 2020 and December 31, 2019, Altria had a 35% economic interest in JUUL. Altria accounted for its investment in JUUL as an investment in an equity security as of March 31, 2020. Since the JUUL shares do not have a readily determinable fair value, Altria has elected to measure its investment in JUUL at its cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. There have been no upward or downward adjustments to the carrying value of Altria’s investment in JUUL resulting from observable price changes in orderly transactions since the JUUL Transaction through March 31, 2020.

Altria reviews its investment in JUUL for impairment by performing a qualitative assessment of impairment indicators on a quarterly basis in connection with the preparation of its financial statements. If this qualitative assessment indicates that
Altria’s investment in JUUL may be impaired, a quantitative assessment is performed. If the quantitative assessment indicates the fair value of the investment is less than its carrying value, the investment is written down to its fair value.

Altria performed its qualitative assessment of potential impairment indicators for its investment in JUUL, which included the consideration of potential impacts of COVID-19 on JUUL’s business, as part of the preparation of its financial statements for the period ended March 31, 2020. Altria’s assessment did not result in impairment at March 31, 2020. The carrying value of Altria’s investment in JUUL was $4.2 billion at March 31, 2020 and December 31, 2019.

Upon Share Conversion, Altria expects to account for its investment in JUUL under the fair value option. Under this option, Altria’s consolidated statement of earnings will include any cash dividends received from its investment in JUUL as well as any changes in the fair value of the investment, which will be calculated quarterly.
Investment in Cronos

In March 2019, Altria completed its acquisition of:
▪
149.8 million newly issued common shares of Cronos (“Acquired Common Shares”), which represented a 45% economic and voting interest and is accounted for under the equity method of accounting;
▪
anti-dilution protections to purchase Cronos common shares, exercisable each quarter upon dilution, to maintain its ownership percentage. Certain of the anti-dilution protections provide Altria the ability to purchase additional Cronos common shares at a per share exercise price of Canadian dollar (“CAD”) $16.25 upon the occurrence of specified events (“Fixed-price Preemptive Rights”). Based on Altria’s assumptions as of March 31, 2020, Altria estimates the Fixed-price Preemptive Rights allows Altria to purchase up to an additional approximately 37 million common shares of Cronos; and
▪
a warrant providing Altria the ability to purchase up to an additional 10% of common shares of Cronos (approximately 78 million common shares at March 31, 2020) at a per share exercise price of CAD $19.00, which expires on March 8, 2023.
The total purchase price for the Acquired Common Shares, Fixed-price Preemptive Rights and warrant (collectively, “Investment in Cronos”) was CAD $2.4 billion (U.S. dollar (“USD”) $1.8 billion). Upon full exercise of the Fixed-price Preemptive Rights, to the extent such rights become available, and the warrant, Altria would own a maximum of 55% of the outstanding common shares of Cronos.
In accounting for the acquisition of these assets as of the date of closing, the Fixed-price Preemptive Rights and warrant were recorded at each of their fair values using Black-Scholes option-pricing models, based on the assumptions described in Note 5. Financial Instruments. In addition, a deferred tax liability related to the Fixed-price Preemptive Rights and warrant was recorded. The residual of the purchase price was allocated to the Acquired Common Shares. Accordingly, the CAD $2.4 billion (USD $1.8 billion) purchase price was recorded in USD as follows:
▪
$1.2 billion to the warrant;
▪
$0.5 billion to the Fixed-price Preemptive Rights;
▪
$0.4 billion to the Acquired Common Shares; and
▪
$0.3 billion to a deferred tax liability.

If exercised in full, the exercise prices for the warrant and Fixed-price Preemptive Rights are approximately CAD $1.5 billion and CAD $0.6 billion (approximately USD $1.1 billion and $0.4 billion, respectively, based on the CAD to USD exchange rate on April 27, 2020).
For a discussion of derivatives related to Altria’s investment in Cronos, including Altria’s accounting for changes in the fair value of these derivatives, see Note 5. Financial Instruments.
At March 31, 2020, Altria had a 45% ownership in Cronos, which Altria accounts for under the equity method of accounting. Altria reports its share of Cronos’s results using a one-quarter lag because Cronos’s results are not available in time for Altria to record them in the concurrent period.

Altria nominated four directors, including one director who is independent from Altria, who serve on Cronos’s seven-member Board of Directors.

The fair value of Altria’s equity method investment in Cronos is based on unadjusted quoted prices in active markets for Cronos’s common shares and was classified in Level 1 of the fair value hierarchy. The fair value of Altria’s equity method investment in Cronos at March 31, 2020 and December 31, 2019 was $0.9 billion and $1.2 billion, respectively, compared with its carrying value of $1.0 billion at March 31, 2020 and December 31, 2019. At March 31, 2020, the fair value of Altria’s
equity method investment in Cronos was less than its carrying value by approximately 14%. Based on Altria’s evaluation of the duration and magnitude of the fair value decline, Altria’s evaluation of Cronos’s financial condition (including its strong cash position) and near-term prospects, and Altria’s intent and ability to hold its investment in Cronos until recovery, Altria concluded that the decline in fair value of its equity method investment in Cronos below its carrying value is temporary and, therefore, no impairment was recorded.
XML 35 R31.htm IDEA: XBRL DOCUMENT v3.20.1
Contingencies (Tables)
 3 Months Ended
Mar. 31, 2020
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Contingencies

The table below lists the number of certain tobacco-related cases pending in the U.S. against PM USA and, in some instances, Altria as of April 27, 2020, April 22, 2019 and April 23, 2018:
 
April 27, 2020
 
April 22, 2019
 
April 23, 2018
Individual Smoking and Health Cases (1)
109
 
98
 
102
Health Care Cost Recovery Actions (2)
—
 
1
 
1
E-vapor Cases(3)
202
 
2
 
3
Other Tobacco-Related Cases(4)
4
 
—
 
—
(1) Includes 22 cases filed in Massachusetts and 46 non-Engle cases filed in Florida. Does not include individual smoking and health cases brought by or on behalf of plaintiffs in Florida state and federal courts following the decertification of the Engle case (these Engle progeny cases are discussed below in Smoking and Health Litigation - Engle Class Action). Also does not include 1,472 cases brought by flight attendants seeking compensatory damages for personal injuries allegedly caused by exposure to environmental tobacco smoke (“ETS”). The flight attendants allege that they are members of an ETS smoking and health class action in Florida, which was settled in 1997 (Broin). The terms of the court-approved settlement in that case allowed class members to file individual lawsuits seeking compensatory damages, but prohibited them from seeking punitive damages. In March 2018, 923 of these cases were voluntarily dismissed without prejudice.
(2) See Health Care Cost Recovery Litigation - Federal Government’s Lawsuit below.
(3) Includes 24 class action lawsuits, 170 individual lawsuits, five state or local government lawsuits and three lawsuits filed by school districts relating to JUUL e-vapor products. JUUL is an additional named defendant in each of these lawsuits.
(4) For 2019 and 2020, includes two inactive smoking and health cases alleging personal injury or seeking court-supervised programs or ongoing medical monitoring and purporting to be brought on behalf of a class of individual plaintiffs, including one case in which the aggregated claims of a number of individual plaintiffs are to be tried in a single proceeding, and two inactive class action lawsuits alleging that use of the terms “Lights” and “Ultra Lights” constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO.
Currently Pending Engle Cases with Accrued Liabilities
(rounded to nearest $ million)

Plaintiff
Verdict Date
Defendant(s)
Court
Compensatory Damages (All Defendants)
Punitive Damages (PM USA)
Appeal Status
Accrual (1)
Berger (Cote)
September 2014
PM USA
Federal Court - Middle District of Florida
$6 million
$21 million
The Eleventh Circuit Court of Appeals reinstated the punitive and compensatory damages awards and remanded the case to the district court. PM USA’s challenge to the punitive damages award was denied by the district court. PM USA’s appeal to the Eleventh Circuit Court of Appeals is pending.
$6 million accrual in the fourth quarter of 2018
(1) Accrual amounts include interest and associated costs, if applicable. For cases with multiple defendants, if any, accrual amounts reflect the portion of compensatory damages PM USA believes it will have to pay if the case is ultimately decided in plaintiff’s favor after taking into account any portion potentially payable by the other defendant(s).
Other Currently Pending Engle Cases with Verdicts Against PM USA
(rounded to nearest $ million)

Plaintiff
Verdict Date
Defendant(s)
Court
Compensatory Damages (1)
Punitive Damages
(PM USA)
Appeal Status
Duignan
February 2020(2)
PM USA and
R.J. Reynolds(3)
Pinellas
$3 million
$12 million
Defendants’ post-trial motions pending.
Cuddihee
January 2020
PM USA
Duval
$3 million
$0
Defendant’s post-trial motions pending.
Rintoul (Caprio)
November 2019(2)
PM USA and R.J. Reynolds
Broward
$9 million ($5 million PM USA)
$74 million
Defendants’ post-trial motion pending.
Gloger
November 2019(2)
PM USA and R.J. Reynolds
Miami-Dade
$15 million ($5 million PM USA)
$11 million
Appeal by defendants to Third District Court of Appeal pending.
McCall
March 2019
PM USA
Broward
<$1 million (<$1 million PM USA)
<$1 million
New trial ordered on punitive damages.
Neff
March 2019
PM USA and R.J. Reynolds
Broward
$4 million
$2 million
Appeals by plaintiff and defendants to Fourth District Court of Appeal pending.
Frogel
March 2019
PM USA
Palm Beach
<$1 million (<$1 million PM USA)
$0
Appeals by plaintiff and defendant to Fourth District Court of Appeal pending.
Other Currently Pending Engle Cases with Verdicts Against PM USA
(rounded to nearest $ million)

Plaintiff
Verdict Date
Defendant(s)
Court
Compensatory Damages (1)
Punitive Damages
(PM USA)
Appeal Status
Mahfuz
February 2019
PM USA and R.J. Reynolds
Broward
$12 million
$10 million
Appeals by plaintiff and defendants to Fourth District Court of Appeal pending.
Holliman
February 2019
PM USA
Miami-Dade
$3 million
$0
Defendant’s appeal to Third District Court of Appeal pending.
Chadwell
September 2018
PM USA
Miami-Dade
$2 million
$0
Appeals by defendant and plaintiff to Third District Court of Appeal pending.
Kaplan
July 2018
PM USA and R.J. Reynolds
Broward
$2 million
$2 million
Appeals by defendants and plaintiff to Fourth District Court of Appeal pending.
Landi
June 2018
PM USA and R.J. Reynolds
Broward
$8 million
$5 million
Appeals by plaintiff and defendants to Fourth District Court of Appeal pending.
R. Douglas
November 2017
PM USA
Duval
<$1 million
$0
Awaiting entry of final judgment by the trial court.
Sommers
April 2017
PM USA
Miami-Dade
$1 million
$0
Third District Court of Appeal affirmed compensatory damages award and granted new trial on punitive damages. Defendant petitioned Florida Supreme Court for review.
Santoro
March 2017
PM USA, R.J. Reynolds and Liggett Group(3)
Broward
$2 million
$0
Trial court set aside punitive damages award; appeals by plaintiff and defendants to Fourth District Court of Appeal pending.
Cooper (Blackwood)
September 2015
PM USA and R.J. Reynolds
Broward
$5 million
(<$1 million PM USA)
$0
Fourth District Court of Appeal affirmed judgment and granted a new trial on punitive damages.
D. Brown
January 2015
PM USA
Federal Court - Middle District of Florida
$8 million
$9 million
Appeal by defendant to U.S. Court of Appeals for the Eleventh Circuit pending.
Kerrivan
October 2014
PM USA and R.J. Reynolds
Federal Court - Middle District of Florida
$16 million
$16 million
U.S. Court of Appeals for the Eleventh Circuit affirmed the judgment. Defendants’ motion for rehearing pending.
Harris
July 2014
PM USA,
R.J. Reynolds and Lorillard(3)
Federal Court - Middle District of Florida
$2 million (<$ 1 million PM USA)
$0
Appeals by plaintiff and defendants to U.S. Court of Appeals for the Eleventh Circuit pending.
(1) PM USA’s portion of the compensatory damages award is noted parenthetically where the court has ruled that comparative fault applies.
(2) Plaintiff’s verdict following a retrial of an initial verdict in favor of plaintiff.
(3) References to “R.J. Reynolds,” “Liggett Group” and “Lorillard” are to R.J. Reynolds Tobacco Company, Liggett Group, LLC and Lorillard Tobacco Company, respectively.
 
 
 
 
 
 
 
Engle Cases Concluded Within Past 12 Months(1) 
(rounded to nearest $ million)
Plaintiff
Verdict Date
Defendant(s)
Court
Accrual Date
Payment Amount
(if any)
Payment Date
Theis(2)
May 2018
PM USA and
R.J. Reynolds
Sarasota
First quarter of 2020
$17 million
February 2020
Alvarez Del Real
September 2019
PM USA
Miami-Dade
Fourth quarter of 2019
<$1 million
October 2019
Engle Cases Concluded Within Past 12 Months(1) 
(rounded to nearest $ million)
Plaintiff
Verdict Date
Defendant(s)
Court
Accrual Date
Payment Amount
(if any)
Payment Date
Zingaro
May 2019
PM USA and
R.J. Reynolds
Broward
Third quarter of 2019
<$1 million
October 2019
Bryant
December 2017
PM USA
Escambia
Second quarter of 2019
<$1 million
July 2019
Wallace
October 2017
PM USA and
R.J. Reynolds
Brevard
Second quarter of 2019
$26 million
May 2019
J. Brown
February 2017
PM USA and
R.J. Reynolds
Pinellas
First quarter of 2019
$4 million
April 2019
L. Martin
May 2017
PM USA
Miami-Dade
First quarter of 2019
$2 million
April 2019
Danielson
November 2015
PM USA
Escambia
First quarter of 2019
$3 million
March 2019
S. Martin
November 2016
PM USA and
R.J. Reynolds
Broward
First quarter of 2019
$5 million
March 2019
Searcy
April 2013
PM USA and
R.J. Reynolds
Federal Court - Middle District of Florida
Third quarter of 2018
$2 million
March 2019
Boatright
November 2014
PM USA and Liggett Group
Polk
Second quarter of 2018
$42 million
March 2019
M. Brown(3)
May 2015
PM USA
Duval
Second quarter of 2018
$8 million
March 2019
Jordan(4)
August 2015
PM USA
Duval
Second quarter of 2018
$11 million
March 2019
Pardue
December 2016
PM USA and
R.J. Reynolds
Alachua
Second and Third quarters of 2018
$11 million
March 2019
McKeever
February 2015
PM USA
Broward
Fourth quarter of 2017
$21 million
March 2019
(1) In two cases in which PM USA paid the judgments more than a year ago, Naugle and Gore, plaintiffs were awarded approximately $8 million and approximately $2 million in fees and other costs, respectively.  In both cases, PM USA has appealed.
(2) In February 2020, the Florida Second District Court of Appeal denied PM USA’s petition for review.  As a result, in the first quarter of 2020, PM USA recorded a pre-tax provision of approximately $17 million for the judgment plus interest, which was subsequently paid in the first quarter of 2020.
(3) The trial court also awarded plaintiff approximately $9 million in fees, interest and costs.  PM USA and plaintiff have appealed.
(4) The trial court also awarded plaintiff approximately $4 million in fees and costs. PM USA and plaintiff have appealed.
The changes in Altria’s accrued liability for tobacco and health litigation items, including related interest costs, for the periods specified below are as follows:
 
For the Three Months Ended March 31,
(in millions)
2020
 
2019
Accrued liability for tobacco and health litigation items at beginning of period (1)
$
14

 
$
112

Pre-tax charges for:
 
 
 
Tobacco and health litigation
22

(2) 
15

Related interest costs
2

 
2

Payments (1)
(28
)
(3) 
(109
)
Accrued liability for tobacco and health litigation items at end of period (1)
$
10

 
$
20

(1) Includes amounts related to the costs of implementing the corrective communications remedy related to the Federal Government’s Lawsuit discussed below.
(2) Includes approximately $7 million related to pre-trial resolution of approximately 100 tobacco and health cases.
(3) Includes approximately $7 million in payments related to above-mentioned pre-trial resolution of approximately 100 tobacco and health cases and $2 million for pre-trial resolution of other tobacco and health cases that was accrued in 2019 but not paid until 2020.
XML 36 R35.htm IDEA: XBRL DOCUMENT v3.20.1
Background and Basis of Presentation (Share Repurchase Table) (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended 18 Months Ended
Mar. 31, 2019
Jun. 30, 2019
Equity, Class of Treasury Stock [Line Items]    
Aggregate cost of shares repurchased $ 151  
January 2018 Share Repurchase Program [Member]    
Equity, Class of Treasury Stock [Line Items]    
Total number of shares repurchased (shares) 2.7 34.0
Aggregate cost of shares repurchased $ 151  
Average price per share of shares repurchased (usd per share) $ 56.34 $ 58.86
XML 37 R39.htm IDEA: XBRL DOCUMENT v3.20.1
Asset Impairment, Exit and Implementation Costs (Narrative) (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Dec. 31, 2020
Restructuring Cost and Reserve [Line Items]      
Restructuring charges $ 392 $ 61  
Wine Business Strategic Reset [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges 392    
Inventory Write-Off [Member] | Wine Business Strategic Reset [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges 292    
Purchase Commitment [Member] | Wine Business Strategic Reset [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges $ 100    
Fulfillment term 5 years    
Forecast [Member] | Wine Business Strategic Reset [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges     $ 25
XML 38 R55.htm IDEA: XBRL DOCUMENT v3.20.1
Other Comprehensive Earnings/Losses (Reclassifications) (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]    
Net periodic benefit income, excluding service cost $ (27) $ (1)
ABI (157) (86)
Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings (1,550) (1,121)
Reclassification out of Accumulated Other Comprehensive Income [Member]    
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]    
ABI (7) (12)
Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings 21 27
Benefit Plans [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]    
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]    
Net periodic benefit income, excluding service cost 28 39
Net loss [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]    
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]    
Net periodic benefit income, excluding service cost 34 49
Prior service cost/credit [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]    
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]    
Net periodic benefit income, excluding service cost $ (6) $ (10)
XML 39 R51.htm IDEA: XBRL DOCUMENT v3.20.1
Benefit Plans (Schedule Of Components Of Net Periodic Benefit Cost (Income)) (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Pension [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Service cost $ 19 $ 17
Interest cost 63 77
Expected return on plan assets (126) (145)
Amortization:    
Net loss 27 42
Prior service cost (credit) 1 1
Curtailment 0 7
Net periodic benefit (income) cost (16) (1)
Postretirement [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Service cost 4 4
Interest cost 15 20
Expected return on plan assets (3) (4)
Amortization:    
Net loss 3 3
Prior service cost (credit) (7) (7)
Curtailment 0 5
Net periodic benefit (income) cost $ 12 $ 21
XML 40 R4.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Earnings - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Income Statement [Abstract]    
Net revenues $ 6,359 $ 5,628
Cost of sales 2,173 1,578
Excise taxes on products 1,313 1,239
Gross profit 2,873 2,811
Marketing, administration and research costs 537 533
Asset impairment and exit costs 0 40
Operating income (expense) 2,336 2,238
Interest and other debt expense, net 275 384
Net periodic benefit income, excluding service cost (27) (1)
Earnings from equity investments (157) (86)
Loss on Cronos-related financial instruments 137 425
Earnings (losses) before income taxes and equity earnings of subsidiaries 2,108 1,516
Provision for income taxes 558 395
Net earnings 1,550 1,121
Net (earnings) losses attributable to noncontrolling interests 2 (1)
Net earnings attributable to Altria $ 1,552 $ 1,120
Per share data:    
Basic and diluted earnings per share attributable to Altria (in usd per share) $ 0.83 $ 0.60
XML 41 R59.htm IDEA: XBRL DOCUMENT v3.20.1
Contingencies (General Information) (Details)
Mar. 31, 2020
state
Commitments and Contingencies Disclosure [Abstract]  
Number of states that cap bond or require no bond 47
XML 42 R8.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Cash Provided by (Used in) Operating Activities    
Net earnings $ 1,550 $ 1,121
Adjustments to reconcile net earnings to operating cash flows:    
Depreciation and amortization 65 53
Deferred income tax provision (benefit) 26 (72)
Earnings from equity investments (157) (86)
Loss on Cronos-related financial instruments 137 425
Asset impairment and exit costs, net of cash paid (23) 17
Cash effects of changes:    
Receivables 5 (16)
Inventories (5) (25)
Accounts payable (45) (189)
Income taxes 495 471
Accrued liabilities and other current assets (421) (513)
Accrued settlement charges 1,073 913
Pension plan contributions (4) (3)
Pension provisions and postretirement, net (20) (8)
Other, net 453 201
Net cash provided by (used in) operating activities 3,129 2,289
Cash Provided by (Used in) Investing Activities    
Capital expenditures (52) (38)
Investment in Cronos 0 (1,831)
Other, net 0 (81)
Net cash provided by (used in) investing activities (52) (1,950)
Cash Provided by (Used in) Financing Activities    
Proceeds from short-term borrowings 3,000 0
Repayment of short-term borrowings 0 (12,800)
Long-term debt issued 0 16,265
Long-term debt repaid (1,000) 0
Repurchases of common stock 0 (151)
Dividends paid on common stock (1,563) (1,502)
Other, net (10) (129)
Net cash provided by (used in) financing activities 427 1,683
Cash, cash equivalents and restricted cash:    
Increase (decrease) 3,504 2,022
Balance at beginning of period 2,160 1,433
Balance at end of period 5,664 3,455
Cash, cash equivalents and restricted cash $ 5,664 $ 3,455
XML 43 R72.htm IDEA: XBRL DOCUMENT v3.20.1
Contingencies (E-vapor Product Litigation) (Details) - E-vapor Litigation [Member]
Apr. 27, 2020
case
claim
Apr. 22, 2019
case
Apr. 23, 2018
case
Loss Contingencies [Line Items]      
Number of cases pending | case   2 3
Subsequent Event [Member]      
Loss Contingencies [Line Items]      
Number of cases pending | case 202    
Number of cases set for trial | claim 0    
Pending Individual Lawsuits [Member] | Subsequent Event [Member]      
Loss Contingencies [Line Items]      
Number of cases pending | claim 170    
XML 44 R76.htm IDEA: XBRL DOCUMENT v3.20.1
Contingencies (Guarantees and Other Similar Matters Narrative) (Details) - USD ($)
Mar. 31, 2020
Dec. 31, 2019
Loss Contingencies [Line Items]    
Contingent liability related to performance surety bonds $ 27,000,000  
Redeemable noncontrolling interest 38,000,000 $ 38,000,000
Letter of Credit [Member]    
Loss Contingencies [Line Items]    
Credit line available under the agreement 50,000,000  
Revolving Credit Facility [Member] | Credit Agreement [Member]    
Loss Contingencies [Line Items]    
Credit line available under the agreement $ 3,000,000,000.0  
XML 45 R17.htm IDEA: XBRL DOCUMENT v3.20.1
Segment Reporting
 3 Months Ended
Mar. 31, 2020
Segment Reporting [Abstract]  
Segment Reporting Segment Reporting:


In the first quarter of 2020, Altria renamed its smokeless products segment as the oral tobacco products segment.

The products of Altria’s subsidiaries include smokeable tobacco products, consisting of combustible cigarettes manufactured and sold by PM USA and Nat Sherman, machine-made large cigars and pipe tobacco manufactured and sold by Middleton and premium cigars sold by Nat Sherman; oral tobacco products, consisting of MST and snus products manufactured and sold by USSTC and oral nicotine pouches manufactured and sold by Helix; and wine produced and/or distributed by Ste. Michelle. The products and services of these subsidiaries constitute Altria’s reportable segments of smokeable products, oral tobacco products (formerly smokeless products) and wine. The financial services and the innovative tobacco products businesses are included in all other.

Altria’s chief operating decision maker (the “CODM”) reviews operating companies income to evaluate the performance of, and allocate resources to, the segments. Operating companies income for the segments is defined as operating income before general corporate expenses and amortization of intangibles. Interest and other debt expense, net, net periodic benefit income/cost, excluding service cost, and provision for income taxes are centrally managed at the corporate level and, accordingly, such items are not presented by segment since they are excluded from the measure of segment profitability reviewed by the CODM.

Segment data were as follows: 
 
 
For the Three Months Ended March 31,
 
 
2020
 
2019
 
 
(in millions)
Net revenues:
 
 
 
 
Smokeable products
 
$
5,606

 
$
4,935

Oral tobacco products
 
601

 
540

Wine
 
146

 
151

All other
 
6

 
2

Net revenues
 
$
6,359

 
$
5,628

Earnings before income taxes:
 
 
 
 
Operating companies income (loss):
 
 
 
 
Smokeable products
 
$
2,370

 
$
1,932

Oral tobacco products
 
414

 
358

Wine
 
(379
)
 
15

All other
 
(5
)
 
(12
)
Amortization of intangibles
 
(19
)
 
(8
)
General corporate expenses
 
(45
)
 
(46
)
Corporate asset impairment and exit costs
 
—

 
(1
)
Operating income
 
2,336

 
2,238

Interest and other debt expense, net
 
(275
)
 
(384
)
Net periodic benefit income, excluding service cost
 
27

 
1

Earnings from equity investments
 
157

 
86

Loss on Cronos-related financial instruments
 
(137
)
 
(425
)
Earnings before income taxes
 
$
2,108

 
$
1,516



The comparability of operating companies income for the reportable segments was affected by the following:

Tobacco and Health Litigation Items - Pre-tax charges related to certain tobacco and health litigation items were recorded in Altria’s condensed consolidated statements of earnings as follows:
 
 
For the Three Months Ended March 31,
 
 
2020
 
2019
 
 
(in millions)
Smokeable products segment
 
$
22

 
$
15

Interest and other debt expense, net
 
2

 
2

Total
 
$
24

 
$
17



The amounts shown in the table above for the smokeable products segment were recorded in marketing, administration and research costs. For further discussion, see Note 11. Contingencies.

Asset Impairment, Exit and Implementation Costs - See Note 3. Asset Impairment, Exit and Implementation Costs for a breakdown of these costs by segment.
XML 46 R13.htm IDEA: XBRL DOCUMENT v3.20.1
Financial Instruments
 3 Months Ended
Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Financial Instruments Financial Instruments:

Altria enters into derivative financial instruments to mitigate the potential impact of certain market risks, including foreign currency exchange rate risk. Altria uses various types of derivative financial instruments, including forward contracts, options and swaps. Altria does not enter into or hold derivative financial instruments for trading or speculative purposes.

Altria’s investment in ABI, whose functional currency is the Euro, exposes Altria to foreign currency exchange risk on the carrying value of its investment. To manage this risk, Altria designates certain foreign exchange contracts, including cross-currency swap contracts and forward contracts (collectively “foreign currency contracts”), and Euro denominated unsecured long-term notes (“foreign currency denominated debt”) as net investment hedges of Altria’s investment in ABI.

At both March 31, 2020 and December 31, 2019, Altria had foreign currency contracts with aggregate notional amounts of $2,246 million. At March 31, 2020, Altria had foreign currency denominated debt with an aggregate fair value and carrying value of $4,595 million and $4,666 million, respectively. At December 31, 2019, Altria had foreign currency denominated debt with an aggregate fair value and carrying value of $5,057 million and $4,741 million, respectively.

Altria’s estimates of the fair values of its foreign currency contracts are determined using valuation models with significant inputs that are readily available in public markets, or can be derived from observable market transactions, and therefore are classified in Level 2 of the fair value hierarchy. An adjustment for credit risk and nonperformance risk is included in the fair values of foreign currency contracts.

Altria’s estimate of the fair value of its short-term borrowings is derived from discounted future cash flows based on the contractual terms of the Credit Agreement (see Note 10. Debt) and observable interest rates and is classified in Level 2 of the fair value hierarchy. The fair value of Altria’s short-term borrowings at March 31, 2020 approximated its carrying value. Altria had no short-term borrowings at December 31, 2019.

Altria’s estimate of the fair value of its total long-term debt is based on observable market information derived from a third-party pricing source and is classified in Level 2 of the fair value hierarchy. The aggregate fair value of Altria’s total long-term debt at March 31, 2020 and December 31, 2019 was $28.3 billion and $30.7 billion, respectively, as compared with its carrying value of $27.0 billion and $28.0 billion, respectively.

Altria’s Fixed-price Preemptive Rights and warrant related to its investment in Cronos, which is further discussed in Note 4. Investments in Equity Securities, are derivative financial instruments, which are required to be recorded at fair value. The fair values of the Fixed-price Preemptive Rights and Cronos warrant are estimated using Black-Scholes option-pricing models, adjusted for observable inputs (which are classified in Level 1 of the fair value hierarchy), including share price, and unobservable inputs, including probability factors and weighting of expected life, volatility levels and risk-free interest rates (which are classified in Level 3 of the fair value hierarchy) based on the following assumptions at:
 
 
March 31, 2020
 
December 31, 2019
 
March 31, 2020
 
December 31, 2019
 
 
Fixed-price Preemptive Rights
 
Cronos Warrant
Share price (1)
 
C$7.99
 
C$9.97
 
C$7.99
 
C$9.97
Expected life (2)
 
1.60 years
 
1.67 years
 
2.93 years
 
3.18 years
Expected volatility (3)
 
79.97%
 
81.61%
 
79.97%
 
81.61%
Risk-free interest rate (4)(5)
 
0.38%
 
1.71%
 
0.49%
 
1.69%
Expected dividend yield (6)
 
—%
 
—%
 
—%
 
—%
(1) Based on the closing market price for Cronos common stock on the Toronto Stock Exchange on the date indicated.
(2) Based on the weighted-average expected life of the Fixed-price Preemptive Rights (with a range from approximately 0.25 year to 6 years at March 31, 2020 and December 31, 2019) and the March 8, 2023 expiration date of the Cronos warrant.
(3) Based on a blend of historical volatility levels of the underlying equity security and peer companies.
(4) Based on the implied yield currently available on Canadian Treasury zero coupon issues (with a range from approximately 0.21% to 0.62% at March 31, 2020 and 1.66% to 1.74% at December 31, 2019) weighted for the remaining expected life of the Fixed-price Preemptive Rights.
(5) Based on the implied yield currently available on Canadian Treasury zero coupon issues and the expected life of the Cronos warrant.
(6) Based on Cronos’s expected dividend payments.

The following table provides a reconciliation of the beginning and ending balance of the Fixed-price Preemptive Rights and Cronos warrant, which are classified in Level 3 of the fair value hierarchy:
 
 
(in millions)
Balance at December 31, 2019
 
$
303

Pre-tax earnings (losses) recognized in net earnings
 
(137
)
Balance at March 31, 2020
 
$
166


Altria elects to record the gross assets and liabilities of derivative financial instruments executed with the same counterparty on its condensed consolidated balance sheets. The fair values of Altria’s derivative financial instruments on a gross basis included on the condensed consolidated balance sheets were as follows:
 
Fair Value of Assets
 
Fair Value of Liabilities
 
Balance Sheet Classification
 
March 31, 2020
 
December 31, 2019
 
Balance Sheet Classification
March 31, 2020
 
December 31, 2019
Derivatives designated as hedging instruments:
(in millions)
Foreign currency contracts
Other current assets
 
$
55

 
$
46

 
Other accrued liabilities
$
—

 
$
7

Foreign currency contracts
Other assets
 
19

 
—

 
Other liabilities
—

 
21

Total
 
$
74

 
$
46

 
 
$
—

 
$
28

 
 
 
 
 
 
 
 
 
 
 
Derivatives not designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
Cronos warrant
Investments in equity securities
 
$
132

 
$
234

 
 
 
 
 
Fixed-price
Preemptive Rights
Investments in equity securities
 
34

 
69

 
 
 
 
 
Total
 
 
$
166

 
$
303

 
 

 

 
 
 
 
 
 
 
 
 
 
 
Total derivatives
 
 
$
240

 
$
349

 
 
$
—

 
$
28


Altria records in its condensed consolidated statements of earnings any changes in the fair values of the Fixed-price Preemptive Rights and Cronos warrant as gains or losses on Cronos-related financial instruments in the periods in which the changes occur. For the three months ended March 31, 2020 and 2019, Altria recognized pre-tax unrealized losses, representing the changes in the fair values of the Fixed-price Preemptive Rights and Cronos warrant, as follows:
 
For the Three Months Ended March 31,
 
2020
 
2019
 
(in millions)
Fixed-price Preemptive Rights
$
(35
)
 
$
(132
)
Cronos warrant
(102
)
 
(262
)
 
(137
)
 
(394
)


Additionally, in January and February 2019, Altria entered into derivative financial instruments in the form of forward contracts, which were settled on March 7, 2019, to hedge Altria’s exposure to CAD to USD foreign currency exchange rate movements, in relation to the CAD $2.4 billion purchase price for the Cronos transaction. The aggregate notional amounts of the forward contracts were USD $1.8 billion (CAD $2.4 billion). The forward contracts did not qualify for hedge accounting; therefore, in the first quarter of 2019, pre-tax losses of USD $31 million representing changes in the fair values of the forward contracts were recorded in loss on Cronos-related financial instruments in Altria’s condensed consolidated statement of earnings.

Counterparties to Altria’s foreign currency contracts are domestic and international financial institutions. Altria is exposed to potential losses due to non-performance by these counterparties. Altria manages its credit risk by entering into transactions with counterparties with investment grade credit ratings, limiting the amount of exposure Altria has with each counterparty and monitoring the financial condition of each counterparty. The counterparty agreements also contain provisions that require Altria to maintain an investment grade credit rating. In the event Altria’s credit rating falls below investment grade, counterparties to Altria’s foreign currency contracts can require Altria to post collateral. No collateral was received or posted related to derivative assets and liabilities at March 31, 2020 and December 31, 2019.

Net Investment Hedging

The pre-tax effects of Altria’s net investment hedges on accumulated other comprehensive losses and the condensed consolidated statements of earnings were as follows:
 
 
Gain (Loss) Recognized in Accumulated Other Comprehensive Losses
 
Gain (Loss) Recognized in Net Earnings (1)
 
 
For the Three Months Ended March 31,
 
 
2020
 
2019
 
2020
 
2019
 
 
(in millions)
Foreign currency contracts
 
$
56

 
$
23

 
$
14

 
$
9

Foreign currency denominated debt
 
77

 
33

 
—

 
—

Total
 
$
133

 
$
56

 
$
14

 
$
9

(1) Related to amounts excluded from effectiveness testing.

The changes in the fair value of the foreign currency contracts and in the carrying value of the foreign currency denominated debt due to changes in the Euro to USD exchange rate were recognized in accumulated other comprehensive losses related to ABI. Gains on the foreign currency contracts arising from components excluded from effectiveness testing were recognized in interest and other debt expense, net in the condensed consolidated statements of earnings based on an amortization approach.
ZIP 47 0000764180-20-000048-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000764180-20-000048-xbrl.zip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�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�M^E,V!*M>:%9DK!@))L9YDDV%8!+IE0,)9EFF]!69WK,BBWZP_0E7 M,=,BPI98-J#OS<6S DPY675'T)%MTE'$2I@+91Y)"@5D_:ZR,H=AI-$:,PI& MJ$&FP!I' J\B)>>"?4EXZEO%#[Y%SI30T%2$7H0F$LL4K TGDMPC1*!_9B*+ M$3Z6PRC,-=T296E,+IPV MO4K-3JNI,\1]Q:G;'RI1)\-?<;3C[4 Q V1"/+6XN[C(56YN[WT=6Z\S(A1(0 M>CA%!Q+A.;V#]T]!P$#F1AQ4$#X^%CR%AW4@X'T!#:ZQ Y[+ CCL+VC+-)UF M!P>GLBX&.V\V03A1-DJ8OS2 M_K%.M]9NAS4N9,03.P-%EB_=*,2PPUG%J3,JX383MLP;KI.E>SZ5NU>0N?!5 M;9&QT$RR0[!"5M'?3?20I37S/B6)%(NA=0:6;S*2T2@P?B!\Y(^@ !DCYKR' MM98)I?5?)UZ\V>S55IEXZT5*'D%*^L]>2KRSMD!10:Z?P$V%2-%^2/#PP%6[ MW,7-578.'ON,U#!P\ .']46(?CXABIZQ$"%;BE23#TGA28\G&'(<@J^69#F% M'QA;H3 LTAHYD;AVWRY$^Y"AM,&'0ZD@TLH4A5&S8>R]R=G"HI07.;NAG,7/ M6,X.I>9]FJ'YWD"\X4\ MEV2P.A@OA0W*5)>*TAM@V\ G'#=S+YEB]&O L.&SLJ]E++F20C>CI;N)WXNP M/8*PB68N4S8J2C 1@2^(;NUT!EY4[Y!-E#9F/&(LJ(F8TN7*1$8R@B: MM:9T!.F/?H:)PZ+@,J7GTK^IQ MH=;P11P?01P'SU@5IRB, MN5!8BGP1H^PIR1TD<%+4*@@)M#H0L2B46FY!Y()'ZJ: D MF[?%3\RT=1GRX\"!BW#YB4V># "$?O3JZ4-4_+%(Q! 8O8/,CQ=T!HHTECI2 MPL#DQGP*YN9_2_ >9_*:XD)$)8@0AV;3@8',<4I?HF$YR=)5JC(49E(J2!7T M%64I6!RA^"P"K#^ENM]@2A"5L$N,^,IHY.BAMCC2C"4,S7*%L:A)JO)!X4!V MOIZ_QHY3TX!,C8GM5'?,<'\#'NW^'"DW^SD$J:M],,4_5JFW'9Y,^%0OU6Z_ M'%90>B7Q*"@T\4Y M=I)40="[#3 94QTPUYQ67$&Z40H(_*\;#+-CD%(0EI6)E1W*B"!>,TE@4%%= MB*KGL-D& ="0-4PL]$UIYX-'P9) O, ;[].M$/3U[A.!>PY;G ME'8P2BCT^3H!N@.K;#6&!B/ )25#*NAV2Z&L"G"F)JBK&P;XJ+)R.)KIF^2C M C!BM5P/I!5K W%T,.)**SFI,\C%WHS\$>01U$M=YN8AKA6+N!XQM'CGID)? M@MI(Z!F:/&H.)T_$M\1)OLCL=;E^^T%D=C^"R!4M-;"\Y<:%]6OE[V[2>VRD MU-C'6:$4%SD\+"B%P=G#%J,.J6G\'A6>F M&MFI)(>DL0]K ![#H,1 SHB1TT(&I6E]SKG#(*\28S+C+\MP;@BXYL ^X$$, M!7X/UK]06>(R5NV)):=!YM!K*<49R_F4/!_;1CV%1!D>VSA/4PQ1O2<$UUWF MZO4R7PE[I>?.[)?=KD5XOVB7>]4NKQY$NWST>8DGXPT<#QY @0PL8L;$"L:J M&[?^FIICO@KJ7.9ESWC7),MR/!9 62$PA4OAQ"4*AL&:L;Q4>:9%Y7%@FGJH M>#[JV T4B47*!LZ.P2514S.Q""D3'Q>B,KEJJH/M8J03/3@=)JO .U#KQ"YL MAQD0PPP^=4P*[;+F(52*E.P'FU :H[L97'',I_,S&N1H:E2BR!&&6]RZO*BX M^U5QKQ]$Q7WA4P*QIMS9;Q(2VH9I- ]R9^ )GEN%0UY) M35Z[(#2#$)KH=YO:9X,<_ JH)7O9.SU4 M=4+=JW5)V,7Y.TE!A-=M;-/QNFC,8S$OH1?L6D,?)2 ("/F437![&Q&"$@W- MHLO(G>X*FK?I'S,G0!4Z/H$%1D3OG._Z3A@]()?.)8TCD'6!ZW*S4YAHJI%7M[=SEK<'_#A MIS(5;VZM;&]D*[YEA=&3,3B F&:"/T[)7WLR[C']^)HF0IMXKI$ (G_&)9W, MT*AT4M,*B/GI"Y$ZW3*[5ZK-B45 >67N/%A\9GSS.;JK2HQ:?9S5 %F^E!@ M=!9)LEKD-\[15 &MWO\*='E;HJX:^E7^M]]8[ FW=&+#)DOH+&IP*, R9O\# ME1&H"!S)"-:3R.470J]T_)!#34>:SVIYTI&)%*4S)=4AI6&4<-OUG33J#92<*TWWLZ+(QCO;H%)>O.1;Z(NW#^(E?TT' M^#&V\D5\@$><#<#\N4,QGM0I!O3CBPO"M2B*I)G24R('H3!9>) $.T"C-+6( M2M1[E6EOE HP68^9?#\=OED\(B'-TM7"SH\I,<,=6!U')=E'WRB).ZA+SL54 MQ.C+:. X_,L]I?!#GHAXB'\X5\/(J-08W-/>.OA"I!$Y;DB[*=116=,G()SF MHE-/_#S4 EG63*IP$.9Q;M(0YS)+3-T#QNOZ.$>AF1K,Y6 MH*J&6;JBB(+_KJ[S/_BI79MM![0]-YR!MWBSA@U]#V_1\E)A<$C6U7'>:UCM M)KM*;?9\4YF<5I2G/.8-4\^C'VDV(9$*>I[#!FWE0Z)*MU-%8A\Z R$SNB+! M0"IPOT#$8^M\&4(EI^1Z"7.%R<>$3_2:.8.&[=N1E4EQY6B0J<,>+@^@V!C6 MTT>Z&-FZPB;61R\BJD!T3$5TS-4/ 01D98%S',XPQ;9KCXM-R+$PJ&J M*8M1IN1?)BPRB8(I,ZF9AML/6D'20:T&Q98*9RZI%N']!W"U40#!_2BCPH4X M53K&E>Z-%6=\.%0&.602);4D#A]GI=&!L\3$I1%HDMD1 2+ :W?)-W.%P'*Q M;4;;75LPM%QED1 QP?5P8]$GF/8BUJCBK3;._0;IJ'2E$/'Y:=O&KLP!4%'=JO\H1(D.WQE9.:Y*L7L+8/M2C&QM:J0(=Z\(43JXH+-^J M-,Q$8CWZ'!-CC9B H$08NA/^K]HF"2L88 8NH=KHC-O65PQ)FH9FNO%FNCES MI.\"^EYTQCWKC%N?2'HCG4%;"L_"+85G"-D" ^**BE\0$*L7G)N[87DD)@7,NTE*8K9;.'(,&0 >!3#]* MI3#N074B<6-;9E"U=K/IO*KWQ-QM:VLM6ZS* (7O?)']17+8S5C MVC ,8)@01CFO9JL;0'<]&46JSCIP@+(7)8K[5DY*V,5 MD%0$AG ^HG5&)JU[7 ?K6.FKDG#DHT._F3GTVT;"N,+ >J/+@'->"<4BX5,1 M%DZ!)2%4-# *>>'@&Q7&Y'+(+_;6];3X'-!V*5'#THCQ5$T= M!\RTX+%_RF;*J>Q4N>XS8YL=3%WWOLC"M64!A*%7=SG,1: M*>Q+I?CE$.JZMGUE>(C:B#.A75+#;CRL5'_[&1DWU/]H\RUKTJB:HE07G;9$ MWJN NVDVVKF?DJASH)2!U#1EP#\;6(OE_940HUD#9=;GDM"8RQ]6VBW%O%-& MEJ\Y=RM5,A +SP$'=.QI(G2R5@5W'[B(7@5 ]ZE?L$/[6= \J"Q7 M",&8=UYS -E%O=HQ-L&J=7^VNCONI-YWM6'?KX6_53=* +4ZOSL]+ H38'/R M@J9B1GFU 1'<$7?'N]KL]L0'1C@%IRJ2XBRDZH:R&#:I-\XW:+@/T0#^=)\ M-5*%"@([C+M5!+[',4VXC MPSB>;#S2JK!(KK!:@(F+@$8DW)X:U?$OK[J@C(K)(!:VC!.<,\PG'8C*S5LF M*8^*0!W<6<05'D0 WZ5X9%( C0K14)V9>:DL=; 'N1.4KYIY525:RD)ME'SD MDC(16'[\YI#C%:<$B,;03ZT@G2U'']B*#TX)> *Y+B^W$A7<)>E0T^:$F-)O+S:Y MGCFGD8?'+-A+N),S(_-F\T41BTMW[(\R!TX"&18H1'!R@[&B@ ,+Z-SH"$/1 M5?WZ$_6T>\&?N$!(J$[0%48OFQ"9J(O&&8+!"QL:41$83<.(JV'CJ*,0@]G8 M1CH!O:$S T)T(\#?65F0KA4VQ*Y_P^-S@FB8]YN\2/;U!/1A3E\X2C&;70G/ M+D1TYPCYI8CIR7B?O?F'CN!+$C/0 ]Z_(L0).A%8A:$W2SIOK+*I_KR[3@6B MMOZ+F1#N^W)5#8/!403A0_22\L4'!YH<(^A8S9Z18M 8%8XCR/'7#B%0UMFC MMW82]45F<==8"Z+>VUIGO9I'9,%.IHN6$UNDIFY\3L,$@SYA#9(ZKKQ,!2YX)$S35(7![7IFA#A]'0<;XY*2#4$WQDS0BP/A'MI5 M OWTI8MT8A8T_OR5V%.@(52D[UXOQD4Z/F'?CWLG1V=G[/NGH].CSQ\[[%IO M/JWVC)7)U!W31C&0V\V$9M/ D]T;NW@?V/Z%%^Y"P]PT5O!\+2N]T4A*X^>P M Y.K])GL(LOQ<%LZ2G9A!^<&U.*YN6..KUPVY/&RR-P%0?U/I4%MA+]:JMN&NYUL3ZY#3+!?1[X*)*+-@J47 UG2UF>4(? +5JO%P &9H !H !E M>&AI8FET,3 R<&5R9F]R;6%C97-T+FAT;>U=[5/CMM;_W/X5NG1N9YD)D/"R M+T!WA@+;I;=E&0C=>3X]H]A*HJYC^V3KHG[&/WSS_8 M[F:[P[J:QZG,I(IYM+5U>K[&UH99ENQO;8W'X\WQSJ;2@ZWNY18.M;L5*96* MS3 +U][_>(A?O?_QA\.AX"'\^\/AOS8VV(D*\I&(,Q9HP3,1LCR5\8!]#D7Z MA778QD9QY;%*)EH.AAG;;F^WV6>EO\@;[J[(9!:)]Z>W0]F3V>&6^0B3;=G9 M#GLJG+P_#.4-2[-))'Y9ZZLXV^CSD8PF^UTY$BD[%V-VJ48\/J"_I?(?L=]I M)]D!4@]WOC_D+.8CN#?=W7G7[K3#G5VQV]]]NQ?R7LC?=O;XV_8[OMW;[:V] M/]SB\#_=Y7ZXF2,9BXVAP+7L=[;;_S[(Q&VVP2,YB/=IA?[\'9K_$+]IHES& M0Z%ETQT]#?/CUQX92Z2 /H[-%#T5A3"$?3JLT][7K>/?OKE%W\<73.GI3>;U"%1V29SZVK[J?C_[#K\[,N._KM\O3T3^#= MMST?9WGF:R/WG2Y_F<:*"O9!S"(]O??9O<+H*H:4O!7OW\ MT]OM[?;!L1HE/)[0I\[!>HMQ]I?4 QE+S@*E$Z4Y.O46@Z%%;\(&X.>SE&6* M94/!Q"B)U$0()I%>V9?@J&5,?R)G?)6IX L[&G,=LE0$.!)3??J[^?(J ^=. M?MX1=&J'=!2Q''BAS2U1IH&LW[3*$UA&'&PR8V&$[BL-_CD0^"U2+=D1*->0P.B!--[AZBL+AI++,ATR)-8!EN^1G7 Y&Q.!_U@$18 M6#KD< G^!GP=P6(- ^R2+:]]WA?7%/.D,"#0!I-](R,OKJY3[[%&$0[( WBH M(:V;%L1C&"_O_>TMJJ^B2(TQV *;,4KIDD#%(05WJ9E5IA6F&^JND85' RVJ M=!3?.&+F?AR(6-]9:3,FQ%I!$. ,%$EP(9@NOGX!"@(X,.9@.O'TD> PW MIYY"]@0,N,F.>2(S$(A_8"PS=*PRIN F/9:I8"%R!OZ&%A/FJ@Z;0IY0CLU3 MI^5HH#;G"X@BT7^DX#?CO4BP0$11PL,0*/YEK;U&G].$!^[S5^1-;"IQ.LQ@ MLBQT-X]EF WWWVR#+J$J9"'^T?ZR19=6+H=GG,F 1Y8#F4K6[F97;;%V.1O( M.J/!\S#L%:^%/);NV50>W$/FPI]J@X[YWHV=@->P=OG;5 ]%.F5E,$@ZQ4(8 MGH&K&@]E,/2\%6@?!1*H0<;K.+>_V_%J M4D17"]05E/HQ7)2)&!V(A#@*8JM[8M-$JQN(M:?4AD%H[H68*RWZ_K0H>,%: MA&(IXI2B2$HHNCS"'.$$HK5()90O8#:$VK!(?^14XJOG=DG5KPJU#3Z<2 VY MD=*4^$PGH(^F9PM+*U9Z]D ]"U^PGIW(E/=D)+/) I6(L[ 8%I2#9PPK+%DD MTJH+ I?4@_RK+[/4*]KP)(F 7RASD8*G@QF3/Z",TUR3LP/?!D'AJ%XM49K1 M/WV& U_EO52&DFLITGJ^]&WJMU*V)U V\8*5[1RCM(A=B@Q\A!<^CJ!;JVN'5P#I*2SU91F7,=V/<>9 L-=[MK@' M(PM74NSC7!/!C<=+A;Z1KEAXWXP+]88K=7P"=>R_8'7T"]+P.[8!0,@7Z@>3 M8ECC!V7*0H$.C>I]/8[5117[>H+3=]XLZ]]LISKO30U\/A"];# M0A(G"])#%// BKOTJ_]6!UJ0 &)9):+L3L;N4XL-.?I9DT8&$J)K-8Z%3HL1EV*Q+AS!Z>%UUF45H%/2;AI MQ1O_YOL8VT>VK64#00E% 1;9;;\[:O9%B QI**ZTK-K*.(CR$&0OD#K(1VF& M$6A:5>NB!"31!_-4Q2#F.#H\+)D0?!=;Y)ER42SKYQK[Y6X%Z1.XR56Y]5EH M_-\O6./_ G>$RK;@+GK1.9_"@M6Q7GDRH[D.#E2#8D] [ZCLBJI6PKQ@S+Z0 M6:[%8DNH2U*I:32V^W6HW= )A.D;/3!&7S9X'T*%?1Z-^21=JUP^'ZQ[R4O] M?H!IVTL!IAT[K")*.FG$L\>8]NM;>!/BX4D1B 3K=0S_&+5('/"&4::&'0 MMR,^ <_ZWQP"Y:FFB[@500[6@L.P<=\@<3GU5M"'GJMX@VI"F6%*"="$N0(5 M@W,5FD\#2GL30B7T)ZY454R)R6T>#!T]-!9'FK'@A&4I3+M-38M4SQL4#>4F M.XO- %C7PFBB535>5:+ZU/\A""K:6DK"XPI!18W-,,);R8/XL9))Z#V#&* Y14NOE>>'8 Y;9,F!'R-+RR,H7%4@$B_,H@D4%54$K M[\-A:P3 0-9/,3]4I;T^!0"=A&8%*'Y-OO%"U@E7-G> M!0GS18Z^6 "9K_@ZV5#<>F T^(8*-L9>^]%RRT.R82>EHOO@4[#G 2I?;C!I M 64J>'$I,-5/P,?M8(FKYFG6?A#- IX.&3K0&].>R<'"1F8&9!X-A\P3X9RH\.4^^9(VB6 /S-+(,;U)9LV#[@E\;&"H9NT!HA%'X !E$GE>O+D]:8..YC\6 M$WYKEX^!R\[0I6.\%;J #F84 P6?(.SLSX!K/PP\-^)?!-:I^C(&!CFJ*SY_ MQDJE'ZI4#05\$WO4F6&:9G#4=/NTN)GHZ" ")Z38)O'_+"YK61T+?%46=&B4VF,NWSQ2WB'035ECF;64I_ M4 D;8@P)FFH-=47TPYP2NA LQ;#%2MAD"WWS%+"K=8>EMU:GP7T6Y[LP5 M43J,SL\D^M)G$^T'LJ-!?_7:S2*F.*!DJ1>0F?4#IJ MQZB6^:D*;P?G<8QEQ"(]A>]==^$U1G[>K'2?LXJ=CMTYMS(TCVIH]I9B:#X4 MM>-GDZ*=]9=@2_H6AVP*."9_,#[W*XW(;&O4NJOT,57R(%V6HY$ RC*!;38* MG.XP,.Q#+5ZAW 9;B0/-DV'+;DR-[ 8D+ZTR:&\::JI 9((M5ZQ#8W(?J[W= M\V03BSU_]X6GU.:X:_A0I(&6/6]S;VUU#XUC)[-+L932IFA$42*,M!3/A?;3 MDX6<^$:S$H/-#H'+.']E*Q_75KY>BJV\X!.'&D/I6*#!G!]+4/0@IF("%PB0 MME$R9$P8BKD77=Y8RT7A347QG,/?P5MV\4<)I$/3:?*4Q#)E]OV=#F6D'C:V M.-/"WNLU7-?!OMFOB^B)( 9HQ-,T)S6;?30'*.R6+<>T"J,VXJ&8U=+PCA5 M)GH$ 2$?U1C/'R!"T#3 L!B&%M(F]X E1A!'4B D'!Y4XUA7,6QIL, MN8O5C&RLC-MB0Q[U&2P,S*B72[M[9OYG*;_&ATY6.7',]#TCD?Y*KA-+304M M%)&DLQ9J.U&K:;1E._Q7YWREBE+>8"-3DDZEB]+$5QCP^YO$2S]AJG:I^_6-I2[327HE05)!CJ=DDUIP M>) @[D;+1PF0,S)H1:27CU2.I=X@T#G,7X]9@//8"0O3TN+G.GCF;V,WSH#9>)-U8.'R\U!/,2L!NOY;K[8X?$PC]]5X/!F;M?[ MH,CA+Y49KQE"7F'$CEU2&O!LLB[Z<1U'(C5A;ZV#06&RZYJ8I1&4H*(?"/?M M"1$[9S)]L$%3;H180FJ0<),:X3TWRO;EK>,P+?4;46HM*$RJ DDQ#*GV#)WU M:'7C^9Y]FAQC+[PMKR83J-@4T,](BMQY\I*HZ4K86.51:-9GUX"?:NWQH8C" M5G/72U6*3Q5O?N]!97Z]FX(GM$*0.6(890\(JQZ05?DF?M4A M8TPK&,3>+M 8OE0$.=JNTCW7^M74%T+-*?A1V@F-B5:\D5D&&=P47(&0+[1T M&"THU/9 Q3=B(D*,DU(0.?S-W:7Q0Q*)<("_N'C!:*1,L?!#IUG 'T0)*5'=2!69[CNLU\4D;ULF3+)1 MCHN"$!5$$]TH&?HH,+K KW%9FU2[H<)(=Z"4=UYD.59/N(H:-M2Q29>B>2U% ML?0L&'_A3I3"X"OBTCVM?&MGFPPZ.KG"DOO&U&\;UEF*#5$DD+!7-"N/>X)MT=@@XL$&Q-J!P%!),EM M0!V4EL&.C+C^(H E6?(8Y_#E%8KL]V72KVZV,S4<#7FX<&ZIV\.]B:]4S;+ MD'XF=U:.[U$=W[NE.+XNO[5-L\_PW(=P.9I2^O9Y^3H?A(RF)L^&2LM_3/QM M,M(),X6?ZFI_YAE#*89&"FYW!L+1$JT"( MD+8LF=,\B\JG@HAUPYB(HC%BW7EI;0J;#IQ(RGJ 7\"R(7#9Z%@ WXN@WYN3 M7)"78Y3Y19-E?X-T52:8R2>RMKZ#FUY"E*H'K4,+$Z_@E:Y;4]0ND#)#"4E& M9>IRY2447=>70M>88DGADFVSO_HDFCQNH$P."F/R8HU8A"%YE/^8T"Y18,PG M==]%;,#$B*(@K_A4-AR0V)@.[>X]"!;C5)I*MRY#K#OWRYL8-FNZ>V*]J%TDM@N! M/.'V$$Y;$!MCKMSAH[K#3GLI_O!7MY$;(;H@91=.):G=<(*-\^?E%Z^=!Z"F MOC/[93$*!;HQ_G=6DW3U#L$NTA&ZL&:5RITL:6;:,OW;5BEOV!(2CW89^&FZYPC>^?1M[(9 MCVPSEG.P/&U;O_*WK5\AH (K)P M$ +-0)3H@#&53?K6YIQA#S(F!-&-B'-AMO,[=PP6 ,$.FBZJ2@INF]%%$&EY$#,X0[B34]\RGBGF%7>>=[Z"HOYJ'?"VXOXOST'K&W'B>N.5QP M^ BO'4R_-<(Y;]R8JD&Z]U^\^UG2'ARYWESMM+:K!!@++\"8C72>LG4V[:AB MKZQ5*XN;[@ _95Z*8RL,^(1!](9W 2J];3D1GPB_\PDB"2FXZ;#)6X?&*2%# M=T/!<>;&P(J"T94]QHV"1@]ID7[1$7@-\QB,D 3 \'PA_!P^(NVX&@EE.9$DVM M;7HQ5=N[TH6OU@6Y;EJ/92AGOJ2>A$@;-IS,1H+#,-[FNKL V55KNV=DB,8( ME4A=L$E":_N;SK1YH_]'G6]&D5=55J:HZ3072/4^ZB1O-TD_%Z1G(6$]K MZCI0W.MYBU='ZS[DMH*QK?*2P+6O?EUO]A2S3@A[]96\6R^+K-AT]B2@94\" MHU,QRVT0?5OGL\\$U_.23H?0+=C"IHO36G'1]D^CWI=O3[V]>%Z MD> UO^K#KWF[K)JN+%[42/N!T(QJE6B$*FM19$!6?@3L@,_ +Y\KJ)#ZF_:+)$SX*]PMX_ E^X!:6E*=4E=>0S8 MNP]#C;BTPK-9TS\@5!W&&%8:?,Y3;45A'8%\(=*JL4FOL5N!A1./1B3DL5'5/!S&P;R7O[!1^W('LU[S&G.BZ"67!G%M=XN@[\+<9C 3W\D(\8 M:DWQI?1HWFD1+:]]5J_K:M'0EFJBY .75 G!]N=?#KE=2HJ'\?/C.=O[I,+T MU'D^MN.$+ &/F=B6<+' ILR+3C$ZU$I)!4^@52-$-WD_D9+-'I4M-.H04Q2 M9@K8,P6'6RB0M*Z_LA5VY=,>V:Y87V[--363&.W+\ W'L5_8M EB0,'65 %\_ M8&V,-H(6<9-IA"$C1J.$ M6D1;-%(W:#MM"D%-:'0-0]QE7X<7ECC%VC;<,=B-5!F@GEL!_JL@^$9;*VPJ M6OT+#V\((F)>N[?2[*]3T.4<9'$:8]6W5)X#R'QN$!9+F<6SB3Z[LX^'PI=M M*[ #17Q%B!<,(K +1%M_7316^M3B3-=6B32V\8MA""_F/LW*H$%*'(E7"Z\["@=(=BBK55J4& K9'NJ.R;DV&-R2".L.OA=RIT98<%O7&-P6KAZ4=5 MU'<>"Q2U0)BAJ4^"&_4,;_'!M1Q@CIOCC[QIC(.B5VG#-;3# ^;I29=CA3'!V=LX^GW7/3Z^NV.>/IY>GGSZTC 3Z)Q 8&,LUOF*V M%,QR7Q:>)V6//:7TRVU@HL.T")GMWF'+>Z!Q*V&81OSL3V!*M\4R,Y6@*Z%3\1?V#H":EQI!K"QC0Q[/ M,^6^H%C=?&->"M!IP^)[2D.8M1$HR)V35.R[7Z:>5/EF ;@$*(Q_6=MU;Q1H M>)& F6)W^]\'Y6L'JG_;F>M/>]Z(][^_H*>R3(UJ4@;L]Y^'_]E<7_G*L,V^ M/\$3 XPD^I$:[P]E"(]^.E:8)[K O3#-;SXHF+ZS-F.M^!:$QUCH'=O!YUWH MT1_=R[,C]MOEI^N+%CL[/Y[Y#H_G\G2M.N_M5 W48SSIU5I7:WW1:WU6BKLL ML[S]C,SRO&'3KW6XVI.)[@(6\WF3?911*'H:4M.,7>5Z$&-!\'=]Q]G9"YCW MV%5&L#FO1<;U9):.N+?I;%5CZ>>0F,P9P.^VGSB ?YH#:[[?]'"O(3W\P7WH MJ7#R_L?#K6$VBM[_#U!+ P04 " ![69Y03,TW$UX( #O-@ % &5X M:&EB:70S,3%Q,3(P,C N:'1M[5MM<]LV$OZ<_ I4G7:<&;W+=AQ)\8PM*ZT[ M:=/S^,9S'R$"%'$&"18 )>M^_>T"I$R].)9CN1XU^F!9!!?8!;#/[K,@U?_A MXLO@^C]_#DED8TG^_/?YY\L!J=0:C9O.H-&XN+X@OU[__IDMRXOFK@4(<-J93A=699Y?1M'YM.W[[I M1YPR^/^F_T.M1BY4D,4\L230G%K.2&9$,B8WC)M;TB*UVEQRH-*9%N/(DG:S MW20W2M^*"2TDK+"2GP[O(C$2MM_PEZ"LD6OKCQ2;G?:9F!!C9Y)_K(0JL;60 MQD+.NMNAYVJ6K3W[S5MW8IM:$$ [LIU+Z6,@:O6) ]M]_@HO?,R(F%POUL[ M;$/+%LP<<&U%* **F#/?9/!_,P-#S+9AS<\_MHZ;O=>VXK)*;H24@L;D4YW\ M(L)0:58EO^EZE01NO6;$1M1VGV7HP@:W#[>SG:M>9^E(H.@15:565!F6=%Y*IB-_$PP/EF&-_,O#2>Z(#[!E0RHS)?%JK3RI#"V ML'Y-K_3)Z]6J+T4U;_7#-O8>,?*%/))$=,*)YA/!IY#%;"0,^2NC&B*%G$%[ MJK0E*B&?E(Y)JUG[%U$A.9-6"TI^T2I+J^0R">J]-;-U6]-P;O(\'WZ_I9"T M]^&GK5=[-WSXG!KP7/#1>$9N$S65G(UYU;MR[L!,P6XE"M@:=*8B(329D2RQ M.N.@"OB;HW+@V93$< 7.+4E( VC21,60]JWR]3F@#%+ MJB$P,%<>5E$BDR 4%6 )T]@G3T!-1$)I9J: L>:CX6Q4%M:0K'1VPU65DMP M-(4Q*]:^*"*='R]P^ST9?!V,'NX&1J\7'/KG'T_:K?<]DZ,PKT\P\:@0ZCJN M#\P[Y^V7A&KN< 4X$>@'X/^$&_0)82+L@6(QY%W,O7C-A FD,AGTPXRLE?0 M2[4*.(-F0PX 3XP#0#UHAG=!1),Q)V>0[*XR"1*M#JVUC@ZXMZ)UQ/R5OQ18 MZR8>V#@^P8Q8PKO'']JRL:)P05$(BG">RU$ ))!2=_?(_C9D.Q[QMR/[\.0; MH7U W^T$MB^X@1'!Q1V_?!Q_5:2^ ZR:)WZ\*2!)@RU&2<'<&:S)1D8P0;7 M"0A/OAW=2'"DS" A=N',./;LDK$R' RRD/RQ4TIQOS))D4/ M)P1]\0:>GB: M7JXNX-N(HR"D>>C/V8NF=>>JBT=V)WOPOP[X1[L(_HU3XTH,V#RI;AP*('Q, M!$.$4Z,2YV[40'3 PAAA3S4K( A!0="1D,+.D'ZO4XL!R:'5 =''D@714F'M M2,I=/J$TTRD$ N/*A2!0FCD#7(D]Y@E4 1+B =SA*08:%,D2ZS$/ 4FDP!/V MJ/].4!_L!NJ'$RHSEQ<1$CP,H>P5$W!FLZ9\G;/]#?*\OUQ?T3J00T?(T<;7 MS2.5V8'@Z^99SN,?@*&&2[@<$+ M[]ZK,,$#Z+S0='?68O$)^1:IM J"3",82KQUS:BQ,A;:\7$PC&5@E8HG/N3@ M@2XAH!HRX9)T;G@ 6'-GYWBLGF1SN]YYJR)JYB0?;S/!-CG!CF ( "9W"!3@/]X M E!$+OY7)L!\%Z6R)'"G\._VQVK?27[?D6.U,PDU)8SIWG2"OGB0' @.>,IY M\OQX:\KI+1)?7V,ZZNNJ8_>(N7C,]"24YB=1_O!]31*E##H:/L^A#R(ZKZFA M"\#2O9'DV+/Q?TIU]>P")0ZU)". MJH ,[I(H8,N]-)&#L.H9J4@F2DXXTM*$CO-W/W2>=WF<2C7C<'<:*9]IZ0+$ M 9);X>SU;9/1%\'&*Y1,L%E=0LY2+23I-*ONM>GGO/"Z:E.I_PK?+.=_O"XK M2##8R3FLP--Q2(>JK<60)6LA^HY%XLVCF55%@WN=V+?XH/+AN/[A_=%QL_@X M^JDW@EC.=2U04M+4\&[QI;Q&.' I3H$(V)M\K+0K#XSRNC92U*E[B8K"LY74N7WOYA2:_''E<+6TO@@]?V.A&@L&6OM2KQ%^/B"\X MO^6=?/;\W( ,:8#+ZEUWKBRKY[6I= MO;7?]Q>$B&=SS(\#">?/&G M"X^RD:5?YVR2@/UO7LH9M7.RI8K:;]'N?JX0FM*OG=X4:^U^^_6V[WZ4=OI_ M4$L#!!0 ( 'M9GE#A.5C]5P@ +\W 4 97AH:6)I=#,Q,G$Q,C R M,"YH=&WM6UMS&KD2?DY^A9:MW7*JP-R,G0!QE8/M/:G*;1/OILZC&&D8'6ND MB:0!7[S+'*\?,^-AT_?]9/.&7P_UG_IUJ-G.HH M3[ER)#*<.LY(;H4:D:^,VTO2)+7:7'*@LZD1H\215J/5(%^UN11C.I-PPDE^ M?':5B*%P_7JXA,GJQ6S]H6;3XSX38V+=5/+7E5@K5XMI*N2T>R%2;LD'/B&? M=4I5S]^SXO^\VVQDKH?:0\_C/B6*IM#7G@[.3P:M3O/LH-WJ#$[/7QT=GK4[ M;\X/VT>#-Z^.!I7C?IW"G^\U^YC-+(7BM83C6KK-5N.7Y>GZV+)*4:$2;H1; MT6-H8#ILGLU:FMO?NU,+QZ]VHMWE;)%RK'U&G#R7NJHMSJ*HG\3DV)2ZCK/DC%C1SDLG4Y M.I0QZ#>=$EB=S,)ECL\X3P5P25H)^R#&\67RI>]$% M\3'N9$1EL2U.9Y5[N:N%_6N$2>^]7\W]&]XK:'V[CKT[E-R0+9*$CCDQ?"SX M!**52X0EWW)JP"/(*;1GVCBB%3G7)B7-1NUWHF-R(IT1E/QF=)Y5R5L5[?=6 MK-8?3=V;R0-MN+FSX:>PX=9VV/ ;:L%RP4;3*;E4>B(Y&_%J,.7"@)F&TU(: M6!ETID(1JJ8D5\[D'*8"GN8I&U@V)2E<@7%+$M,(F@S1*81WIX/6 MFBF*I/22P[RE,2VT,5 &II2>Z\$<*! ) SP1Q!1T!TT8-V22B"@A-L>/Z_X3 M#E$B#((+2(65P "14TZ$2V"!-N.15Q#'S4 US6"9<#BP*<-I>1MV(/T!0=K> MMYE'/%B@L\A,,/#J&C(Z;/?O"6_M;0@WWN *<"+0#L'_"+=J$L GV0+$4 MXB[&7KQFPD92VQSZ840V6@: 949'G$&S)7N )\8!H $T9U=10M6(DQ,(=I]S M"1+--JTU.WL\:-'LL' 5+@7FM"H &\ _X0UW6GBA>F"B&B7"=-[T M2""E[O[#R/YATKRCUE,@^^#EWX3V'GVQ%=@^Y19&!!/W_/)N_%61^D8TM^MW M00XZY("E8J; :G5N8 (A&-A?7@%*:[\.%CJN [,Y>!NN*0>G 6MO098M0C\ M>%- D 9=K):"^5JKS8=6,$&-P 6(0+X]W5 X4FZ1$'MW9CU[]L%86PX*.0C^ MV"FC>%ZYI,@A8%E>B6MB#3T"32]G%_!MR%$0PCSTYVRC8=V;Z@+X?(:.!D5RY0+FP2&)#'C"#O7_$M1'VX'ZLS&5N8^+" D>QY#VBC$8LUV1 MOL[9_AIQ/ERNSF@]R*$CQ&@;\N:ASMWM&JS#1.A(]XBE=91E!L$0XFW MKA@UU=9!.S[VA;$L[-+LB0_9NZ5+#*B&2'A#NE \ JSYVCF6U54^U^M%T"JA M=D[R,89Z+\"9)Q=^/XK /R527')9%-)OR%^623(?KHZ$<)R-M57>O\ MX-4U_X26S1Q)]3JV8:@M@_DZS"$<[T'SE[+LN784,FVGC9TS:]\ 0Z:I<([S M[Q")H0;NCO>9 /W\('L >8C;%GD!_,=\?^:G^+=<@/K>)^4J\C7W%[LBVK\D MFF])$>U$0@8)8_HWFJ OEHTCP0%/!2N>%[,FG%XBS0T9I2>Z/A?V#Y1G#Y7N MA=*B[A1*[2M")F70T?)YQ+P5T44T EI#H5@/7MD"T;9ZFU,""_6(*IK+R M\=LF>/2"+77:.RSN:EK?PR(0Z-A .*H",K@/HH M_XI$ <)JX)]"C;4<D"Q &2C\+0]Q^;>FX$&T^0(,%A=0DYR8R0 MI-VH^I>A'_(:Z[).I?Y+?+,<__&Z/(%"9R?GL )+QR$]JA[-A]S0%KSO2*B@ M'LV=GC7XEX1#2W JKP[W7QUU#ANSC\XOO2'XX0#E_P4 MB("^ZG6E5;G=+84)#V&&RI(S"/?:I7MW^[6A=DZG-[@8;&MYG\O707ZA*6Q' MX5=+QXO@P]F7X^QYQ@^O;! 3]F R9@ _L75^J1QC 6'5;)U]. MWOUY7C[?YL=VA;\^A5XZ7WD#?'>N3':OWRH]1\+_B48X% M=O*GB#CY9"#EP,BVHO*U644&B> Q.9^SH(^AI'$7 [KQ.Y]M8T-E+M%^^4BU MA&"SV_NYM*.E7V\]FYVX_RW;\[[_D=WQ7U!+ P04 " ![69Y0Z+H&, P$ M #X$0 % &5X:&EB:70S,C%Q,3(P,C N:'1M[5AM4]LX$/X,OV(;YAB8 MB=_B0"')9<9UG#8=(#0QP_6CL.585UMR99F0^_6W3A+&T MVGWT/+M:X=Z+P=@/WY\'D*H\@_.+5R6@1\,#@]MUQ[8 M1P?#(]=S#P;NT':"]H'GMX_M1K]G$?S6J]8_Z\@9X]1(J=Y+QVG9OWP9KJ=' M[@/*>$HE4_>LN)(83@^OHV[$KN?^%H6B-\H@&9OQ3LWSPV'5C_-EB"N1Q>AB MI1"X+=.YB_<;H468+%1N1G*^&YMS/S8_F(2CX CAFP"FWN25 M=Q9,C?%O)\%[\/Q0S[1LN_5(X!^ORK\1PN]5J5BR>#B!C?Z(0R0XIY%N C!G M*@654GA7$8F[S!8PH860"D0"7J8D(_!:BJIHPHA')NQIV]V=HU;+[OHB+PA? MU$].=Q_0W5#('!S;> >)D+7? E&(&"B/L3FL]_[=H$^)C%)PG6;=//ZQF]T= MM]4E)20L0S2W>Y_2J$)[ACV$\!B"FR@E?$:Q9>4Y*TO-$WZT98P]#M Y178V MJ5ARMF8"N6K")#3T;&[XQR^["Y/#L ]D5@4N@%O6J]L=&FLO$^) MO"*3NJJ8I,JP?"+4+].I=)M>DGZLF*3ZFE1JMJ>KVG/CD9.2=UCUD-!R. M)P/L(9,G3YVOM+:GAO65QOK4L+Q"L@Q<^^[=Y>?*^,\!_/ +\.H.7I X9GQF M:#R=5OMNX_CAH/Y55C;^[=]:OQ*H7X)L]^JW,_T_ 5!+ P04 " ![69Y0 M/$CM4P@$ "0$0 % &5X:&EB:70S,C)Q,3(P,C N:'1M[5AM;]LV$/Z< M_(JK@P4)8%DO3M+$U@RHLKP:2.S45IKU(R-1$5>)5"DJCO?K=Y1?ZBY9U[P, M28$!?H'(X]W#Y^[AT7;?],=^^.D\@%3E&9Q?O#L=^M P3/.R[9MF/^S#^_#L M% Y:E@VA)+QDB@E.,M,,1@UHI$H5'=.]I:;4A+C]Y;[QC"@+Z(JIUQ!)"E1-(:J9/P:+F-:?@8;#&-MZ8MB M+MEUJL"Q' LNA?S,;LC*0C&5T5YPF[(KIEQS\8C!S&4T]TK$\YX;LQLHU3RC MOS82P961D)QE\T[(CQY4]EP G.:XM!_VC M(^LPL*SCH'WHM8^]D\"W#ZTCQSYQ3M[Z@T;/-0F^ZU6KCU7DC'%JI%3OI6,[ MUB]WP[EZY#Z@C*=4,G7/BBN)X?3P*NI&['KN7U$H>JL,DK%KWJEY?CJL^G&V M"'$ELAA=+#,$;:?E?(OW!Z%%6"Q4;D:R'XS-OA^;'TS"X6#H>^%P/$(=3*87 MWBB$QNK[("\+G]9/=W0=T-Q R!]LR/D B9.VW0!0B!LIC[ ZKO3\8]!F140IM MNUEWCT>[V=UI.UU20L(R1+/>^Y1&%=HS;"*$QQ#<1BGAUQ1[5IZSLM0\X4M; MQMCD )U39&>3B@5G*R:0JR9,279#E) 4S@B/JE(TT3$&4NR&PD<643B7M&2Q M[IXZJI\RFL" <;1F)(-QDJ"1U'G0@99D-P''="DTH:AD61%NEC5;,TON4R"O":6F,;S,Z!R^J\Z\5T\1YHCJ/JMJ, M)O%I>[)LZB'&-=>=@^/B]CE [=G[FD>K>_=3,[I445)E**D(DY?I\EJ7 MG*1?*B:IOCN5FNKI4H]V>X^@DB38AWOQ_CH]7PMT79S+'-DG[8.N+J"7/E=> M9Y*<[R:)<3RFB(@@SQE'8S"!A^E0L4*PZ64T]3;(,?THQ>.)P&<>2/_8OJX2^XS4G:GW;TTH.\UVY?&]@^]_J5A M>85D&;2M;V]9/YT(_]-KQ\;/\:W53_7ZSXEMM_[7I/<74$L#!!0 ( 'M9 MGE#"FJN4;! /.= 4 97AH:6)I=#DY,7$Q,C R,"YH=&WM76U3XL@6 M_KS[*WK=NEM.%8+@N+Y>JQ"8$1?%!71J/S9)0WI-NKG="0S[Z^\YG022$'1& M<=894S4Z$M)OYSGO?=(Y_:79;0S^NFD1Q_=<Y%-2M5%K76V3+\?W)<:4RF\W*L[VR5./*H%?!KMY7 M7"DU*]N^O77V\RE>.OOYIU.'41O^_^GTEYT=TI16X#'A$TLQZC.;!)J+,?ED M,WU/JF1G9W%G0T[FBH\=G]1V:[ODDU3W?$KC.WSNN^RL]=GA0^Z?5L*/,%@E M&NUT*.WYV:G-IT3['^WN[OA\WF[G[]=_A[?^]HM]'8 M.CNM4/@QK1*#NERP'8?A,HZKM=W_G/CLL[]#73X6QV9QJT.?XI6\27/A,,57 M6IB/LW"(H71MZ"(B"SDZ*E=/*WC#5T[- H28>O[0@U&CU!O7V M->FT!^V/]4&[>TVNZH-!J]=_TDQ=-MH )WTMJ38P8%T3D'Q+\2&H BY(//A7 M=W0M?4:JU2>W+S]UZ/ CWG[,?4##0G3A&F@U)BS.]).G]-NO>[437Y*ZZRM. MR4$4L*FPD-)(6_M'2Y;53M MB L*4Z(N3 ,NH!K62/0;JGQ2A:[A&NA@.2*^P\B? 5QFRIV3'IM(N$,*\D$J MN&-WYT\"\YHYW'+@5JY)4N$0^$Q]GUH.#!E/\%_#-:9)"=>D&*'PX[(QT&"B MI,68#3AI(-,4FH,=HF3&;4; Z(T9$L*#E3"ER80)O)-(!?T8RR5"AIU2Q66@ MR:W@2.(^$A;6+X#:4H&L"/)WH+BVN84V%+X94RZT'X%:(AP@T,%0*@L$BNB&)ZPF# *8/>;.;A MW)@N$W(7S=:?3V"6L#[+I=S3L,PY&>*RN0Z7!?UHEB11GG$O(CW#/$J6J'3PP+EL@$Z>G# M"",$P3!FB3!OXLJY\14B%$KQ=(&T84]\&"!9S=*C[W!1TILP&%=B$^T Y YH M7801VMEI28@QTQ1%P1A!+^!08#E#85@ M'JXK9T@2"UJ/)0)X3+;Y.Z(]>6_X"28&'HGK.W"+1LYP@?L,$6$^Z%3!JH%# M@/P@WNCLP&J&S*'N"%<"Z/$IMP-D5Y@H$',T@C5M\X>&F"CN 3 KQ#KJ8$ MG4TWR=B&F$#-!06AE25!0!4S2F$>S2A>V'!.QGA=(&/"@-M#"^ EAFDE(4+*@AL#E,^\$<\S]C"1"R>MA.F_U#? M1[*25-/XI43SEE!#Y>_(C]SX!'(<[OY5]X_V]4=2OX;HME7O#"X2OO=;IM76 M61YS(D>F?,>$CEUOVS29,;"0\'_>/0F!6CI4,9]'S WWHS4@&A1JV&LI(0*H MZ5 00V9/NDUF(#H:@3N"#E@)YP""50=;Z)+:00X .]7X;#0UP?7))/J M8#V%#08#+)\LD"^5?@U/AAMX#!6\K_,ND/XSL@Q\%#%8].CJ(K(Z1 M3630#0K3N0)7$_Q^F();)M-R)OYI@%&A-3KF3L*<9Q!8HT*V$#.8/[/(9N[,)=V30] MGZZ.0CT#R(-294G]#[Y:Z \M0PB(MX2FQF6+R 0>6N"C?V02 \Q$IA[X<]); M-)L$$$N@?Q@U>9YZWD2J8*]V$JI?<*>M0&MT_0PNP'[N0EL4&G:-AFW&45## ML$X]-%%OF5IY8MG""#2IYGKE2_C%Y@(\54T&D9IHR(6.*Y$&5Q:('%R$8+U$ M6BZ;@E)QR"4$S2:A%]U0(DV,K^ V$Q!]<"$6L&G)B+!-KNB<[)=0C;\'67NR MG("0;E!+&:E[I3)OC-QV:"<@K_ M!7(Q3HH>NCYU#YI;5"0D#QV->5+ZIA!%-$WBT%H(85>YC(('?@,!B'9*I",# MKCGXX+&X7VD6C-"=U#@D=TGF4\4\Y\"2$H=7E+K'MRQA=J[XEK#-SP& MHLFL$(A:",1A 40Z.1(E1!KU7HLTNOT!Z;4:W;M6[Z\B1_) CH0^D#2.\H;K MLQR+K,:/D:=(IST?H\O;SDX^Z$*S"55^G,6_#-"=9@:PMTRQ/)9&B4QONJ(< MA:9C-7G0%D#N"5*47GPFL-> M=('?M+3FF,MX8ZS]\6+0K]QV!KTZ"3_$VV"->K_U/57R?,-=A=2N8B5W#_'! MC8+5W8"X!&-E/\!L$^@U)G:%.!')LK1:K0?;>O&JJ$S17OC;47$?$SIF.[@! M>K]#1S"C8^K.Z%QO/;2,-\!S>5;B2DK%UN>4\\U")KRXHDH[6/D1QQ>?&/#A M'5=C+O(L0M7PV&ZU4)L9,(!D-A.(PFI)VUKJ7U# R+I_F/@ D>60VJ$A_%Y! M^$RQ::?>[Y-ZPY29=NJ?^K?M09^TK^^ZG3O<$V_MW-5ONCURT^LV;QN#PG"M MUFHDBT$6^Q^F:"RJ?5JI"#%U-1@ ?3,#]H90RM,NUTSW/>X[26U_>7O;(1TZ MU!D=\[#C?\5MVV4I_S^320^QJ.XC%M6C1#*] ",$XX;1Z9QL0UCAF1+B_HQ1 M4]LIWN7BDS4"#P-T+15*ADA!5'?ID'JIS8Z]:@10 4\:GEZY5=X #GT9K.*0 M:Z#KP1@K^*I[!2#Y?FJYN0E <@4#T^'X;S+A63CV"SCRU1=$"1 FZ U @N*0 MATAR@R*"HU:HJS7[1.7S34A'CEU?V;1+A'$%&OEH7)8_;@*-) SX).8EN+IL MGH/#;H%#+@Y=H(Z#Q6;JI2Q' T8"%RX_RU$K8,F%Y4):SL9@:=%5ZX'"\I=4 M]S$F7JQ09/G0 M_(%IQ$4>/,'9WUATJK\7 .7'*=R?(^EZX (8BGX[QVQ1;%A@LR9J8:.1>6HC MDJ 7,$"YZ;"<[,NB'K%(OZSQ$I@]Q*><7TQ^,KGB!2!%4+/.A]86Q?JGEQ.> M7)PRVRY+G X+G')QBG YEU39H?:!+G92#X5\*XNT!.NH "L7+-QIS@)VKN0, M_RS06D7K%55HU;['"JT\'OR@F(TUL_<%Q[TZ_=#VJ. ;#KJ[BHV7$=WRR9@B MR;XFI)-R\G)^Z(!]ICH&XY**@*HY.8HJ? HH,OL=T;%W/<9=]QLJJAB7L'BA M &8%F(]T. 2?Y86V._X FQY8]XN=P0]LJ P>X7;Y&\?#/([]*A\>P9.IPO.O MWC(^J_)BKJ0+=-M_=OM/A""G-X-)\>#FVMJW>AO4#Y;\C[E%+H!FX?F623V5 MJ%%ON!R?QNOC\8CFQ+I.I_$<=;92&6=*20N;O\;]B@[)BQ\%OV!AQ75=^=QR MHS)I?#Y<"G.:+834BLE1%ICT\Z\#%>9#/(\;?94/15'4F]$K]>M!>]"[[0^* MI\+7AVR"*/;@XRUKGUD]9WAPJ'E&[@/&Y(\R:N'^K%'P#*+:'$W^!7 \,4(( M\3@H\,C%X]R5WO\"KOU_ 9,B9EL#2I-1>P97U+\ 2IAL*D!9.:/VHMYK770[ MS5:/))_9>_-DRM;!N"Q]4.33^?9+//1L3=_SCDY[E;%Z<=!#KD"VKP>MWK5Q M=.N=XE"'-<_&AB\=>/0IU]33K1#2K7D_1MZSKF^9Z#EL&1[T_.:)DK$*%Z"B MK^C?#"Y'[Z]A3""C]@L[NP.0NU]=#+$,TS(Q2-G:Q7'"?V MG(M7;Y2<SQ#5OJ.1\7*=HMA6FQA^ER\-^JF. M%L?)IFJPH@H!4PB07Z< 3 M!HHI'3&EJ3^QN/OEO%MWAY@=+N6S+02?8[JJBA$U0'$H Q_:"1:?UO.\\]L> M?DO#=\"\1:X[P[U]?/T8>P;WIMP&HVKEE)*^)7WT&1YCRO DH^?%FM\]4Q8\ MF.;ZDHD4]<"#YAX\0!\TSX>)+:"N/"+ )Q+^1,$'Q3$+HM MAH4+G?H*=>HKJJ#=^U$J:.LVOBSQA:02.:Q/]3WU+8?-J"AE)=(\;H9O\GO$ MJ+CSZ""%PJB\-J%\[<%G%ZP.N/+),#,39?;Q[:$:K$ MW@9XM(@E?S@F/0>^ BV3G[$+^>J1Q%U>_J]$[C"M@7GJ=9F[%<^\%CZSN5LH MT8(_$XI7Y'X(O:KGEU*OQTZ%!1 M&U^B_)"ASR0UUG52(@,5IN2F/"Q=2S/NHHH_?)+WZ=P W/@#&/Q7&"N^/HX% MUW3(K*_5L1G/-.RD1/"<&P@OD\^P9S;M4)V&W%E[X]Q9,.?ZF"D9*44[$H^> MHS/LQ[(2AR7UVN"=U=.8WY1#G[.H[ 9RI:?/DO#QX4D?;^2](6E M=,NR#!2CIPA/JK)CJ>_CHD\C,/N%RB\8-7D<);7N8>2OWC=><&$WVI5;N_=6 M,J^-!>8LD_V]@Z/W>+9A]_&]N#"+?/!\+5]DD;]GGBTF\/I+:-[GE-#\%'\8 M2GM^]O-IQ?$]]^S_4$L#!!0 ( 'M9GE ;&;7-)@0 (8G 4 97AH M:6)I=#DY,G$Q,C R,"YH=&WM6EM3ZD@0?M9?T2>G/$^&A J2:0* 4NVO)5B M6?LX) .9VVXZ%U=0K5DEZ$G$$N)))PA:EF=:P.,2,K$ MM:SQ>%P:5TI<#*W>G:5%52W*>8I+H0R-QKZONQK[>WZ$4:C^[_G?3!/:/!C% MF$D(!$82AS!*"1O"8XC3)RB#:;[.;/%D(L@PDN#8C@V/7#R19Y3/D$12W.B\ M1*1/I&]-FTJ9-=/F]WDX:?@A>8943B@^-0:<27. 8D(G;H_$.(5K/(8['B/F M96,I^0N[93N1GD:O5C9\! S%:FUZWJP?V2?5ZG&[>5P[MT_.ZF?.<J1L-WT+J+UN5/W+-E#!L1EC;XI8=^\"3^$6:B)(AW?=YB7!"1M"?0*QD12 C#&P4]['0:PA3 M)I)PA"BD,7_2\Q$+06V%5,T-4*HV.S1$A*42;B-"20)77 BE_^&^"5T6E)1 M) $)_(HGU"JA/Y+ N%0:0 JBY,M(\-$P@C]&#$/%GJ(L+1#Q]3A\\U^*3&"( M RZ0/FW=$0NQT,B4+.WCS4:_#1Z>-O5TET@E.-!'%!M2G,->V.8?WRN.EP@^ MQ&SRXWOYR/8VY_G%L2@HR!?KF:Z=KU9[E#J1LG81 >,B1O3M2:;G*)$2]2F& M %,Z&STU;"-KIPD*\O;BU=V8A#)RG5JI7*]5RD[MP.MSH9+-##BE*$FQF__X M8+=&I5YS&8*:HE"P4\/1I9\,]4.\CLY 334=GQQX^:3W8X[S: M/?(FEE]>"'^YM_6];6-I#VK A3<\Y%PJ&^,E#T7E-\ MQN&3E&>U%&IV4Y'?-90VFTYN ^4U&C4%T/[T@FE%%%"<>7$SOB7:, M<<<8=XSQ"XZXXG-7F>XJTZW/V]^ZR=I>UZP[PCD^N,FW_([?\10&\/).V ME&TRSLQE,\[/4EBCL6RV^3^Z6=@&QKL8QE4I+'Q6M)=O*]DG:?M^]JUUF>4-4*B3PX'P <8$! \ !M;RTR,#(P,#,S,2YX2NAO]=3> QOV7OSW/?&$_ST97SCEQ@QG$W.E3"#CTG"?$I\YW#[(? MSIB2F?.=T!]H 0X/0R9'_?',O,_,G<(9< #G%#T&'%X2.CN'8Q#X_,M!@/\; M !^-$?2$"CZ4160(4C]S0">0WX 99'/@PB\'4\[GGX^/GYZ>CH OI(,CE\R. M3SHGG<[I:?? $2 Q^^PC_"-#^_Q(_2-")\>2[EC^_ @8C,EGQ%0P)A@'LW+1 M'J?'_&4.CP71H:""%+E+/CU3ED$2>'S)D];_W7'X8YH4U:!%F'& W27:YX)U MGDX5=??3IT_'ZMM-,B: NM+5PFTN/X3/R@3-=*< M-R'C&K5939/5U2CO30WK3\P@"W[7K$@&W:,)61R[),"*=P#VG&P!CBKAE^.\W%R) M 8/>+?Y5_9VW9\0-B^W+BS>=MZ_[9RV# OG3:R,@["34<=)Z?,7YTVD MTE_V@51TZ V@5'Q:P->)EX)X;5B\;1T6RS+WKJ_US9#">_!L3/XZ ;*B$MHP M.FD=1D*S0PZ>FS+N@^X5_-T7&$^LB+Q0DWWX;6GXW8-''ZZ[#8N$U@7%:>?] M::?;.BC"DG;)LV? _3&A),">L/T98(C=CH=[DFQ M137S9ES WH4)HKLIH' $YP%UIX!!U=.LM:[6%:"MMH51H9FC59E.4JBC2MW7 MX3+_-$F-#&759T3=TV*:;.;6'4R#(!;B^- 'V-1%:8[:]*9[4I;>A.R.XM]1 M0Z^8L]1)J&WHNB=E^4G:$?M$)&50#R%%Q$-N M1"S'3@,L_+.Z'UE SI<][;O9ZJ3[ 'L6 6?S"19WMRO]<9\.4^O;LIA*8+D 9R M:KPC>C3QG^S5[H0APU6B0VV]W3BC34[U]"? MIROZ<^_!HLGO.'%_3(GO0B25&+Z?,C&<:32N]2LFULTPGW9)9ID:!X;RI(L\.NG9SOJFM1TN' M4C\UIFHUT,9686UN3;%5-0K<1UE;'\@][I4.]C06?J6+:F"PLH[Q*3,9J MJ;7*\H'L/ECK8Z+)!'UCJ;73]R?=DNG[AF&RD]/[TB 0FV_WR;+4Y["=\APV MX=]54_?$WYP&C%\)\1.E6=-6VDA8?=O]6.L>Y\U2MI,(W]E&,#',Q3_ MG- A)5[@KL6'&H%:/[[3^/'B<"$+<*(2]M[,&!]/?-CW 6,]5\H7^8KZ2AA+ M4+S<"[?Y(\@"O_G@L%4A.J]W/NB\+@MP5*%.6*HCBG7"KZ."'56R$Q6]CP:6 M]HH8ID"6=LT08GDQF,IHL>L''O1:AL0*)6GC0M>J9P- %9T- \$2E1\EPY$& M^_!@E]"#%/A?R0)2K,8.5^")!8BO'@=:D=KFOVS0GG9X5(*3%/%GYD2%['W* M+GU"Q=C@3 P7Y) PX,WVEAG*TE;;3SHOAJ(=*=N)A.^]Q[Y"+(,[-91;W7O5 MLK3>*YN437LO$IT>+=\"ND=FB$?T&O .:0K[MIM5X2V MN=55U*1$U7VJ,IVH4"G?4"AW/$Z@J[LIU[6,; RE:SU M>=GD4MKG84&.+"G)"H[H"IQ("?53%$7[D$G9\ I-IIP] M"">#\$\U8%D](NKE:1N"]QJ'AS*/E7PG_! .L?:N9#<$IP>]ZZC?6I':&JQS MJ"CA,#MBWE?/M /FLY[W?P'CLI43=IR+40F[@YR'-QY\1WQZTE$K;3+_NH>4 M(B[&,>I3ENP&/OV+T!\M8N&U5-$V"KKD_V9X[22J.;%N<@/7LMSP&OF33K@L M&::.*1W5YSRUT-.1BN[CD*DL.S;L _9$FB_MF%BL-Z$P7.U=/<)6*$0;.V6K MV^G8"8U-][6[A$#+46"#[=CGO*S!P:B]'H$?;D;-NFZUS"S ML(9"M=F);FHWUD'N8 FUD&%R+-?ZKIV'NUX\O#B,=$DE+_LIB)0EDT/!TXXC.\@CW\O4LZ0;!Z4C6 M';+N.7SD9H95E+4[[+H?2W;82;8=L^=J;4PI9VUCTOWXMMCX2S$[?Y5+O$-Z M* 9&\IHN,P\4N.JC_;0DVI>[MH=RH"2%[+#5Y0U;KAB%G",_$+E^_N=&M6-% MV?7UY[1DG;SH0>>-*DR-=Z/B2JCV%4U:H4FR6\%;F^]V3TORW3*7[5[2FSJK M()\K4!-O9HXHY:QM^SJ?2MJ^]#F&I9P==\ 9G"",PXFY"S4NCDXULMOQ)7J& MWI B%P[E1.E<=M3*.:$FBFF6+?=;'3+W'PQ'D,WNCAN@![(JPIG-+KZJ!-M * ^B*0(LTDB$E[[-+E')"K1RY SW1 M*]H9E3UK%ZJVC[/8JI< T7\ /Q 9%D4+-<0H(VL=30W+T<9,86-,1"B]W.9;&RBQ$_7!,/^NN+C :%:<.C,,&M M#P]5O*/*/XP4<$(-#B,5'*7#/DQB\ZTV+V(D2>O@PCBOPL$[/G%29NSP,9L' M3"'PT>_0^PH09FM*&@QD:UU;V#%5X=KXU9ND-$<5Y[R).OF]RV-C-1G&U_#7 M#N4[GTJ&\A6NV[W1?)*LL@$.[\6Z@VY $3<^&U\OHGY\7S:3GY(G7T6,+NM* M1.Z]$]HAGHXJ_M*HN6Q91GVS^;$DY='Y5PRHXHFVLI]WL_6L]5+RXP#W'M%J M^4^K$K114)BTT4=!:APM"'IG@UU?H3;V4)\23%9,@]L6HHV$0AK5-!+"@O?! M8.BG;T'@OW(HE!:A#83"5$G30/CV\'"U#P,C'Y7\V"3W;EU*?8;^L21#UP:# M/EKVV7S&%7?!; ;HR^TX1;6^]J!.NK8I*,R:Z)T;E2AU+W;EH:N#\%>")3F O@3I=/D]V.U[V0_1/TJ-^"5O:>NT&H.&\BS50O M+'1+WF]31V_VJ]HKA]X(NO(T&QHC-]R O]: JI2N#9/"?)U1F!3*VSN]S"U- M.G9#6?7[&-^7=.M&#MV]+GT$%Q 'D%U2,I-'92AP.9/'XOL!XV0&J:'?#.34 M+XJ4;?B.A3IC(=59B@W/PR\%[[V5LO)JDUXKR*T?WIZ6')XP\^;.[Q*X@^H2 MH1&<$RI'(&8>+'#5)]$?2FI;),)9RMAAHR='>JOOC1IP.&N6O[0NI3Z/^5"2 MQQ29S"?(SPF\JOH"XQ)J+WZ3GX%HQMM MP"-3"<&7 TX#>*!<-R/_Z9T-\!E<7,/9(Z0'#@8S^.4@_R7R?6G,F)4%0A;B M@2SG*R7!_,O!\R/UT632/X?F/+P:J> %_>_HAP'\P1![XZ,O<(&%0/(XF!IQ(Z M@@(N0_(Z*;J01X14P?(>T4E8VT2'/,"B&9([.,.C%CT^ >M#C1,UBB%H@'Z*- MD-406.LTQB ?S.8 4?FUB+FS@"$,&;MX1EQ>J9LXSHCT%8%Z\/$U<5X\R^<6 M1#X@JME03DO)U]88[T?F-3:"3HYM%JKH5,[D2C>;]HD?S!X1N /L!^ B>Q5U M-]MSF!!NK'NH -<'&'@(X&C0=0UP,!94(D&D+(O.B-(Z>&0F8D4].MPY.CWM MGHIF2)WFR6'3DED,K'O4Z71N"!<=2 !/.B>GE=BJ*:V&]R&C]+L:>%64%L,[ M.3K)*/VA$EXUI<7P3H^Z)^\2I4^[E?"J*:V#ISJPY6VG.405/]H'0F[>546+ MY/HH#Z+\QTT/;N1=1\DYH?0S\Q=G@_OS'B<#S"$5 [6+9SF^@",I,4:U,O?J MBCM4D!E,72J2"S)A^=61,"5H_L+2"X=TPRTO4JM'5,:W42X@N8AZ)6!%B M14=W<7\776 -EG=E P8O?7F[3(^+H//DS3+9#K IDVV]>^%MQYZ_$);]W8/^ M2*#)@34DMA[D&:2BZFO Y8CL!T4 IS+L=+@*=/9#HR\@GS_KB*P'U9\"[PGZ MNCI6(+,?&"%S;>W*$=D/*O \-(50!RM/9CVP\Z,S2IZP!E>>RGY8 "/H,Z(% M5J"S'UJ )C@_IZRELAY6]/BO!E:>RGY8X/'<)J!NO!_ENIKFOL\U36P5+G=N/;7%)/ MW0WD@W(Y<&:T=D.,GL>K0Y8GV?16_O*SU;W)A,*):,DOGB%U$8-J;VD6D3&/ M;><+:Y&?H_$84BBDGT'^!,704SCL13[CJ [3BL9D^0[64,"41RXG&L.L*K+% M_ETIY%4"(SEI6H\Y0[=5 1#O@Q]@#\ZA^)]T((6N2*O9#9DA#'BRX;R=B WO MKJ]7/MQ9?N&C"1(Z7A(Z#*@[%=V.&?8Z]LWNO3?1^_8)J\L19C* S.%FV;8$ MYDC\)%IJXZBN8K41;M*>KAS0IB)>L;5>&7WZ0,A@'/?+&C_7<&WH1$DMR"BA M6JHI Y.R*9J;=L]F FSHC)/K_N7]BR3@(P@\Y+^<0PZI[%9D4,:IQ U);FO+ M'L5;E["-'W1;"0A6=]YP.!+"1,V]IV@B>M+$U^D'&^)$3;&V,E^;4BUH6=:% MMFT4:@1O941&YQ//"*!>."QD;6Q4+LZ*5+,UD-Y\3J0^WME+6%T@5'<63(GO MB9\?Y@2K?D8,MA?B,\IG;YM1X ]J>T(W8.^J0E_5QC^OXK^^1?]H(;H<6)]# M)K?0_X0 7:'([;5O:@[C]0.U46';;-,P5J*Y()'JR3D#Q$5O$H84A*]FX%5+ MWEYKEV&MKL$0OH[EUZ/%]GKA5H&83/D2?G\J:#;0?*]/DRU..HI&L,(3N^$$ M[135&J1MVZ3!_P9").+J>AMYIREC:DUQ>9MQ#^, ^.&*60MC-2S&UEMR,\A? M4G=BEYHF1[")Y;@5[@M:@#FAR;1C;E&]ZE?;-@A$!^J_$M%B8>6!*_#$A'.R M>/1DF]XH$&EX3X$'57O-9 .5]:SFMFM+;%9'R1ENQ)&9^FY4@P[Z71.3SK==S?#Z]1=\EG<;01L MG3$R.!K:H9QWVTSP5KCS0S/D69:M ]S"YQ6\VV:"=RU,4,&[;29XW\($%;S; M9H(/+4Q0P;MM)OC8P@05O-MF@D\M3%#!NV4FZ'96-T$5[[:9H-O"!!6\VV:" MDQ8FJ.#=-A.T2(>K>+?-!"VRPRK>;3-!F]'A'V5DV'U?AJ.9*>I%;)M!/K2) MBBKF;3/"QS9&J&+>-B-\:F.$*N:M,D(#R-L)\)X"S-2[D/^2-W6L,$VDDV"? M.7ST/,"8+!0GN[KJY]%6$]@&9C";AP2*D8S[A,JE5[10T_4!1BXHB>/&7)M> MM1A@E\J=PN D_=UA^!%ZK;$9D1JVUFV*O=B#RV0%P _>C^CEWX_(^]5 M0V+K8CCW-A)4KP7?DZI%PP;TFX_;!90W>;R,P-.UT)(BX+.A+T\.1Y]N("?C M$620+B!+$#9EVX[%X"6N[U0H?][H3BB / 8JRSC.@ MW1Z/10G< .UK_%9:GV%L#K:5N+)S&\M3DAR*IKEUT-PG^T("]^; M:>[QS],7N8$H>%28UXFAJ'.3"E5/;-TNGPJ'?7MXN,I6GVY+ZS4^4'7_P6 M_MGW 6.EPW,S4OL QFEK=!$A"_RBCVII-IT>)>I=,)>2IW,X)RQYW+[Z9\N2 MH *<9.@8[BB]@A/@7T)YB:L:25Z#Y_1[L*LP;J37:F.#8?C4:W8/KSFY=;UT M#> +H=I,9!ID/"2,RYDL-:V$)->:F5R.GDWD?18J(9.X)5@0*K4+#RN8("JRV SP 8^;0RQCLA+D#>%]2#D:(^@9P"LE MW_!AJU)%10=._(41I@*I?8Z*$Z"B(>CY/G'CZV!R9YC:"MGHT25CY3-WPC3FLC1_S<*(S^FIH4,% MU#R-91&<4>^>BKJ&<.\.13>INE!^GIA J^&UJRE*;BE@\X!#=AMP*<$ 9SF' MI0X=8!"N.QK$9I[63HVN,!?'4U/+MXYO*&#^\)\6DX_/62\7"M M*9K+VA*3K,,46V:"Z%D'/B9456@-VA)R&RL\&5\#'(Q%:QS0U#5NAK1V(DJF MJ,[A OIDKM;3-- JF2S%J*J0#E-,9&F5"O4;03DMKTOVRJBMAG4_!;P/YF<$ M>X2.X'\#1.$-D1^-<-:RVQR3T946YW L=RP982VP6.W85?J^K>SQ:I1.6LM; M;.9C(S&6&2*\\D'TX.?0C2>^5"8;W?+&BI8M650:!AC)@:WYS%L]QU;,NHV@%ZC8 MO"=RT[P8 *_,CFI)-X2#Z<6?2?RS9]PK[7Z)W.?3',VVRIQB66?XL\+^J_(DVOB:?RF0H\M0R6.:BH:U775DZY M:3C7@/Z 4L6>-Q,C9[DQ3TW#8?D8CGRF="K[X24F<_(M.5@D +T(L=XU8DRT MX^@&/EW#9^02\9UH[S![\1< (Y#=AMB8:],;$Z-M=G*&X)+0GN\7QQ_U)):E MFE7>A$#>QB=)!G@>\.]0;G^%7D^T\J+BR8-2\G6G>TASVYA78=RT3V^@T-4E M,R@;FMX"(*4.)^>EW',X 0ZX(S7/D!ZEWL=H(L#4?%YC"E!FY(GX1AMX9 MQ.(/SI:GY&2/#WPRCKZX>';]0.8U=Y ND*M.]LH-#T)-]>Y?ZH!HIBG\*279 MUHJ^CI75NVN!7#F0JX%30"?PM!!&L-7>7K5-\)>R[>-T"D4=;XY\BS;%@*_ A3,4'/D>;Z-YX?1$DOU<[^U M%!N>1%CN*@B7.VXQGT+UB$Y*W3P.#>VF$%6$XJV\4)P\ M1--V.[\%S!N]ZY%DWVJJ+@WC?[0,60T?QA9HD+YO]+PF/YKQ61$WI/26E M-YJ8DULVXY*&FQU$R01>1'8X % C!\RB(6P_"JX4]N:\6S(R4.CN@6JOHZMX M2D8'6JI-Q_,04(Y$VJ[>]DKN+3F7<[WH4<[^B*1'5,_D\P6@ 986(KHN1)'(<)?>_*Q,E M%GP-T=;U*SE#<@U:H$.;-]\Z!&Z9T1J])Z6Q5U-9UIFJHNV.5K:3W53Q.81L MXZTGLRTQCS2.])0[QKRSESMW2H@?-KXN+X5HQ& W6!8K+U/(6WI%W,Q[5'6P M35FM,\!4C*GFUX12Q![N>CF(%3]:#D*TR#U?Q!U0RM1"JB#=>$9%H1C%16L- M\A:,,.&5QRU%QALE.DM(AL2V94!5SBP<<,MYL/KW3;NM;*7(:)BS"N.6N',$ M%\1?2%A*\4O@RDFW%;+HS5)N!"M<[BI[.1?+ 0I.]%ZV- -MNAJL(EGQ%_A9X M)75 2V5;':AIGXK3FZ;$MH%\N+NOJKSE/]D&X+O(&^)M-7=R5RZ<(%>N)N3" MSX#.1FBEW4G9#S]/^5^.I>Y,].8S\.N?_A]02P,$% @ >UF>4'_?)*92 M* /ZL! !, !M;RTR,#(P,#,S,5]C86PN>&UL[7U;E+?OW7&%(295'4D#,#TCY;E7A% M$I?N1J-O:#3^^M]?+B=//H5F5M73GY^2/^.G3\+4U;Z:GO_\],,[=/+N]-6K MI__]MS_]]?\A]#_/WKY^\KQVB\LPG3\Y;8*9!__D/*[#[./3V)37S[Y MO6X^5I\,0LM.3]H_)M7TXU_2/];,PI,OL^HO,W<1+LWKVIEY._?%?'[UEY]^ M^OSY\Y^_V&;RY[HY_XEBS'ZZZ?5@B_0)73=#Z2M$*&+DSU]F_ND3P' Z:^?N M,,EU\R_WVG]F;6NBM?ZI_?6FZ:S:U!"&)3_]SZ^OW[5XHFHZFYNI"T__]J!OBD_3?#V]?W1G$3.9-9?[LZLN?TL\_GOIF_#;-XLW'S1 ">^KHRM)M6\"K/G86ZJR5!8[CQ?7G+\ M9IH&/GT*PV+]T+!YD3MKPGOSI7/S84G0;_+O@5"G9N+H0:EU!X*\)'MO["0, MQ2MW!QL$D6?&?3QOZL74PY3/S*R:O8E Y-GUO-LA[]H["ZB[R:A]1\N"RED] MJ5SU&-_L.DH6T-]=F 8&NUHT[@*LF)9E!UF0#@-G0;#+CMYMC&' #M,0J_G9 MQ$P? VY#R\%!V'$S=N@Y.(C)'/:+27@33^O+JWH*BP/+]%N8GX6F K_#K1HG MT?L*/)'+W7'I/<7@2'?BW@?;#P+.:3WU83H+'OZ8@8CRR7=[9B;))WEW$<)C MGD/W_IG /0/!-)U?A'GES*0O[!L'&P^1=R"06BL#^/+4S"Y>3NK/^]!_ZSB9 MP(NX\7]<2'9O;B?Q?5_&M/ M-!X>\% (]=W]>XP^%JK 'R^K*36/=7';P 78?)S/XFUO>$;J=%/N8 M,QX%23;*\"RDZ3+ST9'H6J*"B;]1362GW(X 929H%\MSW]&&0B7-%J:/>]X; MFPX/Q G\/6\6L_GK:EZ=MWAW9:I=!AD>\!?_-%=U<];4?N%Z =]MH!$0F)Y/ MPNG$S&8G+DT(6ZK]"B"!%E_?0\_)VS!;3+KKCB$&'PG1U<0@><-L??:S,$W' M;ZT\F;K)P@>_)[;[SS \RB\#F%=F\DO]*3335G2^-I]G8&SMCEO7H49 8E(W M(!Z?@Y@/SK&"& O3&.F\Y"DJ7\#YGCS MKKJL)J;YUPMD'TV$F&IX KZOSB_GL S0Q MRS];";P[?IW&&1[\W^KINOKHLT)=AQH!B:O+$_]O,, 2@SRO9E<@:&?OPGR^ M/-[[O9I?4-S:\4D$O ]-4\U!,+>?[C;[+7S^5]U\W /YD4$8GFBM)+R&] -X M!4T+WBTP)^=-6#H^NY-C_\%'0O3=9?UQ:0:M1.:M<;@O>CL,.0)2(.<_5>'S MFWC2-DNJK3F[_# S*UGX-DQ2[.MV%_;0H,---CPA;@^ 5I;NGO*WTSC#@]_1 M9W^HP_ ?5AW8_N87=T&&@@!8- S ^^;9H-,_CS8^?9YUUL,-N5N*[.M MQR @74? SD NIC2"[> \U'H44%)V@ .1];R:@#;RW_[+ M5LVWUL^=^/?K>M95Z>:8>302O315\T\S6< &;ZI/K3#=U&QO0NPW_OCH?I@E MMIT8]Q',)&@]>W/5IK\!Y\(/O]8^3/KCO/LDHR&^FW+=98310%[F[7Z8-N"+ M5/\)_A=336<]]V7W,4=#JXN6>[S?(.#=2J;9J^DR=^!=<(NFO3NP'<).7<<' M\MH8A1LZ+XFE33^L=1=9 @^=%]!^+Q60D M-+<-G1/)#3]VD8!#C3X^JN\6EY>F^?HFKK7JOY0=1AT$M=_"9[!&ZT4;YOAE M4?EDQ_]6S_\5YB>^O@(+=3L2W?MG K<+<^TZRB"@W[?TKQ7,TO[8#G+7WEE M/;TPT_.T#5\8=W&3I?XF#N51Y9L_"[G>!I<"Z56LEK>%AR'"8Z-F0:W+;MMM MC$' ?AL^A>DBS%XV]64*X38&G/%T%'6ZF,WKR] \ G+W_IG WSU<2G M3?#5S4'.>U(T/S<]/R=,GGT,Z"FG_7(YB&G>/:^^6=EFU^&F6 M',(T(JI @USW3R5KA%=5:BD4SLRW9%C-T;LP5D(_HG\)D M/KO^!J5O$":K4DW_M?IZ(]TV<-6VYJ7G7% B#&)6%8A&0I!Q4B%&A8PT4BUE MS">+]Q:WI8.]3*VRJ%#$H*@Y1M9J?LT13$K)CU6B#K= .TG./6AVG[,/I($& M1^_[TSEKA1J>AP@ ^E5IA-FR6$/RS9N9F=1Q^?D&Z'\W(:UOD#[I MO#=S0U%&75@?8!F%L 3I:#PR%LN5.%;2<"&.6->-R+C?P5+DTHP/*/HMRO&! M'B6103,=*;*!1V14P9"/C"'!?)24&.UU.%9V&URO#$^LXU H@^)UA.;F3MKC MQ9>K=,OY5EJLOM@J+CJ:HGDF+@4OG#,>!*@'F22T]H@Z;5R.?J)<4OM< O"7FA M!>,L9\SE8#'^1XDPU"' T05LAEW^^KC6X!B4ZW'9FH\2>5QC]( >Y%B,_IVN MVO$HWDW9"4.>;N]66#OGS/E.^/JQ9,K+<\+6; M,UK6=T5Y0F(SM%NL[:Y#E+XH8L!4HTA91#I(AR0&[1-$+(3F7-MOL\6[&=AC M46)-;>V$_EJ_,A!..;,,,68($EQH9+@@"!=%<,JSJ ([=GMZG 6NQR5CKC.- M^W"_FLX#R-;=M\UZQQ(K&ZWR*<2@);)@]H,[(#UB4A*%*67<=_)&#VF?'HAQ M>M+Q<)R3[&8W#_YM +-X^F::OFO-RVW!CEV&*240-*IT_JV]0-([B3S0 (%' M$ 1L*TE"CWP,=LM5Z,=CJT')>C@F.[E,R=+_:0G])JY=@-Z)QQXQ<", M14HRA2(I#/*"4$2M,3']Z +=G\7X#\UB0U+U6#CL#(C6K$< '@IH]ANPE-8) MRJA#+H7.>!$XBCIZ1(W2F#/GN;3[\YWXD17F2/0]' >FLJ'GTU3@ >B7ME': M1<\7X7U]6Z^O+7F^:)+[U7XD.['D7C.4T2LK*?&@&*0&&GJ+@HT:E 7AUAM> M"-$C(UC^T+(Q%\5'#Q@^]E32D,&)7=\]RAAY2!?;I\#:7V$YMVR]]6:EI>1:XH+0-9+AY&AI$ !$$8XX! %U1*8?Q!W_IAY95R" M96>6E]6TFET$_TM=^]V9Y>'>)?4AT$)1I!B80D(R@3BW$0GB<5#&X$AZY$SS M[Y19!B58+F99N\>=JJT_^+[=!DYYK"M8[9$8CT&-!L]1@:5!1$2'@@F%YD 2 MUDVFC(YY-R3+E([*"B61LXXC:^"?@ N,L"&1:$:X4$=_!6W81:N')%8NEC^M M+R^K^8V3M^DQK0V,L*57R;UFW.*41F(=,D$X%*,%HQ%,1Z]HC#IVQW49EOX/1^7"X/1]A;B\#5U8CJ&*F+"BO30X#ET6R'6.1'^6P/RN94@_6T!;DM,?V( M[EMO6D8LC*5<(&H] 4]9"@3FLD>$2V*$D42('BD%A^*7W19K@XKK2:-<*W_B M?94(9";IO;!7TU-S5.=2&XR]#Q$YYRB*6CM4,&&0E)8$HKBV M]N@33@;FCE&HEJ\,R=RD(Y2;%WYOBV.FPQ6W]0SV\NDQ632=N;8CDO?FR3=CL-E*I ME7*$<8DLYQP9)0L$=,$H,A,J/_BSL"#R< >B:SVKQ(5PF M2FRFPY*"IZ9IOJ8'J"Y3$?>M=LSNPY5>,$NE!>KX=**H342,.HRH<%P&&P-E MQ;'KHU$C,YFHFHOGSIKZ*C3SKVV"07K3#,"_2F'/[9DIV[J5G )2#B0[,=PA MHKU'HG :4/; M>Z:BE8K:H[\]/MRRUB/3[@">P?, 9JBKS/(1[*M):)=HZMM:!YS<306/""91T^K?#S5\!STULXN7D_KSX7(O$P3I_VE!/YE) JN]CU^E^RWI M!UCLNU^LM=P6H\B)PEII"0@>N]=\ M.!X:BJ:'X9GDD.W(-K==2J>BIQZ4N2FB1U[9B&@1"Q0M"U&8Z%S1(T4P3TS_ M6#BG%UFS'2?W(=;RSL^KJ4OAR/ \+/][$]UZ\<6U[[2]!!9Z>G[AY]>FQ',CN@Y0D1*^9:^M98T2-Y,AH72!F"FPBZ,?8+5CQW1H= M(S-0G7%E.3C6PMT/9NY/M7P7PQ^/<6WAC"[=RV!#I%P9\",I09(5'FE/P73T/&5! MXZ#ZE+O((Y^7Z1?OS9=5FZMC+2U9\DX)39XB:B6 M 1#G 41VT,A0HZ(A4?KC3P7/QD-#DS+?!;_KK)WT+._RB/37,+](.OWFB?0:OO9.*EL2B:3R U8!RF M(I?7Y3#>3&^_VWYX_6C?TM*""XTC\E9YY'B;":TITD1['%-I#]8C'SA3XE4V MJ30\-;/&#[N^Q[3A%1Z,M2O UDL;PJ,0N41%L!2F \\5.T)BT<, DC^2\AJ$ M>AGUU3>>YMO@ K#T>L6:S7KJX7ZED58(K@JDI..(T930QAC0$)Q5S7D1N>CA MQA<_E%09FI*'XYSKV_;;HT%;^Y616L8C"$_*N4"$AH!H*EL?#7:"8^U%G]HX MZ@?GG'Z4/!SGG#B7L@=G9^9K8ON=N.>;OB7H6R(E"%LQWU)_2-IJC&(>5 F:A9K/F/8EYTVCU)*#8(7%ZF^''6(PQ9"7J7H!9?! M4Q^*@O9PNM*+%C\X9PU&U[W*>MT'Z;:BX,.,TJUC22F.V#"#G& 2!44U,HY? MOU@2HS:L3P'X'R*H/!HILQTT+!]Y.IDN;VN=@6G?A'G5M.#?E,2<+J]Y0,.M MYQ&[CE6"!C=%"!@ 8SU]AJO++!GFD<@"/44,9R29S@MD+,:%]8ZW.LB,/FAPM>Y*'PX M#FQWU0W95C?F'ROQVG60DGIF@M$,8:D$*B1/UZ>I0,9Z;C5QUO(^%TQ^N/CV M>'0],(?=9M$8J'SCG:7E:U#/G:<,@)0CZPB@LD:'>(.G3-=W"@!-4,!Z-)Q&\ MHV,_%_[^A:,ZE3HBP5-I%$4> M7!/$VYP*20RR&)2[Y[S0[/@3P8^(L48B^C&P7)=87_L,SXG_]V*9[]632WO, M6-IH'0O>(9+^L=%)Y,#Y0M&F5]%)$5B?^OPDCW,Y/#?MP*YYJ;_76=,V\!_. M0NS$GP..7A*)J<(./&\!LH1Y6R!PQE='+=0:QD./&V%YA.QHK'A80A^#8'U9 M-[!^T^7E:/?U?0-[RKA5.G_[:;7F0\G5_2"W_T;^0<5*IFI7VVB\\/6V#CN=^=;#E!G M:%*C@3"%>1(.B:%\^C]2* M("0FPU1O&-,,.("_/1)Q#Q^W.WBH#BA\*PVV1[9OVY6!%-@% @XJ \>Q2L.,M,%9Y)(CSB)S M2!"K4[E-KS !9=VGD%.^G)R!."8' 0]SDV_Y+M("0%^=H((8?Q8B&$UK&8TO MOLP; VM734WS]170?+8S"XXX:\F5MI* MULXIA'EV*$B2@4:FLA"6&>8/6 Y ME)N3Z4Y::$/K4GF+B9<>&>!A)-KGJ#GPDC*6&S"7#:7#A%9&??KP2-;_6]=A M$'KGVKMMK=6E^MK"0VNM2JT<%2868"U:@Z0V#!&:WL43U'J02$SHH^>=WFM4 M#TF??#<;/X7I(EQOEP:*E A.;%EU6D/26BP/_\]O#$'J.55BF' M)3CB6*?"U^G-6>Z\1:8HG%6A$,$=_0M=>Z_UOB7+WXP [>S?30VU5N*WL-##G4HFN'8DE4./Z02'65J9H4A@,PGBUF MU10TTXLOZ8((@'*CL<"W79T\IN]/F^ W&I<#C%J2P JC64#<@PNN".-(^NA7 MV(L0B.@1',XD(@;DF@,0-%^48>F<+8FT*G/T6&+[YBXE*;R,%F/DE3,@@PV( M9&$,I=P&OPJ.6*V C_9ZLW,3-[$ MU1 FV![% M9C+)OV/EY,,OUA^UV([M';%CY=4_:K<=1>VV_X.<-VZMMT,E&=Q_(?"!=(,< M#R3=!^9P3S?*++/HGQ[0K0_/3(ZV&9Z7ME)6.(+HOO&GNVP MXEVZETHI+;&T2*EH$/4B(!8MJ!RFK',^:J%[/"6;Q_$>@!M&HM5>D;VE0GD7 MW&+Y)/(V>W];\_*$GR@86STC5#][_IR?/GNN7K(7@C+)R8O3E\>>5-QC70>D MRYX5NZZGJZ9WC(B%G56^,@\4FNS8LZ3:",Z!)![^0$(&CV0H5C%F0;UF1:>; MQ(=TW/JM[DADRGIW825JNCR(MK%]:;T27/B 7'2@OR(CR,8H4?#88]V)*?9:T1_N==6;ZMFIU$N'9S(WM"\=]T$*IU$B M%2H,-H!?81 G0GFB95&P83)UO@N>&(I&^9R^91WLKX^=I-XV*YTK*(Z<(^XT M1L( ;U.0I&#GJ*!PI";2'EE\.8W](5:\)VFR!=B7J88G,5:3"DS7Q[?[ SW* M"!@!)F#7,B>!8DREUQ@5XH&J0+#DN$_5MYS>P!#+/QR5#N ,/,X$]QN7A6+@ MS=* HF$:<04\;J00B*9,1 SJSL8> C^G&S#$^@]"H(Q%BZY",_^:BC[,P71) M9LO5ZH;R%B;8UJWDE,O@*$?$<(>(]AZ) E0=HYX;%3"8VCT2]XKOQ5$8F$:' M4@N=P@,/=RJ5L-H&K)$@TB,I"4.4L(@4TU&*0$(A>YSQJ^^%&P:E4"Y>6*L[ MNF7QUUJ5G"O)"B6!,(XC:U(N,RXPPH9$HAGA0O'#'5.M0?JXHKO?N&38.R.P M1Z:P'KD8,=)<&\1\88*2VL%OQ^[M[KU:]0CDR1;QNOLV2X?0U\8.I7;I"(8R M5%@>D5. G+46]JMU.EIMO([B.V* O1;NVWC84)3*R OI-96;=/HV![H31SS8 MK93$%HZ!")?<<*0U-XA2SD"B<^D*;#SG/01#GI#'\'PQ)+WVNZ.PA.'VH91K M'+\^O-Y=NI7.&,M!9Z-8% X%X2W2$@3GZJ$57P@^3);M\:_W2/3*Z_LN$=C) M/-C>L8RF*%2RZ UC#GFL>/+VP6H,E L!9 "[_]AC(@-+A,$IEM$E>E_O%B>[ MW[XT!0U%$75Z3] B:5E P<(>\,Y1QZ4QLH^.R!,E&9@CAB)4-D:H4MW[J>]N M1S[0H\31*.:2UZ\81U10NKRIQPOEM66,>M*#&?(QC,H"(6$C&!*2J,%#CJE$'2PXW( M'ECH%W$"J_.#[ ]TK.47&MF"H&TQ0ZQM(<()K /G#"*." B M^9[B#[W88GA:9>2/M3O$J](+Z;AP'8-.QV\[#50Z&;@R@@()"H52I!8920)2 M0'-%M/14]S SLL M5X['0N$>4BE[2*0_PPQ%IL.$2;OFC6SL4I+DOP4-]GQ!*,*,TY03@<%GH(IS MYXT//5+*L@=&^JFHX8ATB&OT.]W-OO,JF 05H84T=N@0Y\7HW,]&S#*TMY/*!R,B/ENE%R9 MKZO]O.Z_;^&5A[J4 CLPL-.+UT(H)*U7R#(O41$\N'%"*5P,\Z[A =X6'YI7 M!B1BME3D&X!O3H).Z\O+>MH6.]DF7+9V+#GQ!0T>(VVHA4FC13JJ@(QG+(K@ M#.U6.>.@%=%RB9BA29DQC_U&-J[S_MLP2;>RSTPS_[J#CMHV1%E0S*WA!!5, M<51$19&)FJ7+ 409*[&S/6S3/.&3 ZBL@6F:\Q[MVM%TY=_7RUI+J8R?F7Y] M]G6'^@K]!RVCB;#@,2(50-=K8B.B@5(4O;(\!,F<[5$^)T]<)1/W9:7R(23= MM;A^63=MQ& WCV3'D4KFO<=4ITQ8*)I3L<:B0)T'F M ")H,&KF]@5!9L(V6#3NPLP ^MW\P8<[ERPJ#%NH ,UN8'(-FT> MC2>167S T.UJ*=_7)^Y_%U43'KRCW&%[/3X(4$/Y*+%%BI.8GHT02(&*0H%C MKCV3DHMAJ@,=8)OU7OT'MMDH9-WK]M0]B!XH(@ZPW99W?C6=S9M%^WVW33;. M1*7%JI"%5$@I19&60![/P5!J;QQ1AR7!/3*D#ALL'HKUCH;T>['G&G3[U[C< MTK7DCEM0C!Y%+BTRTDBD"[IZ^8;:2)GN<4?CL('C 5EH+&(>P-9K;1B5XH(HRGK(I:4#.1XNL$Z X MA-+<;/]XS/\:TBWW99^M#.8U!>6D(&N7E@VON7S?90+&_B=M? M_'Z\=\6N7W MY!CFW9\T=8!YLTUS G^#KSN;OP:S\KP=:[MI-30 +_YIKEJ3UR_U7 !:T^/H>>D[>AMEB\MA[2J, MH("O) P6P?E#.9,3D$R MD:?I+97@\T+W,H"0,I-?ZD^AF;:&^VOS>;:HYIG!F-0-;-MGL)&3"[&8A[SS M_P)*L+DC*3+/OS"- 8LL[6;?.HSOJLMJ8II?S1SLM-EOIFG:N%9>L/X>X.>+ M4].TCX*^#2ZQR==#;?%_+/QYRZ(I3P;HU/KSZ2Y<\KC?U]8X5\/72Z /!>3K MI.IG'Z")6?[9[OF\,("EORYU#D6*WZXN3_R_%\O V_-J=@7;>G9;@>OW:GY! M<1LQ2%S_/C1-!495J]'\W6:_A<__JIN/><%OM^$UV!]@BJ:%]1:RD_,F+(,= M!P#LW67]<:DY5IOT5O7E!N=3>C9E+=L>"!I M]LY=!+^8A#=QI78/L#6S&J ?UFW"K#H$6.+,G(?QIEC/TQEG]'SDN@Z(GL&N MO@!=FV^F9V96N71N5DU R/EO?]X_0KOA+ P2])8O1;; M0F5NH-I\/K;W<"5XJ9A: :XQ=QXYJPH4G%R]>,8$Y^ @'RZ.>P>O[0D?M^W* M0 KL @&&>&0O-O'+5U?*X9/GR M(HAJL#-@J]J$$V 'UL;MY^M=F:#LM#4&G:+D@F$LM$VA'HNPD2DE"\36=+LWM%ZWIN'J@>_8F MOJR^!'!%*P?N%K@#5\ED>-MZ?M#X]V1$Y' 0-D'](L;@TDELNP6N,R#^'OPY MP#T]<6YQN6@M\]:AN'-&FS@Q@VF\">J7IFK:1^ANDWDV-3LL;!]FB0#;K=WR1)LOKZ):ZT.G6&T_5WZ#:U*'4DP(OD?V'BP-A5' M48'=IZC72K+H%>UT>6@0K-UHOYVV!\-?D*U [-)8AAX((;17ERF5Y> MV8+]WF.60@5%G*4(/"P-H$J7LO0(DL1)Q1S&SAW]2T=[KWU]."KF2OMX(,W[ M45ZZUZ,,GD4=*4-. V;!&(*(*P3B,9(8=(%#?5R M$Q@TORPJGSRNW^KYO\+\Q-=7:_&/X77-XW./K>WN.V7K88)#SGQZ8:;GR19X M8=Q%:E=/@87>Q-X>9::"D'?@NHT-=4@FZ]*]),%3:11%WG.+N,81>4D,LI@[ MX3DO-.M4 VJLR_(NG116L7(M8[0O/FY;N"6&J_+H9^"3U[X#I8:2,2L8M)NS/3-X7GG_BONAR1YOFH/_=%<9DN/S\$W M\Y1,.Q-]Y(@:&E AHT?$.(5 56MM+1A@H4=ADCS&ZN$8; 1.[[,T!V7UVE5W M$-F#BS<,46)'8Q%+*>RCQF0QXT;W0K( M2^ C9L8N.K[/L"4M:!","F0EQ\AY\)@5-1'Q()UO;Y"K'N_>Y%'IV;BE/Y?V M(?P1L^G@#)HH)$)D3"O0)<1R9 401Q',_FH\> M0'LLD',/C]$/EQZ#:.R@VMOP*4P7X>8:;6/Q?: MFQ1OPU7=I AGOIEND[ ?OK'17E?.3H/5Y^=F;JZ!S [#H_R_DA3I'VMFX6]_ M^O]02P,$% @ >UF>4.1XJ:Z=O DD8) !, !M;RTR,#(P,#,S,5]D M968N>&ULY+UIE]LXLB;\?7Y%O36?JPK[_H"0J,VTM7$"*RMM=)YTI 2#BB2 B$ A$_/O__/HP_^ES5BQG M^>)O/\-?P<\_98M)/ITM[O[V\Y_O?U'OS:M7/__/__'?_OW_^^67_ZW?O?[) MYI/U0[98_62*+%UETY^^S%;W/_UKFBW_^NFVR!]^^E=>_#7[G/[RR[;33YM? MYK/%7_]6_OB8+K.?OBYG_[:M\DJXVS[Y?K3[]VV^_??GRY=>O'XOY MKWEQ]QL" /^V[W6T1?G7+U6S7\J/?H'H%PQ__;J<_OQ3H'"QW#R[QD.JYN6W MT]6^P]/&]+?ME_NF/PS]!6_:0BGE;YMO]TV7LT,-PZ#PM__]Q^OW&TA^F2V6 MJW0QR7[^'__MIY^VR!7Y/'N7W?Y4_OOGNU?/!DGGJV*6_CK)'WXKO_Y-+9?9 MZM7#IW16E'QR7V?'_* 7(G%%K?_ MWGB8U;=/V=]^7L[*%C__]%O/D_\C_[SYY-7B7;9<%>O):ET$H7T]2S_.YK/5 M+%O:;)7.YK&H;/R\8>%XDQ9%^.MS%I?J8\,.2]Q-D7U(O]9N'A>";@\?%J@/ MZ<=Y%HOPYX-%(42GD[_NBGR]F(9'ZG0Y6[Z]#?@NJ^>>GGG=WH-,M=D+UW:T M04BYR>>SR>RR.R41A28^!!"*SS1C<;(\ZT MLT5V.UO=S-/%N:[DU8F!:K^VPUFZ3SKG,_.%A_A+P/"]+&R@AR:=+E MO9_G7]K@?W*<@:8?7K$BNP]MPN+ATF(1-@.=23DUYC!D1:+D,I-_O\HG?]WG M\VE6+-U_K&>K;QW).#[@I0CJ^O:W&+TO4H-\^-DBK$6S=/YJ<9L7#S7V ,W' M&7CZAUL^6W1K*?8^GS@*2 ZNX8- 4^?)HX.H6E&#B7]030R.7,,)#0QH'KU;#6[V]!=5ZB:#!)_XNZ?Z:>\N"GR MZ7K2:?+U!NJ!@,7=/#/S=+E4D_*!X97:?!1F$EI\^Q!ZSM]ER_6\ONZ(,7A/ MA.X>'%;>;/GTZ3?9HCQVVJPGB\E\/+$K G"WGS:9\= MHX=IK],B7:RR/%^]C";I\4?Z6H5;/5FWJXH0\A U' MZ8YZETU*J?[69?5N.&)\DOZQGMYM7LN;=%:Z8L,R]'E6'JPO?5Y\R#^FDTD> M/M[.LPNE<1X4'X#7L[O[U?+/T"3=_KI9@9O35VN<^--_DR^>JH\N'*H[5 ]$ M?'I0T_\7#+!20.QL^2DLM,OWV6JU/=[[UVQUC\#&CB^7@ ]94_/6\ MV9OLR__)B[]:$-_S%.*#MED)JYG^&78%Q69ZCY-1=T6VW?@TAZ/]X#T1^OXA M_VMK!NV6S$?CL"UY#8;L@:BPSG^>95_>WJI-LU*U%3^R<]/[KEF4A]OLX^KTS:]"U-=J,ED_;#>J/F-]?/,__TZ7]95ND,\ MN3>(?#HK_IG.U^$%+V:?-XOIH6:M@6@W?O_D_KDLQ7:>3OX*9E)HO7S[:1/^ M%B0W?/%'/LWFW6EN_I#>"&^F7)N,T-N4MR&[?RZ*L!>9_6WCYIU9V5-4:-0MJ;[$NP1O/UQLWQ^WHV+>WX-_GJ_V0K M-UMK!W5<,\?!*YWV:1TI,]N9]M;LG% .#?J(*35>=N:C1%EVN^RS]EB MG2U]D3^4+MPB#9OQ\BC*K)>K_"$KSDRY?O^!IMO,2&@_7A1RWF>;<^UWV:>\ M*%?8TY,]UKJ7J3R>B1P_8'^URA[JO:*Q1N^'U.W?-EVEU;S:$75VG%ZF7V=E M.=WGZ+328E+-;/?KT\GMDP3,%JO?IK.'WW9M?DOGWX7J'TE#4&46*%,8T,T\ MG_2,/:GP>[FFYHM?IMEMNIZO6D[QZ#@]3CA_2&>+[O-]-DSTZ6Y&_^4A>_B8 M%6WG>FB,V!.]#^,5D_7'[)<]-"VG>V*DHY,.0C-;S,KU[77X<]>ZG%?<'!?; MYV=?5]EB6NXLAIM!R\01EYCJ:=V^GU$YGVI&\WQR2%8V?HQF__MYS"1I$GW!"-J$?)"<2"M1L(Q PTCE@*E$;3\.?'S,D]-7NRXT2_U MC\; ,T(V1&RV*(_I&4Z T&"41'H/K6- 4DTEM5109W98<&B(J(/%HVRJ8O)3 M7DRSXF\_PZKG;K%II"O+;$)],C8?"K! 6_A@LUC^VV2>+[/IWWX.#\@>/PRF M=GB]W/:%#.ODUCQI(VW+8O5$TL)?WTM9^"C9W^-Y/\D6:3'+U=?9H1?J:-M$ MDD X 90ZARRS5#-C*P"PA$-*S FM\Z,$]<+D/"Y:&W'IB_.[:?VY6'[*)K/; M63:US\R@[[E_K'TB-> 4&>:@LI2%ETR"BB9AJ2+)07.P5TDX:HH^RD$$'N7] MH?,R.'\9CC^C97P,'Y[1/B^R2;I<_?%L]W"$R\\;)\I+ RSDVFN'!%#6RCTU MW DV)(L/[8&^XV]WKAS@<2=(6C(XIJ5\1*?7[)DHII3Q#GA.'4>*2B5Y1:_@ MPK<6 72]&KX?[(:2E0_A:=^A1X9EJ#?Y9I>RT.0/#[--^,=1EI_KDCB) MG;:43AK-*_4B/1*"@_I1UBE@CG=(0F HM)1Q@ M5V3N->?9.0GHA-'+DX7QFW<7$X$()MV_9HM,KY?AYW+Y?E6$5>UN-BD-U>.* MOD:O!#AJO3,.TZ =M2LMF$J=:>NA&Y^1UYD'>5_H7,;[8*\ M"%:,K07?8Y\"1L!H*.Z_SA=WJZQX^-%"W29\/B$) MY[HFDH:WQUMLH&?. J:UJ]9%XXW K:6B-\N_5ZF(C->CA/S[;]]!%>;ZUV ! M'S%J6[RPL! &7) 029B7A%L;7G5&) T[1N@\P*J6K^.EA(5 XX6S5!,"J,36 M$*W5#HN@\_"0!WW=PT)J,[9#6$@SP$87%O(D#^HNW/A$7,CAQHFEAD-&- F+ MGP[V%U$$5!!(#5Y$8$AM-N>1X>KSV/C'"9X,#SC6/.%264@A0PI@SYDQD(L] M1=:!<3H*8K#H)+<[H?,2^#XJI\!8V'V9C$!SID3#BM"94 M.HRYT8B(H&5W]#E!5/MM0B]Q(MW9E/0HY@.J2;8#367A_(#28ENRM[YTX&GK5+).+( 1=DFTM. M(7=&[FEA$*IQFGR1^?0]]R,@=-U<'Y7!-R9F1S@#*O/M9N7JM"M6L3RGS\_V M253I#,5<< L5)L0[3F UZ_+,8SRF7$?4\WX0:<7'MT4ZW]WXKL'!8ZT33"3V MA$F@L(% "$N\KWQ;FK'V3I?>O/6=>1<)B]8GL#78]4.SA&%BK,8.$ATHM,QA MJ26%"#+*+*:P-9^:A]4,Q:>N( RE ]5\OLUD7G=+?+A# KP)N[[P@S(12#+" M$52)GW&D_3$Z&2>+H\+1ZFW\[O@J74PKW5Z>9&T,>?>UK/83#/Q-,=R-I5!^ M;HIL.EL=?GF[CIHP!BP!!%EEH)?2F+#YJRBWU,CQZ=->CE&&A[*5$#VIDFQ+ MT+/IKB[Q7Z[_7L_X?=E.8#)IN3,/I_4=P2K P0?%KJA9Y%P M[#6R 5\HB5- 4X)VO@H/F#,C-!SZ$M*10]_7RMAZ\4LHT- !Z9 $@'(JB<6R MFK_I$B'2FRUSP?6M(5KM]A*E^OV!QE)\F^J^-B,EP91S4"C,&#/.&B*(0Q6% M5C@S/L.G+WD8 +[(.LY]_5060GUNNR->+LK9P M6=UM^?;VI@A\V,WA8@\>37[*;9^@>8S)^N,R^X]UN:Z5V33*/ WG M(L\.]TB$3CB]3)D89T3::$1A%")P M-N[B8/M$6$PEA!H;@D'8Q6GK>44;EVR,T6O=^72:\ZV0Z?.FT=LOB[!;OY]] M.G&K\%F;Q$C+F#<...\9Y PH_XB$[!"3V'-X>3Q5WQ630?AY\L+8=ZT2KX2& MAF-JJ?$:0^J\J.:/,1II(J$.?#C$R4Y87!]/1Z5X+\/*"%[OOV?SV==7BT7^ M>5NV[?5K'8IZ;]ZR M(GB937Z]RS__-LUFVSK$3O#G4:&X$CZ.2@]>A'UC4H,44<*YC@YLAL-@?H'[M,C>99]V&;=NBORN2!_.^8R/=DJP5YP:(H0!B%!@ M$$=@1Z6!J$,RH^;QB9=V&\<"Z;*B<-Y1>*);PC0(BYTAT'*"A8+&N6JE,X0R M.$Z5&Y.%M:2B$UHO63Y&I9Q["B0UHWHG)'<=F2]XQ4.XZOY^4\9 MVU^B9(.F$54!RKYF@WG(A M*W!L^#ED7:-+\3H^3'VZ)!]SM6R#,/[(5O?YM"S*L=QD8/WQTRQ[DSX<"R_H M.F2"!"8:F3)7!#700TQ997992'S[V.#F=PTN>"@Q((1]"M>Q:9YT?Y_NE!CE MK+=(&0D1%81PCBM5:\LT8.,T+8=C:MXSDB]-7D9E:EZCF$0P2I1^M=#9YU/6 MQ[,FB7 <4^,,)!:PQTQ2.S)%+:]ENCEC"46P'D4--J9C7_^^?JD<;C_/G%6 M>L2P#J83!@0SKG45$F&!E>TS5_62NC ^;UI#T8HQIL@7^?+W(E]_>K68_'J* M1P>;)I P"KC!1A#K@R7*-H;)-JZ6"SKD0==%V!4#E:%<,7_,%GD1Z'^U6&5% MH'U_>'L3#-4RCO\NT]]NPKYC<>BN7HM1$FX)TL9SXYT)NQ4@)*AVI([8,2VT M0\22]X?<4!)4Y4XP^(\'2<46AA-1Q M"<)[5.K1'0:(<3L>!36$^/2%6ROC8SN9]]ED'5;%6;;\URQ,:[UZEZ73V?R; MSI,ORCM:@1?A^7?;)EW-I$-C)I!J K!W'#J#'-="R>K-\SZ\ MAP/Z,$>P8@V%XV#GH24L/QX#KL/K5,S^,YNJAWR]6)VRGFJ.D%!H,!;::QI6 M7<(4<;!"W%NJVAB5A5J\\CWB&[8&]95/J4CGA(740BJKFJSV$;<+?)K!&6QPT==<7C MQ! )XT0*@KDBU#%FE*7850@(T,$)WEO6D\%D)1YLK4SHPZO:NVPYF97I%AZ7 MM\KC$"4 $]!H"1IWUR-IRNU >3AN @6SO!^PMH4E/AO)0$#Z* M2R_Y3LZE^[C)Y[/)[(*)3KX+D-@J09.NFH M4X]$CB3W""JDB Y*DDFI)0A6>P4-1 H!J,[M^)'DSD*XY4A@J$+2V M1)*+TOHB$ -?4>JYX^,,]XG)PB8AP^W0>LGR,:KPGK&*18P D2$BR9TDPC". M$: H_,N$"!_L%+$WPZ:@B1!=7)LMS2/)FR%UO4XP9;V'6# @A"=8>(/*D(TM MG<%F&[1,7KQ=:UN#,QY2%Y&(S:%3->'2$;,]YJPK&D>Z)X1I+K@)ZZA @D#E M'<<5Y2*89M<9?Q!%1N) ]A(]III(HSQU3&M*K.2,)H/O\WSBY=SL;%EZ+M;%8Z[I$V]IK?X)HU:4!A.S M'ABE$7-5Z6C(.&&U:L#UM-'9A_#_2,GRD93E.?=:HW$2#ZRQ4A).N*+".:47J(\C-+Q-A8QN S[=]6$M@OBLS7R;%[@^7KTE?^N1:*$L0 C+8FA6'IN MB.;5O '@9IP68DOLO^=<)PRNAX>CLNJ&9=UP+/LC_3I[6!\_,?VA3>(5"&M, ML%PIDX:B0 7?.TLTI^UCP7O)A] *]3P.[4-953^J"5/>;YE]7&_R@^IO[N'3 M//]VTI:J/48B"-*($00%50Q;Q80D>PP\'&&!CGZ=@'TA=SGI*4MP3E;9U*]7 M :%J^L^H>I>5R >VO;WU >&>Y)5:T8<@CT M""WXH>5O(&C[/E%[8O4^FL3[&K#+M[=/JLKN&I?G@Z\688C_(L=20#(&"-'" M \>T9!1SN#D"I9Q; FOIXI=T+,4\9(*(8(P9:)6U%A*\PP-*BMJO#1Q[1#J67* ^CWK$4,)B% MA100SX@'R M+0$4Q)J!]78KACZ5J,Z_IL50SC/[K'$MAQ G@@D-((,:"06W% MWM3#NGT\U?#'4FUEIW_8+N=1>9\5GV>33?AJHSW?DWX)\DASX2"13E$F>9GH MNZ(5.5\K!'&,?K>VNYR8:%U.,JI,18U%XVG'A"!((30.:A4H%0)JZ"MJ@7?M M??(7]HG%DXT.<%W>$1O6VG6Q>+O1JVJYS%;-/$?'ATETL/,,(8(HZ3R"4DI2 M(2& %>WU3F]7#X86G&C@74Z,#OM)U<>@:M-)LU7G]% )9=Y##Y0DFG&G@!' M5(@@VJ&2:6\9$(<6IZ@ 7DZDU$->K&;_N;G:\O;V]X#T\G4>WHIF"]/141+J MH.4 (*0=*:TZCAW=OUK&C*BP_F'=!JNI"014'T72S58FK617F,N/GS5);-2$](C$& >@'*B[#>&P6HL!5^ M)&RG6TMD;]EH%!0CQ\@. 8FU:W\RVEM^ MUW%89@V!&S FHN<;Q28/ RV6Y57]Q3*?SZ9IV 3I-#QYDKV_SY[L02_PZ&W= MB_ML-9ND\V'G\7X5?CYL U!,NKSW\_S+P% \FT+^\*G([DN_^^?,I<5BMKB[ MX'0N/X--VH#[?!X6I^4V3<'%8H#VT]HO5Z<"77YHG'A#)"72 F@QY,8K!+9G M*3L;OO.L80*]-!A(2P0&!FIMO5([BK E>D@?]LGXG"[,^"&5 M> <$1AUMLZ=LEPUD'YEW+B'CJ7X)=YQB"1@ADB,$.+5&5 !QQ8?,N]4L]J8E MGX^)2P1PAK)COYOJV8"*@^T3HSB0V$J'# '!U,*.H>H%LU".]$I/9+X=K, 3 M!ZF7)0VCC*T9DQ!, H!ML("5B%$%"0C M]/IVY,WW29P[(C(4E]5TND$XG=^DL^FKA4D_S5;I_"S'3_9+! (,0\"5Q!YS M2S%@>D\K\B-TQ\;E?DQT!@RG3$L_2K7O.RL"ASLDB&$,O48R6$J."*JI)15U M5':X5-AW"KQ(O(\"RV"O_V2R?EC/RYWW)FCKF0]B>_WF_%)0=XR$0DN!@)(9 MXH D&E8.N( !MK3]LM!W5;U8RT)/2 TE+<_R.9Z5BP.M$\0]9$QBPAE7%-&P ME0+[MT"H]K9@WS7N(DE =TR&XO7STGI5S-59II_JEC #O1*>68^=T,8[!/:H M2=2APF'?E>DB<3\B.$.)05B52I'-;+;]]]7B1Z_LNT"/SXLO:7$JZ7+#D1*! M06DC,T8!M"H82Y;:"@_#R*"9PFIF;8_G:NP7K*&$Y\!AZ<#FP=2IH# &]O/Z1?3PACG>X)Q1!IIXRT3 :"%;:D M8@#5096-;Q,_E(CU -]YP3E0.4=-_]]ZN=J5OVB37_YANCM@? M/H79;D+^WF4!C.5LE>V"_K:A,KMHK,THB^F6ID"*N[W-)JM V &)NL L$A74 MA2K3)6)F-'>*"8KWF@3J]AO(WEP(?0OF^+DP6!#>[/-LFBVFRR?.]S*NYU30 MW9$NB0DOL*=><"6L0QAXBJI#7QHT0OOPAMX<%4,M@)$@NXC/JJ=20<8ABH!T MS&#%7-CO8>]WE#/L.V0Q[LVO,92P] !?SW&9+:+2+A;"&&Q5/PM+]&26SE\M M;O/B8;.HCV *AUL^"_R,G-:K5HK,_;2>SN21N4%5;E*JO3X1Y-=FF$1)AYDG MCG"D)$.4*[4-;4:00$1JWR;0,..54<1 88S!5".PHQ52).VE M P/[96#>)UA#QA#6E:3J[Y MW0F=E\#W4<4"CH7=P['Y7?8I+S8.TM?973IWBU7 .3L>"G2V3P*A=) @ZS % MSEEIK-G31CP<4>WE."S*^P%FL'?;S64Q ^F3L[^NT2!,#TR? W^:(YST]W2E18Y@Q'#ECF,/+2$5\M>X1U MN9X7/=2C![9'Q6:P2QN;G(4UDOX];Y@03[%$ '"%E:2(;>I<[:CQE ]9Z;T> MI_OUT4=!:;#;F.GROLR%%/XI#QT_I_/-9=2528OBVVQQMSE;/2$*M?HGE"+! MF! <.!QDW3KJT5[>B6\?H-];(&Q;YGU_7;,'>(:[N#?)PHS+%$)OLI59%\7F MR.>H*!QLGW %E)&.(\:]PM@P9/;("=7A9DYO0:616!\#CN%N8WS.2E7U+1JZ@XZQ2AM08-,+2 MCMW8DP^$5"L)V,0,'YQ7#<[7[)SH8.\ 0SA@2.GP@EBYMU4I#]"-;P&/Q?%^ M$!I\3?]77OSU:G%3Y)-L%TI^0C :]$X<%\8 (C$@E!$M-$>XHMLJT3X\L<=@ M_@B2T1]$@XN&#]@O[[/I[WD^;2X:QWLGWGB!M2?A'\^)-IBS/=T$V?;&0(_A M]'V(1C2(+F$)UK0 DV#/.F(Y4QZ%'\Z7IB22<:.]85A"Z8#03KG*9\D(XR,LWQ#)RH\#R*!W M^;:4G^?UCXT3X2C&4G =5B*#A1,&F8HJID'[>*K>7NE(;.Z,Q;#.VO/,?4Y+ MF01$>Q^&!$'U<,:<]A4M5LKV]R][NU$2B:]=8!B*I<&"_)05JV^;3:5:3$N/ MX:?2*?U[D2]/662G.R;*$ A9(,LB";VFT$I>42NP:'\ QT?.]*BX#/9B/R9S MLMFG(IO,-D%>X?=YML%_,7U::.,HC:?6A$B/2+BU'!'@"+"<,R\X=W2/(/#M M,P:(D4O6A1"\^$IT>E=PJELB "3((X8XUSC/-O2&\3-?=VE+JG!X#K=PY[98FV0]T(@#20QG%7B6]90[7#T/_:3W1[@ M:74&L+TJ_#Z;K(M-%J7/V2YCPV&O_]'FB418::T]LYABRY!E'.[G:G"'*S1C M/:F-"$?K [SMXV:+9[?"GP0,'3^U.]N\0 ;RECR,&P M$W# 06K8;O9"P ZITN!U^.H: C 4^U[/TH]A5=G<[C@?*76@=2*X=#:0QAU7 M2 G **BTC^"VP\V6ON+AAPF7[0[54"+P_CXO5A^RXD'G19%_>5K,[E NV1]; M)X()C(F1'DN,E2<4.KP7;4W;1T[TMFOJQ)WOD[]V1F2PESU?W)43M=G'&@&P M!UHGS ,N## PJ*%@:$+B]CI(<&A'=%VY#TYW1V1 KWN^7I1E0[^5(;LUSM4. M=DB$,#QL)A@B@)118=3ZZOQ?:*+;9RGJ;<\5D]]10!F0Y<4ZFSZA?S??.C=@ MSO5-M)1$2DZ!)L1XZK Q9$>S)'J,"44C"T)4? :6B3_2XJ^LS"Q79A.L<\A^ MHEN"/$9.$V:$(=1YK#VJ(D0D9QU2?O;G(HW'O<-R$0.H5BZWW?,?"\%7-'X[ MSN0ZW1*G!<.204R1![1,O +U'I"PVHU/S\=G<@] #>N .8;(64_,L8Z)D) Q M##B!VA$LH+6@NCLJ*8=CO!33V[L?%:J!%<(^5W4=F3C:)R%*"VVT!H(C[20R MCE8NC4!]AYR$O3GH>C *.N,RF$.^RDA=>U-PI$?8\^BPVD$D:-CG5XQ$PN8!#MX:+YT>]%;:V''I' /366@_ 8P27$DJV/W7I+08NJH>G*R"7 M<.75.F,[W"$1 #B $!&$:L%--!6[FU%G6Z_E/<6QM:70Z\U*(.MY-EM%N;W M:' \0>)T(..9G@DB0$NEB$),4"HB[O4>$94!S*^LDZ M6X1?5C?;E&YE4.;3V=>*N6@T4&(]])(@",I5D955OVCEUE#AXPZ)SJ[BM*=7 MM ;U#]SD 8IL-2LVGHWOZ&HA1^T'32#7W!-LP^M$$1?8(Z<>%US>H1C"59PK M#8;<938==2._#G9)RHN(2.M IP/681OT;^5ATQ3Z]E6 M5BO'8?G&GHBPF>)<$Q",,8L JJQO#33JD!C]*@Z>HB%S@>UGO7UG8H)2M!90 MBJAB@D-G5>5_U:5,CS#,KZ<=9T,HAF)I6 MB;',":B9,$QQC260^Q3"&@K0_J7N*Y?F,"%C\2 ;2C3>G2D-O+V/4&4'5 ]E M-,4)F6DS7 *-#08V55Y[+:P7 H+*#5<>[;1W3497$(,*TP!8#A:@&*6Z>HTP MF+@/2@R3$$*"'%;AUZ ;M*R" +6WKKWE&EVQ#2J9%T5Y2*6YJ_IZ-N?L=TT3 MK+!W&GHM!:*4,,=(=7QHG.N0X* W!\NE6'I @79 EIU]5I:>?S/[4 M:?S9SHD53&K"D'<." M-V]_&-6;PVUY>*!3 2(P@WK]9R+378[W%X8U$#B^"_R6NZR^FC33A MN:X)T.%5I1XS9(15EDGG]N^K8;S]J4QTO7BQB_P1<'N4E'__[3O(PES_VGQQ MX//=&,_@^_+ERZ_I/,AR^FLP[G_;(+>'Y4EUY<6=GRT"1K-T_FIQFQUF<8*W!Z2^Z1") M8M3J8--"SE18:Y2@=GN/&SJ-%*OEK!^"^DW%Y<8$;^LT&^\(\\ !9C"7 @"E M]8Y&:0@9,D]#^IBL[\A['95I>5\@;5[GDLKIZM\F\SP,^[>?5\5FT[K[,.B6 M\*JX[?W!O_V\S.ZVZ6R'*%._0:E6I?*GC1/"RE@&H[25Q@%A%#:J@H#A+KGS M&LM)\SKE7=EZK$)]6WA:F@8MF5VS/O7SY@DA@1@B$!*6:6JDH5#L*%(0@DMSNA\Q+X?AE^UZI*?CEV#\?F=]FGL&,IEZ_7V5TZ=[M"OB?+&)_L MDRCO-(7$: Z!8M9#@GU%FX2#6@"-JABW95'>#S"#O=MN/GL(MOO&[#G)]C.] M$BXH=]IIS"V07,N@!ROUIRCQ(ZI;&IWQ<:$9AO6/5;MK66_/FR?:4U=_D-E=TR@-1)ZB!Q'FG%03>!J-W'0:H3_?_F HCD^VHLA4 CQV M/NQ_)2(*"V6T\)43+;RR<$36Q1"L;BU5#7&\L#1M"\Q$6JE.#)9@2H#S1$D6 M-O*2$1$,M3TJGK:O_]!OF8 +K%3Q4!Q*MF[2;QMH/N1J\A_K69&UJ>)9?Y!$ M:LHY"5: #G! :=FLF'T.BVD9K!XP6&\^/X#0 1GJYT&)\LQJ:R +6PMJN8!*5BNY MA;Y#ZI'>+E(-(&>CP+J5+#Z96?L*=2>Z)M(A3A&55AC/";>::ES14-;2',_^ M;5AYZ0.]H76;SXN TB3+ILNR&-OFADV]Q:GE2 D4%F& E+4( FJX!J;:\5KI M3?ND6+U=A+J ENL'S/$9Y5&,\22\4DIRR93SA@FFH1/5[L=J!]N["WJ['#6@ M2/6&XX6E:1?\&V>+=V*PA%&&='E9#&AC)W^\(] MS23F<,<$2L"8Y1!C #F@-%AC5<2X$T"W-U1Z2R-Q 6F)@MTEK)6G2^.[;)-4 MYR8M5M\:V"RGAD@H8M)J (+6E=IPAZ@T.P0\1K#]S9O>TDQIHQ4-FVP=V])9*8D!9 M&PS72ZQB3Y3VQC-^ ,":BUF-D8+5Z#2WD",0[,:R%(79NR=\>"W;RUEOM:0N MM*;%!W-\+N8HKN6DS"QE!<#4.V+*@CG"^/T"[U6'^,;>*E,-*%.] 3FDIBQ3 MW8=_RA""S^F\?"UNLF)6QA%,RHQTFP"5[< M9>\"!]SM;796-H>;2&(H$I)IKCU50N-REP4J;O N]WU[.V'I5^@.2/AHN7$5 M[T9?HIZH\A C0.2%L(8RB878YFR''@#5P8KL[0#H>B2W(;B/@CCZ7&7[!-ME MX9PG>8^KSR^:PFR;?+E# K.S R2 :6*89LYZ: EP#GLO*?#A_\ A7RLDNG_* M:R4O.]0G448)23GS3FI&-,(H2.^./B_ED!>=SJP!#<=DET*3AD.LHNN:MJLZAVTK)FP SV;D=+6J9+C4<4L810[QSSWNZM M)$18^T/289.6M6%\7&B&SF#4*FF9A99A@+% 3!BC*2*TH@@;V=YZ&R)I60_6 M6R=XAF9XVY15G%*%K*64(D.=HA1Z4U%%K*#78,.U952]W%7M$'HI_!^Q+7=9 MM@_'[FXIRYR5UBI&H8/."JRM=X]K(#0CNJH?BR%G4I8U Z1/QL9-6>:E50*$ MQWC )"+!QG%D3Q=W0ZKOX1D=#Y@^&=Y'RC*O"=)> :B-M]J7)2OWMJTV'6K- M#IVRK W;HV(SW.V*S]EBG95Q2*:L>Y1.5O^:K>[->KD*)FSAONZ.,=5RF87_ MIJ>K>[88+=&4.LZAH H#1 DE@NR70&I\^S0)_28MB^_5'P[$P8Z4\^7J[>WO M>3[=%$O*BL^S2;9\G\^GI\Z+CW9*M"B3<$,#$+8,XC*U_R.5$H_H-N! HA(- MJZ$D(@CO;)F5&62O>E^;%ZE78K,Z*DKXP!;U>!MJ62_=U MMMI,8V^*O,E6-UMW2?FY*;+IP5<\PJB)L&'/)#U!D+NR@BS24.W/R4B]T)8+ MU*7L15H&!G,H/;%/H_I8IOZ$OCC0.H$*::,#AH9:RD58)278GX=@W3[>-?I] MNH'T1G>0AF)^57)W.U'W]5.)3!#>$Q)PK$LBM:- *T"RI.'MXO&STYKO;-\$.J&QTP2CH-VU%([[O9(W&'8H\7BM[M78F%UF M;2D]P[/%.BR/.],N8*.SV[S(MNTV?B#W->P? []FB[3XMD'M3;XH8[D#.^8; M8W!K#M1>D:(^-8$B;%4]I@8X659N8@[N#\E]0*&];%ZK/W<\: \KU8&2G=;? M605G)?*''HD.;ZDRQ&%+&&?*A/VLJ.ACWG20IFOU#,=!ZC+KV],#U+ FO[T] M??!XOG-"L$;.(NHY\D0A"0';K^J$=RF7=ZW.Y.B@#9C4),CQ&;_08Z-$<0Z\ MEL9I RDIK[M3MU?HS'4P@J[-Q=P9G &W_H_BJ5:K8O9QO8E\_Y WMF$:CY5X M)8)\,^HP\MX+B@S8[RX5D1UB$J[-RSP4AA>1J[HRDS!N!;5>*$.! PI(\N@J M%4JV/Z*"U^I0[H+/8.<(93:E9_>_'Z="PM(D(++HSWA "T M/\N1IOV%>'2M+L'+(CP"B>U/0FOAQ3E#QEIO# O:WW.IP=[=0$0'QR.Z5L?C ML(B.0 +;25_X(NNU2T8#ZU'J;AP#I_-GCBS_UB'Q[G/Y;7L,.,C5]//]$@4 MITYS#AVU6%,DA-6T D62+B?PC<6DUNWT6#S.^X!G*$OEP&R/7E0^VR=AQFB+ MRO+Q!@*-.!9H_YHIHMTX[ZI'X]QY2>B$T\N4B,O6>)R*?3G&^%3)\WGM]/[K/I>IZ]O3T< M(?;CIUGV)GTX9B1T'3)Q7EE8I@/2 1/F%(:45,@@Q(:\SG@)*V)@_/J4K&/3 M/)D(Y72G!#M/+<20*XFIX= &$"OJ"!ES0L-AF)KWC.1+DY=1&1_7*"9-Q>/ MG;I__/GGZZ,&QK/O$V.=A80B1 &0*$R+ZOUJ*CD?,GUM#2=H+&CS[E"T8LQV M_N^SR;K8I $I$R[DZ]6[+)W.YM]LMLJ*,N=>4',^G17_3.?K[.V7158L[V>? M;H+F+&_?W1WR-T4;.U$L6$^2EZ:8@@Y)BXG98PA5AR"FOBS,B$ZJ2\'82IB> MT_W-S-/ELBR^DR]>IU^6ZV-78\]V2Z0G%CFNB0U/M $W1M!^T<.RO7>RMV(( M<44@-D+]GX8\$N[^F7[*BYLBGZXG+_B(P&@G- =A!X!16&>UEFWX%>:>#M'@X/[9"*.L:VOC9WOQ>6[M@,Y0+\?JIG7<"'.R12 ME1DY\,8'0ATA95GCBCI++!GGECT.P\YPOQ-"+TT.1K45'Q/[(QC?-\%RVD1- M3U/-\IL1P K0$I"_LB2QW2DE7SUKB#I[:_O5='!N0]87/! M@[V69_U4,@:[+R28_$E<2E=5X M>?G0BD8A&1JW7N_,N=H'O.UP>IDR,4H=/QY1&(4(M#SK-X)R2J 5UE,,"#). M^+U1!-20'H#.9_VU^53KK+\9,GV>L#W:/Z:LLWK\!/_'ADD@04K&/ JF#+=* M,.?<'A.HVP>@-T\D< F-'P65X7A[XYRN3,R+X'GHU+;8V!UC,/5S^71Q^,,3NW$#[=-)(2":ELW,"J6;: M0*Z%U!J$K0E0H*(#8=7A*N 5\+LWG 8]]E[$=HF$G M&?YV.PH)8JA]FNWACL)K,ZG>47@S1$9]%![/@VXT,-Z4_[-4EHG&2Y-E"PJ5 MPO !Q23&?KHVCVMZT)O!4HJ\H.'_C#KBO,&,"5712+6RX]QJ1^-<;;=I M.YQ>IDR,:BL^/E$8A0BT]*![8*#U#'#B%$$64^W-GC;5H;KW!3SHM?E4RX/> M#)FQ>M##GI. ZMC>-"?N$PVSI^3+O3#C1/* M%?.$8Z^\HE)SIHFMYHG<]T7D1^M#KPUW'AF1.)S;Y =KQ+XG/1+M">..(:(P MWA9J,F(_XYH^I6%X& /V$QQL#TH<-OHLP);.&S'R69^$E)$2B'/-/1$6T&!< M\-VL#;*L?<:(Z+[MGEG9!98XS+S)TF*9+ZS)[[.%R>?SM##WZ:0Z;&O$Y%IC M)0I!)ITDSB(+35F2V5>;!@.AJ'5-:KA*UKVNQ7T %D]%*@I%>F1\ G#H__E86]7EJ4M5/_ MGBXF^>2O1GP^UCTAEDHJ@22JO+'N>=!-H*)%"-8^8*&78B.]\CH21I&6^LT" M,VNVI#_MDV IC'5*,6JIP$!23BL/C?'"MU^Z>ZDETN_2W0&8..S\?1Y^+]X% M8/+U/ B87<_N%NE#(_:>'"-!$$KMO+602DX )$150FHQP^T7[5XJ@?3*[IA M1;+"BRQ[2$\'E)WLDP#N@% *.Z\9< 10;E U:VEI>V]&+X4]>F5O%V#J.:Z6 M%?G+;/+K7?[YMVDVVSJNPB_?^ZS"1\GK["Z=NS*Q\K*F:4 ME]YZ3!1]E$30_G3A,O';3;W/W2'IB9O;^1SU.G[?) E[/PF"<0\I!I;IH$)0 M1;BU8449IW>Y$_QY5"BNA(^C\AA?A'T1=./-_6P^^_1'7A2SY9_OU: M)HA0JAVW'I3FMS)68%C-$4K6WJZ-[EIL#V\>%8,8<;,WZQ*OSYE-']*[;*F^ MI &TZ29[U6'FU>^?*.0M\I0*KADA'"LF917;!I2XKFCIIH%Z?4(5A?%9,O;VYLP\_#A[6W]L/D#?1.M@CKGY<7T0*D, M.U"]W_4XAAXKO%_>@3J<;'2&*8;BVDIF6/!FFR)*-;3/LQZ)A(*3L-)ISHRF M,MAJNIJQUQRU/_>,[C\=1(5T 2BPQ8.1B\\/0B/NV-TH>U;/0=D_ M(53U&MR/O0'5SP+P1S[=.*]:K@-5]V"O.*:H(A@Z&_!QVF%;T>)XE]1HU^D@ MC ;5(]L'RMGP-#+@:9:&G86J%F6-Y\E\'<3XI25N,, KB8%V#&)@-/'04RT9 M-@HP!^M54AJ(TK8U#(S6"%-*G>)>P[#+M&A#H?1: 8)!Y!]I)(R/,P8G&N=JW]9OA]/+E(E1Q?.,3Q1&(0(M$S?80)1% M4@%"O%<*P&"^5K19S8;,^-0Y<4-M/M5*W- ,F>$N>C=+W. L]>%U !I3X(EU MC!%144$P:7]MY4+%#AIJ_"BH7,,E?H9*2&"\8#.V$3*0+_-NKBLUN[C_MDQ#,/+!&0PRQ@W([!S ZXQ.'E'Q.3 MSIN]F4^[)$X"[JR"87X4 \.%\K::,[$=;N$/>RT[!B\[X!*'EV^RV]M&G'SL MD"#ON2*&<86]HXXI3'@U7XE8^TW)L/>O8_"Q-2JQ[M*'WQLFM'K2)1$&&T8% M,YX@);PK%X]JSM!T.%.,'MK7.R<[X!)I=4WO;]?_V6QU?=(E*3,L8>W+ZY#* M*\L-8[":)JN9M M+>V0S?/Z/$&=H(G#TO^5?IHW?$>?=DF4$);@,&\D%>5"&RKV*PLSH$.TY/6Y M@CH $X>9K]/%M%F*L"<]RMN: D)LF;(&J$ V=OO().U0^VTFO#XG4'M<(GF M?K7Y^FZ>-LS>^+Q78ITA9>0V88!(IL+N2KAJYD;3#NKS"MU G;")P]7W^<-# M5C3CZ;,^B:<$*,DUUAR(LFR#XW*O(D2'2ZCP^GQ!79")Q,]T$>#-F_'S:9_$ M,H>M1=R'+14WV#H"]E(H; 88\$4=VKO MS5(.=P@COC[74!=D(NU4LJ*8?6ZZ5WG6*6'8*F[#/MD:ZZ0V3LJ]3ROLHSN8 MN-?G(.H$320745JF,6OF('K2)1'!&D>66V^"&')OC /[LUG-.IQ:HRMT#[4' M)@XS/]QG#7GYI$>9/H([C;E7Q$!/!(/:[\]_1 <_ KH^MU![7.)P4LT_IT7V MG]-L_BYK6"KD4->PU=(N6'- &2R%M=3@1VU! &X??(VNST<4 : X3/Z_F^3V MS?8NS_HD2$%G >((>*[#U@LS+ZI94V4Z%#F_/G]1%V0B!6@6W](3UR/.=4F8 MMS(L,UZS,F8-. H4KN;L'6V?MPQ=GZ^H S!QF/FO=#Y/)\TB^I[U21S&W&B& MI!+<&*0D>W1O644ZL//Z'$5=D(G#SW^TV(O^X[L=%V1 !\G#"F#.F<40/EIT ML(.I>WV.HB[(1#IH^?6/M%C-FC'T>:?$D#*2%%"AG3><(>OU_EA!:-\^R1"Z M/F=1)V@BN8O2Q2R;+_.&#J/GO1*@C0_&G".6*1_^L$3MCW )INVO.: K=!EU MPB:2A[[-B_J\4V*M,$I8K[@!B" N@];8+S!(=MB^7)_3J!,TD5B:A7&^-6/H MDRX)A5 I!* %U@"N/*)\[^@2RK4_0L/7YS3J $RD74N>KHK9W7W#C M@^+K\Q1U "8.,V_28KINYEIXVB6!H,PYP@!FEA$-R\)M^YL:4H/V,=;X^AQ% M'8")=1WI?V5E6M:&%Y*>=DJ$M *&W3,JT_1:XR0V^R,&*F#[M#CX^EQ%G:") M="LI78=/FMU+>M(E(6'\,&?NL#?>>FGE)C$0]8@3R66']_/Z/$4=@(G#S-_S MHADK'SLD7@7M(#&6T)=UPGA0]J6F9\:7-(@.9;>OST'4&I;S;(R4X7)/_?M5 MNEHOSV0N/-0\P4I02@$SLDP*49:5%ON3!JQ1>^?19>I_MDU;& &;2W'];'*Z MPQT2M5$O'CA$4;G]YO8Q*2A"9.39"KLQ[ SW.R'TTN3@,OP_DZ%P#.R_#-MW M.:4?YWQ4U9_ID0@J$-'6$""E!\.]N8/D$G9<=TAZXF;3^M^RU&"<8*&)0E25-P#%HT@K-$ZK MK!/\QPJ!MX/B2O@X*JOJ(NR+X/KH7,==,B>AAEH0[2GC2!*\/]C '+?W6_5? MQ[TVO.?JN#?#8+#=3<\5EYR&!ECL"/3(TJ!C.-Z?@@1-/VB"U\ZU=^+4]XB M4ZNW^/LZ?_G#I[!>E7C79'OC,1(6%C;H9/@1J#/< >CW/G;A3(=(U2O@?M]P MQ1""FW4)[>>LK0"<'BU*Y\V6[S)5BXM%F%R1PR].EW#BB:O7UFB&2CKF^W@\4ZF]OTM6ZR-[> M/E4Q9PZN:P]2IK-32&K@C%0<0L^<(A5TG$D[H##%<(/6EH1S@A4+L0N9>-O) MGS_A/-XKH9PR0J2'02=BA:D)BK*B4VGFQNE8[9.AI\V^"."]7&$9E??V2F0D MPK;@U<.GK1+;'-KE@:RBR";EYM7D#P]A'SO9?'$R(TBS,8)JEU1!IA!%3F)F MI.1^1Y6GX;NQ^PE;\B@?!J^6*T3OI?T 9EH&E0MAP$I #ZE&%16:=K!)F_L' M+V%&1$%E.-X^QGW6XO"3,%%NO#*$<(J,I,XKB_;O@S=4VW$:!5W94Z?>6SMD M7@+/1Z7;Q\#J"(K[J+OFE*8^TRDAG$%&C4.4" "! 9;M02 !F_&HYCCPYSTA MTX6C'XITNC$$9LM2CNUL6;H@@L%QDQ6S?'J2L6?Z)HPK3AV$0A+A4%!=PKK* MJR*%'&-\8CP745\P7?\9#45:$5F>/7#I;/CI\1Y)%X"XJK/;.)[#KB -ZKF? MY\5LFNI\,=W$YCD)>AE#);?6-H:&25[K$''D+GNIG,+( M&JRMYTQBZ-&.0EWFSKD"EWUM)M5TV3="9$B7?2W;NGP3-X_Z/= MW$T=;9]@@X!QWC+")-7&,\U(11,(RF>\6^@(?,K[0^AE<']TF^FQ,+T-LW\( M6E^N/A4EM\7FMY+3XBFGPV>)?WV(I]MO$F$U%L)3"!"Q4BE;YA[8*4''8?L< M*;WLH". G7>A?ZS.:H6HYP8QZ,(>'0-%,-]3X87KD"ON:E1N9U2NP7'I)8%A M(6($6R PH$0INI=6":_+65V;/74\F.V0>0D\'YU^O32K([@V?\Q86-H,S9(_ M/O8(.TVN.=5!QS#$H25(F?U.DQ(SHA/D.,"?2OW8&I96C/PC_3I[6#^4KB:? M%VH^M]EMMIBFB]4A[7JZ0X( UQII" $DE'KJ#:W4DE7*="C,= &W8U/O1U1L MAO0V_IXM2A_ZJ\5M7CQLQ/JTMW$WKVB/7Z=%0"C+EFHQ?;NZSXKWLX?9/"W^ M2%>KK%B^28LBW5R^>&$^4 "LL#\?;/9Q5>K LP'* M/S9/I%6R3%6--#:.45Z6VZG@$!)?6RAR;>[^("R=L1GNS/+Y5&N$D![JD @@ M=;!F D;"":V]%4A4U&EIX#@W:G$8=H;[G1!Z:7(PJLW;F-A_&;:_RS[G\\]A MV3-%-IVM?#J9S6>KXUG_:_5+L!/6E>JT#,&!0$A@*EJM(1TRW?:X;^C&M+P_ M>(82A9+T5XMEL$=*D^.,]O^Q<:*5\%HJS3@'T JFA;(558QW2*-Z&9=L6]W? M&9G+\/M-^G!^S3_6)0G[:@\M5P(I"@TV1/-'B69&C5O[=V'92>YW1N@ERL(H M+8 QB$ $[]]6W:B[(MML($_Y;P\V310@TC!<%H^'DCL.G-35'!5"(TP1U!WN M/"HF0[VRSRV+,^KZQ\:)U)!I1Y"#I$RF!9%WM'*$0-3!4+],$NRVZKHS,I?A M]]GE^5#S!!"CH,>"B?)F&L;"JKWS2UMBQJVFN[#J)-<[H?.2^#]*U7QIME_( M'Y.5AR5O;[=3/KL?/]0\@8)9J)7F5GNHM=&"LXHR$/3B^)1Y-P9][XCICLE@ MW)XMLFJB>V=!=?A8%/F7TI60?@K?K+Z=DH(&PR0<.Z^UM) R[HSR0@"X?XF\ M']%5LCZ/=?I#;"C9V9^WOOTXWX4Q+'F3HA,C=X)=\AYX*%!F%FL M=*"]V@EY1?08&83YDR9W+B= R T9 M9_+W+'Q]'Z:;F7RY>I=-RJNYWQZ#J5Y:?$^HS:1Z\1W-$.DQOF.@DAK. M.6 E11I)B(%GRME K]0"6N,X'3+B+X97J#;[3I34: 9)RULML4LQ,*HU(H09 M0Y2UW!K.U7;2KG1FC_1 IA/\QVHRM(/B2O@X*H_-1=@7X]0D7:336;KXD'], M)Y/\CW2QODTG90JQXF1:M?/]$L>]Q(8:R ESFH4EQ_C-[!%U@NLA(R:;%MNH M#7S>'R##^5^Z5Q5E% )"L*<*4.<$DH&P2M=0W2%!P&7B'YJJSHC87(KK;:M) MEM 8X[SFWB'@N5!H#Y54:.3'*MT85J^L9#N$7IHI+'N^4:&.Q( 9!(0 OBV@R3?8KIA)Z/+H^%KORGK#I\Y9JO+0OR!@ERDKW MV%MM.82&[%T-C*KVEQTN$T'15.''!*=7AD=+_*$,XE(Q*@54VHFP1G)=T62< M&ND=ATA\JI4!I!U"+X/[H]+N8V)Z%,?*I#P,*;Z5#.?5'R6_^1-^[SY.'F/[ MGC#W\ M&>6]X%A)I8,.VU'A'6BO@2]3 +J-!NZ,RG"\;9\1! A'+2 &8^@Q-Y1!Z?84 M,>C'JWB[L*=.:I!VR+P$GH].W5Z:U1$4CJCL=APUYC^BTXN[[A_RO,JYD,=U-:)XNE[M9A _5W5V1!9*S M:?AB]K"LX13I/FA"D5'22ZL,V!17!^^^S4[_"B4:=G@F18";U1#"$9]J@,&"(V\@T,=)"V#QF\ M1-1I4T[W U),-F^\"\LOL]7]^VRUFC_U^39B^HEQ$F/*Z$IE,..<$."5*.-H M=XYHBZZK:GD\$8@'63N!>#PUV#Q^]9>H2MZ&];W@%)G?FV ?GV7+,*?2@[&+AV_*^2/#) $F MKA'G1G$'D=;50;B(':!\_5'.C;BJ[ZD@2/3#_DF3^!- M6IRYWM1@G$18R,IK.9)YYJ@!0,O]&;9VO'T.4G8%TC,$9$/>-?C'>KKQ@@>! MGTW#[FA?]6?I\V(7;K;?2;W<*PA60,H5]U8A(;TGDHIMI5%L+//D!5Q!T!Q8 M""4V1(HR/I :MDN<;(1%=,C]7=LK"+695.\*0C-$>KR"T%U(=#I/%Y/L_7V6 MK5[GVR*Z9T(MCW5)H(82"">IQ-8A XU 8 >+-)0-62DOQME/;2[GO> SE"EP M:+IGP^V.=TJP=A)B+XST"$*$-62THE*PL:>=[,Z\&M+0":F7*A>C.CT:HSA< M1@S4.,-$8ZK,.3_S]Z[;KF-(VNB[[(?H ?WRZR9'T Z/9N ME^UCNZJGSQ\N529M:SI3\I:4KO)Y^@,J167:J0L)@A>I=U'(,FE,V1DY9E-D0NZHX%#<@10;CAU%-#M(5:LJI8ZY"5",;< M]#-@0AKEF2?AM"UZ<$D-_8IT#\. M[;NCR187+(Z,*#AP3K5EQOKX?XP,M[Z6CXD+NEW1F*AE'\#T=*\YK=J X YY MA3$UT>X)7JK@]I^ \S[]RN0X-RC:;N?=(9G(+75I& BB5&#,,DR,QU;7DS;1 M6YGFYMP)_F/7U=.@N! >)[6YCD)?AN/4=U_F=_.OORQ7J_GZUP_F5'+=P4<+ MR1BVSE4%"P5QP*-[5T<#K.5X0F4=T^%=9L5@LO<7 D4K#1<11O04X]Q?:[G]94+F$7'9PGC$&V M1%0_'POGZ1,AZK2:Z/W:EITE2>QHR MU\#YI/;2*5"=86O=)0+,ZD2 .FO@U!Y[>DP!MLJN1JZZQJ&(0UQ:6\\:*S:A M?.,\X"_[ 2:)SA>]=%OU(][-4Q$O>72$.7,J2*N4A%J'P5/4J"OG!"X8)!"8 M!Y%Q+@Y$F\)^?S.KLIS??GJ6 GNV*673EQ3>,\&L%\X9"8XK(0S9HV!#>H^R M]LF%HQXE](782!=.'B??H'OAT5&%(R"M"Y)CC%5UF\<(V,NIL)RFM=8GH:>O MGV0 [WJ595)FWH7H2(X@RZK\N)K/[MZ7Z^7=P[E+C,>>+I#A<=O5@1LI-%86 M26?JF6+>X0+*0+?-$G%?YD:FX[V#K?42IQ#7C9,VX*D117":(N&)PLJ8J,E2 MV#JU E#<-:=C"/;$949TDOC?-DDA>#"LD(LJ3:-08 M1K&%^']@M:0N=#A]'N."<;(ZY$-HI 7"W-RL'J*%LKR["\M5=:NI^1+Q9%HG.,(VK&F93]]1IN8,<'E\X;K6+ M1I(%@ZU3%%F'=[+[H*;?.:T3GXTTI1MBXVK+_FIA:SW9CRPXP6$;D#,0'6CF MM[5\=O)R9B<4=!Y+0U*Q&EDW'N_>-P]!_SRP$$I&0UO+0)V@1DCNY2YQP5&@ M.CU>-)1WTK]FI$&5%F(X5&#C[:>748^MQWPDZ-#J'04EPDGG=$#1JD(4 =^U M):>.6<73%6",PA9M[8N^X>H89_+K",P?KORZ7,_/UB_YX>'".*FX(("J@NDT M?A AA'J>\6NXK%H5*;1FP67(D@*OYY^_;-:_QD=FC[_=*MRU50P(55J=!X&Q MJ"*VQ@6U:Y7-J S0*']A($D3*P8@3*A!&"D2A%$H6,]VW3A9-#,['/ /5S&@ M,4G-*@:T0V32%0,^//R^+O_K(?XX_RW^4B5$G$D!.#*BT"(0IK4*5?+X0A @)5=L#;$!&3Y.;>M?% MLDL&6&]AO P\G68^"9FIWJZ(&Z2QKIJ[ 0^&*FG)3@IBN!LR"#?&CI\%E4O( MM'<$451!X$E45ZVH9ZR6"&/DIKFM=Z6G2OXRL$';?71(TV],P[)'=#JP>Y[&W8R< M5V"E$EH3@J.Y*8(0>T&M&;(2SRA\)<'0TS7OM.(+E%DF00KA4=#@)=/6U%-' MJ,,UXG&*+[0UC[I#,I%+^]90@5C@PAF%B;.8NGIMH,18/TWSIQ/\QV[OIT%Q M(3Q.RJ09A;X,NUSGX@L*"ZI,P1K*^.6O)NC']CP;%E\H3&\YXHOM,,@ MQ\'\MN,%+!]6F^--A!J,BMN]J$I%6&4XBVCOGB:[M,H9!IH=UQ\CM[4YT)IQ& M2K[*WD0L5+T4F,<\X."CV A"K>4L:)%>1'",'-\\A\<9>/-OOU M=GQ0C ,6@5#G!1?$,Q64YBA@1*M 0*-;:]/.WZ"8*^R5= N&B7!R:K2]59" MP0*[A/R-QB0UR]]HA\B0^1N]G]E$FT-*+S (1C@Q*B"PM>B$\R%KF^4(2C1F M\O2933M4+B%^7]6.H0H[4K6LYPI)HMU.(DD)I=,,6G2EIU&;YR1DKH'S204X MID!U!F?K)SOI1<_A.*%WJWE!8D\<%H+P,F.OZ>[65SP^[J MG?HZ-Z5H.1A6&?5@]GQ2?UV5Y2)!"XZ^I# 2A:I("$=.@F?>,(IJN5 (Z5SU:S^WE7%?CA+86)3JEVR% %&ENDE/.FE@Q'*:?C:H^@ M UV@ZFT9B*[!_*[S.O#\+04%@:0,2@!P'Q>Z('CM'TD".KWP0O8[3V,L!!V@ MFM2!,M+(@N/88FF\I (;S/=>,"+I*1SCY-NU]=VZ0S*1@TB>8Q%THN("X M]C8J^F[2RCL]3=^L$_S'3B33H+@0'B?E;XU"WQ0.E"D')ITTFDG!/1;:8-@+ M222 M,X0)TM2Q6BIC$4R'V1Y"W'W#E4,)WCU4T'XK4Q7@Q/BB:C]2M;J H*I3,Z1! MU($BS7!(-WG'.(#N3GX^J/K]^LW=W:XAY[MH0$;+//Y=Q\7@T"N+*M[#%*:> M&X$,1ERY>NG47G3(3QCC!+K/M2$#>H.>2W^]-[?_]V&]J4[8W'S]]6%3KI\J MJ_UCOOE"T#;M9FT6MQ_+N ]&F>?;__KQL3?E'_]?9#H07*%#KL*1> M T-662VJOK?64M)(\:=]GATE(P1SB@, 8^0".)10N5,($,>8::>9S03MX+O/NN81H MZ] .-H]DFKN(E*UC"I^?-,,M&1CKO$E]#2SKU_F M-[.[$REN1Y\O@E/:26:#$)Y2H20/9&=C,8U5^OX_SFE)V_T_)SB]$OYH7#Z? MX/?%,(XK2EFSDAML2+!!5I/$OEA4Q?/ M)S!D 'O91?ZD$.TOL]7WN]GB]I?Y>KU\6,W?E'_\4OXYWS:@?%J.#!(F$,WBLR<>D'-+WDI^5CM6^D)I65H@-21&/) M).8>$>HPK6-9//[%D EH8]A9W2&92#:#%&"Q88P2))W$)CCGZDG;@"9J/G6" M_UA:0QH4%\+CI RA4>B;0E8*#HI*Q*Q''ICP+!A4+_A<2#9H[E#+K)3&\)[+ M2FF'P7 W<-K=J!-,,D2M"9QJZP%9"%!+H35*KWO*XZI4]X&QB6JYV_$L-6H.UR4:$S#LD=T\K-; M/1J_9O[FW2]/23[IG)]Z7<&5E(([0F@(G''EL*U]>F&C73(=3 M+YK"XN1D%]UX]H*"<\Q"7! C-I0SI>^?G_N)K% MS;#Z[3_+V:J[.IQ\7\&#@V (0PB#(LM5'KITZ/3V9-)1]*.G/#ULZW\ ML(IUVE$.O"G:6,1I7-VE0$&'ZC"=^5K"N#^GQT"SW[\<<3/I#EP_^T@VU3CT MIB(ND-1Q8:1" 3.AI15U-$MB4.G7C[+WK1MQ9^D.7"^JP;.IQJ$W%1(XB]B9 MX)UFH;*V!*\E1,*DQP#%]:A&!N!Z40V1334.O:G UFBLE?)"CVID *X7U9#95./0FPK00!22QG,M632VB35[TUM@2#=&U?6H1@;@ M>E$-E4TU#KVI""1@'>)6&;S0FL7=$]6&MC*F@Y^BKTW0_@5=CVYD0*X/W< HEVX%D?G6DX.O*I0S@C@JL$-"46^QW)\^:ZI$>B@=7T_ - MTO:B'RJ<> M!U]56*2#)$%0A)T 24A5&[K^!'"7>A#7$S3- ETOZJ'SJBB11FQ MB?\$93G1^T] XPYE!J\G;IH%NL1T\/95R/8YM=4%[(?UF>I2AQXOO,1!,RNE MX?$7JJ74M1ENA.MPY;&]_S)F::D,V(S%^MD"0H<'%%&)KPB$(8%!@% M,$)X+;4BVHD]7-1.Z ))+J)^+B"5!9BAB-\U76U!_)$1131RA3"$<6=E_@\P Q%_*O%S?*^W-?8>;VK<7S&VCLQJ@"D +ST5<&/:,Y2 M$O:WE8VG,KV>6/NPY)A&7SZ(1E:%LUO_R7&%X\$$H%'#.6%"!.E [F2U'F,R M;4LP"XO--*,37M>M(Y.T$J>G&N.H1!7J>/OIP^RN/!Y6.OIL88S3DG)$&:9& M@79F?['%4I#I(8+>[,1,'"WS(I,4-?RI^<&;A^H'+S\]M@7X8[[Y\L*(?6H- M\';1K!]%VY<6$()RSE!0QF.OXY?$]@@&I2?4AZB' O:#XY=#;YY^OOF\*K>_ M63].NY&&'!]>$$R1B )1HPU5UENCZ_O[@)">4./6070A&U(#K1:Y%HC"1D_, MT4"T9L%6)RC"U[D^ *%#EM0876H&61-:0I9#(=ZMEC=E>;NNP-C6*GM2UT.^ M9+L7%$XY1BA7R CFK&)$[N^R@=,X/1DJ>Y[<("J0$:NLB\%^%J[\5MXMOS9G M__0K"NJ#XTQ9;*I>C-&\IG*_P#%/T\^?L^?"#;L$Y$ KIP:8V]LMPE$C,VT, MC=Y8(,NYH!R,X,1RKUS@M*]=CE[6,".584MZ7MP_;5)N/RV?1E$9KQN&A!47$ M^[C^46<1\MA(3/8R(,_30Q'94]X&612RH#1"!L.3UWR_?(B_/C;TK+3V[>9+ MN7HW6VV^-TMM:/*FPD(@PE%KN564Q?U34V.U4I)B;;U*KY&6_PIQGRT8>T6M MI[#5N]GW[;_*U7QYFQJ\^N$E!;,!(8RP84@'AYA NO;#G<.\0UKU9<8S,P.6 M/Y*5$+0J&/*!&1)]+!;M9XFPQ[6[Y02H#A_)16;8R7#]%#_E0N MUBG'%C^^H-"(>L]850"#"FJ$?\H%K!>,' MQQ=4$ R2&T0H.(B.#"8[A]9035V'[A.7''7,@54:\P=L2K_>S.^C#BX_O8MS MG?]^5_[U<"I*J_&%=P(KR:KC>\XU\LY274L3 NV0EW I\<2^L'IB_G_]CY]@ MBA/^U_8O#OSY[AT_(/;''W_\97:W6V'6(ETN_F?-W?+=7G[O_]CLWHHG_XP_H3X!?C'3^5__\?ZL?'?=%KJ M!8LQ4S;8JC:NTH3@75FI**^5H8-1UEH#$_UI,M#8H+X7$<_EJTU.N=O@Q&6>HYXB< $ MQZ4%$,[;>HX42#/+8*26>HWA/=M2KQ4&B6<6O;?4H]%D "6EJ1*.GFGT-/?'KO0TZK.6 MA,PU<#ZIO70*5&?86E^&"^(?'(T8G-IY4]Y4 ,+@%5,$ :! %;!=)X\H(7K> M/GWTC3D/42>GAJQ;$Q2LXAE.T1ZC%AFJ)WR\/NZ_*^' MZICD6_REVA#/5%$X,J*P(;:]P_,]NRM^*-CHBL,6IIH)1/I(&@576*WDU&BN$]-T^/+QMQY3>B$TW7J MQ*0\PNFIPB14X'P]K4//%TXR0V4T3)&D&ANCK%2U;-5][^F9]AEX.LU\$C)] M!G[V%2'^6BX_KV9?O\QO9G"(0T+C/4*&I1]KCA/6 M;;O_YP2G5\(?CWK4R(]RQGX>O-U5;&MMK^KF%;/F8Y_5ICWASA]_)M"!T("4PK;H +U M',7_W$W2(6HZ-&GI(VB; >QE%_G[(PG,,9+ %)18" )3QKGAA'F@#-63Q*S# MD7?VZQD]D-1:_OY(<$<":QZ7#U:9<-! AO<)#]DL5/9#4 M6OX>28*C)$&!P09K"64AH.BP22G\7I.B+9[^)66_!M$'26WE[X^D\/H82>%U M$;3%UDI*6+#,$T>$%_4D*77I[F+V6PL]D-1:_OY(>G64I%>O"V:19/&(JH"*,>P(O4D08CT M$YOL94'Z(*FM_/V1]/FVB@>,9Q+58*!E=01W_%U5J-TFD?'IR2_9:&CV0U%K^_DCZ MQ1TCZ1<7A3,6!QD, LF\QU%[]I^[ ]6A74?VTA4]L-0:@!Y9>G64I5>%-R%H M1A& T88[RS2JSTZ\C M .DN7$'-H#4"/++TYRM*;PEE-HR.'*0J(AB UDWHW MR>@[= D,74+0H34 _;'TYK=C++WYK9"8!RL0)=0*0X1"FM2G40$KU.%;NH2H M0VL >F3I/X^R])\%YX(Y1JT$+<$@A[&MO>X@C>E01.<2P@ZM >B1I7\>9>F? MA11Q+M1BR:GF'BQPMU6&H-0(\L_?TH2W\OE(C"<)!.!1)X_-6K^EBE"H]TN MP M"9&'U@#TR-+1P[^W[PLO>%7N1%J.M8W?OE"J]KR#HKC#MW0)H8?6 /3'TKNC MH8=WIE":"<=-,%(ZL(P(RF"7LXR N Y>[27$'EH#D,C2377)8O6](DK6_U%Q M)9]QM?OCXMVAC^KI+POGG(V?/HF>'6!E+77:U1/FN$/8-7\WZ;R,)6/0WZ?U MX>AQX _+$1PP)6@3@9NJ:=<[S);*<+.^O0Z MH&3B88ED#,Z3=N!:MEU%?-9?8'GWQ^&O16&PWNG+L$UV+@P6:/1AI#6 N0)& N9LOY4#"8.RU+(P6&-X MSQ4&:X=!#IYFBUNSK0/QU]7RX6L+U@X-+#@VA#,/2A!G#66,[PY=X_PIB XF MS05PF &1)$9AMIC=SF>+C\O?9SQ*-@/0(?V0'I\P98E\I](*0+C",$/BA/D!+&U%)X M0]+O.K1W',>ZXMD9E>&X3:_B9K@ Q[BP%L>O@0:A?;WX5%=RPC0-V*[T-"GG MEH;,-7 ^*6-W"E1GV(%/U7V/ZEB,AEZ0Q/W4VV<[PS7(#Y6HS_S0O;Q]; MG1Q6C&9C"V9,M#V9D-1%([1JBNIH72N+$S/!JAT9"W_U!5/B#M"QYMOW=^6V MR\VCOA[5C>:#JRPDPX3RRE>-L2KEQ&PGM<*$=CB3NP#EZ VG'$M!W=KJ!^^C MT4)P<&3!2)#:.8J\]-'_--+0>B_5!JETEWR,9G'=EX$<(.6@^;=R=3N_V:Q_ M_?JEO&O6[//'(86!:FN*RX?3@=A B ]U4%!SI=.)':,E7'=B.Z&3Q.@/A5TW MRY-5=4\]7F@B$ F$$0>*V0!:[X,*T=H(Z;< QFCSEL!D+F2>6!R@/NZWBG@1.'.G1<;?V! M)O?Z:DI2L\JY[1"9_7M4SHW $DMM7.B4%8R H-S7H'B/+JTA6&..&U;.;0?/ M4)Y6WBJI0L?-3U&F'5"@\9L3L L=!&$M7&CEW,;,-2Z7FH;3=>K$I"*RTU.% M2:A 8N5<%92FDGDG(!CLN9%V+YOP'>I5C5 YMS%/C2KGMD-F4NE]<1/$2* 0 M-):"<\51[5H&H1E.=]?&*9#;=IOO#LE$TL*$DX!Y%= '8T1P/M"]"B)')[I7 M=X+_6'Y8&A07PN.D]M=1Z,N?-M8^O8];#G&*3 :$K??6DCJU+4C"GZJ*C+\5 MIL-[+KVO'0;32^_3REAOG= 0MXF 6/"A-O[ !^RX^?P'&9 9*KY8%;8N/M3 M8;V6&AAC2K%:BD";];Z:T(6%MA9-%E0N(3?(428-#4IB(H(6)M0U?J-$E/D) M5_KO0D^3)*$T9*Z!\TE91U.@.L,FO#W!BFO1LW.@:A+G>[8>'1-G+:0SBCF% M-#92T3CSW:P=(V1BA?Z[@[_L!Y@D.G=99+-5"I(WB1<10^#,\: "#H2S MVB5T/BZ'T\G:R:T5PR*7I#%^\?FN?+=:1J/S^]EU_T#GR2.WRP7K3[0X\\7U&&EJ@,)$TCT( 5A3NYF MZS'@B35)R,EF-E#Z=)'R]3R,N" #&A-'/-(1'TVAELDK.>1B/%8 )! MK>L=%I2:JE JU1$?&[>;_?&CI\Y-^&9V$L MMQIA).(T6;#.6E2?DP0''2ZC#5P"L"U/:?+W1]+)/I4J6*8%QP#@ P-KG*I= MYX 5';)NU? DM9:_1Y(^'B7I8\$=Q2%8*RQ75A)/->PUB3J1GHL^<-&_-)+: MRM\?22=;((("'3@U2C,@A$L49U9/,AKFZ8[CP)7]DDAJ+7]_))WL":905"6K ML.?,:N*"=*J.101 +/U(9>!.!$DDM9:_/Y)^.4K2+Z802F(D$5,>^5"YL\32 M>I*,0OJ>-' C@B226LO?(TE'6R#^\J% 5@C!M8U^2 #V]<$$9F[XG#=R' M((VDMO+W2-+;HR2]+12F-AJ>!&-NI1=Q>D3O;H A!/9B6B"FD=16_OY(>G.T M/63K5$,P3'X40 M!ALMK192.8_K26(,(IVEB8<=T@#HD:53#<$"\<9S+ .B(G[B0@:HK[RB8&R' M CB7$'1H#4!_+)UL"$9 (04D&*7 J3A/O;-"XR09X9?3 C&)I=8 ],?2R29& M()VSVE)#@M!41=$(^26$'5H#T!]+[X_V\'C_JC"8F.A=*R.DT((Z M)G"M2CBZ#AU**%]"W*$U /VQ]/%H:]Z/;XHHBP_1^"3<*1RL8]Z'?2D&I3OL M2Y<0>&@-0'\L_>-H:]Y__%8HP@664.4W$*\YC?_IZTE&-;N<%HA)++4&("E5 MYV!MKK>?7BUF-U6AG&W6R0&*&HXLE#'(,8JD%DAK3P+H_6I@D)[0X6 /!5SZ M 2GQ?']R]0\%X8I3%QA5E KBG'=H)S7!TJ2KQACU#_/4]LF 4[Y%8/EIJYT? MRLVGY>KC:CZ[:[$.O!Q<(*MLM*4IX!!PH-8K@?=R6)J^FH]1!3'74M 9IQQ\ M/ZJ;*V_F5?6S)B3_,*+ !!RA&JR70D*H2K:J>L8H=&B".T89Q.[,=@$G.YUA M]FVYJC(2VY4S/OJ" I#G-OYX!]&X1U1Q@O?JR<&G?\9C5$K,3'8WK+)S_^OB M4U?V7[RBD!*#48%[R261!*+M K5,4=73^<_N.0W/?U>T\FG ^W*]O/O6MHCY MBX&%$ !R1 ,E5XI!V9_8B.I%.F7*;)[8 .RW0FC'!SO"NV^+[^5JW4KD@^. M+"!0+*6G'BK?7VC$1'WBHUCHT"TQ^^'Q("SG .F)YOX+X7ZX^5+>/MR5;S_5 M_D-E4UY;C5O)B0I.<\(T"X*3^(VP:$L9J@AP+1HE= TD:6*-6T4%$EX1P8,P MEF"05?Y6)2$&YT.'D^?6GV%JC=O&)#6K<=L.D5E_-6X'JFMG/4=@!98<&@A#P$?O':K+M!(3XWD]:8:8 MG^;=ID[P'RN,E@;%A? X#G\MZMKU3E\&X[9S7;OX.J>R&Q MF%")UW1XS]6U:X?!4&<(^0J[DV"-, @[P9G'6$2S8J_(-H3T=/YQ*KZVW1GS MPC,B_1V*> -7 EME1134:Q]T1.UI+6-\FIMJ-N8:5_-.P^DZ=6)2&_3T5&$2 M*I!8V!T)KH+Q@F$K&79(8[M'R]@PH6JV&7EJ5-B]'3*)K/=>$=414J6\:*$- M%IX3@]#>- )GA[P*.\:.GP65X;A-KX[)%(V+'7>6XN 8!^05[($11D]S6^]* M3Y,RF6G(7 /GD]JVIT!U!C<[2\D\IR@"*07QVM@X0T&9KN>)(@;3V73SP'V^ M9%X[1)*8Z[UD'HG*JZW2'#G,HA"&R;TJ*^+3KQ8,6P U@=4^\$G[.C]^V,U@ M]GP&X6[^^*.1%!A1MM]O2(>,G&&+UJ;LP#D 2:*MAV+R 0GB".*! M.\.=]LAZ5<]:.I5N2 U;I3:!QJS #'898@] 50?P87WF%./0XP6E5C-K+0:M M.0< 89ZV)P[IA_OC5#A-/<+(@,U8K)\-5!\>4 !F7F,@44HN*!<.V; /R&$_ MT5*G>0@[PWXGA*Y-#R85]I@2_>/0OLNF;&"NG1E14"4"\UA _(48$R7TMI8O MXMBA6DE?9Q5=B5KV 4Q:>LGCCWYR(5_/_E@_S$_[TF<&%89;KK56&B,=G!,J M/.755/UTIQ,QR4QH=FRZ<%K_X#"_*V_M]VV)YK>KUQ'MN[]6#MZBRNYLPG.; M%Q7(!8J0)%;QZ"!:"Q2C_6$=1>FI*/U=9,S-?8]X9="'>E8W7Y;+.S=?;U;S MF^.GS&V&%Q$IIJFJ(DUQ\]/>$[PW>@F7Z0MY?U<=>^(^'TI]'ECEZT_A+85 M"'7 XZJ&2%47K+8.!<$')WF05?E/"!A'<50M MDXGKV#2=MDP\-6I5D(;0=; _*5=M2J2GD)V]9+$T#AE&, ?-M0.OA$#U)*/+ MT:%R4!_1U0Q@+[O(WQ])IRNT [4>A/782">1#]SNA:L*7TS'A^J!I-;R#Q;K MZKGLCT,NKCK<4QL@VID5V:>&+E?="2DGRZ/4="I+;-YP1GI8]\5LYBO[^?K4W4%V@PO!"+. M<\JP1YI3:3FAH99< DN_U3Q&W:=,'WP.I')\\L\Z^^[<^D;?_UP@@%*]45U*JBDCLLJE\91R ,@ H[";40:L@;7*FUJAJ3U*Q6 M53M$9OW5JII&MJM1B&$>)#@DG332HEVWC@@'9SC=2ARGE%5C=IMDN[;#YM*R M'(/#(7#,-2%"(^]"U0:]EH[B2\QV;4Q8LW3'-(2N30\F=80Z)?JGFO1HP0?I M PI1:$".&M@U0B745%W5)WATTY& YDF/[; 9ZE/.5W]+& .:$4)5T)C@P.(^ M6,N'=(?$MW'J;Z5NYWG@&9'^#K66%%<2K$)/?XZ:C")%0@L?X6E9*8N),BAXWE1@#V>]GHP!ER7>MO->:I M4?VM=LA<1OJST]KKP!@EG&J)HQ4LS$XF&TB'0GOC5.-JN__G!.="$F#!55W9 M>92&$!E_5'"ZEDE(CJ>YVV?BJ5DF;!)"U\'^I/;U*9&>0G9*9BT<37\&4P@E MB!-$>(54B!L0EA$I6VYG5(;C-KT8HM&TNI<1-=T#EUJ!<74TRA)!)QHO[TI/DZJ( M:3VU_'ICI#3/S7#Q^;5=XZ\&#AI;0$>4<"\L@3Q!S!]6&QDFI0PCK4 M:VH,\S(C&M=R=85%.R+@8(0T2$E&P;/:KPLQT9O+"2-0BJG95P!M6&2::@-3@#BTHORC7'UI:UF M# M>[YEQW\K5N]GG\L>?VC@7+;$EU:O%I^7J?K:;[='4L],#"@;:R&"L()AJ MJ\ A;PS5+KI1E'&;G':6)M2)Y+(7SQ0&/!::&C"F:K+)!"7L<>H4HM^0_@5E MRB?+A?S/?;82 9AT^M@^%K/]VN,RL%G>_.ODEDI9 M.]&0%*\9S"I87E_7^5)Q1^*_A+_G+Z;K7Z;W3V4IUSE M,X,*X[WV@@3BI&>4!\$IVNV+" <^(;W)WLK.:!ICNQ\H=9\,;$'AQ7 MD,I4,2"HH)PXRB4.?C=[@JU)+\[1VUW]'HC- 4U78LE?R ^SD V)/3*N$-81 M866T/PU1E%BPAM>SE^!AP+.DL8C- TU78NE?,.%/LZ"X(;%'QL7U1A,2L/(( M6+0R@,?]HYX]*)EN,O5V)S\[L7F@23RJ/Q<)<D?:79[J4=2NX'2,[_ORM5\>>L7MRXZ'9PBD"7@)1''&K%>=.UVK*"#+I@2:)2+^:G-UFZNO4(1V-7JE\7WZN"HG/%ILWL_N3YT8_/5H8 MC!"7SG+GF8P.677]KA8B&)6>*Y>])E%OE'9"I%=:7RUNEJNX;.PO8I:P?%AL M5M]A>7N:Y9,C"R2K.YQ!I0;Z3G!*A7'?@X^_/5 M;=Q)YI_F-]O)-EBRCXR)[J)$GN (ENY,(2J8SK2^&Z>ZP#,$R MQ-^^77U<_G'HQ._$TX6N,L*1Q-4Q&:$4([!0BR)-!X:?*B1?"L7)J Q!\*[% MS[O5\MM\<7-ZUSX\I*#:0S!4(DRQT%$VSVN A#8=N@_C2XAM981F"+[?+=>; MV=W_._]ZUD8[-* 9VST"3GB$/<@HP$A\;1"V0XWD"XAY)4-F)Z8KE8:LRIG M)[A]_DBAHR\A,' )(#4*H.(_^^6(^@[)>9<0Y.H 14_\O:X:K;W[LER<#GS\ M_%A!"#?.2L^4XL01PARJC[HD=EV^RDL(9G6$HR'HB+#]_O?EX?* MZKYXII#*.JVT$MY!_$5S@E@];00=,FGP)02NNF#1\^?H_[SY,EM\+D\$(@\] M6F 5*+9(@@2#C; X[$^UI" =COKP)02E,D#2JW$+#ZM5N=@\'F)4FK>M"G?2 MO#T\I##*>.:IXT)RJ@SREJB%,IRQRFC0>]5EGN1'H4BEQ.%ZH)(KZ1^N)_=W=F'=91Q?7JM M_N')(JC@C>,:.8H%9L@^!54TE1T^67(Y\:8NB/1*JK\O5Y_CGO'7U?*/S1=8 MWG^=+4Y_L0='%$S9J*@,!X.15=&ZL*Q>?#3&,OUV&+F<0%,.9/K]@K^4=W=- M.'[^8 $!HSAWJA&(RB$7_DF J,<=J+V$J%-G0/HUI)_2;[>7O-=O'S;KS6QQ MI-54LX$%1\*1J)V!TN":^7-Q666'A;G:, M[!^>*;2V@3*&@D:,<,H-TGHW;2-EZ% >X1)B55VPZ#DY,LS7-[.[?Y:S58A_ MO[C2P(K])3(\DE!*_RH#((P8_IN&4<\=&CM1BXAH)4+EWXWXSC!U>SNU>*V_//OY6D+ MZZ=G"Z&MCZZ K'I,*ZRE!FEK,:1P':XF7% M2"M"\*BZ_Q0T!(HD[/742-]AD;Z$P%4F6)XX[J7HD"M__ZEB0\;^>]7+)]-H MKYK,J\5ZL]JNJGMN#RCUF1$%&(0E4<+@0#3B"",=0&@AD2+*Z_ MWH&G"XFP((@BT%)P00CGC#[*)IU@9LBJ"2>;ZW7F9ID;B]F4ZR+]-HL?9I3I M?5R SI1#^OG1P@0"PC(9%RACA*<0'8@=#%4!Q_0+W#VWT^M$Z3(K*,TVZKPT MGZV"\_+AP@B!L5/1+V0NFI4T8%3#XQUF;-IED-)).L%V)V2NA?=Q^#Y3_6A, MNL>A^?5R<;M<;,]"?Y\M_O7VTZ=R5=Y6TW[]RKY]?[:;3J/QA;8@/>>!$##1 MML6HNE:YDUV@+BF7N:WV' 2^J#&;'Z*AU./#E^5J\[%0[M#WW% OYP[?&99QR#Y?VO; XX5"AB,5 M#5;M-#&"!6G,+BB&0**)MOG)0=5)UCNAA^7WY;WGVKVE7\ M,.>S._K)<845P2L@(=AH_6@D)2!7R\JX32^NVE\MY$Z4+?L#9\!8S^=-(*TEWYGMOXY=SH,P S%N5G%_O# PKFJL*RE#.@ M6(!R+OH_^\\D:#7M[;X;86?8[X30M>G!)+?]*=!_F1X\8R M@^2EFE#]WESTG'?@VV$R6)BN7,R7JVW=Z+-$OWBV$)*R0#VUPB!9E:]5O+97 M<- AO91"CQW?LO+<%9*A:/[1C#ECP+U\N(@+F\!($,R(D99''0ZHEHI[/F2Q MT-',M\ZPC$-V=?O\[+9];$AA':52!.2L4X"5Q93:6D)/J9BV =>%LI/L=T;H M&G5ADD;<%%2@+?4'FF<D+8:JG(5!+RN MI4&!3+!;57=BEOT#-?C!JUVN5LL_HB2-$B^>GBZTX: "P104IB)8%8V8.G$U M,!@RRS)) 5YW3L'MCLHXZWO4UM+<5[6/&Z_O3T,*QP0%8IT&[W&@.CHKI):0 M,)'NI/=FS?>;>IT,S3CD5_K:F/;JX8)A9PAVT0YV2AH3]1I\+94G/#VSHK=& M9SWGVK<')6DS_VF_VM;A6W[RU064RJ8YTIO]W*@B@/6$<1NT!<8HY1RS>N98 M=JC?TEM[LUQTYD,<.89;0. M"Q*I.U0CS7Y[? !*TX$99\NUL_5\_>'KJIS=OET\3_T^5.2_[2N*X&S4.P? M&2!)HNNB:@2H"C8]Z);]SODPVW,VJ,91EFTF?[G>;*\&/*RB4W%T0VCW@@)S M+8DDC'DJO.?!>E2[N=2C#C7EL]]>'T91,@&587. Y;=R,:O^O5@O[^:W<4*W MWK[ZZ,QF6<^RVLD6ZTJ1Y\M?(@?W#XVVD<17%R IRR'X3OO<-9Q@(LZA1LPDVTYMF[RH(UC+8@"DCP:@HKS1U>(L20!V*?68O M!SF IO0"VE ;43W5=[/OU9YYO +LZ0$%>(VIQ-( JNJ[2.6A/MRD8$B'$X"+ M"0UF06:X%,Z=<[1^^ZDZ^:ZO*)S,WCP\I) 2(^2Y)@)X98Y3C=1>LS7J<#'W M8L*#F; 9]ZLWB]LWR\5-XA+PP^C"! 24J1"\L0@8EYC78='XIQUZT.5OB3+L M>M %IB?UZ*7,CI^M%M6!1C2)MZ45?_SA&4ON_/R#*O?M)@+CYG8 M_UG>OEO-;\IWJ[*\_UH517H___QELXX/_Z,JDQ1?,'Z5I-7\V[9>T^M&%9)> M/%TPPYWVF@&A@C).'.?.,&5%0!XL-"H?T+=LYRLC_?!DP3FV/JX>P5 KG&4( M*[23"80E';H7M5YQSU1%ZL#'"^^^"P:S*5=#"K/YZK?9W4-IO^]_^[=YN8J3 M_O+]=?FMO#N3K-?L!84@P!VWSJ$@0"MN.)$[R)QP'2J$]UXY*9'ZY0 P#67( M[6?\2SE;/ZRV:KI^*<;9S*Y6[RF0P1H,QU4Z;/Q:@P6,:RR\P&;:J7^Y"3^F M3SU"^>^M7I/,)KPHK1I9FUXMOCYLUEM0CJTY;.F UW(%;OYD^.ROOY^E]G+R0<'U9X3K54SG.DK0V. MH !02QJ]ZP[M$B[#LLD(SO!J ,NJZ/1-L[N%IX85@2ENN7)4!T]IB*H/]9+K MO:)RVM9*'A*/:D8VO*Y90R9I<$Q/,<91"/]?#]NV,(_3/6M.''J\B/APXRFR M#"MO2/R]%[5D)+@)EI[(0]0R.S:#VY)ORLT3%F:]+C>OY[/?=Z4SMB;6[=O% M^ZKOZFH;Z%S/U[\NEK^OR]6W:G/=&DCQKY>+ZC;'MJ+^^^7=75BN_IBM3B7@ M##.!Z"]X;(S!5BB*,$&2"%NCSP.?8)W3G.&]28)\"2K^C_GFRPL &@4+L_VP M@E 9.5>4QP6$:6<]Y[79&DB #KV[>W?.)J)N&;^&+!Q=@N:_%/)'(OX:%>'U M[@M;U\MZN._H1;[QA,J6)4SH*0+PBFB07M/:,T.YZQ#A\?__H*F MRV//I_R'3H3]IT_E396[$G%YM?A6KC?5'_^MO/UD'!A6=,@37&,N*,4E@HQ1#% M7#NO?*.0T@@(V.\5EU$7WY=W6V5=?YE_M=^CJB[ORZHM_38.^;J:;OQ+^_V8 M;]G\2+KO210^>A^,8.ZBFR.<- $)LV-"&"N'#/TV/.W.HU@-8GR30'S29^M] M1)MUU3 M1/:LE<%R'B@).W@D#G1(3RTQVCP=#6H3R&Z'^R6'*3&2R#($#"M. MF?0V&A([22' U%L?Y"&Q3;PR#:]KUI#+"V2/HA@C>;W+53G_O/!_WGR9+3Z7 MC2/:)\<5SO'H:Z @!,*"4A6-B;VL%LBD XA=J/O9\\L(4M*UK=T$'K/ ;^)& MN5C>1T\L^E15WOFI DU-1A8:J"9,"?! 9? 4,UI_)PZ8G&"]Q:PT]P/3F,D/ MITVP!$/U_ L+RCP$;:SUAAMLI>>DML\<,3C]MO!@"1,79<)F9V0H?3TPV[-V MR]$QA=.><2%I57 S:!S1#:26T2%A+\^LS4GLLE\8KU-E+L;.G:2FC*,A+T+/ MMW"QN/\[^/*$\^7]8@:KZX)IIP8P. MV 85S=@=JMXS.\D*J;W&IT?'> J:^X1Q]#^WAX/5@\O%MB#-S:J'.\1SHKW M9^A/PAYZ;#HGPD\S;G<0?&!<@;W$! $VTEH2N,9([Y0&P 0]XOGO?K+/E'"] MN]?]X4M9'O1PGT=>]A:H*]?SSXOML^?.>_O[H47@W(IHE413QSFE( CI=D@3 M,NQ.VO!\MY.^'$M4&1O8BSO&'2-N1EA>)D[1BXS*"'YM:SZJH>X]A8Z3QELI:1:N.N,D[6F-C&T8\T&*]39:XI M3C:\IEQ'G(P'2Z*/ 0J ^R -%63G3H/R2 R:,] U3M:8L>9QLG;P7/)U:6# M'9;42Z*C_TFJ$]A:TL ';?)QC59,(LX7G8YD*$@2M.9&&6>#5;CV?A0),/$> MOWE(;)67E(37-6O(Q1@HXRK&-26L!:Z%!X\T)]8;)S'4&7^@I743M$?R4-?N"GZ> MRDX\,2#:SH@0X,QI[!P/#D'@]7PU$1/,/>T&^[('5#*P^*R2ZZNJDFMS.@^/ M+(0 CR5"BL3-#A$=G:W:S=)623R];[0?7K/ ,W!DZ9F/<\99/#R@X 09!$P9 M)36G! PSNUP4,)A">J7_]H6]+]U-S(+P>/K3-##Y8D@AJ>"."XR(HM&,,28$ MNY<0N8G?9.I*VUDMZ(32->K#)-W J:C!6-& QWF6MV:]F_J3-WS6]&\PNO"! M6:2TQZ#B]BE#X+CV<8R7,OTV0M^!Z0X4O@@*Y(9IL%.*Y>)V/_GSQQ,OGRY$ M,+ZZE04F((P5$9;M,3-FBL5/LM/?'9:AZ#YD1YTQ+X\-*1RA#FA4:J\4=E&) ML=XOH-[2].^^?;/B2SB$U+7JQ23-S2FIPSAJ\)AYO6NC5=7L.A[).C>D0%PIQH2W00)( M6U55QSL)K:4=&N/V9ESFH.M@*GMG= ;EOPWQ/\@DF7(N5$W5 K64$86,KV7R M0:7[F+W9DWTQW@&6I&CTXP^]N5D]E+=UF;UY>3(,?7)(X002G&FOB94R (- MJ)ZSDQVN?_;66S CE9G1&?3C;<+^Z0&%5J QJ8J41B<(*\2K;KH[Z81CZ?<" MVGL'(W_&7;%)^I:?TN36KQ:/IR$?JC*99[_H!@,+C[$@1B@;G9M 01!>WWT" M&SQ*;_S#+X#;7C :/C=H[P6__?13A=5&.4+'AQ*FI22F^[LT M!D^PGG0_=X-Z &LB:K*OP9NN*OM7%)I:R2Q3((R7Q./XQ=0Q$PA!I:O+ (DD M ZI+*F!CWCS]=5T59;Z;W?SKP\V7^/3Z[=?J_57;VBIQ>WE;WDWG^NGKQ!:U M"B%AA1>($F19D([P7=\-PK!#C0R=OF5KVZ+6A7$/A/U/S:DX(9IZSA2NNH)HAD8 MI&I8#&=#EO3IU*RM,;W+7H 9:B<_--VS(=GC@PJ)#"'$NV@D&\TQ]M;:6DI& ME)AVJ+X[>0VTH1-2UZH7DPS53TD=IJ$&'[[,5F5EGY5GXS[GAA8@F:&:,L.E M=L%'FQ6AB"N2TBH989R>'YB#OC,:T1&EL?3"__FUO-F4MQ_+U7UKS7@YN*!* M1C,->:>)IUP'8G#]@3D)*KT20V].WP"ZT1FGL;1CJ\^_+:MKOH^=>5HJR,'Q M!3916HN- 8HLT5%DBFK9;>C07KRWTX,!="0'5&.I277W+JS*\E7TA%;E>O-^ MMFF_S1Q_2<&(D,AZ%I#$( 4!*VN,G7? DA6FMR.' 10F&UYC;SUN_FU^6RYN MD[3F^$L*@;2FBA!# S(0B-28[%% *OV@JK?#C &WHLYX)1U>_3R;?Y3SSU^J MY-IOY6KVN6QDC*2\IO":"A'7T("(B'NN=!*+6C;B(#WA2%R +@R V"67W1", M,0!%/#)>!X&IUG7 R&&/ANS<,$K@*R,XEUP)@1"-06!+16"8!&N,8SM)/9:! M3CL EH?$-B41TO"Z9@V99"AL>HJ1P8[H^WJU"1J8]<"D9R::1.!E+0&C>M#T MY PE$!H3TO::=2N8QJ^&H"1CA&OEA216^2"XJ)UI#X),,#;5+ZU=T$EK MS;,U//[7S^MW_*/B?55OY8A%]\/?%X"YTDX930-SC%H7^'[.Q.AT1GN^"M_5 M=.N"0N_,'?T\?WJB0!(!94%7\7%01@EO:JE]T'JBMX,2L?^9N4X87 Z'D[*) MAJ5N.,I^B?#=/QP/F;QXIL"$8\&=0)PJ,%AX0>KCAQ#W@?00?'8+)QGU91[9 M>^5M]N=YWIX_4SA%$5AOI"2"2.*4D+[.@9*J0^V7["9,%MXZR#Z\H[G-^_TY MT-;(USPXLC#!4&TD1=&X \&$)ICNY*U2S@?ML=;67'V=,6LO!SHC),N^J:SK M:OY7D E+L%4.<:,06Z?"=N4CS.9L.TPF'0F[#XUW7[?__9O\W(5)_WE^^OR6WEWYHB@ MV0L*SKW'2+KJ'H!#7DKA0@U9D(/F/G7R.!M3?ZPO3DZ8AMJK]S-^MINL7XIQ M-DKH3RWUN])N6!7Z16 MC:Q-6WMWO06%G"_M?7Q4H20RP@(1C"IJK:,,X[VX$BS^PD: M-=U87@Z-X. KS-.\*]_3W"\?JMZRC4V8$\,++;B-2 LF&9:$2TN)KA%00@\: MX$JQ7+*J3@^(_?NN/A.V9++0V^.R,XX*^?5F?C_;E&\_==*A-J\II V2$(2\ M$XQ0*2+8=H<$1])/,!VD5R7J$;NAM AFJ]7W;6/"K_&+*&\?@4E1I)9O*K # M03FE8$%C3EW$H_ZJ.'"2WC2GMRM-O>I2O_"-F6P^1G=KJ1%% :@U(*P.E$G. M:G283Y93JDPT"VU!*E;>_,&7,!AR%B5:G-"H$B_C@F<)!.J4]N(!#[<@)+:8>Q^U"V4GV.R-TC;HP4.IR<@B5 5%!<$8(>&H\B;XVI$7 MS)%!VWPWS27M2L:R3XCZ3 O_KRO]4NY^;*\?3)&7OYI658 MG;@RU>65!8X[J@/"@F,.:T6HT[Y&AE.6;ABT+Z0QJ&$P,'!]JM2Q:1[=+,X/ M*J1R'C,$R GJHD!6R=JP%G'Y5=,T'88C==DSDM>F+Y,R+RY133*8(;!:+I;K MOZZ6#U]?+6[^C<)EI5S4I(""QZRR)N MF,B$VF^6CNE!JR)U;!/=F*(&;:+;P3)F2D/7^GG8:&PP8QIA%\TCS 347XJR MKMGMT(,*("]C^\\(SO!JD+$Z&@=),/=,($R4(\CO'1Z%+$R\@40>$EN524O" MZYHU9)+FP?048QR%V,70_9\W7ZJJ'O6\SU](.S6NH("54R1PAQ3%4/5K#+6L MDF(\/>,A#W4_)_]G!&E A?ACMKJMYWJ^G^SA 4406%N$1-Q^E;32$[5/IE#8 MXO34V9&J\J6K0'=TAM\=WBPKU&=WCQF^C7:&'X<4S)" N*4 4CN.B<"X!DQC MX.G1HV'+W'0NR=$)EG'2#?8)W8VS#?8C"N_!&V+#DI[H[(&)]ODR7[X/.% ,N1L1AKJA&S.F"Q7YJ8Q>D%LWIKI]+7!YV* M2=*)[+O9]VVR^V9I;O[K8;XJ#Y]%KV>+VX-)\H^/1.T\?(J;[?6%$" P\<0Q M$H1"!D6[98>%01!DLG[TUF(EAWZ,".'PQOZV$F."Q7]@7.$--5A8S045@* J MLR)J63VWZ?9?^ZCQJ&9_=VR&UX/ZXLW;Q3/WI6RF"T?&%M)ZIK@3VG*CF>"! M^]K1-<%W*,ZO+DL?\N#SI!.#U3M]MRH_SO[\=;$J9W?S_Z^\K0195Y*4Z\NO M@&I4Y+%"&BFNJ= !P6/2,3?.19:;:&??LK6M@"H1$4&3H(/3-OHA""NZDRDZ MH7C(T_K6%5 ;\W&F FH[#&93KH#:R]&N!J0QU>"9=Y)B*T'5\&@00Y[8=#K: M;4QSJZ/=5N!<\L$=58YC\(8XT,96EV@$V4O*IW])+ >);4[PTO"Z9@VYP*/= M,10C0[R@Y]9H/C!%D%1!XD"TB/8H8O7&:P2;4'YW7D):MD9K!U,&HCNV1@,> M]\'@+#)$4N<\1][5\]6VP]WO<0YA.]/:!9VAUO$?7:V??<93-M^9D475H27Z MF%)@;8 XK>V3=0U=NLP,>B2;ZB/D16<$3WQK\Q[SMG=SZ? CGX4T7RT>/YL/ MYX$ MROC FU5N&0F)<_&+9B\H,*H2]&U53"YNN?$SE6Z7.!&W7D*&K')^,JS1!ZD_ M'U'V@=B009"+O"[O" *#N#$LHL=%_$]C:CB5'/1"1*N@26YMR76+OAV>EW8K M6B$&C&%)/0?OHJ<)]:T#X[S%:)JQE>%(;7X].@W):].7245:+E%-,KCFQKY: MV/+;*6?\AT<*P4 @6?FKDG$C@?L@]VLJ@@DUG,\)\#(+&N/4.:#8$Z*=-I12 M[VB@./#:)"-$I&>[]-*(-3]C.5 9*E 2)[B\+RM'/D14CA@W)QR/1N,+&Y6D$#CHTVK N/,P '*K&\96F$LV,$@(>$>!!8#ODYYXK MS-"8U,0P0RO$)IUK,52W6:^5H]@9[5UU:\ '1.6.$11_&3)%IY=00E.-2&M" MVPZ]P>Y-CM(E5$93#A-^M7I.* M2ERD5HVL3<]:H^*D)K2X/DL7.@3OM>2(,T4"(J(V,A X/\%R03WQV* );1IF M?48TIW;6 I0(3(W3T7T$SBE2BM8F*[)^R%O$4S"0!L;STF+GAB@>F)6,"ZZI M#CP874L7%_=K/6MI3&KS('H:DM>F+Y.R:BY133)$\O_SUU]?GPK?/_U]87GP M4IF@==R@-0K4^'IKQE0+,QW3(R>TR^Y0#',(QB3" 9QS!C/O'<'!\WWXB>$A M6\^/0D\7-(;R!PXO*V__6)2KJN76NV@!Q?^>?3X58&W\CH)X;+P6T@GK.#@L M\7Y%(AKTD*E<^8]44J.M?<'7(0G]Y\F\>:A06G[Z\&6V*M?5U&[?Q[]:S6\V M52[HH:4@X46%<0P1$))*,(8("HZC6CZ(Z$YGP1A /0;!L%\=@>7]_?*0J=;^ M)86+%@R)L-E@98@;FL3!U7+QP-,CY[V5'YJ(;B3A-^[V\Q2,>6HLW7K_.?22 M AL:18^K90! 6C!.0@TT8;)#39/>*AR-M@%EP&]D+6JO,M%DLY5(R'(O0#)) M+-O+QZE*]RAZJXDTGGZT!"OC5N/FGSZ55>>WTI:;/\IR4;>G?RRW,EO<[G7W MI &;]P<4%KQ%SI&(L4;,: 2F]L%HD&B"!9/&V**&P#:CKKVZ_QJG\YB(T%R! MGD851!")N-?1*-/:1*N,(ZAG3J'#^4AO=9'&T(IDP)*H/G11_-%T>KLSG:J6 M$L=2")V^F_16 JE?ZGL"+IL*/)_#N^A/50O0 M]L^:Z\'15Q3.! D*C$#4:1>0=+8VP*F4)KTLLKX>9>+%!T!9EF3(JXT#KKC7-L"R@+("E)*H!U>I;'\C0//%5X1H("$:BP MOFKB:ZH^+H^S4]1T\-,R)6-V1G692_;_3JN'*(ZC6I+(.+U*IKR9UD"CL.BC#,D="*".5)+2<.P][][2-WLC&/+7(GVV$V MF&Z\+-MSSK0Y/*( [T.TH9WA4@H9OS(I82>?,3ZDUVKJ*0,RJRV3!9.A./^X MFBW6G\K5VBQN/Y2K;_.;^>+SVT\'*SC%B:T/_]79S2?GCRD80=6E8&(I8TC8 MZ*,P6R/I+2(3-WVZZL=R+9 MPFMIL0P>J,.&4\$$$;5,#LD)U=H8E])E7B"'4HX^RJ#+JB:& $TI@%$D6([4 M3E*K.!NRE]G@-E9&8(97@8P%KI&7TF@642.8,X$%W4LJ>6#3-H3RD-BJTG42 M7M>L(9.T/J:G&-DR,WHK@8Y]W#.Y\=)A0CV5/OY32X "F6"AGSR$M"R!W@ZF M#$1W+($>]T!AC::*8&,A&"TDW\]7-&OQ,Z42Z%UI[8).GQ?]IG8%&:FJV!GW MT:BV&''&%*Z!!D\AO2-"^QSAP8S#@4'K4YWZN#<:K. 1TBBB1#JN>LJ;9\?Z M@D_36!R.U.872-.0O#9]F93I>(EJDL'6Z%PQ5$K,,& MD!(24X6LW(MM38?^ MR6/U0N9S[9T82I1A#EAGPQJBJ<&TMER(D_6YB=K8SYJ;U"]*X MUX/ZNN,& %'ABB(AZO\/ *2XGY';D4I2^,'^=@["JYP (Q)\*9J(B]1=(MKJ2#J_X!1Y;&7B$P8];8]^+OYYWETE,)R M]>YA=?-EMFYU/^SLRPIB/%6.1%?:8$? 2X/K8(DS<7<3&62 M;#I=4_O$4MN,K1E9=$ER3[*_?D&)E)U$IB@2!*'T/'0ZL4D0^,X'X)R#@W.X M])HZRJ43#E/6 NV$5\,MU.A73R=?9^+#E&L24A[;5V)PD:'BL1/1+K+'MFW*>\6 MN[+=%_=V^R5JR.D6"F&Y0AK[8,K)VNLKM+/MB"!F(^I<7)^[- I$@X3>6MXV M+$8W >#MN^IAN5Z\FK/O]><+ZR7U7@M.'6(&: 0ZPA>:C B2.KZO)M3(#9J M@A_.WK;OU[O[4E>+S>T+RG9/]:XW"Z"TJ%/3"RT H'410-X&A'NNX(@SKYR] MF!- ,^])UW3I% U25@H!E9":0*.-L^U=3"_MF!*)V7HR)T=I9JY<3HP"H;#] M&8D(,,A0:0BG;2BA5P2,6":R=4G&A22B=I!I:D0E*0+42LM4'5A"O6#R>2_$ M(P*BKL\5F0+!F4,KPHZY^72_6'\J'QZKS6+SM3.+XO#&"B%QD(I#4B$@ZO45 M,ZRE8(Y#+H$;P:OLO9.3H_7,H7F3J/WUZ6GUIZW+JX"@07W4(?5Y;T,L47" M!')7>1]$!Q2!H>/6KI!,*<[1ET)Z0WNR)-UE4,0,VGNV(_Z^#$-[VGTL%[?+ MU==@/)2;VCU?AQ>V-O9%\7H7M5P0QHV0BDLD*4#.40UXBT"=NBX?,B108N 0=BB (T9KI3F4"IM +5F@36ME^VB MP3U[?=Y6VZU:KY\6JX-_\:P#+M)W"D"UXB)8$%) Z1W6"*L62P='E,/)H6+; M4!-^3H@SINL4U&PPLL #RA&PWFCGB6(PJ"X-1EKPX?ZC'$J^):3A(#A3;;_O MJK?AT;M%+:*PG"^KS@B8D4T7)@S84D(-((!AK(BQQVGG+1@>W99#E;@TF^]H M5-,Q:VVJA\?PJX_EJEQLRT^;Y=U=N8G.LJ[/%% &4RJ@3XVB%AE)(),M-LA M,YAQ.9262\6XB AGP+Y&97W_^1G3]B"YPZY-VX?""J^$<^$/Y(S!1 IPG--: MJN%F2@[%[V;G;63X4Y'Z?YX6Z]URMS_/5=MMN=WNPZ1O__'4!$QW6RO3?[20 M'"E-.#)AZFMI)%-&M[AQ*(>'%>10N"\-;2?$.]GBVY0FW =_-M&@\5;5$XT7 MBG),'(8&0X><=@+RHV@HE\.W^1QJ!"9:+L?C.B>_?GNLUOM[\*8*&&Y>GO!. M0KD3WRL()!A)J!W4Q'OBB*+'74,Y.:(J3?2[6E=%P_%8IV;FBPL.J4G:_].% M8KVQG4B,N[ M4SB*-;56.>\0I'74F7]V]P$S(GWF-9X/79$HTBLAAPG;W*Q_Q7,.GWF<*>STS-T\/3 MZG"B.D&\9*]/%E):I "W3%@MO=/4JJ/RZS7IX>'Q>;KRRB9[? T B?VR)ZW_U]+ &&$T)@QKA$6 %E&N.,& M<>T]LU;P7E?&+NOE:S?S3U62,T98@8%RP=Y$U'N/O6UZ)XD1*4M9G;Q^/QK5 M*M;84UZDOW@+>J4J?<<.\EH=>TRMIH!!ATU=K04ZI4T#BG+6IKS4-K@\8F_! M5E-@DDKMB%EFOH,H4:O9(ZH "&9-,.K#KA>@4P'*!DFE.<[S^GPT?E390?MO ML@Y'=!Z2GJD0?M4;A^IV^U/45], O/IL8:&1%$#G(:=&,>: QNV8I.0I M\\?T-)CF$6D5%\A4Y#A5&N+CU'@1+EW:JR4@(?1J1H]#JFC[4BU99GF$8HKQ%>9 M$0VOGYDA66H?^1$CVB%)^^VFU%17PJ".%PH.)6/ "FDEQMQHP4B[RVGJ5$:% MAN/"__TY0@QT(DCSPZ8L'Q[KP7U\_V_87Z^DW"X8TE%X;!6J?E/*XOEUZ M&('QC@[WGTP6X3NM?*/ -&76M]SR43IMD>9 :0TP<)8+H%V+C,5X^/6AX52J/)7%=$+MGTUP&)(_&U^R4AVO MD281U!"EWZQU^4>7OO'-(P5VQF..3!BN5Q);4:=O;/ID:-)$V>-33_8&N(J" MQB )79 6%&L@%50>: -#,QX0TZJMQA&2TJ$SBVP&0S%(,&93K:OM+YOJZ?'- M^N8O73(Z^6CAN%$0(B*$!% K11%5[>$Q@GRX:1W]:M(TXHJ!2MK@JAAUC(+Q MXCQ27!$#^NC AH#S PA6#CWPAOI$/3#YWZR^IA# MY3\!/!,'K[XK_Z5N;NKE9[F^^^5I>;M8WY3OJMW_ECMU6SV^*)H;/3SU_*#UEP][#OZMD<]L$N;*GB81P1 *@1P$H=YQ246 M!&!(H2$"]]IW9D7E7&VP2YHID$4:*TR,0]Q00J63OD&#AG^F]&9U5@B;3LQ5 M,O2R#G+^=1>&_.P./*XGVS.Q.)WO!?N9*"9M4&N@XEAQH0!O 0)8L(3TNJC^ MUS0L^+XD743HTMJ/QZZ>C<(X^7PAG$18 021(@(J&2:I;,;&@,WUS"6RW$Y: MA'&0^KG8D-6)2HXDF$?X/=;(LQ&_O=LH'$40(\@\](YX!ACFZ(B!4B-N#$\5 M^C%2EI?K)8.0FH$MMA9#>:O+=?C+[L-JL=X^W^*\A#(]&BHL!MKIL#=[XB2M MDX4BU:(A@1J1%7 JWDP@Z=>Y%!_"80>VSSUZQ9^N=L$Z_OUI5VM(:<@/AXH6"/4\!J9DR6]SI1T Q%-Q;SO^^L#KCUT9_.TJ;$]%%_LL^5& M_4ZA%0)8LV"^>R<)QI"85GX6HAPKN*9@YYP8S\K7ZF;YS2 &4/%$$X7"' 63 M4'(89JL!%**C'*P+OQC,LLDR1L_&LO'P7=."UV/OC?F90C(M)>$,:\(PH\PA MU1[E.B%(Q7 X\@1]$11AZ5B@H/:A:J/(T=V1&WJ MR=(@SZWI#81NX@#9<[&:/VBF]602(-EW[&="^0AF6UQ4(& "4B!/.89<40H 6VUG1:-45_-%?7#@N8?&2CQ.5&@,9 M&!'=#'GY8;.L-H?,SZ6IMCNS*6^7\5:[,U\H@##$>P",%HZ%A<-0P5L3B#DZ M?-=,$;J:"3LC CR79[VOJ7+&KAO3;$&8T@Q+K"73&AJNA/(M4@*/*'\S42;N M>_K@TPJ"-9+L^+V>O]PCNKE+(* MF;"YA3EL"-?'L5.;H7&> P.GP#85KSYLJC!5ZKYWD.?YH4(&@U$0%;0>2Z@B M%@%"VE%0"X=?]IOLOD$.#!D,X,QA01.GKJM7YO53N9\V;EW=6V:.M]A=RC4^*[\>HB?^%@^UA[G]5VR#STGWO]4_;ZXN:G4^O:_R_#6 M_=O0]MU^MNQY'[6B=OO5ZO.'36CW2_/MQ8_?-O>+S5UYKN[V\/8*[Z61BG!N MA0<":>CAX;X/T800T.O2Z!0C[JCA/:RM@BH>[%02U'-OJ//<,.6;D0(*E9L[ MV"J1'*NT.$X82K5M(=Z6-W^YJ_[XS]MR>=CUPU^^W^S#CXJWY=UBY=:[H)N\ MXE,_\51AF99<^K!E6<@1=*BH& RWA M7O6W7NP%BVU74;\?'RPH,,&.9Y)# 8"W5%EGVU$X9K([/4ZW-48!+)W8.ZOU M=CU>,">)P%XR&D;B-$+4F'9$!IA,SVG'BN=5*8]&YF>0>5;;; ZBCK#K=JQ3 MH2^=97M[O5H@JKEUDEN#N92(22)%,P:$),HH9#*.**I)\9ER&IMJO:U6R]MG MYU3'KGWZX0( 0(1@3% N &->J=HE>QB-]R-"$* M*"&QL)Y@!JG&1B#DS7%$")M\=^^Q(NJ4]BAT?@:Y9[>#YR#N>4XGWX?5<;$_ MJC@X1L_?H'CEC4( )+TRA#LI+?%$(*N>Q^>&YTF;9(^3[U74"J!\09++K6BQ"K:9#0-8\64 M#-\#+L]@EYD*. 5^R;ARZ.+9L.=OGBMLZ+=QREF$'50,2*-:=R2V#+ \]<#( M^A$0NFZI9Z4%YB3L"/Z<7Q^J?Y;UZO1A4]T^W>S:870YJ!J%?3())JLM9Q976\5= ]RO7-5W5SLWE:K,((_EB^ MW/E.3-\S;Q;$<"QI4%\-(P9CH]71J4F,H\,K64Q1X3UAL,LT^$TBVI85@+)RVBHAV1@S330J\Q1-3'*3P,G9]![EE9?[F(^]K/ +B6 MP1 *_P5%V03=F4O6;++&"^&3"GV$^[>WF'J> 5P&R[6? 0#@,,)08:LX]9)2 M0'P[6F/,\+2S:<\ AI(@*CJIN&"J35!S0L_?5>MSKJ*S[Q36",,#V:'2Q%M. MI*'MFNDY ,-]_]&O,$["@%C 7/IP#"$KEOJ61D!.0D[ MSR,@1ZGW!%J G4>.::J=;WMM.$_IU!ET!-0;]=Y'0)+57-XT4." MKSU=2$8PDQA1YA6#$C-,;=M38>%PV4V6>&2T[")A,4AJ?P\K1P]Q_?!8 8WD MF@2K #,EH+<&-C7/0]^T&'%J/EGZC]%R&@M"JCU0K5;[=!Z]W22G7R@$0S*H M_V&%P")8?'4^,7T<'73##>3)BGN.$W%4.%()NTE?\C)[R6 7$,DQ6-NE!W/00)O>W/J>UZN-K?7ZZ M4)A(RKT5"F/C$+'(R2.&T*>\&9L#-<9#E&P+.>2\/^2"_/QFO5NL[Y9!NZQ) MVYE=KOO%@BCJJ40"&4B1"S!:?!RMM3+EA:L<"!$5K53<^*5;.@-?V)=PQQ:+SCS+DCC,S0#*N)3\J.N' -,@_V1'SS M\+A8;NIQ+M:WK;/!?5GNZG29K^3BZO%B@33BF!F$(%6*"X>E:[S,%C&KAD=J M3E:>>Q)Q3X)6JL4@K%GEIMSN#CM:P\QW95>RW-=>*?B^&@%@M7\:,H!=K1$U M(Q3(#S?])RND/>GTCX13*B9<;[9EZ2'17#+$/")0L+J"?8LGY6JX4C)9W>Q) M>32H4:B<)QP@.SP8FKY(HL0&;9U4Y M7+)X"N TEG^UWNHRP'0LP_2E#(MJ4.N#L);KQ>;K'K5WU;H.I0["6.UQ/:@! MO=>BJ%\M@$98@:!IN/ _& #G\(@SA'K$=2IPEE'_\?MB M6_[7?_P_4$L#!!0 ( 'M9GE IC.,*22 ! &*"#P 3 ;6\M,C R,# S M,S%?;&%B+GAM;.R];7/C.)8N^/W^"F[/QIWJ"&<508($T7=F;H 6).[^>+( MS.Z^'14;"J9$V[PEBVY1SDS/KU^0%"79U@M>2=;&1G=D.94RSW,>$,\Y Z M?_N?/^Z7WK=B79?5ZM__!'[V_^05JWFU*%>W__ZGOWY^0S[3MV__]#__X[_] MV__QYLW_2C^]\U@U?[PO5AN/KHM\4RR\[^7FSOO[HJA_]V[6U;WW]VK]>_DM M?_.F^R6O_6%9KG[_2_/'U[PNO!]U^9=Z?E?;YI;=]M-@]_^>67[]^_ M__SCZWKY<[6^_27P_?"7W6^=_$;SMS?]U]XT'[T!P9L0_/RC7OS)$QZNZM:V MA)'^ZS]>??][V'X;8(Q_:?]U]]6Z//9%\5CPR_]Z_^YSZ^>;W)]'A7YIO_+(J;AN^KXMU62T^;_+UYEW^M5@* M&.W3[M;%S?%'+-?K9T]H&,(-0R!N&/J7"P_>/#T4__ZGNKQ_6 IZ?C' KP%X M\QJL*W0M"1]T0)YC]>4#+>/](KIN81?QZT=:QMR]:'RUQV(3M] M,ZI-OK3\9KQZY$G,R^9;[\1/VR\V3S\COZWQK:@>/+CXL2E6BV+1BN:S1WOE MXM__)'Z:/=9O;O/\8<9$ZW\3H>1;\58H[;H-4359+?ZS6-R*8$;FXI_*35G4 MK*SGRZI^7!?DJ_AB/M_,8DP23B'% 2%9@I,($99 /P0Q8"A&X:PU.2M6;_[Z MN0?8?C02;O/[:XMZR)_ #_$NQW-3])V^:3][X8!O( M_\4"S2\;KYH/VGA=6RR;E*=:;[O+L[>:K.=>M5X4:Y&*];^4K^<7&GW[C5_F ME<@O'C9OGK5_DY*-X&DU?-?HV!5D'&/VC%Y\R;\NBQF-"(^B, 4X0ED$_(0D M_M8*IR#DL\TN+"H(@=RS53KWYD1TENOAO[6 3G=8.U2IRJ5]EK0E\!)!CA6M MM2ZE4FJ<34UY%-&?5!,=%F05(LO+]=_RY6.1/NU^_,^R6(O?OWMZ5WP3I/TH MZUD4<0Y\Q'P*"/,Y0C'+>N,9(I&*<%@RZ5A/&FA>B\W;@6OSA0_D;R(K$ @5 M!<86TW*Z,P+):G)DPJ\3?9)C[(QL6:9\&FIFVZG*Z6NJJ7WOB[Q)QMI\[34, M5MWGY6H64Q]P$"(0LB2!8B\\+O-\ZB+J2J$.JH@ ZYE-7 M[C2H=*MVKWF2T38#=B>F9":>G-(M8W8T1K8'6IGF=5FW.65 _(QG !$(DU0, MI6GBH\YJ +%(+S6'M%JV'*O5 2:O!64Z@-4C5'GDZIQ+-:52IM'U./48/W(# M5"-F)Z92IMZ<'I):8$E9K?9K V\WQ3VYKQY%@K=-YW X9C3B&%%#1N*7.T1IA*O;O7L#%ZZ6C=5<&2SPW $S#8G1"R!A&<,D!3'C,#8I[1'$&542>ILVG6L M>%NH7K[Q3G52K=&E5>KE-' LUM6DT +A3E11@;TSXNBB#::AD4X\J]R_P6J* MR>M->9]OBH\W,A#2# 6"2\YB&(0H%IJ=;B%$/N*^BF1:->Q8,WNL7G5C5S3M MLB^GFJ,1KR:;-CAWHILJ_)T13B?-, WE=.-:-AX ML>@RW-,H *-Q&(4A32D&4<@$BE[!(QH%5$4^;=MVK* ]3&O*:9U[.?$;EZ5]5U^K0M;/Y4+-OM M;?5=^=!.D2+LAWY&PY30.,59"%$$>S P84J9J",(CA6UWU1PB$MKT<55"\@) MZ@3(5]-5'=Z'V[]QD3FIHF@G33$-=77MI,R&#=N(P)-I0OE%6=$[2S"F=AH)9 M\*.R_;*IZ="'8O-V]:VH-XT:;HWW26889"'&D+$X(U2('R3]TG<4I9E2";2! M&<=*))!Y>VB[_:%Z(V$3-N7$:" BU=1(ET,G>G2:H3."9('6:2B2#44,I")2W2>+QC#6H0'>Q4UQPZJI,F M.RQTRI>:U"A2Y6BT]Y*0LR,Y;?:FH2@F#KP:@1ERH:<@'_+[8I=$X8S#!&2( M)9A3EH&L7WR(<:Q6:*)M9%@UN?(::)J#*WTB=;3%$8=&"B-+WP!*LZ='6F\T M&)VBZNBX<59[M'FYI$#WU2RKUD5YNZ*/ZW6QFC^Q8E7=EZOFL*$&PS9SRC@* M>!P X/LQ"Q-.,M[7W,60!5+[$6S9I#> 4JO[6UJ@RUK%)^7J#'8 M55.JR1*[V)ZGV$YA3(K@9\B&)/I%>+BOA.0WL+:"+\G%$=VWS>*X\F_=F\K- MNR87#.KU9M:YGXFO)U1" ':X)QE7,X-ZN!7VUYK3UE;IOIHX1Q 'WJLSADPD::H'X% M)>98+N>V8&9PO50:^=O@\;(F#DBAJ>K9&/A+Z=YY3DXHFR4BQ]KJOYU73T^O%W-?^[KG2$(2 0X3P,$$8JS(-N>Y!>@#(12A^EI/]RQ MUG2@O!:5U\!2'W%JDG9Q[.Z>+S5A&8\JZ=&X>\KTAM\:U%T>;A]U]OCXVHR7 MT0?4AO K2^^'5GT<*VHQ9F]?ES9G9$D6ICC%B#) 4R'=--T9@R&&&L5QJB8& MJHP[@*6U'JQ+H-RZS0#$'.Y%$Z7R6FLUI@Z<;P(SHP3?:7I MCT5(0A8G,<.41C&)>.KO-ED@&C"EFA-M(V.HC4D9K@:-NHKC@$$+FC-F#>XK M+%^GZVVJUV)HJ%OT)>82C(,@RB!,8BT&J3[)^$0(Q MB$.EPEN-YSO6G _59M=EBH67U[N"T<.Z+KWZ6QTVY?3'-9%JTF.'0S?UMZ^) M.B-#)K1.0X&,/'A9:FO,ALE>ST]E_7LW,T\P( !"[ ,&$PA@3/M$*TE9K'2L MKY$AYY5R1^Z)LK9Q4YY..04:C$DU*=(B<;!=F#U!9ROF+/ Z#2VRXXK$ODE- M?M35B5:K]LJL+^+WMXE8$%$4@(C#V =!P@*?[]8-$S^EL9XZ:1@:3IUZ<-I5 MO"9TJJJ38R:UU4F>1,?J])H@*74RX'5JZF3BRDEU,N9'^O3>KI*,_YC?B5=M M9W>;KX44)"P)LHCY20BHGT;][35!@D( E([M-;+D6)_ZJLAY7Q4YW\*K=2]% M,.-53J>&HU1-J'HV>V '#JC5W;XG89@6?+EY9F\%AE2D*SO^7K1 MVZK[]AX/4L"D";,%W98@!!, MTA F6TL8!+KS2?+/'VZ@]EL#RFM1:8_1%'A3'9JYH4Q[1";%EN/!V(X2J3&8 M.H'34!0C#TZ.N'394->2#U6S$I.=>8Y-U)BHTGGU!1' MUXV3LF/$B]X1$KNC6&><4T80))0%44!CPF"$=]9\I#1DTK7A7'F^;KSRX 2$ MF^;,]V_MV<6+W5&T)@=)*- IJT'NF525H!?'2!P2-^[]Y;"#1JVJ)&D)R@..-&347VM+!SM#A1BT,*SDB$%E/3T 4] MZ)6%-T5- 3[?5>M-8R.MUNOJ>[FZK6<(^CP+TPS@& 'Q_XC G:64I$K'!.L\ MW[$>M)"Z-__K#I2:+&BQ)J<.K@E3$XD#KH97B2-4G!$+$^*FH1E&'E3V7B/] M'&*?K\0TC7R2 H!#[,,49R#>Y2LP!5PWF9"W,&A6<3B0T<\P%.A33S7<,&>2 MHWBV,:@X '# 99G/C$1YAMH1&?9DARK_QP@!SK5X?;NV^!>^4> M^97W('[E+J\+[V%=SB7E;-BV.J]^DVTF-;'L?? VE;?UPMNV6N?'P<'HM2<\ M\8[62XL&W7DSQ;:4/D-@FFVJ=^[ D&U[^< ":\P>":&C--SH!R.,X'(U8D?1 M77LE=5UL7JRY_KW4C& W^V*C:JBJ5K2ZJ3X:Z3];"TJA]N!4#OIZ6 M^&>O6GF+PZ*20EN\M"E6%3"G_!J7EOS:DONN)_=9U5S0Y3TBM 8NC27AC]\28K5_EJ7N;+ZZHNV[-QOM9M7>\,^!C$E-.$ M\#@B(<01"%O320K]B&>RBQLV;#E<[>CA>=6-MP/H]0B]WWJ, Y>4RM!V;F7$ M)NO3Z(9V77JY=F*?+]G.V"8U] ^(#'./$A#5,>1CLC$&3^[%NQ_EK) MCH84'Z[2SPYQ2'>W#H]:HJ!*D)PN.61&38$Z(*,)S7,>SDB*)F'3$ ]=\)65 MET9-$&A>WY'5HOE/,XOS+5\V,S1D0_/U^JEZ>\R.1<=S)PVZ=EITWOQ0['&JJ8DE=N5$9GABU;1GQVG[PP'$*R_? M>#W*,99KI9@[HU9VF9^&B%GVJ7+YKJI)WJ=B7@B+7Y=%+48]W:4ZFUD28QI# MZB01X3 MFJ0)"5B20)Y%Z?8@A"2-"4=2I?0.S+JNC2WR&V]3??%:&16 MM25*8/5V8*^\%N[N@T[!JANOQSP>^])E76.V@N:E,?U0N"O3:(Y(%I1O[@KO M:RZ^."^\^JX0[; 0^)M_>5A7B\?FH!NABW795M:T'[=-=Y]OA)?BM\48NZR; M$A#OL2Z:BLSVB;?KZOOF;O_UVZI:G&[5RZ5>BFP?+^ARU62CEVTY_Q M26NG-48O1JPQR%2+5!V/I^.5;GRRQK%T7!J#:[UX9(OSR]%#DI/C4<,VH:-' M"^L.5/LWYDK]7Z]_?KJ[7U;RH&\L?]Y9C$D=!&L<^CS*G9JIL<:6LJYEY:H48[3%K\UHZKEE803"B#.9* MZTPV[#G6M1Y9/TC5%#830A6%;2 NM85MQV@+<"JZ=IHU&5VSP/G$=,V&1Z=T MS1I;.NM;,\"2)$JB,,(X1!P2/P&["0,<JI)F:F%XH03^S-*7HOZP"M./%KB"Q7TIO;G#+ M,&$LHS#): 2S*-X:0CZ&D4HBH_'X0>;KNOM!-MW^2<5!F0YEI'0H\(BT(.61CQW@:$OE(& MH?9DQRG$E^97C$1#D2@YO7#'D9I4C"H2LOJ@1]8TI$$3^]%]!WH,R K"];IZ M*-:;IW9ADJP631'P0[,R\>NZJNN9#V"HQMTNL=I7Q/:0MO6/TY M3]490;+$\304RI8SE9/W4#&IF<\?[Q^7S7W7K'A8%_.R7585/R^+=BOG:D'N MJ_6F_*_V\Y,89S'%&8Q2&J#=.?9O9.Y^)_!K%$0P0I01'+."X-XDXS52&QD:&'(^4 M+Z2\RA/P9J0:)KNV^;2:Z@X^:7^.)ITT5X7=:2B@'5=D4UQU?F25JEE?_%XN MES,>0@@3%"<( BMGE$$96ZFT?O585>&[X3J8OY&-'_Y==F=<-@4$/ ?\^7CHES=[DVS%'$$ M>13Z(/59'(:LWR?+" @4)^"LF'0^#=>M9)4[K-L)?*UR !L4RY8)#,RM:OG MCLY^^K\I6/IIA]'K0?YYZ-J"R[R=K3FP2/LTA,NN2Z]J%*SS);$7J3N8^G,Q M?UR+_QX<33V#"*0Q85%"(Y0%(DF"VUM_A:D81ZF\EZMV?+5Y M\NH.:JFP.<: QO,B-AA_:J*U/2F_!W5X5OX0G$EO(1J&.[U-0SH<7MX@=-+C M(U)MA:#1-P%9<*&R^,)HEXU]$)[V2\HLP)D?!HPPBH(T"TG2Y[7,#^)8+;G4 MLS%0-FE8.*9"FERZZ)XM-:E]7CZVAS1:!=D>@EP1F0:+TTCW#'TX74JFS8A: M-=DL25&6-AO7 Y;$&4,0[?8FLHQ&2G/EDH\K@KZ:"V8HL_2-WN6^==RV0Y%=B&1R 4KS*4X?#R\DYC-G0N!^XK5@E H5 I3,+F2E#B@V!W*!OG#"I=+Z[S?,<+5UL8WD-3 MPE"MFKV?RV=W!>O?#RS-H*2H."9/451>W W<\_@^WUR:#W-^1_#ELG03+BG+D=6(\-A2+/Y@RV^CI_:LZ2W1F#6G*%G MQ'FFTN/R'CI@RG676M1)CE'<;6'. M3$B9#5XYKD@U^).I^MM8^%YO-LKUI ML=?"I]XD3S$D&+ XB E.:8 9[:>C. 5RQ[!9,>18CO;(O/E=OKY5J/JQ0.)Y M71JJ#S-B]7"ETD8/C%4/VJ!N]-O43.&"1GV0)B])^X*Y0EFSLB- M*9?3$!MC+RJ[;YAVL>8ND8H@2V@($,TB3-,P2/:)5,226*4 6^/Q2O)B>ICG MP6JD=M&F-&]R"N.8,C5Q&7](I32,,N!N&F)BXL#I:DT]+G2*-0\VB20$^ 3 M% 8!X@BS*([VB1'/F&+)MYX1YW,V[RS5:*H0)ZDC[AE3U)(7E9K[LP*F5+,I MM5',D-N):(VA$V>*-[4YD1X?%3>%>/Y^0':@=NUU"9S[21PG +$D"C*4DMT9 M*UD6*XZ3#&VY'B]MX7FE]ER-,9N28ZB.[I^9P MWQ:SMP7M;5&W!T^.MWE?CRV7[CA4*A:X%DJP+C;ENBU3 M>('K-*"$A"GDG"/Q)PA"H>Q^#X@$L9*2.H0QE*H^ ^_=%?ER<^?-\W6A([0N MFT6A/F'\%M$6X*Z,X;D#KU5Y5#76I_A2U8/;=IN&2@_AZ+%JB2&X55+OXP99 M!CEA+ 20XI $B4P[@U2$G-E==8SXUA]NUZNO>)@PI^"C+JG3DTF.]:>#\;' MU$ MC3,C=4(:9NC(,8VRP8W&:NMN?3ZOZ^[ [% M)*L%K5;-;J5B-6\L8AIF* UX'&8A@RF%84A[BR(+4JPR-['D?+GR&1SOIP_5 MIO .'U&MWTNY31C*!+5-.0 57L?RS-A.E8\J>R_=&JJ M]*E8%,5]4^75I#["H*! ?/WV[4J,+XIZTQWL2_/U^DE\2NZ;TRMF.(8<9R3- MH$\CF!*?<+9+C2A1.C;""0#'XZ@]9F_U#'1SR4.+6DW.W#2"G,Z-SK^: !Y0 M_QROUP.^\CK(5UX/VNM0#RN/.KR>T4VGS30-077K8C7@:Z\FP9\WU?SWNVHI MZ*T[LV]7V[JDZ^XH/K+9K,NOCYL&[I?J..#=$1PQSX(,\ MK3?>H3O>ICH5#T8[D\AN@YR)#2.U_#2BQEC.5Y/H?>I3$-6JA?JW?/E8S!C& M"4*$DYA'P*<)2:.L-P.8GZK$"N6'.U;[#H]7-X"NO(=\[7UK8'G_I_]S&'K@ ME]![*-9>?=>L.?\47"5^=(5CV5=/Q8+C:D)-8[EYR.+M MBN8/Y29?'EB?H2!)>!!$* $!";,XB,*=Q!&81DJ[U\W-N2Y\V2$44E0NWI0K M;]Z!5-S4;H%8.<$9F%,U"3J@LT'7W$*WQ2>&_0?R-/".]XN4G5$HBWQ/0[-L M.O1R,[QMKN2G2S=Y4\'"\_5*Y&TUF<\?[Q^7^:98-+4M\U*D;M"/(/03[(E5W6NLP/G[0C^Z0"?MP4X\/6VEQD[.XMIC>YI:)Q-AU[-4%KF2N' H=Y0 M6QXC5/5A7=PU%=??BFZWRKNJ;O:H?+SYDO^8123D8<9IYH!4:! M^I4%5JT[5[_#+EFUI6+S0\C>4J#5.+K(;A-(IGPCRPX=-?VX?CH8 MA0H) 'E',.L'X4CP& X6Q6W#6HY#=4P(-55<==5#[$H3!K5;1]< M%P_B&W=Y+7IN.S?G_80ANHIP>!5$N)]ZRYNM^.)K7@BNO.8$UK;:I?DB1O@* MQ>'!%UDQ+^Z_"@GHO@NPXHR=3G/(Z:FK=M"2S![,LWF[8>7P-1]G%,^ O&F( MFHD#E;47R70M>H:C!":(^U'"?1HBD6;B?B\&BA.D=!B3QN,'*5:NCZP,%]T] M\_F+54:R%'_/31>,+[.JN^AKE5#SA=M7J[37^?#;)EZSI+2:*DWI-'3'Q(&+ MJYJ*7,CJSOMR5:W;1=-N(72603&230..>90 &!&"$-K)&Z9*=VTJ/]SQ6L"' MXS6#BF-$=\TU$4??F7I/1NCNFX&./01 M]E$4 SC",8I#GMP* T3LRS(":21,ZWPO"GHEWO(/--^:T#TQ<9HRB.P@0S%L89Q1$# M$>U.&&P2[P 3Z1H*6P9=EE(<8&P[W1:EMX;$TC:&TV_%#\VZ;(I;&MNP,--YH.A^$'\U^=9CR(C M5.D@.=NV'4^[%5/W0..N\2PXM1Z3G^5&I/G MQH..VF0:$NK,NY-%#V2-(DQ3"D 4\PES-]>W^:K\K_8:;UJMZFI9+MJ_ MB-!P+?I#?\7WQYNL7.6K>9DO/XM/BNX7!VB.P+AZ*OBL?BY]HLN\/DQ$(8YH["9DTK4[' _ M#2&U[M7)A,PF:_(7_WS=L+*>+RMAN=@I;W.^:1:#2&1[4.1^A/AQM\,!8HH" MZ8()S:>[ZWP-(&^/:+2,YS@Q9_J6(9/3Z$JF3KRZ^\4")WH=9=\M&28D\!.6 MT P$:4(1YF%O#:2A4I:@:\-Q5L"4+Q#5)DM'5MSP9*@KHX7Q$]Q(2XLZFU/4 M%@TOSHJ++BL63@$_HG \\7W(<032. A!Q!@%"8[\#/AA'& L.PUJUZC#C/G< MZ=93B.9*1)[IB6X:9!K]TY%O\B=E&S,H?^UX73^SW [L9L) GB"&*6,I2!C M*.&],9C!4"51T#3A.$]H4+WHG-V@]G1WM$J@G.H-P)V:O&G0YNBR\6/$G*OX M,V-R&KIDZL2KR\8M<')):>KU9O:NW)2WW?QJ7A?D1UG/6 P0XC&@,0RB@"29 M3].=G$61U%!$\]&NE66'R&L@B4 O0$FJBBY9Y]5D )X4542-(AD%$3X>J(?X MVTOE.$["$<4P9&M*C +.M M*10&H50&8F1@:)7H8&GKA IUJFKAB#5#S;A$F"/5V),AI1T:W$U-071<.*DC MVGQ<4I/[:O:A6O'5[;*X7E&':N/ /RF1>QM(7M;S)X [76HVVYVY?7 MO=\ZZ)(*Y:8YSBO7Z"VAIFA_U$985//'^[XH8KJ-\0RFRT:1C4#WU9OF&# _ MW,86'8:.Q!RG1(\;B]RZ5@WPHAK&KOP0PJ_KHECU CR,\K3+/(9HAQR D._ M!^!GF=2U%P[,CA:W\I>]LX-M2S -&D(S9@W3!K8BUG3I-XQ6PS2#[5BEW1RZ M(>LD32H!RYSKB88K"XY="E:VN+,3JM[EZ_R^W"&(28293\*$8I#Z2<(XZ1$ M@<9>K%*S.YU@M<7M1"X5V\)&N'+7#,[BU81:P&;$NGQ_D<(7YJ>*<4O$_8LC;7$FUTN>P0AC7V$LB2F-.)BU)?%45][@0**I>ZC M=6%W.@%LB]M-OJ_6%E;&6\Z:P=V :SHM8'7(Y:PEW(^Y.NB.QUJ'_.@/MK18 M_B.$*TW/U(9;!NQ="E>+HIR]*V[S)1]?]NG==S'^^K;[] M(KSKEKW%#R]7O(]X?D163/@95S:,D%?F;X=\M^\>OETLAX!$$ 20DXQE?H1Y MBH+^\0EG4H?)*S_4<8?O7VBETA=U9B[W=&>DJ'5S63YL=/%#ET_T;RU6QN_< M>K KP[=!>O!Y?5PJ ],-)FZ./YS3Y):M^_P>!V@0:F2'JBYITQO-/::.ANSA$>] M/3ZV,B-F] &4(?S*T@MBN&?I7;DJWFZ*^WJ6P(B". M"QN,H#CA,LF1G,$92 M,FK!C.N!TI%-. TXKT5GNH%)@QB"3'8!VZ)%UW,.6VBV@HT1N:J!9BA> M38/,CF2[ <:(:]W@,A3GM@*++O?*0>4,,5(!Q0:Q4PLF5GPZ&4CL,69S]$*6 M+?_BK;TNQ$LJWN#;8M;L@8$)"'E$8I\ /TI8/SN.>8R [<&,%HC1QC977K[# MZSWL -M/O/7:QM[XQWFSN!T.[>%[UY-K)?NC)>>M-/Z_:"BAW4ME0$!Y0$./4YQ00!D,6<=%=4 M!)"C&"M=?V;1[+"K%D]>AU.ITLL%V9J+&,/P;!;X)"D>9DWC)&$J:QSFK$]T MS<."8Y?60&QQIZ>(6^/;LIH(13&$6&ANS$,21I2F.XLDC;F^!*K9&5CSKG8] M4JGFS0JC.CKGCDS3C%Z6QP&T[1E)TF*F1^T4U4O3D[-R9<*.Q*S'V_N'9;$; MHE1"$-?KHKDRIF@.Y7U[KZ_%ZSP&K%ZS9;H"+( RDI]E-S3@..%MXW@$^;PM07>F,*;T8489D4RV$3(M( MZ1@Q)*%Z0>$UL?^JP.SE*'"!@>.R;XNVT77>FB.5]5=*5)(QW=B,?)UAVNX\E:XYU_>#2FX<6D*KV M&+,IJ^5#$JDGZ2U";P_QZO!*H>MQV%45^"%9-M-Y$[:EU?X"'6=%WQ:54]%^ M:_Z\"@%VF=*< B?S^?HQ7UZOJV]E@V(6!2F!. D@1I@S\6<6PMXJ%W ,IL&5 M;;FNR.R!>.MBF6^*A;>IO.7^4'\QX*KD*S2M$:PU*^Z46\,EORVVYGCJ+;I1 MY\9?4B4_/ZY-\B3GR/6].3]/;LB2]#WTCU_KXI^/(I+R;^*/YA:'=N60Q*E( MH/TT2L. (^QG+ I3'(_'R G@KK!BHSG9%$%$?TS"C(/$I"G'$&,EZ M>TF8*I50Z5L91WFT2@<,J-16'P&\QF@Q(G,'YN=-OFE7GW\MJMMU_G!7SO-EFU5E+,$, MP32+8QZ&<8*B+.AL88A!(C6Z,K/@6%\.\2A?E&O VWEE&8XR-6518&%,W 3TQ]Z&R^3))ZLGF83W[ M\(]93!C&(8",()R"),A8%O9/];GD5=R2SW*L$1^*[]X_JO7OBN,8:28N*($# M$M3Z_ ?^=^\?'S_]WT9'"S=N-/T\:7]J^GARV,<[)X_U9D7W1^ZWJF@KO4:6 M+BUZGZ^?1&,NWI=UT[ZE>)??%S_*>24^NRY6J_II^2U?E?EVG,+\&"2<$4Z2 MC-/4CPD!N]PB8++GS%FVZKA_]VBOO![OE=?T^0YR>T7'(6CU:DC;C7!>,,;E M7TU:_G#42YN5+UIOB9C!"_M9H3&(@NX?!ABG'06AW"=2Z MJ1VL-UZ/TMO"5-<^*P1?C#5#O>!A@>;+X4*"BN,QPB:' MHP<&J\Y43MXS.R&@X44,$Z,/U^_)XG\_UIMV*\862I0@%$@0>6)<^LGXBSDV"<6N1S!7S+F.7 M; N8QZH#=O2BDPZ]DX]'6D[)1R!]SDQCSI=UOJK+YL=_%/GZ%9:,T8P$T/+?DH&2UM,FIC@O/9N'&+(H8!PZ"Y[-3/<-94 MCD/>HR"4^K;F-G5LCQ\PF^>_F(5Q,&6FU2[FW*7K5G$Z M;:G<.A8F+(\0ICE7:4+]M..>L7<*,Y3F+-J8G#R&0HQ20Q;%!"5^!F",41HG M/0I $]DSS9S8GD2L@\[55:]=S&)DZG,B;:&O=E-UZWB=)ISA%AWC##- MF4\3ZB1*R+G:NK7KL8 MQSKG3>(BUDVU-:S%.N>MXC+6J;>.>:P[1IA>K#.B?O*QSLP[^5AG@44+L0X= M0T$Q#1(?$1YA!%&0!"G9E=S$@%HI<]&U/8E8AYRKJUZ[&,(RUJFWCGFL.T:87JPSHG[RL<[,._E89X%%"[$N.88B"S* LQBCC,<8 M0Q;%?E\ADQ!BIZ13U_8D8EWB7%WUVL4XUCEO$A>Q;JJM82W6.6\5E[%.O77, M8]TQPO1BG1'UDX]U9M[)QSH++%J(=?AHQ(TC',0TAB%'D(*PUBGT3K&L>XH85JQSHSZJ<\55S&.O76,8]UQPC3BW5&U$\^UIEY)Q_K++!H(=8%QZM!&:8I MCD(4PAAD:?.>]2APE!%+L4[+]B1B7>!<7?7:Q3C6.6\2%[%NJJUA+=8Y;Q67 ML4Z]=T8XP"'Z:4TXS"V.<^3?N+ M\9(H"&V-Z[1L3R+6.3^I0[-=C&.=\R9Q$>NFVAK68IWS5G$9ZT8X-^4H87JQ MSHCZR<)8A3G@2$81\@F/0E,CBEV-8DII[Q240[][?(Z#:-<;QSWRHN M MYT&\1:R'/?,"YCWA@W^5B\Q<>0_#1XM!+[X&(PM&!ZG$'/$ M$LX "WF(PKA?2<2,(=E+N5U"F$00?'E,A /--6HFXU X5 NY"(BG&V=BK60M M/@[56BZCI$:7,H^29XC3BY4V6F+R$=.*D_)QTQZG%J(G.AK$$T;B@(4Q8'Z< MA#P%:'>; PZ3V-(99)K&)Q$Q7QXVX2!B:C:-<:QTWRHNHN1T&\1:6'3?,"X# MHD8#F0?$HY3IA4(S]B/Q-PE#& L8@(C_94D:!7@7?S&P->+3,SZ) MP/?R& H'.JO9-,:!SWVKN A\TVT0:X'/?<.X#'P:#60>^(Y2IA?XS-B??. S M=$\^\-G@\5+@>ZS?W.;YP^Q=N2EOVY?YLWBG'VORHZQG'($,PQ0A$HD_0HP0 M[HMQ2,RPU+6P1@8?P5A3"S#*A+W0I2V6%L=- M7G]MP6Q]_:5YXW\IEINZ_Z2Y01N_\<&;K8J=(^6(4EGA<%PULN-"9?&=,E,5 M5MWGY6HF- MD/(KCF,8T3 *4A?VD%8E *'6DKZ&)X96E V:H+;($ZJF+ ^Z, M]>42;8,H3 ="06,4F9RFRJ@Z<4%GM#B159K/Q6:S+!9[F]ML*29^!D-*21QS MC' 28!;O="U,I79HFMIPK#5;6-Y!YU$;T!ES**5)7:L4 M^9VT6JGZ(J=76@S)*E:S\O;QYG.^+/KU-4(81F'DAQ"$)*&8$=AOQ$M#BI06 MO=2?[EB9VD7GZL9K(6D.V30HDU,@MVRIJ8XB44Z4YA4?9]1%G[MI*(H!_LK6 M6R1=*O:NJFM:K39BV%>LYD\?'ALSU4VK7/7WW/GB-$UZ]G:5= M[F=,RM5\^=A.HWPHOGO_J-:_7WGUX]>Z^.=CDR$4/Q[R52V^*%W0Y+Q%SRO@ MQ!I3<=&N:4=ZV(X?=NWX^: =7\^V7WE['SSAQ'2:2[H2;4K-IE>3-D#S7:Y. M,Z3Q>)W:4&TS>L7:8(Y6@[_WNC%Y;XW#YPV@\ZP:Q M@?BV%:[T>%>.2:=9D8H^%DB=6IRQX=+)B&*-+R?CN5D*,L["+, 89FFS_2CF M_9F\E&;2)[\[L.PXFGR0'*,YS.4OD^]@M&65]Z$&6*,V@L,QE-7&&'K8-.@P MR=;(2)KQJ04IJ[Z9C'\4&50/6]?K:EX4B[IAXUUQFR_W(;2>L83!((P2G\20 MI0D,4!SUQAD&LJ>WVS3I.%#]]W]) C_\'SU$K\'H+1N0VVC5HM152#.R5>/3 M8#R;!J:CI+>(#]+TD4C7C4>#D6\K$!DV@G(8.D>05/RQPO#4 H\=ITY&'(N< M&8R0=C99\:U85@^=^9!G+())"HB?4I90&J+= WR4/8T(+M&QUS-VL]0+ X@ M&V?GFNQKCX[<$V]Q8+3GG$V <^/!D'ON'8R#%-M ?P!TE!VUL8\9P5.+/K;< MNCSBL<&;?@0BBT79O*\B_IT9>OEI%,5A1$D>^R.9_@LM9%I>!N^K>Q'._,VTXY_ M4O0IA4.[#3+5Z&C9RXO!T@6K]F(G_[$I5D+W3Z""T(]PD&4!R4*0^C3875!" M"4P,5[SL8IE4+"VVKKA:*;/-YS[^&C:>[3@\7",.$8^U M&]-:8#[+IU& MM-2?Y1 ;2D@0XC@@PA3BB9\R MV)]LP9(8J9TU86+(<11G.#JBC%:IG<8>*#NNO#R>PAX_ZB.-3\7BL3W.]$MUL"UK M%OH!YV(D$[+4]SD@" 0[LSZ/-/<_:1H;?*RP[G%ZFTK\2[?/L&ZPZB:3NC2K MIOH#,&R:R^\@>E^J[HCEC]M-G$.3JYN*#T"RK5Q;@VSE3/HX'5*ILB&34\N% M3=TYF>Q:X4GC2-A]A?=]]2C^_)X+,A=-H/JXN2O6U_EZ\S1+:1;$+$S3*$U" M2 '#(4EQDJ 0X)0GL>99L59L#QXZYB)VE"()%H&CNKD1&:_WL,V+M8^5M=,( MKP4\VB&U,FR>R:%=M93)U%WD=\&AO]?;SH!3:V=YHE4I7.QE=[5A4*]!5 MXVMJDJ[KAN260T5>3.7Z[^7FKGK8L.GQT54J793-8=,FQ;Y+TM5H^-2;>=$."0=F=;VV7I M-PP0SZG1"!>:W$X[>.@Z)1E*C#@S#2R?BN:P7_%/,Y00AH,H@#[,8( 2'R>[ M\4<4Q)F-F")O;?21@;?NL=K1.@6BS:**&XZM!Y1/H]%K)XJXH=E9 +E,MV'H MV!G0B!KJ7$X[8&CX(QDK=)G2#1,?;UA9/SP*RQ\?-T(8VZMW9F$< (HBX@./U2+V/ M(U-M%D+<4VXYC*A2KQE*CO*B$$[,>)UF2#'TZ4)8L<&83&@YLE+/ZTUY+T): M=7,MD)5?E\6OS:TCG,4@0;"Y;"2*L,]9&N+>=I:%4K>!V+7H.+3TJ)I0\K#% MY=T*8/+"9I'=RS%D'&(58\CQ:J)#JGNDWJ]C42T?0\:A7#.&V*)>(H9(\W(B MAMCG=?P8XL"GRN6;*!=#ZO5F)H+7HID@6Z2Y>./FQ>>[HMCL+J_ZD@O+,T!C MFA%*( 4)I32,TL!/H!^" ( HP%('8=FRY3AN["!Z6XQ>"_+@WK;?6IR2ETU9 M8_A\!!F#7+788/=J]4>E=?"4KH] MV(0X*45RS9FR"*G295-UCI!Q6FA,F)N$MA@Y4%E[BTP49'ME9\0("GR*DA2A M)*(TAK 7JP 1)+6$9V1@#!51NN'7C#X=)7' G 4ML7&3KZ::G+RXUPI_4U04 M51?.:HH6'S*J\JEXJ-:;)NEIMZWSU4:,]G9W>@* .8 !XV'D<\XP971G#V8@ MDI46,RN.]64/;GLX0P]/\>9>"W1>EIKAF%33&P,2K:G.66Y.2(\=/L?7'TM^ M5+;?-,W\AB_+^W+5_MA;1"$,&0LAS@+(Q"@,@ICT%K,8(JTT1\..8S7Z4FU$ M[SD N;KUR.)_/]:;[F0>=4TR)E8Q 7+,J4$>=.4=8AM0F2[P(Y,6&; ZOCI9 M\^14DF3,CII"%8M>#MO!'DI8+&3/CUGD)^('D"5\:RH,DU0Z3=(V,-@(K%@< M!';MF1Q5^E0$R"%SNLJC0)H#Q7E.R$6IT>1O2AJCZ\)1<3'B0U=5ML.]-(Z0 M'Y&,@2 (4C_(2)3TQE@42ETG9FAB'&4QF-U1)U%/71SP9T5?1ICC>4F*@L8H MLCA-E5%UXH+.:'$BHS37^5H,(6AU_Y"OGK99$O;#B& :^@GUL\3/6!"1G944 M2>TIU'VV8VTAR\VZS+U?U]7CPY7W=C7_66/PI,79945Q39>:E'1HO"V< <=% M1V@X(1XFA(VO&D;H*SNOC;Q._/J8K_.5X.KSX]>Z7)3Y>C_O0X, $9YA*)X< M142,L5+<6P,82VT",+7A6#>NWWM__4PTM,*(M\N:,11E:MJQ0^4=PAI00\[0 MZ-;O^QSNAE 1J03#4-,N'1F@Z=9^>$%%FB='PULN5(9?UULU5K7-/\ MH9U??E>NBG91?D8P#^,,RN L5:5;).6TA-\XS7#,J3/Y9;8*#ZY=DRYR-^9,] MB)P]%LV!O.3FIER6PCA]7#=#V!F.$4TS&H<88.XG*2>\SRAC&".E \=U;3A6 M20&K.[OZR$14OEIX]4%,4SM87)O4\QHX))]JGLLQIX">H.:)A MMLBQEY4=E\QZ4W(;U??BJYTIEP=3K8?)I3":HKBD"&6$> '-$K9;KL' MBM.$2&X_MF++L2CM,7KEJCG<8K^&I*Y'UO@]KTMC4*NF3\]9?;8R]WD\5J7W M&@_.KMXN8U.6+V\NEB'BB-;;IG#T#<5VO:G@'0<(NZ(21#\(H;,HY M<$H3C/L5% 1A(#6,MV#F_S/IJ JU>AFI(U;-D](]L''STCT.A=14@]5I9JBAL3Q!\>O:3FO/P8T3D9Z3'QXK3K&C$@+3G%3B.K[HLO M^8]W9?ZU7+8E:!^*S2R ?HH)@22(DX@G&(8[F2,)$*'[6['^6DF+CZ$UE^RRI)>8#_,(P#F M09JB%'&?\9!Q\>/67!J!+%;L8+IFW/>L04*\"K$Z4=X1HZ:!?L0!QU%RI,.] M!I\342=C-\X&?6U>9/6(5O?W9;>9E*P6^\-!FZD7RF*>@#1.:$Q0&F(?[W:W MI"#QI3:RV;#COGYA#V;8?G.&E3-=QP:7T^@]5CRI[+]IZGVH6GW>5//?_Y8O M'XM92,*,I\U=4$D013#F,8RW9B@7J81:+%=^O/,8WB'RZ@;2\!WFD(L+O42+ MMNET#3WX1_J# 0^RG>#+NLCKQ_73@2&*6',>! TY"4" (TX)Z@TE 4YGJ^*V MF>__(A]&-*Q(]0;<]897@!2Z1+UI#K9=%P_B&W=Y4XPU0O]XS<^9'F) YC3Z MB(D#E;472ZV?O&_MM&57;U8^23( @X0P@3' ' TS3M#<(@4:K"-# SD@8IG3)@@TU] M'7) I!TELG'<@!4M.GGT@$5:IZM'JHY(*)(6-[J:]/DN7Q?7ZW)>]#L.$6RN MG8$D0IAE','4]X4Z^@BE"1)B:*),RL8!Q&JEWPIR)4VU=,4+7UW+DB7(4^Z L9_/!3S;B+A?FLX3)#OQSYG M..!AA+. @#Z;8X@F4I=:633G6,1Z1-Z[\L:6C.F0JB=DCODTEK(=NPW B8C9 M:\X4Y,R \&D*FHE#%R3-F"M=46ME]&_5,M\T51+]@3. "&LI((2&?AI@83+T M>]MI!J1VR]BU.)2T[8%9$CA-@O4TSCVWQC+7Y6HJ- ^B=$>94Q [,^:GJ7>& M/EV0/!N,Z:K>I[+^/5L7Q=N5T(JBWGS*-WTN"8,8^2F'F8\ 17% 4]0/AAEG M%*HM\UHT['P!N,'F->"\'IW7P+.D@R:4ZXGA0%P;*Z(V[X,(XVD6%=310E-, M4R)M.'9!)ZUQ9SKN9>6WBO+T3MHE(O/+;XLAHGN,PCD5.F_E!+(;TB"$0]Q "1J5V^3DQ M[%@K>X#>%J'J--< S)\7S=%)-Y;-/T 32!]C,6Y3Z)UIX:!)+A]SH4S4D2CE ME._1#\!PZ%HUP/LJ':OX/Q_+S5-3,K_.YYMK,9*X?]B4WXI/;P62_J3-F&28 MPI13B#@D(E12CK96.0RQ;'BR8LMQ1,K*'\7B3;<4OT#Y_7XKIXQ^W9,9J5#R^ ,ZT43&TQ?#A\R9!R/&%9I'#U(V/6FXZ;I:5;6W M166J28H,*HJ\.^H,M7T<]C2%W!V+EO1;FDU5U7[FN8Q8ZU$U,8W6=.*4-)MP M(G4YNW@WNIT!%$0)9@G!8089#%.61;MG!P1+U9*I/=%US6O3,^I-.<^7WN$8 M6/52406*SBNL.W;4!%63&'N7J/<<'!$%/8[&/W!= W-E\E8H]O"M?OC(IR', M<%.F2A.2Q)S@_ND9EAMFJSYSK%ZN?,&G$E&2/=T!1Y;Z^F"7>![P<*Z_*S(U MD1ZOBOIEG]?R6J;7OR]7Y?UC/ZD'@@C$$8O]*$PH 3&/@[Z6,Q,IA50]I?I3 M'??\+1B->ZP4R;GWD'1J>7JY$CT;D8R$F*#0!T%& M8QCC (1;JQ&,$Z6#/DQM.5:$/3PO;_!=>?<'B6W90%0\Y=&4V_/2,0:M:H)R MP"CI&'U5,S#T,;5GJ3I3T6:+Y&F4L5GSYM4QM399DM6P_=4<-?E:M].;LX#P M $>,$Y;Y&2*$A32B 4JS+,9A& #)OJ7S:'?]Z0"-]UN/9^#ZT".,G.DV)OQ- MHZL8>5#9>YLTK@VKO^1?E\6,TJ3)'0C'7(P4LBP+,]9;@#21.H]"Y[F.P_6S MSM BDE^P4^?HXAJG4WH,9,(Y,QI7=3E@R/1:KLM,J5S!U3EX?&U2FX;1%R3U MD1^[1DO+>]F4("M7^6I>YLNW*Z&S[9O1+H.$$4LC/P8\I#!C"> DI5MKA#,6 MJ QG=&TXUL4=+&^/2^O00FT.Y5*K(>A3TTT=YISD6">H.9-GF9(YC5S+V(O* M[BNF>JAPOJIO1(KVX\W1T#4S2%E]?%_VIY=%D3$]Q/(?93Z MB E,1&#<0B0I"E6$:E!@(ZA;K7D>XK -)J>*DVTKIF7"L('^8HG)9GD:?P['BA%Q1N1HGUG9\!BG M64J)'T/$218&%&RMTHQ'@>9^'TUK*OU#:^//V6USDEL_Q]\V)\GBQ'J/J3>J MV^:46)+H3R1]NTJ+;_VYG)QF(0HH3UE&<,B2@/C]XVE$I+*D#M&U-),DGHM$.>,2*\(N6-&;SE(GJ'+DOG,M^/:J.?^Z"*H";LR M;'9I6?N__OK7=_VS4Q\30#(_I4 T4.9#VJ<@E$.()35-X8F.!:U!HMY_51BY M*&>.R%#3,O<\2(N8(S[T%$R.E\OJM7?JN'1I.#VZ;NE@KDR:65JQNMW[[?7B MS>7B_8DYB!( I@DV B2:=4C4W=.E%]T.JO)MJ[3FK7]MY?;&& M39V?T474#/W16C9=%F17#KL)HO?%YJY:')B=90CP+""(P% ,GN(X(>E>L,-( M\G0C4RO.4X7#][Q<>44WZ5D7\\=UN2F+6FU149M,N:7%(5A4D]OM)'$'Z5 T MAEUD/$',F:5&4RJGL>!H[$5E]P73D9[/N[[V]U+8?=Q\*O)%N7QBAHA!0D5?Z8=#CX>(G'7%R@6.H19J]7GG? M._#>ND/O+0[@>S<"O_>M<>#*RUL7=/3-28NI*.#83:6ED9]?M]$6MG>(VVN M>W_KVHB<;R.'6JI!\46U==EL4])CIWX>56SWS&KLF)R%(,@P($%$0X:%#1JF M>&N!BP_1;%-M\J6<1JL\5VDDOH.@DS*JJ:<2-W)ZZ(H6[4'W:%M&SZB/#DG3 MT!,MY*>WABIZKW[2PTYC/MZ\V+ M4DCBIZ$?QA3",.'\H&:'!R!33-FLF'2> MG;T^]^$P ;M=5W7=_8/NZ0\F?,L)S.!$JRG/ZW,@#M.G7UN&R5F&'9\&<9JU M,X)EE?1I*)E=ETX>#F&-+YFSK&BU6A2KNECLROV;LPN+;B- \6.3"@)^G]&4 M(XR2R(^0CPGS,60H@;Z0XB !:41ES[BR8\WQ*L4.9%,W6%?+[: MN:G6]^WLM/S!6):8/B]YXY"LIG=[?O>,[A%ZOS48O1;D &=L29%U1.;L$SW^ MF5R6_:E%W2@'Q M85GLCR%!20"9#P.:$$Z9GS(2^BTRP*B?!+)7, X!Q5V_%>B]/33O.7XO7PF] M[#QH%B&>?;%W8K1C>2P0?R;5&;)9IY$)#>IQ-5XG4AU#UO-U^="D!1]OSL#\ M4&W^46S(HGK8%(L9(2 .,D01C1B.".-"[WHLU(^8VAF"+A XSK=>Z,JOCR+A M$D ] =(3*+TM3-7QI9.VD!UPCMT,JB/0'5ZONO'."WW3+$_[9K&7KVF,4#5H M/CMD==ELTU!NQSZ^&M2Z9U1ZI39?KX3A^KI8?[[+U\4N&("4A1$E) 0A#F&< M8<[7+7;0O($)J\%-5H&=HJ=9N_%RN8S@+(YXD$?!12C(0\S#K[259)+4GSMR*X^SD=1]2+#?0IT]/=]PP M9RX\HZ4))PE2T!YU4J?C^C9?E?_53K8>S,=6*S'8NQ:O M8%\F?'!@S7YNB97U?%DUIRSO848^3@#.@,^%/L:$D9AT8S_$$>>!U'T-HX%S M+'9I/O_]=BWRLD4[GY/F=5DW(X)#7]3D;_CFDU/-2;>NG+E/7.F;<5# M=YK&/#KKOG=I1*6VW2AG!'ZT]I]&7!C/_6HB_5 M"GTN;AN+GXJ':MT,7WYMS.S1QS9-NNN5>UA>6JR*FW+$NW@4 M&#O3)5WP/HVNZ<2SUV> .F)/.@69WQ6+QV5;3'E3KHK%]KV\%N_MP0!B>]]& MYC/*,(8((A(EG//4]WL,"6-(*1FQ:MEU6K(%VTP0;.'V/=AK 1^$5\5[^O4Q\'#(HJZM[*6^L-F?&=Y>' M0+\Y$S[T00RI&% BW^>],0RYU*G+AB8<*^5!BM/ \AI<6C<(Z3(H)WP#D*>= M&DKSYD3'CC-S1K ,J9R&,IDZ45E]O4RU9GL1!8]2"IN#9%@&,8HC$-!>VJ(@ MP$H5"-I&1M$;K2M]]'G4U1P'%-I0G5%NVCG%CI+R*!(Z5>U1=>.B^FCQ(JL_ MUV((*P:P77KU+./:G@PHM(ZP!*0H@2CV$Y!PF/9F@4]\%1TR-N98C[;X-*^L M,:=23HH&95%-DGH"6ST:YT*;2^R0Y(DB N#(,J(L:-)ZK,7+8*--03Z<>OJP4@X,3PV;?UL4?Z=ZE'&E@F7 MD]+AN5833RLT.]J/)\'<&;VTR_PT%-*R3Z_VU]EG3%\%VQNZRJ^/S6)OG3[Q M^X=E]=2H, R$41B )")QR$B<8-C;3S.0FBFAKM6!U/#KMIL^B'^]:O_LCLNJ MK[SY(7+OZY-7;+&;JJ-V0^@JY!!M8*Z25YU6DBW]]"7]_!+] ZGF"3:5E-.T M1::JGL9^7510.\SIJRC_\5#,-\4B>]P(%>_-/T/UJ6@F.P7W355\/<^7_RCR M]0R@B*?E0]X<59 O%F6#-%_N MI/:Y")L*K[NVTU7F232;#>GN'?$Z3W9B_5S&K[R=-]U6I\8?KW%H;%'7;0@E MU7?>VE,-"^X=OQ@W!N)>O>[Q0]%/E-"JWG1%0?L"Z3#,LC@@,0P118"G21 E MW:[=!&!.$[V*1S.; ]8Z"J#-)O6R6I3SG>+\]'8UK^Z+/WL->-TB1T/:Y01_ M#,;5U/PEV3W'+=5;E@FU73-@$3[A]<>X^:(9MGCR06@O,F"A13?/VQ+2#:_/\ M.(4T3F/.,L"@S[F0Q=XX#S)B*DL:)D?3J&;F;HM68TG)-O'Z N:8/B^;D@KHNQ/\77_(?LS2*.$+-Q&SH!Q&,8 )WVAS1#*H5,+E X+R J1E: MK3O@BK.83@B7&[V.S;2:1F[1>DU_]'J\[3UX7H^XF:;<8O9ZT)Y /72AN3*M M9VO0W372- :[3CU\5;GNFDWY,PSJS<>;7ZMJT9R;_KE8?ROG1?VY6BYF:0(X MB0#U@Y#%(/032O8&<:BTDF1@QGF*66^:6:DZ7ZIJI@EWJ!0NJ*> MT2P+(2(Q1QP#$(" (]I;H@E2JIK4>;YCS>D@>9L&BU>MO(=UM7BTUB=?K MZJ;ORG.5M$/]SM[N)LB'%HN:7BB1 M(Z<3KGA1TX>.DNOSE#A1A0/_SZB!#DO34 $MY)7Y.R+7Z^^KV?M\_7O1'F&Y MN"]797.&5%O:U1PR51?B 7?M>N(LI@$DS?U.,8-53D-L4GU>6D9B64UQ#@@FKPGN47;5#<,3O*CFC_?] MD6>S?E M^OY?ZSZO;ANEWHYD1)>HO>_BF\U_=UVA^<:B^%8LJX=V\;9[=O-I+KY9M3L5 M;XM5L19VVT\/"/M6>,6/YGR[HO[98^6Z$!9[*/T_>#_=5&OQM_S^85E<>?-U ML2@W5][W?+W.5YNGJ^U#OQ7K35F+7_RSU]R6L?OMS5TN,.4K[VOA+5H+RR>O M8:YS7,!KYR_:>8R'8E[>E//=H.)G[^UJ<0+542.K:J-CY\H[<-';%,OBX:Y: M[9]_)7 (+5LU5ULWWCX(BIM6O,O7MPUSG\ZWQ;IXZ X";U'LWX7N7\O5_'$M M2/46C^OV%1 ]<7]WV4-;VM5X<*S!O57Q?>>%D-OYW:I:5K>EH.3[7;%J[>T_ M;2I);XJ\+K^6RW+SY-V)UZAC3'QU7>1-2_^0"U5LE'>U2!^%R!1US7]L M"ZYV,\X?BLWVS(+F<]KJU"QAE(0X@P% W&?-%@A >D0(RA4>#('#<5K5XO?* MG0-M[RX$=,5,RGU[7$RQ)M44:KE7UPIOG[="C]YKX'=YU^$J7%??VQVXTDY? M_]2Y\><)M9ETUC:IMM-+YX9IP\NQSY3*XT%QL 8:/5H.YVDU_.NO>.2.R-CR M)KIW)3/OJKJ> 1*D-/4YIQ&+4!(*.WYO*0A3JC(%J?-\QU.1.TA-*MN4B_VT MS6TE9=6(.KD)2M>LJ86N/6';^KJ?&D#2 F;I=)O7E)R9NS0AO#Q] MQI@-63EIQ\I%O>D,\:Y?"3F;X91'/B$, 1J%!&/Q9]J;8X2!V:H=%R_$=^6$ M1=N25#_!73]Y 4JZQ_3@V@2AFX99%%\W_2#:^ZE3GC]?B4&\XG*(/L-RTN.6 M5RW]V;'9R\\6E:#OPQGZG,C0*7K.:)$QH],0)',W*LMOFIHTM4E5MU?R^?[7 M>FNZJ6Y;U_GRX\WV@UT^MBTG:9.QZOZA6HD$;H;BE$5 O"8$I 'P*4=T-]_A M9T$D%$U2RH9&IJ: BM+7C'<>^CVI_?DQO=ZU,PY70@;[T=%V>KO]7$T'!V]. M.?F<9%MJJ>ZSS<4OCC6H/=Y'LMZ?9AIXK\O[\>_6JV[LN_-K6-&VW"AGM'ZL MYI]&B!C-^VH:G5 U5^Z3\::@FO_SL=P\O2\V=]7B[>J;B(OMSI59$($P2:D? M0(HACRA#%.QLHS;,M#GJ%_G20CN&-?+H+QHUA]L;V[N-"T6+58S;=S!5DV]R."9#FJ/_6ET3HO^O#JJR2Y3 M>LE)L]NK7#V*0+R=2FQ.%RQNJG71?:\MCN8_-NM<4"U>S?53N\OV@V"OV2=6 MM?4[_7A_!I+F/.LPHC['80C#F(-H=QJ!>-M4UA?&Q.EXG6*7^ORTK)H-=7\6 MP^G&E7[9HMN'T2[F=V&[Z'^AJ7-Z_%J7B[*MT#')D09N>9W,:KJ-;IR/[5WS M]K[UK\'V^ZU[5]YS=[S>GS$3-ZL-(YWNC?,Z3",.38*)LZGEF*VC%OL$DNWD MP';R8):*R$HHY"&#,8H)]5F2]-;BC *UDQITK:@(D-YU,NOJ6]G6J_RTG;_] MQAV=$**!J$JX< MDUI2+B#M)TJWJ 9>-C_!S44UU6=S2DIHX,51%3-E M12_[_GR0RXF,_^--$#WX$3"769-.!HTHGY*2V7'H;&IF@2OI.TG;?95M M'1)!R,]23'E*000!3X.([Z8O8NZK3 8H/-;QV+WI.KU8*=XQJD"-G @Y8D5] M-?F9X#3[JOHUXNMJW>Y"))ONN/'V6.5--8TQ[9Z^,ZJCP?$TU$4'^,O+0G5] M5ZC]U4HI>_Z&FKYSVMW/J@J%T.&DJZZF:,QK&CA-.4/65*SU?%.&J>:8BH M0_]>5[8X95)+DF$)RHY'!J3QXPC7NEF60I_IX; M*.1EWC34SRIEMI7M.E^/4?PGM65$C\4)"I \]G/BHLB QL@/ 1#0)/"9R T1 MC1'U8[RK)HFIXL''"@]V/H,N-?J;Q&!%EJIIO.8ZP$\/5M1\E]Y0V>SV:4I' MU\5=LX?S6['O4[M9E3",*2)Q2"D.DPC!-,!H-VO,B=+DK16#CJ=O6XS- 2![ MD/NXVIBZ*\XV6D%N? [> .H1>6.^V?X7L[$C#71*\/< M&1VS2OPT%,ZN2R^W@=KG2_Z\[E=6>XN[:<#M+*#4J(8E28A9 ),T00G-,@C] M8+=[%=-09<0Q-#;'8Q9Z5&55CP@?N+GDE';*+:4FRI)R_(>9)+?<,F=$?ZQW M8!KQ833O7QVW/F8K6(@Z4J@0B@/*6$9IG&5)AG#J[\K+8++?=V <9ZR@T5A/ ML!%9'*TE.&\[XY S7*.Y#3%_M(#B+H!8;=')!PR[WLH'" L@9"O544YKX MR2NBO"?R:J?(CEJ%\.Z&2_*U;J]CF]$0PB0FB* @!&$!GK4#4?A7'H4RK2?4IYQ(, PQYEE 6IRL+HT-@/5BM6R%5/E'M_S]E M2ZMEIZ$9HWGO^)0MM58PW5%E"I]%1C;V0W(.JQHKT!;?;J2'1QS_?Y>MBEZ 3XL<4H9 @C%.$ M$_''OI\BAI1NN=4UXKKKB*2X;@!YBWR3_V7@2UM/D'*FPQCS.(T>8^[&RSM< M[?"BVV?2O"[G9+5@Y?)1#-9F498 '/IQ$A$ $TJ!2,E[JP0Q8-)U5&TY[D$M MG.Z^L@[0?J[Y8=>YCL\Z-\<%>X_U8O]%Q9L9C)M!;I)LR!90FRS;'1W5Z%B+ M[WV7+ZGN]T]@( M!PD,P@QB)*P%<4ICGD _! D *4YE;VLVLN&NC^UGHJL;KP'FM/N5)M<94.WQ;B%'UTU_K8O%VM;O%AU^?O)\:T&+4^V=O?W_1 M'KCRMKW_E[UW:VX<2=)$W\^OP-NI,E/U @ >Q;7+O4DY7*DU)5VV[9&@U) M0A*G*$##2U9E__H3N)&41)%Q!9"]NSM6G1+TBZ\M(TJ-6E@6_+BFZQU#BJF"(,<'VS5Y#&),5IQ$@O M(,RX6LE#X;,#["A\'\<498&:QF314?S]8XIJMLL.;K3XKUUWK?M=];FH+5NN MBAVK[IU5S<'' M?7E$_$VUCY3S.IS>UTGG^T7("3E8+JF9O&_5TIY7;MT;Y+V]$$'\]?>2(+EP MTAFV'W5,3"-NC M!-:$YJOJ R+.@TF5SF;3X]:IHCAV5"_14GT#Z5_LR>9C" M.$Q2 BE!,($AC<-L+YI!I?U>*P(=QYIC'9NJ;WZDG%HHL8.O7&@8'%HUJC]6 M[\K;*]@ C&0 =O04RV70SE"O5 Z5*=S MA?T%L,X2FQV8I\)IEJQY0V^]28+_%2FH35[E-]Z4T-*=BI^+NIA-=_NUF+55O?D;F81 MR](T"9*$^ &" 4VCI,]>0(A!HI)':'S>=1UNLRFVWO+I.5^NFQW\YA&UOY;; MIFM^L[^(K"F^B1]ZOU7&&IYR>8-C*-52A1?*-.][#\Q*;]$X0T,&T$V#=TP, MJ*P-(^7F^W61;PI:M/][5!TB^?-RFZ_VI2'(8,*2( 0IS^ICLBS.2*\ 83%6 M?ES+EN!A.A>*^_MBOFT>MID_BK\M5.O]-J&6(Z.1,%8CJ5Y)[X=>S1]%&G54 M:>]4'?,XL22*9\C-@2NF07HN#'M[JL(-=OHD^;F8%R+K^[(J-C/?YXA"%A(( M2>+'F*-X+S,#::BV"C*3Y7P%=*2,*?LI8:A+>-;!L\EQ,F .1&E'JBBQF Z^ M4R4N+5LNCI0QI2M)'2)^>T'Q> M[;%6>BGD-=+VYAF<9B%U(_Z^G7D9VI=:>;27)>V.G6\YU8?4YY2 M!E.7JUSB:(6O]LA^NH#L0*3U"C EXM(%>ZKDI6W/10(S0\J(Q-:[HSVY8J\! M#U"8B/\7)1Q"[L*;O6?@_$*L &%#< LI:2LW[W MOY@2X9V&3Y7Z#)TP81(TM4R&#JV@9["!4%]85U\:O%O7=Z] MES?J&V\X6'*-]O;#@#ZQNAG1^.*@N-=JWOCI2/?F*N&Q25@.8[6M"KMNFRH] MVS;S\C:&"UPO$?=3=4*3VV*[736'Z/MH@6,_#%C@8P@ Y"#B%-)>*,)(ZB(< M2Z+<+\@; M[L%:LW>-T+HOE!,&N6[Q_8L8MN"X"W:UA[!(]W-HW6T.H*\JS']338H/54BT-0Z=F%& M#I<3P<0RH..&#-O&5$X&G>+9^?HJ_.901!.%/E6;[;K8+M>-Z*ZQF-3/?M2W M?XD?W,PP8S2BF!!$_#C)*()X7UA)<9*I)>SVY3O/U#N5O6?QI][\6#>UO-P! M]'()^4B8:X43,?H;!JLO1NV!K]/M-A5_J;K77VL[\!T)JG">2;K=N68:V;9# M^UY?S. 82?W"R$&SETK=?%DM'_)6%YX0GS$4$\(YH 3&H=]W><9!"I7>G7:C M@>-L?$^R_4&Q=I7]_$+?\R\@#.D.W4K(T)ZP4P;9*W*\ 2GGHJSS1:5&L4LZJ_F)G?8M4>Q+Q^-*H77]IU.&NL-SY M[::7/2!'I2.!KT:E&K>93O4*TS/1?9F3F]U]OV3=%&'C'BU*%<895; M3_EA:C=%GP%6G6YM>&G2M&O%0#GZM8>E]&Y7NYNPN:O0_+]WRW4A5!(Q8/OM MDQCT6U0NF/C3Y_I'9I!"C"-**(_#+&8)!GRO0!Q!H/'-6O^O;(#;VE)@WAN M+\N^)Z;!G"X,>[U[Y0H[B;:P-[)K6=MOOQ3;QVK1+R;=*#6*X\ZS M\I2=9<;<=P?F;@WR6HN\(Y,\5#_BMC?*.[+JRF ),Y:KI7OHINYRO9Z[D5Q_ MN37/ =RG6_G&].OHK7^C&E]-8F[I+;9XM1;9R[PH%ALN &UV+4YI$8:01'Z4 M0 Y A )$HZ!_HPWS.$8&*RY;*@R3!.CNM%H'7&W%-2C(9L&[[B;\H5?6JZ?Y MC]W.JPDUVUU[2<(IL0"S[9AIK<*L6_?.4LP-BO8W$&8B/4 1C&&$0PCB@*:$ M@UZ!B":!A?/=\^ M5NNM6!H_T>++=A9&+*9Q"E,(8TXS&&,?]O($[P/%5WLUI2@EJ!HG6HZ7F]ZF M5NTG\9DG[TNU7E=_GGW;US:>D@O[0:!47,*_0/'V@&*MU^!O(Y^&Y]R2W!C2 M:?"7!3O>/J1L!1GYMU2>NX7]S?U+>2RA"8T(!0!0%D$Z$BC#JDO M;)B*XUZ_^ED#"]1D *X<-3D&5/.9E5ZG&L51J>E=>,Y0DSFDTZ F"W:\>87% M#C(ZB=+U9K,3>5IQ<_^A*A_V@BF*6<(S1J(8XU@P)/;[]Z5(E@*NFS%IBG.< M.M6ZM%-I(;3QED+)0O&I)QN8JF=- \!IDC[UZM5\= T-AA0A60RTQWPCZ(]4 M3T]5>;NMYG_,TBA@(4@B#OTD "'(@K1OIB6(^I'BY5;F C4X27GIURG6OFG7 MZ.9M:N6TNT^TT55N.'$*JWF/R4&]&MM60>_V++:N>TK>04RNC<04[FGPF$V# MWF\6L8.5*K?=W--E7>< MMM>J>1.X?JG;G-9T@56C-)>(FM&9X*^;]6)9YNMOWE['JPEPVFG()/C,$.MI M<9FI,>_PF!6,=.I>1T3:=-J=V*Z< 9@AH0D(: !X%@,JLL5>BQ3[2+<(9D.V MXXJ8=HNP;8C5:V)#HVM2(/OA.)OK6X25VE^'WQWKY-+H,P!4& ,@C2.(MQP&E_511-$ZB4?SI1P'$26BM[U3)J<="Y MN;="_*OM>CD7*_?F[_^'&H^Z\88EGT]*). M]A."2R%,3$AKMP'FZD1T.1CG[6/0ZS^3#$?UA1B=Z5YONU<;[[76#Q^CAO/L MA>@VP2$VG;@X17!.1-0IJCE<+)[Y! ,0^YB@"/HLYJD/T[U.&2"S]L6ZVVV^ MW@X08"_JHT*EKU679E6EF59-V O>R> >*A59^, M$MZ^HQ#E*N)(._'?((#(VVHS'B@B/ R]HQC!, /UD_(\AB+P1/NW)BCA/NSH MG962O25NM5$G]UYQ'6HOZO?;+Y+Z_T$4(>N>?P>*D+;5*D6H(6Q6'D=;DJ_7 MWT3J\EN^VA4SF KA&(6 @ 2CB&<9ZKMV&?6IKW9IAAV9*A->_YZ,.CMX70>? M0F7U%5K*I51=M*A(<;S@=)>#-;%LV2^%F&]FKFMZ<>:NHES?/IJF>JM$"56Y] MY!Y/M77/J[6,6 *U*@U]EN8$*F=8R@S%:;"2H0UOCM"8(Z+'.A^%N9VXQ$\@ M2@.8)@%%C)$$L*07AR+LZQ./@I#1N<><,R3,4B@X3ZA 4@ 9 32L1"J>\@8I%0=K"]WHN:.-ZZ;:?? MZW7+J?Z=_UN[D'?6-*;X0+9:K5VH(2S_N'=_)_Y=\=<6K^KS*QD/,2892%(_ MBF.6A%F%8&6-KF8M .72$]?8 MJ64F1X_O_%[KXS4*#=PB=P*2,Y1F N TB,K(@C=/9)NB(4LJM_/'8K%;%3?W M[SR_<9=_616S%$.*<.#[29PQRD#&XP@1B""-$C\@2MM]C_44-C/DIW&6IL2O[Q6.(IQ%">@5J)>)5CE17NPT>+'6UVL4MDV."@ZP1)!N ML'="DC*PC\.4>Q!-V%+=$]\)8VH8ILJ:NM@I/+2Z??F4VV&=]L^E4&:W_5SD MB^7J&RWJ&\^694WC/%^NVPW&*($DS1#,1&+KAXS5MR/W6B59&LK0Z5"Z..;8 MXU>5\^Z!QJ*=]!O%M>]@WCG/M5-TC!H!GWKI^DT]PNML\#HCO&,KO-H,K[%C M8KY3?@]U,CXT? #5J2_EWSLU@?-$.!W:49-YT708:]\^83H@RA+16$.)FS]+ M$:4>E\^?"C%CQ'1Z*&8QB?TTQ("0,(HIQ'X2!+U> 2%2A\*'T\9Q1&:OH^^5 M5_5:UFVQG9K2O#Z4CRY&Y0FZ1RTN:_/VE;E(O.@_ET%9&F2< 1P"U.O( A^JE"2'U6SH^.W]V7'*NN.4Q3&GW-><\K7EE.7> M*&\EK+KR\L8N+V\,4RMN#NQMN?KG=!UMF@G\*1LW#O9X'QH?MR9YZ+R/G512 MK;KC3+%U'+=/HQX[DNW5%":>RW7DQ^J#^-&')M]K#_W/B-"!QE%,_,A/ $ 1 MH7NU./6E=LD&4V:Z4:BLO-7>&J73]<-YTL5BT[$3!UMK?JR\@R'=%3)3\Y_+ MI:9C/PZ^TE3RIY.5YEM$K2TT#9SU/:XS3D>GH6?_6Y6-4W M]=RMEP\/Q;I3,]U1 MWG .:XLYA!67?I_YA!W3#7,+B_@/GF=T1?>;^T,#V\OK*&C*4+IE;X X2:Y4'&$MFW+B_>\Q?7(#A%&^Y- W MCJIANZO%+4?^FO@49@HB!@(" A0RS-(#[HYHQS%SNM>FH,]V$ MIVS,J>M37VJ#O*?6(J%^O02R3NH9X7 V_NT3 VPDKO4UMIC??VSET7-$:#$-E M#*['P=A)A%<;Z#46>N3[&@)#9QNNA\)4$A#%(3%86G("?Z>9BHF__UV2%R,, MK.7U"8)(S[A($YPPK,81 3X^Y;G#$B]]C(99;^' MQ&=Y,'(R'QIII(R0&AU9.I4TR>8@&2)C&FFPC)@\V1HT3A,I>;=8 MSZD53,N9GX:K*Z'GYVI9;HL%_M:V!57K4^K3Q >0^QG% 80I MY QCWJM/DZ$WF"PI_3TD82\3K[PWW/ORK>N@KM;3J$G9&DA#E:E&&$.C5Z[V M-GOXF]=;/8UZEJWA,W2):X1A-)FJEXWA-%@M3,Y13LMCEL?*]YS2N83%>A'- MB=]&3/&*XG9;S?]XK%:+=[)5%@,<4XH89V$0UT]F\,/U CZ1>B]LT@;\6Z1^ M1>%MCG"8:!YH8;2-EA,..]"FF!^*,78,P42310MC;/3$<=BQ-N4DTFS,C9=1 M7O3@L-FEO0'U;YMI6H3(?=9IVY^N=W;;3/EC5?_$=ED^D.KI:;D59M!BLWPH MB^*T#20(212@* @YI!3R$(?['GM.I.XFGJ;FWT/.N:\IEGOC12[962\^T)D_ MY@ZPHV'E=CMX_!$URMYP-Y@.=GM[P[V]Y6/N%#L:3,-L&X\_J$;=0W8QN!SO M*&MYS,'VLMN1\SVGB\ZQL;3Q/(0'W2:(=+DNYL*&3:MQ?K&^"@..4C]C 0D@ M97[L\V2_A1ZFV0 -@-95_AY2PD5O=)?^Y9/9?K8_@EPF@:,.GA&RO[V]WL'@ M:>P[VQ\W0^1[HXZ?$1,]R^/(:8:GZB/KJ9VS0?(]YW3N0+&2S#GVF=LL[E0& M^KX]17%RXSQ&&8L#1'V((>=9O"WC1*/3QN9G,R MG[A\9F X([Z'!+;J89#.7\6W3L;CP%FNEE,'2'7=#K9_KWS7,5:.DMXA/'PI\]UM?GK( M\V<=PWY]_C-?+SZME_/B\$@'V3WM5NT3'MU#'1D-D0]IDE*<<89CBO8=$HR$ M4JVBHRLYW7QUU]CG/=<&OG@+;+ZW4>D]L-&AOI!:CJ[?D%GCG[)1NC7-:VQ[ M\;[3P3S%-YXZPQJC[O/-E\:R#GQA89#]1[':;OH_^:G^DY_\X*;S-44JQ+?IF4]$ MY+\]5%__H[:B9KVT^57-=ND1VW4VGB E5>O'Y0YE;2L]'\O79,N'5?%I73T4 MY3>2;XK-K5CX%NTPGO$ 8AAC(2P)84"C$)&LEQ9'1/K%61,9KO/"6C>O4\YK MM+OR&OT4)[,QEI?K?4/!J)A3309!^8K54$AJUI(,$)6H[)PQ_IV:BPVXQJ^& M6+&BLCN(I'GZE_ROY=/N"5?E@E=KM%K1XKXH%WFYWAFW=?K;U\M1(+]EX]:7XQ0O$B00\%H!H_]]C5 M:GE"+T\HYM&!L9.FYJ$PU&-F72POL_(9NT^3L@V@1N=D*T945@>/-"-_>ERN MEL^_5.OUT-)KU?0:/=6S02L(7V3MH<%58^_)XBK-Z$/CJ\?L M-G"^S/(26)QF>YL@CL[Z5HVIG PTZ2APLWTLUG?YEWP^KSX7JWIOL5D,=/(H M2"!%:413/PL03$&6H$Z>6!2$LE=+&TIQS/V-=EZGWD^=?NVZ59V<3 &]R/<# M8JE&]9."49K>!X13C]F-8+U,Z>?M/\WFEC ;GGA8%P^-%JM\^;3YL-PN'YKAURD4LB1!8BD1 MT9BG/.!A' 6]0@PGLIN]#WYR[I>#4EM^D%-./9]O]8"'N&,)Z.BT/Y9O3 M.9BAU>#C7G_GN1/$>.#S+$P8"I*881;7Y^4[00&3OQ)=\_/#[S=;V":5A4Y] MC]D!:L;;RP,"IK^E[ X:[O)3K:1E7:0%=$9G;"-#3BS;ZR%A03!7I>+Y=?E M8I>OWG#_"[$)"%'"0! 0ANK*& Q[L5D644FZM2/,,?D>E/1.)5%ZW&()YHO4 M/#S":D1] EPT%7"E:7QXD/5(W "R;4SD:<=+!X6-5 MOA>( W2%/ ZW0^3-$K"B,).5GT)*Y"," 82'(&\C)MOV_W::ZV@-/H!&W#ALKFR)&CXGE]P&;];4;0# 4Q MB1#F 60XQ0'R2= O %@<,E^&=Q4^YYAD25[FRB=B5- X3Z".@%!C2X(^(L-C M,9T=]'(&OK/&<(QSOS 3\1W M(XXIQG[?/L(I05(GK66_Y7A^HE6^^4/KQ)H,#N=BA7DH9G?*<90E<4 (83PB&-&TWXS@00I"Z7DH\2WG M<7*UO*_6Y5)K+LI@(3$7+<.@&B4_7/.;SQ^OG<_'DP%2%8 )S$<5;2L]-ZO, MQ[M93$' .<8)CE,,0P8RLI_E@";R1[DEON5Z/E9E6G9'R"$QA1BIH6^GY66%&?A#SW!>?Q6G X@AG M(>60IGW!D!,_DFH\EOV6XQGYH=HM-TNQG-29CS)02,Q'RRBHS<WUZ+ MM:3KV?CAW?BH8/\$9J.*MI6>EQ5FXR]HEJ0P\*$?IN9^WM_7_??IT[7Q&OD%@ M/\;E$9C"C%30MM+SL\J,O)FE <"8XC (8@Q9(KX7MI7;R/=]@J7Z/V6_-<", M%'^G-QTED)"9CG9!4)^.-[]^=C\7;]Z=B_+F3V$N*FA;Z3E982Y^_'F69I C M&"*1 \=!%@<29+_E>"Y^+/[T?LZ?GC>/R[7JS532<$A,2,M( MJ$W(C^R?WL_HET^W/U]_9JYGY<>?WYN5"AA,8%:J:%OI>5IE5OYCQD+& $U0 M@#*(LP2FE 7]5X- [KXGV6\-,"O_4?^S;UI34@(+F2EI%P;U*?D/]OF6_4_G M\_$?[\Y'>0"F,!\5M*WTW*PP'V]^GH4D]5,25SDR404%B)EH&0&TFWOQ\?>-Z#MZ\&Q,53)_ '%31MM)SL,(< M_(1F!%**,PQ0R),,I%@DPW'_U3"D7'H.2GS+\1S\5)3EYMOJ:Z[9$R"#AL1< MM R$VES\Q#Y^O/V?'WY# W0%?'JWMJH P03FI(JVE9ZC%>;DY^L9"D+D(Y"B M!"99 FB4!/U,#S*$,^DY*?$MQW/R\V.U*+SKS:H^9:,Q)V70D)B3EH%0FY.? M?[ZAS+N^_8 ^4M=S\O/U>W-2 8()S$D5;2L]1RO,R;N/,S&U&0=A%L8T#3BF M$6.\_RI),_D.5HEO.9Z3=R).%IM-H57-D8%"8D):1D%M0MZ)(,EN;YGS2L[= MQ_=FHX+]$YB-*MI6>EY6F(W__&V6AG$20%(?(@E9%@/Q6]9_5 :VU[$]$#HPL-*':P<'6.^8K06@+Q^XE<'B!%G;1G'T0[AV MK:GL(9]5O0R9"?X MS '>TWCJTZ9!E;.Q:9;E5O?M*U;%]KY:WZV7^6KFXQ2',08DX#S@ +,T"?:" M,9"]BM&6.->]"*](;5-LF[>FZC<$5F99F ZV>AFN8U@M);D"X_:RD]L.X[MQ M,#9+=AUC;3G?5<1<,^E]BXE"WFL Z#137Q.#+F2_QEBIQXDV*-%BOEP4BUD0 M$AJ"C& &$TAX'*(T[:7Y/$!ZP4%-QF 1063)B^5\N_'6Q7:W+HN%+E".1@_'V?:_8GL&M,(\R MQ$8\[A)=N[3N[56]6+5P"K<5WG<)NYLPH "_66!X!8UZG-#%=M)A0]LHN2AB MAIEA4/FUO'\E'L* H)3'#,8PA"%!R">]>!'N;(05=:&#!99=Z2BT: !M%%S< M8FPYO!PI:S7 :(!N)<2X!=]1D%%Q@EF8>0./>J#11WC2H<; ++E@8XJ;;KCY M+ ;FZFNQZ+<^$D*X#SE' +(TI03MCS5# !/9UTELB!IN]Z&=;NM./3."4\53 M+Y8XA-)2!.DUM!,V5%$U"Q8.T;4<(J11UHP++Y%0B ::$$XS!N@:*N$@@) !1NJNZB3SHZ0_,9]&'$G=[&M+UAB["ZV"NNRD MB:DJZ;N'TY3U.PV]7D53VM<$5I?WW0-LB_B5@59F_I-82%&_&8I3XWY#:]XE M?QLHR393WHKQ5M3#[N;^=EO-_WBL5@*_#?OOW7+[#7W9;-?Y?#NC'$2$1\VU M*80C'R'0%K;2",2I?^FDI%UA[EAKKU\= HXU_'^]5D?O]UY+Z<> [#3_22%W MIO_/+O+3: &T;%/EK4_"WA&@)_1* 4^"3"F'*%>"(TNGE/6_.H0 MT^SW1I6QYE(C7&;2J $VL=FAJ/Q[TT ' ^7QWLXN4CT]5Z7X[0;]M=S,((,Q MR/PDBC(8ACZ,*4E[F1#!6*V9WTR6RJ30ZN/OXLQ!+1%RA&*2QS8M :K()\Z1 M5*,790C=LLPI=&1(QPC5B7&0F2WO49(%A&09ZI4H6CWERW)&$/0S0#,6DLB/ MLQ2P).QD133(I*ZJ-I/@N"#R>BIYO[=Z*=*1)GIR-.0>.#/ZN8R9$_XY"-][E8EE^+S;98>&)N;1\+#^\VR_H*+$VZTH54 MCJ<&0%.-H'J%O#VBX_#2:6#.$)(ADM-@(E,C*JNC2S%?FL]W3[N56 @N;L2\ M6]=9VKIX+,K-\FMQ727I M2%6OT=5[H:Q7;SH5ND1E$7_)'&L4X!7SK1MR[:'M=KW\LMLV?ZV81 M.$[")8O:N>3+.O+3H#\'=KU.RAPA)TN2=^LBW^S6WYK]JYZ.(0^2) ,13""* MPY@CY._I.$5*)2N=[SM.S4BU:39O/Q?/XB<>\XT@OT8]39[3@E".T5RCI\9= MO3:R:#FAJQ.0G"$F$P"G04%&%E3VAI,:K7P4QE7E5A@J?NCANA335*R!.I$) M"3A*>4(Y8"DFG(7^OCR6A1E0X1:G6'LF1..@<2&?(R JVTV E.Z94#L:>9E?!![$LO1:_W,PXB;(XRJ@?4!! MPE'H@UX0#YE2]J/Q><><=-174^OD-4KI=@XH@*;8+N &+S7.483*;8? 'A"9 MM@!U]*;!*B8&O-< H(N%+(.(-5J=516T:/_WNGS;"OA9,!JOUG_FZ\4L!7Y* M_?H)7J$'@BBC,>VU($DD]>21*]F.N:=7U_NA5_C'NB9^NHFVUMOK%%?D)^LN MD2.O,;VAQFP.'.&$_101/4.-KGPS#=YT9ETUS A7S=E>RQ1ZK7;U!:R?JG6] MPWE<7[VK3J>5,^9C@'"&,$4X!7$ ?=C7T^*49='LN5@OJX4().NM;+8WB&(J MO/#:!FF*P,7#LJSW:+PON?B+>3%TWF,#RK.YTJ"^F@9/#&WTFYQL!,RE*U;% MMBVWUWM>%_5:%XNB>&KN63BM9,2CB%*6A!@D/J !A-V]"T))SGRI>S9'4LUU M5:S8>D6W_ZM8_QK819(5L^EZ1['&)AS36N+]4-ORXY6W-\?K['FS=?G").^= M,MW U3FK#CE7SQO'\].()6,9_[IF.*8/9&/+>SN[M<["@)O[N_RO60R"$#-$ M,IID0B("-.J3Y1A3$*@UH5@1Z;S_I.TYF;_H.>EC@_?#JND^$314%LV&[:*X M+];KII&N8:EM_I?\^S]VN$4&UC.,8=4KT^ !NR95#D>Q])4G:/%?N\VV+AYN MMM7+KMEEWS5[^YBOBR]U[T"MGM"MN9+A?&I67Y]+N;5 M0]E^I5RT%@C%V?U],=\*,V9(I*V(Q9B A&#(4)+&8)_1!EAJRV&*>CO?RZC; M$/*ZU. U3TJ)%87T52&3 ^OR?2Z34]EAF]S!U#K+?'5*P3N<4KCR&HM_:DSV MCFV^\O96>YW97FNW=V2X5S\-WF6]PG:O-?[*$^9_QT-)^@:;R:FN,J3T;L,Y MF.S=O1U9UZ]'EH=/CJR-R"SG==LL$N.']HE)RTBH9J1-,[+J?G^1IGA?BK*X M7XK!G&\VU7S9--S^N=P^>O71@";;$?G-LT!P[;4E.Z^^2;"747]IG_QL#JQG M\OCAT)X_D15->?R-?H_0=)&IIL\>:LLS*C*'15$N-D+#IZK=TR#YYG%&1&+) M8YY"E%(6 K]Y J(3)Q:)V:PL'NJI?"=?R].6)46,64N,;]22[XT5JGB+7D=! M.O.5<)_DS7;F>,I5W-QBJ)6O[%6Z\EJEVE!P53_>]3CL$O4]=,XL2XT!G<92 MU-R,RO) ,^C%_RU?[0HT%S2YKJFS[H/;/E:+&6%A'/H92PA "8NC#'#>B4X M1[X&)UF1.PP_'7KVFXQIWLZU)B4R:-K7QEJ.KX;#UT);_Y77:'CE]3K6C+;9 M>JV:(_;ZOP.<;/._*>[3H#B[)IT['F 'KX%[.I(8!3'P81I2#&GLTR!.>N50 MR$G7T\'*Q: ='9?44N_HZ"V0GN2L?9SZ_S9S6'#3-*A@:*/=-'.H8:[5S/%2 MC\^7M@#]-.$9$=06IC[ &<=BD=EJ%/(,9DH-NB[U&+!-P\M?[?J7+_?YE_W! M)H-^#MM>TFC>&-%!AIT:;]HR/D^Y)T,-9]D&#$?>FP;9#V+IN=8*I^C*TOK1 M,GR_-/]4K)L2(^U*5;,X V$4^5F2$0[3+( PBWK14>!3M3X**R*=]U'0-Q4[ M[X?=9E'O)7B;6M4?U9C9#M!R%#PXPFI<^[*<=U3G$SJV.T17'KU4)G7"J3+ MG2%/J[A/@R7MFE0Y'*>*&Q3%%T'%F^UZ=[AE&_I!$OK )QE,XB0,XS@"),D2 MZ$.:1$@I3=7YONO>COECL=B)]*6Z]SY4Y<-/XAM/7JVH=]!T<_%R>'MP2FY- M.$92C;LL@>AFF^(M4N=V* QPG08W&5GP>E_"& U9YODM7R_KSW_.MT5S=3;B M(4EP!"FA""4,$+_.\QHQ3!"=TNEXY8\[YIQ>'Z]62.M.?76XY&C%*5)JG*($ MDA/F> W&&=K0QFT:G*&O?F5I_.BS17<5-DJ2(*"IGV51W9X+>.#WM,1H$$6Z M?"'Y^6$90^OB>QW0U%G# 5Y&O#'*??=O 9'D#D7TIL<>J@:R4^DWI? MVJY$QSS3*NGMM?0Z-=O)]$.CZ8^:MXI9@ER.DH9'6XVE+ 'MA+VDL#M#:':Q MGP;'6;:I%@H!810!S"A,0AR3$':R. FI MTK%R/0FNZSZU4H@'(\YAX[Q4J/#FQNFCU.(7.N=\,(R6FP MD*$-KSLK+""BS3)==L<3@".,0"0^G@4TC&F8[:7%0.DU(5T9XS"-UAI.&T9- MMG& H!6^&655]PXZ*IRCB.=$64?5BDN\HX6*]$IO618W]T3D4\O^BE>48AKZ M]26O2802 !GB_9*2XY!!I66=^N==K^'J.T2K>Z_527>QIH&:Y,K,+6"*RS!% MK-RLM]X@*E1B")4;CITW@!RKA]' M'[UI,(B) :][;4RQT&.0+N%)?13[*8OCC&8A2B(.$6I%I3Z!OE)KC9: H5E$ M:\VC!YT.DSA S9!+1EGGG )%FD\4,9PBHZB:<)93M/"0?_7T:[7ZNBP?7LKL M>](ZY6^"4-\B5,7.U&_X&E_.;W_HP3H-M MS$QXN[5MBH=IMMZ(>@DQV)Q @RXFHJDH]EV,\3TGB(VZKR3 ILZ?NE M1P)=[V9HB^!?OG]9'ID30<(-LJ/?>>S"ILKE6#0YQO]A_S M07X PS1! 0\S M/_8#/^.=M#"FD5+?DZX,QT'DU9ES@\>GM4&4RUB'P$\M)&A!-\"1_0\2+U*; MHCF-5-;8BK/']W5146[QQM5Z7?U9W^7!@E2@5J;2&.XW*MB91+ M,XH2>%/D$C4#SE_(I8Z%1(WZI8R/N[I04=VSO[;UPYA5N9EQ@ED8Q9AGF$01 M '$<1+W$ "925^W8D#,THY2-BO5QH6*OI'15U!S5BX7G00$UY)R/>RS9&%A* MUY4'Q52OFFR&[>4"\B4(3I>-K0$W>K'8GB65_6&ER>KLK^>B?O'Q<_&GM^X5[=[(U"0F M;9 5F7X(? WIOE?1V^O8/9$[-+2:Q#\$Q);87QUJU1#P#A@R<< 4QXD% V-S MWHL(=G#2" M= &I6%EE A0S* &=IA*((1Z#OT@UAAJ6ZV0Q%#!\".NT4R@>F M*"JSO2L C3F^Q^YL0<$J=MIT[@I#:R0NA:4Z7Y$:S#C% AI*2!P1'X8 D[07#U*.@7Y1UT#HT*S] MI5;5VS2Z>F+.?.VO %X+=4UJP"; ZU2&!\+LY#\/GS2 MY64+'IABT=F&66=+T=9PTV/(_CVPYM[HW;I^&[)-F(,X@R$,HXB!A+&88^;C M7CCS>:;/C]HBAV;'_M'$A@V]1:.J4F'#-N0ZS#@(VH:\V.O8WN'<:JFX]G;! MBN]!)\V)QMA/D1'-C3K+AY8P4U[!D^IK4>;U_Y:;:K5<"/$+AJ_O*-I6O4YU M<:'W'-W M9XCWN?7@+]/TH&;=8PJ>M%0A<>91U9J*)J8RU1?7[II8G<:YN>]5=(;!62.6 MRZDS"X,,87*2TC/[D0J-M^]Z/A4Z0E"WK]:(^Y=_J M"B+9K=="J1EA60!@ !'Q8S_F,&6DOX@!$!0F*F4\31&.P]A^LCVW:EUY&Z6# M95;1E*O0#0"D6N398_BIQ[#3:=CRVVEW:[/9 MW-S75TC==5=(S2 ,?)_%69B0N-[E=46XIAY#G>@+>K$H&Y^ M7 Y7.IJ!1>S>(W*Q4=A?S=G$?<)B%+.&<(^B6(8 MQ/T)-_&G1&D2V9#G>#ZA^7R]$XGT?L%9E=[JQ1RS$<05(3:)Z.[0-0OO4XCJ M+[!1#O%ZR$Z#N:Q:)!7\3="2Y[.O0FYSN*Z6?%?\M<7"ZC]FT$\@A&$

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end XML 48 R38.htm IDEA: XBRL DOCUMENT v3.20.1
Asset Impairment, Exit and Implementation Costs (Movement in Restructuring Liabilities) (Details)
$ in Millions
 3 Months Ended
Mar. 31, 2020
USD ($)
Restructuring Reserve [Roll Forward]  
Restructuring reserve, beginning of period $ 67
Charges 0
Cash spent (23)
Restructuring reserve, end of period $ 44

XML 49 R30.htm IDEA: XBRL DOCUMENT v3.20.1
Segment Reporting (Tables)
 3 Months Ended
Mar. 31, 2020
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
Segment data were as follows: 
 
 
For the Three Months Ended March 31,
 
 
2020
 
2019
 
 
(in millions)
Net revenues:
 
 
 
 
Smokeable products
 
$
5,606

 
$
4,935

Oral tobacco products
 
601

 
540

Wine
 
146

 
151

All other
 
6

 
2

Net revenues
 
$
6,359

 
$
5,628

Earnings before income taxes:
 
 
 
 
Operating companies income (loss):
 
 
 
 
Smokeable products
 
$
2,370

 
$
1,932

Oral tobacco products
 
414

 
358

Wine
 
(379
)
 
15

All other
 
(5
)
 
(12
)
Amortization of intangibles
 
(19
)
 
(8
)
General corporate expenses
 
(45
)
 
(46
)
Corporate asset impairment and exit costs
 
—

 
(1
)
Operating income
 
2,336

 
2,238

Interest and other debt expense, net
 
(275
)
 
(384
)
Net periodic benefit income, excluding service cost
 
27

 
1

Earnings from equity investments
 
157

 
86

Loss on Cronos-related financial instruments
 
(137
)
 
(425
)
Earnings before income taxes
 
$
2,108

 
$
1,516
Schedule of Pre-tax Tobacco and Health Litigation Items
Tobacco and Health Litigation Items - Pre-tax charges related to certain tobacco and health litigation items were recorded in Altria’s condensed consolidated statements of earnings as follows:
 
 
For the Three Months Ended March 31,
 
 
2020
 
2019
 
 
(in millions)
Smokeable products segment
 
$
22

 
$
15

Interest and other debt expense, net
 
2

 
2

Total
 
$
24

 
$
17
XML 50 R34.htm IDEA: XBRL DOCUMENT v3.20.1
Background and Basis of Presentation (Narrative) (Details) - USD ($)
$ / shares in Units, shares in Millions
 3 Months Ended 18 Months Ended
Mar. 31, 2020
Sep. 30, 2019
Mar. 31, 2019
Jun. 30, 2019
Apr. 30, 2020
Dec. 31, 2019
Jul. 31, 2019
May 31, 2018
Jan. 31, 2018
ABI [Member]                  
Equity, Class of Treasury Stock [Line Items]                  
Equity method investment, ownership percentage 10.10%                
JUUL [Member]                  
Equity, Class of Treasury Stock [Line Items]                  
Equity securities, ownership percentage 35.00%         35.00%      
Cronos [Member]                  
Equity, Class of Treasury Stock [Line Items]                  
Equity method investment, ownership percentage 45.00%   45.00%            
January 2018 Share Repurchase Program [Member]                  
Equity, Class of Treasury Stock [Line Items]                  
Planned share repurchase program               $ 2,000,000,000.0 $ 1,000,000,000.0
Repurchase of common stock (shares)     2.7 34.0          
Average price of repurchased shares, per share (usd per share)     $ 56.34 $ 58.86          
July 2019 Share Repurchase Program [Member]                  
Equity, Class of Treasury Stock [Line Items]                  
Planned share repurchase program             $ 1,000,000,000.0    
Repurchase of common stock (shares) 0.0                
Helix Innovations LLC [Member]                  
Equity, Class of Treasury Stock [Line Items]                  
Noncontrolling interest, ownership percentage by parent 80.00%                
Business Combination, Consideration Transferred   $ 353,000,000              
Noncontrolling interest, ownership percentage by noncontrolling owners 20.00%                
Subsequent Event [Member] | July 2019 Share Repurchase Program [Member]                  
Equity, Class of Treasury Stock [Line Items]                  
Stock repurchase program, remaining authorized repurchase amount         $ 500,000,000        
XML 51 R25.htm IDEA: XBRL DOCUMENT v3.20.1
Investments in Equity Securities Investments in Equity Securities (Tables)
 3 Months Ended
Mar. 31, 2020
Investments [Abstract]  
Investment

Altria’s investments consisted of the following:
 
 
Carrying Amount
 
 
March 31, 2020
 
December 31, 2019
 
 
(in millions)
ABI
 
$
18,453

 
$
18,071

JUUL
 
4,205

 
4,205

Cronos (1)
 
1,203

 
1,305

Total
 
$
23,861

 
$
23,581

(1) March 31, 2020 includes Altria’s equity method investment in Cronos ($1,037 million), the Cronos warrant ($132 million) and the Fixed-price Preemptive Rights ($34 million) and December 31, 2019 includes Altria’s equity method investment in Cronos ($1,002 million), the Cronos warrant ($234 million) and the Fixed -price Preemptive Rights ($69 million), as discussed further below.
Equity Method Investments
Earnings from equity investments accounted for under the equity method of accounting consisted of the following:
 
 
For the Three Months Ended March 31,
 
 
2020
 
2019
 
 
(in millions)
ABI
 
$
134

 
$
86

Cronos (1)
 
23

 
—

Total
 
$
157

 
$
86

(1) Represents Altria’s share of Cronos’s earnings, which includes the change in fair value of Cronos’s derivative financial instruments associated with the issuance of additional shares. As a result of the acquisition of Cronos in March 2019 and Altria reporting its share of Cronos’s results using a one-quarter lag, no equity earnings from Altria’s investment in Cronos were recorded for the three months ended March 31, 2019.
XML 52 R21.htm IDEA: XBRL DOCUMENT v3.20.1
New Accounting Guidance Not Yet Adopted
 3 Months Ended
Mar. 31, 2020
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]  
New Accounting Guidance Not Yet Adopted New Accounting Guidance Not Yet Adopted:

The following table provides a description of issued accounting guidance applicable to, but not yet adopted by, Altria:
Standards
Description
Effective Date for Public Entity
Effect on Financial Statements
ASU 2019-12 Simplifying the Accounting for Income Taxes (Topic 740)
The guidance removes certain exceptions for investments, intraperiod allocations and interim calculations, and adds guidance to reduce complexity in accounting for income taxes.
The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early application is permitted, including adoption in any interim period.
Altria is in the process of evaluating the impact of this guidance on its consolidated financial statements and related disclosures.
ASU 2020-01 Clarifying the Interactions between Topic 321, Topic 323, and Topic 815
The guidance provides clarification of the interaction of rules for equity securities, the equity method of accounting, and forward contracts and purchase options on certain types of securities.
The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early application is permitted, including adoption in any interim period.
Altria is in the process of evaluating the impact of this guidance on its consolidated financial statements and related disclosures.
XML 53 R29.htm IDEA: XBRL DOCUMENT v3.20.1
Other Comprehensive Earnings/Losses (Tables)
 3 Months Ended
Mar. 31, 2020
Equity [Abstract]  
Schedule of Accumulated Other Comprehensive Income (Loss)

The following tables set forth the changes in each component of accumulated other comprehensive losses, net of deferred income taxes, attributable to Altria:
 
 
For the Three Months Ended March 31, 2020
 
 
Benefit Plans
 
ABI
 
Currency
Translation
Adjustments and Other
 
Accumulated
Other
Comprehensive
Losses
 
 
(in millions)
Balances, December 31, 2019
 
$
(2,192
)
 
$
(693
)
 
$
21

 
$
(2,864
)
 
 
 
 
 
 
 
 
 
Other comprehensive earnings (losses) before reclassifications
 
—

 
388

 
12

 
400

Deferred income taxes
 
—

 
(85
)
 
—

 
(85
)
Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes
 
—

 
303

 
12

 
315

 
 
 
 
 
 
 
 
 
Amounts reclassified to net earnings
 
28

 
(7
)
 
—

 
21

Deferred income taxes
 
(7
)
 
2

 
—

 
(5
)
Amounts reclassified to net earnings, net of deferred income taxes
 
21

 
(5
)
 
—

 
16

 
 
 
 
 
 
 
 
 
Other comprehensive earnings (losses), net of deferred income taxes
 
21

 
298

(1) 
12

 
331

 
 
 
 
 
 
 
 
 
Balances, March 31, 2020
 
$
(2,171
)
 
$
(395
)
 
$
33

 
$
(2,533
)

 
 
For the Three Months Ended March 31, 2019
 
 
Benefit Plans
 
ABI
 
Currency
Translation
Adjustments and Other
 
Accumulated
Other
Comprehensive
Losses
 
 
(in millions)
Balances, December 31, 2018
 
$
(2,168
)
 
$
(374
)
 
$
(5
)
 
$
(2,547
)
 
 
 
 
 
 
 
 
 
Other comprehensive earnings (losses) before reclassifications
 
—

 
(238
)
 
—

 
(238
)
Deferred income taxes
 
—

 
49

 
—

 
49

Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes
 
—

 
(189
)
 
—

 
(189
)
 
 
 
 
 
 
 
 
 
Amounts reclassified to net earnings
 
39

 
(12
)
 
—

 
27

Deferred income taxes
 
(10
)
 
2

 
—

 
(8
)
Amounts reclassified to net earnings, net of deferred income taxes
 
29

 
(10
)
 
—

 
19

 
 
 
 
 
 
 
 
 
Other comprehensive earnings (losses), net of deferred income taxes
 
29

 
(199
)
(1) 
—

 
(170
)
 
 
 
 
 
 
 
 
 
Balances, March 31, 2019
 
$
(2,139
)
 
$
(573
)
 
$
(5
)
 
$
(2,717
)

(1) Primarily reflects Altria’s share of ABI’s currency translation adjustments and the impact of Altria’s designated net investment hedges. For further discussion of designated net investment hedges, see Note 5. Financial Instruments.
Reclassification out of Accumulated Other Comprehensive Income
The following table sets forth pre-tax amounts by component, reclassified from accumulated other comprehensive losses to net earnings:
 
 
For the Three Months Ended March 31,
 
 
2020
 
2019
 
 
(in millions)
Benefit Plans: (1)
 
 
 
 
Net loss
 
$
34

 
$
49

Prior service cost/credit
 
(6
)
 
(10
)
 
 
28

 
39

 
 
 
 
 
ABI (2)
 
(7
)
 
(12
)
 
 
 
 
 
Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings
 
$
21

 
$
27

(1) Amounts are included in net defined benefit plan costs. For further details, see Note 6. Benefit Plans.
(2) Amounts are included in earnings from equity investments. For further information, see Note 4. Investments in Equity Securities.
XML 54 R48.htm IDEA: XBRL DOCUMENT v3.20.1
Financial Instruments (Fair Value Derivative Financial Instruments) (Details) - Net Investment Hedging [Member] - USD ($)
$ in Millions
Mar. 31, 2020
Dec. 31, 2019
Derivatives, Fair Value [Line Items]    
Fair Value of Assets $ 240 $ 349
Fair Value of Liabilities 0 28
Foreign currency contracts [Member] | Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Fair Value of Assets 74 46
Fair Value of Liabilities 0 28
Foreign currency contracts [Member] | Designated as Hedging Instrument [Member] | Other Current Assets [Member]    
Derivatives, Fair Value [Line Items]    
Fair Value of Assets 55 46
Foreign currency contracts [Member] | Designated as Hedging Instrument [Member] | Other Assets [Member]    
Derivatives, Fair Value [Line Items]    
Fair Value of Assets 19 0
Foreign currency contracts [Member] | Designated as Hedging Instrument [Member] | Other Accrued Liabilities [Member]    
Derivatives, Fair Value [Line Items]    
Fair Value of Liabilities 0 7
Foreign currency contracts [Member] | Designated as Hedging Instrument [Member] | Other Liabilities [Member]    
Derivatives, Fair Value [Line Items]    
Fair Value of Liabilities 0 21
Equity Contract [Member] | Not Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Fair Value of Assets 166 303
Cronos Warrant [Member] | Not Designated as Hedging Instrument [Member] | Investments In Equity Securities [Member]    
Derivatives, Fair Value [Line Items]    
Fair Value of Assets 132 234
Fixed-price Preemptive Rights [Member] | Not Designated as Hedging Instrument [Member] | Investments In Equity Securities [Member]    
Derivatives, Fair Value [Line Items]    
Fair Value of Assets $ 34 $ 69
XML 55 R40.htm IDEA: XBRL DOCUMENT v3.20.1
Investments in Equity Securities (Summary of Investments) (Details) - USD ($)
$ in Millions
Mar. 31, 2020
Dec. 31, 2019
Investments [Line Items]    
Investments $ 23,861.0 $ 23,581.0
ABI [Member]    
Investments [Line Items]    
Investments in equity securities 18,453.0 18,071.0
JUUL [Member]    
Investments [Line Items]    
Equity securities without readily determinable fair value, amount 4,205.0 4,205.0
Cronos [Member]    
Investments [Line Items]    
Investments in equity securities 1,203.0 1,305.0
Equity Contract, Warrant [Member] | Cronos [Member]    
Investments [Line Items]    
Derivative asset, fair value, gross asset 132.0 234.0
Equity Contract, Preemptive Rights [Member] | Cronos [Member]    
Investments [Line Items]    
Derivative asset, fair value, gross asset 34.0 69.0
Common Stock [Member] | Cronos [Member]    
Investments [Line Items]    
Investments in equity securities $ 1,037.0 $ 1,002.0
XML 56 a2020form10qq12020_htm.xml IDEA: XBRL DOCUMENT 0000764180 2020-01-01 2020-03-31 0000764180 mo:CommonStock2.200NotesDue2027Member 2020-01-01 2020-03-31 0000764180 mo:CommonStock3.125NotesDue2031Member 2020-01-01 2020-03-31 0000764180 mo:CommonStock1.700NotesDue2025Member 2020-01-01 2020-03-31 0000764180 mo:CommonStock0.3313ParValueMember 2020-01-01 2020-03-31 0000764180 mo:CommonStock1.000NotesDue2023Member 2020-01-01 2020-03-31 0000764180 2020-04-21 0000764180 2019-12-31 0000764180 2020-03-31 0000764180 2019-01-01 2019-03-31 0000764180 us-gaap:TreasuryStockMember 2019-03-31 0000764180 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0000764180 us-gaap:RetainedEarningsMember 2019-03-31 0000764180 us-gaap:TreasuryStockMember 2019-01-01 2019-03-31 0000764180 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0000764180 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0000764180 us-gaap:CommonStockMember 2019-03-31 0000764180 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0000764180 2018-12-31 0000764180 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000764180 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000764180 us-gaap:RetainedEarningsMember 2018-12-31 0000764180 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0000764180 2019-03-31 0000764180 us-gaap:NoncontrollingInterestMember 2018-12-31 0000764180 us-gaap:CommonStockMember 2018-12-31 0000764180 us-gaap:NoncontrollingInterestMember 2019-03-31 0000764180 us-gaap:TreasuryStockMember 2018-12-31 0000764180 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000764180 us-gaap:CommonStockMember 2019-12-31 0000764180 us-gaap:RetainedEarningsMember 2020-03-31 0000764180 us-gaap:CommonStockMember 2020-03-31 0000764180 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0000764180 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000764180 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0000764180 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0000764180 us-gaap:NoncontrollingInterestMember 2019-12-31 0000764180 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-03-31 0000764180 us-gaap:TreasuryStockMember 2020-01-01 2020-03-31 0000764180 us-gaap:RetainedEarningsMember 2019-12-31 0000764180 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0000764180 us-gaap:NoncontrollingInterestMember 2020-03-31 0000764180 us-gaap:TreasuryStockMember 2019-12-31 0000764180 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0000764180 us-gaap:TreasuryStockMember 2020-03-31 0000764180 mo:January2018ShareRepurchaseProgramMember 2019-01-01 2019-03-31 0000764180 mo:CronosGroupInc.Member 2019-03-31 0000764180 mo:July2019ShareRepurchaseProgramMember 2019-07-31 0000764180 mo:January2018ShareRepurchaseProgramMember 2018-01-01 2019-06-30 0000764180 mo:HelixInnovationsLLCMember 2019-07-01 2019-09-30 0000764180 mo:CronosGroupInc.Member 2020-03-31 0000764180 mo:JUULMember 2020-03-31 0000764180 mo:July2019ShareRepurchaseProgramMember us-gaap:SubsequentEventMember 2020-04-30 0000764180 mo:HelixInnovationsLLCMember 2020-03-31 0000764180 mo:January2018ShareRepurchaseProgramMember 2018-05-31 0000764180 mo:July2019ShareRepurchaseProgramMember 2020-01-01 2020-03-31 0000764180 mo:January2018ShareRepurchaseProgramMember 2018-01-31 0000764180 mo:ABInBevMember 2020-03-31 0000764180 us-gaap:OperatingSegmentsMember mo:SmokeableProductsSegmentMember 2020-01-01 2020-03-31 0000764180 us-gaap:OperatingSegmentsMember mo:WineSegmentMember 2019-01-01 2019-03-31 0000764180 us-gaap:OperatingSegmentsMember mo:WineSegmentMember 2020-01-01 2020-03-31 0000764180 us-gaap:OperatingSegmentsMember mo:SmokeableProductsSegmentMember 2019-01-01 2019-03-31 0000764180 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2019-01-01 2019-03-31 0000764180 us-gaap:CorporateNonSegmentMember 2020-01-01 2020-03-31 0000764180 us-gaap:OperatingSegmentsMember mo:OralTobaccoSegmentMember 2020-01-01 2020-03-31 0000764180 us-gaap:OperatingSegmentsMember mo:OralTobaccoSegmentMember 2019-01-01 2019-03-31 0000764180 us-gaap:CorporateNonSegmentMember 2019-01-01 2019-03-31 0000764180 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2020-01-01 2020-03-31 0000764180 mo:InventoryWriteOffMember mo:WineBusinessStrategicResetMember 2020-01-01 2020-03-31 0000764180 mo:WineBusinessStrategicResetMember 2020-01-01 2020-03-31 0000764180 us-gaap:PurchaseCommitmentMember mo:WineBusinessStrategicResetMember 2020-01-01 2020-03-31 0000764180 srt:ScenarioForecastMember mo:WineBusinessStrategicResetMember 2020-04-01 2020-12-31 0000764180 mo:ABInBevMember 2019-01-01 2019-03-31 0000764180 mo:ABInBevMember 2020-01-01 2020-03-31 0000764180 mo:CronosGroupInc.Member 2019-01-01 2019-03-31 0000764180 mo:CronosGroupInc.Member 2020-01-01 2020-03-31 0000764180 mo:CronosGroupInc.Member us-gaap:CommonStockMember 2019-12-31 0000764180 mo:CronosGroupInc.Member mo:EquityContractPreemptiveRIghtsMember 2019-12-31 0000764180 mo:ABInBevMember 2019-12-31 0000764180 mo:ABInBevMember us-gaap:FairValueInputsLevel1Member 2019-12-31 0000764180 mo:CronosGroupInc.Member mo:EquityContractWarrantMember 2019-12-31 0000764180 mo:ABInBevMember us-gaap:FairValueInputsLevel1Member 2020-03-31 0000764180 mo:CronosGroupInc.Member mo:EquityContractWarrantMember 2020-03-31 0000764180 mo:ABInBevMember 2019-01-01 2019-12-31 0000764180 mo:CronosGroupInc.Member us-gaap:CommonStockMember 2020-03-31 0000764180 mo:CronosGroupInc.Member mo:EquityContractPreemptiveRIghtsMember 2020-03-31 0000764180 mo:CronosGroupInc.Member 2019-12-31 0000764180 mo:JUULMember 2019-12-31 0000764180 mo:JUULMember 2020-01-28 0000764180 mo:JUULMember 2018-12-01 2018-12-31 0000764180 mo:JUULMember 2020-01-28 2020-01-28 0000764180 mo:JUULMember 2019-01-01 2019-12-31 0000764180 mo:CronosGroupInc.Member us-gaap:FairValueInputsLevel1Member 2020-03-31 0000764180 mo:CronosGroupInc.Member 2019-03-31 2019-03-31 0000764180 mo:CronosGroupInc.Member mo:EquityContractWarrantMember 2019-03-31 0000764180 mo:CronosGroupInc.Member mo:EquityContractWarrantMember 2020-01-01 2020-03-31 0000764180 mo:CronosGroupInc.Member us-gaap:FairValueInputsLevel1Member 2019-12-31 0000764180 mo:CronosGroupInc.Member mo:EquityContractPreemptiveRIghtsMember 2019-03-31 2019-03-31 0000764180 mo:CronosGroupInc.Member mo:EquityContractPreemptiveRIghtsMember 2020-01-01 2020-03-31 0000764180 mo:CronosGroupInc.Member mo:EquityContractPreemptiveRIghtsMember 2019-03-31 0000764180 mo:CronosGroupInc.Member mo:EquityContractWarrantMember 2019-03-31 2019-03-31 0000764180 mo:CronosGroupInc.Member 2019-01-01 2019-09-30 0000764180 mo:CronosGroupInc.Member us-gaap:CommonStockMember 2020-01-01 2020-03-31 0000764180 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-03-31 0000764180 mo:ForeignCurrencyDenominatedDebtMember 2019-12-31 0000764180 mo:CronosGroupInc.Member 2019-03-07 2019-03-07 0000764180 mo:ForeignCurrencyDenominatedDebtMember 2020-03-31 0000764180 us-gaap:ForwardContractsMember us-gaap:NondesignatedMember 2019-01-01 2019-03-31 0000764180 srt:MaximumMember mo:EquityContractPreemptiveRIghtsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2020-03-31 0000764180 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-12-31 0000764180 srt:MaximumMember mo:EquityContractPreemptiveRIghtsMember mo:MeasurementInputWeightedAverageExpectedTermMember 2020-03-31 0000764180 srt:MinimumMember mo:EquityContractPreemptiveRIghtsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2019-12-31 0000764180 srt:MaximumMember mo:EquityContractPreemptiveRIghtsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2019-12-31 0000764180 srt:MinimumMember mo:EquityContractPreemptiveRIghtsMember mo:MeasurementInputWeightedAverageExpectedTermMember 2020-03-31 0000764180 us-gaap:ForwardContractsMember us-gaap:NondesignatedMember 2019-03-07 0000764180 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2020-03-31 0000764180 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-12-31 0000764180 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-03-31 0000764180 srt:MinimumMember mo:EquityContractPreemptiveRIghtsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2020-03-31 0000764180 mo:EquityContractPreemptiveRIghtsMember us-gaap:MeasurementInputPriceVolatilityMember 2019-12-31 0000764180 mo:EquityContractPreemptiveRIghtsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2019-12-31 0000764180 mo:EquityContractWarrantMember us-gaap:MeasurementInputExpectedDividendRateMember 2019-12-31 0000764180 mo:EquityContractWarrantMember us-gaap:MeasurementInputExpectedDividendRateMember 2020-03-31 0000764180 mo:EquityContractWarrantMember us-gaap:MeasurementInputSharePriceMember 2019-12-31 0000764180 mo:EquityContractPreemptiveRIghtsMember us-gaap:MeasurementInputSharePriceMember 2019-12-31 0000764180 mo:EquityContractPreemptiveRIghtsMember us-gaap:MeasurementInputSharePriceMember 2020-03-31 0000764180 mo:EquityContractPreemptiveRIghtsMember us-gaap:MeasurementInputPriceVolatilityMember 2020-03-31 0000764180 mo:EquityContractWarrantMember us-gaap:MeasurementInputSharePriceMember 2020-03-31 0000764180 mo:EquityContractPreemptiveRIghtsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2020-03-31 0000764180 mo:EquityContractWarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2019-12-31 0000764180 mo:EquityContractWarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2020-03-31 0000764180 mo:EquityContractWarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2019-12-31 0000764180 mo:EquityContractPreemptiveRIghtsMember us-gaap:MeasurementInputExpectedDividendRateMember 2020-03-31 0000764180 mo:EquityContractPreemptiveRIghtsMember us-gaap:MeasurementInputExpectedDividendRateMember 2019-12-31 0000764180 mo:EquityContractWarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2020-03-31 0000764180 us-gaap:NetInvestmentHedgingMember 2019-01-01 2019-03-31 0000764180 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2020-01-01 2020-03-31 0000764180 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2019-01-01 2019-03-31 0000764180 us-gaap:NetInvestmentHedgingMember 2020-01-01 2020-03-31 0000764180 mo:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember 2020-01-01 2020-03-31 0000764180 mo:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember 2019-01-01 2019-03-31 0000764180 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel3Member 2020-03-31 0000764180 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel3Member 2020-01-01 2020-03-31 0000764180 us-gaap:EquityContractMember us-gaap:FairValueInputsLevel3Member 2019-12-31 0000764180 mo:EquityContractPreemptiveRIghtsMember 2019-01-01 2019-03-31 0000764180 mo:EquityContractWarrantMember 2020-01-01 2020-03-31 0000764180 mo:EquityContractWarrantMember 2019-01-01 2019-03-31 0000764180 mo:EquityContractPreemptiveRIghtsMember 2020-01-01 2020-03-31 0000764180 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000764180 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000764180 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000764180 us-gaap:EquityContractMember us-gaap:NetInvestmentHedgingMember us-gaap:NondesignatedMember 2019-12-31 0000764180 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000764180 us-gaap:NetInvestmentHedgingMember 2019-12-31 0000764180 us-gaap:OtherAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000764180 mo:InvestmentsInEquitySecuritiesMember mo:EquityContractWarrantMember us-gaap:NetInvestmentHedgingMember us-gaap:NondesignatedMember 2020-03-31 0000764180 mo:OtherAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000764180 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000764180 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000764180 us-gaap:NetInvestmentHedgingMember 2020-03-31 0000764180 us-gaap:OtherAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000764180 mo:InvestmentsInEquitySecuritiesMember mo:EquityContractPreemptiveRIghtsMember us-gaap:NetInvestmentHedgingMember us-gaap:NondesignatedMember 2020-03-31 0000764180 mo:InvestmentsInEquitySecuritiesMember mo:EquityContractPreemptiveRIghtsMember us-gaap:NetInvestmentHedgingMember us-gaap:NondesignatedMember 2019-12-31 0000764180 us-gaap:EquityContractMember us-gaap:NetInvestmentHedgingMember us-gaap:NondesignatedMember 2020-03-31 0000764180 mo:InvestmentsInEquitySecuritiesMember mo:EquityContractWarrantMember us-gaap:NetInvestmentHedgingMember us-gaap:NondesignatedMember 2019-12-31 0000764180 mo:OtherAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000764180 mo:EquityContractWarrantMember us-gaap:MeasurementInputExpectedTermMember 2020-03-31 0000764180 mo:EquityContractPreemptiveRIghtsMember us-gaap:MeasurementInputExpectedTermMember 2020-03-31 0000764180 mo:EquityContractWarrantMember us-gaap:MeasurementInputExpectedTermMember 2019-12-31 0000764180 mo:EquityContractPreemptiveRIghtsMember us-gaap:MeasurementInputExpectedTermMember 2019-12-31 0000764180 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2019-12-31 0000764180 srt:MaximumMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-03-31 0000764180 us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-03-31 0000764180 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-01-01 2020-03-31 0000764180 srt:MaximumMember us-gaap:PensionPlansDefinedBenefitMember 2020-03-31 0000764180 us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-03-31 0000764180 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-01-01 2019-03-31 0000764180 mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember 2020-01-01 2020-03-31 0000764180 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-12-31 0000764180 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-03-31 0000764180 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-03-31 0000764180 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-03-31 0000764180 mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember 2020-03-31 0000764180 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0000764180 us-gaap:AccumulatedTranslationAdjustmentMember 2020-03-31 0000764180 mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember 2019-12-31 0000764180 mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember 2018-12-31 0000764180 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-03-31 0000764180 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-03-31 0000764180 mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember 2019-01-01 2019-03-31 0000764180 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0000764180 mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember 2019-03-31 0000764180 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-03-31 0000764180 us-gaap:AccumulatedTranslationAdjustmentMember 2019-03-31 0000764180 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-31 0000764180 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2019-01-01 2019-03-31 0000764180 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0000764180 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2020-01-01 2020-03-31 0000764180 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-03-31 0000764180 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2020-01-01 2020-03-31 0000764180 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0000764180 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-03-31 0000764180 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2019-01-01 2019-03-31 0000764180 us-gaap:MaterialReconcilingItemsMember 2020-01-01 2020-03-31 0000764180 mo:OralTobaccoSegmentMember 2020-01-01 2020-03-31 0000764180 mo:WineSegmentMember 2019-01-01 2019-03-31 0000764180 mo:OralTobaccoSegmentMember 2019-01-01 2019-03-31 0000764180 us-gaap:AllOtherSegmentsMember 2020-01-01 2020-03-31 0000764180 mo:SmokeableProductsSegmentMember 2020-01-01 2020-03-31 0000764180 mo:SmokeableProductsSegmentMember 2019-01-01 2019-03-31 0000764180 mo:WineSegmentMember 2020-01-01 2020-03-31 0000764180 us-gaap:MaterialReconcilingItemsMember 2019-01-01 2019-03-31 0000764180 us-gaap:AllOtherSegmentsMember 2019-01-01 2019-03-31 0000764180 mo:TobaccoandHealthLitigationCasesMember 2019-01-01 2019-03-31 0000764180 us-gaap:OperatingSegmentsMember mo:TobaccoandHealthLitigationCasesMember mo:SmokeableProductsSegmentMember mo:PhilipMorrisUSAMember 2019-01-01 2019-03-31 0000764180 us-gaap:OperatingSegmentsMember mo:TobaccoandHealthLitigationCasesMember mo:SmokeableProductsSegmentMember mo:PhilipMorrisUSAMember 2020-01-01 2020-03-31 0000764180 us-gaap:MaterialReconcilingItemsMember mo:TobaccoandHealthLitigationCasesMember 2019-01-01 2019-03-31 0000764180 us-gaap:MaterialReconcilingItemsMember mo:TobaccoandHealthLitigationCasesMember 2020-01-01 2020-03-31 0000764180 mo:TobaccoandHealthLitigationCasesMember 2020-01-01 2020-03-31 0000764180 us-gaap:RevolvingCreditFacilityMember mo:RevolvingCreditFacilityDueAugust2023Member us-gaap:LineOfCreditMember 2020-03-31 0000764180 us-gaap:RevolvingCreditFacilityMember mo:RevolvingCreditFacilityDueAugust2023Member us-gaap:LineOfCreditMember 2018-08-01 0000764180 us-gaap:RevolvingCreditFacilityMember mo:RevolvingCreditFacilityDueAugust2023Member us-gaap:LineOfCreditMember 2020-01-01 2020-03-31 0000764180 us-gaap:SeniorNotesMember 2020-01-01 2020-03-31 0000764180 us-gaap:RevolvingCreditFacilityMember mo:RevolvingCreditFacilityDueAugust2023Member us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2020-01-01 2020-03-31 0000764180 us-gaap:RevolvingCreditFacilityMember mo:RevolvingCreditFacilityDueAugust2023Member us-gaap:LineOfCreditMember 2020-01-01 2020-03-31 0000764180 mo:EvaporLitigationMember us-gaap:SubsequentEventMember 2020-04-27 0000764180 mo:OtherTabaccoRelatedCasesMember us-gaap:SubsequentEventMember 2020-04-27 0000764180 mo:OtherTabaccoRelatedCasesMember 2018-04-23 0000764180 mo:EvaporLitigationMember 2019-04-22 0000764180 mo:IndividualSmokingAndHealthCasesMember us-gaap:SubsequentEventMember 2020-04-27 0000764180 mo:HealthCareCostRecoveryActionsMember 2018-04-23 0000764180 mo:OtherTabaccoRelatedCasesMember 2019-04-22 0000764180 mo:HealthCareCostRecoveryActionsMember us-gaap:SubsequentEventMember 2020-04-27 0000764180 mo:HealthCareCostRecoveryActionsMember 2019-04-22 0000764180 mo:EvaporLitigationMember 2018-04-23 0000764180 mo:IndividualSmokingAndHealthCasesMember 2019-04-22 0000764180 mo:IndividualSmokingAndHealthCasesMember 2018-04-23 0000764180 mo:InterestExpenseRelatedToLitigationMember 2019-01-01 2019-03-31 0000764180 mo:TobaccoandHealthJudgmentMember mo:LitigationCasesResultsMember 2019-01-01 2019-03-31 0000764180 mo:TobaccoandHealthJudgmentMember mo:LitigationCasesResultsMember 2020-01-01 2020-03-31 0000764180 mo:InterestExpenseRelatedToLitigationMember 2020-01-01 2020-03-31 0000764180 mo:ETSSmokingandHealthCaseFlightAttendantsMember us-gaap:PendingLitigationMember us-gaap:SubsequentEventMember 2020-04-27 2020-04-27 0000764180 mo:NonEngleProgenyCasesMember stpr:OH us-gaap:SubsequentEventMember mo:PhilipMorrisUSAMember 1999-01-01 2020-04-27 0000764180 mo:HealthCareCostRecoveryActionsMember us-gaap:SettledLitigationMember mo:PhilipMorrisUSAMember 2020-01-01 2020-03-31 0000764180 mo:EngleProgenyCasesReiderandBanksMember us-gaap:SubsequentEventMember mo:PhilipMorrisUSAMember 2020-04-27 2020-04-27 0000764180 mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:MI mo:PhilipMorrisUSAMember 1996-05-01 2020-03-31 0000764180 mo:LightsUltraLightsClassActionsMember us-gaap:SubsequentEventMember 2020-04-27 0000764180 mo:EngleProgenyCasesStateMember 2008-01-31 0000764180 mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:IL mo:PhilipMorrisUSAMember 1996-05-01 2020-03-31 0000764180 mo:HealthCareCostRecoveryActions2008NPMAdjustmentMember mo:PhilipMorrisUSAMember 2020-01-01 2020-03-31 0000764180 mo:HealthCareCostRecoveryActions2003NPMAdjustmentMember us-gaap:PendingLitigationMember mo:PhilipMorrisUSAMember 2013-09-01 2013-09-30 0000764180 mo:NonEngleProgenyCasesMember us-gaap:SubsequentEventMember mo:PhilipMorrisUSAMember 1999-01-01 2020-04-27 0000764180 mo:NonEngleProgenyCasesMember stpr:MS us-gaap:SubsequentEventMember mo:PhilipMorrisUSAMember 1999-01-01 2020-04-27 0000764180 mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:LA mo:PhilipMorrisUSAMember 1996-05-01 2020-03-31 0000764180 2019-10-01 2019-12-31 0000764180 mo:HealthCareCostRecoveryActions20032015NPMAdjustmentsMember us-gaap:SettledLitigationMember mo:PhilipMorrisUSAMember 2018-12-31 0000764180 mo:HealthCareCostRecoveryActionsMember mo:PhilipMorrisUSAMember 2019-01-01 2019-03-31 0000764180 mo:EngleProgenyCasesMember us-gaap:SubsequentEventMember mo:PhilipMorrisUSAMember 2020-04-27 0000764180 mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:AR mo:PhilipMorrisUSAMember 1996-05-01 2020-03-31 0000764180 mo:USTLitigationMember mo:PendingIndividualLawsuitsMember us-gaap:SubsequentEventMember 2020-04-27 0000764180 mo:EvaporLitigationMember mo:PendingIndividualLawsuitsMember us-gaap:SubsequentEventMember 2020-04-27 0000764180 mo:NonEngleProgenyCasesMember stpr:TN us-gaap:SubsequentEventMember mo:PhilipMorrisUSAMember 1999-01-01 2020-04-27 0000764180 mo:HealthCareCostRecoveryActions2019NPMAdjustmentsMember mo:PhilipMorrisUSAMember 2020-01-01 2020-03-31 0000764180 mo:HealthCareCostRecoveryActions20042017Member us-gaap:SettledLitigationMember mo:PhilipMorrisUSAMember 2018-04-01 2018-04-30 0000764180 mo:EngleProgenyCasesWeingartandHancockMember us-gaap:SubsequentEventMember mo:PhilipMorrisUSAMember 2020-04-27 2020-04-27 0000764180 mo:HealthCareCostRecoveryActionsMember mo:PhilipMorrisUSAMember 2020-01-01 2020-03-31 0000764180 mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember country:CA mo:CanadianTobaccoManufacturersMember 2019-03-31 0000764180 mo:IndividualSmokingAndHealthCasesMember stpr:MA us-gaap:PendingLitigationMember us-gaap:SubsequentEventMember 2020-04-27 0000764180 mo:HealthCareCostRecoveryActions2003NPMAdjustmentMember mo:MarylandMissouriNewMexicoandPennsylvaniaMember us-gaap:PendingLitigationMember mo:PhilipMorrisUSAMember 2013-09-01 2013-09-30 0000764180 mo:NonEngleProgenyCasesMember stpr:NH us-gaap:SubsequentEventMember mo:PhilipMorrisUSAMember 1999-01-01 2020-04-27 0000764180 mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:CA mo:PhilipMorrisUSAMember 1996-05-01 2020-03-31 0000764180 mo:NonEngleProgenyCasesMember stpr:CT us-gaap:SubsequentEventMember mo:PhilipMorrisUSAMember 1999-01-01 2020-04-27 0000764180 mo:EngleProgenyCasesM.BrownMember mo:PhilipMorrisUSAMember 2018-04-01 2018-06-30 0000764180 mo:HealthCareCostRecoveryActionsMember 1998-11-01 1998-11-30 0000764180 us-gaap:AssetsMember us-gaap:PendingLitigationMember mo:PhilipMorrisUSAMember 2020-03-31 0000764180 us-gaap:SubsequentEventMember 2020-04-30 0000764180 mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:PA mo:PhilipMorrisUSAMember 1996-05-01 2020-03-31 0000764180 mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:WI mo:PhilipMorrisUSAMember 1996-05-01 2020-03-31 0000764180 mo:NonEngleProgenyCasesMember stpr:NY us-gaap:SubsequentEventMember mo:PhilipMorrisUSAMember 1999-01-01 2020-04-27 0000764180 mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember mo:BritishColumbiaSaskatchewanMember us-gaap:SubsequentEventMember mo:PhilipMorrisUSAandAltriaGroupMember 2020-04-27 0000764180 mo:HealthCareCostRecoveryActionsMember country:CA us-gaap:SubsequentEventMember mo:PhilipMorrisUSAMember 2020-04-27 0000764180 mo:HealthCareCostRecoveryActions2014NPMAdjustmentMember mo:PhilipMorrisUSAMember 2020-01-01 2020-03-31 0000764180 mo:NonEngleProgenyCasesMember stpr:MA us-gaap:SubsequentEventMember mo:PhilipMorrisUSAMember 1999-01-01 2020-04-27 0000764180 mo:EvaporLitigationMember mo:PendingLawsuitsFiledByStateOrLocalGovernmentsMember us-gaap:SubsequentEventMember 2020-04-27 0000764180 mo:NonEngleProgenySmokingandHealthCaseGentileMember 2017-10-31 0000764180 mo:HealthCareCostRecoveryActionsMember country:CA us-gaap:SubsequentEventMember mo:PhilipMorrisUSAandAltriaGroupMember 2020-04-27 0000764180 us-gaap:LetterOfCreditMember 2020-03-31 0000764180 mo:HealthCareCostRecoveryActions2007NPMAdjustmentMember mo:PhilipMorrisUSAMember 2020-01-01 2020-03-31 0000764180 mo:HealthCareCostRecoveryActions2009NPMAdjustmentMember mo:PhilipMorrisUSAMember 2020-01-01 2020-03-31 0000764180 mo:NonEngleProgenyCasesMember stpr:WV us-gaap:SubsequentEventMember mo:PhilipMorrisUSAMember 1999-01-01 2020-04-27 0000764180 mo:HealthCareCostRecoveryActions2005NPMAdjustmentMember mo:PhilipMorrisUSAMember 2020-01-01 2020-03-31 0000764180 mo:HealthCareCostRecoveryActionsMember 1998-11-30 0000764180 mo:EngleProgenyCasesStateMember us-gaap:SubsequentEventMember mo:PhilipMorrisUSAMember 2020-04-27 2020-04-27 0000764180 mo:HealthCareCostRecoveryActions20042017Member us-gaap:SettledLitigationMember mo:PhilipMorrisUSAMember 2018-01-01 2018-12-31 0000764180 mo:NonEngleProgenyCasesMember stpr:RI us-gaap:SubsequentEventMember mo:PhilipMorrisUSAMember 1999-01-01 2020-04-27 0000764180 mo:TobaccoandHealthJudgmentMember mo:PreTrialResolutionMember 2020-01-01 2020-03-31 0000764180 mo:HealthCareCostRecoveryActions2004NPMAdjustmentMember mo:PhilipMorrisUSAMember 2020-01-01 2020-03-31 0000764180 mo:EngleProgenyCasesMember 2004-10-01 2020-03-31 0000764180 mo:FederalGovernmentsLawsuitMember mo:ImplementationofCorrectiveCommunicationsMember 2014-01-01 2014-12-31 0000764180 mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:SC mo:PhilipMorrisUSAMember 1996-05-01 2020-03-31 0000764180 mo:NonEngleProgenySmokingandHealthCaseGentileMember mo:PhilipMorrisUSAMember 2017-10-31 0000764180 mo:HealthCareCostRecoveryActions20042017Member us-gaap:SettledLitigationMember mo:PhilipMorrisUSAMember 2020-01-01 2020-03-31 0000764180 mo:EngleProgenyCasesFreemanMember us-gaap:SubsequentEventMember mo:PhilipMorrisUSAMember 2020-04-27 2020-04-27 0000764180 mo:NonEngleProgenyCasesMember stpr:CA us-gaap:SubsequentEventMember mo:PhilipMorrisUSAMember 1999-01-01 2020-04-27 0000764180 mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:KS mo:PhilipMorrisUSAMember 1996-05-01 2020-03-31 0000764180 mo:HealthCareCostRecoveryActions20042017Member us-gaap:SettledLitigationMember us-gaap:SubsequentEventMember mo:PhilipMorrisUSAMember 2020-04-01 2020-04-30 0000764180 mo:EngleProgenyCasesMember us-gaap:SubsequentEventMember mo:PhilipMorrisUSAMember 2020-04-27 2020-04-27 0000764180 mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:OK mo:PhilipMorrisUSAMember 1996-05-01 2020-03-31 0000764180 mo:HealthCareCostRecoveryActions2010NPMAdjustmentMember mo:PhilipMorrisUSAMember 2020-01-01 2020-03-31 0000764180 mo:EngleProgenyCasesStateMember us-gaap:SubsequentEventMember 2020-04-27 2020-04-27 0000764180 mo:HealthCareCostRecoveryActions2017NPMAdjustmentsMember mo:PhilipMorrisUSAMember 2020-01-01 2020-03-31 0000764180 mo:PreTrialResolutionMember 2020-01-01 2020-03-31 0000764180 mo:OtherDisputesUndertheStateSettlementAgreementsMember mo:PhilipMorrisUSAMember 2018-08-01 2018-08-31 0000764180 mo:HealthCareCostRecoveryActions2006NPMAdjustmentMember mo:PhilipMorrisUSAMember 2020-01-01 2020-03-31 0000764180 mo:HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember mo:PhilipMorrisUSAMember 2020-01-01 2020-03-31 0000764180 mo:HealthCareCostRecoveryActionsMember 2020-01-01 2020-03-31 0000764180 mo:HealthCareCostRecoveryActions20042017Member us-gaap:SettledLitigationMember mo:PhilipMorrisUSAMember 2019-04-01 2019-04-30 0000764180 mo:TobaccoandHealthJudgmentMember 2004-10-01 2020-03-31 0000764180 mo:PhilipMorrisUSAMember 2020-01-01 2020-03-31 0000764180 mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:OR mo:PhilipMorrisUSAMember 1996-05-01 2020-03-31 0000764180 mo:IndividualSmokingAndHealthCasesMember us-gaap:SubsequentEventMember mo:PhilipMorrisUSAMember 2020-04-27 0000764180 mo:EngleProgenyCasesNaugleMember mo:PhilipMorrisUSAMember 2020-01-01 2020-03-31 0000764180 mo:TobaccoandHealthJudgmentMember mo:PreTrialResolutionMember 2020-03-31 0000764180 mo:HealthCareCostRecoveryActionsTransitionYears20042017Member stpr:NY us-gaap:SettledLitigationMember mo:PhilipMorrisUSAMember 2020-01-01 2020-03-31 0000764180 mo:EngleProgenyCasesGlogerRintoulandDuignamMember us-gaap:SubsequentEventMember mo:PhilipMorrisUSAMember 2020-04-27 2020-04-27 0000764180 mo:NonEngleProgenyCasesMember stpr:NJ us-gaap:SubsequentEventMember mo:PhilipMorrisUSAMember 1999-01-01 2020-04-27 0000764180 mo:HealthCareCostRecoveryActionsMember 2019-01-01 2019-03-31 0000764180 mo:HealthCareCostRecoveryActions20032015NPMAdjustmentsMember us-gaap:SettledLitigationMember mo:PhilipMorrisUSAMember 2017-10-01 2017-10-31 0000764180 mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember country:CA us-gaap:SubsequentEventMember mo:PhilipMorrisUSAandAltriaGroupMember 2020-04-27 0000764180 mo:NonEngleProgenySmokingandHealthCaseLaramieMember 2019-08-31 0000764180 mo:EngleProgenyCasesStateMember us-gaap:SubsequentEventMember 2020-04-27 0000764180 mo:HealthCareCostRecoveryActions2013NPMAdjustmentMember mo:PhilipMorrisUSAMember 2020-01-01 2020-03-31 0000764180 mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember mo:PhilipMorrisUSAMember 1996-05-01 2020-03-31 0000764180 mo:FederalGovernmentsLawsuitMember 2006-08-01 2006-08-31 0000764180 mo:EngleProgenyCasesFederalMember us-gaap:SubsequentEventMember mo:PhilipMorrisUSAMember 2020-04-27 0000764180 mo:EngleProgenyCasesStateMember stpr:FL 2009-06-30 0000764180 mo:NonEngleProgenySmokingAndHealthCasePrincipeMember 2020-02-29 0000764180 mo:NonEngleProgenyCasesMember stpr:LA us-gaap:SubsequentEventMember mo:PhilipMorrisUSAMember 1999-01-01 2020-04-27 0000764180 mo:HealthCareCostRecoveryActionsMember mo:PhilipMorrisUSAMember 2017-01-01 2017-12-31 0000764180 mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:TX mo:PhilipMorrisUSAMember 1996-05-01 2020-03-31 0000764180 mo:EngleProgenyCasesMember 2000-07-31 0000764180 mo:IndividualSmokingAndHealthCasesMember stpr:FL us-gaap:PendingLitigationMember us-gaap:SubsequentEventMember 2020-04-27 0000764180 mo:HealthCareCostRecoveryActions2018NPMAdjustmentsMember mo:PhilipMorrisUSAMember 2020-01-01 2020-03-31 0000764180 mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:DC mo:PhilipMorrisUSAMember 1996-05-01 2020-03-31 0000764180 mo:HealthCareCostRecoveryActionsMember country:CA us-gaap:ThreatenedLitigationMember 2020-03-31 0000764180 mo:HealthCareCostRecoveryActions2015NPMAdjustmentsMember mo:PhilipMorrisUSAMember 2020-01-01 2020-03-31 0000764180 mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:NV mo:PhilipMorrisUSAMember 1996-05-01 2020-03-31 0000764180 mo:EvaporLitigationMember mo:PendingLawsuitFiledBySchoolDistrictMember us-gaap:SubsequentEventMember 2020-04-27 0000764180 mo:ETSSmokingandHealthCaseFlightAttendantsMember us-gaap:PendingLitigationMember 2018-03-01 2018-03-31 0000764180 mo:HealthCareCostRecoveryActionsMember mo:PhilipMorrisUSAMember 2018-01-01 2018-12-31 0000764180 mo:LightsMember us-gaap:SubsequentEventMember 2020-04-27 0000764180 mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:NY mo:PhilipMorrisUSAMember 1996-05-01 2020-03-31 0000764180 mo:EngleProgenyCasesGoreMember mo:PhilipMorrisUSAMember 2020-01-01 2020-03-31 0000764180 mo:LightsMember us-gaap:SubsequentEventMember mo:PhilipMorrisUSAMember 2020-04-27 0000764180 mo:EngleProgenyCasesMember mo:PhilipMorrisUSAMember 2006-07-01 2006-07-31 0000764180 mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:NJ mo:PhilipMorrisUSAMember 1996-05-01 2020-03-31 0000764180 mo:NonEngleProgenyCasesMember stpr:PA us-gaap:SubsequentEventMember mo:PhilipMorrisUSAMember 1999-01-01 2020-04-27 0000764180 mo:NonEngleProgenyCasesMember stpr:AK us-gaap:SubsequentEventMember mo:PhilipMorrisUSAMember 1999-01-01 2020-04-27 0000764180 mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:DE mo:PhilipMorrisUSAMember 1996-05-01 2020-03-31 0000764180 mo:NonEngleProgenyCasesMember stpr:MO us-gaap:SubsequentEventMember mo:PhilipMorrisUSAMember 1999-01-01 2020-04-27 0000764180 mo:NonEngleProgenyCasesMember stpr:FL us-gaap:SubsequentEventMember mo:PhilipMorrisUSAMember 1999-01-01 2020-04-27 0000764180 mo:EngleProgenyCasesJordanMember mo:PhilipMorrisUSAMember 2018-04-01 2018-06-30 0000764180 mo:NonEngleProgenySmokingandHealthCaseGreeneMember 2019-09-30 0000764180 mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:OH mo:PhilipMorrisUSAMember 1996-05-01 2020-03-31 0000764180 mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:MN mo:PhilipMorrisUSAMember 1996-05-01 2020-03-31 0000764180 mo:EngleProgenyCasesPearsonDCohenCollarChaconMemberMember us-gaap:SubsequentEventMember mo:PhilipMorrisUSAMember 2020-04-27 2020-04-27 0000764180 mo:PreTrialResolutionMember 2020-03-31 0000764180 mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember country:PR mo:PhilipMorrisUSAMember 1996-05-01 2020-03-31 0000764180 mo:EngleProgenyCasesMember mo:PhilipMorrisUSAMember 2000-07-31 0000764180 mo:HealthCareCostRecoveryActions2011NPMAdjustmentMember mo:PhilipMorrisUSAMember 2020-01-01 2020-03-31 0000764180 mo:HealthCareCostRecoveryActions2003NPMAdjustmentMember us-gaap:CostOfSalesMember us-gaap:PendingLitigationMember mo:PhilipMorrisUSAMember 2013-09-01 2013-09-30 0000764180 mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:IA mo:PhilipMorrisUSAMember 1996-05-01 2020-03-31 0000764180 mo:HealthCareCostRecoveryActions2012NPMAdjustmentMember mo:PhilipMorrisUSAMember 2020-01-01 2020-03-31 0000764180 mo:EngleProgenyCasesPollariMember us-gaap:SubsequentEventMember mo:PhilipMorrisUSAMember 2020-04-27 2020-04-27 0000764180 mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:FL mo:PhilipMorrisUSAMember 1996-05-01 2020-03-31 0000764180 mo:HealthCareCostRecoveryActions20042017Member us-gaap:SettledLitigationMember mo:PhilipMorrisUSAMember 2018-01-01 2018-03-31 0000764180 mo:FederalGovernmentsLawsuitMember mo:ImplementationofCorrectiveCommunicationsMember 2019-10-01 2019-12-31 0000764180 mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember stpr:MD mo:PhilipMorrisUSAMember 1996-05-01 2020-03-31 0000764180 mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember country:CA mo:CanadianTobaccoManufacturersMember 2019-03-01 2019-03-31 0000764180 mo:CreditAgreementMember us-gaap:RevolvingCreditFacilityMember 2020-03-31 0000764180 mo:HealthCareCostRecoveryActions2003NPMAdjustmentMember us-gaap:SettledLitigationMember mo:PhilipMorrisUSAMember 2013-09-01 2013-09-30 0000764180 mo:EngleProgenyCasesJordanMember us-gaap:SettledLitigationMember mo:PhilipMorrisUSAMember 2018-04-01 2018-06-30 0000764180 mo:EngleProgenyCasesWallaceMember us-gaap:SettledLitigationMember mo:PhilipMorrisUSAMember 2019-04-01 2019-06-30 0000764180 mo:EngleProgenyCasesJ.BrownMember us-gaap:SettledLitigationMember mo:PhilipMorrisUSAMember 2019-01-01 2019-03-31 0000764180 mo:EngleProgenyCasesM.BrownMember us-gaap:SettledLitigationMember mo:PhilipMorrisUSAMember 2018-04-01 2018-06-30 0000764180 mo:EngleProgenyCasesDanielsonMember us-gaap:SettledLitigationMember mo:PhilipMorrisUSAMember 2019-01-01 2019-03-31 0000764180 mo:EngleProgenyCasesS.MartinMember us-gaap:SettledLitigationMember mo:PhilipMorrisUSAMember 2019-01-01 2019-03-31 0000764180 mo:EngleProgenyCasesPardueMember us-gaap:SettledLitigationMember mo:PhilipMorrisUSAMember 2018-04-01 2018-09-30 0000764180 mo:EngleProgenyCasesZingaroMember us-gaap:SettledLitigationMember mo:PhilipMorrisUSAMember 2019-07-01 2019-09-30 0000764180 mo:EngleProgenyCasesBoatrightMember us-gaap:SettledLitigationMember mo:PhilipMorrisUSAMember 2018-04-01 2018-06-30 0000764180 mo:EngleProgenyCasesBryantMember us-gaap:SettledLitigationMember mo:PhilipMorrisUSAMember 2019-04-01 2019-06-30 0000764180 mo:EngleProgenyCasesTheisMember us-gaap:SettledLitigationMember mo:PhilipMorrisUSAMember 2020-01-01 2020-03-31 0000764180 mo:EngleProgenyCasesSearcyMember us-gaap:SettledLitigationMember mo:PhilipMorrisUSAMember 2018-07-01 2018-09-30 0000764180 mo:EngleProgenyCasesAlvarezdelRealMember us-gaap:SettledLitigationMember mo:PhilipMorrisUSAMember 2019-10-01 2019-12-31 0000764180 mo:EngleProgenyCasesL.MartinMember us-gaap:SettledLitigationMember mo:PhilipMorrisUSAMember 2019-01-01 2019-03-31 0000764180 mo:EngleProgenyCasesMcKeeverMember us-gaap:SettledLitigationMember mo:PhilipMorrisUSAMember 2017-10-01 2017-12-31 0000764180 mo:EngleProgenyCasesRintoulMember us-gaap:PendingLitigationMember mo:PhilipMorrisUSAMember 2019-11-30 0000764180 mo:EngleProgenyCasesD.BrownMember us-gaap:PendingLitigationMember mo:PhilipMorrisUSAMember 2015-01-31 0000764180 mo:EngleProgenyCasesLandiMember us-gaap:PendingLitigationMember mo:PhilipMorrisUSAMember 2018-06-30 0000764180 mo:EngleProgenyCasesKerrivanMember us-gaap:PendingLitigationMember 2014-10-31 0000764180 mo:EngleProgenyCasesChadwellMember us-gaap:PendingLitigationMember mo:PhilipMorrisUSAMember 2018-09-30 0000764180 mo:EngleProgenyCasesCuddiheeMember us-gaap:PendingLitigationMember mo:PhilipMorrisUSAMember 2020-01-31 0000764180 mo:EngleProgenyCasesNeffMember us-gaap:PendingLitigationMember mo:PhilipMorrisUSAMember 2019-03-31 0000764180 mo:EngleProgenyCasesMcCallMember us-gaap:PendingLitigationMember 2019-03-31 0000764180 mo:EngleProgenyCasesHollimanMember us-gaap:PendingLitigationMember 2019-02-28 0000764180 mo:EngleProgenyCasesSantoroMember us-gaap:PendingLitigationMember mo:PhilipMorrisUSAMember 2017-03-31 0000764180 mo:EngleProgenyCasesHarrisMember us-gaap:PendingLitigationMember 2014-07-31 0000764180 mo:EngleProgenyCasesFrogelMember us-gaap:PendingLitigationMember mo:PhilipMorrisUSAMember 2019-03-31 0000764180 mo:EngleProgenyCasesCooperMember us-gaap:PendingLitigationMember 2015-09-30 0000764180 mo:EngleProgenyCasesHarrisMember us-gaap:PendingLitigationMember mo:PhilipMorrisUSAMember 2014-07-31 0000764180 mo:EngleProgenyCasesKerrivanMember us-gaap:PendingLitigationMember mo:PhilipMorrisUSAMember 2014-10-31 0000764180 mo:EngleProgenyCasesDuignanMember us-gaap:PendingLitigationMember mo:PhilipMorrisUSAMember 2020-02-29 0000764180 mo:EngleProgenyCasesR.DouglasMember us-gaap:PendingLitigationMember mo:PhilipMorrisUSAMember 2017-11-30 0000764180 mo:EngleProgenyCasesSommersMember us-gaap:PendingLitigationMember 2017-04-30 0000764180 mo:EngleProgenyCasesLandiMember us-gaap:PendingLitigationMember 2018-06-30 0000764180 mo:EngleProgenyCasesMahfuzMember us-gaap:PendingLitigationMember mo:PhilipMorrisUSAMember 2019-02-28 0000764180 mo:EngleProgenyCasesMcCallMember us-gaap:PendingLitigationMember mo:PhilipMorrisUSAMember 2019-03-31 0000764180 mo:EngleProgenyCasesSantoroMember us-gaap:PendingLitigationMember 2017-03-31 0000764180 mo:EngleProgenyCasesChadwellMember us-gaap:PendingLitigationMember 2018-09-30 0000764180 mo:EngleProgenyCasesGlogerMember us-gaap:PendingLitigationMember 2019-11-30 0000764180 mo:EngleProgenyCasesHollimanMember us-gaap:PendingLitigationMember mo:PhilipMorrisUSAMember 2019-02-28 0000764180 mo:EngleProgenyCasesKaplanMember us-gaap:PendingLitigationMember mo:PhilipMorrisUSAMember 2018-07-31 0000764180 mo:EngleProgenyCasesDuignanMember us-gaap:PendingLitigationMember 2020-02-29 0000764180 mo:EngleProgenyCasesR.DouglasMember us-gaap:PendingLitigationMember 2017-11-30 0000764180 mo:EngleProgenyCasesCooperMember us-gaap:PendingLitigationMember mo:PhilipMorrisUSAMember 2015-09-30 0000764180 mo:EngleProgenyCasesRintoulMember us-gaap:PendingLitigationMember 2019-11-30 0000764180 mo:EngleProgenyCasesFrogelMember us-gaap:PendingLitigationMember 2019-03-31 0000764180 mo:EngleProgenyCasesGlogerMember us-gaap:PendingLitigationMember mo:PhilipMorrisUSAMember 2019-11-30 0000764180 mo:EngleProgenyCasesSommersMember us-gaap:PendingLitigationMember mo:PhilipMorrisUSAMember 2017-04-30 0000764180 mo:EngleProgenyCasesCuddiheeMember us-gaap:PendingLitigationMember 2020-01-31 0000764180 mo:EngleProgenyCasesBergerMember us-gaap:PendingLitigationMember mo:PhilipMorrisUSAMember 2014-09-30 0000764180 mo:EngleProgenyCasesBergerMember us-gaap:PendingLitigationMember 2014-09-30 0000764180 mo:EngleProgenyCasesBergerMember us-gaap:PendingLitigationMember 2018-10-01 2018-12-31 0000764180 srt:GuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2019-12-31 0000764180 srt:ParentCompanyMember srt:ReportableLegalEntitiesMember 2019-12-31 0000764180 srt:ConsolidationEliminationsMember 2019-12-31 0000764180 srt:NonGuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2019-12-31 0000764180 srt:NonGuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2020-03-31 0000764180 srt:ConsolidationEliminationsMember 2020-03-31 0000764180 srt:GuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2020-03-31 0000764180 srt:ParentCompanyMember srt:ReportableLegalEntitiesMember 2020-03-31 0000764180 srt:ParentCompanyMember srt:ReportableLegalEntitiesMember 2019-01-01 2019-03-31 0000764180 srt:ConsolidationEliminationsMember 2019-01-01 2019-03-31 0000764180 srt:GuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2019-01-01 2019-03-31 0000764180 srt:NonGuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2019-01-01 2019-03-31 0000764180 srt:ParentCompanyMember srt:ReportableLegalEntitiesMember 2020-01-01 2020-03-31 0000764180 srt:NonGuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2020-01-01 2020-03-31 0000764180 srt:GuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2020-01-01 2020-03-31 0000764180 srt:ConsolidationEliminationsMember 2020-01-01 2020-03-31 0000764180 srt:GuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2018-12-31 0000764180 srt:NonGuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2018-12-31 0000764180 srt:ConsolidationEliminationsMember 2019-03-31 0000764180 srt:NonGuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2019-03-31 0000764180 srt:ConsolidationEliminationsMember 2018-12-31 0000764180 srt:ParentCompanyMember srt:ReportableLegalEntitiesMember 2018-12-31 0000764180 srt:GuarantorSubsidiariesMember srt:ReportableLegalEntitiesMember 2019-03-31 0000764180 srt:ParentCompanyMember srt:ReportableLegalEntitiesMember 2019-03-31 mo:case mo:year iso4217:USD mo:director iso4217:CAD shares iso4217:CAD mo:state mo:Extension mo:board_member iso4217:EUR shares iso4217:USD shares shares mo:lawsuit pure mo:ruling mo:settlement_development mo:manufacture mo:claim mo:shareholder mo:court mo:plantiff false --12-31 Q1 2020 0000764180 0 0 P1Y 0 6000000 1000000 5000000 2000000 8000000 2000000 1000000 1000000 4000000 1000000 1000000 1000000 2000000 16000000 8000000 1000000 1000000 2000000 12000000 3000000 5000000 5000000 15000000 9000000 3000000 3000000 2 21000000 0 0 5000000 0 0 1000000 2000000 0 16000000 9000000 0 0 2000000 0 10000000 11000000 74000000 12000000 0 0.80 0.84 0.3333 0.3333 2805961317 2805961317 P5Y 1.67 3.18 1.60 2.93 2246000000 1000000000 4205000000 6000000 11000000 21000000 0 11000000 8000000 2000000 3000000 4000000 2000000 5000000 1000000 26000000 1000000 1000000 17000000 1000000 947979763 947593259 10-Q true 2020-03-31 false 1-08940 Altria Group, Inc. VA 13-3260245 6601 West Broad Street, Richmond, VA 23230 804 274-2200 Common Stock, $0.33 1/3 par value MO NYSE 1.000% Notes due 2023 MO23A NYSE 1.700% Notes due 2025 MO25 NYSE 2.200% Notes due 2027 MO27 NYSE 3.125% Notes due 2031 MO31 NYSE Yes Yes Large Accelerated Filer false false false 1858368058 5616000000 2117000000 147000000 152000000 895000000 874000000 193000000 192000000 467000000 696000000 451000000 531000000 2006000000 2293000000 166000000 262000000 7935000000 4824000000 5103000000 5074000000 3106000000 3075000000 1997000000 1999000000 5177000000 5177000000 12668000000 12687000000 23861000000 23581000000 980000000 1003000000 52618000000 49271000000 3000000000 0 0 1000000000 278000000 325000000 467000000 393000000 4419000000 3346000000 1032000000 1533000000 393000000 12000000 1565000000 1565000000 11154000000 8174000000 26971000000 27042000000 5191000000 5083000000 427000000 473000000 1798000000 1797000000 402000000 345000000 45943000000 42914000000 38000000 38000000 935000000 935000000 5959000000 5970000000 36528000000 36539000000 -2533000000 -2864000000 34346000000 34358000000 6543000000 6222000000 94000000 97000000 6637000000 6319000000 52618000000 49271000000 6359000000 5628000000 2173000000 1578000000 1313000000 1239000000 2873000000 2811000000 537000000 533000000 0 40000000 2336000000 2238000000 -275000000 -384000000 -27000000 -1000000 157000000 86000000 -137000000 -425000000 2108000000 1516000000 558000000 395000000 1550000000 1121000000 -2000000 1000000 1552000000 1120000000 0.83 0.60 1550000000 1121000000 -21000000 -29000000 298000000 -199000000 12000000 0 331000000 -170000000 1881000000 951000000 -2000000 1000000 1883000000 950000000 935000000 5970000000 36539000000 -2864000000 -34358000000 97000000 6319000000 1552000000 -3000000 1549000000 331000000 331000000 -11000000 12000000 1000000 1563000000 1563000000 935000000 5959000000 36528000000 -2533000000 -34346000000 94000000 6637000000 935000000 5961000000 43962000000 -2547000000 -33524000000 2000000 14789000000 1120000000 1120000000 -170000000 -170000000 -18000000 11000000 -7000000 1500000000 1500000000 151000000 151000000 935000000 5943000000 43582000000 -2717000000 -33664000000 2000000 14081000000 1000000 1550000000 1121000000 65000000 53000000 26000000 -72000000 157000000 86000000 -137000000 -425000000 -23000000 17000000 -5000000 16000000 5000000 25000000 -45000000 -189000000 495000000 471000000 421000000 513000000 1073000000 913000000 4000000 3000000 -20000000 -8000000 -453000000 -201000000 3129000000 2289000000 52000000 38000000 0 1831000000 0 81000000 -52000000 -1950000000 3000000000 0 0 12800000000 0 16265000000 1000000000 0 0 151000000 1563000000 1502000000 -10000000 -129000000 427000000 1683000000 3504000000 2022000000 2160000000 1433000000 5664000000 3455000000 5616000000 2117000000 3000000 0 45000000 43000000 5664000000 2160000000 Background and Basis of Presentation:<div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Background </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">When used in these notes, the term "Altria” refers to Altria Group, Inc. and its subsidiaries, unless otherwise specified or unless otherwise required.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">At </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">, Altria Group, Inc.’s wholly-owned subsidiaries included Philip Morris USA Inc. (“PM USA”), which is engaged in the manufacture and sale of cigarettes in the United States; John Middleton Co. (“Middleton”), which is engaged in the manufacture and sale of machine-made large cigars and pipe tobacco and is a wholly-owned subsidiary of PM USA; Sherman Group Holdings, LLC and its subsidiaries (“Nat Sherman”), which are engaged in the manufacture and sale of super premium cigarettes and the sale of premium cigars; UST LLC (“UST”), which through its wholly-owned subsidiaries, including U.S. Smokeless Tobacco Company LLC (“USSTC”) and Ste. Michelle Wine Estates Ltd. (“Ste. Michelle”), is engaged in the manufacture and sale of moist smokeless tobacco (“MST”) and snus products and wine; and Philip Morris Capital Corporation (“PMCC”), which maintains a portfolio of finance assets, substantially all of which are leveraged leases. In addition, Altria owned an </span><span style="font-family:inherit;font-size:10pt;"><span>80%</span></span><span style="font-family:inherit;font-size:10pt;"> interest in Helix Innovations LLC (“Helix”), which is engaged in the manufacture and sale of oral nicotine pouches. Other Altria wholly-owned subsidiaries included Altria Group Distribution Company, which provides sales and distribution services to certain Altria operating subsidiaries, and Altria Client Services LLC, which provides various support services in areas such as legal, regulatory, consumer engagement, finance, human resources and external affairs to Altria and its subsidiaries. Altria’s access to the operating cash flows of its wholly-owned subsidiaries consists of cash received from the payment of dividends and distributions, and the payment of interest on intercompany loans by its subsidiaries. At </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">, Altria’s significant wholly-owned subsidiaries were not limited by long-term debt or other agreements in their ability to pay cash dividends or make other distributions with respect to their equity interests. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">At </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">, Altria had a </span><span style="font-family:inherit;font-size:10pt;"><span>10.1%</span></span><span style="font-family:inherit;font-size:10pt;"> ownership in Anheuser-Busch InBev SA/NV (“ABI”), which Altria accounts for under the equity method of accounting using a one-quarter lag. Altria receives cash dividends on its interest in ABI and will continue to do so as long as ABI pays dividends. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">At </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">, Altria had a </span><span style="font-family:inherit;font-size:10pt;"><span>35%</span></span><span style="font-family:inherit;font-size:10pt;"> economic interest in JUUL Labs, Inc. (“JUUL”), which Altria accounts for as an investment in an equity security. JUUL is engaged in the manufacture and sale of e-vapor products globally and is the U.S. leader in e-vapor.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">During the third quarter of 2019, Helix acquired Burger Söhne Holding and its subsidiaries as well as certain affiliated companies (the “Burger Group”) that are engaged in the manufacture and sale of </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">on!</span><span style="font-family:inherit;font-size:10pt;"> oral nicotine pouches. At closing, Altria indirectly owned an </span><span style="font-family:inherit;font-size:10pt;"><span>80%</span></span><span style="font-family:inherit;font-size:10pt;"> interest in Helix, for which Altria paid </span><span style="font-family:inherit;font-size:10pt;"><span>$353 million</span></span><span style="font-family:inherit;font-size:10pt;"> in third quarter of 2019. The financial results of Helix are included in Altria’s condensed consolidated financial statements as part of its oral tobacco products segment (formerly smokeless products segment), with the </span><span style="font-family:inherit;font-size:10pt;"><span>20%</span></span><span style="font-family:inherit;font-size:10pt;"> minority ownership interest in Helix (held by the former shareholders of the Burger Group) included as a noncontrolling interest. The final purchase price allocation, which is subject to post-closing adjustments, will be completed by the third quarter of 2020.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In March 2019, Altria completed its acquisition of a </span><span style="font-family:inherit;font-size:10pt;"><span>45%</span></span><span style="font-family:inherit;font-size:10pt;"> ownership in Cronos Group Inc. (“Cronos”), a global cannabinoid company headquartered in Toronto, Canada. At </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">, Altria had a </span><span style="font-family:inherit;font-size:10pt;"><span>45%</span></span><span style="font-family:inherit;font-size:10pt;"> ownership in Cronos, which Altria accounts for under the equity method of accounting using a one-quarter lag. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For further discussion of Altria’s investments in equity securities, see </span><span style="font-family:inherit;font-size:10pt;">Note 4</span><span style="font-family:inherit;font-size:10pt;">. </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Investments in Equity Securities</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Share Repurchases </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In January 2018, Altria’s Board of Directors (the “Board of Directors”) authorized a new </span><span style="font-family:inherit;font-size:10pt;"><span>$1.0 billion</span></span><span style="font-family:inherit;font-size:10pt;"> share repurchase program that it expanded to </span><span style="font-family:inherit;font-size:10pt;"><span>$2.0 billion</span></span><span style="font-family:inherit;font-size:10pt;"> in May 2018 (as expanded, the “January 2018 share repurchase program”). In June 2019, Altria completed the January 2018 share repurchase program, under which it purchased a total of </span><span style="font-family:inherit;font-size:10pt;"><span>34.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> shares of its common stock at an average price of </span><span style="font-family:inherit;font-size:10pt;"><span>$58.86</span></span><span style="font-family:inherit;font-size:10pt;"> per share. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In July 2019, the Board of Directors authorized a new </span><span style="font-family:inherit;font-size:10pt;"><span>$1.0 billion</span></span><span style="font-family:inherit;font-size:10pt;"> share repurchase program (the “July 2019 share repurchase program”). During the first quarter of 2020, there were </span><span style="font-family:inherit;font-size:10pt;"><span>no</span></span><span style="font-family:inherit;font-size:10pt;"> share repurchases made under the July 2019 share repurchase program. In April 2020, the Board of Directors rescinded the </span><span style="font-family:inherit;font-size:10pt;"><span>$500 million</span></span><span style="font-family:inherit;font-size:10pt;"> remaining in the July 2019 share repurchase program to strengthen Altria’s liquidity position amidst the COVID-19 pandemic.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Altria’s share repurchase activity for the three months ended March 31, 2019 was as follows:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:75%;"/><td style="width:3%;"/><td style="width:1%;"/><td style="width:20%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions, except per share data)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total number of shares repurchased</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Aggregate cost of shares repurchased</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>151</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Average price per share of shares repurchased</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>56.34</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis of Presentation</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The interim condensed consolidated financial statements of Altria are unaudited. It is the opinion of Altria’s management that all adjustments necessary for a fair statement of the interim results presented have been reflected in the interim condensed consolidated financial statements. All such adjustments were of a normal recurring nature. Net revenues and net earnings for any interim period are not necessarily indicative of results that may be expected for the entire year.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In the first quarter of 2020, Altria renamed its smokeless products segment as the oral tobacco products segment.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">These statements should be read in conjunction with the audited consolidated financial statements and related notes, which appear in Altria’s Annual Report on Form 10-K for the year ended December 31, 2019.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On January 1, 2020, Altria adopted Accounting Standards Update (“ASU”) No. 2016-13, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Measurement of Credit Losses on Financial Instruments </span><span style="font-family:inherit;font-size:10pt;">and all related ASU amendments</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> </span><span style="font-family:inherit;font-size:10pt;">(collectively “ASU No. 2016-13”). This guidance replaces the current incurred loss impairment methodology for recognizing credit losses for financial assets with a methodology that reflects the entity’s current estimate of all expected credit losses and requires consideration of a broader range of reasonable and supportable information for estimating credit losses. The adoption of ASU No. 2016-13 did not have a material impact on Altria’s condensed consolidated financial statements.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Additionally, on January 1, 2020, Altria adopted ASU No. 2018-15, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="font-family:inherit;font-size:10pt;"> (“ASU No. 2018-15”). This guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The adoption of ASU No. 2018-15 did not have a material impact on Altria’s condensed consolidated financial statements.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For a description of issued accounting guidance applicable to, but not yet adopted by, Altria, see </span><span style="font-family:inherit;font-size:10pt;">Note 13</span><span style="font-family:inherit;font-size:10pt;">. </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">New Accounting Guidance Not Yet Adopted</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Certain immaterial prior year amounts have been reclassified to conform with the current year’s presentation.</span></div> 0.80 0.101 0.35 0.80 353000000 0.20 0.45 0.45 1000000000.0 2000000000.0 34000000.0 58.86 1000000000.0 0 500000000 <div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Altria’s share repurchase activity for the three months ended March 31, 2019 was as follows:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:75%;"/><td style="width:3%;"/><td style="width:1%;"/><td style="width:20%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions, except per share data)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total number of shares repurchased</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Aggregate cost of shares repurchased</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>151</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Average price per share of shares repurchased</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>56.34</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 2700000 151000000 56.34 <div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On January 1, 2020, Altria adopted Accounting Standards Update (“ASU”) No. 2016-13, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Measurement of Credit Losses on Financial Instruments </span><span style="font-family:inherit;font-size:10pt;">and all related ASU amendments</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> </span><span style="font-family:inherit;font-size:10pt;">(collectively “ASU No. 2016-13”). This guidance replaces the current incurred loss impairment methodology for recognizing credit losses for financial assets with a methodology that reflects the entity’s current estimate of all expected credit losses and requires consideration of a broader range of reasonable and supportable information for estimating credit losses. The adoption of ASU No. 2016-13 did not have a material impact on Altria’s condensed consolidated financial statements.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Additionally, on January 1, 2020, Altria adopted ASU No. 2018-15, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="font-family:inherit;font-size:10pt;"> (“ASU No. 2018-15”). This guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The adoption of ASU No. 2018-15 did not have a material impact on Altria’s condensed consolidated financial statements.</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:18%;"/><td style="width:28%;"/><td style="width:29%;"/><td style="width:25%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Standards</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Description</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Effective Date for Public Entity</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Effect on Financial Statements </span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">ASU 2019-12 </span><span style="font-family:inherit;font-size:9pt;font-style:italic;">Simplifying the Accounting for Income Taxes (Topic 740)</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">The guidance removes certain exceptions for investments, intraperiod allocations and interim calculations, and adds guidance to reduce complexity in accounting for income taxes. </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early application is permitted, including adoption in any interim period. </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Altria is in the process of evaluating the impact of this guidance on its consolidated financial statements and related disclosures. </span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">ASU 2020-01 </span><span style="font-family:inherit;font-size:9pt;font-style:italic;">Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">The guidance provides clarification of the interaction of rules for equity securities, the equity method of accounting, and forward contracts and purchase options on certain types of securities. </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early application is permitted, including adoption in any interim period. </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Altria is in the process of evaluating the impact of this guidance on its consolidated financial statements and related disclosures.</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> Revenues from Contracts with Customers:<div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Altria disaggregates net revenues based on product type. For further discussion, see </span><span style="font-family:inherit;font-size:10pt;">Note 9</span><span style="font-family:inherit;font-size:10pt;">. </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Segment Reporting</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Altria’s businesses offer cash discounts to customers for prompt payment and calculate cash discounts as a percentage of the list price based on historical experience and agreed-upon payment terms. Altria’s businesses record an allowance for cash discounts, which is included as a contra-asset against receivables on Altria’s condensed consolidated balance sheets. Cash discounts at </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> were de minimis, and there were </span><span style="font-family:inherit;font-size:10pt;">no</span><span style="font-family:inherit;font-size:10pt;"> differences between amounts recorded as an allowance for cash discounts and cash discounts subsequently given to customers.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Altria’s businesses that receive payments in advance of product shipment record such payments as deferred revenue. These payments are included in other accrued liabilities on Altria’s condensed consolidated balance sheets until control of such products is obtained by the customer. Deferred revenue was </span><span style="font-family:inherit;font-size:10pt;"><span>$219 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$362 million</span></span><span style="font-family:inherit;font-size:10pt;"> at </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, respectively. When cash is received in advance of product shipment, Altria’s businesses satisfy their performance </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">obligations within </span><span style="font-family:inherit;font-size:10pt;"><span>three days</span></span><span style="font-family:inherit;font-size:10pt;"> of receiving payment. At </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, there were </span><span style="font-family:inherit;font-size:10pt;">no</span><span style="font-family:inherit;font-size:10pt;"> differences between amounts recorded as deferred revenue and amounts subsequently recognized as revenue.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receivables, which primarily reflect sales of wine produced and/or distributed by Ste. Michelle, were </span><span style="font-family:inherit;font-size:10pt;"><span>$147 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$152 million</span></span><span style="font-family:inherit;font-size:10pt;"> at </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, respectively. At </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, there were </span><span style="font-family:inherit;font-size:10pt;">no</span><span style="font-family:inherit;font-size:10pt;"> expected differences between amounts recorded and subsequently received, and Altria’s businesses did not record an allowance for doubtful accounts against these receivables.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Altria’s businesses record an allowance for returned goods, which is included in other accrued liabilities on Altria’s condensed consolidated balance sheets. While all of Altria’s tobacco operating companies sell tobacco products with dates relative to freshness as printed on product packaging, it is USSTC’s policy to accept authorized sales returns from its customers for products that have passed such dates due to the limited shelf life of USSTC’s MST and snus products. Altria’s businesses record estimated sales returns, which are based principally on historical volume and return rates, as a reduction to revenues. Actual sales returns will differ from estimated sales returns to the extent actual results differ from estimated assumptions. Altria’s businesses reflect differences between actual and estimated sales returns in the period in which the actual amounts become known. These differences, if any, have not had a material impact on Altria’s condensed consolidated financial statements. All returned goods are destroyed upon return and not included in inventory. Consequently, Altria’s businesses do not record an asset for their right to recover goods from customers upon return.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Sales incentives include variable payments related to goods sold by Altria’s businesses. Altria’s businesses include estimates of variable consideration as a reduction to revenues upon shipment of goods to customers. The sales incentives that require significant estimates and judgments are as follows:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Price promotion payments- </span><span style="font-family:inherit;font-size:10pt;">Altria’s businesses make price promotion payments, substantially all of which are made to their retail partners, to incent the promotion of certain product offerings in select geographic areas. </span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Wholesale and retail participation payments-</span><span style="font-family:inherit;font-size:10pt;"> Altria’s businesses make payments to their wholesale and retail partners to incent merchandising and sharing of sales data in accordance with each business’s trade agreements.</span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">These estimates primarily include estimated wholesale to retail sales volume and historical acceptance rates. Actual payments will differ from estimated payments to the extent actual results differ from estimated assumptions. Differences between actual and estimated payments are reflected in the period such information becomes available. These differences, if any, have not had a material impact on Altria’s condensed consolidated financial statements.</span></div> 219000000 362000000 three days 147000000 152000000 Asset Impairment, Exit and Implementation Costs:<div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pre-tax asset impairment, exit and implementation costs consisted of the following:</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;text-align:-moz-right;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;margin-left:auto;margin-right:0;"><tr><td colspan="21"/></tr><tr><td style="width:34%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:5%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31, </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Implementation Costs </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Asset Impairment and Exit Costs</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Implementation Costs </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="20" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Smokeable products</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>44</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Oral tobacco products</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Wine</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>392</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>392</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">All other</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">General corporate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>392</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>392</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>40</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>49</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Plus amounts included in net periodic benefit income, excluding service cost </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>392</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>392</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>52</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>61</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-left:18px;text-indent:-18px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(1) Included in cost of sales for 2020 and marketing, administration and research costs for 2019 in Altria’s condensed consolidated statements of earnings.</span></div><div style="line-height:120%;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(2) Represents curtailment costs. See </span><span style="font-family:inherit;font-size:9pt;">Note 6</span><span style="font-family:inherit;font-size:9pt;">. </span><span style="font-family:inherit;font-size:9pt;font-style:italic;">Benefit Plans</span><span style="font-family:inherit;font-size:9pt;">.</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:58%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:10%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Implementation costs for 2020 were related to Ste. Michelle’s inventory-related charges, as discussed below. The 2019 pre-tax asset impairment, exit and implementation costs were related to the cost reduction program, which was completed in 2019. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The movement in the restructuring liabilities, substantially all of which were severance liabilities, related to the cost reduction program was as follows:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:74%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balances at December 31, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>67</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Charges</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash spent</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(23</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balances at March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>44</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Wine Business Strategic Reset</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Evolving adult consumer preferences have posed strategic challenges for Ste. Michelle, which has seen slowing growth in the wine category and increased inventory levels in recent periods. Against a backdrop of product volume demand uncertainty and long-term non-cancelable grape purchase commitments, which have been further negatively impacted by the economic uncertainty surrounding the COVID-19 pandemic, Ste. Michelle has experienced additional increases in inventory levels that at March 31, 2020 significantly exceed long-term forecasted demand. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As a result, in connection with the preparation of Altria’s first quarter financial statements, Ste. Michelle recorded pre-tax charges of </span><span style="font-family:inherit;font-size:10pt;"><span>$392 million</span></span><span style="font-family:inherit;font-size:10pt;">, which were included in cost of sales in Altria’s condensed consolidated statement of earnings for the three months ended March 31, 2020. The charges consisted of the following: (i) write-off of inventory (</span><span style="font-family:inherit;font-size:10pt;"><span>$292 million</span></span><span style="font-family:inherit;font-size:10pt;">) as Ste. Michelle no longer believes that the benefit of the blending and production plans for its inventory outweighs inventory carrying cost given the reduced product volume demand; and (ii) estimated losses on future non-cancelable grape purchase commitments that Ste. Michelle believes no longer have a future economic benefit (</span><span style="font-family:inherit;font-size:10pt;"><span>$100 million</span></span><span style="font-family:inherit;font-size:10pt;">). Such commitments will continue to require cash payments as grape commitments are fulfilled over the next </span><span style="font-family:inherit;font-size:10pt;"><span>five years</span></span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Given such uncertainty in economic conditions and product volume demand, as well as long-term supply-side contractual challenges, Altria and Ste. Michelle undertook a review of the wine business. As a result, Altria and Ste. Michelle implemented a strategic reset in order to maximize Ste. Michelle’s profitability and achieve improved long-term cash-flow generation. This strategic reset includes: (i) an updated approach to forecasting demand; (ii) supply chain optimization; (iii) SKU rationalization to reduce the number of products and eliminate underperforming brands; and (iv) streamlining operations by reducing future capital expenditures, working capital requirements and ongoing operating costs. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span style="font-family:inherit;font-size:10pt;">Additionally, Ste. Michelle expects to record additional charges of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$25 million</span></span> during the remainder of 2020, consisting of inventory disposal costs and other charges. <div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pre-tax asset impairment, exit and implementation costs consisted of the following:</span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;text-align:-moz-right;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;margin-left:auto;margin-right:0;"><tr><td colspan="21"/></tr><tr><td style="width:34%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:5%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31, </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Implementation Costs </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Asset Impairment and Exit Costs</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Implementation Costs </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="20" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Smokeable products</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>44</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Oral tobacco products</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Wine</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>392</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>392</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">All other</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">General corporate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>392</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>392</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>40</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>49</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Plus amounts included in net periodic benefit income, excluding service cost </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>392</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>392</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>52</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>61</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-left:18px;text-indent:-18px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(1) Included in cost of sales for 2020 and marketing, administration and research costs for 2019 in Altria’s condensed consolidated statements of earnings.</span></div><div style="line-height:120%;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(2) Represents curtailment costs. See </span><span style="font-family:inherit;font-size:9pt;">Note 6</span><span style="font-family:inherit;font-size:9pt;">. </span><span style="font-family:inherit;font-size:9pt;font-style:italic;">Benefit Plans</span><span style="font-family:inherit;font-size:9pt;">.</span></div> 0 0 36000000 8000000 44000000 0 0 8000000 1000000 9000000 392000000 392000000 0 0 0 0 0 -5000000 0 -5000000 0 0 1000000 0 1000000 392000000 392000000 40000000 9000000 49000000 0 0 12000000 0 12000000 392000000 392000000 52000000 9000000 61000000 <div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The movement in the restructuring liabilities, substantially all of which were severance liabilities, related to the cost reduction program was as follows:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:74%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balances at December 31, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>67</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Charges</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash spent</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(23</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balances at March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>44</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 67000000 0 23000000 44000000 392000000 292000000 100000000 P5Y 25000000 Investments in Equity Securities:<div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Altria’s investments consisted of the following:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:64%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Carrying Amount</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">ABI</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18,453</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18,071</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">JUUL</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,205</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,205</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cronos</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt"> (1)</sup></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,203</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,305</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23,861</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23,581</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;padding-left:18px;text-indent:-18px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(1)</span><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt"> </sup></span><span style="font-family:inherit;font-size:9pt;">March 31, 2020 includes Altria’s equity method investment in Cronos (</span><span style="font-family:inherit;font-size:9pt;"><span>$1,037 million</span></span><span style="font-family:inherit;font-size:9pt;">), the Cronos warrant (</span><span style="font-family:inherit;font-size:9pt;"><span>$132 million</span></span><span style="font-family:inherit;font-size:9pt;">) and the Fixed-price Preemptive Rights (</span><span style="font-family:inherit;font-size:9pt;"><span>$34 million</span></span><span style="font-family:inherit;font-size:9pt;">) and December 31, 2019 includes Altria’s equity method investment in Cronos (</span><span style="font-family:inherit;font-size:9pt;"><span>$1,002 million</span></span><span style="font-family:inherit;font-size:9pt;">), the Cronos warrant (</span><span style="font-family:inherit;font-size:9pt;"><span>$234 million</span></span><span style="font-family:inherit;font-size:9pt;">) and the Fixed -price Preemptive Rights (</span><span style="font-family:inherit;font-size:9pt;"><span>$69 million</span></span><span style="font-family:inherit;font-size:9pt;">), as discussed further below.</span></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Earnings from equity investments accounted for under the equity method of accounting consisted of the following:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:64%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">ABI</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>134</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>86</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cronos</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt"> (1)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>157</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>86</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;padding-left:18px;text-indent:-18px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(1)</span><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt"> </sup></span><span style="font-family:inherit;font-size:9pt;">Represents Altria’s share of Cronos’s earnings, which includes the change in fair value of Cronos’s derivative financial instruments associated with the issuance of additional shares. As a result of the acquisition of Cronos in March 2019 and Altria reporting its share of Cronos’s results using a one-quarter lag, no equity earnings from Altria’s investment in Cronos were recorded for the three months ended March 31, 2019.</span></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Altria reviews its equity investments accounted for under the equity method of accounting (ABI and Cronos) for impairment on a quarterly basis in connection with the preparation of its financial statements by comparing the fair value of each of its investments to its respective carrying value. If the carrying value of an investment exceeds its fair value and the loss in value is other than temporary, the investment is considered impaired and reduced to fair value, and the impairment is recognized in the period identified. For further discussion, see </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Investment in ABI</span><span style="font-family:inherit;font-size:10pt;"> and</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> Investment in Cronos</span><span style="font-family:inherit;font-size:10pt;"> below.</span></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Investment in ABI</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">At </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">, Altria had a </span><span style="font-family:inherit;font-size:10pt;"><span>10.1%</span></span><span style="font-family:inherit;font-size:10pt;"> ownership in ABI, consisting of </span><span style="font-family:inherit;font-size:10pt;"><span>185 million</span></span><span style="font-family:inherit;font-size:10pt;"> restricted shares of ABI (the “Restricted Shares”) and </span><span style="font-family:inherit;font-size:10pt;"><span>12 million</span></span><span style="font-family:inherit;font-size:10pt;"> ordinary shares of ABI. Altria accounts for its investment in ABI under the equity method of accounting because Altria has the ability to exercise significant influence over the operating and financial policies of ABI, including having active representation on ABI’s board of directors (“ABI Board”) and certain ABI Board committees. Through this representation, Altria participates in ABI policy making processes.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Altria reports its share of ABI’s results using a one-quarter lag because ABI’s results are not available in time for Altria to record them in the concurrent period.</span></div><div style="line-height:120%;padding-bottom:5px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The fair value of Altria’s equity investment in ABI is based on (i) unadjusted quoted prices in active markets for ABI’s ordinary shares and was classified in Level 1 of the fair value hierarchy and (ii) observable inputs other than Level 1 prices, such as quoted prices for similar assets for the Restricted Shares, and was classified in Level 2 of the fair value hierarchy. Altria may, in certain instances, pledge or otherwise grant a security interest in all or part of its Restricted Shares. In the event the pledgee or security interest holder forecloses on the Restricted Shares, the relevant Restricted Shares will be automatically converted, one-for-one, into ordinary shares. Therefore, the fair value of each Restricted Share is based on the value of an ordinary share. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The fair value of Altria’s equity investment in ABI at </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> was </span><span style="font-family:inherit;font-size:10pt;"><span>$8.8 billion</span></span><span style="font-family:inherit;font-size:10pt;"> (carrying value of </span><span style="font-family:inherit;font-size:10pt;"><span>$18.5 billion</span></span><span style="font-family:inherit;font-size:10pt;">) and </span><span style="font-family:inherit;font-size:10pt;"><span>$16.1 billion</span></span><span style="font-family:inherit;font-size:10pt;"> (carrying value of </span><span style="font-family:inherit;font-size:10pt;"><span>$18.1 billion</span></span><span style="font-family:inherit;font-size:10pt;">), respectively, which was less than its carrying by approximately </span><span style="font-family:inherit;font-size:10pt;"><span>52%</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>11%</span></span><span style="font-family:inherit;font-size:10pt;">, respectively. As recently as September 30, 2019, the fair value of Altria’s equity investment in ABI exceeded its carrying value. In October 2019, the fair value of Altria’s equity investment in ABI declined below its carrying value and has not recovered. Altria has evaluated the factors related to the fair value decline, including the recent impact on the fair value of ABI’s shares amidst the COVID-19 pandemic, which has impacted the equity markets. Altria has also evaluated ABI’s financial condition and near-term prospects, and Altria’s intent and ability to hold its investment in ABI until recovery. Altria concluded at March 31, 2020 and December 31, 2019, the decline in fair value of its investment in ABI below its carrying value was temporary and, therefore, </span><span style="font-family:inherit;font-size:10pt;"><span>no</span></span><span style="font-family:inherit;font-size:10pt;"> impairment was recorded.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span style="font-family:inherit;font-size:10pt;">Consistent with the one-quarter lag for reporting ABI’s results in Altria’s financial results, in the second quarter of 2020 Altria will record its share of ABI’s first quarter 2020 net mark-to-market losses on certain ABI financial instruments associated with ABI’s share commitments, primarily related to ABI’s derivative financial instruments used to hedge exposure to approximately </span><span style="font-family:inherit;font-size:10pt;"><span>100 million</span></span><span style="font-family:inherit;font-size:10pt;"> shares of ABI common stock. Such activity is primarily driven by the change in ABI’s share price, which decreased from </span><span style="font-family:inherit;font-size:10pt;"><span>€72.71</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>€40.47</span></span><span style="font-family:inherit;font-size:10pt;"> at </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span>, respectively.<div style="line-height:120%;padding-top:6px;font-size:11pt;"><span style="font-family:inherit;font-size:11pt;font-style:italic;">Investment in JUUL</span></div><div style="line-height:120%;font-size:11pt;"><span style="font-family:inherit;font-size:11pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In December 2018, Altria made a minority investment in JUUL for </span><span style="font-family:inherit;font-size:10pt;"><span>$12.8 billion</span></span><span style="font-family:inherit;font-size:10pt;">. In exchange for the investment, Altria received a </span><span style="font-family:inherit;font-size:10pt;"><span>35%</span></span><span style="font-family:inherit;font-size:10pt;"> economic interest in JUUL through non-voting shares, which are convertible at Altria’s election into voting shares (“Share Conversion”), and for </span><span style="font-family:inherit;font-size:10pt;">no</span><span style="font-family:inherit;font-size:10pt;"> additional payment, a security convertible into additional non-voting or voting shares, as applicable, upon settlement or exercise of certain JUUL convertible securities (the “JUUL Transaction”). During 2019, Altria recorded total pre-tax impairment charges of $</span><span style="font-family:inherit;font-size:10pt;"><span>8.6 billion</span></span><span style="font-family:inherit;font-size:10pt;"> related to its investment in JUUL resulting in a </span><span style="font-family:inherit;font-size:10pt;"><span>$4.2 billion</span></span><span style="font-family:inherit;font-size:10pt;"> carrying value of its investment in JUUL at December 31, 2019. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Altria received a broad preemptive right to purchase JUUL shares, exercisable each quarter upon dilution, to maintain its ownership percentage and is subject to a standstill restriction under which it may not acquire additional JUUL shares above its </span><span style="font-family:inherit;font-size:10pt;"><span>35%</span></span><span style="font-family:inherit;font-size:10pt;"> interest. Furthermore, Altria agreed not to sell or transfer any of its JUUL shares until December 20, 2024. </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On January 28, 2020, Altria and JUUL amended certain JUUL Transaction agreements and entered into a new cooperation agreement, which included the following provisions:</span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;">▪</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Altria will continue to provide regulatory affairs support for JUUL’s pursuit of its pre-market tobacco applications (PMTA) and/or its modified risk tobacco products authorization (MRTP) and discontinued all other services as of March 31, 2020;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;">▪</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Altria will have the option to be released from its non-compete obligation (i) in the event JUUL is prohibited by federal law from selling e-vapor products in the U.S. for a continuous period of at least </span><span style="font-family:inherit;font-size:10pt;"><span>12 months</span></span><span style="font-family:inherit;font-size:10pt;"> (subject to tolling of this period in certain circumstances) or (ii) if the carrying value of Altria’s investment in JUUL is not more than </span><span style="font-family:inherit;font-size:10pt;"><span>10%</span></span><span style="font-family:inherit;font-size:10pt;"> of its initial carrying value of </span><span style="font-family:inherit;font-size:10pt;"><span>$12.8 billion</span></span><span style="font-family:inherit;font-size:10pt;">;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;">▪</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Altria and JUUL agreed that for a period of </span><span style="font-family:inherit;font-size:10pt;"><span>one year</span></span><span style="font-family:inherit;font-size:10pt;"> they will not pursue any litigation against each other in connection with any conduct that occurred prior to the date of such cooperation agreement, with statutes of limitation being tolled during the one-year period; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;">▪</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">with respect to certain litigation in which Altria and JUUL are both defendants against third-party plaintiffs, Altria will not pursue any claims against JUUL for indemnification or reimbursement except for any non-contractual claims for contribution or indemnity where a judgment has been entered against Altria and JUUL; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;">▪</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">upon Share Conversion, JUUL will:</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">▪</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">restructure JUUL’s current </span><span style="font-family:inherit;font-size:10pt;"><span>seven</span></span><span style="font-family:inherit;font-size:10pt;">-member Board of Directors to a </span><span style="font-family:inherit;font-size:10pt;"><span>nine</span></span><span style="font-family:inherit;font-size:10pt;">-member board that will include independent board members. The new structure will include: (i) </span><span style="font-family:inherit;font-size:10pt;"><span>three</span></span><span style="font-family:inherit;font-size:10pt;"> independent directors (</span><span style="font-family:inherit;font-size:10pt;"><span>one</span></span><span style="font-family:inherit;font-size:10pt;"> of whom will be designated by Altria and </span><span style="font-family:inherit;font-size:10pt;"><span>two</span></span><span style="font-family:inherit;font-size:10pt;"> of whom will be designated by JUUL stockholders other than Altria) unanimously certified as independent by a nominating committee, which will include at least </span><span style="font-family:inherit;font-size:10pt;"><span>one</span></span><span style="font-family:inherit;font-size:10pt;"> Altria designee, (ii) </span><span style="font-family:inherit;font-size:10pt;"><span>two</span></span><span style="font-family:inherit;font-size:10pt;"> directors designated by Altria, (iii) </span><span style="font-family:inherit;font-size:10pt;"><span>three</span></span><span style="font-family:inherit;font-size:10pt;"> directors designated by JUUL stockholders other than Altria, and (iv) the JUUL Chief Executive Officer; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">▪</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">create a Litigation Oversight Committee, which will include </span><span style="font-family:inherit;font-size:10pt;"><span>two</span></span><span style="font-family:inherit;font-size:10pt;"> Altria designated directors (</span><span style="font-family:inherit;font-size:10pt;"><span>one</span></span><span style="font-family:inherit;font-size:10pt;"> of whom will chair the Litigation Oversight Committee) that will have oversight authority and review of litigation management for matters in which JUUL and Altria are co-defendants and have or reasonably could have a written joint defense agreement in effect between them. Subject to certain limitations, the Litigation Oversight Committee will recommend to JUUL changes to outside counsel and litigation strategy by majority vote, with disagreements by JUUL’s management being resolved by majority vote of JUUL’s Board of Directors.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:6px;text-align:justify;padding-left:72px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On April 1, 2020, the U.S. Federal Trade Commission (“FTC”) issued an administrative complaint challenging Altria’s investment in JUUL. The FTC has not sought to preliminarily enjoin Altria from converting its non-voting JUUL shares to voting shares. Altria has not converted its non-voting JUUL shares to voting shares and is considering whether to do so. For further discussion on the FTC litigation, see Note 11. </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Contingencies -  Antitrust Litigation</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">At March 31, 2020 and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, Altria had a </span><span style="font-family:inherit;font-size:10pt;"><span>35%</span></span><span style="font-family:inherit;font-size:10pt;"> economic interest in JUUL. Altria accounted for its investment in JUUL as an investment in an equity security as of </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">. Since the JUUL shares do not have a readily determinable fair value, Altria has elected to measure its investment in JUUL at its cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. There have been </span><span style="font-family:inherit;font-size:10pt;"><span>no</span></span><span style="font-family:inherit;font-size:10pt;"> upward or downward adjustments to the carrying value of Altria’s investment in JUUL resulting from observable price changes in orderly transactions since the JUUL Transaction through March 31, 2020.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Altria reviews its investment in JUUL for impairment by performing a qualitative assessment of impairment indicators on a quarterly basis in connection with the preparation of its financial statements. If this qualitative assessment indicates that </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Altria’s investment in JUUL may be impaired, a quantitative assessment is performed. If the quantitative assessment indicates the fair value of the investment is less than its carrying value, the investment is written down to its fair value. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Altria performed its qualitative assessment of potential impairment indicators for its investment in JUUL, which included the consideration of potential impacts of COVID-19 on JUUL’s business, as part of the preparation of its financial statements for the period ended </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">. Altria’s assessment did not result in impairment at </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">. The carrying value of Altria’s investment in JUUL was </span><span style="font-family:inherit;font-size:10pt;"><span>$4.2 billion</span></span><span style="font-family:inherit;font-size:10pt;"> at March 31, 2020 and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div>Upon Share Conversion, Altria expects to account for its investment in JUUL under the fair value option. Under this option, Altria’s consolidated statement of earnings will include any cash dividends received from its investment in JUUL as well as any changes in the fair value of the investment, which will be calculated quarterly.<div style="line-height:120%;padding-top:6px;font-size:11pt;"><span style="font-family:inherit;font-size:11pt;font-style:italic;">Investment in Cronos</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In March 2019, Altria completed its acquisition of:</span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">▪</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>149.8 million</span></span><span style="font-family:inherit;font-size:10pt;"> newly issued common shares of Cronos (“Acquired Common Shares”), which represented a </span><span style="font-family:inherit;font-size:10pt;"><span>45%</span></span><span style="font-family:inherit;font-size:10pt;"> economic and voting interest and is accounted for under the equity method of accounting; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">▪</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">anti-dilution protections to purchase Cronos common shares, exercisable each quarter upon dilution, to maintain its ownership percentage. Certain of the anti-dilution protections provide Altria the ability to purchase additional Cronos common shares at a per share exercise price of Canadian dollar (“CAD”) </span><span style="font-family:inherit;font-size:10pt;"><span>$16.25</span></span><span style="font-family:inherit;font-size:10pt;"> upon the occurrence of specified events (“Fixed-price Preemptive Rights”). Based on Altria’s assumptions as of March 31, 2020, Altria estimates the Fixed-price Preemptive Rights allows Altria to purchase up to an additional approximately </span><span style="font-family:inherit;font-size:10pt;"><span>37 million</span></span><span style="font-family:inherit;font-size:10pt;"> common shares of Cronos; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">▪</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">a warrant providing Altria the ability to purchase up to an additional </span><span style="font-family:inherit;font-size:10pt;"><span>10%</span></span><span style="font-family:inherit;font-size:10pt;"> of common shares of Cronos (approximately </span><span style="font-family:inherit;font-size:10pt;"><span>78 million</span></span><span style="font-family:inherit;font-size:10pt;"> common shares at March 31, 2020) at a per share exercise price of CAD </span><span style="font-family:inherit;font-size:10pt;"><span>$19.00</span></span><span style="font-family:inherit;font-size:10pt;">, which expires on March 8, 2023.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The total purchase price for the Acquired Common Shares, Fixed-price Preemptive Rights and warrant (collectively, “Investment in Cronos”) was CAD </span><span style="font-family:inherit;font-size:10pt;"><span>$2.4 billion</span></span><span style="font-family:inherit;font-size:10pt;"> (U.S. dollar (“USD”) </span><span style="font-family:inherit;font-size:10pt;"><span>$1.8 billion</span></span><span style="font-family:inherit;font-size:10pt;">). Upon full exercise of the Fixed-price Preemptive Rights, to the extent such rights become available, and the warrant, Altria would own a maximum of </span><span style="font-family:inherit;font-size:10pt;"><span>55%</span></span><span style="font-family:inherit;font-size:10pt;"> of the outstanding common shares of Cronos. </span></div><div style="line-height:120%;padding-bottom:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In accounting for the acquisition of these assets as of the date of closing, the Fixed-price Preemptive Rights and warrant were recorded at each of their fair values using Black-Scholes option-pricing models, based on the assumptions described in </span><span style="font-family:inherit;font-size:10pt;">Note 5</span><span style="font-family:inherit;font-size:10pt;">. </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments</span><span style="font-family:inherit;font-size:10pt;">. In addition, a deferred tax liability related to the Fixed-price Preemptive Rights and warrant was recorded. The residual of the purchase price was allocated to the Acquired Common Shares. Accordingly, the CAD </span><span style="font-family:inherit;font-size:10pt;"><span>$2.4 billion</span></span><span style="font-family:inherit;font-size:10pt;"> (USD </span><span style="font-family:inherit;font-size:10pt;"><span>$1.8 billion</span></span><span style="font-family:inherit;font-size:10pt;">) purchase price was recorded in USD as follows:</span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">▪</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>$1.2 billion</span></span><span style="font-family:inherit;font-size:10pt;"> to the warrant;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">▪</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>$0.5 billion</span></span><span style="font-family:inherit;font-size:10pt;"> to the Fixed-price Preemptive Rights; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">▪</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>$0.4 billion</span></span><span style="font-family:inherit;font-size:10pt;"> to the Acquired Common Shares; and </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">▪</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>$0.3 billion</span></span><span style="font-family:inherit;font-size:10pt;"> to a deferred tax liability.</span></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If exercised in full, the exercise prices for the warrant and Fixed-price Preemptive Rights are approximately CAD $</span><span style="font-family:inherit;font-size:10pt;"><span>1.5 billion</span></span><span style="font-family:inherit;font-size:10pt;"> and CAD </span><span style="font-family:inherit;font-size:10pt;"><span>$0.6 billion</span></span><span style="font-family:inherit;font-size:10pt;"> (approximately USD </span><span style="font-family:inherit;font-size:10pt;"><span>$1.1 billion</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$0.4 billion</span></span><span style="font-family:inherit;font-size:10pt;">, respectively, based on the CAD to USD exchange rate on April 27, 2020). </span></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For a discussion of derivatives related to Altria’s investment in Cronos, including Altria’s accounting for changes in the fair value of these derivatives, see </span><span style="font-family:inherit;font-size:10pt;">Note 5</span><span style="font-family:inherit;font-size:10pt;">. </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">At </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">, Altria had a </span><span style="font-family:inherit;font-size:10pt;"><span>45%</span></span><span style="font-family:inherit;font-size:10pt;"> ownership in Cronos, which Altria accounts for under the equity method of accounting. Altria reports its share of Cronos’s results using a one-quarter lag because Cronos’s results are not available in time for Altria to record them in the concurrent period. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Altria nominated </span><span style="font-family:inherit;font-size:10pt;"><span>four</span></span><span style="font-family:inherit;font-size:10pt;"> directors, including </span><span style="font-family:inherit;font-size:10pt;"><span>one</span></span><span style="font-family:inherit;font-size:10pt;"> director who is independent from Altria, who serve on Cronos’s </span><span style="font-family:inherit;font-size:10pt;"><span>seven</span></span><span style="font-family:inherit;font-size:10pt;">-member Board of Directors.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The fair value of Altria’s equity method investment in Cronos is based on unadjusted quoted prices in active markets for Cronos’s common shares and was classified in Level 1 of the fair value hierarchy. The fair value of Altria’s equity method investment in Cronos at </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> was </span><span style="font-family:inherit;font-size:10pt;"><span>$0.9 billion</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$1.2 billion</span></span><span style="font-family:inherit;font-size:10pt;">, respectively, compared with its carrying value of </span><span style="font-family:inherit;font-size:10pt;"><span>$1.0 billion</span></span><span style="font-family:inherit;font-size:10pt;"> at </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;">. At </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">, the fair value of Altria’s </span></div><span style="font-family:inherit;font-size:10pt;">equity method investment in Cronos was less than its carrying value by approximately </span><span style="font-family:inherit;font-size:10pt;"><span>14%</span></span><span style="font-family:inherit;font-size:10pt;">. Based on Altria’s evaluation of the duration and magnitude of the fair value decline, Altria’s evaluation of Cronos’s financial condition (including its strong cash position) and near-term prospects, and Altria’s intent and ability to hold its investment in Cronos until recovery, Altria concluded that the decline in fair value of its equity method investment in Cronos below its carrying value is temporary and, therefore, </span><span style="font-family:inherit;font-size:10pt;"><span>no</span></span> impairment was recorded. <div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Altria’s investments consisted of the following:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:64%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Carrying Amount</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">ABI</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18,453</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18,071</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">JUUL</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,205</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,205</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cronos</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt"> (1)</sup></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,203</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,305</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23,861</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23,581</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;padding-left:18px;text-indent:-18px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(1)</span><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt"> </sup></span><span style="font-family:inherit;font-size:9pt;">March 31, 2020 includes Altria’s equity method investment in Cronos (</span><span style="font-family:inherit;font-size:9pt;"><span>$1,037 million</span></span><span style="font-family:inherit;font-size:9pt;">), the Cronos warrant (</span><span style="font-family:inherit;font-size:9pt;"><span>$132 million</span></span><span style="font-family:inherit;font-size:9pt;">) and the Fixed-price Preemptive Rights (</span><span style="font-family:inherit;font-size:9pt;"><span>$34 million</span></span><span style="font-family:inherit;font-size:9pt;">) and December 31, 2019 includes Altria’s equity method investment in Cronos (</span><span style="font-family:inherit;font-size:9pt;"><span>$1,002 million</span></span><span style="font-family:inherit;font-size:9pt;">), the Cronos warrant (</span><span style="font-family:inherit;font-size:9pt;"><span>$234 million</span></span><span style="font-family:inherit;font-size:9pt;">) and the Fixed -price Preemptive Rights (</span><span style="font-family:inherit;font-size:9pt;"><span>$69 million</span></span><span style="font-family:inherit;font-size:9pt;">), as discussed further below.</span></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><br/></span></div> 18453000000 18071000000 4205000000 4205000000 1203000000 1305000000 23861000000 23581000000 1037000000 132000000 34000000 1002000000 234000000 69000000 <div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Earnings from equity investments accounted for under the equity method of accounting consisted of the following:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:64%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">ABI</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>134</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>86</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cronos</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt"> (1)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>157</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>86</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;padding-left:18px;text-indent:-18px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(1)</span><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt"> </sup></span><span style="font-family:inherit;font-size:9pt;">Represents Altria’s share of Cronos’s earnings, which includes the change in fair value of Cronos’s derivative financial instruments associated with the issuance of additional shares. As a result of the acquisition of Cronos in March 2019 and Altria reporting its share of Cronos’s results using a one-quarter lag, no equity earnings from Altria’s investment in Cronos were recorded for the three months ended March 31, 2019.</span></div> 134000000 86000000 23000000 0 157000000 86000000 0.101 185000000 12000000 The fair value of Altria’s equity investment in ABI is based on (i) unadjusted quoted prices in active markets for ABI’s ordinary shares and was classified in Level 1 of the fair value hierarchy and (ii) observable inputs other than Level 1 prices, such as quoted prices for similar assets for the Restricted Shares, and was classified in Level 2 of the fair value hierarchy. Altria may, in certain instances, pledge or otherwise grant a security interest in all or part of its Restricted Shares. In the event the pledgee or security interest holder forecloses on the Restricted Shares, the relevant Restricted Shares will be automatically converted, one-for-one, into ordinary shares. Therefore, the fair value of each Restricted Share is based on the value of an ordinary share.<div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Altria reviews its equity investments accounted for under the equity method of accounting (ABI and Cronos) for impairment on a quarterly basis in connection with the preparation of its financial statements by comparing the fair value of each of its investments to its respective carrying value. If the carrying value of an investment exceeds its fair value and the loss in value is other than temporary, the investment is considered impaired and reduced to fair value, and the impairment is recognized in the period identified. For further discussion, see </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Investment in ABI</span><span style="font-family:inherit;font-size:10pt;"> and</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> Investment in Cronos</span><span style="font-family:inherit;font-size:10pt;"> below.</span></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><br/></span></div>The fair value of Altria’s equity method investment in Cronos is based on unadjusted quoted prices in active markets for Cronos’s common shares and was classified in Level 1 of the fair value hierarchy. 8800000000 18500000000 16100000000 18100000000 -0.52 -0.11 0 100000000 72.71 40.47 12800000000 0.35 8600000000 4200000000 0.35 P12M 0.10 12800000000 P1Y 7 9 3 1 2 1 2 3 2 1 0.35 Altria accounted for its investment in JUUL as an investment in an equity security as of <span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">. Since the JUUL shares do not have a readily determinable fair value, Altria has elected to measure its investment in JUUL at its cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. There have been </span><span style="font-family:inherit;font-size:10pt;"><span>no</span></span><span style="font-family:inherit;font-size:10pt;"> upward or downward adjustments to the carrying value of Altria’s investment in JUUL resulting from observable price changes in orderly transactions since the JUUL Transaction through March 31, 2020.</span><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Altria reviews its investment in JUUL for impairment by performing a qualitative assessment of impairment indicators on a quarterly basis in connection with the preparation of its financial statements. If this qualitative assessment indicates that </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Altria’s investment in JUUL may be impaired, a quantitative assessment is performed. If the quantitative assessment indicates the fair value of the investment is less than its carrying value, the investment is written down to its fair value. </span></div> 0 4200000000 149800000 0.45 16.25 37000000 0.10 78000000 19.00 2400000000 1800000000 0.55 2400000000 1800000000 1200000000 500000000 400000000 300000000 1500000000 600000000 1100000000 400000000 0.45 4 1 7 900000000 1200000000 1000000000.0 -0.14 0 Financial Instruments:<div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Altria enters into derivative financial instruments to mitigate the potential impact of certain market risks, including foreign currency exchange rate risk. Altria uses various types of derivative financial instruments, including forward contracts, options and swaps. Altria does not enter into or hold derivative financial instruments for trading or speculative purposes.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Altria’s investment in ABI, whose functional currency is the Euro, exposes Altria to foreign currency exchange risk on the carrying value of its investment. To manage this risk, Altria designates certain foreign exchange contracts, including cross-currency swap contracts and forward contracts (collectively “foreign currency contracts”), and Euro denominated unsecured long-term notes (“foreign currency denominated debt”) as net investment hedges of Altria’s investment in ABI. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">At both </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, Altria had foreign currency contracts with aggregate notional amounts of </span><span style="font-family:inherit;font-size:10pt;"><span>$2,246 million</span></span><span style="font-family:inherit;font-size:10pt;">. At </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">, Altria had foreign currency denominated debt with an aggregate fair value and carrying value of </span><span style="font-family:inherit;font-size:10pt;"><span>$4,595 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$4,666 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively. At </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, Altria had foreign currency denominated debt with an aggregate fair value and carrying value of </span><span style="font-family:inherit;font-size:10pt;"><span>$5,057 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$4,741 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Altria’s estimates of the fair values of its foreign currency contracts are determined using valuation models with significant inputs that are readily available in public markets, or can be derived from observable market transactions, and therefore are classified in Level 2 of the fair value hierarchy. An adjustment for credit risk and nonperformance risk is included in the fair values of foreign currency contracts. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Altria’s estimate of the fair value of its short-term borrowings is derived from discounted future cash flows based on the contractual terms of the Credit Agreement (see </span><span style="font-family:inherit;font-size:10pt;">Note 10</span><span style="font-family:inherit;font-size:10pt;">.</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> Debt</span><span style="font-family:inherit;font-size:10pt;">) and observable interest rates and is classified in Level 2 of the fair value hierarchy. The fair value of Altria’s short-term borrowings at March 31, 2020 approximated its carrying value. Altria had </span><span style="font-family:inherit;font-size:10pt;"><span>no</span></span><span style="font-family:inherit;font-size:10pt;"> short-term borrowings at December 31, 2019.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Altria’s estimate of the fair value of its total long-term debt is based on observable market information derived from a third-party pricing source and is classified in Level 2 of the fair value hierarchy. The aggregate fair value of Altria’s total long-term debt at </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> was </span><span style="font-family:inherit;font-size:10pt;"><span>$28.3 billion</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$30.7 billion</span></span><span style="font-family:inherit;font-size:10pt;">, respectively, as compared with its carrying value of </span><span style="font-family:inherit;font-size:10pt;"><span>$27.0 billion</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$28.0 billion</span></span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Altria’s Fixed-price Preemptive Rights and warrant related to its investment in Cronos, which is further discussed in </span><span style="font-family:inherit;font-size:10pt;">Note 4</span><span style="font-family:inherit;font-size:10pt;">. </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Investments in Equity Securities</span><span style="font-family:inherit;font-size:10pt;">, are derivative financial instruments, which are required to be recorded at fair value. The fair values of the Fixed-price Preemptive Rights and Cronos warrant are estimated using Black-Scholes option-pricing models, adjusted for observable inputs (which are classified in Level 1 of the fair value hierarchy), including share price, and unobservable inputs, including probability factors and weighting of expected life, volatility levels and risk-free interest rates (which are classified in Level 3 of the fair value hierarchy) based on the following assumptions at:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:29%;"/><td style="width:2%;"/><td style="width:15%;"/><td style="width:2%;"/><td style="width:17%;"/><td style="width:2%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:17%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fixed-price Preemptive Rights</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cronos Warrant</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Share price </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>C$7.99</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>C$9.97</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>C$7.99</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>C$9.97</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Expected life </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1.60 years</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1.67 years</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2.93 years</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">3.18 years</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Expected volatility </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>79.97%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>81.61%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>79.97%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>81.61%</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Risk-free interest rate </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(4)(5)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.38%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.71%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.49%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.69%</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Expected dividend yield </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(6)</sup></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—%</span></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(1) Based on the closing market price for Cronos common stock on the Toronto Stock Exchange on the date indicated.</span></div><div style="line-height:120%;text-align:left;padding-left:18px;text-indent:-18px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(2) Based on the weighted-average expected life of the Fixed-price Preemptive Rights (with a range from approximately </span><span style="font-family:inherit;font-size:9pt;"><span>0.25</span></span><span style="font-family:inherit;font-size:9pt;"> year to </span><span style="font-family:inherit;font-size:9pt;"><span>6</span></span><span style="font-family:inherit;font-size:9pt;"> years at March 31, 2020 and December 31, 2019) and the March 8, 2023 expiration date of the Cronos warrant.</span></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(3) Based on a blend of historical volatility levels of the underlying equity security and peer companies.</span></div><div style="line-height:120%;text-align:left;padding-left:18px;text-indent:-18px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(4) Based on the implied yield currently available on Canadian Treasury zero coupon issues (with a range from approximately </span><span style="font-family:inherit;font-size:9pt;"><span>0.21%</span></span><span style="font-family:inherit;font-size:9pt;"> to </span><span style="font-family:inherit;font-size:9pt;"><span>0.62%</span></span><span style="font-family:inherit;font-size:9pt;"> at March 31, 2020 and </span><span style="font-family:inherit;font-size:9pt;"><span>1.66%</span></span><span style="font-family:inherit;font-size:9pt;"> to </span><span style="font-family:inherit;font-size:9pt;"><span>1.74%</span></span><span style="font-family:inherit;font-size:9pt;"> at December 31, 2019) weighted for the remaining expected life of the Fixed-price Preemptive Rights.</span></div><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(5) Based on the implied yield currently available on Canadian Treasury zero coupon issues and the expected life of the Cronos warrant.</span></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(6) Based on Cronos’s expected dividend payments.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table provides a reconciliation of the beginning and ending balance of the Fixed-price Preemptive Rights and Cronos warrant, which are classified in Level 3 of the fair value hierarchy:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:82%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>303</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pre-tax earnings (losses) recognized in net earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(137</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at March 31, 2020</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>166</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Altria elects to record the gross assets and liabilities of derivative financial instruments executed with the same counterparty on its condensed consolidated balance sheets. The fair values of Altria’s derivative financial instruments on a gross basis included on the condensed consolidated balance sheets were as follows:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="19"/></tr><tr><td style="width:29%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Fair Value of Assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Fair Value of Liabilities</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Balance Sheet Classification</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">December 31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Balance Sheet Classification</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">December 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Derivatives designated as hedging instruments:</span></div></td><td colspan="18" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(in millions)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Foreign currency contracts</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other current assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>55</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>46</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other accrued liabilities</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Foreign currency contracts</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>19</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other liabilities</span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>74</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>46</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>28</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Derivatives not designated as hedging instruments:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Cronos warrant</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Investments in equity securities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>132</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>234</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-indent:12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Fixed-price </span></div><div style="text-indent:24px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Preemptive Rights</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Investments in equity securities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>34</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>69</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>166</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>303</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total derivatives</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>240</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>349</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>28</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Altria records in its condensed consolidated statements of earnings any changes in the fair values of the Fixed-price Preemptive Rights and Cronos warrant as gains or losses on Cronos-related financial instruments in the periods in which the changes occur. For the </span><span style="font-family:inherit;font-size:10pt;">three</span><span style="font-family:inherit;font-size:10pt;"> months ended </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, Altria recognized pre-tax unrealized losses, representing the changes in the fair values of the Fixed-price Preemptive Rights and Cronos warrant, as follows:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:67%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fixed-price Preemptive Rights</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(35</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(132</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cronos warrant</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(102</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(262</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(137</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(394</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Additionally, in January and February 2019, Altria entered into derivative financial instruments in the form of forward contracts, which were settled on March 7, 2019, to hedge Altria’s exposure to CAD to USD foreign currency exchange rate movements, in relation to the CAD </span><span style="font-family:inherit;font-size:10pt;"><span>$2.4 billion</span></span><span style="font-family:inherit;font-size:10pt;"> purchase price for the Cronos transaction. The aggregate notional amounts of the forward contracts were USD </span><span style="font-family:inherit;font-size:10pt;"><span>$1.8 billion</span></span><span style="font-family:inherit;font-size:10pt;"> (CAD </span><span style="font-family:inherit;font-size:10pt;"><span>$2.4 billion</span></span><span style="font-family:inherit;font-size:10pt;">). The forward contracts did not qualify for hedge accounting; therefore, in the first quarter of 2019, pre-tax losses of USD </span><span style="font-family:inherit;font-size:10pt;"><span>$31 million</span></span><span style="font-family:inherit;font-size:10pt;"> representing changes in the fair values of the forward contracts were recorded in loss on Cronos-related financial instruments in Altria’s condensed consolidated statement of earnings.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Counterparties to Altria’s foreign currency contracts are domestic and international financial institutions. Altria is exposed to potential losses due to non-performance by these counterparties. Altria manages its credit risk by entering into transactions with counterparties with investment grade credit ratings, limiting the amount of exposure Altria has with each counterparty and monitoring the financial condition of each counterparty. The counterparty agreements also contain provisions that require Altria to maintain an investment grade credit rating. In the event Altria’s credit rating falls below investment grade, counterparties to Altria’s foreign currency contracts can require Altria to post collateral. </span><span style="font-family:inherit;font-size:10pt;">No</span><span style="font-family:inherit;font-size:10pt;"> collateral was received or posted related to derivative assets and liabilities at </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Net Investment Hedging</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The pre-tax effects of Altria’s net investment hedges on accumulated other comprehensive losses and the condensed consolidated statements of earnings were as follows:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:48%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gain (Loss) Recognized in Accumulated Other Comprehensive Losses</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gain (Loss) Recognized in Net Earnings </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>56</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency denominated debt</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>77</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>33</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>133</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>56</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(1) Related to amounts excluded from effectiveness testing. </span></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The changes in the fair value of the foreign currency contracts and in the carrying value of the foreign currency denominated debt due to changes in the Euro to USD exchange rate were recognized in accumulated other comprehensive losses related to ABI. Gains on the foreign currency contracts arising from components excluded from effectiveness testing were recognized in interest and other debt expense, net in the condensed consolidated statements of earnings based on an amortization approach.</span></div> 2246000000 4595000000 4666000000 5057000000 4741000000 0 28300000000 30700000000 27000000000.0 28000000000.0 The fair values of the Fixed-price Preemptive Rights and Cronos warrant are estimated using Black-Scholes option-pricing models, adjusted for observable inputs (which are classified in Level 1 of the fair value hierarchy), including share price, and unobservable inputs, including probability factors and weighting of expected life, volatility levels and risk-free interest rates (which are classified in Level 3 of the fair value hierarchy) based on the following assumptions at:<div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:29%;"/><td style="width:2%;"/><td style="width:15%;"/><td style="width:2%;"/><td style="width:17%;"/><td style="width:2%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:17%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fixed-price Preemptive Rights</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cronos Warrant</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Share price </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>C$7.99</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>C$9.97</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>C$7.99</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>C$9.97</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Expected life </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1.60 years</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1.67 years</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2.93 years</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">3.18 years</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Expected volatility </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>79.97%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>81.61%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>79.97%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>81.61%</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Risk-free interest rate </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(4)(5)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.38%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.71%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.49%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.69%</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Expected dividend yield </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(6)</sup></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—%</span></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(1) Based on the closing market price for Cronos common stock on the Toronto Stock Exchange on the date indicated.</span></div><div style="line-height:120%;text-align:left;padding-left:18px;text-indent:-18px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(2) Based on the weighted-average expected life of the Fixed-price Preemptive Rights (with a range from approximately </span><span style="font-family:inherit;font-size:9pt;"><span>0.25</span></span><span style="font-family:inherit;font-size:9pt;"> year to </span><span style="font-family:inherit;font-size:9pt;"><span>6</span></span><span style="font-family:inherit;font-size:9pt;"> years at March 31, 2020 and December 31, 2019) and the March 8, 2023 expiration date of the Cronos warrant.</span></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(3) Based on a blend of historical volatility levels of the underlying equity security and peer companies.</span></div><div style="line-height:120%;text-align:left;padding-left:18px;text-indent:-18px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(4) Based on the implied yield currently available on Canadian Treasury zero coupon issues (with a range from approximately </span><span style="font-family:inherit;font-size:9pt;"><span>0.21%</span></span><span style="font-family:inherit;font-size:9pt;"> to </span><span style="font-family:inherit;font-size:9pt;"><span>0.62%</span></span><span style="font-family:inherit;font-size:9pt;"> at March 31, 2020 and </span><span style="font-family:inherit;font-size:9pt;"><span>1.66%</span></span><span style="font-family:inherit;font-size:9pt;"> to </span><span style="font-family:inherit;font-size:9pt;"><span>1.74%</span></span><span style="font-family:inherit;font-size:9pt;"> at December 31, 2019) weighted for the remaining expected life of the Fixed-price Preemptive Rights.</span></div><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(5) Based on the implied yield currently available on Canadian Treasury zero coupon issues and the expected life of the Cronos warrant.</span></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(6) Based on Cronos’s expected dividend payments.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 7.99 9.97 7.99 9.97 0.7997 0.8161 0.7997 0.8161 0.0038 0.0171 0.0049 0.0169 0 0 0 0 0.25 6 0.0021 0.0062 0.0166 0.0174 <div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table provides a reconciliation of the beginning and ending balance of the Fixed-price Preemptive Rights and Cronos warrant, which are classified in Level 3 of the fair value hierarchy:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"/></tr><tr><td style="width:82%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>303</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pre-tax earnings (losses) recognized in net earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(137</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at March 31, 2020</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>166</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 303000000 -137000000 166000000 The fair values of Altria’s derivative financial instruments on a gross basis included on the condensed consolidated balance sheets were as follows:<div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="19"/></tr><tr><td style="width:29%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Fair Value of Assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Fair Value of Liabilities</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Balance Sheet Classification</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">December 31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Balance Sheet Classification</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">December 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Derivatives designated as hedging instruments:</span></div></td><td colspan="18" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(in millions)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Foreign currency contracts</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other current assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>55</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>46</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other accrued liabilities</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Foreign currency contracts</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>19</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other liabilities</span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>74</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>46</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>28</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Derivatives not designated as hedging instruments:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Cronos warrant</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Investments in equity securities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>132</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>234</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-indent:12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Fixed-price </span></div><div style="text-indent:24px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Preemptive Rights</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Investments in equity securities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>34</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>69</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>166</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>303</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total derivatives</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>240</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>349</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>28</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 55000000 46000000 0 7000000 19000000 0 0 21000000 74000000 46000000 0 28000000 132000000 234000000 34000000 69000000 166000000 303000000 240000000 349000000 0 28000000 -35000000 -132000000 -102000000 -262000000 -137000000 -394000000 2400000000 1800000000 2400000000 31000000 <div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The pre-tax effects of Altria’s net investment hedges on accumulated other comprehensive losses and the condensed consolidated statements of earnings were as follows:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:48%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gain (Loss) Recognized in Accumulated Other Comprehensive Losses</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gain (Loss) Recognized in Net Earnings </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>56</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency denominated debt</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>77</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>33</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>133</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>56</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(1) Related to amounts excluded from effectiveness testing. </span></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><br/></span></div>For the <span style="font-family:inherit;font-size:10pt;">three</span><span style="font-family:inherit;font-size:10pt;"> months ended </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, Altria recognized pre-tax unrealized losses, representing the changes in the fair values of the Fixed-price Preemptive Rights and Cronos warrant, as follows:</span><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:67%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fixed-price Preemptive Rights</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(35</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(132</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cronos warrant</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(102</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(262</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(137</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(394</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 56000000 23000000 14000000 9000000 77000000 33000000 0 0 133000000 56000000 14000000 9000000 Benefit Plans:<div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Components of Net Periodic Benefit (Income) Cost</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net periodic benefit (income) cost consisted of the following:</span><span style="font-family:inherit;font-size:9pt;"> </span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:64%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pension</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Postretirement</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Service cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>63</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>77</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Expected return on plan assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(126</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(145</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net loss</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>42</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prior service cost (credit)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Curtailment</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net periodic benefit (income) cost </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(16</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Curtailment costs shown in the table above were related to the cost reduction program discussed in </span><span style="font-family:inherit;font-size:10pt;">Note 3</span><span style="font-family:inherit;font-size:10pt;">. </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Asset Impairment, Exit and Implementation Costs</span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Employer Contributions</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Altria makes contributions to the pension plans to the extent that the contributions are tax deductible and pays benefits that relate to plans for salaried employees that cannot be funded under Internal Revenue Service regulations. Altria made employer contributions of </span><span style="font-family:inherit;font-size:10pt;"><span>$4 million</span></span><span style="font-family:inherit;font-size:10pt;"> to its pension plans during the </span><span style="font-family:inherit;font-size:10pt;">three months ended March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">. Currently, Altria anticipates making additional employer contributions to its pension plans during the remainder of </span><span style="font-family:inherit;font-size:10pt;">2020</span><span style="font-family:inherit;font-size:10pt;"> of up to approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$25 million</span></span><span style="font-family:inherit;font-size:10pt;"> based on current tax law. Altria did </span><span style="font-family:inherit;font-size:10pt;"><span>no</span></span><span style="font-family:inherit;font-size:10pt;">t make any employer contributions to its postretirement plans during the </span><span style="font-family:inherit;font-size:10pt;">three months ended March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">. Currently, Altria anticipates making employer contributions to its postretirement plans of up to approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$60 million</span></span><span style="font-family:inherit;font-size:10pt;"> in </span><span style="font-family:inherit;font-size:10pt;">2020</span><span style="font-family:inherit;font-size:10pt;">. However, these estimates may be subject to change as a result of changes in tax and other benefit laws, as well as asset performance significantly above or below the assumed long-term rate of return on assets, changes in interest rates or other considerations.</span></div> <div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net periodic benefit (income) cost consisted of the following:</span><span style="font-family:inherit;font-size:9pt;"> </span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:64%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pension</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Postretirement</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Service cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>63</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>77</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Expected return on plan assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(126</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(145</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net loss</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>42</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prior service cost (credit)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Curtailment</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net periodic benefit (income) cost </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(16</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 19000000 17000000 4000000 4000000 63000000 77000000 15000000 20000000 126000000 145000000 3000000 4000000 -27000000 -42000000 -3000000 -3000000 1000000 1000000 -7000000 -7000000 0 -7000000 0 -5000000 -16000000 -1000000 12000000 21000000 4000000 25000000 0 60000000 Earnings Per Share:<div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Basic and diluted earnings per share (“EPS”) were calculated using the following:</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:64%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net earnings attributable to Altria</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,552</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,120</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: Distributed and undistributed earnings attributable to share-based awards</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Earnings for basic and diluted EPS</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,550</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,118</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted-average shares for basic and diluted EPS</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,858</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,874</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> <div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Basic and diluted earnings per share (“EPS”) were calculated using the following:</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:64%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net earnings attributable to Altria</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,552</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,120</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: Distributed and undistributed earnings attributable to share-based awards</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Earnings for basic and diluted EPS</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,550</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,118</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted-average shares for basic and diluted EPS</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,858</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,874</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 1552000000 1120000000 2000000 2000000 1550000000 1118000000 1858000000 1874000000 Other Comprehensive Earnings/Losses:<div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following tables set forth the changes in each component of accumulated other comprehensive losses, net of deferred income taxes, attributable to Altria:</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:42%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:3%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Benefit Plans</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">ABI</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Currency</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Translation</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Adjustments and Other</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accumulated</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Comprehensive</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Losses</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balances, December 31, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2,192</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(693</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2,864</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive earnings (losses) before reclassifications</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>388</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>400</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred income taxes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(85</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(85</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>303</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>315</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amounts reclassified to net earnings</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred income taxes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amounts reclassified to net earnings, net of deferred income taxes</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>298</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>331</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balances, March 31, 2020</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2,171</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(395</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>33</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2,533</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:42%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:3%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Benefit Plans</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">ABI</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Currency</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Translation</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Adjustments and Other</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accumulated</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Comprehensive</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Losses</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balances, December 31, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2,168</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(374</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2,547</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive earnings (losses) before reclassifications</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(238</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(238</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred income taxes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>49</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>49</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:18px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(189</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(189</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amounts reclassified to net earnings</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>39</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(12</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred income taxes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:18px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amounts reclassified to net earnings, net of deferred income taxes</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>29</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:18px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>29</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(199</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(170</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balances, March 31, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2,139</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(573</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2,717</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span style="font-family:inherit;font-size:10pt;">(1) Primarily reflects Altria’s share of ABI’s currency translation adjustments and the impact of Altria’s designated net investment hedges. For further discussion of designated net investment hedges, see </span><span style="font-family:inherit;font-size:10pt;">Note 5</span><span style="font-family:inherit;font-size:10pt;font-style:italic;">. Financial Instruments.</span><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table sets forth pre-tax amounts by component, reclassified from accumulated other comprehensive losses to net earnings: </span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:46%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Benefit Plans: </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net loss</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>34</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>49</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prior service cost/credit</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>39</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">ABI </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(12</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(1) Amounts are included in net defined benefit plan costs. For further details, see </span><span style="font-family:inherit;font-size:9pt;">Note 6</span><span style="font-family:inherit;font-size:9pt;">. </span><span style="font-family:inherit;font-size:9pt;font-style:italic;">Benefit Plans.</span></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(2) Amounts are included in earnings from equity investments. For further information, see </span><span style="font-family:inherit;font-size:9pt;">Note 4</span><span style="font-family:inherit;font-size:9pt;">. </span><span style="font-family:inherit;font-size:9pt;font-style:italic;">Investments in Equity Securities.</span></div> <div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following tables set forth the changes in each component of accumulated other comprehensive losses, net of deferred income taxes, attributable to Altria:</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:42%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:3%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Benefit Plans</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">ABI</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Currency</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Translation</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Adjustments and Other</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accumulated</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Comprehensive</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Losses</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balances, December 31, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2,192</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(693</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2,864</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive earnings (losses) before reclassifications</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>388</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>400</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred income taxes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(85</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(85</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>303</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>315</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amounts reclassified to net earnings</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred income taxes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amounts reclassified to net earnings, net of deferred income taxes</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>298</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>331</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balances, March 31, 2020</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2,171</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(395</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>33</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2,533</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:42%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:3%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Benefit Plans</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">ABI</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Currency</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Translation</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Adjustments and Other</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accumulated</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Comprehensive</span></div><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Losses</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balances, December 31, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2,168</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(374</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2,547</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive earnings (losses) before reclassifications</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(238</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(238</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred income taxes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>49</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>49</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:18px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(189</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(189</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amounts reclassified to net earnings</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>39</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(12</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred income taxes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:18px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amounts reclassified to net earnings, net of deferred income taxes</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>29</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:18px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>29</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(199</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(170</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balances, March 31, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2,139</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(573</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2,717</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span style="font-family:inherit;font-size:10pt;">(1) Primarily reflects Altria’s share of ABI’s currency translation adjustments and the impact of Altria’s designated net investment hedges. For further discussion of designated net investment hedges, see </span><span style="font-family:inherit;font-size:10pt;">Note 5</span><span style="font-family:inherit;font-size:10pt;font-style:italic;">. Financial Instruments.</span> -2192000000 -693000000 21000000 -2864000000 0 388000000 12000000 400000000 0 85000000 0 85000000 0 303000000 12000000 315000000 -28000000 7000000 0 -21000000 -7000000 2000000 0 -5000000 -21000000 5000000 0 -16000000 21000000 298000000 12000000 331000000 -2171000000 -395000000 33000000 -2533000000 -2168000000 -374000000 -5000000 -2547000000 0 -238000000 0 -238000000 0 -49000000 0 -49000000 0 -189000000 0 -189000000 -39000000 12000000 0 -27000000 -10000000 2000000 0 -8000000 -29000000 10000000 0 -19000000 29000000 -199000000 0 -170000000 -2139000000 -573000000 -5000000 -2717000000 <div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table sets forth pre-tax amounts by component, reclassified from accumulated other comprehensive losses to net earnings: </span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:46%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Benefit Plans: </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net loss</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>34</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>49</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prior service cost/credit</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>39</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">ABI </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(12</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(1) Amounts are included in net defined benefit plan costs. For further details, see </span><span style="font-family:inherit;font-size:9pt;">Note 6</span><span style="font-family:inherit;font-size:9pt;">. </span><span style="font-family:inherit;font-size:9pt;font-style:italic;">Benefit Plans.</span></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(2) Amounts are included in earnings from equity investments. For further information, see </span><span style="font-family:inherit;font-size:9pt;">Note 4</span><span style="font-family:inherit;font-size:9pt;">. </span><span style="font-family:inherit;font-size:9pt;font-style:italic;">Investments in Equity Securities.</span></div> 34000000 49000000 -6000000 -10000000 28000000 39000000 7000000 12000000 -21000000 -27000000 Segment Reporting:<div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In the first quarter of 2020, Altria renamed its smokeless products segment as the oral tobacco products segment.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The products of Altria’s subsidiaries include smokeable tobacco products, consisting of combustible cigarettes manufactured and sold by PM USA and Nat Sherman, machine-made large cigars and pipe tobacco manufactured and sold by Middleton and premium cigars sold by Nat Sherman; oral tobacco products, consisting of MST and snus products manufactured and sold by USSTC and oral nicotine pouches manufactured and sold by Helix; and wine produced and/or distributed by Ste. Michelle. The products and services of these subsidiaries constitute Altria’s reportable segments of smokeable products, oral tobacco products (formerly smokeless products) and wine. The financial services and the innovative tobacco products businesses are included in all other. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Altria’s chief operating decision maker (the “CODM”) reviews operating companies income to evaluate the performance of, and allocate resources to, the segments. Operating companies income for the segments is defined as operating income before general corporate expenses and amortization of intangibles. Interest and other debt expense, net, net periodic benefit income/cost, excluding service cost, and provision for income taxes are centrally managed at the corporate level and, accordingly, such items are not presented by segment since they are excluded from the measure of segment profitability reviewed by the CODM.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Segment data were as follows: </span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:73%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net revenues:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Smokeable products</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,606</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,935</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Oral tobacco products</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>601</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>540</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Wine</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>146</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>151</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">All other</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net revenues</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,359</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,628</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Earnings before income taxes:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating companies income (loss):</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Smokeable products</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,370</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,932</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Oral tobacco products</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>414</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>358</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Wine</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(379</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">All other</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(12</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of intangibles</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(19</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">General corporate expenses</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(45</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(46</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Corporate asset impairment and exit costs</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating income</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,336</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,238</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest and other debt expense, net</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(275</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(384</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;text-indent:-6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net periodic benefit income, excluding service cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Earnings from equity investments</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>157</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>86</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:24px;text-indent:-24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Loss on Cronos-related financial instruments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(137</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(425</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Earnings before income taxes</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,108</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,516</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The comparability of operating companies income for the reportable segments was affected by the following:</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Tobacco and Health Litigation Items - Pre-tax charges related to certain tobacco and health litigation items were recorded in Altria’s condensed consolidated statements of earnings as follows:</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:74%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Smokeable products segment</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest and other debt expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>24</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The amounts shown in the table above for the smokeable products segment were recorded in marketing, administration and research costs. For further discussion, see </span><span style="font-family:inherit;font-size:10pt;">Note 11</span><span style="font-family:inherit;font-size:10pt;">. </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Contingencies</span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Asset Impairment, Exit and Implementation Costs - See </span><span style="font-family:inherit;font-size:10pt;">Note 3</span><span style="font-family:inherit;font-size:10pt;">. </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Asset Impairment, Exit and Implementation Costs</span><span style="font-family:inherit;font-size:10pt;"> for a breakdown of these costs by segment.</span></div> <div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Segment data were as follows: </span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:73%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net revenues:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Smokeable products</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,606</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,935</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Oral tobacco products</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>601</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>540</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Wine</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>146</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>151</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">All other</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net revenues</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,359</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,628</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Earnings before income taxes:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating companies income (loss):</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Smokeable products</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,370</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,932</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Oral tobacco products</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>414</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>358</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Wine</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(379</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">All other</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(12</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization of intangibles</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(19</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">General corporate expenses</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(45</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(46</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Corporate asset impairment and exit costs</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating income</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,336</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,238</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest and other debt expense, net</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(275</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(384</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;text-indent:-6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net periodic benefit income, excluding service cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Earnings from equity investments</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>157</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>86</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:24px;text-indent:-24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Loss on Cronos-related financial instruments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(137</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(425</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Earnings before income taxes</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,108</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,516</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 5606000000 4935000000 601000000 540000000 146000000 151000000 6000000 2000000 6359000000 5628000000 2370000000 1932000000 414000000 358000000 -379000000 15000000 -5000000 -12000000 19000000 8000000 45000000 46000000 0 1000000 2336000000 2238000000 -275000000 -384000000 -27000000 -1000000 157000000 86000000 -137000000 -425000000 2108000000 1516000000 <div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Tobacco and Health Litigation Items - Pre-tax charges related to certain tobacco and health litigation items were recorded in Altria’s condensed consolidated statements of earnings as follows:</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:74%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Smokeable products segment</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest and other debt expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>24</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 22000000 15000000 2000000 2000000 24000000 17000000 Debt:<div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Short-term Borrowings and Borrowing Arrangements</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Altria had </span><span style="font-family:inherit;font-size:10pt;"><span>$3.0 billion</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>no</span></span><span style="font-family:inherit;font-size:10pt;"> short-term borrowings at March 31, 2020 and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, respectively. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">At March 31, 2020, Altria had a senior unsecured </span><span style="font-family:inherit;font-size:10pt;">5</span><span style="font-family:inherit;font-size:10pt;">-year revolving credit agreement, dated August 1, 2018 (as amended, the “Credit Agreement”), that provides for borrowings up to an aggregate principal amount of </span><span style="font-family:inherit;font-size:10pt;"><span>$3.0 billion</span></span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On March 23, 2020, Altria provided notice to JPMorgan Chase Bank, N.A., as administrative agent under the Credit Agreement, to borrow the entire available amount (</span><span style="font-family:inherit;font-size:10pt;"><span>$3.0 billion</span></span><span style="font-family:inherit;font-size:10pt;">) under the Credit Agreement and, as of March 31, 2020, </span><span style="font-family:inherit;font-size:10pt;"><span>$3.0 billion</span></span><span style="font-family:inherit;font-size:10pt;"> was outstanding under the Credit Agreement. Altria typically accesses the commercial paper market early in the second quarter to help fund payments related to the 1998 Master Settlement Agreement (the “MSA”) and shareholder dividends. In light of the current uncertainty in the global capital markets, including the commercial paper markets, resulting from the COVID-19 pandemic, Altria elected to borrow the entire amount available under the Credit Agreement as a precautionary measure to increase its cash position and preserve financial flexibility. Altria used a portion of the proceeds from the borrowing under the Credit Agreement to help fund these payments and for other general corporate purposes. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">All borrowings under the Credit Agreement mature on August 1, 2023, unless extended pursuant to the terms of the Credit Agreement. The Credit Agreement includes an option, subject to certain conditions, for Altria to extend the expiration date for </span><span style="font-family:inherit;font-size:10pt;"><span>two</span></span><span style="font-family:inherit;font-size:10pt;"> additional </span><span style="font-family:inherit;font-size:10pt;">one</span><span style="font-family:inherit;font-size:10pt;">-year periods. Altria may repay the borrowings under the Credit Agreement at any time without penalty. Altria has the intent and ability to repay the entire outstanding balance under the Credit Agreement within </span><span style="font-family:inherit;font-size:10pt;"><span>one year</span></span><span style="font-family:inherit;font-size:10pt;"> and believes it has adequate liquidity and access to financial resources to meet its anticipated obligations in the foreseeable future. As a result, Altria has classified the full amount of the borrowings as a current liability on its condensed consolidated balance sheet at March 31, 2020. Interest on the outstanding borrowings at March 31, 2020 was based on the </span><span style="font-family:inherit;font-size:10pt;">three</span><span style="font-family:inherit;font-size:10pt;">-month London Interbank Offered Rate (“LIBOR”) plus an applicable percentage based on the higher of the ratings of Altria’s long-term senior unsecured debt from Moody’s Investors Service, Inc. and Standard &amp; Poor’s Ratings Services. The applicable percentage based on Altria’s long-term senior unsecured debt ratings at March 31, 2020 for borrowings under the Credit Agreement was </span><span style="font-family:inherit;font-size:10pt;"><span>1.0%</span></span><span style="font-family:inherit;font-size:10pt;">. At March 31, 2020, the interest rate for Altria’s current borrowings under the Credit Agreement was </span><span style="font-family:inherit;font-size:10pt;"><span>2.23%</span></span><span style="font-family:inherit;font-size:10pt;">. The Credit Agreement does not include any other rating triggers or any provisions that could require the posting of collateral. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Credit Agreement includes various covenants, one of which requires Altria to maintain a ratio of consolidated earnings before interest, taxes, depreciation and amortization (“EBITDA”) to Consolidated Interest Expense of not less than </span><span style="font-family:inherit;font-size:10pt;"><span>4.0</span></span><span style="font-family:inherit;font-size:10pt;"> to 1.0, calculated as of the end of the applicable quarter on a rolling four quarters basis. At March 31, 2020, the ratio of consolidated EBITDA to Consolidated Interest Expense, calculated in accordance with the Credit Agreement, was </span><span style="font-family:inherit;font-size:10pt;"><span>9.0</span></span><span style="font-family:inherit;font-size:10pt;"> to 1.0. At March 31, 2020, Altria was in compliance with its covenants in the Credit Agreement. The terms “Consolidated EBITDA” and “Consolidated Interest Expense,” each as defined in the Credit Agreement, include certain adjustments.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">At March 31, 2020, accrued interest on short-term borrowings under the Credit Agreement of </span><span style="font-family:inherit;font-size:10pt;"><span>$1 million</span></span><span style="font-family:inherit;font-size:10pt;"> was included in other accrued liabilities on Altria’s condensed consolidated balance sheet.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Any commercial paper issued by Altria and borrowings under the Credit Agreement are guaranteed by PM USA as further discussed in </span><span style="font-family:inherit;font-size:10pt;">Note 12</span><span style="font-family:inherit;font-size:10pt;">. </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Condensed Consolidating Financial Information.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For discussion of the fair value of Altria’s short-term borrowings, see </span><span style="font-family:inherit;font-size:10pt;">Note 5</span><span style="font-family:inherit;font-size:10pt;">. </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Long-term Debt</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">During the first quarter of 2020, Altria repaid in full at maturity senior unsecured notes in the aggregate principal amount of </span><span style="font-family:inherit;font-size:10pt;"><span>$1,000 million</span></span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">At </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, accrued interest on long-term debt of </span><span style="font-family:inherit;font-size:10pt;"><span>$270 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$470 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively, was included in other accrued liabilities on Altria’s condensed consolidated balance sheets.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Altria designated its Euro denominated senior unsecured notes as a net investment hedge of its investment in ABI. </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For discussion of Altria’s net investment hedge and the fair value of Altria’s long-term debt, see </span><span style="font-family:inherit;font-size:10pt;">Note 5</span><span style="font-family:inherit;font-size:10pt;">. </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments</span><span style="font-family:inherit;font-size:10pt;">.</span></div> 3000000000.0 0 3000000000.0 3000000000.0 3000000000.0 2 P1Y 0.010 0.0223 4.0 9.0 1000000 1000000000 270000000 470000000 Contingencies<div style="line-height:120%;text-align:left;font-size:11pt;"><span style="font-family:inherit;font-size:11pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Legal proceedings covering a wide range of matters are pending or threatened in various U.S. and foreign jurisdictions against Altria and its subsidiaries, including PM USA and USSTC, as well as their respective indemnitees and Altria’s investees. Various types of claims may be raised in these proceedings, including product liability, unfair trade practices, antitrust, tax, contraband shipments, patent infringement, employment matters, claims for contribution and claims of competitors, shareholders or distributors.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Litigation is subject to uncertainty and it is possible that there could be adverse developments in pending or future cases. An unfavorable outcome or settlement of pending tobacco-related or other litigation could encourage the commencement of additional litigation. Damages claimed in some tobacco-related and other litigation are or can be significant and, in certain cases, have ranged in the billions of dollars. The variability in pleadings in multiple jurisdictions, together with the actual experience of management in litigating claims, demonstrate that the monetary relief that may be specified in a lawsuit bears little relevance to the ultimate outcome. In certain cases, plaintiffs claim that defendants’ liability is joint and several. In such cases, Altria or its subsidiaries may face the risk that one or more co-defendants decline or otherwise fail to participate in the bonding required for an appeal or to pay their proportionate or jury-allocated share of a judgment. As a result, Altria or its subsidiaries under certain circumstances may have to pay more than their proportionate share of any bonding- or judgment-related amounts. Furthermore, in those cases where plaintiffs are successful, Altria or its subsidiaries may also be required to pay interest and attorneys’ fees.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Although PM USA has historically been able to obtain required bonds or relief from bonding requirements in order to prevent plaintiffs from seeking to collect judgments while adverse verdicts have been appealed, there remains a risk that such relief may not be obtainable in all cases. This risk has been substantially reduced given that </span><span style="font-family:inherit;font-size:10pt;"><span>47</span></span><span style="font-family:inherit;font-size:10pt;"> states and Puerto Rico limit the dollar amount of bonds or require no bond at all. As discussed below, however, tobacco litigation plaintiffs have challenged the constitutionality of Florida’s bond cap statute in several cases and plaintiffs may challenge state bond cap statutes in other jurisdictions as well. Such challenges may include the applicability of state bond caps in federal court. States, including Florida, may also seek to repeal or alter bond cap statutes through legislation. Although Altria cannot predict the outcome of such challenges, it is possible that the consolidated results of operations, cash flows or financial position of Altria, or one or more of its subsidiaries, could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome of one or more such challenges.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Altria and its subsidiaries record provisions in the condensed consolidated financial statements for pending litigation when they determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. At the present time, while it is reasonably possible that an unfavorable outcome in a case may occur, except to the extent discussed elsewhere in this </span><span style="font-family:inherit;font-size:10pt;">Note 11</span><span style="font-family:inherit;font-size:10pt;">. </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Contingencies</span><span style="font-family:inherit;font-size:10pt;">: (i) management has concluded that it is not probable that a loss has been incurred in any of the pending cases; (ii) management is unable to estimate the possible loss or range of loss that could result from an unfavorable outcome in any of the pending cases; and (iii) accordingly, management has not provided any amounts in the condensed consolidated financial statements for unfavorable outcomes, if any. Litigation defense costs are expensed as incurred. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Altria and its subsidiaries have achieved substantial success in managing litigation. Nevertheless, litigation is subject to uncertainty and significant challenges remain. It is possible that the consolidated results of operations, cash flows or financial position of Altria, or one or more of its subsidiaries, could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome or settlement of certain pending litigation. Altria and each of its subsidiaries named as a defendant believe, and each has been so advised by counsel handling the respective cases, that it has valid defenses to the litigation pending against it, as well as valid bases for appeal of adverse verdicts. Each of the companies has defended, and will continue to defend, vigorously against litigation challenges. However, Altria and its subsidiaries may enter into settlement discussions in particular cases if they believe it is in the best interests of Altria to do so.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Overview of Altria and/or PM USA Tobacco-Related Litigation </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Types and Number of U.S. Cases</span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Claims related to tobacco products generally fall within the following categories: (i) smoking and health cases alleging personal injury brought on behalf of individual plaintiffs; (ii) health care cost recovery cases brought by governmental (both domestic and foreign) plaintiffs seeking reimbursement for health care expenditures allegedly caused by cigarette smoking and/or disgorgement of profits; (iii) e-vapor cases alleging violation of the Racketeer Influenced and Corrupt Organizations Act (“RICO”), fraud, failure to warn, design defect, negligence and unfair trade practices; and (iv) other tobacco-related litigation described below. Plaintiffs’ theories of recovery and the defenses raised in tobacco-related litigation are discussed below.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The table below lists the number of certain tobacco-related cases pending in the U.S. against PM USA and, in some instances, Altria as of April 27, 2020, April 22, 2019 and April 23, 2018:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:56%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:14%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">April 27, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">April 22, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">April 23, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Individual Smoking and Health Cases</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt"> (1)</sup></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>109</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>98</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>102</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Health Care Cost Recovery Actions </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">E-vapor Cases</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>202</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other Tobacco-Related Cases</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(4)</sup></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(1) Includes </span><span style="font-family:inherit;font-size:9pt;"><span>22</span></span><span style="font-family:inherit;font-size:9pt;"> cases filed in Massachusetts and </span><span style="font-family:inherit;font-size:9pt;"><span>46</span></span><span style="font-family:inherit;font-size:9pt;"> non-</span><span style="font-family:inherit;font-size:9pt;font-style:italic;">Engle </span><span style="font-family:inherit;font-size:9pt;">cases filed in Florida. Does not include individual smoking and health cases brought by or on behalf of plaintiffs in Florida state and federal courts following the decertification of the </span><span style="font-family:inherit;font-size:9pt;font-style:italic;">Engle </span><span style="font-family:inherit;font-size:9pt;">case (these </span><span style="font-family:inherit;font-size:9pt;font-style:italic;">Engle</span><span style="font-family:inherit;font-size:9pt;"> progeny cases are discussed below in </span><span style="font-family:inherit;font-size:9pt;font-style:italic;">Smoking and Health Litigation - Engle Class Action</span><span style="font-family:inherit;font-size:9pt;">). Also does not include </span><span style="font-family:inherit;font-size:9pt;"><span>1,472</span></span><span style="font-family:inherit;font-size:9pt;"> cases brought by flight attendants seeking compensatory damages for personal injuries allegedly caused by exposure to environmental tobacco smoke (“ETS”). The flight attendants allege that they are members of an ETS smoking and health class action in Florida, which was settled in 1997 (</span><span style="font-family:inherit;font-size:9pt;font-style:italic;">Broin</span><span style="font-family:inherit;font-size:9pt;">). The terms of the court-approved settlement in that case allowed class members to file individual lawsuits seeking compensatory damages, but prohibited them from seeking punitive damages. In March 2018, </span><span style="font-family:inherit;font-size:9pt;"><span>923</span></span><span style="font-family:inherit;font-size:9pt;"> of these cases were voluntarily dismissed without prejudice. </span></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(2) See </span><span style="font-family:inherit;font-size:9pt;font-style:italic;">Health Care Cost Recovery Litigation - Federal Government’s Lawsuit</span><span style="font-family:inherit;font-size:9pt;"> below.</span></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(3) Includes </span><span style="font-family:inherit;font-size:9pt;"><span>24</span></span><span style="font-family:inherit;font-size:9pt;"> class action lawsuits, </span><span style="font-family:inherit;font-size:9pt;"><span>170</span></span><span style="font-family:inherit;font-size:9pt;"> individual lawsuits, </span><span style="font-family:inherit;font-size:9pt;"><span>five</span></span><span style="font-family:inherit;font-size:9pt;"> state or local government lawsuits and </span><span style="font-family:inherit;font-size:9pt;"><span>three</span></span><span style="font-family:inherit;font-size:9pt;"> lawsuits filed by school districts relating to JUUL e-vapor products. JUUL is an additional named defendant in each of these lawsuits.</span></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(4)</span><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt"> </sup></span><span style="font-family:inherit;font-size:9pt;">For 2019 and 2020, includes </span><span style="font-family:inherit;font-size:9pt;"><span>two</span></span><span style="font-family:inherit;font-size:9pt;"> inactive smoking and health cases alleging personal injury or seeking court-supervised programs or ongoing medical monitoring and purporting to be brought on behalf of a class of individual plaintiffs, including </span><span style="font-family:inherit;font-size:9pt;"><span>one</span></span><span style="font-family:inherit;font-size:9pt;"> case in which the aggregated claims of a number of individual plaintiffs are to be tried in a single proceeding, and </span><span style="font-family:inherit;font-size:9pt;"><span>two</span></span><span style="font-family:inherit;font-size:9pt;"> inactive class action lawsuits alleging that use of the terms “Lights” and “Ultra Lights” constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO.</span></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">International Tobacco-Related Cases </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of April 27, 2020, PM USA is a named defendant in </span><span style="font-family:inherit;font-size:10pt;"><span>10</span></span><span style="font-family:inherit;font-size:10pt;"> health care cost recovery actions in Canada, </span><span style="font-family:inherit;font-size:10pt;"><span>eight</span></span><span style="font-family:inherit;font-size:10pt;"> of which also name Altria as a defendant. PM USA and Altria are also named defendants in </span><span style="font-family:inherit;font-size:10pt;"><span>seven</span></span><span style="font-family:inherit;font-size:10pt;"> smoking and health class actions filed in various Canadian provinces. See </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Guarantees and Other Similar Matters</span><span style="font-family:inherit;font-size:10pt;"> below for a discussion of the Distribution Agreement between Altria and Philip Morris International Inc. (“PMI”) that provides for indemnities for certain liabilities concerning tobacco products. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Tobacco-Related Cases Set for Trial </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of April 27, 2020, </span><span style="font-family:inherit;font-size:10pt;"><span>two</span></span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Engle</span><span style="font-family:inherit;font-size:10pt;"> progeny cases are set for trial through June 30, 2020. In addition, there are </span><span style="font-family:inherit;font-size:10pt;"><span>no</span></span><span style="font-family:inherit;font-size:10pt;"> individual smoking and health cases against PM USA set for trial during this period. Cases against other companies in the tobacco industry may be scheduled for trial during this period. Trial dates are subject to change and some trials have been postponed due to the COVID-19 pandemic. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Trial Results</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Since January 1999, excluding the </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Engle </span><span style="font-family:inherit;font-size:10pt;">progeny cases (separately discussed below), verdicts have been returned in </span><span style="font-family:inherit;font-size:10pt;"><span>69</span></span><span style="font-family:inherit;font-size:10pt;"> tobacco-related cases in which PM USA was a defendant. Verdicts in favor of PM USA and other defendants were returned in </span><span style="font-family:inherit;font-size:10pt;"><span>44</span></span><span style="font-family:inherit;font-size:10pt;"> of the </span><span style="font-family:inherit;font-size:10pt;"><span>69</span></span><span style="font-family:inherit;font-size:10pt;"> cases. These </span><span style="font-family:inherit;font-size:10pt;"><span>44</span></span><span style="font-family:inherit;font-size:10pt;"> cases were tried in Alaska (</span><span style="font-family:inherit;font-size:10pt;"><span>1</span></span><span style="font-family:inherit;font-size:10pt;">), California (</span><span style="font-family:inherit;font-size:10pt;"><span>7</span></span><span style="font-family:inherit;font-size:10pt;">), Connecticut (</span><span style="font-family:inherit;font-size:10pt;"><span>1</span></span><span style="font-family:inherit;font-size:10pt;">), Florida (</span><span style="font-family:inherit;font-size:10pt;"><span>10</span></span><span style="font-family:inherit;font-size:10pt;">), Louisiana (</span><span style="font-family:inherit;font-size:10pt;"><span>1</span></span><span style="font-family:inherit;font-size:10pt;">), Massachusetts (</span><span style="font-family:inherit;font-size:10pt;"><span>4</span></span><span style="font-family:inherit;font-size:10pt;">), Mississippi (</span><span style="font-family:inherit;font-size:10pt;"><span>1</span></span><span style="font-family:inherit;font-size:10pt;">), Missouri (</span><span style="font-family:inherit;font-size:10pt;"><span>4</span></span><span style="font-family:inherit;font-size:10pt;">), New Hampshire (</span><span style="font-family:inherit;font-size:10pt;"><span>1</span></span><span style="font-family:inherit;font-size:10pt;">), New Jersey (</span><span style="font-family:inherit;font-size:10pt;"><span>1</span></span><span style="font-family:inherit;font-size:10pt;">), New York (</span><span style="font-family:inherit;font-size:10pt;"><span>5</span></span><span style="font-family:inherit;font-size:10pt;">), Ohio (</span><span style="font-family:inherit;font-size:10pt;"><span>2</span></span><span style="font-family:inherit;font-size:10pt;">), Pennsylvania (</span><span style="font-family:inherit;font-size:10pt;"><span>1</span></span><span style="font-family:inherit;font-size:10pt;">), Rhode Island (</span><span style="font-family:inherit;font-size:10pt;"><span>1</span></span><span style="font-family:inherit;font-size:10pt;">), Tennessee (</span><span style="font-family:inherit;font-size:10pt;"><span>2</span></span><span style="font-family:inherit;font-size:10pt;">) and West Virginia (</span><span style="font-family:inherit;font-size:10pt;"><span>2</span></span><span style="font-family:inherit;font-size:10pt;">).</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Of the </span><span style="font-family:inherit;font-size:10pt;"><span>25</span></span><span style="font-family:inherit;font-size:10pt;"> non-</span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Engle</span><span style="font-family:inherit;font-size:10pt;"> progeny cases in which verdicts were returned in favor of plaintiffs, </span><span style="font-family:inherit;font-size:10pt;"><span>20</span></span><span style="font-family:inherit;font-size:10pt;"> have reached final resolution, and </span><span style="font-family:inherit;font-size:10pt;"><span>one</span></span><span style="font-family:inherit;font-size:10pt;"> case (</span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Gentile</span><span style="font-family:inherit;font-size:10pt;">) that was initially returned in favor of plaintiff was reversed post-trial and remains pending. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">See </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Smoking and Health Litigation - Engle Progeny Trial Results</span><span style="font-family:inherit;font-size:10pt;"> below for a discussion of verdicts in state and federal </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Engle</span><span style="font-family:inherit;font-size:10pt;"> progeny cases involving PM USA as of April 27, 2020. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Judgments Paid and Provisions for Tobacco and Health Litigation Items (Including Engle Progeny Litigation)</span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">After exhausting all appeals in those cases resulting in adverse verdicts associated with tobacco-related litigation, since October 2004, PM USA has paid judgments and settlements (including related costs and fees) totaling approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$748 million</span></span><span style="font-family:inherit;font-size:10pt;"> and interest totaling approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$216 million</span></span><span style="font-family:inherit;font-size:10pt;"> as of March 31, 2020. These amounts include payments for </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Engle</span><span style="font-family:inherit;font-size:10pt;"> progeny </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">judgments (and related costs and fees) totaling approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$327 million</span></span><span style="font-family:inherit;font-size:10pt;"> and related interest totaling approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$54 million</span></span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The changes in Altria’s accrued liability for tobacco and health litigation items, including related interest costs, for the periods specified below are as follows:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:68%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:4%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:18px;text-indent:-18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accrued liability for tobacco and health litigation items at beginning of period </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>112</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pre-tax charges for:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:36px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Tobacco and health litigation </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:36px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Related interest costs</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Payments </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(28</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(109</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-left:18px;text-indent:-18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accrued liability for tobacco and health litigation items at end of period </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;padding-left:18px;text-indent:-18px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(1) Includes amounts related to the costs of implementing the corrective communications remedy related to the </span><span style="font-family:inherit;font-size:9pt;font-style:italic;">Federal Government’s Lawsuit</span><span style="font-family:inherit;font-size:9pt;"> discussed below.</span></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(2)</span><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt"> </sup></span><span style="font-family:inherit;font-size:9pt;">Includes approximately </span><span style="font-family:inherit;font-size:9pt;"><span>$7 million</span></span><span style="font-family:inherit;font-size:9pt;"> related to pre-trial resolution of approximately </span><span style="font-family:inherit;font-size:9pt;"><span>100</span></span><span style="font-family:inherit;font-size:9pt;"> tobacco and health cases.</span></div><div style="line-height:120%;text-align:left;padding-left:18px;text-indent:-18px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(3) Includes approximately </span><span style="font-family:inherit;font-size:9pt;"><span>$7 million</span></span><span style="font-family:inherit;font-size:9pt;"> in payments related to above-mentioned pre-trial resolution of approximately </span><span style="font-family:inherit;font-size:9pt;"><span>100</span></span><span style="font-family:inherit;font-size:9pt;"> tobacco and health cases and </span><span style="font-family:inherit;font-size:9pt;"><span>$2 million</span></span><span style="font-family:inherit;font-size:9pt;"> for pre-trial resolution of other tobacco and health cases that was accrued in 2019 but not paid until 2020</span><span style="font-family:inherit;font-size:8pt;">. </span></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The accrued liability for tobacco and health litigation items, including related interest costs, was included in accrued liabilities on Altria’s condensed consolidated balance sheets. Pre-tax charges for tobacco and health litigation were included in marketing, administration and research costs on Altria’s condensed consolidated statements of earnings (losses). Pre-tax charges for related interest costs were included in interest and other debt expense, net on Altria’s condensed consolidated statements of earnings (losses).</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Security for Judgments</span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">To obtain stays of judgments pending appeal, PM USA has posted various forms of security. As of March 31, 2020, PM USA has posted appeal bonds totaling approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$48 million</span></span><span style="font-family:inherit;font-size:10pt;">, which have been collateralized with restricted cash that are included in assets on the condensed consolidated balance sheet.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Smoking and Health Litigation</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Overview</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Plaintiffs’ allegations of liability in smoking and health cases are based on various theories of recovery, including negligence, gross negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, nuisance, breach of express and implied warranties, breach of special duty, conspiracy, concert of action, violations of unfair trade practice laws and consumer protection statutes, and claims under the federal and state anti-racketeering statutes. Plaintiffs in the smoking and health cases seek various forms of relief, including compensatory and punitive damages, treble/multiple damages and other statutory damages and penalties, creation of medical monitoring and smoking cessation funds, disgorgement of profits, and injunctive and equitable relief. Defenses raised in these cases include lack of proximate cause, assumption of the risk, comparative fault and/or contributory negligence, statutes of limitations and preemption by the Federal Cigarette Labeling and Advertising Act. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Non-Engle Progeny Litigation</span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Summarized below are the non-</span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Engle </span><span style="font-family:inherit;font-size:10pt;">progeny smoking and health cases pending during 2020 in which a verdict was returned in favor of plaintiff and against PM USA. Charts listing certain verdicts for plaintiffs in the </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Engle </span><span style="font-family:inherit;font-size:10pt;">progeny cases can be found in </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Smoking and Health Litigation - Engle Progeny Trial Results</span><span style="font-family:inherit;font-size:10pt;"> below.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Principe</span><span style="font-family:inherit;font-size:10pt;">: In February 2020, a jury in a Florida state court returned a verdict in favor of plaintiff and against PM USA, awarding approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$11 million</span></span><span style="font-family:inherit;font-size:10pt;"> in compensatory damages. There was no claim for punitive damages. PM USA’s post-trial motions are pending. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Greene</span><span style="font-family:inherit;font-size:10pt;">:</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> </span><span style="font-family:inherit;font-size:10pt;">In September 2019, a jury in a Massachusetts state court returned a verdict in favor of plaintiffs and against PM USA, awarding approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$10 million</span></span><span style="font-family:inherit;font-size:10pt;"> in compensatory damages. An additional claim by plaintiffs remains pending.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Laramie</span><span style="font-family:inherit;font-size:10pt;">: In August 2019, a jury in a Massachusetts state court returned a verdict in favor of plaintiff, awarding </span><span style="font-family:inherit;font-size:10pt;"><span>$11 million</span></span><span style="font-family:inherit;font-size:10pt;"> in compensatory damages and </span><span style="font-family:inherit;font-size:10pt;"><span>$10 million</span></span><span style="font-family:inherit;font-size:10pt;"> in punitive damages. PM USA and plaintiff have appealed. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Gentile</span><span style="font-family:inherit;font-size:10pt;">: In October 2017, a jury in a Florida state court returned a verdict in favor of plaintiff, awarding approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$7.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> in compensatory damages and allocating </span><span style="font-family:inherit;font-size:10pt;"><span>75%</span></span><span style="font-family:inherit;font-size:10pt;"> of the fault to PM USA (an amount of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$5.3 million</span></span><span style="font-family:inherit;font-size:10pt;">). PM USA appealed. In September 2019, the Florida Fourth District Court of Appeal reversed the judgment entered by the trial court, granted PM USA judgment on certain claims and remanded for a new trial on the remaining claims. Plaintiff has petitioned the Florida Supreme Court for further review.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Federal Government’s Lawsuit</span><span style="font-family:inherit;font-size:10pt;">:</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> </span><span style="font-family:inherit;font-size:10pt;">See </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Health Care Cost Recovery Litigation - Federal Government’s Lawsuit</span><span style="font-family:inherit;font-size:10pt;"> below for a discussion of the verdict and post-trial developments in the </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">United States of America</span><span style="font-family:inherit;font-size:10pt;"> health care cost recovery case.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Engle Class Action</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In July 2000, in the second phase of the </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Engle</span><span style="font-family:inherit;font-size:10pt;"> smoking and health class action in Florida, a jury returned a verdict assessing punitive damages totaling approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$145 billion</span></span><span style="font-family:inherit;font-size:10pt;"> against various defendants, including </span><span style="font-family:inherit;font-size:10pt;"><span>$74 billion</span></span><span style="font-family:inherit;font-size:10pt;"> against PM USA. Following entry of judgment, PM USA appealed. In May 2003, the Florida Third District Court of Appeal reversed the judgment entered by the trial court and instructed the trial court to order the decertification of the class. Plaintiffs petitioned the Florida Supreme Court for further review. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In July 2006, the Florida Supreme Court ordered that the punitive damages award be vacated, that the class approved by the trial court be decertified and that members of the decertified class could file individual actions against defendants within </span><span style="font-family:inherit;font-size:10pt;"><span>one year</span></span><span style="font-family:inherit;font-size:10pt;"> of issuance of the mandate. The court further declared the following Phase I findings are entitled to </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">res judicata</span><span style="font-family:inherit;font-size:10pt;"> effect in such individual actions brought within </span><span style="font-family:inherit;font-size:10pt;"><span>one year</span></span><span style="font-family:inherit;font-size:10pt;"> of the issuance of the mandate: (i) that smoking causes various diseases; (ii) that nicotine in cigarettes is addictive; (iii) that defendants’ cigarettes were defective and unreasonably dangerous; (iv) that defendants concealed or omitted material information not otherwise known or available knowing that the material was false or misleading or failed to disclose a material fact concerning the health effects or addictive nature of smoking; (v) that defendants agreed to misrepresent information regarding the health effects or addictive nature of cigarettes with the intention of causing the public to rely on this information to their detriment; (vi) that defendants agreed to conceal or omit information regarding the health effects of cigarettes or their addictive nature with the intention that smokers would rely on the information to their detriment; (vii) that all defendants sold or supplied cigarettes that were defective; and (viii) that defendants were negligent. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2006, PM USA and plaintiffs sought rehearing from the Florida Supreme Court on parts of its July 2006 opinion. In December 2006, the Florida Supreme Court refused to revise its July 2006 ruling, except that it revised the set of Phase I findings entitled to </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">res judicata</span><span style="font-family:inherit;font-size:10pt;"> effect by excluding finding (v) listed above (relating to agreement to misrepresent information), and added the finding that defendants sold or supplied cigarettes that, at the time of sale or supply, did not conform to the representations of fact made by defendants. In February 2008, the trial court decertified the class. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Pending Engle Progeny Cases </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The deadline for filing</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> Engle</span><span style="font-family:inherit;font-size:10pt;"> progeny cases expired in January 2008, at which point a total of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>9,300</span></span><span style="font-family:inherit;font-size:10pt;"> federal and state claims were pending. As of April 27, 2020, approximately </span><span style="font-family:inherit;font-size:10pt;"><span>1,500</span></span><span style="font-family:inherit;font-size:10pt;"> state court cases were pending against PM USA or Altria asserting individual claims by or on behalf of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>1,900</span></span><span style="font-family:inherit;font-size:10pt;"> state court plaintiffs.  Because of a number of factors, including docketing delays, duplicated filings and overlapping dismissal orders, these numbers are estimates. While the Federal </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Engle </span><span style="font-family:inherit;font-size:10pt;">Agreement (discussed below) resolved nearly all </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Engle </span><span style="font-family:inherit;font-size:10pt;">progeny cases pending in federal court, as of April 27, 2020, </span><span style="font-family:inherit;font-size:10pt;"><span>four</span></span><span style="font-family:inherit;font-size:10pt;"> cases were pending against PM USA in federal court representing the cases excluded from that agreement.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Engle Progeny Trial Results</span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of April 27, 2020, </span><span style="font-family:inherit;font-size:10pt;"><span>134</span></span><span style="font-family:inherit;font-size:10pt;"> federal and state </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Engle</span><span style="font-family:inherit;font-size:10pt;"> progeny cases involving PM USA have resulted in verdicts since the Florida Supreme Court </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Engle</span><span style="font-family:inherit;font-size:10pt;"> decision. </span><span style="font-family:inherit;font-size:10pt;"><span>Seventy-eight</span></span><span style="font-family:inherit;font-size:10pt;"> verdicts were returned in favor of plaintiffs and </span><span style="font-family:inherit;font-size:10pt;"><span>four</span></span><span style="font-family:inherit;font-size:10pt;"> verdicts (</span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Skolnick</span><span style="font-family:inherit;font-size:10pt;">,</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> Calloway</span><span style="font-family:inherit;font-size:10pt;">,</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> Oshinsky-Blacker </span><span style="font-family:inherit;font-size:10pt;">and </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Freeman</span><span style="font-family:inherit;font-size:10pt;">) that were initially returned in favor of plaintiffs were reversed post-trial or on appeal and remain pending. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>Forty-seven</span></span><span style="font-family:inherit;font-size:10pt;"> verdicts were returned in favor of PM USA, of which </span><span style="font-family:inherit;font-size:10pt;"><span>42</span></span><span style="font-family:inherit;font-size:10pt;"> were state cases. In addition, there have been a number of mistrials, only some of which have resulted in new trials as of April 27, 2020. </span><span style="font-family:inherit;font-size:10pt;"><span>Four</span></span><span style="font-family:inherit;font-size:10pt;"> verdicts (</span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Pearson, D. Cohen</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Collar </span><span style="font-family:inherit;font-size:10pt;">and</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> Chacon</span><span style="font-family:inherit;font-size:10pt;">) that were returned in favor of PM USA were subsequently reversed for new trials. Juries in </span><span style="font-family:inherit;font-size:10pt;"><span>two</span></span><span style="font-family:inherit;font-size:10pt;"> cases (</span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Reider </span><span style="font-family:inherit;font-size:10pt;">and </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Banks</span><span style="font-family:inherit;font-size:10pt;">)</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> </span><span style="font-family:inherit;font-size:10pt;">returned </span><span style="font-family:inherit;font-size:10pt;"><span>zero</span></span><span style="font-family:inherit;font-size:10pt;"> damages verdicts in favor of PM USA</span><span style="font-family:inherit;font-size:10pt;font-style:italic;">. </span><span style="font-family:inherit;font-size:10pt;">Juries in </span><span style="font-family:inherit;font-size:10pt;"><span>two</span></span><span style="font-family:inherit;font-size:10pt;"> other cases (</span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Weingart</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Hancock</span><span style="font-family:inherit;font-size:10pt;">) returned verdicts against PM USA awarding </span><span style="font-family:inherit;font-size:10pt;"><span>no</span></span><span style="font-family:inherit;font-size:10pt;"> damages, but the trial court in each case decided to award plaintiffs damages. </span><span style="font-family:inherit;font-size:10pt;"><span>One</span></span><span style="font-family:inherit;font-size:10pt;"> case, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Pollari, </span><span style="font-family:inherit;font-size:10pt;">resulted in a verdict in favor of PM USA following a retrial of an initial verdict returned in favor of plaintiff. Appeals by plaintiff and defendants are pending. </span><span style="font-family:inherit;font-size:10pt;"><span>Three</span></span><span style="font-family:inherit;font-size:10pt;"> cases, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Gloger,</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Rintoul </span><span style="font-family:inherit;font-size:10pt;">(</span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Caprio</span><span style="font-family:inherit;font-size:10pt;">) and </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Duignan</span><span style="font-family:inherit;font-size:10pt;">, resulted in verdicts in favor of plaintiffs following retrial of initial verdicts returned in favor of plaintiffs. Post-trial motions or appeals are pending. </span><span style="font-family:inherit;font-size:10pt;"><span>One</span></span><span style="font-family:inherit;font-size:10pt;"> case, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Freeman</span><span style="font-family:inherit;font-size:10pt;">, resulted in an appellate reversal of a jury verdict in favor of plaintiff and a judgment in favor of PM USA. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The charts below list the verdicts and post-trial developments in certain </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Engle</span><span style="font-family:inherit;font-size:10pt;"> progeny cases in which verdicts were returned in favor of plaintiffs. The first chart lists such cases that are pending as of April 27, 2020 where PM USA has recorded a provision in its consolidated financial statements because PM USA has determined that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated; the second chart lists other such cases that are pending as of April 27, 2020 but where PM USA has determined an unfavorable outcome is not probable and the amount of loss cannot be reasonably estimated; and the third chart lists other such cases that have concluded within the previous 12 months. Unless otherwise noted for a particular case, the jury’s award for compensatory damages will not be reduced by any finding of plaintiff’s comparative fault. Further, the damages noted reflect adjustments based on post-trial or appellate rulings.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" style="padding-left:0px;padding-right:0px;padding-top:4px;padding-bottom:4px;"><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Currently Pending Engle Cases with Accrued Liabilities</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">(rounded to nearest $ million)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="width:10%;"/><td style="width:11%;"/><td style="width:11%;"/><td style="width:10%;"/><td style="width:12%;"/><td style="width:10%;"/><td style="width:22%;"/><td style="width:14%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Plaintiff</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Verdict Date</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Defendant(s)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Court</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Compensatory Damages (All Defendants)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Punitive Damages (PM USA)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Appeal Status</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Accrual </span><span style="font-family:inherit;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Berger </span><span style="font-family:inherit;font-size:9pt;">(</span><span style="font-family:inherit;font-size:9pt;font-style:italic;">Cote</span><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">September 2014</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Federal Court - Middle District of Florida</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$6 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$21 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">The Eleventh Circuit Court of Appeals reinstated the punitive and compensatory damages awards and remanded the case to the district court. PM USA’s challenge to the punitive damages award was denied by the district court. PM USA’s appeal to the Eleventh Circuit Court of Appeals is pending.</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$6 million accrual in the fourth quarter of 2018</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(1)</span><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt"> </sup></span><span style="font-family:inherit;font-size:9pt;">Accrual amounts include interest and associated costs, if applicable. For cases with multiple defendants, if any, accrual amounts reflect the portion of compensatory damages PM USA believes it will have to pay if the case is ultimately decided in plaintiff’s favor after taking into account any portion potentially payable by the other defendant(s). </span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" style="padding-left:0px;padding-right:0px;padding-top:4px;padding-bottom:4px;"><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Other Currently Pending Engle Cases with Verdicts Against PM USA </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">(rounded to nearest $ million)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="width:10%;"/><td style="width:12%;"/><td style="width:13%;"/><td style="width:12%;"/><td style="width:15%;"/><td style="width:11%;"/><td style="width:27%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Plaintiff</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Verdict Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Defendant(s)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Court</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Compensatory Damages </span><span style="font-family:inherit;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1) </sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Punitive Damages <br/>(PM USA)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Appeal Status</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Duignan </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">February 2020</span><span style="font-family:inherit;font-size:9pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2</sup></span><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">)</sup></span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA and <br/>R.J. Reynolds</span><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup></span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Pinellas</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$3 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$12 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Defendants’ post-trial motions pending.</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Cuddihee</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">January 2020</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Duval</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$3 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$0</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Defendant’s post-trial motions pending.</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Rintoul (Caprio)</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">November 2019</span><span style="font-family:inherit;font-size:9pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2</sup></span><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">)</sup></span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;background-color:#cceeff;">PM USA and R.J. Reynolds</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Broward</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$9 million ($5 million PM USA)</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$74 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Defendants’ post-trial motion pending.</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Gloger</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">November 2019</span><span style="font-family:inherit;font-size:9pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2</sup></span><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">)</sup></span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA and R.J. Reynolds</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Miami-Dade</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$15 million ($5 million PM USA)</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$11 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Appeal by defendants to Third District Court of Appeal pending.</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">McCall</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">March 2019</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;background-color:#cceeff;">PM USA</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Broward</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">&lt;$1 million (&lt;$1 million PM USA)</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">&lt;$1 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">New trial ordered on punitive damages.</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Neff</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">March 2019</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA and R.J. Reynolds</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Broward</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$4 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$2 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Appeals by plaintiff and defendants to Fourth District Court of Appeal pending. </span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Frogel</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">March 2019</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;background-color:#cceeff;">PM USA </span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Palm Beach</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">&lt;$1 million (&lt;$1 million PM USA)</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$0</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Appeals by plaintiff and defendant to Fourth District Court of Appeal pending.</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" style="padding-left:0px;padding-right:0px;padding-top:4px;padding-bottom:4px;"><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Other Currently Pending Engle Cases with Verdicts Against PM USA </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">(rounded to nearest $ million)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="width:10%;"/><td style="width:12%;"/><td style="width:13%;"/><td style="width:12%;"/><td style="width:15%;"/><td style="width:11%;"/><td style="width:27%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Plaintiff</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Verdict Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Defendant(s)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Court</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Compensatory Damages </span><span style="font-family:inherit;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1) </sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Punitive Damages <br/>(PM USA)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Appeal Status</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Mahfuz</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">February 2019</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA and R.J. Reynolds</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Broward</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$12 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$10 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Appeals by plaintiff and defendants to Fourth District Court of Appeal pending.</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;background-color:#cceeff;font-style:italic;">Holliman</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">February 2019</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Miami-Dade</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$3 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$0</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Defendant’s appeal to Third District Court of Appeal pending.</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Chadwell</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">September 2018</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Miami-Dade</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$2 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$0</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Appeals by defendant and plaintiff to Third District Court of Appeal pending.</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Kaplan</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">July 2018</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA and R.J. Reynolds</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Broward</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$2 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$2 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Appeals by defendants and plaintiff to Fourth District Court of Appeal pending.</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Landi</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">June 2018</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA and R.J. Reynolds</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Broward</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$8 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$5 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Appeals by plaintiff and defendants to Fourth District Court of Appeal pending.</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">R. Douglas</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">November 2017</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Duval</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">&lt;$1 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$0</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Awaiting entry of final judgment by the trial court.</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Sommers</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">April 2017</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Miami-Dade</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$1 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$0</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Third District Court of Appeal affirmed compensatory damages award and granted new trial on punitive damages. Defendant petitioned Florida Supreme Court for review.</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Santoro</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">March 2017</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA, R.J. Reynolds and Liggett Group</span><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup></span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Broward</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$2 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$0</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Trial court set aside punitive damages award; appeals by plaintiff and defendants to Fourth District Court of Appeal pending.</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Cooper (Blackwood)</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">September 2015</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA and R.J. Reynolds</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Broward</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$5 million <br/>(&lt;$1 million PM USA)</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$0</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Fourth District Court of Appeal affirmed judgment and granted a new trial on punitive damages.</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">D. Brown</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">January 2015</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Federal Court - Middle District of Florida</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$8 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$9 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Appeal by defendant to U.S. Court of Appeals for the Eleventh Circuit pending. </span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Kerrivan</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">October 2014</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA and R.J. Reynolds</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Federal Court - Middle District of Florida</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$16 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$16 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">U.S. Court of Appeals for the Eleventh Circuit affirmed the judgment. Defendants’ motion for rehearing pending.</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Harris</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">July 2014</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA, <br/>R.J. Reynolds and Lorillard</span><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup></span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Federal Court - Middle District of Florida</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$2 million (&lt;$ 1 million PM USA) </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$0</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Appeals by plaintiff and defendants to U.S. Court of Appeals for the Eleventh Circuit pending.</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(1)</span><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt"> </sup></span><span style="font-family:inherit;font-size:9pt;">PM USA’s portion of the compensatory damages award is noted parenthetically where the court has ruled that comparative fault applies. </span></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(2) Plaintiff’s verdict following a retrial of an initial verdict in favor of plaintiff.</span></div><div style="line-height:120%;text-align:left;padding-left:18px;text-indent:-18px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(3) References to “R.J. Reynolds,” “Liggett Group” and “Lorillard” are to R.J. Reynolds Tobacco Company, Liggett Group, LLC and Lorillard Tobacco Company, respectively.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:13%;"/><td style="width:13%;"/><td style="width:16%;"/><td style="width:13%;"/><td style="width:18%;"/><td style="width:12%;"/><td style="width:15%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" style="padding-left:0px;padding-right:0px;padding-top:4px;padding-bottom:4px;"><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Engle Cases Concluded Within Past 12 Months</span><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">(rounded to nearest $ million)</span></div></td></tr><tr><td style="width:13%;"/><td style="width:13%;"/><td style="width:14%;"/><td style="width:13%;"/><td style="width:20%;"/><td style="width:13%;"/><td style="width:14%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Plaintiff</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Verdict Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Defendant(s)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Court</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Accrual Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Payment Amount</span></div><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(if any)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Payment Date</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Theis</span><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">May 2018</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA and <br/>R.J. Reynolds</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Sarasota</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">First quarter of 2020</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$17 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">February 2020</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Alvarez Del Real</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">September 2019</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Miami-Dade</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Fourth quarter of 2019</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">&lt;$1 million</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">October 2019</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" style="padding-left:0px;padding-right:0px;padding-top:4px;padding-bottom:4px;"><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Engle Cases Concluded Within Past 12 Months</span><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">(rounded to nearest $ million)</span></div></td></tr><tr><td style="width:13%;"/><td style="width:13%;"/><td style="width:14%;"/><td style="width:13%;"/><td style="width:20%;"/><td style="width:13%;"/><td style="width:14%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Plaintiff</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Verdict Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Defendant(s)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Court</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Accrual Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Payment Amount</span></div><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(if any)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Payment Date</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;background-color:#cceeff;font-style:italic;">Zingaro</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">May 2019</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA and <br/>R.J. Reynolds</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Broward </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Third quarter of 2019</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">&lt;$1 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">October 2019</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Bryant</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">December 2017</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Escambia</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Second quarter of 2019</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">&lt;$1 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">July 2019</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;background-color:#cceeff;font-style:italic;">Wallace</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">October 2017</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA and <br/>R.J. Reynolds</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Brevard</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Second quarter of 2019</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$26 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">May 2019</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">J. Brown</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">February 2017</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA and <br/>R.J. Reynolds</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Pinellas</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">First quarter of 2019</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$4 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">April 2019</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;background-color:#cceeff;font-style:italic;">L. Martin</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">May 2017</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Miami-Dade</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">First quarter of 2019</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$2 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">April 2019</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Danielson</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">November 2015</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Escambia</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">First quarter of 2019</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$3 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">March 2019</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;background-color:#cceeff;font-style:italic;">S. Martin </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">November 2016</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;background-color:#cceeff;">PM USA and <br/>R.J. Reynolds</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Broward</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">First quarter of 2019</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$5 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">March 2019</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Searcy</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">April 2013</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA and <br/>R.J. Reynolds</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Federal Court - Middle District of Florida</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Third quarter of 2018</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$2 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">March 2019</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Boatright</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">November 2014</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA and Liggett Group</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Polk</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Second quarter of 2018</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$42 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">March 2019</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">M. Brown</span><span style="font-family:inherit;font-size:9pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;background-color:transparent; font-size:6pt">(3)</sup></span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">May 2015</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Duval</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Second quarter of 2018</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$8 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">March 2019</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Jordan</span><span style="font-family:inherit;font-size:9pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(4)</sup></span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">August 2015</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Duval</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Second quarter of 2018</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$11 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">March 2019</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Pardue</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">December 2016</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA and <br/>R.J. Reynolds</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Alachua</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Second and Third quarters of 2018</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$11 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">March 2019</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">McKeever</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">February 2015</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Broward</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Fourth quarter of 2017</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$21 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">March 2019</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;padding-left:18px;text-indent:-18px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(1)</span><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt"> </sup></span><span style="font-family:inherit;font-size:9pt;">In two cases in which PM USA paid the judgments more than a year ago, </span><span style="font-family:inherit;font-size:9pt;font-style:italic;">Naugle</span><span style="font-family:inherit;font-size:9pt;"> and </span><span style="font-family:inherit;font-size:9pt;font-style:italic;">Gore</span><span style="font-family:inherit;font-size:9pt;">, plaintiffs were awarded approximately </span><span style="font-family:inherit;font-size:9pt;"><span>$8 million</span></span><span style="font-family:inherit;font-size:9pt;"> and approximately </span><span style="font-family:inherit;font-size:9pt;"><span>$2 million</span></span><span style="font-family:inherit;font-size:9pt;"> in fees and other costs, respectively.  In both cases, PM USA has appealed.</span></div><div style="line-height:120%;text-align:left;padding-left:18px;text-indent:-18px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(2) In February 2020, the Florida Second District Court of Appeal denied PM USA’s petition for review.  As a result, in the first quarter of 2020, PM USA recorded a pre-tax provision of approximately </span><span style="font-family:inherit;font-size:9pt;"><span>$17 million</span></span><span style="font-family:inherit;font-size:9pt;"> for the judgment plus interest, which was subsequently paid in the first quarter of 2020.</span></div><div style="line-height:120%;text-align:left;padding-left:18px;text-indent:-18px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(3) The trial court also awarded plaintiff approximately </span><span style="font-family:inherit;font-size:9pt;"><span>$9 million</span></span><span style="font-family:inherit;font-size:9pt;"> in fees, interest and costs.  PM USA and plaintiff have appealed.</span></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(4) The trial court also awarded plaintiff approximately </span><span style="font-family:inherit;font-size:9pt;"><span>$4 million</span></span><span style="font-family:inherit;font-size:9pt;"> in fees and costs. PM USA and plaintiff have appealed.</span></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Florida Bond Statute </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In June 2009, Florida amended its existing bond cap statute by adding a </span><span style="font-family:inherit;font-size:10pt;"><span>$200 million</span></span><span style="font-family:inherit;font-size:10pt;"> bond cap that applies to all state </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Engle</span><span style="font-family:inherit;font-size:10pt;"> progeny lawsuits in the aggregate and establishes individual bond caps for individual </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Engle</span><span style="font-family:inherit;font-size:10pt;"> progeny cases in amounts that vary depending on the number of judgments in effect at a given time. Plaintiffs have been unsuccessful in various challenges to the bond cap statute in Florida state court.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">No federal court has yet addressed the constitutionality of the bond cap statute or the applicability of the bond cap to </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Engle </span><span style="font-family:inherit;font-size:10pt;">progeny cases tried in federal court.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">From time to time, legislation has been presented to the Florida legislature that would repeal the bond cap statute; however to date, no legislation repealing the statute has passed.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Other Smoking and Health Class Actions</span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Since the dismissal in May 1996 of a purported nationwide class action brought on behalf of allegedly addicted smokers, plaintiffs have filed numerous putative smoking and health class action suits in various state and federal courts. In general, these cases purport to be brought on behalf of residents of a particular state or states (although a few cases purport to be nationwide in scope) and raise addiction claims and, in many cases, claims of physical injury as well.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Class certification has been denied or reversed by courts in </span><span style="font-family:inherit;font-size:10pt;"><span>61</span></span><span style="font-family:inherit;font-size:10pt;"> smoking and health class actions involving PM USA in Arkansas (</span><span style="font-family:inherit;font-size:10pt;"><span>1</span></span><span style="font-family:inherit;font-size:10pt;">), California (</span><span style="font-family:inherit;font-size:10pt;"><span>1</span></span><span style="font-family:inherit;font-size:10pt;">), Delaware (</span><span style="font-family:inherit;font-size:10pt;"><span>1</span></span><span style="font-family:inherit;font-size:10pt;">), the District of Columbia (</span><span style="font-family:inherit;font-size:10pt;"><span>2</span></span><span style="font-family:inherit;font-size:10pt;">), Florida (</span><span style="font-family:inherit;font-size:10pt;"><span>2</span></span><span style="font-family:inherit;font-size:10pt;">), Illinois (</span><span style="font-family:inherit;font-size:10pt;"><span>3</span></span><span style="font-family:inherit;font-size:10pt;">), Iowa (</span><span style="font-family:inherit;font-size:10pt;"><span>1</span></span><span style="font-family:inherit;font-size:10pt;">), Kansas (</span><span style="font-family:inherit;font-size:10pt;"><span>1</span></span><span style="font-family:inherit;font-size:10pt;">), Louisiana (</span><span style="font-family:inherit;font-size:10pt;"><span>1</span></span><span style="font-family:inherit;font-size:10pt;">), Maryland (</span><span style="font-family:inherit;font-size:10pt;"><span>1</span></span><span style="font-family:inherit;font-size:10pt;">), Michigan (</span><span style="font-family:inherit;font-size:10pt;"><span>1</span></span><span style="font-family:inherit;font-size:10pt;">), Minnesota (</span><span style="font-family:inherit;font-size:10pt;"><span>1</span></span><span style="font-family:inherit;font-size:10pt;">), Nevada (</span><span style="font-family:inherit;font-size:10pt;"><span>29</span></span><span style="font-family:inherit;font-size:10pt;">), New Jersey (</span><span style="font-family:inherit;font-size:10pt;"><span>6</span></span><span style="font-family:inherit;font-size:10pt;">), New York (</span><span style="font-family:inherit;font-size:10pt;"><span>2</span></span><span style="font-family:inherit;font-size:10pt;">), Ohio (</span><span style="font-family:inherit;font-size:10pt;"><span>1</span></span><span style="font-family:inherit;font-size:10pt;">), Oklahoma (</span><span style="font-family:inherit;font-size:10pt;"><span>1</span></span><span style="font-family:inherit;font-size:10pt;">), Oregon (</span><span style="font-family:inherit;font-size:10pt;"><span>1</span></span><span style="font-family:inherit;font-size:10pt;">), Pennsylvania (</span><span style="font-family:inherit;font-size:10pt;"><span>1</span></span><span style="font-family:inherit;font-size:10pt;">), Puerto Rico (</span><span style="font-family:inherit;font-size:10pt;"><span>1</span></span><span style="font-family:inherit;font-size:10pt;">), South Carolina (</span><span style="font-family:inherit;font-size:10pt;"><span>1</span></span><span style="font-family:inherit;font-size:10pt;">), Texas (</span><span style="font-family:inherit;font-size:10pt;"><span>1</span></span><span style="font-family:inherit;font-size:10pt;">) and Wisconsin (</span><span style="font-family:inherit;font-size:10pt;"><span>1</span></span><span style="font-family:inherit;font-size:10pt;">). See </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Certain Other Tobacco-Related </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Litigation </span><span style="font-family:inherit;font-size:10pt;">below for a discussion of “Lights” and “Ultra Lights” class action cases and medical monitoring class action cases pending against PM USA. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of April 27, 2020, PM USA and Altria are named as defendants, along with other cigarette manufacturers, in </span><span style="font-family:inherit;font-size:10pt;"><span>seven</span></span><span style="font-family:inherit;font-size:10pt;"> class actions filed in the Canadian provinces of Alberta, Manitoba, Nova Scotia, Saskatchewan, British Columbia and Ontario. In Saskatchewan, British Columbia (</span><span style="font-family:inherit;font-size:10pt;"><span>two</span></span><span style="font-family:inherit;font-size:10pt;"> separate cases) and Ontario, plaintiffs seek class certification on behalf of individuals who suffer or have suffered from various diseases, including chronic obstructive pulmonary disease, emphysema, heart disease or cancer, after smoking defendants’ cigarettes. In the actions filed in Alberta, Manitoba and Nova Scotia, plaintiffs seek certification of classes of all individuals who smoked defendants’ cigarettes. In March 2019, all of these class actions were stayed as a result of </span><span style="font-family:inherit;font-size:10pt;"><span>three</span></span><span style="font-family:inherit;font-size:10pt;"> Canadian tobacco manufacturers (none of which is related to Altria or its subsidiaries) seeking protection under Canada’s Companies’ Creditors Arrangement Act (which is similar to Chapter 11 bankruptcy in the U.S.). The companies entered into these proceedings following a Canadian appellate court upholding </span><span style="font-family:inherit;font-size:10pt;"><span>two</span></span><span style="font-family:inherit;font-size:10pt;"> smoking and health class action verdicts against those companies totaling approximately CAD </span><span style="font-family:inherit;font-size:10pt;"><span>$13 billion</span></span><span style="font-family:inherit;font-size:10pt;">. See </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Guarantees and Other Similar Matters</span><span style="font-family:inherit;font-size:10pt;"> below for a discussion of the Distribution Agreement between Altria and PMI, which provides for indemnities for certain liabilities concerning tobacco products. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Health Care Cost Recovery Litigation</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Overview </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In the health care cost recovery litigation, governmental entities seek reimbursement of health care cost expenditures allegedly caused by tobacco products and, in some cases, of future expenditures and damages. Relief sought by some but not all plaintiffs includes punitive damages, multiple damages and other statutory damages and penalties, injunctions prohibiting alleged marketing and sales to minors, disclosure of research, disgorgement of profits, funding of anti-smoking programs, additional disclosure of nicotine yields, and payment of attorney and expert witness fees. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Although there have been some decisions to the contrary, most judicial decisions in the U.S. have dismissed all or most health care cost recovery claims against cigarette manufacturers. Nine federal circuit courts of appeals and eight state appellate courts, relying primarily on grounds that plaintiffs’ claims were too remote, have ordered or affirmed dismissals of health care cost recovery actions. The United States Supreme Court has refused to consider plaintiffs’ appeals from the cases decided by five federal circuit courts of appeal. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In addition to the cases brought in the U.S., health care cost recovery actions have also been brought against tobacco industry participants, including PM USA and Altria, in Canada (</span><span style="font-family:inherit;font-size:10pt;"><span>10</span></span><span style="font-family:inherit;font-size:10pt;"> cases), and other entities have stated that they are considering filing such actions.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Since the beginning of 2008, the Canadian Provinces of British Columbia, New Brunswick, Ontario, Newfoundland and Labrador, Quebec, Alberta, Manitoba, Saskatchewan, Prince Edward Island and Nova Scotia have brought health care reimbursement claims against cigarette manufacturers. PM USA is named as a defendant in the British Columbia and Quebec cases, while both Altria and PM USA are named as defendants in the New Brunswick, Ontario, Newfoundland and Labrador, Alberta, Manitoba, Saskatchewan, Prince Edward Island and Nova Scotia cases. The Nunavut Territory and Northwest Territory have passed legislation permitting similar claims, but lawsuits based on this legislation have not been filed. All of these cases have been stayed pending resolution of proceedings in Canada involving </span><span style="font-family:inherit;font-size:10pt;"><span>three</span></span><span style="font-family:inherit;font-size:10pt;"> tobacco manufacturers (none of which are affiliated with Altria or its subsidiaries) under the Creditors Arrangement Act discussed above. See </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Smoking and Health Litigation - Other Smoking and Health Class Actions</span><span style="font-family:inherit;font-size:10pt;"> above for a discussion of these proceedings. See </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Guarantees and Other Similar Matters</span><span style="font-family:inherit;font-size:10pt;"> below for a discussion of the Distribution Agreement between Altria and PMI that provides for indemnities for certain liabilities concerning tobacco products. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Settlements of Health Care Cost Recovery Litigation </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In </span><span style="font-family:inherit;font-size:10pt;">November 1998</span><span style="font-family:inherit;font-size:10pt;">, PM USA and certain other tobacco product manufacturers entered into the MSA with </span><span style="font-family:inherit;font-size:10pt;"><span>46</span></span><span style="font-family:inherit;font-size:10pt;"> states, the District of Columbia and certain U.S. territories to settle asserted and unasserted health care cost recovery and other claims. PM USA and certain other tobacco product manufacturers had previously entered into agreements to settle similar claims brought by Mississippi, Florida, Texas and Minnesota (together with the MSA, the “State Settlement Agreements”). The State Settlement Agreements require that the original participating manufacturers or “OPMs” (now PM USA and R.J. Reynolds and, with respect to certain brands, ITG Brands, LLC (“ITG”)) make annual payments of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$9.4 billion</span></span><span style="font-family:inherit;font-size:10pt;">, subject to adjustments for several factors, including inflation, market share and industry volume. In addition, the OPMs are required to pay settling plaintiffs’ attorneys’ fees, subject to an annual cap of </span><span style="font-family:inherit;font-size:10pt;"><span>$500 million</span></span><span style="font-family:inherit;font-size:10pt;">. For the three months ended March 31, 2020 and </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019, the aggregate amount recorded in cost of sales with respect to the State Settlement Agreements was approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$1.1</span></span><span style="font-family:inherit;font-size:10pt;"> billion and </span><span style="font-family:inherit;font-size:10pt;"><span>$0.9 billion</span></span><span style="font-family:inherit;font-size:10pt;">, respectively. These amounts include PM USA’s estimate of amounts related to NPM Adjustments discussed below.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">NPM Adjustment Disputes</span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">PM USA is participating in proceedings regarding the NPM Adjustment for 2003-2019. The “NPM Adjustment” is a reduction in MSA payments made by the OPMs and those manufacturers that are subsequent signatories to the MSA (collectively, the “participating manufacturers” or “PMs”) that applies if the PMs collectively lose at least a specified level of market share to non-participating manufacturers since 1997, subject to certain conditions and defenses. The independent auditor (the “IA”) appointed under the MSA calculates the maximum amount of the NPM Adjustment, if any, for each year.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">NPM Adjustment Disputes - Settlement with</span><span style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;"> </span><span style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;"><span>36</span></span><span style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;"> </span><span style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">States and Territories and Settlement with New York</span><span style="font-family:inherit;font-size:10pt;font-style:italic;">. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">PM USA has entered into </span><span style="font-family:inherit;font-size:10pt;"><span>two</span></span><span style="font-family:inherit;font-size:10pt;"> settlements of NPM Adjustment disputes with a total of </span><span style="font-family:inherit;font-size:10pt;"><span>37</span></span><span style="font-family:inherit;font-size:10pt;"> states and territories, one with </span><span style="font-family:inherit;font-size:10pt;"><span>36</span></span><span style="font-family:inherit;font-size:10pt;"> states and territories (the “multi-state settlement”) and the other with the State of New York. In the multi-state settlement, PM USA, by the end of October 2017, had settled the NPM Adjustment disputes for 2003-2015 with </span><span style="font-family:inherit;font-size:10pt;"><span>26</span></span><span style="font-family:inherit;font-size:10pt;"> states in exchange for a total of </span><span style="font-family:inherit;font-size:10pt;"><span>$740 million</span></span><span style="font-family:inherit;font-size:10pt;">. In 2018, there were </span><span style="font-family:inherit;font-size:10pt;"><span>two</span></span><span style="font-family:inherit;font-size:10pt;"> principal developments with respect to this settlement. First, PM USA agreed to settle the NPM Adjustment disputes for 2016 and 2017 with the </span><span style="font-family:inherit;font-size:10pt;"><span>26</span></span><span style="font-family:inherit;font-size:10pt;"> states mentioned above. Second, PM USA settled the NPM Adjustment disputes for 2004-2017 with </span><span style="font-family:inherit;font-size:10pt;"><span>ten</span></span><span style="font-family:inherit;font-size:10pt;"> additional states. As a result of these </span><span style="font-family:inherit;font-size:10pt;"><span>two</span></span><span style="font-family:inherit;font-size:10pt;"> developments, PM USA will receive approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$248 million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$68 million</span></span><span style="font-family:inherit;font-size:10pt;"> of which it received in April 2018, </span><span style="font-family:inherit;font-size:10pt;"><span>$121 million</span></span><span style="font-family:inherit;font-size:10pt;"> of which it received in April 2019 and </span><span style="font-family:inherit;font-size:10pt;"><span>$47 million</span></span><span style="font-family:inherit;font-size:10pt;"> of which it received in April 2020. In connection with these </span><span style="font-family:inherit;font-size:10pt;"><span>two</span></span><span style="font-family:inherit;font-size:10pt;"> developments, PM USA recorded a reduction to cost of sales in the amount of </span><span style="font-family:inherit;font-size:10pt;"><span>$39 million</span></span><span style="font-family:inherit;font-size:10pt;"> in 2017 and in the amount of </span><span style="font-family:inherit;font-size:10pt;"><span>$209 million</span></span><span style="font-family:inherit;font-size:10pt;"> in 2018. In the first quarter of 2019, PM USA also recorded a reduction to cost of sales in the amount of </span><span style="font-family:inherit;font-size:10pt;"><span>$52 million</span></span><span style="font-family:inherit;font-size:10pt;"> for its estimate of the 2018 NPM Adjustment settlement credit it expects to receive under the multi-state settlement.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In the first quarter of 2020, the PMs agreed that certain conditions set forth in the multi-state settlement by the </span><span style="font-family:inherit;font-size:10pt;"><span>10</span></span><span style="font-family:inherit;font-size:10pt;"> states that settled the NPM Adjustment in 2018 had been met. As a result, PM USA’s and the other PMs’ settlement with Pennsylvania was extended to include NPM Adjustments for 2018-2024, and settlements with the other </span><span style="font-family:inherit;font-size:10pt;"><span>nine</span></span><span style="font-family:inherit;font-size:10pt;"> states were extended to include NPM Adjustments for 2018-2019. As a result of this development, PM USA will receive approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$43 million</span></span><span style="font-family:inherit;font-size:10pt;"> in credits to offset PM USA’s MSA payments over </span><span style="font-family:inherit;font-size:10pt;"><span>nine years</span></span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In the NPM Adjustment settlement with New York, which was entered into in 2015, PM USA has received approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$317 million</span></span><span style="font-family:inherit;font-size:10pt;"> for 2004-2018. PM USA and the other participating manufacturers are involved in a proceeding pursuant to the New York settlement in which an independent investigator will determine the amounts due to the participating manufacturers from New York for 2019 and 2020. PM USA expects to receive such amounts in April 2021 and April 2022, respectively.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Both the New York settlement and the multi-state settlement also contain provisions resolving certain disputes regarding the application of the NPM Adjustment going forward.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">2003 and Subsequent NPM Adjustments - Continuing Disputes with States that have not Settled</span><span style="font-family:inherit;font-size:10pt;font-style:italic;">. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">▪</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">2003 NPM Adjustment.</span><span style="font-family:inherit;font-size:10pt;"> In September 2013, an arbitration panel issued rulings regarding the </span><span style="font-family:inherit;font-size:10pt;"><span>15</span></span><span style="font-family:inherit;font-size:10pt;"> states and territories that remained in the arbitration, ruling that </span><span style="font-family:inherit;font-size:10pt;"><span>six</span></span><span style="font-family:inherit;font-size:10pt;"> of them did not establish valid defenses to the NPM Adjustment for 2003. In June 2014, </span><span style="font-family:inherit;font-size:10pt;"><span>two</span></span><span style="font-family:inherit;font-size:10pt;"> of these </span><span style="font-family:inherit;font-size:10pt;"><span>six</span></span><span style="font-family:inherit;font-size:10pt;"> states joined the multi-state settlement discussed above. With respect to the remaining </span><span style="font-family:inherit;font-size:10pt;"><span>four</span></span><span style="font-family:inherit;font-size:10pt;"> states, following the outcome of challenges in state courts, PM USA ultimately recorded </span><span style="font-family:inherit;font-size:10pt;"><span>$74 million</span></span><span style="font-family:inherit;font-size:10pt;"> primarily as a reduction to cost of sales. Subsequently, another </span><span style="font-family:inherit;font-size:10pt;">one</span><span style="font-family:inherit;font-size:10pt;"> of the </span><span style="font-family:inherit;font-size:10pt;"><span>six</span></span><span style="font-family:inherit;font-size:10pt;"> states joined the multi-state settlement. </span><span style="font-family:inherit;font-size:10pt;"><span>Two</span></span><span style="font-family:inherit;font-size:10pt;"> potential disputes remain outstanding regarding the amount of interest due to PM USA and there is no assurance that PM USA will prevail in either of these disputes.</span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">▪</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">2004 and Subsequent NPM Adjustments.</span><span style="font-family:inherit;font-size:10pt;"> PM USA has continued to pursue the NPM Adjustments for 2004 and subsequent years in multi-state arbitrations against the states that did not join either of the settlements discussed above. In September 2019, a New Mexico state appellate court affirmed a trial court’s order compelling New Mexico to arbitrate the 2004 NPM Adjustment claims in the multi-state arbitration with the other states. In November 2019, the New Mexico Supreme Court declined to review that decision. The arbitration hearing has not yet been scheduled. The Montana state courts ruled that Montana may litigate its claims in state court, rather than participate in a multi-state arbitration and the PMs have agreed not to contest the applicability of the 2004 NPM Adjustment to Montana. In April 2020, the State of Montana filed a motion in Montana state court against the PMs, including PM USA and a Nat </span></div></td></tr></table><div style="line-height:120%;padding-left:48px;text-align:left;"><span style="font-family:inherit;font-size:10pt;">Sherman affiliate, claiming that Montana’s share of the NPM Adjustment amounts should be paid to the state in advance of the resolution of disputes over the applicability of those adjustments. PM USA and the Nat Sherman affiliate have been placing the disputed NPM Adjustment amounts in the disputed payments account established pursuant to the terms of the MSA. Montana seeks a total of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$43 million</span></span><span style="font-family:inherit;font-size:10pt;"> in disputed payments from all defendants combined, as well as treble and punitive damages. </span></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The hearings in a 2004 multi-state arbitration with all of the states that have not settled other than Montana and New Mexico concluded in July 2019. As of April 27, 2020, no decisions have resulted from the arbitration.</span></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">No assurance can be given as to when proceedings for 2005 and subsequent years will be scheduled or the precise form those proceedings will take.</span></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The IA has calculated that PM USA’s share of the maximum potential NPM Adjustments for 2004-2018 is (exclusive of interest or earnings): </span><span style="font-family:inherit;font-size:10pt;"><span>$388 million</span></span><span style="font-family:inherit;font-size:10pt;"> for 2004; </span><span style="font-family:inherit;font-size:10pt;"><span>$181 million</span></span><span style="font-family:inherit;font-size:10pt;"> for 2005; </span><span style="font-family:inherit;font-size:10pt;"><span>$154 million</span></span><span style="font-family:inherit;font-size:10pt;"> for 2006; </span><span style="font-family:inherit;font-size:10pt;"><span>$185 million</span></span><span style="font-family:inherit;font-size:10pt;"> for 2007; </span><span style="font-family:inherit;font-size:10pt;"><span>$250 million</span></span><span style="font-family:inherit;font-size:10pt;"> for 2008; </span><span style="font-family:inherit;font-size:10pt;"><span>$211 million</span></span><span style="font-family:inherit;font-size:10pt;"> for 2009; </span><span style="font-family:inherit;font-size:10pt;"><span>$218 million</span></span><span style="font-family:inherit;font-size:10pt;"> for 2010; </span><span style="font-family:inherit;font-size:10pt;"><span>$166 million</span></span><span style="font-family:inherit;font-size:10pt;"> for 2011; </span><span style="font-family:inherit;font-size:10pt;"><span>$214 million</span></span><span style="font-family:inherit;font-size:10pt;"> for 2012; </span><span style="font-family:inherit;font-size:10pt;"><span>$224 million</span></span><span style="font-family:inherit;font-size:10pt;"> for 2013; </span><span style="font-family:inherit;font-size:10pt;"><span>$258 million</span></span><span style="font-family:inherit;font-size:10pt;"> for 2014; </span><span style="font-family:inherit;font-size:10pt;"><span>$313 million</span></span><span style="font-family:inherit;font-size:10pt;"> for 2015; </span><span style="font-family:inherit;font-size:10pt;"><span>$305 million</span></span><span style="font-family:inherit;font-size:10pt;"> for 2016; </span><span style="font-family:inherit;font-size:10pt;"><span>$297 million</span></span><span style="font-family:inherit;font-size:10pt;"> for 2017; </span><span style="font-family:inherit;font-size:10pt;"><span>$340 million</span></span><span style="font-family:inherit;font-size:10pt;"> for 2018 and </span><span style="font-family:inherit;font-size:10pt;"><span>$441 million</span></span><span style="font-family:inherit;font-size:10pt;"> for 2019. These maximum amounts will be reduced, likely substantially, to reflect the settlements with the signatory states and New York, and potentially for current and future calculation disputes and other developments. Finally, PM USA’s recovery of these amounts, even as reduced, is dependent upon subsequent determinations regarding state-specific defenses and disputes with other PMs. </span></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Other Disputes Under the State Settlement Agreements</span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The payment obligations of the tobacco product manufacturers that are parties to the State Settlement Agreements, as well as the allocations of any NPM Adjustments and related settlements, have been and may continue to be affected by R.J. Reynolds’s acquisition of Lorillard and its related sale of certain cigarette brands to ITG (the “ITG brands”). In particular, R.J. Reynolds and ITG have asserted that they do not have to make payments on the ITG brands under the Florida, Minnesota and Texas State Settlement Agreements or include the ITG brands for purposes of certain calculations under the State Settlement Agreements. PM USA believes that R.J. Reynolds’s and ITG’s position violates the State Settlement Agreements and applicable law. PM USA further believes that these actions: (i) improperly increased PM USA’s payments for 2015-2019; (ii) may improperly increase PM USA’s payments for subsequent years; (iii) improperly decreased PM USA’s share of the 2015-2019 NPM Adjustments and of the settlements of related disputes; and (iv) may improperly decrease PM USA’s share of NPM Adjustments and related settlements for subsequent years. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In January 2017, PM USA and the State of Florida each filed a motion in Florida state court against R.J. Reynolds and ITG seeking to enforce the Florida State Settlement Agreement. In August 2018, the Florida trial court entered final judgment ruling that R.J. Reynolds (and not ITG) must make settlement payments under the Florida State Settlement Agreement on the ITG brands, and ordering R.J. Reynolds to pay PM USA approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$9.8 million</span></span><span style="font-family:inherit;font-size:10pt;"> (inclusive of interest) for the 2015-2017 period. R.J. Reynolds and PM USA have each filed notices of appeal of the trial court’s decision, which proceedings may result in further modifications to PM USA’s settlement payments under the Florida State Settlement Agreement. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In March 2018, PM USA and the State of Minnesota filed pleadings in Minnesota state court asserting claims against R.J. Reynolds and ITG, similar to those made in Florida, and seeking to enforce the Minnesota State Settlement Agreement. In September 2019, the Minnesota court granted the State of Minnesota’s and PM USA’s motions to enforce the agreement against R.J. Reynolds. The Minnesota court concluded, however, that it could not yet resolve the question of ITG’s liability under the Minnesota State Settlement Agreement. An evidentiary hearing on the question of ITG’s potential liability is to be held in 2020.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In December 2018, PM USA filed a motion in Mississippi state court seeking to enforce the Mississippi State Settlement Agreement against R.J. Reynolds and ITG with respect to the accuracy of certain submissions made by R.J. Reynolds and ITG concerning the calculation of payments relating to the ITG brands. In December 2019, in a separate matter, the State of Mississippi filed a motion in Mississippi state court seeking to enforce the Mississippi State Settlement Agreement against PM USA, R.J. Reynolds and ITG concerning the calculation of the April 2019 payments.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In January 2019, PM USA and the State of Texas each filed a motion in federal court in the Eastern District of Texas asserting claims against R.J. Reynolds and ITG, similar to those made in Florida and Minnesota, seeking to enforce the Texas State Settlement Agreement. On February 25, 2020, the Texas court granted the State of Texas’ and PM USA’s motions to enforce the settlement agreement against R.J. Reynolds. The Texas court, however, deferred the ultimate resolution of the motions to </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">enforce against ITG, because it concluded that question was dependent upon the outcome of separate litigation pending between ITG and R.J. Reynolds in the Delaware Court of Chancery.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Federal Government’s Lawsuit </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In 1999, the United States government filed a lawsuit in the U.S. District Court for the District of Columbia against various cigarette manufacturers, including PM USA, and others, including Altria, asserting claims under three federal statutes. The case ultimately proceeded only under the civil provisions of RICO. In August 2006, the district court held that certain defendants, including Altria and PM USA, violated RICO and engaged in </span><span style="font-family:inherit;font-size:10pt;">seven</span><span style="font-family:inherit;font-size:10pt;"> of the </span><span style="font-family:inherit;font-size:10pt;">eight</span><span style="font-family:inherit;font-size:10pt;"> “sub-schemes” to defraud that the government had alleged. Specifically, the court found that: </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">▪</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">defendants falsely denied, distorted and minimized the significant adverse health consequences of smoking; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">▪</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">defendants hid from the public that cigarette smoking and nicotine are addictive; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">▪</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">defendants falsely denied that they control the level of nicotine delivered to create and sustain addiction; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">▪</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">defendants falsely marketed and promoted “low tar/light” cigarettes as less harmful than full-flavor cigarettes; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">▪</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">defendants falsely denied that they intentionally marketed to youth; </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">▪</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">defendants publicly and falsely denied that ETS is hazardous to non-smokers; and </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">▪</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">defendants suppressed scientific research.</span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The court did not impose monetary penalties on defendants, but ordered the following relief: (i) an injunction against “committing any act of racketeering” relating to the manufacturing, marketing, promotion, health consequences or sale of cigarettes in the United States; (ii) an injunction against participating directly or indirectly in the management or control of the Council for Tobacco Research, the Tobacco Institute, or the Center for Indoor Air Research, or any successor or affiliated entities of each; (iii) an injunction against “making, or causing to be made in any way, any material false, misleading, or deceptive statement or representation or engaging in any public relations or marketing endeavor that is disseminated to the United States public and that misrepresents or suppresses information concerning cigarettes;” (iv) an injunction against conveying any express or implied health message or health descriptors on cigarette packaging or in cigarette advertising or promotional material, including “lights,” “ultra lights” and “low tar,” which the court found could cause consumers to believe </span><span style="font-family:inherit;font-size:10pt;">one</span><span style="font-family:inherit;font-size:10pt;"> cigarette brand is less hazardous than another brand; (v) the issuance of “corrective statements” in various media regarding the adverse health effects of smoking, the addictiveness of smoking and nicotine, the lack of any significant health benefit from smoking “low tar” or “light” cigarettes, defendants’ manipulation of cigarette design to ensure optimum nicotine delivery and the adverse health effects of exposure to ETS; (vi) the disclosure on defendants’ public document websites and in the Minnesota document repository of all documents produced to the government in the lawsuit or produced in any future court or administrative action concerning smoking and health until 2021, with certain additional requirements as to documents withheld from production under a claim of privilege or confidentiality; (vii) the disclosure of disaggregated marketing data to the government in the same form and on the same schedule as defendants now follow in disclosing such data to the FTC for a period of </span><span style="font-family:inherit;font-size:10pt;"><span>10</span></span><span style="font-family:inherit;font-size:10pt;"> years; (viii) certain restrictions on the sale or transfer by defendants of any cigarette brands, brand names, formulas or cigarette businesses within the U.S.; and (ix) payment of the government’s costs in bringing the action.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Following several years of appeals relating to the content of the corrective statements remedy described above, in October 2017, the district court approved the parties’ proposed consent order implementing corrective statements in newspapers and on television. The corrective statements began appearing in newspapers and on television in the fourth quarter of 2017. In April 2018, the parties reached agreement on the implementation details of the corrective statements on websites and onserts. The corrective statements began appearing on websites in the second quarter of 2018 and the onserts began appearing in the fourth quarter of 2018.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In 2014, Altria and PM USA recorded provisions totaling </span><span style="font-family:inherit;font-size:10pt;"><span>$31 million</span></span><span style="font-family:inherit;font-size:10pt;"> for the estimated costs of implementing the corrective communications remedy. In the fourth quarter of 2019, PM USA updated its estimate and recorded approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$5 million</span></span><span style="font-family:inherit;font-size:10pt;"> for additional costs to finish implementing the corrective communications remedy. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The requirements related to corrective statements at point-of-sale remain outstanding. In May 2014, the district court ordered further briefing on the issue, which was completed in June 2014. In May 2018, the parties submitted a joint status report and additional briefing on point-of-sale signage to the district court. In May 2019, the district court ordered a hearing on the point-of-sale signage issue.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">E-vapor Product Litigation</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of April 27, 2020, Altria and/or its subsidiaries, including PM USA, were named as defendants in </span><span style="font-family:inherit;font-size:10pt;">24</span><span style="font-family:inherit;font-size:10pt;"> class action lawsuits relating to JUUL e-vapor products. JUUL is an additional named defendant in each of these lawsuits. The theories of recovery include violation of RICO, fraud, failure to warn, design defect, negligence and unfair trade practices. Plaintiffs also are seeking to add antitrust claims due to the recent action by the FTC. See </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Antitrust Litigation</span><span style="font-family:inherit;font-size:10pt;"> below for further discussion. Plaintiffs seek various remedies, including compensatory and punitive damages and an injunction prohibiting product sales. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Altria and/or its subsidiaries, including PM USA, also have been named as defendants in other lawsuits involving JUUL e-vapor products, including </span><span style="font-family:inherit;font-size:10pt;"><span>170</span></span><span style="font-family:inherit;font-size:10pt;"> individual lawsuits, </span><span style="font-family:inherit;font-size:10pt;"><span>five</span></span><span style="font-family:inherit;font-size:10pt;"> lawsuits filed by state or local governments and </span><span style="font-family:inherit;font-size:10pt;"><span>three</span></span><span style="font-family:inherit;font-size:10pt;"> lawsuits filed by school districts. JUUL is an additional named defendant in each of these lawsuits.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The majority of the individual and class action lawsuits mentioned above were filed in federal court. In October 2019, the United States Judicial Panel on Multidistrict Litigation ordered the coordination or consolidation of these lawsuits in the U.S. District Court for the Northern District of California for pretrial purposes.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">An additional group of cases is pending in California state courts. In January 2020, the Judicial Council of California determined that this group of cases was appropriate for coordination and assigned the group to the Superior Court of California, Los Angeles County, for pretrial purposes. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Neither Altria nor any of its subsidiaries has filed a response in any of these cases, and </span><span style="font-family:inherit;font-size:10pt;"><span>no</span></span><span style="font-family:inherit;font-size:10pt;"> case in which Altria or any of its subsidiaries is named has been set for trial. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">JUUL also is named in a significant number of additional individual and class action lawsuits to which neither Altria nor any of its subsidiaries is currently named.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Certain Other Tobacco-Related Litigation</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">IQOS </span><span style="font-family:inherit;font-size:10pt;">Litigation</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In April 2020, RAI Strategic Holdings, Inc. and R.J. Reynolds Vapor Co., which are affiliates of R.J. Reynolds, filed a lawsuit against Altria, PM USA, Altria Client Services LLC, PMI and its affiliate Philip Morris Products S.A., in the United States District Court for the Eastern District of Virginia. The lawsuit asserts claims of patent infringement based on the sale of the </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">IQOS</span><span style="font-family:inherit;font-size:10pt;"> electronic device and </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">HeatSticks</span><span style="font-family:inherit;font-size:10pt;"> in the United States. Plaintiffs seek various remedies, including preliminary and permanent injunctive relief, treble damages and attorneys’ fees. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Also in April 2020, a related action was filed against the same defendants by the same plaintiffs, as well as R.J. Reynolds, with the United States International Trade Commission (“ITC”). There, the plaintiffs also allege patent infringement, but the remedies sought include a prohibition on the importation of the</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> IQOS</span><span style="font-family:inherit;font-size:10pt;"> electronic device, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">HeatSticks</span><span style="font-family:inherit;font-size:10pt;"> and component parts into the United States. No damages are recoverable in the proceedings before the ITC.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">“Lights/Ultra Lights” Cases and Other Smoking and Health Class Actions</span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Plaintiffs have sought certification of their cases as class actions, alleging among other things, that the uses of the terms “Lights” and/or “Ultra Lights” constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment or breach of warranty, and have sought injunctive and equitable relief, including restitution and, in certain cases, punitive damages. These class actions have been brought against PM USA and, in certain instances, Altria or its other subsidiaries, on behalf of individuals who purchased and consumed various brands of cigarettes. Defenses raised in these cases include lack of misrepresentation, lack of causation, injury and damages, the statute of limitations, non-liability under state statutory provisions exempting conduct that complies with federal regulatory directives, and the First Amendment. </span><span style="font-family:inherit;font-size:10pt;"><span>Twenty-one</span></span><span style="font-family:inherit;font-size:10pt;"> state courts in </span><span style="font-family:inherit;font-size:10pt;"><span>23</span></span><span style="font-family:inherit;font-size:10pt;"> “Lights” cases have refused to certify class actions, dismissed class action allegations, reversed prior class certification decisions or have entered judgment in favor of PM USA. As of April 27, 2020, </span><span style="font-family:inherit;font-size:10pt;"><span>two</span></span><span style="font-family:inherit;font-size:10pt;"> “Lights/Ultra Lights” class actions are pending in U.S. state court. Neither case is active.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of April 27, 2020, </span><span style="font-family:inherit;font-size:10pt;"><span>two</span></span><span style="font-family:inherit;font-size:10pt;"> smoking and health cases alleging personal injury or seeking court-supervised programs or ongoing medical monitoring and purporting to be brought on behalf of a class of individual plaintiffs, are pending in their respective U.S. state courts. Neither case is active.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">UST Litigation</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">UST and/or its tobacco subsidiaries have been named in a number of individual tobacco and health lawsuits over time. Plaintiffs’ allegations of liability in these cases have been based on various theories of recovery, such as negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, breach of implied warranty, addiction and breach of consumer protection statutes. Plaintiffs have typically sought various forms of relief, including compensatory and punitive damages, and certain equitable relief, including but not limited to disgorgement. Defenses raised in these cases include lack of causation, assumption of the risk, comparative fault and/or contributory negligence, and statutes of limitations. As of April 27, 2020, there is </span><span style="font-family:inherit;font-size:10pt;"><span>one</span></span><span style="font-family:inherit;font-size:10pt;"> case pending against USSTC.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Antitrust Litigation </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In April 2020, the FTC issued an administrative complaint against Altria and JUUL alleging that Altria’s </span><span style="font-family:inherit;font-size:10pt;"><span>35%</span></span><span style="font-family:inherit;font-size:10pt;"> investment in JUUL and the associated agreements constitute an unreasonable restraint of trade in violation of Section 1 of the Sherman Antitrust Act of 1890 (“Sherman Act”) and Section 5 of the Federal Trade Commission Act of 1914 (“FTC Act”), and substantially lessened competition in violation of Section 7 of the Clayton Antitrust Act (“Clayton Act”). If the FTC’s challenge is successful, the FTC may order a broad range of remedies, including divestiture of Altria’s minority investment in JUUL, rescission of the transaction and all associated agreements, and prohibition against any officer or director of either Altria or JUUL serving on the other party’s board of directors or attending meetings of the other party’s board of directors. The administrative trial will take place before an FTC administrative law judge and is currently scheduled to begin March 11, 2021. Any ruling by the FTC is subject to review by the FTC Commissioners and subsequently, by a federal appellate court.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Also as of April 27, 2020, </span><span style="font-family:inherit;font-size:10pt;"><span>three</span></span><span style="font-family:inherit;font-size:10pt;"> putative class action lawsuits were filed against Altria and JUUL in the United States District Court for the Northern District of California. The lawsuits cite the FTC administrative complaint and allege that Altria and JUUL violated Sections 1 and 2 of the Sherman Act and Section 7 of the Clayton Act by restraining trade and/or substantially lessening competition in the U.S. closed-system electronic cigarette market. Plaintiffs seek various remedies, including treble damages, attorneys’ fees, a declaration that the agreements between Altria and JUUL are invalid, divestiture of Altria’s minority investment in JUUL and rescission of the transaction.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Neither the FTC nor the private plaintiffs has sought to preliminarily enjoin Altria from converting Altria’s non-voting JUUL shares to voting shares or appointing directors to the JUUL board of directors. As of April 30, 2020, Altria has not exercised these rights. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Shareholder Class Actions</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In October and December 2019, </span><span style="font-family:inherit;font-size:10pt;"><span>two</span></span><span style="font-family:inherit;font-size:10pt;"> purported Altria shareholders filed putative class action lawsuits against Altria, Howard A. Willard III, Altria’s former Chairman and Chief Executive Officer, and William F. Gifford, Jr., Altria’s former Vice Chairman and Chief Financial Officer and current Chief Executive Officer, in the United States District Court for the Eastern District of New York. In December 2019, the court consolidated the </span><span style="font-family:inherit;font-size:10pt;"><span>two</span></span><span style="font-family:inherit;font-size:10pt;"> lawsuits into a single proceeding. The consolidated lawsuit was subsequently transferred to the United States District Court for the Eastern District of Virginia. The lawsuit asserts claims under Sections 10(b) and 20(a) and under Rule 10b-5 of the Exchange Act. In April 2020, JUUL, its founders, and some of its current and former executives were added to the lawsuit. The claims involve allegedly false and misleading statements and omissions relating to Altria’s investment in JUUL. Plaintiffs seek various remedies, including damages and attorneys’ fees. A response to the lawsuit has not yet been filed. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Environmental Regulation</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Altria and its subsidiaries (and former subsidiaries) are subject to various federal, state and local laws and regulations concerning the discharge of materials into the environment, or otherwise related to environmental protection, including, in the U.S.: the Clean Air Act, the Clean Water Act, the Resource Conservation and Recovery Act and the Comprehensive Environmental Response, Compensation and Liability Act (commonly known as “Superfund”), which can impose joint and several liability on each responsible party. Subsidiaries (and former subsidiaries) of Altria are involved in several matters subjecting them to potential costs of remediation and natural resource damages under Superfund or other laws and regulations. Altria’s subsidiaries expect to continue to make capital and other expenditures in connection with environmental laws and regulations.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Altria provides for expenses associated with environmental remediation obligations on an undiscounted basis when such amounts are probable and can be reasonably estimated. Such accruals are adjusted as new information develops or </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">circumstances change. Other than those amounts, it is not possible to reasonably estimate the cost of any environmental remediation and compliance efforts that subsidiaries of Altria may undertake in the future. In the opinion of management, however, compliance with environmental laws and regulations, including the payment of any remediation costs or damages and the making of related expenditures, has not had, and is not expected to have, a material adverse effect on Altria’s consolidated results of operations, capital expenditures, financial position or cash flows.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Guarantees and Other Similar Matters</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In the ordinary course of business, certain subsidiaries of Altria have agreed to indemnify a limited number of third parties in the event of future litigation. At </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">, Altria and certain of its subsidiaries (i) had </span><span style="font-family:inherit;font-size:10pt;"><span>$50 million</span></span><span style="font-family:inherit;font-size:10pt;"> of unused letters of credit obtained in the ordinary course of business; (ii) were contingently liable for guarantees related to their own performance, including </span><span style="font-family:inherit;font-size:10pt;"><span>$27 million</span></span><span style="font-family:inherit;font-size:10pt;"> for surety bonds; and (iii) had a redeemable noncontrolling interest of </span><span style="font-family:inherit;font-size:10pt;"><span>$38 million</span></span><span style="font-family:inherit;font-size:10pt;"> recorded on its condensed consolidated balance sheet. In addition, from time to time, subsidiaries of Altria issue lines of credit to affiliated entities. These items have not had, and are not expected to have, a significant impact on Altria’s liquidity.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Under the terms of a distribution agreement between Altria and PMI (the “Distribution Agreement”), entered into as a result of Altria’s 2008 spin-off of its former subsidiary PMI, liabilities concerning tobacco products will be allocated based in substantial part on the manufacturer. PMI will indemnify Altria and PM USA for liabilities related to tobacco products manufactured by PMI or contract manufactured for PMI by PM USA, and PM USA will indemnify PMI for liabilities related to tobacco products manufactured by PM USA, excluding tobacco products contract manufactured for PMI. Altria does not have a related liability recorded on its condensed consolidated balance sheet at </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> as the fair value of this indemnification is insignificant.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As more fully discussed in </span><span style="font-family:inherit;font-size:10pt;">Note 12</span><span style="font-family:inherit;font-size:10pt;">. </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Condensed Consolidating Financial Information</span><span style="font-family:inherit;font-size:10pt;">, PM USA has issued guarantees relating to Altria’s obligations under its outstanding debt securities, borrowings under its </span><span style="font-family:inherit;font-size:10pt;"><span>$3.0 billion</span></span><span style="font-family:inherit;font-size:10pt;"> Credit Agreement and amounts outstanding under its commercial paper program.</span></div> 47 <div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The table below lists the number of certain tobacco-related cases pending in the U.S. against PM USA and, in some instances, Altria as of April 27, 2020, April 22, 2019 and April 23, 2018:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:56%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:14%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">April 27, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">April 22, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">April 23, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Individual Smoking and Health Cases</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt"> (1)</sup></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>109</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>98</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>102</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Health Care Cost Recovery Actions </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">E-vapor Cases</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>202</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other Tobacco-Related Cases</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(4)</sup></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(1) Includes </span><span style="font-family:inherit;font-size:9pt;"><span>22</span></span><span style="font-family:inherit;font-size:9pt;"> cases filed in Massachusetts and </span><span style="font-family:inherit;font-size:9pt;"><span>46</span></span><span style="font-family:inherit;font-size:9pt;"> non-</span><span style="font-family:inherit;font-size:9pt;font-style:italic;">Engle </span><span style="font-family:inherit;font-size:9pt;">cases filed in Florida. Does not include individual smoking and health cases brought by or on behalf of plaintiffs in Florida state and federal courts following the decertification of the </span><span style="font-family:inherit;font-size:9pt;font-style:italic;">Engle </span><span style="font-family:inherit;font-size:9pt;">case (these </span><span style="font-family:inherit;font-size:9pt;font-style:italic;">Engle</span><span style="font-family:inherit;font-size:9pt;"> progeny cases are discussed below in </span><span style="font-family:inherit;font-size:9pt;font-style:italic;">Smoking and Health Litigation - Engle Class Action</span><span style="font-family:inherit;font-size:9pt;">). Also does not include </span><span style="font-family:inherit;font-size:9pt;"><span>1,472</span></span><span style="font-family:inherit;font-size:9pt;"> cases brought by flight attendants seeking compensatory damages for personal injuries allegedly caused by exposure to environmental tobacco smoke (“ETS”). The flight attendants allege that they are members of an ETS smoking and health class action in Florida, which was settled in 1997 (</span><span style="font-family:inherit;font-size:9pt;font-style:italic;">Broin</span><span style="font-family:inherit;font-size:9pt;">). The terms of the court-approved settlement in that case allowed class members to file individual lawsuits seeking compensatory damages, but prohibited them from seeking punitive damages. In March 2018, </span><span style="font-family:inherit;font-size:9pt;"><span>923</span></span><span style="font-family:inherit;font-size:9pt;"> of these cases were voluntarily dismissed without prejudice. </span></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(2) See </span><span style="font-family:inherit;font-size:9pt;font-style:italic;">Health Care Cost Recovery Litigation - Federal Government’s Lawsuit</span><span style="font-family:inherit;font-size:9pt;"> below.</span></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(3) Includes </span><span style="font-family:inherit;font-size:9pt;"><span>24</span></span><span style="font-family:inherit;font-size:9pt;"> class action lawsuits, </span><span style="font-family:inherit;font-size:9pt;"><span>170</span></span><span style="font-family:inherit;font-size:9pt;"> individual lawsuits, </span><span style="font-family:inherit;font-size:9pt;"><span>five</span></span><span style="font-family:inherit;font-size:9pt;"> state or local government lawsuits and </span><span style="font-family:inherit;font-size:9pt;"><span>three</span></span><span style="font-family:inherit;font-size:9pt;"> lawsuits filed by school districts relating to JUUL e-vapor products. JUUL is an additional named defendant in each of these lawsuits.</span></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(4)</span><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt"> </sup></span><span style="font-family:inherit;font-size:9pt;">For 2019 and 2020, includes </span><span style="font-family:inherit;font-size:9pt;"><span>two</span></span><span style="font-family:inherit;font-size:9pt;"> inactive smoking and health cases alleging personal injury or seeking court-supervised programs or ongoing medical monitoring and purporting to be brought on behalf of a class of individual plaintiffs, including </span><span style="font-family:inherit;font-size:9pt;"><span>one</span></span><span style="font-family:inherit;font-size:9pt;"> case in which the aggregated claims of a number of individual plaintiffs are to be tried in a single proceeding, and </span><span style="font-family:inherit;font-size:9pt;"><span>two</span></span><span style="font-family:inherit;font-size:9pt;"> inactive class action lawsuits alleging that use of the terms “Lights” and “Ultra Lights” constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" style="padding-left:0px;padding-right:0px;padding-top:4px;padding-bottom:4px;"><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Currently Pending Engle Cases with Accrued Liabilities</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">(rounded to nearest $ million)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="width:10%;"/><td style="width:11%;"/><td style="width:11%;"/><td style="width:10%;"/><td style="width:12%;"/><td style="width:10%;"/><td style="width:22%;"/><td style="width:14%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Plaintiff</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Verdict Date</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Defendant(s)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Court</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Compensatory Damages (All Defendants)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Punitive Damages (PM USA)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Appeal Status</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Accrual </span><span style="font-family:inherit;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Berger </span><span style="font-family:inherit;font-size:9pt;">(</span><span style="font-family:inherit;font-size:9pt;font-style:italic;">Cote</span><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">September 2014</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Federal Court - Middle District of Florida</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$6 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$21 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">The Eleventh Circuit Court of Appeals reinstated the punitive and compensatory damages awards and remanded the case to the district court. PM USA’s challenge to the punitive damages award was denied by the district court. PM USA’s appeal to the Eleventh Circuit Court of Appeals is pending.</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$6 million accrual in the fourth quarter of 2018</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(1)</span><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt"> </sup></span><span style="font-family:inherit;font-size:9pt;">Accrual amounts include interest and associated costs, if applicable. For cases with multiple defendants, if any, accrual amounts reflect the portion of compensatory damages PM USA believes it will have to pay if the case is ultimately decided in plaintiff’s favor after taking into account any portion potentially payable by the other defendant(s). </span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" style="padding-left:0px;padding-right:0px;padding-top:4px;padding-bottom:4px;"><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Other Currently Pending Engle Cases with Verdicts Against PM USA </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">(rounded to nearest $ million)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="width:10%;"/><td style="width:12%;"/><td style="width:13%;"/><td style="width:12%;"/><td style="width:15%;"/><td style="width:11%;"/><td style="width:27%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Plaintiff</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Verdict Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Defendant(s)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Court</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Compensatory Damages </span><span style="font-family:inherit;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1) </sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Punitive Damages <br/>(PM USA)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Appeal Status</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Duignan </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">February 2020</span><span style="font-family:inherit;font-size:9pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2</sup></span><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">)</sup></span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA and <br/>R.J. Reynolds</span><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup></span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Pinellas</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$3 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$12 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Defendants’ post-trial motions pending.</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Cuddihee</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">January 2020</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Duval</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$3 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$0</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Defendant’s post-trial motions pending.</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Rintoul (Caprio)</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">November 2019</span><span style="font-family:inherit;font-size:9pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2</sup></span><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">)</sup></span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;background-color:#cceeff;">PM USA and R.J. Reynolds</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Broward</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$9 million ($5 million PM USA)</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$74 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Defendants’ post-trial motion pending.</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Gloger</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">November 2019</span><span style="font-family:inherit;font-size:9pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2</sup></span><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">)</sup></span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA and R.J. Reynolds</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Miami-Dade</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$15 million ($5 million PM USA)</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$11 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Appeal by defendants to Third District Court of Appeal pending.</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">McCall</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">March 2019</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;background-color:#cceeff;">PM USA</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Broward</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">&lt;$1 million (&lt;$1 million PM USA)</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">&lt;$1 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">New trial ordered on punitive damages.</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Neff</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">March 2019</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA and R.J. Reynolds</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Broward</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$4 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$2 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Appeals by plaintiff and defendants to Fourth District Court of Appeal pending. </span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Frogel</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">March 2019</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;background-color:#cceeff;">PM USA </span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Palm Beach</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">&lt;$1 million (&lt;$1 million PM USA)</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$0</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Appeals by plaintiff and defendant to Fourth District Court of Appeal pending.</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" style="padding-left:0px;padding-right:0px;padding-top:4px;padding-bottom:4px;"><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Other Currently Pending Engle Cases with Verdicts Against PM USA </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">(rounded to nearest $ million)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="width:10%;"/><td style="width:12%;"/><td style="width:13%;"/><td style="width:12%;"/><td style="width:15%;"/><td style="width:11%;"/><td style="width:27%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Plaintiff</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Verdict Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Defendant(s)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Court</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Compensatory Damages </span><span style="font-family:inherit;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1) </sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Punitive Damages <br/>(PM USA)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Appeal Status</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Mahfuz</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">February 2019</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA and R.J. Reynolds</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Broward</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$12 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$10 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Appeals by plaintiff and defendants to Fourth District Court of Appeal pending.</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;background-color:#cceeff;font-style:italic;">Holliman</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">February 2019</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Miami-Dade</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$3 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$0</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Defendant’s appeal to Third District Court of Appeal pending.</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Chadwell</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">September 2018</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Miami-Dade</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$2 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$0</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Appeals by defendant and plaintiff to Third District Court of Appeal pending.</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Kaplan</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">July 2018</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA and R.J. Reynolds</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Broward</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$2 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$2 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Appeals by defendants and plaintiff to Fourth District Court of Appeal pending.</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Landi</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">June 2018</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA and R.J. Reynolds</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Broward</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$8 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$5 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Appeals by plaintiff and defendants to Fourth District Court of Appeal pending.</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">R. Douglas</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">November 2017</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Duval</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">&lt;$1 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$0</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Awaiting entry of final judgment by the trial court.</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Sommers</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">April 2017</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Miami-Dade</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$1 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$0</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Third District Court of Appeal affirmed compensatory damages award and granted new trial on punitive damages. Defendant petitioned Florida Supreme Court for review.</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Santoro</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">March 2017</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA, R.J. Reynolds and Liggett Group</span><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup></span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Broward</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$2 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$0</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Trial court set aside punitive damages award; appeals by plaintiff and defendants to Fourth District Court of Appeal pending.</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Cooper (Blackwood)</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">September 2015</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA and R.J. Reynolds</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Broward</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$5 million <br/>(&lt;$1 million PM USA)</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$0</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Fourth District Court of Appeal affirmed judgment and granted a new trial on punitive damages.</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">D. Brown</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">January 2015</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Federal Court - Middle District of Florida</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$8 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$9 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Appeal by defendant to U.S. Court of Appeals for the Eleventh Circuit pending. </span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Kerrivan</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">October 2014</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA and R.J. Reynolds</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Federal Court - Middle District of Florida</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$16 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$16 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">U.S. Court of Appeals for the Eleventh Circuit affirmed the judgment. Defendants’ motion for rehearing pending.</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Harris</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">July 2014</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA, <br/>R.J. Reynolds and Lorillard</span><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup></span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Federal Court - Middle District of Florida</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$2 million (&lt;$ 1 million PM USA) </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$0</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Appeals by plaintiff and defendants to U.S. Court of Appeals for the Eleventh Circuit pending.</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(1)</span><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt"> </sup></span><span style="font-family:inherit;font-size:9pt;">PM USA’s portion of the compensatory damages award is noted parenthetically where the court has ruled that comparative fault applies. </span></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(2) Plaintiff’s verdict following a retrial of an initial verdict in favor of plaintiff.</span></div><div style="line-height:120%;text-align:left;padding-left:18px;text-indent:-18px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(3) References to “R.J. Reynolds,” “Liggett Group” and “Lorillard” are to R.J. Reynolds Tobacco Company, Liggett Group, LLC and Lorillard Tobacco Company, respectively.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:13%;"/><td style="width:13%;"/><td style="width:16%;"/><td style="width:13%;"/><td style="width:18%;"/><td style="width:12%;"/><td style="width:15%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" style="padding-left:0px;padding-right:0px;padding-top:4px;padding-bottom:4px;"><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Engle Cases Concluded Within Past 12 Months</span><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">(rounded to nearest $ million)</span></div></td></tr><tr><td style="width:13%;"/><td style="width:13%;"/><td style="width:14%;"/><td style="width:13%;"/><td style="width:20%;"/><td style="width:13%;"/><td style="width:14%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Plaintiff</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Verdict Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Defendant(s)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Court</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Accrual Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Payment Amount</span></div><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(if any)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Payment Date</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Theis</span><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">May 2018</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA and <br/>R.J. Reynolds</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Sarasota</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">First quarter of 2020</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$17 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">February 2020</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Alvarez Del Real</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">September 2019</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Miami-Dade</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Fourth quarter of 2019</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">&lt;$1 million</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">October 2019</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" style="padding-left:0px;padding-right:0px;padding-top:4px;padding-bottom:4px;"><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Engle Cases Concluded Within Past 12 Months</span><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">(rounded to nearest $ million)</span></div></td></tr><tr><td style="width:13%;"/><td style="width:13%;"/><td style="width:14%;"/><td style="width:13%;"/><td style="width:20%;"/><td style="width:13%;"/><td style="width:14%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Plaintiff</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Verdict Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Defendant(s)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Court</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Accrual Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Payment Amount</span></div><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(if any)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Payment Date</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;background-color:#cceeff;font-style:italic;">Zingaro</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">May 2019</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA and <br/>R.J. Reynolds</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Broward </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Third quarter of 2019</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">&lt;$1 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">October 2019</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Bryant</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">December 2017</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Escambia</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Second quarter of 2019</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">&lt;$1 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">July 2019</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;background-color:#cceeff;font-style:italic;">Wallace</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">October 2017</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA and <br/>R.J. Reynolds</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Brevard</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Second quarter of 2019</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$26 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">May 2019</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">J. Brown</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">February 2017</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA and <br/>R.J. Reynolds</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Pinellas</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">First quarter of 2019</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$4 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">April 2019</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;background-color:#cceeff;font-style:italic;">L. Martin</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">May 2017</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Miami-Dade</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">First quarter of 2019</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$2 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">April 2019</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Danielson</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">November 2015</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Escambia</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">First quarter of 2019</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$3 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">March 2019</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;background-color:#cceeff;font-style:italic;">S. Martin </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">November 2016</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;background-color:#cceeff;">PM USA and <br/>R.J. Reynolds</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Broward</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">First quarter of 2019</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$5 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">March 2019</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Searcy</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">April 2013</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA and <br/>R.J. Reynolds</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Federal Court - Middle District of Florida</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Third quarter of 2018</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$2 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">March 2019</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Boatright</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">November 2014</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA and Liggett Group</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Polk</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Second quarter of 2018</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$42 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">March 2019</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">M. Brown</span><span style="font-family:inherit;font-size:9pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;background-color:transparent; font-size:6pt">(3)</sup></span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">May 2015</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Duval</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Second quarter of 2018</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$8 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">March 2019</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Jordan</span><span style="font-family:inherit;font-size:9pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(4)</sup></span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">August 2015</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Duval</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Second quarter of 2018</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$11 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">March 2019</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">Pardue</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">December 2016</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA and <br/>R.J. Reynolds</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Alachua</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Second and Third quarters of 2018</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$11 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">March 2019</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-style:italic;">McKeever</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">February 2015</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">PM USA</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Broward</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Fourth quarter of 2017</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$21 million</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">March 2019</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;padding-left:18px;text-indent:-18px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(1)</span><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt"> </sup></span><span style="font-family:inherit;font-size:9pt;">In two cases in which PM USA paid the judgments more than a year ago, </span><span style="font-family:inherit;font-size:9pt;font-style:italic;">Naugle</span><span style="font-family:inherit;font-size:9pt;"> and </span><span style="font-family:inherit;font-size:9pt;font-style:italic;">Gore</span><span style="font-family:inherit;font-size:9pt;">, plaintiffs were awarded approximately </span><span style="font-family:inherit;font-size:9pt;"><span>$8 million</span></span><span style="font-family:inherit;font-size:9pt;"> and approximately </span><span style="font-family:inherit;font-size:9pt;"><span>$2 million</span></span><span style="font-family:inherit;font-size:9pt;"> in fees and other costs, respectively.  In both cases, PM USA has appealed.</span></div><div style="line-height:120%;text-align:left;padding-left:18px;text-indent:-18px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(2) In February 2020, the Florida Second District Court of Appeal denied PM USA’s petition for review.  As a result, in the first quarter of 2020, PM USA recorded a pre-tax provision of approximately </span><span style="font-family:inherit;font-size:9pt;"><span>$17 million</span></span><span style="font-family:inherit;font-size:9pt;"> for the judgment plus interest, which was subsequently paid in the first quarter of 2020.</span></div><div style="line-height:120%;text-align:left;padding-left:18px;text-indent:-18px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(3) The trial court also awarded plaintiff approximately </span><span style="font-family:inherit;font-size:9pt;"><span>$9 million</span></span><span style="font-family:inherit;font-size:9pt;"> in fees, interest and costs.  PM USA and plaintiff have appealed.</span></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(4) The trial court also awarded plaintiff approximately </span><span style="font-family:inherit;font-size:9pt;"><span>$4 million</span></span><span style="font-family:inherit;font-size:9pt;"> in fees and costs. PM USA and plaintiff have appealed.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The changes in Altria’s accrued liability for tobacco and health litigation items, including related interest costs, for the periods specified below are as follows:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:68%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:4%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:18px;text-indent:-18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accrued liability for tobacco and health litigation items at beginning of period </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>112</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pre-tax charges for:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:36px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Tobacco and health litigation </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:36px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Related interest costs</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Payments </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(28</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(109</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-left:18px;text-indent:-18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accrued liability for tobacco and health litigation items at end of period </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;padding-left:18px;text-indent:-18px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(1) Includes amounts related to the costs of implementing the corrective communications remedy related to the </span><span style="font-family:inherit;font-size:9pt;font-style:italic;">Federal Government’s Lawsuit</span><span style="font-family:inherit;font-size:9pt;"> discussed below.</span></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(2)</span><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt"> </sup></span><span style="font-family:inherit;font-size:9pt;">Includes approximately </span><span style="font-family:inherit;font-size:9pt;"><span>$7 million</span></span><span style="font-family:inherit;font-size:9pt;"> related to pre-trial resolution of approximately </span><span style="font-family:inherit;font-size:9pt;"><span>100</span></span><span style="font-family:inherit;font-size:9pt;"> tobacco and health cases.</span></div><div style="line-height:120%;text-align:left;padding-left:18px;text-indent:-18px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">(3) Includes approximately </span><span style="font-family:inherit;font-size:9pt;"><span>$7 million</span></span><span style="font-family:inherit;font-size:9pt;"> in payments related to above-mentioned pre-trial resolution of approximately </span><span style="font-family:inherit;font-size:9pt;"><span>100</span></span><span style="font-family:inherit;font-size:9pt;"> tobacco and health cases and </span><span style="font-family:inherit;font-size:9pt;"><span>$2 million</span></span><span style="font-family:inherit;font-size:9pt;"> for pre-trial resolution of other tobacco and health cases that was accrued in 2019 but not paid until 2020</span><span style="font-family:inherit;font-size:8pt;">. </span></div> 109 98 102 0 1 1 202 2 3 4 0 0 22 46 1472 923 24 170 5 3 2 1 2 10 8 7 2 0 69 44 69 44 1 7 1 10 1 4 1 4 1 1 5 2 1 1 2 2 25 20 1 748000000 216000000 327000000 54000000 14000000 112000000 22000000 15000000 2000000 2000000 28000000 109000000 10000000 20000000 7000000 100 7000000 100 2000000 48000000 11000000 10000000 11000000 10000000 7100000 0.75 5300000 145000000000 74000000000 P1Y P1Y 9300 1500 1900 4 134 78 4 47 42 4 2 0 2 0 1 3 1 8000000 2000000 17000000 9000000 4000000 200000000 61 1 1 1 2 2 3 1 1 1 1 1 1 29 6 2 1 1 1 1 1 1 1 1 7 2 3 2 13000000000 10 3 46 9400000000 500000000 1100000000 900000000 36 2 37 36 26 740000000 2 26 10 2 248000000 68000000 121000000 47000000 2 39000000 209000000 52000000 10 9 43000000 P9Y 317000000 15 6 2 6 4 74000000 6 2 43000000 388000000 181000000 154000000 185000000 250000000 211000000 218000000 166000000 214000000 224000000 258000000 313000000 305000000 297000000 340000000 441000000 9800000 P10Y 31000000 5000000 170 5 3 0 21 23 2 2 1 0.35 3 2 2 50000000 27000000 38000000 3000000000.0 Condensed Consolidating Financial Information:<div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">PM USA, which is a 100% owned subsidiary of Altria Group, Inc., has guaranteed Altria Group, Inc.’s obligations under its outstanding debt securities, borrowings under its Credit Agreement and amounts outstanding under its commercial paper program (the “Guarantees”). Pursuant to the Guarantees, PM USA fully and unconditionally guarantees, as primary obligor, the payment and performance of Altria Group, Inc.’s obligations under the guaranteed debt instruments (the “Obligations”), subject to release under certain customary circumstances as noted below.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Guarantees provide that PM USA guarantees the punctual payment when due, whether at stated maturity, by acceleration or otherwise, of the Obligations. The liability of PM USA under the Guarantees is absolute and unconditional irrespective of: any lack of validity, enforceability or genuineness of any provision of any agreement or instrument relating thereto; any change in the time, manner or place of payment of, or in any other term of, all or any of the Obligations, or any other amendment or waiver of or any consent to departure from any agreement or instrument relating thereto; any exchange, release or non-perfection of any collateral, or any release or amendment or waiver of or consent to departure from any other guarantee, for all or any of the Obligations; or any other circumstance that might otherwise constitute a defense available to, or a discharge of, Altria Group, Inc. or PM USA.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The obligations of PM USA under the Guarantees are limited to the maximum amount as will not result in PM USA’s obligations under the Guarantees constituting a fraudulent transfer or conveyance, after giving effect to such maximum amount and all other contingent and fixed liabilities of PM USA that are relevant under Bankruptcy Law, the Uniform Fraudulent Conveyance Act, the Uniform Fraudulent Transfer Act or any similar federal or state law to the extent applicable to the Guarantees. For this purpose, “Bankruptcy Law” means Title 11, U.S. Code, or any similar federal or state law for the relief of debtors.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">PM USA will be unconditionally released and discharged from the Obligations upon the earliest to occur of:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">▪</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the date, if any, on which PM USA consolidates with or merges into Altria Group, Inc. or any successor;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">▪</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the date, if any, on which Altria Group, Inc. or any successor consolidates with or merges into PM USA;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">▪</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the payment in full of the Obligations pertaining to such Guarantees; and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">▪</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the rating of Altria Group, Inc.’s long-term senior unsecured debt by Standard &amp; Poor’s Ratings Services of A or higher.</span></div></td></tr></table><div style="line-height:120%;padding-left:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">At </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">, the respective principal 100% owned subsidiaries of Altria Group, Inc. and PM USA were not limited by long-term debt or other agreements in their ability to pay cash dividends or make other distributions with respect to their equity interests.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following sets forth the condensed consolidating balance sheets as of </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;">, condensed consolidating statements of earnings and comprehensive earnings for the </span><span style="font-family:inherit;font-size:10pt;">three</span><span style="font-family:inherit;font-size:10pt;"> months ended </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, and condensed consolidating statements of cash flows for the </span><span style="font-family:inherit;font-size:10pt;">three</span><span style="font-family:inherit;font-size:10pt;"> months ended </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;"> for Altria Group, Inc., PM USA and, collectively, Altria Group, Inc.’s other subsidiaries that are not guarantors of Altria Group, Inc.’s debt instruments (the “Non-Guarantor Subsidiaries”). </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The financial information may not necessarily be indicative of results of operations or financial position had PM USA and the Non-Guarantor Subsidiaries operated as independent entities. Altria Group, Inc. and PM USA account for investments in their subsidiaries under the equity method of accounting.</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Condensed Consolidating Balance Sheets </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions of dollars)</span></div><div style="line-height:120%;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Altria Group, Inc.</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">PM USA</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Non-</span></div><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Guarantor</span></div><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Subsidiaries</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Total</span></div><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Consolidating</span></div><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Adjustments</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Consolidated</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,548</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>67</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,616</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receivables</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>130</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>147</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Inventories:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Leaf tobacco</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>508</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>387</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>895</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other raw materials</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>123</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>70</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>193</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Work in process</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>461</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>467</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Finished product</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>87</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>364</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>451</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>724</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,282</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,006</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Due from Altria Group, Inc. and subsidiaries</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>91</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,660</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,361</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7,112</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other current assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>301</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>68</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(226</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>166</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,940</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,425</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,908</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7,338</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,935</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Property, plant and equipment, at cost</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,970</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,133</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,103</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less accumulated depreciation</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,186</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>920</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,106</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>784</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,213</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,997</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,177</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,177</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other intangible assets, net</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12,666</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12,668</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Investments in equity securities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18,453</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,408</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23,861</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Investment in consolidated subsidiaries</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18,905</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,867</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(21,772</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Due from Altria Group, Inc. and subsidiaries</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,790</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4,790</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>71</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>950</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>567</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(608</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>980</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total Assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>48,159</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,028</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27,939</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(34,508</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>52,618</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Condensed Consolidating Balance Sheets (Continued)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions of dollars)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Altria Group, Inc.</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">PM USA</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Non-</span></div><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Guarantor</span></div><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Subsidiaries</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Total</span></div><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Consolidating</span></div><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Adjustments</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Consolidated</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Short-term borrowings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,000</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,000</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounts payable</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>136</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>141</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>278</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accrued liabilities:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Marketing</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>391</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>76</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>467</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Settlement charges</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,410</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,419</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>312</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>343</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>377</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,032</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Income taxes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>508</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>105</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(226</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>393</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dividends payable</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,565</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,565</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Due to Altria Group, Inc. and subsidiaries</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,278</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>587</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>247</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7,112</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total current liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,162</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,375</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>955</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7,338</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,154</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term debt</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>26,971</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>26,971</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred income taxes</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,228</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,571</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(608</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,191</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accrued pension costs</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>196</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>231</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>427</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accrued postretirement health care costs</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,076</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>722</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,798</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Due to Altria Group, Inc. and subsidiaries</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,790</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4,790</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>59</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>90</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>253</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>402</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>41,616</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,541</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9,522</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(12,736</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>45,943</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contingencies </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span></span><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span></span><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span></span><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span></span><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span></span><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Redeemable noncontrolling interest</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Stockholders’ Equity</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Common stock</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>935</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>935</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Additional paid-in capital</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,959</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,310</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27,566</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(30,876</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,959</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Earnings reinvested in the business</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36,528</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>393</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7,441</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,048</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36,528</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accumulated other comprehensive losses</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2,533</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(216</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,849</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,065</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2,533</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cost of repurchased stock</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(34,346</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(34,346</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:12px;text-indent:0px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total stockholders’ equity attributable</span></div><div style="padding-left:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> to Altria Group, Inc.</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,543</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,487</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18,285</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(21,772</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,543</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Noncontrolling interests</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>94</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>94</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total stockholders’ equity</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,543</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,487</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18,379</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(21,772</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,637</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total Liabilities and Stockholders’ Equity</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>48,159</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,028</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27,939</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(34,508</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>52,618</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Condensed Consolidating Balance Sheets</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions of dollars)</span></div><div style="line-height:120%;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Altria Group, Inc.</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">PM USA</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Non-<br/>Guarantor<br/>Subsidiaries</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Total<br/>Consolidating<br/>Adjustments</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Consolidated</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,022</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>95</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,117</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receivables</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>122</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>152</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Inventories:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Leaf tobacco</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>494</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>380</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>874</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other raw materials</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>120</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>72</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>192</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Work in process</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>692</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>696</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Finished product</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>119</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>412</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>531</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>737</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,556</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,293</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Due from Altria Group, Inc. and subsidiaries</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>88</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,005</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,359</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5,452</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other current assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>133</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>64</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>114</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(49</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>262</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,243</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,836</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,246</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5,501</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,824</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Property, plant and equipment, at cost</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,956</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,118</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,074</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less accumulated depreciation</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,166</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>909</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,075</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>790</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,209</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,999</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,177</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,177</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other intangible assets, net</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12,685</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12,687</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Investments in equity securities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18,071</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,510</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23,581</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Investment in consolidated subsidiaries</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19,312</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,831</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(22,143</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Due from Altria Group, Inc. and subsidiaries</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,790</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4,790</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>58</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>951</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>603</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(609</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,003</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total Assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>44,474</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9,410</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28,430</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(33,043</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>49,271</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Condensed Consolidating Balance Sheets (Continued)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions of dollars)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Altria Group, Inc.</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">PM USA</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Non-<br/>Guarantor<br/>Subsidiaries</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Total<br/>Consolidating<br/>Adjustments</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Consolidated</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current portion of long-term debt</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,000</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,000</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounts payable</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>146</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>179</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>325</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accrued liabilities:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Marketing</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>320</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>73</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>393</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Settlement charges</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,340</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,346</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>570</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>482</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>481</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,533</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Income taxes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>55</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(49</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dividends payable</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,565</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,565</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Due to Altria Group, Inc. and subsidiaries</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,693</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>514</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>245</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5,452</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total current liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,834</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,802</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,039</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5,501</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,174</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term debt</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27,042</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27,042</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred income taxes</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,099</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,593</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(609</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,083</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accrued pension costs</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>197</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>276</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>473</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accrued postretirement health care costs</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,078</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>719</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,797</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Due to Altria Group, Inc. and subsidiaries</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,790</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4,790</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>80</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>87</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>178</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>345</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38,252</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,967</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9,595</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10,900</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>42,914</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contingencies </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span></span><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span></span><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span></span><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span></span><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span></span><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Redeemable noncontrolling interest</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Stockholders’ Equity</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Common stock</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>935</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>935</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Additional paid-in capital</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,970</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,310</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27,565</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(30,875</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,970</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Earnings reinvested in the business</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36,539</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>352</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6,997</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,645</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36,539</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accumulated other comprehensive losses</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2,864</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(219</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,877</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,096</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2,864</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cost of repurchased stock</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(34,358</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(34,358</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:12px;text-indent:0px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total stockholders’ equity attributable </span></div><div style="padding-left:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">to Altria Group, Inc. </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,222</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,443</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18,700</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(22,143</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,222</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Noncontrolling interests</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>97</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>97</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total stockholders’ equity</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,222</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,443</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18,797</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(22,143</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,319</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total Liabilities and Stockholders’ Equity</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>44,474</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9,410</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28,430</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(33,043</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>49,271</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Condensed Consolidating Statements of Earnings and Comprehensive Earnings</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions of dollars)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"/></tr><tr><td style="width:41%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Altria Group, Inc.</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">PM USA</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Non-<br/>Guarantor<br/>Subsidiaries</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Total<br/>Consolidating<br/>Adjustments</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Consolidated</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net revenues</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,359</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,008</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,359</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,532</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>649</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,173</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Excise taxes on products</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,267</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>46</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,313</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gross profit</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,560</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>313</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,873</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Marketing, administration and research costs</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>387</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>128</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>537</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating income (expense)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(22</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,173</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>185</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,336</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest and other debt expense (income), net</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>237</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(18</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>56</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>275</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:24px;text-indent:-24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net periodic benefit (income) cost, excluding service cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(22</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(27</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Earnings from equity investments</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(134</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(23</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(157</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Loss on Cronos-related financial instruments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>137</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>137</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Earnings (losses) before income taxes and equity earnings of subsidiaries</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(125</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,213</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,108</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Provision (benefit) for income taxes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(32</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>550</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>40</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>558</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Equity earnings of subsidiaries</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,645</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>126</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,771</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,552</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,789</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(20</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,771</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,550</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:24px;text-indent:-24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net (earnings) losses attributable to noncontrolling interests</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net earnings attributable to Altria</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,552</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,789</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(18</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,771</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,552</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net earnings</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,552</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,789</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(20</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,771</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,550</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>331</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(31</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>331</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Comprehensive earnings</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,883</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,792</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,802</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,881</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Comprehensive (earnings) losses attributable to noncontrolling interests</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Comprehensive earnings attributable to Altria</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,883</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,792</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,802</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,883</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Condensed Consolidating Statements of Earnings and Comprehensive Earnings</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions of dollars)</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Altria Group, Inc.</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">PM USA</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Non-<br/>Guarantor<br/>Subsidiaries</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Total<br/>Consolidating<br/>Adjustments</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Consolidated</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net revenues</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,725</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>913</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,628</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,340</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>248</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,578</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Excise taxes on products</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,185</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>54</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,239</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gross profit</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,200</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>611</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,811</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Marketing, administration and research costs</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>384</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>114</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>533</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Asset impairment and exit costs</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>40</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating income (expense)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(36</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,781</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>493</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,238</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest and other debt expense (income), net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>355</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(25</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>54</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>384</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net periodic benefit (income) cost, excluding service cost</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Earnings from equity investments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(86</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(86</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Loss on Cronos-related financial instruments</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>425</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>425</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Earnings (losses) before income taxes and equity earnings of subsidiaries</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(306</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,806</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,516</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Provision (benefit) for income taxes</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(75</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>459</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>395</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Equity earnings of subsidiaries</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,351</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>95</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,446</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net earnings</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,120</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,442</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,446</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,121</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net (earnings) losses attributable to noncontrolling interests</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net earnings attributable to Altria</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,120</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,442</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,446</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,120</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,120</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,442</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,446</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,121</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(170</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(28</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(170</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Comprehensive earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>950</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,447</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,474</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>951</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Comprehensive (earnings) losses attributable to noncontrolling interests</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Comprehensive earnings attributable to Altria</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>950</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,447</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,474</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>950</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Condensed Consolidating Statements of Cash Flows</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions of dollars)</span></div><div style="line-height:120%;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.90503323836657%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Altria Group, Inc.</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">PM USA</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Non-</span></div><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Guarantor</span></div><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Subsidiaries</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Total</span></div><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Consolidating</span></div><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Adjustments</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Consolidated</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash Provided by (Used In) Operating Activities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net cash provided by (used in) operating activities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,515</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,351</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>437</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2,174</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,129</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash Provided by (Used in) Investing Activities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Capital expenditures</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(15</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(37</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(52</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Investment in consolidated subsidiaries</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net cash provided by (used in) investing activities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(15</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(37</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(52</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash Provided by (Used in) Financing Activities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:24px;text-indent:0px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Proceeds from short-term borrowings</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term debt repaid</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,000</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,000</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dividends paid on common stock</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,563</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,563</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:24px;text-indent:0px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Changes in amounts due to/from Altria Group, Inc. </span></div><div style="padding-left:24px;text-indent:0px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">and subsidiaries</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,584</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,582</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash dividends paid to parent</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,748</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(426</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,174</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net cash provided by (used in) financing activities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,012</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3,330</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(428</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,173</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>427</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash, cash equivalents and restricted cash </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span><span style="font-family:inherit;font-size:10pt;">:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Increase (decrease)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,526</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(28</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,504</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at beginning of period</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,022</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>43</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>95</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,160</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at end of period</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,548</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>49</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>67</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,664</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Restricted cash consisted of cash deposits collateralizing appeal bonds posted by PM USA to obtain stays of judgments pending appeals. See </span><span style="font-family:inherit;font-size:10pt;">Note 11</span><span style="font-family:inherit;font-size:10pt;">. </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Contingencies</span><span style="font-family:inherit;font-size:10pt;">.</span></div></td></tr></table><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Condensed Consolidating Statements of Cash Flows</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions of dollars)</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.90503323836657%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Altria Group, Inc.</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">PM USA</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Non-</span></div><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Guarantor</span></div><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Subsidiaries</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Total</span></div><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Consolidating</span></div><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Adjustments</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Consolidated</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash Provided by (Used In) Operating Activities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net cash provided by (used in) operating activities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,642</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,520</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>166</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2,039</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,289</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash Provided by (Used in) Investing Activities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Capital expenditures</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(29</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(38</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Investment in Cronos</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,831</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,831</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Investment in consolidated subsidiaries</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,947</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,947</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other, net</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(78</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(81</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net cash provided by (used in) investing activities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,950</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,938</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,947</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,950</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash Provided by (Used in) Financing Activities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Repayment of short-term borrowings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(12,800</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(12,800</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term debt issued</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16,265</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16,265</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Repurchases of common stock</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(151</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(151</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dividends paid on common stock</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,502</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,502</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:24px;text-indent:0px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Changes in amounts due to/from Altria Group, Inc. </span></div><div style="padding-left:24px;text-indent:0px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">and subsidiaries</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>657</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(771</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,061</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,947</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash dividends paid to parent</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,737</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(302</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,039</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(120</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(129</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net cash provided by (used in) financing activities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,349</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2,508</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,750</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>92</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,683</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash, cash equivalents and restricted cash </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span><span style="font-family:inherit;font-size:10pt;">:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Increase (decrease)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,041</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(22</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,022</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at beginning of period</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,277</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>56</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,433</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at end of period</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,318</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>103</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>34</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,455</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(1) Restricted cash consisted of cash deposits collateralizing appeal bonds posted by PM USA to obtain stays of judgments pending appeals. See </span><span style="font-family:inherit;font-size:10pt;">Note 11</span><span style="font-family:inherit;font-size:10pt;">. </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Contingencies</span><span style="font-family:inherit;font-size:10pt;">.</span></div> <div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Condensed Consolidating Balance Sheets </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions of dollars)</span></div><div style="line-height:120%;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Altria Group, Inc.</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">PM USA</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Non-</span></div><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Guarantor</span></div><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Subsidiaries</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Total</span></div><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Consolidating</span></div><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Adjustments</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Consolidated</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,548</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>67</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,616</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receivables</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>130</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>147</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Inventories:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Leaf tobacco</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>508</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>387</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>895</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other raw materials</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>123</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>70</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>193</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Work in process</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>461</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>467</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Finished product</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>87</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>364</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>451</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>724</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,282</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,006</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Due from Altria Group, Inc. and subsidiaries</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>91</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,660</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,361</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7,112</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other current assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>301</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>68</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(226</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>166</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,940</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,425</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,908</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7,338</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,935</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Property, plant and equipment, at cost</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,970</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,133</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,103</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less accumulated depreciation</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,186</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>920</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,106</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>784</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,213</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,997</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,177</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,177</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other intangible assets, net</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12,666</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12,668</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Investments in equity securities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18,453</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,408</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23,861</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Investment in consolidated subsidiaries</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18,905</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,867</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(21,772</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Due from Altria Group, Inc. and subsidiaries</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,790</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4,790</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>71</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>950</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>567</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(608</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>980</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total Assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>48,159</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,028</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27,939</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(34,508</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>52,618</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Condensed Consolidating Balance Sheets (Continued)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions of dollars)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Altria Group, Inc.</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">PM USA</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Non-</span></div><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Guarantor</span></div><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Subsidiaries</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Total</span></div><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Consolidating</span></div><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Adjustments</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Consolidated</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Short-term borrowings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,000</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,000</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounts payable</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>136</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>141</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>278</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accrued liabilities:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Marketing</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>391</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>76</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>467</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Settlement charges</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,410</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,419</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>312</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>343</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>377</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,032</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Income taxes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>508</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>105</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(226</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>393</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dividends payable</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,565</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,565</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Due to Altria Group, Inc. and subsidiaries</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,278</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>587</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>247</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7,112</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total current liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,162</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,375</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>955</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7,338</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,154</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term debt</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>26,971</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>26,971</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred income taxes</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,228</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,571</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(608</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,191</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accrued pension costs</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>196</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>231</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>427</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accrued postretirement health care costs</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,076</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>722</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,798</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Due to Altria Group, Inc. and subsidiaries</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,790</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4,790</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>59</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>90</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>253</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>402</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>41,616</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,541</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9,522</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(12,736</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>45,943</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contingencies </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span></span><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span></span><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span></span><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span></span><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span></span><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Redeemable noncontrolling interest</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Stockholders’ Equity</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Common stock</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>935</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>935</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Additional paid-in capital</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,959</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,310</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27,566</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(30,876</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,959</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Earnings reinvested in the business</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36,528</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>393</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7,441</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,048</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36,528</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accumulated other comprehensive losses</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2,533</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(216</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,849</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,065</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2,533</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cost of repurchased stock</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(34,346</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(34,346</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:12px;text-indent:0px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total stockholders’ equity attributable</span></div><div style="padding-left:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> to Altria Group, Inc.</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,543</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,487</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18,285</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(21,772</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,543</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Noncontrolling interests</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>94</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>94</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total stockholders’ equity</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,543</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,487</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18,379</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(21,772</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,637</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total Liabilities and Stockholders’ Equity</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>48,159</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,028</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27,939</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(34,508</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>52,618</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Condensed Consolidating Balance Sheets</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions of dollars)</span></div><div style="line-height:120%;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Altria Group, Inc.</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">PM USA</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Non-<br/>Guarantor<br/>Subsidiaries</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Total<br/>Consolidating<br/>Adjustments</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Consolidated</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,022</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>95</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,117</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receivables</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>122</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>152</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Inventories:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Leaf tobacco</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>494</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>380</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>874</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other raw materials</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>120</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>72</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>192</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Work in process</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>692</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>696</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Finished product</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>119</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>412</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>531</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>737</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,556</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,293</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Due from Altria Group, Inc. and subsidiaries</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>88</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,005</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,359</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5,452</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other current assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>133</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>64</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>114</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(49</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>262</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,243</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,836</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,246</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5,501</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,824</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Property, plant and equipment, at cost</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,956</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,118</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,074</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less accumulated depreciation</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,166</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>909</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,075</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>790</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,209</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,999</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,177</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,177</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other intangible assets, net</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12,685</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12,687</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Investments in equity securities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18,071</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,510</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23,581</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Investment in consolidated subsidiaries</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19,312</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,831</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(22,143</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Due from Altria Group, Inc. and subsidiaries</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,790</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4,790</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>58</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>951</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>603</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(609</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,003</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total Assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>44,474</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9,410</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28,430</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(33,043</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>49,271</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Condensed Consolidating Balance Sheets (Continued)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">December 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions of dollars)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Altria Group, Inc.</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">PM USA</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Non-<br/>Guarantor<br/>Subsidiaries</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Total<br/>Consolidating<br/>Adjustments</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Consolidated</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current portion of long-term debt</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,000</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,000</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounts payable</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>146</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>179</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>325</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accrued liabilities:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Marketing</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>320</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>73</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>393</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Settlement charges</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,340</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,346</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>570</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>482</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>481</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,533</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Income taxes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>55</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(49</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dividends payable</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,565</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,565</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Due to Altria Group, Inc. and subsidiaries</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,693</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>514</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>245</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5,452</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total current liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,834</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,802</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,039</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5,501</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,174</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term debt</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27,042</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27,042</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred income taxes</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,099</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,593</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(609</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,083</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accrued pension costs</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>197</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>276</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>473</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accrued postretirement health care costs</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,078</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>719</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,797</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Due to Altria Group, Inc. and subsidiaries</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,790</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4,790</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>80</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>87</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>178</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>345</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38,252</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,967</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9,595</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10,900</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>42,914</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contingencies </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span></span><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span></span><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span></span><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span></span><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span></span><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Redeemable noncontrolling interest</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Stockholders’ Equity</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Common stock</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>935</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>935</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Additional paid-in capital</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,970</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,310</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27,565</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(30,875</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,970</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Earnings reinvested in the business</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36,539</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>352</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6,997</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,645</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36,539</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accumulated other comprehensive losses</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2,864</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(219</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,877</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,096</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2,864</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cost of repurchased stock</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(34,358</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(34,358</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:12px;text-indent:0px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total stockholders’ equity attributable </span></div><div style="padding-left:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">to Altria Group, Inc. </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,222</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,443</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18,700</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(22,143</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,222</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Noncontrolling interests</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>97</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>97</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total stockholders’ equity</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,222</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,443</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18,797</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(22,143</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,319</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total Liabilities and Stockholders’ Equity</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>44,474</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9,410</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28,430</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(33,043</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>49,271</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 5548000000 1000000 67000000 0 5616000000 0 17000000 130000000 0 147000000 0 508000000 387000000 0 895000000 0 123000000 70000000 0 193000000 0 6000000 461000000 0 467000000 0 87000000 364000000 0 451000000 0 724000000 1282000000 0 2006000000 91000000 5660000000 1361000000 -7112000000 0 301000000 23000000 68000000 -226000000 166000000 5940000000 6425000000 2908000000 -7338000000 7935000000 0 2970000000 2133000000 0 5103000000 0 2186000000 920000000 0 3106000000 0 784000000 1213000000 0 1997000000 0 0 5177000000 0 5177000000 0 2000000 12666000000 0 12668000000 18453000000 0 5408000000 0 23861000000 18905000000 2867000000 0 -21772000000 0 4790000000 0 0 -4790000000 0 71000000 950000000 567000000 -608000000 980000000 48159000000 11028000000 27939000000 -34508000000 52618000000 3000000000 0 0 0 3000000000 1000000 136000000 141000000 0 278000000 0 391000000 76000000 0 467000000 0 4410000000 9000000 0 4419000000 312000000 343000000 377000000 0 1032000000 6000000 508000000 105000000 -226000000 393000000 1565000000 0 0 0 1565000000 6278000000 587000000 247000000 -7112000000 0 11162000000 6375000000 955000000 -7338000000 11154000000 26971000000 0 0 0 26971000000 3228000000 0 2571000000 -608000000 5191000000 196000000 0 231000000 0 427000000 0 1076000000 722000000 0 1798000000 0 0 4790000000 -4790000000 0 59000000 90000000 253000000 0 402000000 41616000000 7541000000 9522000000 -12736000000 45943000000 0 0 38000000 0 38000000 935000000 0 9000000 -9000000 935000000 5959000000 3310000000 27566000000 -30876000000 5959000000 36528000000 393000000 -7441000000 7048000000 36528000000 -2533000000 -216000000 -1849000000 2065000000 -2533000000 34346000000 0 0 0 34346000000 6543000000 3487000000 18285000000 -21772000000 6543000000 0 0 94000000 0 94000000 6543000000 3487000000 18379000000 -21772000000 6637000000 48159000000 11028000000 27939000000 -34508000000 52618000000 2022000000 0 95000000 0 2117000000 0 30000000 122000000 0 152000000 0 494000000 380000000 0 874000000 0 120000000 72000000 0 192000000 0 4000000 692000000 0 696000000 0 119000000 412000000 0 531000000 0 737000000 1556000000 0 2293000000 88000000 4005000000 1359000000 -5452000000 0 133000000 64000000 114000000 -49000000 262000000 2243000000 4836000000 3246000000 -5501000000 4824000000 0 2956000000 2118000000 0 5074000000 0 2166000000 909000000 0 3075000000 0 790000000 1209000000 0 1999000000 0 0 5177000000 0 5177000000 0 2000000 12685000000 0 12687000000 18071000000 0 5510000000 0 23581000000 19312000000 2831000000 0 -22143000000 0 4790000000 0 0 -4790000000 0 58000000 951000000 603000000 -609000000 1003000000 44474000000 9410000000 28430000000 -33043000000 49271000000 1000000000 0 0 0 1000000000 0 146000000 179000000 0 325000000 0 320000000 73000000 0 393000000 0 3340000000 6000000 0 3346000000 570000000 482000000 481000000 0 1533000000 6000000 0 55000000 -49000000 12000000 1565000000 0 0 0 1565000000 4693000000 514000000 245000000 -5452000000 0 7834000000 4802000000 1039000000 -5501000000 8174000000 27042000000 0 0 0 27042000000 3099000000 0 2593000000 -609000000 5083000000 197000000 0 276000000 0 473000000 0 1078000000 719000000 0 1797000000 0 0 4790000000 -4790000000 0 80000000 87000000 178000000 0 345000000 38252000000 5967000000 9595000000 -10900000000 42914000000 0 0 38000000 0 38000000 935000000 0 9000000 -9000000 935000000 5970000000 3310000000 27565000000 -30875000000 5970000000 36539000000 352000000 -6997000000 6645000000 36539000000 -2864000000 -219000000 -1877000000 2096000000 -2864000000 34358000000 0 0 0 34358000000 6222000000 3443000000 18700000000 -22143000000 6222000000 0 0 97000000 0 97000000 6222000000 3443000000 18797000000 -22143000000 6319000000 44474000000 9410000000 28430000000 -33043000000 49271000000 <div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Condensed Consolidating Statements of Earnings and Comprehensive Earnings</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions of dollars)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"/></tr><tr><td style="width:41%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Altria Group, Inc.</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">PM USA</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Non-<br/>Guarantor<br/>Subsidiaries</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Total<br/>Consolidating<br/>Adjustments</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Consolidated</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net revenues</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,359</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,008</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,359</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,532</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>649</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,173</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Excise taxes on products</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,267</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>46</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,313</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gross profit</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,560</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>313</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,873</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Marketing, administration and research costs</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>387</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>128</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>537</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating income (expense)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(22</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,173</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>185</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,336</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest and other debt expense (income), net</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>237</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(18</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>56</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>275</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:24px;text-indent:-24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net periodic benefit (income) cost, excluding service cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(22</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(27</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Earnings from equity investments</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(134</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(23</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(157</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Loss on Cronos-related financial instruments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>137</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>137</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Earnings (losses) before income taxes and equity earnings of subsidiaries</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(125</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,213</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,108</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Provision (benefit) for income taxes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(32</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>550</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>40</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>558</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Equity earnings of subsidiaries</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,645</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>126</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,771</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,552</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,789</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(20</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,771</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,550</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:24px;text-indent:-24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net (earnings) losses attributable to noncontrolling interests</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net earnings attributable to Altria</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,552</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,789</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(18</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,771</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,552</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net earnings</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,552</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,789</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(20</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,771</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,550</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>331</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(31</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>331</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Comprehensive earnings</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,883</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,792</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,802</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,881</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Comprehensive (earnings) losses attributable to noncontrolling interests</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Comprehensive earnings attributable to Altria</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,883</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,792</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,802</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,883</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Condensed Consolidating Statements of Earnings and Comprehensive Earnings</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions of dollars)</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Altria Group, Inc.</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">PM USA</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Non-<br/>Guarantor<br/>Subsidiaries</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Total<br/>Consolidating<br/>Adjustments</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Consolidated</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net revenues</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,725</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>913</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,628</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,340</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>248</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,578</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Excise taxes on products</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,185</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>54</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,239</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gross profit</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,200</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>611</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,811</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Marketing, administration and research costs</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>384</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>114</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>533</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Asset impairment and exit costs</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>35</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>40</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Operating income (expense)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(36</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,781</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>493</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,238</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest and other debt expense (income), net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>355</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(25</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>54</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>384</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net periodic benefit (income) cost, excluding service cost</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Earnings from equity investments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(86</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(86</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Loss on Cronos-related financial instruments</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>425</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>425</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Earnings (losses) before income taxes and equity earnings of subsidiaries</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(306</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,806</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,516</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Provision (benefit) for income taxes</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(75</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>459</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>395</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Equity earnings of subsidiaries</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,351</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>95</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,446</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net earnings</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,120</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,442</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,446</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,121</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net (earnings) losses attributable to noncontrolling interests</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net earnings attributable to Altria</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,120</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,442</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,446</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,120</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,120</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,442</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,446</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,121</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(170</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(28</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(170</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Comprehensive earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>950</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,447</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,474</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>951</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Comprehensive (earnings) losses attributable to noncontrolling interests</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Comprehensive earnings attributable to Altria</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>950</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,447</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,474</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>950</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 0 5359000000 1008000000 -8000000 6359000000 0 1532000000 649000000 -8000000 2173000000 0 1267000000 46000000 0 1313000000 0 2560000000 313000000 0 2873000000 22000000 387000000 128000000 0 537000000 -22000000 2173000000 185000000 0 2336000000 -237000000 18000000 -56000000 0 -275000000 0 -22000000 -5000000 0 -27000000 134000000 0 23000000 0 157000000 0 0 -137000000 0 -137000000 -125000000 2213000000 20000000 0 2108000000 -32000000 550000000 40000000 0 558000000 1645000000 126000000 0 -1771000000 0 1552000000 1789000000 -20000000 -1771000000 1550000000 0 0 -2000000 0 -2000000 1552000000 1789000000 -18000000 -1771000000 1552000000 1552000000 1789000000 -20000000 -1771000000 1550000000 331000000 3000000 28000000 -31000000 331000000 1883000000 1792000000 8000000 -1802000000 1881000000 0 0 -2000000 0 -2000000 1883000000 1792000000 10000000 -1802000000 1883000000 0 4725000000 913000000 -10000000 5628000000 0 1340000000 248000000 -10000000 1578000000 0 1185000000 54000000 0 1239000000 0 2200000000 611000000 0 2811000000 35000000 384000000 114000000 0 533000000 1000000 35000000 4000000 0 40000000 -36000000 1781000000 493000000 0 2238000000 -355000000 25000000 -54000000 0 -384000000 1000000 0 -2000000 0 -1000000 86000000 0 0 0 86000000 0 0 -425000000 0 -425000000 -306000000 1806000000 16000000 0 1516000000 -75000000 459000000 11000000 0 395000000 1351000000 95000000 0 -1446000000 0 1120000000 1442000000 5000000 -1446000000 1121000000 0 0 1000000 0 1000000 1120000000 1442000000 4000000 -1446000000 1120000000 1120000000 1442000000 5000000 -1446000000 1121000000 -170000000 5000000 23000000 -28000000 -170000000 950000000 1447000000 28000000 -1474000000 951000000 0 0 1000000 0 1000000 950000000 1447000000 27000000 -1474000000 950000000 <div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Condensed Consolidating Statements of Cash Flows</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31, 2020</span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions of dollars)</span></div><div style="line-height:120%;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.90503323836657%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Altria Group, Inc.</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">PM USA</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Non-</span></div><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Guarantor</span></div><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Subsidiaries</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Total</span></div><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Consolidating</span></div><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Adjustments</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Consolidated</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash Provided by (Used In) Operating Activities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net cash provided by (used in) operating activities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,515</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,351</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>437</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2,174</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,129</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash Provided by (Used in) Investing Activities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Capital expenditures</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(15</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(37</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(52</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Investment in consolidated subsidiaries</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net cash provided by (used in) investing activities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(15</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(37</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(52</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash Provided by (Used in) Financing Activities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:24px;text-indent:0px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Proceeds from short-term borrowings</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,000</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term debt repaid</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,000</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,000</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dividends paid on common stock</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,563</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,563</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:24px;text-indent:0px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Changes in amounts due to/from Altria Group, Inc. </span></div><div style="padding-left:24px;text-indent:0px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">and subsidiaries</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,584</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,582</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash dividends paid to parent</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,748</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(426</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,174</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net cash provided by (used in) financing activities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,012</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3,330</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(428</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,173</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>427</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash, cash equivalents and restricted cash </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span><span style="font-family:inherit;font-size:10pt;">:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Increase (decrease)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,526</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(28</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,504</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at beginning of period</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,022</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>43</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>95</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,160</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at end of period</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,548</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>49</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>67</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,664</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Restricted cash consisted of cash deposits collateralizing appeal bonds posted by PM USA to obtain stays of judgments pending appeals. See </span><span style="font-family:inherit;font-size:10pt;">Note 11</span><span style="font-family:inherit;font-size:10pt;">. </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Contingencies</span><span style="font-family:inherit;font-size:10pt;">.</span></div></td></tr></table><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Condensed Consolidating Statements of Cash Flows</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31, 2019</span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(in millions of dollars)</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.90503323836657%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Altria Group, Inc.</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">PM USA</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Non-</span></div><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Guarantor</span></div><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Subsidiaries</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Total</span></div><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Consolidating</span></div><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Adjustments</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Consolidated</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash Provided by (Used In) Operating Activities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net cash provided by (used in) operating activities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,642</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,520</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>166</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2,039</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,289</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash Provided by (Used in) Investing Activities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Capital expenditures</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(29</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(38</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Investment in Cronos</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,831</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,831</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Investment in consolidated subsidiaries</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,947</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,947</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other, net</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(78</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(81</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net cash provided by (used in) investing activities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,950</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,938</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,947</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,950</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash Provided by (Used in) Financing Activities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Repayment of short-term borrowings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(12,800</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(12,800</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term debt issued</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16,265</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16,265</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Repurchases of common stock</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(151</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(151</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dividends paid on common stock</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,502</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,502</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:24px;text-indent:0px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Changes in amounts due to/from Altria Group, Inc. </span></div><div style="padding-left:24px;text-indent:0px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">and subsidiaries</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>657</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(771</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,061</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,947</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash dividends paid to parent</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,737</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(302</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,039</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(120</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(129</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net cash provided by (used in) financing activities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,349</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2,508</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,750</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>92</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,683</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash, cash equivalents and restricted cash </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span><span style="font-family:inherit;font-size:10pt;">:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Increase (decrease)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,041</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(22</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,022</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at beginning of period</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,277</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>56</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,433</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at end of period</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,318</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>103</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>34</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,455</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(1) Restricted cash consisted of cash deposits collateralizing appeal bonds posted by PM USA to obtain stays of judgments pending appeals. See </span><span style="font-family:inherit;font-size:10pt;">Note 11</span><span style="font-family:inherit;font-size:10pt;">. </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Contingencies</span><span style="font-family:inherit;font-size:10pt;">.</span></div> 1515000000 3351000000 437000000 -2174000000 3129000000 0 15000000 37000000 0 52000000 1000000 0 0 -1000000 0 0 0 0 0 0 -1000000 -15000000 -37000000 1000000 -52000000 3000000000 0 0 0 3000000000 1000000000 0 0 0 1000000000 1563000000 0 0 0 1563000000 1584000000 -1582000000 -1000000 -1000000 0 0 -1748000000 -426000000 2174000000 0 -9000000 0 -1000000 0 -10000000 2012000000 -3330000000 -428000000 2173000000 427000000 3526000000 6000000 -28000000 0 3504000000 2022000000 43000000 95000000 0 2160000000 5548000000 49000000 67000000 0 5664000000 1642000000 2520000000 166000000 -2039000000 2289000000 0 9000000 29000000 0 38000000 0 0 1831000000 0 1831000000 1947000000 0 0 -1947000000 0 3000000 0 78000000 0 81000000 -1950000000 -9000000 -1938000000 1947000000 -1950000000 12800000000 0 0 0 12800000000 16265000000 0 0 0 16265000000 151000000 0 0 0 151000000 1502000000 0 0 0 1502000000 657000000 -771000000 2061000000 -1947000000 0 0 -1737000000 -302000000 2039000000 0 -120000000 0 -9000000 0 -129000000 2349000000 -2508000000 1750000000 92000000 1683000000 2041000000 3000000 -22000000 0 2022000000 1277000000 100000000 56000000 0 1433000000 3318000000 103000000 34000000 0 3455000000 New Accounting Guidance Not Yet Adopted:<div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table provides a description of issued accounting guidance applicable to, but not yet adopted by, Altria:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:18%;"/><td style="width:28%;"/><td style="width:29%;"/><td style="width:25%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Standards</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Description</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Effective Date for Public Entity</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Effect on Financial Statements </span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">ASU 2019-12 </span><span style="font-family:inherit;font-size:9pt;font-style:italic;">Simplifying the Accounting for Income Taxes (Topic 740)</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">The guidance removes certain exceptions for investments, intraperiod allocations and interim calculations, and adds guidance to reduce complexity in accounting for income taxes. </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early application is permitted, including adoption in any interim period. </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Altria is in the process of evaluating the impact of this guidance on its consolidated financial statements and related disclosures. </span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">ASU 2020-01 </span><span style="font-family:inherit;font-size:9pt;font-style:italic;">Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">The guidance provides clarification of the interaction of rules for equity securities, the equity method of accounting, and forward contracts and purchase options on certain types of securities. </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early application is permitted, including adoption in any interim period. </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Altria is in the process of evaluating the impact of this guidance on its consolidated financial statements and related disclosures.</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> <div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table provides a description of issued accounting guidance applicable to, but not yet adopted by, Altria:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:18%;"/><td style="width:28%;"/><td style="width:29%;"/><td style="width:25%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Standards</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Description</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Effective Date for Public Entity</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Effect on Financial Statements </span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">ASU 2019-12 </span><span style="font-family:inherit;font-size:9pt;font-style:italic;">Simplifying the Accounting for Income Taxes (Topic 740)</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">The guidance removes certain exceptions for investments, intraperiod allocations and interim calculations, and adds guidance to reduce complexity in accounting for income taxes. </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early application is permitted, including adoption in any interim period. </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Altria is in the process of evaluating the impact of this guidance on its consolidated financial statements and related disclosures. </span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">ASU 2020-01 </span><span style="font-family:inherit;font-size:9pt;font-style:italic;">Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">The guidance provides clarification of the interaction of rules for equity securities, the equity method of accounting, and forward contracts and purchase options on certain types of securities. </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early application is permitted, including adoption in any interim period. </span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Altria is in the process of evaluating the impact of this guidance on its consolidated financial statements and related disclosures.</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> Amounts attributable to noncontrolling interests for the three months ended March 31, 2020 and 2019 exclude net earnings of $1 million due to the redeemable noncontrolling interest related to Stag’s Leap Wine Cellars, which is reported in the mezzanine equity section on the condensed consolidated balance sheets. Restricted cash consisted of cash deposits collateralizing appeal bonds posted by PM USA to obtain stays of judgments pending appeals. See Note 11. Contingencies. XML 57 R44.htm IDEA: XBRL DOCUMENT v3.20.1
Investments in Equity Securities (Investment in Cronos Narrative) (Details) - Cronos Group Inc. [Member]
$ / shares in Units, shares in Millions, $ in Billions
 3 Months Ended 9 Months Ended
Mar. 31, 2019
USD ($)
shares
Mar. 31, 2019
CAD ($)
Mar. 07, 2019
CAD ($)
Mar. 31, 2020
USD ($)
director
board_member
shares
Mar. 31, 2020
CAD ($)
Sep. 30, 2019
Dec. 31, 2019
USD ($)
Mar. 31, 2019
$ / shares
Investments [Line Items]                
Number of ordinary shares owned (approximately) (in shares) | shares 149.8              
Ownership percentage (approximately) 45.00%     45.00%        
Equity method investments, purchase price $ 1,800,000,000 $ 2.4 $ 2.4          
Equity method investment, warrant exercised, ownership percentage (approximately) 55.00% 55.00%            
Payments to acquire equity method investments $ 400,000,000              
Payments for deferred tax liability 300,000,000              
Number of directors nominated | director       4        
Equity method investment, number of independent directors nominated | director       1        
Number of members on the Board of Directors | board_member       7        
Equity method investments       $ 1,203,000,000     $ 1,305,000,000  
Equity method investment, difference between carrying amount and fair value, percentage (approximately)           (14.00%)    
Equity Contract, Preemptive Rights [Member]                
Investments [Line Items]                
Equity method investment, shares purchased, (CAD per share) | $ / shares               $ 16.25
Equity method investment, number of shares eligible for purchase (in shares) | shares       37.0        
Payments for derivative instrument, investing activities $ 500,000,000              
Equity method investment, aggregate exercise price       $ 400,000,000 $ 0.6      
Equity Contract, Warrant [Member]                
Investments [Line Items]                
Equity method investment, shares purchased, (CAD per share) | $ / shares               $ 19.00
Equity method investment, number of shares eligible for purchase (in shares) | shares       78.0        
Equity method investment, percentage of shares eligible for purchase 10.00%              
Payments for derivative instrument, investing activities $ 1,200,000,000              
Equity method investment, aggregate exercise price       $ 1,100,000,000 $ 1.5      
Common Stock [Member]                
Investments [Line Items]                
Equity method investments       1,037,000,000     1,002,000,000  
Equity method investment, impairment       0        
Fair Value, Inputs, Level 1 [Member]                
Investments [Line Items]                
Fair value of equity investment       $ 900,000,000     $ 1,200,000,000  
XML 58 R67.htm IDEA: XBRL DOCUMENT v3.20.1
Contingencies (Other Smoking and Health Class Actions) (Details) - Smoking and Health Class Actions and Aggregated Claims Litigation [Member]
$ in Billions
 1 Months Ended 287 Months Ended
Mar. 31, 2019
CAD ($)
ruling
manufacture
Mar. 31, 2020
case
Apr. 27, 2020
case
PM USA [Member]      
Loss Contingencies [Line Items]      
Class not certified   61  
Arkansas [Member] | PM USA [Member]      
Loss Contingencies [Line Items]      
Class not certified   1  
California [Member] | PM USA [Member]      
Loss Contingencies [Line Items]      
Class not certified   1  
Delaware [Member] | PM USA [Member]      
Loss Contingencies [Line Items]      
Class not certified   1  
District of Columbia [Member] | PM USA [Member]      
Loss Contingencies [Line Items]      
Class not certified   2  
Florida [Member] | PM USA [Member]      
Loss Contingencies [Line Items]      
Class not certified   2  
Illinois [Member] | PM USA [Member]      
Loss Contingencies [Line Items]      
Class not certified   3  
Iowa [Member] | PM USA [Member]      
Loss Contingencies [Line Items]      
Class not certified   1  
Kansas [Member] | PM USA [Member]      
Loss Contingencies [Line Items]      
Class not certified   1  
Louisiana [Member] | PM USA [Member]      
Loss Contingencies [Line Items]      
Class not certified   1  
Maryland [Member] | PM USA [Member]      
Loss Contingencies [Line Items]      
Class not certified   1  
Michigan [Member] | PM USA [Member]      
Loss Contingencies [Line Items]      
Class not certified   1  
Minnesota [Member] | PM USA [Member]      
Loss Contingencies [Line Items]      
Class not certified   1  
Nevada [Member] | PM USA [Member]      
Loss Contingencies [Line Items]      
Class not certified   29  
New Jersey [Member] | PM USA [Member]      
Loss Contingencies [Line Items]      
Class not certified   6  
New York [Member] | PM USA [Member]      
Loss Contingencies [Line Items]      
Class not certified   2  
Ohio [Member] | PM USA [Member]      
Loss Contingencies [Line Items]      
Class not certified   1  
Oklahoma [Member] | PM USA [Member]      
Loss Contingencies [Line Items]      
Class not certified   1  
Oregon [Member] | PM USA [Member]      
Loss Contingencies [Line Items]      
Class not certified   1  
Pennsylvania [Member] | PM USA [Member]      
Loss Contingencies [Line Items]      
Class not certified   1  
Puerto Rico [Member] | PM USA [Member]      
Loss Contingencies [Line Items]      
Class not certified   1  
South Carolina [Member] | PM USA [Member]      
Loss Contingencies [Line Items]      
Class not certified   1  
Texas [Member] | PM USA [Member]      
Loss Contingencies [Line Items]      
Class not certified   1  
Wisconsin [Member] | PM USA [Member]      
Loss Contingencies [Line Items]      
Class not certified   1  
Canada [Member] | Canadian Tobacco Manufacturers [Member]      
Loss Contingencies [Line Items]      
Number of manufacturers | manufacture 3    
Number of verdicts upheld | ruling 2    
Amount awarded to other party | $ $ 13    
Subsequent Event [Member] | Canada [Member] | Philip Morris USA and Altria Group [Member]      
Loss Contingencies [Line Items]      
Number of cases pending     7
Subsequent Event [Member] | British Columbia and Saskatchewan [Member] | Philip Morris USA and Altria Group [Member]      
Loss Contingencies [Line Items]      
Number of cases pending     2
XML 59 R63.htm IDEA: XBRL DOCUMENT v3.20.1
Contingencies (Non-Engle Progeny Litigation) (Details) - USD ($)
$ in Millions
Feb. 29, 2020
Sep. 30, 2019
Aug. 31, 2019
Oct. 31, 2017
Non-Engle Progeny Smoking And Health Case, Principe [Member]        
Loss Contingencies [Line Items]        
Compensatory damages awarded $ 11.0      
Non-Engle Progeny Smoking and Health Case, Greene [Member]        
Loss Contingencies [Line Items]        
Compensatory damages awarded   $ 10.0    
Non-Engle Progeny Smoking and Health Case, Laramie [Member]        
Loss Contingencies [Line Items]        
Compensatory damages awarded     $ 11.0  
Punitive damages awarded     $ 10.0  
Non-Engle Progeny Smoking and Health Case, Gentile [Member]        
Loss Contingencies [Line Items]        
Compensatory damages awarded       $ 7.1
Non-Engle Progeny Smoking and Health Case, Gentile [Member] | PM USA [Member]        
Loss Contingencies [Line Items]        
Compensatory damages awarded       $ 5.3
Compensatory damages award, allocation percentage       75.00%
XML 60 R70.htm IDEA: XBRL DOCUMENT v3.20.1
Contingencies (Other Disputes Under the State Settlement Agreements) (Details)
$ in Millions
 1 Months Ended
Aug. 31, 2018
USD ($)
PM USA [Member] | Other Disputes Under the State Settlement Agreements [Member]  
Loss Contingencies [Line Items]  
Amount ordered to be paid from other party $ 9.8
XML 61 R74.htm IDEA: XBRL DOCUMENT v3.20.1
Contingencies (UST Litigations Narrative) (Details)
 3 Months Ended
Dec. 31, 2019
shareholder
Apr. 27, 2020
claim
Loss Contingencies [Line Items]    
Loss contingency, number of shareholders filing class action lawsuits | shareholder 2  
Pending Individual Lawsuits [Member] | Subsequent Event [Member] | UST Litigation [Member]    
Loss Contingencies [Line Items]    
Claims filed, number | claim   1
XML 62 R78.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidating Financial Information (Condensed Consolidating Statements of Earnings and Comprehensive Earnings) (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Condensed Income Statements, Captions [Line Items]    
Net revenues $ 6,359 $ 5,628
Cost of sales 2,173 1,578
Excise taxes on products 1,313 1,239
Gross profit 2,873 2,811
Marketing, administration and research costs 537 533
Asset impairment and exit costs 0 40
Operating income (expense) 2,336 2,238
Interest and other debt expense (income), net 275 384
Net periodic benefit (income) cost, excluding service cost (27) (1)
Earnings from equity investments (157) (86)
Loss on Cronos-related financial instruments 137 425
Earnings (losses) before income taxes and equity earnings of subsidiaries 2,108 1,516
Provision (benefit) for income taxes 558 395
Equity earnings of subsidiaries 0 0
Net earnings 1,550 1,121
Net (earnings) losses attributable to noncontrolling interests 2 (1)
Net earnings attributable to Altria 1,552 1,120
Net earnings 1,550 1,121
Other comprehensive earnings (losses), net of deferred income taxes 331 (170)
Comprehensive earnings 1,881 951
Comprehensive earnings attributable to noncontrolling interests 2 (1)
Comprehensive earnings attributable to Altria 1,883 950
Reportable Legal Entities [Member] | Altria Group, Inc. [Member]    
Condensed Income Statements, Captions [Line Items]    
Net revenues 0 0
Cost of sales 0 0
Excise taxes on products 0 0
Gross profit 0 0
Marketing, administration and research costs 22 35
Asset impairment and exit costs   1
Operating income (expense) (22) (36)
Interest and other debt expense (income), net 237 355
Net periodic benefit (income) cost, excluding service cost 0 1
Earnings from equity investments (134) (86)
Loss on Cronos-related financial instruments 0 0
Earnings (losses) before income taxes and equity earnings of subsidiaries (125) (306)
Provision (benefit) for income taxes (32) (75)
Equity earnings of subsidiaries 1,645 1,351
Net earnings 1,552 1,120
Net (earnings) losses attributable to noncontrolling interests 0 0
Net earnings attributable to Altria 1,552 1,120
Net earnings 1,552 1,120
Other comprehensive earnings (losses), net of deferred income taxes 331 (170)
Comprehensive earnings 1,883 950
Comprehensive earnings attributable to noncontrolling interests 0 0
Comprehensive earnings attributable to Altria 1,883 950
Reportable Legal Entities [Member] | PM USA [Member]    
Condensed Income Statements, Captions [Line Items]    
Net revenues 5,359 4,725
Cost of sales 1,532 1,340
Excise taxes on products 1,267 1,185
Gross profit 2,560 2,200
Marketing, administration and research costs 387 384
Asset impairment and exit costs   35
Operating income (expense) 2,173 1,781
Interest and other debt expense (income), net (18) (25)
Net periodic benefit (income) cost, excluding service cost (22) 0
Earnings from equity investments 0 0
Loss on Cronos-related financial instruments 0 0
Earnings (losses) before income taxes and equity earnings of subsidiaries 2,213 1,806
Provision (benefit) for income taxes 550 459
Equity earnings of subsidiaries 126 95
Net earnings 1,789 1,442
Net (earnings) losses attributable to noncontrolling interests 0 0
Net earnings attributable to Altria 1,789 1,442
Net earnings 1,789 1,442
Other comprehensive earnings (losses), net of deferred income taxes 3 5
Comprehensive earnings 1,792 1,447
Comprehensive earnings attributable to noncontrolling interests 0 0
Comprehensive earnings attributable to Altria 1,792 1,447
Reportable Legal Entities [Member] | Non-Guarantor Subsidiaries [Member]    
Condensed Income Statements, Captions [Line Items]    
Net revenues 1,008 913
Cost of sales 649 248
Excise taxes on products 46 54
Gross profit 313 611
Marketing, administration and research costs 128 114
Asset impairment and exit costs   4
Operating income (expense) 185 493
Interest and other debt expense (income), net 56 54
Net periodic benefit (income) cost, excluding service cost (5) (2)
Earnings from equity investments (23) 0
Loss on Cronos-related financial instruments 137 425
Earnings (losses) before income taxes and equity earnings of subsidiaries 20 16
Provision (benefit) for income taxes 40 11
Equity earnings of subsidiaries 0 0
Net earnings (20) 5
Net (earnings) losses attributable to noncontrolling interests 2 (1)
Net earnings attributable to Altria (18) 4
Net earnings (20) 5
Other comprehensive earnings (losses), net of deferred income taxes 28 23
Comprehensive earnings 8 28
Comprehensive earnings attributable to noncontrolling interests 2 (1)
Comprehensive earnings attributable to Altria 10 27
Total Consolidating Adjustments [Member]    
Condensed Income Statements, Captions [Line Items]    
Net revenues (8) (10)
Cost of sales (8) (10)
Excise taxes on products 0 0
Gross profit 0 0
Marketing, administration and research costs 0 0
Asset impairment and exit costs   0
Operating income (expense) 0 0
Interest and other debt expense (income), net 0 0
Net periodic benefit (income) cost, excluding service cost 0 0
Earnings from equity investments 0 0
Loss on Cronos-related financial instruments 0 0
Earnings (losses) before income taxes and equity earnings of subsidiaries 0 0
Provision (benefit) for income taxes 0 0
Equity earnings of subsidiaries (1,771) (1,446)
Net earnings (1,771) (1,446)
Net (earnings) losses attributable to noncontrolling interests 0 0
Net earnings attributable to Altria (1,771) (1,446)
Net earnings (1,771) (1,446)
Other comprehensive earnings (losses), net of deferred income taxes (31) (28)
Comprehensive earnings (1,802) (1,474)
Comprehensive earnings attributable to noncontrolling interests 0 0
Comprehensive earnings attributable to Altria $ (1,802) $ (1,474)
XML 63 R57.htm IDEA: XBRL DOCUMENT v3.20.1
Segment Reporting (Schedule of Tobacco and Health Litigation Items) (Details) - Tobacco and Health Litigation Cases [Member] - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]    
Provision related to litigation recorded $ 24 $ 17
Segment Reconciling Items [Member]    
Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]    
Provision related to litigation recorded 2 2
PM USA [Member] | Operating Segments [Member] | Smokeable Products Segment [Member]    
Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]    
Provision related to litigation recorded $ 22 $ 15
XML 64 R2.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2020
Dec. 31, 2019
Mar. 31, 2019
Dec. 31, 2018
Assets        
Cash and cash equivalents $ 5,616,000,000 $ 2,117,000,000    
Receivables 147,000,000 152,000,000    
Inventories:        
Leaf tobacco 895,000,000 874,000,000    
Other raw materials 193,000,000 192,000,000    
Work in process 467,000,000 696,000,000    
Finished product 451,000,000 531,000,000    
Inventory, net 2,006,000,000 2,293,000,000    
Other current assets 166,000,000 262,000,000    
Total current assets 7,935,000,000 4,824,000,000    
Property, plant and equipment, at cost 5,103,000,000 5,074,000,000    
Less accumulated depreciation 3,106,000,000 3,075,000,000    
Property, plant and equipment, net 1,997,000,000 1,999,000,000    
Goodwill 5,177,000,000 5,177,000,000    
Other intangible assets, net 12,668,000,000 12,687,000,000    
Investments in equity securities 23,861,000,000 23,581,000,000    
Other assets 980,000,000 1,003,000,000    
Total Assets 52,618,000,000 49,271,000,000    
Liabilities        
Short-term borrowings 3,000,000,000.0 0    
Current portion of long-term debt 0 1,000,000,000    
Accounts payable 278,000,000 325,000,000    
Accrued liabilities:        
Marketing 467,000,000 393,000,000    
Settlement charges 4,419,000,000 3,346,000,000    
Other 1,032,000,000 1,533,000,000    
Income taxes 393,000,000 12,000,000    
Dividends payable 1,565,000,000 1,565,000,000    
Total current liabilities 11,154,000,000 8,174,000,000    
Long-term debt 26,971,000,000 27,042,000,000    
Deferred income taxes 5,191,000,000 5,083,000,000    
Accrued pension costs 427,000,000 473,000,000    
Accrued postretirement health care costs 1,798,000,000 1,797,000,000    
Other liabilities 402,000,000 345,000,000    
Total liabilities 45,943,000,000 42,914,000,000    
Contingencies (Note 11)    
Redeemable noncontrolling interest 38,000,000 38,000,000    
Stockholders’ Equity        
Common stock, par value $0.33 1/3 per share (2,805,961,317 shares issued) 935,000,000 935,000,000    
Additional paid-in capital 5,959,000,000 5,970,000,000    
Earnings reinvested in the business 36,528,000,000 36,539,000,000    
Accumulated other comprehensive losses (2,533,000,000) (2,864,000,000)    
Cost of repurchased stock (947,593,259 shares at March 31, 2020 and 947,979,763 shares at December 31, 2019) (34,346,000,000) (34,358,000,000)    
Total stockholders’ equity attributable to Altria 6,543,000,000 6,222,000,000    
Noncontrolling interests 94,000,000 97,000,000    
Total stockholders’ equity 6,637,000,000 6,319,000,000 $ 14,081,000,000 $ 14,789,000,000
Total Liabilities and Stockholders’ Equity $ 52,618,000,000 $ 49,271,000,000    
XML 65 R6.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Millions
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Earnings Reinvested in the Business [Member]
Accumulated Other Comprehensive Losses [Member]
Cost of Repurchased Stock [Member]
Non-controlling Interests [Member]
Beginning balance at Dec. 31, 2018 $ 14,789 $ 935 $ 5,961 $ 43,962 $ (2,547) $ (33,524) $ 2
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings [1] 1,120     1,120      
Other comprehensive earnings (losses), net of deferred income taxes (170)       (170)    
Stock award activity (7)   (18)     11  
Cash dividends declared (1,500)     (1,500)      
Repurchases of common stock (151)         (151)  
Ending balance at Mar. 31, 2019 14,081 935 5,943 43,582 (2,717) (33,664) 2
Beginning balance at Dec. 31, 2019 6,319 935 5,970 36,539 (2,864) (34,358) 97
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings [1] 1,549     1,552     (3)
Other comprehensive earnings (losses), net of deferred income taxes 331       331    
Stock award activity 1   (11)     12  
Cash dividends declared (1,563)     (1,563)      
Ending balance at Mar. 31, 2020 $ 6,637 $ 935 $ 5,959 $ 36,528 $ (2,533) $ (34,346) $ 94
[1]
Amounts attributable to noncontrolling interests for the three months ended March 31, 2020 and 2019 exclude net earnings of $1 million due to the redeemable noncontrolling interest related to Stag’s Leap Wine Cellars, which is reported in the mezzanine equity section on the condensed consolidated balance sheets.

XML 66 R53.htm IDEA: XBRL DOCUMENT v3.20.1
Earnings Per Share (Basic and Diluted Earnings Per Share) (Details) - USD ($)
shares in Millions, $ in Millions
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Earnings Per Share [Abstract]    
Net earnings attributable to Altria $ 1,552 $ 1,120
Less: Distributed and undistributed earnings attributable to share-based awards (2) (2)
Earnings for basic and diluted EPS $ 1,550 $ 1,118
Weighted-average shares for basic and diluted EPS (in shares) 1,858 1,874
XML 67 R32.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidating Financial Information (Tables)
 3 Months Ended
Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Condensed Consolidating Balance Sheet
Condensed Consolidating Balance Sheets
March 31, 2020
(in millions of dollars)

 
 
Altria Group, Inc.

 
PM USA

 
Non-
Guarantor
Subsidiaries

 
Total
Consolidating
Adjustments

 
Consolidated

Assets
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
5,548

 
$
1

 
$
67

 
$
—

 
$
5,616

Receivables
 
—

 
17

 
130

 
—

 
147

Inventories:
 
 
 
 
 
 
 
 
 
 
Leaf tobacco
 
—

 
508

 
387

 
—

 
895

Other raw materials
 
—

 
123

 
70

 
—

 
193

Work in process
 
—

 
6

 
461

 
—

 
467

Finished product
 
—

 
87

 
364

 
—

 
451

 
 
—

 
724

 
1,282

 
—

 
2,006

Due from Altria Group, Inc. and subsidiaries
 
91

 
5,660

 
1,361

 
(7,112
)
 
—

Other current assets
 
301

 
23

 
68

 
(226
)
 
166

Total current assets
 
5,940

 
6,425

 
2,908

 
(7,338
)
 
7,935

Property, plant and equipment, at cost
 
—

 
2,970

 
2,133

 
—

 
5,103

Less accumulated depreciation
 
—

 
2,186

 
920

 
—

 
3,106

 
 
—

 
784

 
1,213

 
—

 
1,997

Goodwill
 
—

 
—

 
5,177

 
—

 
5,177

Other intangible assets, net
 
—

 
2

 
12,666

 
—

 
12,668

Investments in equity securities
 
18,453

 
—

 
5,408

 
—

 
23,861

Investment in consolidated subsidiaries
 
18,905

 
2,867

 
—

 
(21,772
)
 
—

Due from Altria Group, Inc. and subsidiaries
 
4,790

 
—

 
—

 
(4,790
)
 
—

Other assets
 
71

 
950

 
567

 
(608
)
 
980

Total Assets
 
$
48,159

 
$
11,028

 
$
27,939

 
$
(34,508
)
 
$
52,618

Condensed Consolidating Balance Sheets (Continued)
March 31, 2020
(in millions of dollars)

 
 
Altria Group, Inc.

 
PM USA

 
Non-
Guarantor
Subsidiaries

 
Total
Consolidating
Adjustments

 
Consolidated

Liabilities
 
 
 
 
 
 
 
 
 
 
Short-term borrowings
 
$
3,000

 
$
—

 
$
—

 
$
—

 
$
3,000

Accounts payable
 
1

 
136

 
141

 
—

 
278

Accrued liabilities:
 
 
 
 
 
 
 
 
 
 
Marketing
 
—

 
391

 
76

 
—

 
467

Settlement charges
 
—

 
4,410

 
9

 
—

 
4,419

Other
 
312

 
343

 
377

 
—

 
1,032

Income taxes
 
6

 
508

 
105

 
(226
)
 
393

Dividends payable
 
1,565

 
—

 
—

 
—

 
1,565

Due to Altria Group, Inc. and subsidiaries
 
6,278

 
587

 
247

 
(7,112
)
 
—

Total current liabilities
 
11,162

 
6,375

 
955

 
(7,338
)
 
11,154

Long-term debt
 
26,971

 
—

 
—

 
—

 
26,971

Deferred income taxes
 
3,228

 
—

 
2,571

 
(608
)
 
5,191

Accrued pension costs
 
196

 
—

 
231

 
—

 
427

Accrued postretirement health care costs
 
—

 
1,076

 
722

 
—

 
1,798

Due to Altria Group, Inc. and subsidiaries
 
—

 
—

 
4,790

 
(4,790
)
 
—

Other liabilities
 
59

 
90

 
253

 
—

 
402

Total liabilities
 
41,616

 
7,541

 
9,522

 
(12,736
)
 
45,943

Contingencies
 


 


 


 


 


Redeemable noncontrolling interest
 
—

 
—

 
38

 
—

 
38

Stockholders’ Equity
 
 
 
 
 
 
 
 
 
 
Common stock
 
935

 
—

 
9

 
(9
)
 
935

Additional paid-in capital
 
5,959

 
3,310

 
27,566

 
(30,876
)
 
5,959

Earnings reinvested in the business
 
36,528

 
393

 
(7,441
)
 
7,048

 
36,528

Accumulated other comprehensive losses
 
(2,533
)
 
(216
)
 
(1,849
)
 
2,065

 
(2,533
)
Cost of repurchased stock
 
(34,346
)
 
—

 
—

 
—

 
(34,346
)
Total stockholders’ equity attributable
 to Altria Group, Inc.
 
6,543

 
3,487

 
18,285

 
(21,772
)
 
6,543

Noncontrolling interests
 
—

 
—

 
94

 
—

 
94

Total stockholders’ equity
 
6,543

 
3,487

 
18,379

 
(21,772
)
 
6,637

Total Liabilities and Stockholders’ Equity
 
$
48,159

 
$
11,028

 
$
27,939

 
$
(34,508
)
 
$
52,618

Condensed Consolidating Balance Sheets
December 31, 2019
(in millions of dollars)

 
 
Altria Group, Inc.

 
PM USA

 
Non-
Guarantor
Subsidiaries

 
Total
Consolidating
Adjustments

 
Consolidated

Assets
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
2,022

 
$
—

 
$
95

 
$
—

 
$
2,117

Receivables
 
—

 
30

 
122

 
—

 
152

Inventories:
 
 
 
 
 
 
 
 
 
 
Leaf tobacco
 
—

 
494

 
380

 
—

 
874

Other raw materials
 
—

 
120

 
72

 
—

 
192

Work in process
 
—

 
4

 
692

 
—

 
696

Finished product
 
—

 
119

 
412

 
—

 
531

 
 
—

 
737

 
1,556

 
—

 
2,293

Due from Altria Group, Inc. and subsidiaries
 
88

 
4,005

 
1,359

 
(5,452
)
 
—

Other current assets
 
133

 
64

 
114

 
(49
)
 
262

Total current assets
 
2,243

 
4,836

 
3,246

 
(5,501
)
 
4,824

Property, plant and equipment, at cost
 
—

 
2,956

 
2,118

 
—

 
5,074

Less accumulated depreciation
 
—

 
2,166

 
909

 
—

 
3,075

 
 
—

 
790

 
1,209

 
—

 
1,999

Goodwill
 
—

 
—

 
5,177

 
—

 
5,177

Other intangible assets, net
 
—

 
2

 
12,685

 
—

 
12,687

Investments in equity securities
 
18,071

 
—

 
5,510

 
—

 
23,581

Investment in consolidated subsidiaries
 
19,312

 
2,831

 
—

 
(22,143
)
 
—

Due from Altria Group, Inc. and subsidiaries
 
4,790

 
—

 
—

 
(4,790
)
 
—

Other assets
 
58

 
951

 
603

 
(609
)
 
1,003

Total Assets
 
$
44,474

 
$
9,410

 
$
28,430

 
$
(33,043
)
 
$
49,271

Condensed Consolidating Balance Sheets (Continued)
December 31, 2019
(in millions of dollars)

 
 
Altria Group, Inc.

 
PM USA

 
Non-
Guarantor
Subsidiaries

 
Total
Consolidating
Adjustments

 
Consolidated

Liabilities
 
 
 
 
 
 
 
 
 
 
Current portion of long-term debt
 
$
1,000

 
$
—

 
$
—

 
$
—

 
$
1,000

Accounts payable
 
—

 
146

 
179

 
—

 
325

Accrued liabilities:
 
 
 
 
 
 
 
 
 
 
Marketing
 
—

 
320

 
73

 
—

 
393

Settlement charges
 
—

 
3,340

 
6

 
—

 
3,346

Other
 
570

 
482

 
481

 
—

 
1,533

Income taxes
 
6

 
—

 
55

 
(49
)
 
12

Dividends payable
 
1,565

 
—

 
—

 
—

 
1,565

Due to Altria Group, Inc. and subsidiaries
 
4,693

 
514

 
245

 
(5,452
)
 
—

Total current liabilities
 
7,834

 
4,802

 
1,039

 
(5,501
)
 
8,174

Long-term debt
 
27,042

 
—

 
—

 
—

 
27,042

Deferred income taxes
 
3,099

 
—

 
2,593

 
(609
)
 
5,083

Accrued pension costs
 
197

 
—

 
276

 
—

 
473

Accrued postretirement health care costs
 
—

 
1,078

 
719

 
—

 
1,797

Due to Altria Group, Inc. and subsidiaries
 
—

 
—

 
4,790

 
(4,790
)
 
—

Other liabilities
 
80

 
87

 
178

 
—

 
345

Total liabilities
 
38,252

 
5,967

 
9,595

 
(10,900
)
 
42,914

Contingencies
 


 


 


 


 


Redeemable noncontrolling interest
 
—

 
—

 
38

 
—

 
38

Stockholders’ Equity
 
 
 
 
 
 
 
 
 
 
Common stock
 
935

 
—

 
9

 
(9
)
 
935

Additional paid-in capital
 
5,970

 
3,310

 
27,565

 
(30,875
)
 
5,970

Earnings reinvested in the business
 
36,539

 
352

 
(6,997
)
 
6,645

 
36,539

Accumulated other comprehensive losses
 
(2,864
)
 
(219
)
 
(1,877
)
 
2,096

 
(2,864
)
Cost of repurchased stock
 
(34,358
)
 
—

 
—

 
—

 
(34,358
)
Total stockholders’ equity attributable
to Altria Group, Inc.
 
6,222

 
3,443

 
18,700

 
(22,143
)
 
6,222

Noncontrolling interests
 
—

 
—

 
97

 
—

 
97

Total stockholders’ equity
 
6,222

 
3,443

 
18,797

 
(22,143
)
 
6,319

Total Liabilities and Stockholders’ Equity
 
$
44,474

 
$
9,410

 
$
28,430

 
$
(33,043
)
 
$
49,271
Condensed Consolidating Statements of Earnings and Comprehensive Earnings
Condensed Consolidating Statements of Earnings and Comprehensive Earnings
For the Three Months Ended March 31, 2020
(in millions of dollars)

 
 
Altria Group, Inc.

 
PM USA

 
Non-
Guarantor
Subsidiaries

 
Total
Consolidating
Adjustments

 
Consolidated

Net revenues
 
$
—

 
$
5,359

 
$
1,008

 
$
(8
)
 
$
6,359

Cost of sales
 
—

 
1,532

 
649

 
(8
)
 
2,173

Excise taxes on products
 
—

 
1,267

 
46

 
—

 
1,313

Gross profit
 
—

 
2,560

 
313

 
—

 
2,873

Marketing, administration and research costs
 
22

 
387

 
128

 
—

 
537

Operating income (expense)
 
(22
)
 
2,173

 
185

 
—

 
2,336

Interest and other debt expense (income), net
 
237

 
(18
)
 
56

 
—

 
275

Net periodic benefit (income) cost, excluding service cost
 
—

 
(22
)
 
(5
)
 
—

 
(27
)
Earnings from equity investments
 
(134
)
 
—

 
(23
)
 
—

 
(157
)
Loss on Cronos-related financial instruments
 
—

 
—

 
137

 
—

 
137

Earnings (losses) before income taxes and equity earnings of subsidiaries
 
(125
)
 
2,213


20


—


2,108

Provision (benefit) for income taxes
 
(32
)
 
550

 
40

 
—

 
558

Equity earnings of subsidiaries
 
1,645

 
126

 
—

 
(1,771
)
 
—

Net earnings
 
1,552

 
1,789

 
(20
)
 
(1,771
)
 
1,550

Net (earnings) losses attributable to noncontrolling interests
 
—

 
—

 
2

 
—

 
2

Net earnings attributable to Altria
 
$
1,552

 
$
1,789

 
$
(18
)
 
$
(1,771
)
 
$
1,552

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net earnings
 
$
1,552

 
$
1,789

 
$
(20
)
 
$
(1,771
)
 
$
1,550

Other comprehensive earnings (losses), net of deferred income taxes
 
331

 
3

 
28

 
(31
)
 
331

Comprehensive earnings
 
1,883

 
1,792

 
8

 
(1,802
)
 
1,881

Comprehensive (earnings) losses attributable to noncontrolling interests
 
—

 
—

 
2

 
—

 
2

Comprehensive earnings attributable to Altria
 
$
1,883

 
$
1,792

 
$
10

 
$
(1,802
)
 
$
1,883


Condensed Consolidating Statements of Earnings and Comprehensive Earnings
For the Three Months Ended March 31, 2019
(in millions of dollars)

 
 
Altria Group, Inc.

 
PM USA

 
Non-
Guarantor
Subsidiaries

 
Total
Consolidating
Adjustments

 
Consolidated

Net revenues
 
$
—

 
$
4,725

 
$
913

 
$
(10
)
 
$
5,628

Cost of sales
 
—

 
1,340

 
248

 
(10
)
 
1,578

Excise taxes on products
 
—

 
1,185

 
54

 
—

 
1,239

Gross profit
 
—

 
2,200

 
611

 
—

 
2,811

Marketing, administration and research costs
 
35

 
384

 
114

 
—

 
533

Asset impairment and exit costs
 
1

 
35

 
4

 
—

 
40

Operating income (expense)
 
(36
)
 
1,781

 
493

 
—

 
2,238

Interest and other debt expense (income), net
 
355

 
(25
)
 
54

 
—

 
384

Net periodic benefit (income) cost, excluding service cost
 
1

 
—

 
(2
)
 
—

 
(1
)
Earnings from equity investments
 
(86
)
 
—

 
—

 
—

 
(86
)
Loss on Cronos-related financial instruments
 
—

 
—

 
425

 
—

 
425

Earnings (losses) before income taxes and equity earnings of subsidiaries
 
(306
)
 
1,806

 
16

 
—

 
1,516

Provision (benefit) for income taxes
 
(75
)
 
459

 
11

 
—

 
395

Equity earnings of subsidiaries
 
1,351

 
95

 
—

 
(1,446
)
 
—

Net earnings
 
1,120

 
1,442

 
5

 
(1,446
)
 
1,121

Net (earnings) losses attributable to noncontrolling interests
 
—

 
—

 
(1
)
 
—

 
(1
)
Net earnings attributable to Altria
 
$
1,120

 
$
1,442

 
$
4

 
$
(1,446
)
 
$
1,120

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net earnings
 
$
1,120

 
$
1,442

 
$
5

 
$
(1,446
)
 
$
1,121

Other comprehensive earnings (losses), net of deferred income taxes
 
(170
)
 
5

 
23

 
(28
)
 
(170
)
Comprehensive earnings
 
950

 
1,447

 
28

 
(1,474
)
 
951

Comprehensive (earnings) losses attributable to noncontrolling interests
 
—

 
—

 
(1
)
 
—

 
(1
)
Comprehensive earnings attributable to Altria
 
$
950

 
$
1,447

 
$
27

 
$
(1,474
)
 
$
950
Condensed Consolidating Statements of Cash Flows
Condensed Consolidating Statements of Cash Flows
For the Three Months Ended March 31, 2020
(in millions of dollars)

 
 
Altria Group, Inc.

 
PM USA

 
Non-
Guarantor
Subsidiaries

 
Total
Consolidating
Adjustments

 
Consolidated

Cash Provided by (Used In) Operating Activities
 
 
 
 
 
 
 
 
 
 
Net cash provided by (used in) operating activities
 
$
1,515

 
$
3,351

 
$
437

 
$
(2,174
)
 
$
3,129

Cash Provided by (Used in) Investing Activities
 
 
 
 
 
 
 
 
 
 
Capital expenditures
 
—

 
(15
)
 
(37
)
 
—

 
(52
)
Investment in consolidated subsidiaries
 
(1
)
 
—

 
—

 
1

 
—

Other, net
 
—

 
—

 
—

 
—

 
—

Net cash provided by (used in) investing activities
 
(1
)
 
(15
)
 
(37
)
 
1

 
(52
)
Cash Provided by (Used in) Financing Activities
 
 
 
 
 
 
 
 
 
 
Proceeds from short-term borrowings
 
3,000

 
—

 
—

 
—

 
3,000

Long-term debt repaid
 
(1,000
)
 
—

 
—

 
—

 
(1,000
)
Dividends paid on common stock
 
(1,563
)
 
—

 
—

 
—

 
(1,563
)
Changes in amounts due to/from Altria Group, Inc.
and subsidiaries
 
1,584

 
(1,582
)
 
(1
)
 
(1
)
 
—

Cash dividends paid to parent
 
—

 
(1,748
)
 
(426
)
 
2,174

 
—

Other, net
 
(9
)
 
—

 
(1
)
 
—

 
(10
)
Net cash provided by (used in) financing activities
 
2,012

 
(3,330
)
 
(428
)
 
2,173

 
427

Cash, cash equivalents and restricted cash (1):
 
 
 
 
 
 
 
 
 
 
Increase (decrease)
 
3,526

 
6

 
(28
)
 
—

 
3,504

Balance at beginning of period
 
2,022

 
43

 
95

 
—

 
2,160

Balance at end of period
 
$
5,548

 
$
49

 
$
67

 
$
—

 
$
5,664

(1)
Restricted cash consisted of cash deposits collateralizing appeal bonds posted by PM USA to obtain stays of judgments pending appeals. See Note 11. Contingencies.
Condensed Consolidating Statements of Cash Flows
For the Three Months Ended March 31, 2019
(in millions of dollars)

 
 
Altria Group, Inc.

 
PM USA

 
Non-
Guarantor
Subsidiaries

 
Total
Consolidating
Adjustments

 
Consolidated

Cash Provided by (Used In) Operating Activities
 
 
 
 
 
 
 
 
 
 
Net cash provided by (used in) operating activities
 
$
1,642

 
$
2,520

 
$
166

 
$
(2,039
)
 
$
2,289

Cash Provided by (Used in) Investing Activities
 
 
 
 
 
 
 
 
 
 
Capital expenditures
 
—

 
(9
)
 
(29
)
 
—

 
(38
)
Investment in Cronos
 
—

 
—

 
(1,831
)
 
—

 
(1,831
)
Investment in consolidated subsidiaries
 
(1,947
)
 
—

 
—

 
1,947

 
—

Other, net
 
(3
)
 
—

 
(78
)
 
—

 
(81
)
Net cash provided by (used in) investing activities
 
(1,950
)
 
(9
)
 
(1,938
)
 
1,947

 
(1,950
)
Cash Provided by (Used in) Financing Activities
 
 
 
 
 
 
 
 
 
 
Repayment of short-term borrowings
 
(12,800
)
 
—

 
—

 
—

 
(12,800
)
Long-term debt issued
 
16,265

 
—

 
—

 
—

 
16,265

Repurchases of common stock
 
(151
)
 
—

 
—

 
—

 
(151
)
Dividends paid on common stock
 
(1,502
)
 
—

 
—

 
—

 
(1,502
)
Changes in amounts due to/from Altria Group, Inc.
and subsidiaries
 
657

 
(771
)
 
2,061

 
(1,947
)
 
—

Cash dividends paid to parent
 
—

 
(1,737
)
 
(302
)
 
2,039

 
—

Other
 
(120
)
 
—

 
(9
)
 
—

 
(129
)
Net cash provided by (used in) financing activities
 
2,349

 
(2,508
)
 
1,750

 
92

 
1,683

Cash, cash equivalents and restricted cash (1):
 
 
 
 
 
 
 
 
 
 
Increase (decrease)
 
2,041

 
3

 
(22
)
 
—

 
2,022

Balance at beginning of period
 
1,277

 
100

 
56

 
—

 
1,433

Balance at end of period
 
$
3,318

 
$
103

 
$
34

 
$
—

 
$
3,455

(1) Restricted cash consisted of cash deposits collateralizing appeal bonds posted by PM USA to obtain stays of judgments pending appeals. See Note 11. Contingencies.
XML 68 R36.htm IDEA: XBRL DOCUMENT v3.20.1
Revenues from Contracts with Customers (Narrative) (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2020
Dec. 31, 2019
Revenue from Contract with Customer [Abstract]    
Allowance for sales discounts, goods $ 0 $ 0
Deferred revenue $ 219 362
Expected period for satisfaction of performance obligation three days  
Receivables $ 147 $ 152
XML 69 R19.htm IDEA: XBRL DOCUMENT v3.20.1
Contingencies
 3 Months Ended
Mar. 31, 2020
Commitments and Contingencies Disclosure [Abstract]  
Contingencies Contingencies

Legal proceedings covering a wide range of matters are pending or threatened in various U.S. and foreign jurisdictions against Altria and its subsidiaries, including PM USA and USSTC, as well as their respective indemnitees and Altria’s investees. Various types of claims may be raised in these proceedings, including product liability, unfair trade practices, antitrust, tax, contraband shipments, patent infringement, employment matters, claims for contribution and claims of competitors, shareholders or distributors.

Litigation is subject to uncertainty and it is possible that there could be adverse developments in pending or future cases. An unfavorable outcome or settlement of pending tobacco-related or other litigation could encourage the commencement of additional litigation. Damages claimed in some tobacco-related and other litigation are or can be significant and, in certain cases, have ranged in the billions of dollars. The variability in pleadings in multiple jurisdictions, together with the actual experience of management in litigating claims, demonstrate that the monetary relief that may be specified in a lawsuit bears little relevance to the ultimate outcome. In certain cases, plaintiffs claim that defendants’ liability is joint and several. In such cases, Altria or its subsidiaries may face the risk that one or more co-defendants decline or otherwise fail to participate in the bonding required for an appeal or to pay their proportionate or jury-allocated share of a judgment. As a result, Altria or its subsidiaries under certain circumstances may have to pay more than their proportionate share of any bonding- or judgment-related amounts. Furthermore, in those cases where plaintiffs are successful, Altria or its subsidiaries may also be required to pay interest and attorneys’ fees.

Although PM USA has historically been able to obtain required bonds or relief from bonding requirements in order to prevent plaintiffs from seeking to collect judgments while adverse verdicts have been appealed, there remains a risk that such relief may not be obtainable in all cases. This risk has been substantially reduced given that 47 states and Puerto Rico limit the dollar amount of bonds or require no bond at all. As discussed below, however, tobacco litigation plaintiffs have challenged the constitutionality of Florida’s bond cap statute in several cases and plaintiffs may challenge state bond cap statutes in other jurisdictions as well. Such challenges may include the applicability of state bond caps in federal court. States, including Florida, may also seek to repeal or alter bond cap statutes through legislation. Although Altria cannot predict the outcome of such challenges, it is possible that the consolidated results of operations, cash flows or financial position of Altria, or one or more of its subsidiaries, could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome of one or more such challenges.

Altria and its subsidiaries record provisions in the condensed consolidated financial statements for pending litigation when they determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. At the present time, while it is reasonably possible that an unfavorable outcome in a case may occur, except to the extent discussed elsewhere in this Note 11. Contingencies: (i) management has concluded that it is not probable that a loss has been incurred in any of the pending cases; (ii) management is unable to estimate the possible loss or range of loss that could result from an unfavorable outcome in any of the pending cases; and (iii) accordingly, management has not provided any amounts in the condensed consolidated financial statements for unfavorable outcomes, if any. Litigation defense costs are expensed as incurred.

Altria and its subsidiaries have achieved substantial success in managing litigation. Nevertheless, litigation is subject to uncertainty and significant challenges remain. It is possible that the consolidated results of operations, cash flows or financial position of Altria, or one or more of its subsidiaries, could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome or settlement of certain pending litigation. Altria and each of its subsidiaries named as a defendant believe, and each has been so advised by counsel handling the respective cases, that it has valid defenses to the litigation pending against it, as well as valid bases for appeal of adverse verdicts. Each of the companies has defended, and will continue to defend, vigorously against litigation challenges. However, Altria and its subsidiaries may enter into settlement discussions in particular cases if they believe it is in the best interests of Altria to do so.

Overview of Altria and/or PM USA Tobacco-Related Litigation

Types and Number of U.S. Cases

Claims related to tobacco products generally fall within the following categories: (i) smoking and health cases alleging personal injury brought on behalf of individual plaintiffs; (ii) health care cost recovery cases brought by governmental (both domestic and foreign) plaintiffs seeking reimbursement for health care expenditures allegedly caused by cigarette smoking and/or disgorgement of profits; (iii) e-vapor cases alleging violation of the Racketeer Influenced and Corrupt Organizations Act (“RICO”), fraud, failure to warn, design defect, negligence and unfair trade practices; and (iv) other tobacco-related litigation described below. Plaintiffs’ theories of recovery and the defenses raised in tobacco-related litigation are discussed below.

The table below lists the number of certain tobacco-related cases pending in the U.S. against PM USA and, in some instances, Altria as of April 27, 2020, April 22, 2019 and April 23, 2018:
 
April 27, 2020
 
April 22, 2019
 
April 23, 2018
Individual Smoking and Health Cases (1)
109
 
98
 
102
Health Care Cost Recovery Actions (2)
—
 
1
 
1
E-vapor Cases(3)
202
 
2
 
3
Other Tobacco-Related Cases(4)
4
 
—
 
—
(1) Includes 22 cases filed in Massachusetts and 46 non-Engle cases filed in Florida. Does not include individual smoking and health cases brought by or on behalf of plaintiffs in Florida state and federal courts following the decertification of the Engle case (these Engle progeny cases are discussed below in Smoking and Health Litigation - Engle Class Action). Also does not include 1,472 cases brought by flight attendants seeking compensatory damages for personal injuries allegedly caused by exposure to environmental tobacco smoke (“ETS”). The flight attendants allege that they are members of an ETS smoking and health class action in Florida, which was settled in 1997 (Broin). The terms of the court-approved settlement in that case allowed class members to file individual lawsuits seeking compensatory damages, but prohibited them from seeking punitive damages. In March 2018, 923 of these cases were voluntarily dismissed without prejudice.
(2) See Health Care Cost Recovery Litigation - Federal Government’s Lawsuit below.
(3) Includes 24 class action lawsuits, 170 individual lawsuits, five state or local government lawsuits and three lawsuits filed by school districts relating to JUUL e-vapor products. JUUL is an additional named defendant in each of these lawsuits.
(4) For 2019 and 2020, includes two inactive smoking and health cases alleging personal injury or seeking court-supervised programs or ongoing medical monitoring and purporting to be brought on behalf of a class of individual plaintiffs, including one case in which the aggregated claims of a number of individual plaintiffs are to be tried in a single proceeding, and two inactive class action lawsuits alleging that use of the terms “Lights” and “Ultra Lights” constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO.

International Tobacco-Related Cases

As of April 27, 2020, PM USA is a named defendant in 10 health care cost recovery actions in Canada, eight of which also name Altria as a defendant. PM USA and Altria are also named defendants in seven smoking and health class actions filed in various Canadian provinces. See Guarantees and Other Similar Matters below for a discussion of the Distribution Agreement between Altria and Philip Morris International Inc. (“PMI”) that provides for indemnities for certain liabilities concerning tobacco products.

Tobacco-Related Cases Set for Trial

As of April 27, 2020, two Engle progeny cases are set for trial through June 30, 2020. In addition, there are no individual smoking and health cases against PM USA set for trial during this period. Cases against other companies in the tobacco industry may be scheduled for trial during this period. Trial dates are subject to change and some trials have been postponed due to the COVID-19 pandemic.

Trial Results

Since January 1999, excluding the Engle progeny cases (separately discussed below), verdicts have been returned in 69 tobacco-related cases in which PM USA was a defendant. Verdicts in favor of PM USA and other defendants were returned in 44 of the 69 cases. These 44 cases were tried in Alaska (1), California (7), Connecticut (1), Florida (10), Louisiana (1), Massachusetts (4), Mississippi (1), Missouri (4), New Hampshire (1), New Jersey (1), New York (5), Ohio (2), Pennsylvania (1), Rhode Island (1), Tennessee (2) and West Virginia (2).

Of the 25 non-Engle progeny cases in which verdicts were returned in favor of plaintiffs, 20 have reached final resolution, and one case (Gentile) that was initially returned in favor of plaintiff was reversed post-trial and remains pending.
See Smoking and Health Litigation - Engle Progeny Trial Results below for a discussion of verdicts in state and federal Engle progeny cases involving PM USA as of April 27, 2020.

Judgments Paid and Provisions for Tobacco and Health Litigation Items (Including Engle Progeny Litigation)

After exhausting all appeals in those cases resulting in adverse verdicts associated with tobacco-related litigation, since October 2004, PM USA has paid judgments and settlements (including related costs and fees) totaling approximately $748 million and interest totaling approximately $216 million as of March 31, 2020. These amounts include payments for Engle progeny
judgments (and related costs and fees) totaling approximately $327 million and related interest totaling approximately $54 million.

The changes in Altria’s accrued liability for tobacco and health litigation items, including related interest costs, for the periods specified below are as follows:
 
For the Three Months Ended March 31,
(in millions)
2020
 
2019
Accrued liability for tobacco and health litigation items at beginning of period (1)
$
14

 
$
112

Pre-tax charges for:
 
 
 
Tobacco and health litigation
22

(2) 
15

Related interest costs
2

 
2

Payments (1)
(28
)
(3) 
(109
)
Accrued liability for tobacco and health litigation items at end of period (1)
$
10

 
$
20

(1) Includes amounts related to the costs of implementing the corrective communications remedy related to the Federal Government’s Lawsuit discussed below.
(2) Includes approximately $7 million related to pre-trial resolution of approximately 100 tobacco and health cases.
(3) Includes approximately $7 million in payments related to above-mentioned pre-trial resolution of approximately 100 tobacco and health cases and $2 million for pre-trial resolution of other tobacco and health cases that was accrued in 2019 but not paid until 2020.

The accrued liability for tobacco and health litigation items, including related interest costs, was included in accrued liabilities on Altria’s condensed consolidated balance sheets. Pre-tax charges for tobacco and health litigation were included in marketing, administration and research costs on Altria’s condensed consolidated statements of earnings (losses). Pre-tax charges for related interest costs were included in interest and other debt expense, net on Altria’s condensed consolidated statements of earnings (losses).

Security for Judgments

To obtain stays of judgments pending appeal, PM USA has posted various forms of security. As of March 31, 2020, PM USA has posted appeal bonds totaling approximately $48 million, which have been collateralized with restricted cash that are included in assets on the condensed consolidated balance sheet.

Smoking and Health Litigation

Overview

Plaintiffs’ allegations of liability in smoking and health cases are based on various theories of recovery, including negligence, gross negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, nuisance, breach of express and implied warranties, breach of special duty, conspiracy, concert of action, violations of unfair trade practice laws and consumer protection statutes, and claims under the federal and state anti-racketeering statutes. Plaintiffs in the smoking and health cases seek various forms of relief, including compensatory and punitive damages, treble/multiple damages and other statutory damages and penalties, creation of medical monitoring and smoking cessation funds, disgorgement of profits, and injunctive and equitable relief. Defenses raised in these cases include lack of proximate cause, assumption of the risk, comparative fault and/or contributory negligence, statutes of limitations and preemption by the Federal Cigarette Labeling and Advertising Act.

Non-Engle Progeny Litigation

Summarized below are the non-Engle progeny smoking and health cases pending during 2020 in which a verdict was returned in favor of plaintiff and against PM USA. Charts listing certain verdicts for plaintiffs in the Engle progeny cases can be found in Smoking and Health Litigation - Engle Progeny Trial Results below.

Principe: In February 2020, a jury in a Florida state court returned a verdict in favor of plaintiff and against PM USA, awarding approximately $11 million in compensatory damages. There was no claim for punitive damages. PM USA’s post-trial motions are pending.

Greene: In September 2019, a jury in a Massachusetts state court returned a verdict in favor of plaintiffs and against PM USA, awarding approximately $10 million in compensatory damages. An additional claim by plaintiffs remains pending.

Laramie: In August 2019, a jury in a Massachusetts state court returned a verdict in favor of plaintiff, awarding $11 million in compensatory damages and $10 million in punitive damages. PM USA and plaintiff have appealed.

Gentile: In October 2017, a jury in a Florida state court returned a verdict in favor of plaintiff, awarding approximately $7.1 million in compensatory damages and allocating 75% of the fault to PM USA (an amount of approximately $5.3 million). PM USA appealed. In September 2019, the Florida Fourth District Court of Appeal reversed the judgment entered by the trial court, granted PM USA judgment on certain claims and remanded for a new trial on the remaining claims. Plaintiff has petitioned the Florida Supreme Court for further review.

Federal Government’s Lawsuit: See Health Care Cost Recovery Litigation - Federal Government’s Lawsuit below for a discussion of the verdict and post-trial developments in the United States of America health care cost recovery case.

Engle Class Action

In July 2000, in the second phase of the Engle smoking and health class action in Florida, a jury returned a verdict assessing punitive damages totaling approximately $145 billion against various defendants, including $74 billion against PM USA. Following entry of judgment, PM USA appealed. In May 2003, the Florida Third District Court of Appeal reversed the judgment entered by the trial court and instructed the trial court to order the decertification of the class. Plaintiffs petitioned the Florida Supreme Court for further review.

In July 2006, the Florida Supreme Court ordered that the punitive damages award be vacated, that the class approved by the trial court be decertified and that members of the decertified class could file individual actions against defendants within one year of issuance of the mandate. The court further declared the following Phase I findings are entitled to res judicata effect in such individual actions brought within one year of the issuance of the mandate: (i) that smoking causes various diseases; (ii) that nicotine in cigarettes is addictive; (iii) that defendants’ cigarettes were defective and unreasonably dangerous; (iv) that defendants concealed or omitted material information not otherwise known or available knowing that the material was false or misleading or failed to disclose a material fact concerning the health effects or addictive nature of smoking; (v) that defendants agreed to misrepresent information regarding the health effects or addictive nature of cigarettes with the intention of causing the public to rely on this information to their detriment; (vi) that defendants agreed to conceal or omit information regarding the health effects of cigarettes or their addictive nature with the intention that smokers would rely on the information to their detriment; (vii) that all defendants sold or supplied cigarettes that were defective; and (viii) that defendants were negligent.

In August 2006, PM USA and plaintiffs sought rehearing from the Florida Supreme Court on parts of its July 2006 opinion. In December 2006, the Florida Supreme Court refused to revise its July 2006 ruling, except that it revised the set of Phase I findings entitled to res judicata effect by excluding finding (v) listed above (relating to agreement to misrepresent information), and added the finding that defendants sold or supplied cigarettes that, at the time of sale or supply, did not conform to the representations of fact made by defendants. In February 2008, the trial court decertified the class.

Pending Engle Progeny Cases

The deadline for filing Engle progeny cases expired in January 2008, at which point a total of approximately 9,300 federal and state claims were pending. As of April 27, 2020, approximately 1,500 state court cases were pending against PM USA or Altria asserting individual claims by or on behalf of approximately 1,900 state court plaintiffs.  Because of a number of factors, including docketing delays, duplicated filings and overlapping dismissal orders, these numbers are estimates. While the Federal Engle Agreement (discussed below) resolved nearly all Engle progeny cases pending in federal court, as of April 27, 2020, four cases were pending against PM USA in federal court representing the cases excluded from that agreement.

Engle Progeny Trial Results

As of April 27, 2020, 134 federal and state Engle progeny cases involving PM USA have resulted in verdicts since the Florida Supreme Court Engle decision. Seventy-eight verdicts were returned in favor of plaintiffs and four verdicts (Skolnick, Calloway, Oshinsky-Blacker and Freeman) that were initially returned in favor of plaintiffs were reversed post-trial or on appeal and remain pending.

Forty-seven verdicts were returned in favor of PM USA, of which 42 were state cases. In addition, there have been a number of mistrials, only some of which have resulted in new trials as of April 27, 2020. Four verdicts (Pearson, D. Cohen, Collar and Chacon) that were returned in favor of PM USA were subsequently reversed for new trials. Juries in two cases (Reider and
Banks) returned zero damages verdicts in favor of PM USA. Juries in two other cases (Weingart and Hancock) returned verdicts against PM USA awarding no damages, but the trial court in each case decided to award plaintiffs damages. One case, Pollari, resulted in a verdict in favor of PM USA following a retrial of an initial verdict returned in favor of plaintiff. Appeals by plaintiff and defendants are pending. Three cases, Gloger, Rintoul (Caprio) and Duignan, resulted in verdicts in favor of plaintiffs following retrial of initial verdicts returned in favor of plaintiffs. Post-trial motions or appeals are pending. One case, Freeman, resulted in an appellate reversal of a jury verdict in favor of plaintiff and a judgment in favor of PM USA.

The charts below list the verdicts and post-trial developments in certain Engle progeny cases in which verdicts were returned in favor of plaintiffs. The first chart lists such cases that are pending as of April 27, 2020 where PM USA has recorded a provision in its consolidated financial statements because PM USA has determined that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated; the second chart lists other such cases that are pending as of April 27, 2020 but where PM USA has determined an unfavorable outcome is not probable and the amount of loss cannot be reasonably estimated; and the third chart lists other such cases that have concluded within the previous 12 months. Unless otherwise noted for a particular case, the jury’s award for compensatory damages will not be reduced by any finding of plaintiff’s comparative fault. Further, the damages noted reflect adjustments based on post-trial or appellate rulings.
Currently Pending Engle Cases with Accrued Liabilities
(rounded to nearest $ million)

Plaintiff
Verdict Date
Defendant(s)
Court
Compensatory Damages (All Defendants)
Punitive Damages (PM USA)
Appeal Status
Accrual (1)
Berger (Cote)
September 2014
PM USA
Federal Court - Middle District of Florida
$6 million
$21 million
The Eleventh Circuit Court of Appeals reinstated the punitive and compensatory damages awards and remanded the case to the district court. PM USA’s challenge to the punitive damages award was denied by the district court. PM USA’s appeal to the Eleventh Circuit Court of Appeals is pending.
$6 million accrual in the fourth quarter of 2018
(1) Accrual amounts include interest and associated costs, if applicable. For cases with multiple defendants, if any, accrual amounts reflect the portion of compensatory damages PM USA believes it will have to pay if the case is ultimately decided in plaintiff’s favor after taking into account any portion potentially payable by the other defendant(s).
Other Currently Pending Engle Cases with Verdicts Against PM USA
(rounded to nearest $ million)

Plaintiff
Verdict Date
Defendant(s)
Court
Compensatory Damages (1)
Punitive Damages
(PM USA)
Appeal Status
Duignan
February 2020(2)
PM USA and
R.J. Reynolds(3)
Pinellas
$3 million
$12 million
Defendants’ post-trial motions pending.
Cuddihee
January 2020
PM USA
Duval
$3 million
$0
Defendant’s post-trial motions pending.
Rintoul (Caprio)
November 2019(2)
PM USA and R.J. Reynolds
Broward
$9 million ($5 million PM USA)
$74 million
Defendants’ post-trial motion pending.
Gloger
November 2019(2)
PM USA and R.J. Reynolds
Miami-Dade
$15 million ($5 million PM USA)
$11 million
Appeal by defendants to Third District Court of Appeal pending.
McCall
March 2019
PM USA
Broward
<$1 million (<$1 million PM USA)
<$1 million
New trial ordered on punitive damages.
Neff
March 2019
PM USA and R.J. Reynolds
Broward
$4 million
$2 million
Appeals by plaintiff and defendants to Fourth District Court of Appeal pending.
Frogel
March 2019
PM USA
Palm Beach
<$1 million (<$1 million PM USA)
$0
Appeals by plaintiff and defendant to Fourth District Court of Appeal pending.
Other Currently Pending Engle Cases with Verdicts Against PM USA
(rounded to nearest $ million)

Plaintiff
Verdict Date
Defendant(s)
Court
Compensatory Damages (1)
Punitive Damages
(PM USA)
Appeal Status
Mahfuz
February 2019
PM USA and R.J. Reynolds
Broward
$12 million
$10 million
Appeals by plaintiff and defendants to Fourth District Court of Appeal pending.
Holliman
February 2019
PM USA
Miami-Dade
$3 million
$0
Defendant’s appeal to Third District Court of Appeal pending.
Chadwell
September 2018
PM USA
Miami-Dade
$2 million
$0
Appeals by defendant and plaintiff to Third District Court of Appeal pending.
Kaplan
July 2018
PM USA and R.J. Reynolds
Broward
$2 million
$2 million
Appeals by defendants and plaintiff to Fourth District Court of Appeal pending.
Landi
June 2018
PM USA and R.J. Reynolds
Broward
$8 million
$5 million
Appeals by plaintiff and defendants to Fourth District Court of Appeal pending.
R. Douglas
November 2017
PM USA
Duval
<$1 million
$0
Awaiting entry of final judgment by the trial court.
Sommers
April 2017
PM USA
Miami-Dade
$1 million
$0
Third District Court of Appeal affirmed compensatory damages award and granted new trial on punitive damages. Defendant petitioned Florida Supreme Court for review.
Santoro
March 2017
PM USA, R.J. Reynolds and Liggett Group(3)
Broward
$2 million
$0
Trial court set aside punitive damages award; appeals by plaintiff and defendants to Fourth District Court of Appeal pending.
Cooper (Blackwood)
September 2015
PM USA and R.J. Reynolds
Broward
$5 million
(<$1 million PM USA)
$0
Fourth District Court of Appeal affirmed judgment and granted a new trial on punitive damages.
D. Brown
January 2015
PM USA
Federal Court - Middle District of Florida
$8 million
$9 million
Appeal by defendant to U.S. Court of Appeals for the Eleventh Circuit pending.
Kerrivan
October 2014
PM USA and R.J. Reynolds
Federal Court - Middle District of Florida
$16 million
$16 million
U.S. Court of Appeals for the Eleventh Circuit affirmed the judgment. Defendants’ motion for rehearing pending.
Harris
July 2014
PM USA,
R.J. Reynolds and Lorillard(3)
Federal Court - Middle District of Florida
$2 million (<$ 1 million PM USA)
$0
Appeals by plaintiff and defendants to U.S. Court of Appeals for the Eleventh Circuit pending.
(1) PM USA’s portion of the compensatory damages award is noted parenthetically where the court has ruled that comparative fault applies.
(2) Plaintiff’s verdict following a retrial of an initial verdict in favor of plaintiff.
(3) References to “R.J. Reynolds,” “Liggett Group” and “Lorillard” are to R.J. Reynolds Tobacco Company, Liggett Group, LLC and Lorillard Tobacco Company, respectively.
 
 
 
 
 
 
 
Engle Cases Concluded Within Past 12 Months(1) 
(rounded to nearest $ million)
Plaintiff
Verdict Date
Defendant(s)
Court
Accrual Date
Payment Amount
(if any)
Payment Date
Theis(2)
May 2018
PM USA and
R.J. Reynolds
Sarasota
First quarter of 2020
$17 million
February 2020
Alvarez Del Real
September 2019
PM USA
Miami-Dade
Fourth quarter of 2019
<$1 million
October 2019
Engle Cases Concluded Within Past 12 Months(1) 
(rounded to nearest $ million)
Plaintiff
Verdict Date
Defendant(s)
Court
Accrual Date
Payment Amount
(if any)
Payment Date
Zingaro
May 2019
PM USA and
R.J. Reynolds
Broward
Third quarter of 2019
<$1 million
October 2019
Bryant
December 2017
PM USA
Escambia
Second quarter of 2019
<$1 million
July 2019
Wallace
October 2017
PM USA and
R.J. Reynolds
Brevard
Second quarter of 2019
$26 million
May 2019
J. Brown
February 2017
PM USA and
R.J. Reynolds
Pinellas
First quarter of 2019
$4 million
April 2019
L. Martin
May 2017
PM USA
Miami-Dade
First quarter of 2019
$2 million
April 2019
Danielson
November 2015
PM USA
Escambia
First quarter of 2019
$3 million
March 2019
S. Martin
November 2016
PM USA and
R.J. Reynolds
Broward
First quarter of 2019
$5 million
March 2019
Searcy
April 2013
PM USA and
R.J. Reynolds
Federal Court - Middle District of Florida
Third quarter of 2018
$2 million
March 2019
Boatright
November 2014
PM USA and Liggett Group
Polk
Second quarter of 2018
$42 million
March 2019
M. Brown(3)
May 2015
PM USA
Duval
Second quarter of 2018
$8 million
March 2019
Jordan(4)
August 2015
PM USA
Duval
Second quarter of 2018
$11 million
March 2019
Pardue
December 2016
PM USA and
R.J. Reynolds
Alachua
Second and Third quarters of 2018
$11 million
March 2019
McKeever
February 2015
PM USA
Broward
Fourth quarter of 2017
$21 million
March 2019
(1) In two cases in which PM USA paid the judgments more than a year ago, Naugle and Gore, plaintiffs were awarded approximately $8 million and approximately $2 million in fees and other costs, respectively.  In both cases, PM USA has appealed.
(2) In February 2020, the Florida Second District Court of Appeal denied PM USA’s petition for review.  As a result, in the first quarter of 2020, PM USA recorded a pre-tax provision of approximately $17 million for the judgment plus interest, which was subsequently paid in the first quarter of 2020.
(3) The trial court also awarded plaintiff approximately $9 million in fees, interest and costs.  PM USA and plaintiff have appealed.
(4) The trial court also awarded plaintiff approximately $4 million in fees and costs. PM USA and plaintiff have appealed.

Florida Bond Statute

In June 2009, Florida amended its existing bond cap statute by adding a $200 million bond cap that applies to all state Engle progeny lawsuits in the aggregate and establishes individual bond caps for individual Engle progeny cases in amounts that vary depending on the number of judgments in effect at a given time. Plaintiffs have been unsuccessful in various challenges to the bond cap statute in Florida state court.

No federal court has yet addressed the constitutionality of the bond cap statute or the applicability of the bond cap to Engle progeny cases tried in federal court.

From time to time, legislation has been presented to the Florida legislature that would repeal the bond cap statute; however to date, no legislation repealing the statute has passed.

Other Smoking and Health Class Actions

Since the dismissal in May 1996 of a purported nationwide class action brought on behalf of allegedly addicted smokers, plaintiffs have filed numerous putative smoking and health class action suits in various state and federal courts. In general, these cases purport to be brought on behalf of residents of a particular state or states (although a few cases purport to be nationwide in scope) and raise addiction claims and, in many cases, claims of physical injury as well.

Class certification has been denied or reversed by courts in 61 smoking and health class actions involving PM USA in Arkansas (1), California (1), Delaware (1), the District of Columbia (2), Florida (2), Illinois (3), Iowa (1), Kansas (1), Louisiana (1), Maryland (1), Michigan (1), Minnesota (1), Nevada (29), New Jersey (6), New York (2), Ohio (1), Oklahoma (1), Oregon (1), Pennsylvania (1), Puerto Rico (1), South Carolina (1), Texas (1) and Wisconsin (1). See Certain Other Tobacco-Related
Litigation below for a discussion of “Lights” and “Ultra Lights” class action cases and medical monitoring class action cases pending against PM USA.

As of April 27, 2020, PM USA and Altria are named as defendants, along with other cigarette manufacturers, in seven class actions filed in the Canadian provinces of Alberta, Manitoba, Nova Scotia, Saskatchewan, British Columbia and Ontario. In Saskatchewan, British Columbia (two separate cases) and Ontario, plaintiffs seek class certification on behalf of individuals who suffer or have suffered from various diseases, including chronic obstructive pulmonary disease, emphysema, heart disease or cancer, after smoking defendants’ cigarettes. In the actions filed in Alberta, Manitoba and Nova Scotia, plaintiffs seek certification of classes of all individuals who smoked defendants’ cigarettes. In March 2019, all of these class actions were stayed as a result of three Canadian tobacco manufacturers (none of which is related to Altria or its subsidiaries) seeking protection under Canada’s Companies’ Creditors Arrangement Act (which is similar to Chapter 11 bankruptcy in the U.S.). The companies entered into these proceedings following a Canadian appellate court upholding two smoking and health class action verdicts against those companies totaling approximately CAD $13 billion. See Guarantees and Other Similar Matters below for a discussion of the Distribution Agreement between Altria and PMI, which provides for indemnities for certain liabilities concerning tobacco products.

Health Care Cost Recovery Litigation

Overview

In the health care cost recovery litigation, governmental entities seek reimbursement of health care cost expenditures allegedly caused by tobacco products and, in some cases, of future expenditures and damages. Relief sought by some but not all plaintiffs includes punitive damages, multiple damages and other statutory damages and penalties, injunctions prohibiting alleged marketing and sales to minors, disclosure of research, disgorgement of profits, funding of anti-smoking programs, additional disclosure of nicotine yields, and payment of attorney and expert witness fees.

Although there have been some decisions to the contrary, most judicial decisions in the U.S. have dismissed all or most health care cost recovery claims against cigarette manufacturers. Nine federal circuit courts of appeals and eight state appellate courts, relying primarily on grounds that plaintiffs’ claims were too remote, have ordered or affirmed dismissals of health care cost recovery actions. The United States Supreme Court has refused to consider plaintiffs’ appeals from the cases decided by five federal circuit courts of appeal.

In addition to the cases brought in the U.S., health care cost recovery actions have also been brought against tobacco industry participants, including PM USA and Altria, in Canada (10 cases), and other entities have stated that they are considering filing such actions.

Since the beginning of 2008, the Canadian Provinces of British Columbia, New Brunswick, Ontario, Newfoundland and Labrador, Quebec, Alberta, Manitoba, Saskatchewan, Prince Edward Island and Nova Scotia have brought health care reimbursement claims against cigarette manufacturers. PM USA is named as a defendant in the British Columbia and Quebec cases, while both Altria and PM USA are named as defendants in the New Brunswick, Ontario, Newfoundland and Labrador, Alberta, Manitoba, Saskatchewan, Prince Edward Island and Nova Scotia cases. The Nunavut Territory and Northwest Territory have passed legislation permitting similar claims, but lawsuits based on this legislation have not been filed. All of these cases have been stayed pending resolution of proceedings in Canada involving three tobacco manufacturers (none of which are affiliated with Altria or its subsidiaries) under the Creditors Arrangement Act discussed above. See Smoking and Health Litigation - Other Smoking and Health Class Actions above for a discussion of these proceedings. See Guarantees and Other Similar Matters below for a discussion of the Distribution Agreement between Altria and PMI that provides for indemnities for certain liabilities concerning tobacco products.

Settlements of Health Care Cost Recovery Litigation

In November 1998, PM USA and certain other tobacco product manufacturers entered into the MSA with 46 states, the District of Columbia and certain U.S. territories to settle asserted and unasserted health care cost recovery and other claims. PM USA and certain other tobacco product manufacturers had previously entered into agreements to settle similar claims brought by Mississippi, Florida, Texas and Minnesota (together with the MSA, the “State Settlement Agreements”). The State Settlement Agreements require that the original participating manufacturers or “OPMs” (now PM USA and R.J. Reynolds and, with respect to certain brands, ITG Brands, LLC (“ITG”)) make annual payments of approximately $9.4 billion, subject to adjustments for several factors, including inflation, market share and industry volume. In addition, the OPMs are required to pay settling plaintiffs’ attorneys’ fees, subject to an annual cap of $500 million. For the three months ended March 31, 2020 and
2019, the aggregate amount recorded in cost of sales with respect to the State Settlement Agreements was approximately $1.1 billion and $0.9 billion, respectively. These amounts include PM USA’s estimate of amounts related to NPM Adjustments discussed below.

NPM Adjustment Disputes

PM USA is participating in proceedings regarding the NPM Adjustment for 2003-2019. The “NPM Adjustment” is a reduction in MSA payments made by the OPMs and those manufacturers that are subsequent signatories to the MSA (collectively, the “participating manufacturers” or “PMs”) that applies if the PMs collectively lose at least a specified level of market share to non-participating manufacturers since 1997, subject to certain conditions and defenses. The independent auditor (the “IA”) appointed under the MSA calculates the maximum amount of the NPM Adjustment, if any, for each year.

NPM Adjustment Disputes - Settlement with 36 States and Territories and Settlement with New York.

PM USA has entered into two settlements of NPM Adjustment disputes with a total of 37 states and territories, one with 36 states and territories (the “multi-state settlement”) and the other with the State of New York. In the multi-state settlement, PM USA, by the end of October 2017, had settled the NPM Adjustment disputes for 2003-2015 with 26 states in exchange for a total of $740 million. In 2018, there were two principal developments with respect to this settlement. First, PM USA agreed to settle the NPM Adjustment disputes for 2016 and 2017 with the 26 states mentioned above. Second, PM USA settled the NPM Adjustment disputes for 2004-2017 with ten additional states. As a result of these two developments, PM USA will receive approximately $248 million, $68 million of which it received in April 2018, $121 million of which it received in April 2019 and $47 million of which it received in April 2020. In connection with these two developments, PM USA recorded a reduction to cost of sales in the amount of $39 million in 2017 and in the amount of $209 million in 2018. In the first quarter of 2019, PM USA also recorded a reduction to cost of sales in the amount of $52 million for its estimate of the 2018 NPM Adjustment settlement credit it expects to receive under the multi-state settlement.

In the first quarter of 2020, the PMs agreed that certain conditions set forth in the multi-state settlement by the 10 states that settled the NPM Adjustment in 2018 had been met. As a result, PM USA’s and the other PMs’ settlement with Pennsylvania was extended to include NPM Adjustments for 2018-2024, and settlements with the other nine states were extended to include NPM Adjustments for 2018-2019. As a result of this development, PM USA will receive approximately $43 million in credits to offset PM USA’s MSA payments over nine years.

In the NPM Adjustment settlement with New York, which was entered into in 2015, PM USA has received approximately $317 million for 2004-2018. PM USA and the other participating manufacturers are involved in a proceeding pursuant to the New York settlement in which an independent investigator will determine the amounts due to the participating manufacturers from New York for 2019 and 2020. PM USA expects to receive such amounts in April 2021 and April 2022, respectively.
 
Both the New York settlement and the multi-state settlement also contain provisions resolving certain disputes regarding the application of the NPM Adjustment going forward.

2003 and Subsequent NPM Adjustments - Continuing Disputes with States that have not Settled.

▪
2003 NPM Adjustment. In September 2013, an arbitration panel issued rulings regarding the 15 states and territories that remained in the arbitration, ruling that six of them did not establish valid defenses to the NPM Adjustment for 2003. In June 2014, two of these six states joined the multi-state settlement discussed above. With respect to the remaining four states, following the outcome of challenges in state courts, PM USA ultimately recorded $74 million primarily as a reduction to cost of sales. Subsequently, another one of the six states joined the multi-state settlement. Two potential disputes remain outstanding regarding the amount of interest due to PM USA and there is no assurance that PM USA will prevail in either of these disputes.

▪
2004 and Subsequent NPM Adjustments. PM USA has continued to pursue the NPM Adjustments for 2004 and subsequent years in multi-state arbitrations against the states that did not join either of the settlements discussed above. In September 2019, a New Mexico state appellate court affirmed a trial court’s order compelling New Mexico to arbitrate the 2004 NPM Adjustment claims in the multi-state arbitration with the other states. In November 2019, the New Mexico Supreme Court declined to review that decision. The arbitration hearing has not yet been scheduled. The Montana state courts ruled that Montana may litigate its claims in state court, rather than participate in a multi-state arbitration and the PMs have agreed not to contest the applicability of the 2004 NPM Adjustment to Montana. In April 2020, the State of Montana filed a motion in Montana state court against the PMs, including PM USA and a Nat
Sherman affiliate, claiming that Montana’s share of the NPM Adjustment amounts should be paid to the state in advance of the resolution of disputes over the applicability of those adjustments. PM USA and the Nat Sherman affiliate have been placing the disputed NPM Adjustment amounts in the disputed payments account established pursuant to the terms of the MSA. Montana seeks a total of approximately $43 million in disputed payments from all defendants combined, as well as treble and punitive damages.

The hearings in a 2004 multi-state arbitration with all of the states that have not settled other than Montana and New Mexico concluded in July 2019. As of April 27, 2020, no decisions have resulted from the arbitration.

No assurance can be given as to when proceedings for 2005 and subsequent years will be scheduled or the precise form those proceedings will take.

The IA has calculated that PM USA’s share of the maximum potential NPM Adjustments for 2004-2018 is (exclusive of interest or earnings): $388 million for 2004; $181 million for 2005; $154 million for 2006; $185 million for 2007; $250 million for 2008; $211 million for 2009; $218 million for 2010; $166 million for 2011; $214 million for 2012; $224 million for 2013; $258 million for 2014; $313 million for 2015; $305 million for 2016; $297 million for 2017; $340 million for 2018 and $441 million for 2019. These maximum amounts will be reduced, likely substantially, to reflect the settlements with the signatory states and New York, and potentially for current and future calculation disputes and other developments. Finally, PM USA’s recovery of these amounts, even as reduced, is dependent upon subsequent determinations regarding state-specific defenses and disputes with other PMs.

Other Disputes Under the State Settlement Agreements

The payment obligations of the tobacco product manufacturers that are parties to the State Settlement Agreements, as well as the allocations of any NPM Adjustments and related settlements, have been and may continue to be affected by R.J. Reynolds’s acquisition of Lorillard and its related sale of certain cigarette brands to ITG (the “ITG brands”). In particular, R.J. Reynolds and ITG have asserted that they do not have to make payments on the ITG brands under the Florida, Minnesota and Texas State Settlement Agreements or include the ITG brands for purposes of certain calculations under the State Settlement Agreements. PM USA believes that R.J. Reynolds’s and ITG’s position violates the State Settlement Agreements and applicable law. PM USA further believes that these actions: (i) improperly increased PM USA’s payments for 2015-2019; (ii) may improperly increase PM USA’s payments for subsequent years; (iii) improperly decreased PM USA’s share of the 2015-2019 NPM Adjustments and of the settlements of related disputes; and (iv) may improperly decrease PM USA’s share of NPM Adjustments and related settlements for subsequent years.

In January 2017, PM USA and the State of Florida each filed a motion in Florida state court against R.J. Reynolds and ITG seeking to enforce the Florida State Settlement Agreement. In August 2018, the Florida trial court entered final judgment ruling that R.J. Reynolds (and not ITG) must make settlement payments under the Florida State Settlement Agreement on the ITG brands, and ordering R.J. Reynolds to pay PM USA approximately $9.8 million (inclusive of interest) for the 2015-2017 period. R.J. Reynolds and PM USA have each filed notices of appeal of the trial court’s decision, which proceedings may result in further modifications to PM USA’s settlement payments under the Florida State Settlement Agreement.

In March 2018, PM USA and the State of Minnesota filed pleadings in Minnesota state court asserting claims against R.J. Reynolds and ITG, similar to those made in Florida, and seeking to enforce the Minnesota State Settlement Agreement. In September 2019, the Minnesota court granted the State of Minnesota’s and PM USA’s motions to enforce the agreement against R.J. Reynolds. The Minnesota court concluded, however, that it could not yet resolve the question of ITG’s liability under the Minnesota State Settlement Agreement. An evidentiary hearing on the question of ITG’s potential liability is to be held in 2020.

In December 2018, PM USA filed a motion in Mississippi state court seeking to enforce the Mississippi State Settlement Agreement against R.J. Reynolds and ITG with respect to the accuracy of certain submissions made by R.J. Reynolds and ITG concerning the calculation of payments relating to the ITG brands. In December 2019, in a separate matter, the State of Mississippi filed a motion in Mississippi state court seeking to enforce the Mississippi State Settlement Agreement against PM USA, R.J. Reynolds and ITG concerning the calculation of the April 2019 payments.

In January 2019, PM USA and the State of Texas each filed a motion in federal court in the Eastern District of Texas asserting claims against R.J. Reynolds and ITG, similar to those made in Florida and Minnesota, seeking to enforce the Texas State Settlement Agreement. On February 25, 2020, the Texas court granted the State of Texas’ and PM USA’s motions to enforce the settlement agreement against R.J. Reynolds. The Texas court, however, deferred the ultimate resolution of the motions to
enforce against ITG, because it concluded that question was dependent upon the outcome of separate litigation pending between ITG and R.J. Reynolds in the Delaware Court of Chancery.

Federal Government’s Lawsuit

In 1999, the United States government filed a lawsuit in the U.S. District Court for the District of Columbia against various cigarette manufacturers, including PM USA, and others, including Altria, asserting claims under three federal statutes. The case ultimately proceeded only under the civil provisions of RICO. In August 2006, the district court held that certain defendants, including Altria and PM USA, violated RICO and engaged in seven of the eight “sub-schemes” to defraud that the government had alleged. Specifically, the court found that:

▪
defendants falsely denied, distorted and minimized the significant adverse health consequences of smoking;
▪
defendants hid from the public that cigarette smoking and nicotine are addictive;
▪
defendants falsely denied that they control the level of nicotine delivered to create and sustain addiction;
▪
defendants falsely marketed and promoted “low tar/light” cigarettes as less harmful than full-flavor cigarettes;
▪
defendants falsely denied that they intentionally marketed to youth;
▪
defendants publicly and falsely denied that ETS is hazardous to non-smokers; and
▪
defendants suppressed scientific research.

The court did not impose monetary penalties on defendants, but ordered the following relief: (i) an injunction against “committing any act of racketeering” relating to the manufacturing, marketing, promotion, health consequences or sale of cigarettes in the United States; (ii) an injunction against participating directly or indirectly in the management or control of the Council for Tobacco Research, the Tobacco Institute, or the Center for Indoor Air Research, or any successor or affiliated entities of each; (iii) an injunction against “making, or causing to be made in any way, any material false, misleading, or deceptive statement or representation or engaging in any public relations or marketing endeavor that is disseminated to the United States public and that misrepresents or suppresses information concerning cigarettes;” (iv) an injunction against conveying any express or implied health message or health descriptors on cigarette packaging or in cigarette advertising or promotional material, including “lights,” “ultra lights” and “low tar,” which the court found could cause consumers to believe one cigarette brand is less hazardous than another brand; (v) the issuance of “corrective statements” in various media regarding the adverse health effects of smoking, the addictiveness of smoking and nicotine, the lack of any significant health benefit from smoking “low tar” or “light” cigarettes, defendants’ manipulation of cigarette design to ensure optimum nicotine delivery and the adverse health effects of exposure to ETS; (vi) the disclosure on defendants’ public document websites and in the Minnesota document repository of all documents produced to the government in the lawsuit or produced in any future court or administrative action concerning smoking and health until 2021, with certain additional requirements as to documents withheld from production under a claim of privilege or confidentiality; (vii) the disclosure of disaggregated marketing data to the government in the same form and on the same schedule as defendants now follow in disclosing such data to the FTC for a period of 10 years; (viii) certain restrictions on the sale or transfer by defendants of any cigarette brands, brand names, formulas or cigarette businesses within the U.S.; and (ix) payment of the government’s costs in bringing the action.

Following several years of appeals relating to the content of the corrective statements remedy described above, in October 2017, the district court approved the parties’ proposed consent order implementing corrective statements in newspapers and on television. The corrective statements began appearing in newspapers and on television in the fourth quarter of 2017. In April 2018, the parties reached agreement on the implementation details of the corrective statements on websites and onserts. The corrective statements began appearing on websites in the second quarter of 2018 and the onserts began appearing in the fourth quarter of 2018.

In 2014, Altria and PM USA recorded provisions totaling $31 million for the estimated costs of implementing the corrective communications remedy. In the fourth quarter of 2019, PM USA updated its estimate and recorded approximately $5 million for additional costs to finish implementing the corrective communications remedy.

The requirements related to corrective statements at point-of-sale remain outstanding. In May 2014, the district court ordered further briefing on the issue, which was completed in June 2014. In May 2018, the parties submitted a joint status report and additional briefing on point-of-sale signage to the district court. In May 2019, the district court ordered a hearing on the point-of-sale signage issue.

E-vapor Product Litigation

As of April 27, 2020, Altria and/or its subsidiaries, including PM USA, were named as defendants in 24 class action lawsuits relating to JUUL e-vapor products. JUUL is an additional named defendant in each of these lawsuits. The theories of recovery include violation of RICO, fraud, failure to warn, design defect, negligence and unfair trade practices. Plaintiffs also are seeking to add antitrust claims due to the recent action by the FTC. See Antitrust Litigation below for further discussion. Plaintiffs seek various remedies, including compensatory and punitive damages and an injunction prohibiting product sales.

Altria and/or its subsidiaries, including PM USA, also have been named as defendants in other lawsuits involving JUUL e-vapor products, including 170 individual lawsuits, five lawsuits filed by state or local governments and three lawsuits filed by school districts. JUUL is an additional named defendant in each of these lawsuits.

The majority of the individual and class action lawsuits mentioned above were filed in federal court. In October 2019, the United States Judicial Panel on Multidistrict Litigation ordered the coordination or consolidation of these lawsuits in the U.S. District Court for the Northern District of California for pretrial purposes.

An additional group of cases is pending in California state courts. In January 2020, the Judicial Council of California determined that this group of cases was appropriate for coordination and assigned the group to the Superior Court of California, Los Angeles County, for pretrial purposes.

Neither Altria nor any of its subsidiaries has filed a response in any of these cases, and no case in which Altria or any of its subsidiaries is named has been set for trial.

JUUL also is named in a significant number of additional individual and class action lawsuits to which neither Altria nor any of its subsidiaries is currently named.

Certain Other Tobacco-Related Litigation

IQOS Litigation

In April 2020, RAI Strategic Holdings, Inc. and R.J. Reynolds Vapor Co., which are affiliates of R.J. Reynolds, filed a lawsuit against Altria, PM USA, Altria Client Services LLC, PMI and its affiliate Philip Morris Products S.A., in the United States District Court for the Eastern District of Virginia. The lawsuit asserts claims of patent infringement based on the sale of the IQOS electronic device and HeatSticks in the United States. Plaintiffs seek various remedies, including preliminary and permanent injunctive relief, treble damages and attorneys’ fees.

Also in April 2020, a related action was filed against the same defendants by the same plaintiffs, as well as R.J. Reynolds, with the United States International Trade Commission (“ITC”). There, the plaintiffs also allege patent infringement, but the remedies sought include a prohibition on the importation of the IQOS electronic device, HeatSticks and component parts into the United States. No damages are recoverable in the proceedings before the ITC.

“Lights/Ultra Lights” Cases and Other Smoking and Health Class Actions

Plaintiffs have sought certification of their cases as class actions, alleging among other things, that the uses of the terms “Lights” and/or “Ultra Lights” constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment or breach of warranty, and have sought injunctive and equitable relief, including restitution and, in certain cases, punitive damages. These class actions have been brought against PM USA and, in certain instances, Altria or its other subsidiaries, on behalf of individuals who purchased and consumed various brands of cigarettes. Defenses raised in these cases include lack of misrepresentation, lack of causation, injury and damages, the statute of limitations, non-liability under state statutory provisions exempting conduct that complies with federal regulatory directives, and the First Amendment. Twenty-one state courts in 23 “Lights” cases have refused to certify class actions, dismissed class action allegations, reversed prior class certification decisions or have entered judgment in favor of PM USA. As of April 27, 2020, two “Lights/Ultra Lights” class actions are pending in U.S. state court. Neither case is active.

As of April 27, 2020, two smoking and health cases alleging personal injury or seeking court-supervised programs or ongoing medical monitoring and purporting to be brought on behalf of a class of individual plaintiffs, are pending in their respective U.S. state courts. Neither case is active.

UST Litigation

UST and/or its tobacco subsidiaries have been named in a number of individual tobacco and health lawsuits over time. Plaintiffs’ allegations of liability in these cases have been based on various theories of recovery, such as negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, breach of implied warranty, addiction and breach of consumer protection statutes. Plaintiffs have typically sought various forms of relief, including compensatory and punitive damages, and certain equitable relief, including but not limited to disgorgement. Defenses raised in these cases include lack of causation, assumption of the risk, comparative fault and/or contributory negligence, and statutes of limitations. As of April 27, 2020, there is one case pending against USSTC.

Antitrust Litigation

In April 2020, the FTC issued an administrative complaint against Altria and JUUL alleging that Altria’s 35% investment in JUUL and the associated agreements constitute an unreasonable restraint of trade in violation of Section 1 of the Sherman Antitrust Act of 1890 (“Sherman Act”) and Section 5 of the Federal Trade Commission Act of 1914 (“FTC Act”), and substantially lessened competition in violation of Section 7 of the Clayton Antitrust Act (“Clayton Act”). If the FTC’s challenge is successful, the FTC may order a broad range of remedies, including divestiture of Altria’s minority investment in JUUL, rescission of the transaction and all associated agreements, and prohibition against any officer or director of either Altria or JUUL serving on the other party’s board of directors or attending meetings of the other party’s board of directors. The administrative trial will take place before an FTC administrative law judge and is currently scheduled to begin March 11, 2021. Any ruling by the FTC is subject to review by the FTC Commissioners and subsequently, by a federal appellate court.

Also as of April 27, 2020, three putative class action lawsuits were filed against Altria and JUUL in the United States District Court for the Northern District of California. The lawsuits cite the FTC administrative complaint and allege that Altria and JUUL violated Sections 1 and 2 of the Sherman Act and Section 7 of the Clayton Act by restraining trade and/or substantially lessening competition in the U.S. closed-system electronic cigarette market. Plaintiffs seek various remedies, including treble damages, attorneys’ fees, a declaration that the agreements between Altria and JUUL are invalid, divestiture of Altria’s minority investment in JUUL and rescission of the transaction.

Neither the FTC nor the private plaintiffs has sought to preliminarily enjoin Altria from converting Altria’s non-voting JUUL shares to voting shares or appointing directors to the JUUL board of directors. As of April 30, 2020, Altria has not exercised these rights.

Shareholder Class Actions

In October and December 2019, two purported Altria shareholders filed putative class action lawsuits against Altria, Howard A. Willard III, Altria’s former Chairman and Chief Executive Officer, and William F. Gifford, Jr., Altria’s former Vice Chairman and Chief Financial Officer and current Chief Executive Officer, in the United States District Court for the Eastern District of New York. In December 2019, the court consolidated the two lawsuits into a single proceeding. The consolidated lawsuit was subsequently transferred to the United States District Court for the Eastern District of Virginia. The lawsuit asserts claims under Sections 10(b) and 20(a) and under Rule 10b-5 of the Exchange Act. In April 2020, JUUL, its founders, and some of its current and former executives were added to the lawsuit. The claims involve allegedly false and misleading statements and omissions relating to Altria’s investment in JUUL. Plaintiffs seek various remedies, including damages and attorneys’ fees. A response to the lawsuit has not yet been filed.

Environmental Regulation

Altria and its subsidiaries (and former subsidiaries) are subject to various federal, state and local laws and regulations concerning the discharge of materials into the environment, or otherwise related to environmental protection, including, in the U.S.: the Clean Air Act, the Clean Water Act, the Resource Conservation and Recovery Act and the Comprehensive Environmental Response, Compensation and Liability Act (commonly known as “Superfund”), which can impose joint and several liability on each responsible party. Subsidiaries (and former subsidiaries) of Altria are involved in several matters subjecting them to potential costs of remediation and natural resource damages under Superfund or other laws and regulations. Altria’s subsidiaries expect to continue to make capital and other expenditures in connection with environmental laws and regulations.

Altria provides for expenses associated with environmental remediation obligations on an undiscounted basis when such amounts are probable and can be reasonably estimated. Such accruals are adjusted as new information develops or
circumstances change. Other than those amounts, it is not possible to reasonably estimate the cost of any environmental remediation and compliance efforts that subsidiaries of Altria may undertake in the future. In the opinion of management, however, compliance with environmental laws and regulations, including the payment of any remediation costs or damages and the making of related expenditures, has not had, and is not expected to have, a material adverse effect on Altria’s consolidated results of operations, capital expenditures, financial position or cash flows.

Guarantees and Other Similar Matters

In the ordinary course of business, certain subsidiaries of Altria have agreed to indemnify a limited number of third parties in the event of future litigation. At March 31, 2020, Altria and certain of its subsidiaries (i) had $50 million of unused letters of credit obtained in the ordinary course of business; (ii) were contingently liable for guarantees related to their own performance, including $27 million for surety bonds; and (iii) had a redeemable noncontrolling interest of $38 million recorded on its condensed consolidated balance sheet. In addition, from time to time, subsidiaries of Altria issue lines of credit to affiliated entities. These items have not had, and are not expected to have, a significant impact on Altria’s liquidity.

Under the terms of a distribution agreement between Altria and PMI (the “Distribution Agreement”), entered into as a result of Altria’s 2008 spin-off of its former subsidiary PMI, liabilities concerning tobacco products will be allocated based in substantial part on the manufacturer. PMI will indemnify Altria and PM USA for liabilities related to tobacco products manufactured by PMI or contract manufactured for PMI by PM USA, and PM USA will indemnify PMI for liabilities related to tobacco products manufactured by PM USA, excluding tobacco products contract manufactured for PMI. Altria does not have a related liability recorded on its condensed consolidated balance sheet at March 31, 2020 as the fair value of this indemnification is insignificant.

As more fully discussed in Note 12. Condensed Consolidating Financial Information, PM USA has issued guarantees relating to Altria’s obligations under its outstanding debt securities, borrowings under its $3.0 billion Credit Agreement and amounts outstanding under its commercial paper program.
EXCEL 70 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 71 R15.htm IDEA: XBRL DOCUMENT v3.20.1
Earnings Per Share
 3 Months Ended
Mar. 31, 2020
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share:

Basic and diluted earnings per share (“EPS”) were calculated using the following:
 
 
For the Three Months Ended March 31,
 
 
2020
 
2019
 
 
(in millions)
Net earnings attributable to Altria
 
$
1,552

 
$
1,120

Less: Distributed and undistributed earnings attributable to share-based awards
 
(2
)
 
(2
)
Earnings for basic and diluted EPS
 
$
1,550

 
$
1,118

 
 
 
 
 
Weighted-average shares for basic and diluted EPS
 
1,858

 
1,874

XML 72 R11.htm IDEA: XBRL DOCUMENT v3.20.1
Asset Impairment, Exit and Implementation Costs
 3 Months Ended
Mar. 31, 2020
Restructuring and Related Activities [Abstract]  
Asset Impairment, Exit and Implementation Costs Asset Impairment, Exit and Implementation Costs:

Pre-tax asset impairment, exit and implementation costs consisted of the following:
 
 
For the Three Months Ended March 31,
 
 
2020
 
2019
 
 
Implementation Costs (1)
 
Total
 
Asset Impairment and Exit Costs
 
Implementation Costs (1)
 
Total
 
(in millions)
Smokeable products
 
$
—

 
$
—

 
$
36

 
$
8

 
$
44

Oral tobacco products
 
—

 
—

 
8

 
1

 
9

Wine
 
392

 
392

 
—

 
—

 
—

All other
 
—

 
—

 
(5
)
 
—

 
(5
)
General corporate
 
—

 
—

 
1

 
—

 
1

Total
 
392

 
392

 
40

 
9

 
49

Plus amounts included in net periodic benefit income, excluding service cost (2)
 
—

 
—

 
12

 
—

 
12

Total
 
$
392

 
$
392

 
$
52

 
$
9

 
$
61

(1) Included in cost of sales for 2020 and marketing, administration and research costs for 2019 in Altria’s condensed consolidated statements of earnings.
(2) Represents curtailment costs. See Note 6. Benefit Plans.
 
 
 
 
 
 

Implementation costs for 2020 were related to Ste. Michelle’s inventory-related charges, as discussed below. The 2019 pre-tax asset impairment, exit and implementation costs were related to the cost reduction program, which was completed in 2019.

The movement in the restructuring liabilities, substantially all of which were severance liabilities, related to the cost reduction program was as follows:
 
(in millions)
Balances at December 31, 2019
$
67

Charges
—

Cash spent
(23
)
Balances at March 31, 2020
$
44



Wine Business Strategic Reset

Evolving adult consumer preferences have posed strategic challenges for Ste. Michelle, which has seen slowing growth in the wine category and increased inventory levels in recent periods. Against a backdrop of product volume demand uncertainty and long-term non-cancelable grape purchase commitments, which have been further negatively impacted by the economic uncertainty surrounding the COVID-19 pandemic, Ste. Michelle has experienced additional increases in inventory levels that at March 31, 2020 significantly exceed long-term forecasted demand.

As a result, in connection with the preparation of Altria’s first quarter financial statements, Ste. Michelle recorded pre-tax charges of $392 million, which were included in cost of sales in Altria’s condensed consolidated statement of earnings for the three months ended March 31, 2020. The charges consisted of the following: (i) write-off of inventory ($292 million) as Ste. Michelle no longer believes that the benefit of the blending and production plans for its inventory outweighs inventory carrying cost given the reduced product volume demand; and (ii) estimated losses on future non-cancelable grape purchase commitments that Ste. Michelle believes no longer have a future economic benefit ($100 million). Such commitments will continue to require cash payments as grape commitments are fulfilled over the next five years.

Given such uncertainty in economic conditions and product volume demand, as well as long-term supply-side contractual challenges, Altria and Ste. Michelle undertook a review of the wine business. As a result, Altria and Ste. Michelle implemented a strategic reset in order to maximize Ste. Michelle’s profitability and achieve improved long-term cash-flow generation. This strategic reset includes: (i) an updated approach to forecasting demand; (ii) supply chain optimization; (iii) SKU rationalization to reduce the number of products and eliminate underperforming brands; and (iv) streamlining operations by reducing future capital expenditures, working capital requirements and ongoing operating costs.

Additionally, Ste. Michelle expects to record additional charges of approximately $25 million during the remainder of 2020, consisting of inventory disposal costs and other charges.
XML 73 R27.htm IDEA: XBRL DOCUMENT v3.20.1
Benefit Plans (Tables)
 3 Months Ended
Mar. 31, 2020
Retirement Benefits [Abstract]  
Schedule of Net Periodic Benefit (Income) Cost
Net periodic benefit (income) cost consisted of the following: 
 
For the Three Months Ended March 31,
 
Pension
 
Postretirement
 
2020
 
2019
 
2020
 
2019
 
(in millions)
Service cost
$
19

 
$
17

 
$
4

 
$
4

Interest cost
63

 
77

 
15

 
20

Expected return on plan assets
(126
)
 
(145
)
 
(3
)
 
(4
)
Amortization:
 
 
 
 
 
 
 
Net loss
27

 
42

 
3

 
3

Prior service cost (credit)
1

 
1

 
(7
)
 
(7
)
Curtailment
—

 
7

 
—

 
5

Net periodic benefit (income) cost
$
(16
)
 
$
(1
)
 
$
12

 
$
21
XML 74 R23.htm IDEA: XBRL DOCUMENT v3.20.1
Background and Basis of Presentation (Tables)
 3 Months Ended
Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Share Repurchase Activity
Altria’s share repurchase activity for the three months ended March 31, 2019 was as follows:
(in millions, except per share data)
 
2019
Total number of shares repurchased
 
2.7

Aggregate cost of shares repurchased
 
$
151

Average price per share of shares repurchased
 
$
56.34
XML 75 R69.htm IDEA: XBRL DOCUMENT v3.20.1
Contingencies (NPM Adjustment Disputes - Settlement with 20 States and Territories and Settlement with New York) (Details)
$ in Millions
 1 Months Ended 3 Months Ended 12 Months Ended
Apr. 30, 2020
USD ($)
Apr. 30, 2019
USD ($)
Apr. 30, 2018
USD ($)
Oct. 31, 2017
USD ($)
state
Sep. 30, 2013
USD ($)
state
Nov. 30, 1998
state
Mar. 31, 2020
USD ($)
state
claim
Mar. 31, 2019
USD ($)
Mar. 31, 2018
state
Dec. 31, 2018
USD ($)
settlement_development
Dec. 31, 2017
USD ($)
Health Care Cost Recovery Actions [Member]                      
Loss Contingencies [Line Items]                      
Number of states with settled litigation | state           46          
PM USA [Member] | Health Care Cost Recovery Actions [Member]                      
Loss Contingencies [Line Items]                      
Loss contingency, reduction to cost of sales               $ 52   $ 209 $ 39
Loss contingency, credits to offset payments             $ 43        
Loss contingency, settlement agreement, payment period             9 years        
PM USA [Member] | Health Care Cost Recovery Actions [Member] | Settled Litigation [Member]                      
Loss Contingencies [Line Items]                      
Loss contingency, number of states with settled litigation including New York, subsequent expansion | state             36        
Settlement agreements, number | claim             2        
Number of states with settled litigation | state             37        
PM USA [Member] | Health Care Cost Recovery Actions, 2003-2015 NPM Adjustments [Member] | Settled Litigation [Member]                      
Loss Contingencies [Line Items]                      
Loss contingency, number of states with settled litigation including New York, subsequent expansion | state       26              
​Proceeds from legal settlements       $ 740              
Loss contingency, number of settlement developments | settlement_development                   2  
PM USA [Member] | Health Care Cost Recovery Actions, 2004-2017 [Member] | Settled Litigation [Member]                      
Loss Contingencies [Line Items]                      
Loss contingency, number of additional states added | state             10   10    
Loss contingency, number of additional states extended with settled litigation | state             9        
Payments received from litigation settlement   $ 121 $ 68             $ 248  
PM USA [Member] | Health Care Cost Recovery Actions, 2003 NPM Adjustment [Member] | Settled Litigation [Member]                      
Loss Contingencies [Line Items]                      
Number of states with settled litigation | state         2            
PM USA [Member] | Health Care Cost Recovery Actions, 2003 NPM Adjustment [Member] | Pending Litigation [Member]                      
Loss Contingencies [Line Items]                      
Loss contingency, number of states | state         15            
Number of states without defense | state         6            
Loss contingency, number of disputes outstanding | state         2            
PM USA [Member] | Health Care Cost Recovery Actions, 2003 NPM Adjustment [Member] | Pending Litigation [Member] | Cost of Sales [Member]                      
Loss Contingencies [Line Items]                      
Loss contingency, reduction to cost of sales         $ 74            
PM USA [Member] | Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member]                      
Loss Contingencies [Line Items]                      
Estimate of possible gain             $ 388        
PM USA [Member] | Health Care Cost Recovery Actions, 2005 NPM Adjustment [Member]                      
Loss Contingencies [Line Items]                      
Estimate of possible gain             181        
PM USA [Member] | Health Care Cost Recovery Actions, 2006 NPM Adjustment [Member]                      
Loss Contingencies [Line Items]                      
Estimate of possible gain             154        
PM USA [Member] | Health Care Cost Recovery Actions, 2007 NPM Adjustment [Member]                      
Loss Contingencies [Line Items]                      
Estimate of possible gain             185        
PM USA [Member] | Health Care Cost Recovery Actions, 2008 NPM Adjustment [Member]                      
Loss Contingencies [Line Items]                      
Estimate of possible gain             250        
PM USA [Member] | Health Care Cost Recovery Actions, 2009 NPM Adjustment [Member]                      
Loss Contingencies [Line Items]                      
Estimate of possible gain             211        
PM USA [Member] | Health Care Cost Recovery Actions, 2010 NPM Adjustment [Member]                      
Loss Contingencies [Line Items]                      
Estimate of possible gain             218        
PM USA [Member] | Health Care Cost Recovery Actions, 2011 NPM Adjustment [Member]                      
Loss Contingencies [Line Items]                      
Estimate of possible gain             166        
PM USA [Member] | Health Care Cost Recovery Actions, 2012 NPM Adjustment [Member]                      
Loss Contingencies [Line Items]                      
Estimate of possible gain             214        
PM USA [Member] | Health Care Cost Recovery Actions, 2013 NPM Adjustment [Member]                      
Loss Contingencies [Line Items]                      
Estimate of possible gain             224        
PM USA [Member] | Health Care Cost Recovery Actions, 2014 NPM Adjustment [Member]                      
Loss Contingencies [Line Items]                      
Estimate of possible gain             258        
PM USA [Member] | Health Care Cost Recovery Actions, 2015 NPM Adjustments [Member]                      
Loss Contingencies [Line Items]                      
Estimate of possible gain             313        
PM USA [Member] | Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member]                      
Loss Contingencies [Line Items]                      
Estimate of possible gain             305        
PM USA [Member] | Health Care Cost Recovery Actions, 2017 NPM Adjustments [Member]                      
Loss Contingencies [Line Items]                      
Estimate of possible gain             297        
PM USA [Member] | Health Care Cost Recovery Actions, 2018 NPM Adjustments [Member]                      
Loss Contingencies [Line Items]                      
Estimate of possible gain             340        
PM USA [Member] | Health Care Cost Recovery Actions, 2019 NPM Adjustments [Member]                      
Loss Contingencies [Line Items]                      
Estimate of possible gain             441        
New York [Member] | PM USA [Member] | Health Care Cost Recovery Actions, Transition Years 2004-2017 [Member] | Settled Litigation [Member]                      
Loss Contingencies [Line Items]                      
​Proceeds from legal settlements             $ 317        
Maryland, Missouri, New Mexico and Pennsylvania [Member] | PM USA [Member] | Health Care Cost Recovery Actions, 2003 NPM Adjustment [Member] | Pending Litigation [Member]                      
Loss Contingencies [Line Items]                      
Loss contingency, number of states remaining | state         4            
Subsequent Event [Member] | PM USA [Member] | Health Care Cost Recovery Actions, 2004-2017 [Member] | Settled Litigation [Member]                      
Loss Contingencies [Line Items]                      
Payments received from litigation settlement $ 47                    
XML 76 R65.htm IDEA: XBRL DOCUMENT v3.20.1
Contingencies (Engle Progeny Cases Trial Results - Pending and Concluded) (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Dec. 31, 2017
Sep. 30, 2018
Feb. 29, 2020
Jan. 31, 2020
Nov. 30, 2019
Feb. 28, 2019
Jul. 31, 2018
Nov. 30, 2017
Apr. 30, 2017
Mar. 31, 2017
Sep. 30, 2015
Jan. 31, 2015
Oct. 31, 2014
Sep. 30, 2014
Jul. 31, 2014
PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Pre-tax charges (gain) included in net earning $ 17                                            
Engle Progeny Cases, Berger [Member] | Pending Litigation [Member]                                              
Loss Contingencies [Line Items]                                              
Compensatory damages awarded                                           $ 6  
Provision related to litigation recorded           $ 6                                  
Engle Progeny Cases, Berger [Member] | Pending Litigation [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Punitive damages awarded                                           $ 21  
Engle Progeny Cases, Duignan [Member] | Pending Litigation [Member]                                              
Loss Contingencies [Line Items]                                              
Compensatory damages awarded                     $ 3                        
Engle Progeny Cases, Duignan [Member] | Pending Litigation [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Punitive damages awarded                     $ 12                        
Engle Progeny Cases, Cuddihee [Member] | Pending Litigation [Member]                                              
Loss Contingencies [Line Items]                                              
Compensatory damages awarded                       $ 3                      
Engle Progeny Cases, Cuddihee [Member] | Pending Litigation [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Punitive damages awarded                       $ 0                      
Engle Progeny Cases, Rintoul [Member] | Pending Litigation [Member]                                              
Loss Contingencies [Line Items]                                              
Compensatory damages awarded                         $ 9                    
Engle Progeny Cases, Rintoul [Member] | Pending Litigation [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Compensatory damages awarded                         5                    
Punitive damages awarded                         74                    
Engle Progeny Cases, Gloger [Member] | Pending Litigation [Member]                                              
Loss Contingencies [Line Items]                                              
Compensatory damages awarded                         15                    
Engle Progeny Cases, Gloger [Member] | Pending Litigation [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Compensatory damages awarded                         5                    
Punitive damages awarded                         $ 11                    
Engle Progeny Cases, McCall [Member] | Pending Litigation [Member]                                              
Loss Contingencies [Line Items]                                              
Compensatory damages awarded         $ 1                                    
Engle Progeny Cases, McCall [Member] | Pending Litigation [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Compensatory damages awarded         1                                    
Punitive damages awarded         1                                    
Engle Progeny Cases, Neff [Member] | Pending Litigation [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Compensatory damages awarded         4                                    
Punitive damages awarded         2                                    
Engle Progeny Cases, Frogel [Member] | Pending Litigation [Member]                                              
Loss Contingencies [Line Items]                                              
Compensatory damages awarded         1                                    
Engle Progeny Cases, Frogel [Member] | Pending Litigation [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Compensatory damages awarded         1                                    
Punitive damages awarded         0                                    
Engle Progeny Cases, Mahfuz [Member] | Pending Litigation [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Compensatory damages awarded                           $ 12                  
Punitive damages awarded                           10                  
Engle Progeny Cases, Holliman [Member] | Pending Litigation [Member]                                              
Loss Contingencies [Line Items]                                              
Compensatory damages awarded                           3                  
Engle Progeny Cases, Holliman [Member] | Pending Litigation [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Punitive damages awarded                           $ 0                  
Engle Progeny Cases, Chadwell [Member] | Pending Litigation [Member]                                              
Loss Contingencies [Line Items]                                              
Compensatory damages awarded             $ 2     $ 2                          
Engle Progeny Cases, Chadwell [Member] | Pending Litigation [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Punitive damages awarded             0     0                          
Engle Progeny Cases, Kaplan [Member] | Pending Litigation [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Compensatory damages awarded                             $ 2                
Punitive damages awarded                             $ 2                
Engle Progeny Cases, Landi [Member] | Pending Litigation [Member]                                              
Loss Contingencies [Line Items]                                              
Compensatory damages awarded               $ 8                              
Engle Progeny Cases, Landi [Member] | Pending Litigation [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Punitive damages awarded               5                              
Engle Progeny Cases, R. Douglas [Member] | Pending Litigation [Member]                                              
Loss Contingencies [Line Items]                                              
Compensatory damages awarded                               $ 1              
Engle Progeny Cases, R. Douglas [Member] | Pending Litigation [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Punitive damages awarded                               $ 0              
Engle Progeny Cases, Sommers [Member] | Pending Litigation [Member]                                              
Loss Contingencies [Line Items]                                              
Compensatory damages awarded                                 $ 1            
Engle Progeny Cases, Sommers [Member] | Pending Litigation [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Punitive damages awarded                                 $ 0            
Engle Progeny Cases, Santoro [Member] | Pending Litigation [Member]                                              
Loss Contingencies [Line Items]                                              
Compensatory damages awarded                                   $ 2          
Engle Progeny Cases, Santoro [Member] | Pending Litigation [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Punitive damages awarded                                   $ 0          
Engle Progeny Cases, Cooper [Member] | Pending Litigation [Member]                                              
Loss Contingencies [Line Items]                                              
Compensatory damages awarded                                     $ 5        
Engle Progeny Cases, Cooper [Member] | Pending Litigation [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Compensatory damages awarded                                     1        
Punitive damages awarded                                     $ 0        
Engle Progeny Cases, D. Brown [Member] | Pending Litigation [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Compensatory damages awarded                                       $ 8      
Punitive damages awarded                                       $ 9      
Engle Progeny Cases, Kerrivan [Member] | Pending Litigation [Member]                                              
Loss Contingencies [Line Items]                                              
Compensatory damages awarded                                         $ 16    
Engle Progeny Cases, Kerrivan [Member] | Pending Litigation [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Punitive damages awarded                                         $ 16    
Engle Progeny Cases, Harris [Member] | Pending Litigation [Member]                                              
Loss Contingencies [Line Items]                                              
Compensatory damages awarded                                             $ 2
Engle Progeny Cases, Harris [Member] | Pending Litigation [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Compensatory damages awarded                                             1
Punitive damages awarded                                             $ 0
Engle Progeny Cases, Theis [Member] | Settled Litigation [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Damages awarded, value 17                                            
Engle Progeny Cases, Alvarez del Real [Member] | Settled Litigation [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Damages awarded, value   $ 1                                          
Engle Progeny Cases, Zingaro [Member] | Settled Litigation [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Damages awarded, value     $ 1                                        
Engle Progeny Cases, Bryant [Member] | Settled Litigation [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Damages awarded, value       $ 1                                      
Engle Progeny Cases, Wallace [Member] | Settled Litigation [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Damages awarded, value       $ 26                                      
Engle Progeny Cases, J. Brown [Member] | Settled Litigation [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Damages awarded, value         4                                    
Engle Progeny Cases, L. Martin [Member] | Settled Litigation [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Damages awarded, value         2                                    
Engle Progeny Cases, Danielson [Member] | Settled Litigation [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Damages awarded, value         3                                    
Engle Progeny Cases, S. Martin [Member] | Settled Litigation [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Damages awarded, value         $ 5                                    
Engle Progeny Cases, Searcy [Member] | Settled Litigation [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Damages awarded, value             $ 2                                
Engle Progeny Cases, Boatright [Member] | Settled Litigation [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Damages awarded, value               0                              
Engle Progeny Cases, M. Brown [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Damages awarded, value               9                              
Engle Progeny Cases, M. Brown [Member] | Settled Litigation [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Damages awarded, value               8                              
Engle Progeny Cases, Jordan [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Damages awarded, value               4                              
Engle Progeny Cases, Jordan [Member] | Settled Litigation [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Damages awarded, value               $ 11                              
Engle Progeny Cases, Pardue [Member] | Settled Litigation [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Damages awarded, value                   $ 11                          
Engle Progeny Cases, McKeever [Member] | Settled Litigation [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Damages awarded, value                 $ 21                            
Engle Progeny Cases, Naugle [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Damages awarded, value 8                                            
Engle Progeny Cases, Gore [Member] | PM USA [Member]                                              
Loss Contingencies [Line Items]                                              
Damages awarded, value $ 2                                            
XML 77 R61.htm IDEA: XBRL DOCUMENT v3.20.1
Contingencies (Overview of Altria and/or PM USA Tobacco-Related Litigation Narrative) (Details) - case
 256 Months Ended
Apr. 27, 2020
Apr. 27, 2020
Apr. 22, 2019
Apr. 23, 2018
Other Tabacco-Related Cases [Member]        
Loss Contingencies [Line Items]        
Loss contingency, number of inactive cases     2  
Number of cases pending     0 0
Health Care Cost Recovery Actions [Member]        
Loss Contingencies [Line Items]        
Number of cases pending     1 1
Individual Smoking and Health Cases [Member]        
Loss Contingencies [Line Items]        
Number of cases pending     98 102
Subsequent Event [Member] | Other Tabacco-Related Cases [Member]        
Loss Contingencies [Line Items]        
Loss contingency, number of inactive cases 2 2    
Number of cases pending 4 4    
Subsequent Event [Member] | Health Care Cost Recovery Actions [Member]        
Loss Contingencies [Line Items]        
Number of cases pending 0 0    
Subsequent Event [Member] | Individual Smoking and Health Cases [Member]        
Loss Contingencies [Line Items]        
Number of cases pending 109 109    
Subsequent Event [Member] | PM USA [Member] | Health Care Cost Recovery Actions [Member] | Canada [Member]        
Loss Contingencies [Line Items]        
Number of cases pending 10 10    
Subsequent Event [Member] | PM USA [Member] | Engle Progeny Cases [Member]        
Loss Contingencies [Line Items]        
Number of cases set for trial 2 2    
Number of verdicts returned 134      
Number of favorable verdicts 47      
Number of unfavorable verdicts 78      
Subsequent Event [Member] | PM USA [Member] | Individual Smoking and Health Cases [Member]        
Loss Contingencies [Line Items]        
Number of cases set for trial 0 0    
Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member]        
Loss Contingencies [Line Items]        
Number of verdicts returned   69    
Number of favorable verdicts   44    
Number of unfavorable verdicts   25    
Number of claims resolved   20    
Number of verdicts reversed   1    
Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Alaska [Member]        
Loss Contingencies [Line Items]        
Number of favorable verdicts   1    
Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | California [Member]        
Loss Contingencies [Line Items]        
Number of favorable verdicts   7    
Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Connecticut [Member]        
Loss Contingencies [Line Items]        
Number of favorable verdicts   1    
Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Florida [Member]        
Loss Contingencies [Line Items]        
Number of favorable verdicts   10    
Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Louisiana [Member]        
Loss Contingencies [Line Items]        
Number of favorable verdicts   1    
Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Massachusetts [Member]        
Loss Contingencies [Line Items]        
Number of favorable verdicts   4    
Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Mississippi [Member]        
Loss Contingencies [Line Items]        
Number of favorable verdicts   1    
Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Missouri [Member]        
Loss Contingencies [Line Items]        
Number of favorable verdicts   4    
Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | New Hampshire [Member]        
Loss Contingencies [Line Items]        
Number of favorable verdicts   1    
Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | New Jersey [Member]        
Loss Contingencies [Line Items]        
Number of favorable verdicts   1    
Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | New York [Member]        
Loss Contingencies [Line Items]        
Number of favorable verdicts   5    
Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Ohio [Member]        
Loss Contingencies [Line Items]        
Number of favorable verdicts   2    
Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Pennsylvania [Member]        
Loss Contingencies [Line Items]        
Number of favorable verdicts   1    
Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Rhode Island [Member]        
Loss Contingencies [Line Items]        
Number of favorable verdicts   1    
Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Tennessee [Member]        
Loss Contingencies [Line Items]        
Number of favorable verdicts   2    
Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | West Virginia [Member]        
Loss Contingencies [Line Items]        
Number of favorable verdicts   2    
Subsequent Event [Member] | Philip Morris USA and Altria Group [Member] | Health Care Cost Recovery Actions [Member] | Canada [Member]        
Loss Contingencies [Line Items]        
Number of cases pending 8 8    
Subsequent Event [Member] | Philip Morris USA and Altria Group [Member] | Smoking and Health Class Actions and Aggregated Claims Litigation [Member] | Canada [Member]        
Loss Contingencies [Line Items]        
Number of cases pending 7 7    
XML 78 R9999.htm IDEA: XBRL DOCUMENT v3.20.1
Label Element Value
Restricted Cash, Noncurrent us-gaap_RestrictedCashNoncurrent $ 45,000,000
Restricted Cash, Noncurrent us-gaap_RestrictedCashNoncurrent 43,000,000
Restricted Cash, Current us-gaap_RestrictedCashCurrent 3,000,000
Restricted Cash, Current us-gaap_RestrictedCashCurrent $ 0
[1]
Restricted cash consisted of cash deposits collateralizing appeal bonds posted by PM USA to obtain stays of judgments pending appeals. See Note 11. Contingencies.
XML 79 R42.htm IDEA: XBRL DOCUMENT v3.20.1
Investments in Equity Securities (Investment in ABI Narrative) (Details) - ABI [Member]
shares in Millions
 3 Months Ended 12 Months Ended
Mar. 31, 2020
USD ($)
shares
Dec. 31, 2019
USD ($)
Mar. 31, 2020
€ / shares
Dec. 31, 2019
€ / shares
Schedule of Equity Method Investments [Line Items]        
Equity method investment, ownership percentage 10.10%      
Number of restricted shares owned (in shares) | shares 185      
Number of ordinary shares owned (in shares) | shares 12      
Investments in equity securities | $ $ 18,453,000,000 $ 18,071,000,000    
Difference between carrying amount and fair value, percentage (approximately) 52.00% 11.00%    
Equity method investment, impairment | $ $ 0 $ 0    
Derivative instrument, number of shares hedged (in shares) | shares 100      
Derivative instrument, shares hedged, price per share (in eur per share) | € / shares     € 40.47 € 72.71
Fair Value, Inputs, Level 1 [Member]        
Schedule of Equity Method Investments [Line Items]        
Fair value of equity investment | $ $ 8,800,000,000 $ 16,100,000,000    
XML 80 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 81 R46.htm IDEA: XBRL DOCUMENT v3.20.1
Financial Instruments (Fair Value Using Black-Scholes Option-Pricing Model) (Details)
Mar. 31, 2020
year
Dec. 31, 2019
year
Share price [Member] | Fixed-price Preemptive Rights [Member]    
Derivative [Line Items]    
Derivative asset, measurement input 7.99 9.97
Share price [Member] | Cronos Warrant [Member]    
Derivative [Line Items]    
Derivative asset, measurement input 7.99 9.97
Expected Life [Member] | Fixed-price Preemptive Rights [Member]    
Derivative [Line Items]    
Derivative asset, measurement input 1.60 1.67
Expected Life [Member] | Cronos Warrant [Member]    
Derivative [Line Items]    
Derivative asset, measurement input 2.93 3.18
Expected Volatility [Member] | Fixed-price Preemptive Rights [Member]    
Derivative [Line Items]    
Derivative asset, measurement input 0.7997 0.8161
Expected Volatility [Member] | Cronos Warrant [Member]    
Derivative [Line Items]    
Derivative asset, measurement input 0.7997 0.8161
Risk Free Interest Rate [Member] | Fixed-price Preemptive Rights [Member]    
Derivative [Line Items]    
Derivative asset, measurement input 0.0038 0.0171
Risk Free Interest Rate [Member] | Fixed-price Preemptive Rights [Member] | Minimum [Member]    
Derivative [Line Items]    
Derivative asset, measurement input 0.0021 0.0166
Risk Free Interest Rate [Member] | Fixed-price Preemptive Rights [Member] | Maximum [Member]    
Derivative [Line Items]    
Derivative asset, measurement input 0.0062 0.0174
Risk Free Interest Rate [Member] | Cronos Warrant [Member]    
Derivative [Line Items]    
Derivative asset, measurement input 0.0049 0.0169
Expected Dividend Yield [Member] | Fixed-price Preemptive Rights [Member]    
Derivative [Line Items]    
Derivative asset, measurement input 0 0
Expected Dividend Yield [Member] | Cronos Warrant [Member]    
Derivative [Line Items]    
Derivative asset, measurement input 0 0
Weighted Average Expected Term [Member] | Fixed-price Preemptive Rights [Member] | Minimum [Member]    
Derivative [Line Items]    
Derivative asset, measurement input 0.25  
Weighted Average Expected Term [Member] | Fixed-price Preemptive Rights [Member] | Maximum [Member]    
Derivative [Line Items]    
Derivative asset, measurement input 6  
XML 82 R26.htm IDEA: XBRL DOCUMENT v3.20.1
Financial Instruments (Tables)
 3 Months Ended
Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Fair Value Measurement Inputs and Valuation Techniques The fair values of the Fixed-price Preemptive Rights and Cronos warrant are estimated using Black-Scholes option-pricing models, adjusted for observable inputs (which are classified in Level 1 of the fair value hierarchy), including share price, and unobservable inputs, including probability factors and weighting of expected life, volatility levels and risk-free interest rates (which are classified in Level 3 of the fair value hierarchy) based on the following assumptions at:
 
 
March 31, 2020
 
December 31, 2019
 
March 31, 2020
 
December 31, 2019
 
 
Fixed-price Preemptive Rights
 
Cronos Warrant
Share price (1)
 
C$7.99
 
C$9.97
 
C$7.99
 
C$9.97
Expected life (2)
 
1.60 years
 
1.67 years
 
2.93 years
 
3.18 years
Expected volatility (3)
 
79.97%
 
81.61%
 
79.97%
 
81.61%
Risk-free interest rate (4)(5)
 
0.38%
 
1.71%
 
0.49%
 
1.69%
Expected dividend yield (6)
 
—%
 
—%
 
—%
 
—%
(1) Based on the closing market price for Cronos common stock on the Toronto Stock Exchange on the date indicated.
(2) Based on the weighted-average expected life of the Fixed-price Preemptive Rights (with a range from approximately 0.25 year to 6 years at March 31, 2020 and December 31, 2019) and the March 8, 2023 expiration date of the Cronos warrant.
(3) Based on a blend of historical volatility levels of the underlying equity security and peer companies.
(4) Based on the implied yield currently available on Canadian Treasury zero coupon issues (with a range from approximately 0.21% to 0.62% at March 31, 2020 and 1.66% to 1.74% at December 31, 2019) weighted for the remaining expected life of the Fixed-price Preemptive Rights.
(5) Based on the implied yield currently available on Canadian Treasury zero coupon issues and the expected life of the Cronos warrant.
(6) Based on Cronos’s expected dividend payments.
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation
The following table provides a reconciliation of the beginning and ending balance of the Fixed-price Preemptive Rights and Cronos warrant, which are classified in Level 3 of the fair value hierarchy:
 
 
(in millions)
Balance at December 31, 2019
 
$
303

Pre-tax earnings (losses) recognized in net earnings
 
(137
)
Balance at March 31, 2020
 
$
166
Schedule of Derivative Liabilities at Fair Value The fair values of Altria’s derivative financial instruments on a gross basis included on the condensed consolidated balance sheets were as follows:
 
Fair Value of Assets
 
Fair Value of Liabilities
 
Balance Sheet Classification
 
March 31, 2020
 
December 31, 2019
 
Balance Sheet Classification
March 31, 2020
 
December 31, 2019
Derivatives designated as hedging instruments:
(in millions)
Foreign currency contracts
Other current assets
 
$
55

 
$
46

 
Other accrued liabilities
$
—

 
$
7

Foreign currency contracts
Other assets
 
19

 
—

 
Other liabilities
—

 
21

Total
 
$
74

 
$
46

 
 
$
—

 
$
28

 
 
 
 
 
 
 
 
 
 
 
Derivatives not designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
Cronos warrant
Investments in equity securities
 
$
132

 
$
234

 
 
 
 
 
Fixed-price
Preemptive Rights
Investments in equity securities
 
34

 
69

 
 
 
 
 
Total
 
 
$
166

 
$
303

 
 

 

 
 
 
 
 
 
 
 
 
 
 
Total derivatives
 
 
$
240

 
$
349

 
 
$
—

 
$
28
Pre-tax Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses
The pre-tax effects of Altria’s net investment hedges on accumulated other comprehensive losses and the condensed consolidated statements of earnings were as follows:
 
 
Gain (Loss) Recognized in Accumulated Other Comprehensive Losses
 
Gain (Loss) Recognized in Net Earnings (1)
 
 
For the Three Months Ended March 31,
 
 
2020
 
2019
 
2020
 
2019
 
 
(in millions)
Foreign currency contracts
 
$
56

 
$
23

 
$
14

 
$
9

Foreign currency denominated debt
 
77

 
33

 
—

 
—

Total
 
$
133

 
$
56

 
$
14

 
$
9

(1) Related to amounts excluded from effectiveness testing.

For the three months ended March 31, 2020 and 2019, Altria recognized pre-tax unrealized losses, representing the changes in the fair values of the Fixed-price Preemptive Rights and Cronos warrant, as follows:
 
For the Three Months Ended March 31,
 
2020
 
2019
 
(in millions)
Fixed-price Preemptive Rights
$
(35
)
 
$
(132
)
Cronos warrant
(102
)
 
(262
)
 
(137
)
 
(394
)
XML 83 R22.htm IDEA: XBRL DOCUMENT v3.20.1
Background and Basis of Presentation (Policies)
 3 Months Ended
Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
New Accounting Pronouncements
On January 1, 2020, Altria adopted Accounting Standards Update (“ASU”) No. 2016-13, Measurement of Credit Losses on Financial Instruments and all related ASU amendments (collectively “ASU No. 2016-13”). This guidance replaces the current incurred loss impairment methodology for recognizing credit losses for financial assets with a methodology that reflects the entity’s current estimate of all expected credit losses and requires consideration of a broader range of reasonable and supportable information for estimating credit losses. The adoption of ASU No. 2016-13 did not have a material impact on Altria’s condensed consolidated financial statements.

Additionally, on January 1, 2020, Altria adopted ASU No. 2018-15, Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (“ASU No. 2018-15”). This guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The adoption of ASU No. 2018-15 did not have a material impact on Altria’s condensed consolidated financial statements.
Standards
Description
Effective Date for Public Entity
Effect on Financial Statements
ASU 2019-12 Simplifying the Accounting for Income Taxes (Topic 740)
The guidance removes certain exceptions for investments, intraperiod allocations and interim calculations, and adds guidance to reduce complexity in accounting for income taxes.
The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early application is permitted, including adoption in any interim period.
Altria is in the process of evaluating the impact of this guidance on its consolidated financial statements and related disclosures.
ASU 2020-01 Clarifying the Interactions between Topic 321, Topic 323, and Topic 815
The guidance provides clarification of the interaction of rules for equity securities, the equity method of accounting, and forward contracts and purchase options on certain types of securities.
The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early application is permitted, including adoption in any interim period.
Altria is in the process of evaluating the impact of this guidance on its consolidated financial statements and related disclosures.
Equity Method Investments The fair value of Altria’s equity investment in ABI is based on (i) unadjusted quoted prices in active markets for ABI’s ordinary shares and was classified in Level 1 of the fair value hierarchy and (ii) observable inputs other than Level 1 prices, such as quoted prices for similar assets for the Restricted Shares, and was classified in Level 2 of the fair value hierarchy. Altria may, in certain instances, pledge or otherwise grant a security interest in all or part of its Restricted Shares. In the event the pledgee or security interest holder forecloses on the Restricted Shares, the relevant Restricted Shares will be automatically converted, one-for-one, into ordinary shares. Therefore, the fair value of each Restricted Share is based on the value of an ordinary share.
Altria reviews its equity investments accounted for under the equity method of accounting (ABI and Cronos) for impairment on a quarterly basis in connection with the preparation of its financial statements by comparing the fair value of each of its investments to its respective carrying value. If the carrying value of an investment exceeds its fair value and the loss in value is other than temporary, the investment is considered impaired and reduced to fair value, and the impairment is recognized in the period identified. For further discussion, see Investment in ABI and Investment in Cronos below.

The fair value of Altria’s equity method investment in Cronos is based on unadjusted quoted prices in active markets for Cronos’s common shares and was classified in Level 1 of the fair value hierarchy.
Equity Securities Without Readily Determinable Fair Value Altria accounted for its investment in JUUL as an investment in an equity security as of March 31, 2020. Since the JUUL shares do not have a readily determinable fair value, Altria has elected to measure its investment in JUUL at its cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. There have been no upward or downward adjustments to the carrying value of Altria’s investment in JUUL resulting from observable price changes in orderly transactions since the JUUL Transaction through March 31, 2020.

Altria reviews its investment in JUUL for impairment by performing a qualitative assessment of impairment indicators on a quarterly basis in connection with the preparation of its financial statements. If this qualitative assessment indicates that
Altria’s investment in JUUL may be impaired, a quantitative assessment is performed. If the quantitative assessment indicates the fair value of the investment is less than its carrying value, the investment is written down to its fair value.
XML 84 R64.htm IDEA: XBRL DOCUMENT v3.20.1
Contingencies (Engle Class Action And Engle Progeny Trial Results) (Details)
 1 Months Ended
Apr. 27, 2020
USD ($)
case
plantiff
Jul. 31, 2006
Jan. 31, 2008
case
Jul. 31, 2000
USD ($)
Engle Progeny Cases [Member]        
Loss Contingencies [Line Items]        
Punitive damages awarded | $       $ 145,000,000,000
Engle Progeny Cases [Member] | PM USA [Member]        
Loss Contingencies [Line Items]        
Punitive damages awarded | $       $ 74,000,000,000
Period for decertified class members could file individual actions   1 year    
Engle Progeny Cases, State [Member]        
Loss Contingencies [Line Items]        
Number of cases pending     9,300  
Subsequent Event [Member] | Engle Progeny Cases [Member] | PM USA [Member]        
Loss Contingencies [Line Items]        
Number of verdicts returned 134      
Number of unfavorable verdicts 78      
Number of claims with unfavorable verdicts pending/reversed 4      
Number of favorable verdicts 47      
Subsequent Event [Member] | Engle Progeny Cases, State [Member]        
Loss Contingencies [Line Items]        
Number of cases pending 1,500      
Number of plaintiffs | plantiff 1,900      
Subsequent Event [Member] | Engle Progeny Cases, State [Member] | PM USA [Member]        
Loss Contingencies [Line Items]        
Number of favorable verdicts 42      
Subsequent Event [Member] | Engle Progeny Cases, Federal [Member] | PM USA [Member]        
Loss Contingencies [Line Items]        
Number of cases pending 4      
Subsequent Event [Member] | Engle Progeny Cases, D Cohen, Collar, Chacon [Member] | PM USA [Member]        
Loss Contingencies [Line Items]        
Number of verdicts reversed 4      
Subsequent Event [Member] | Engle Progeny Cases, Reider and Banks [Member] | PM USA [Member]        
Loss Contingencies [Line Items]        
Zero damages verdicts 2      
Damages awarded, value | $ $ 0      
Subsequent Event [Member] | Engle Progeny Cases, Weingart and Hancock [Member] | PM USA [Member]        
Loss Contingencies [Line Items]        
Damages awarded, value | $ $ 0      
Zero damages verdict modified 2      
Subsequent Event [Member] | Engle Progeny Cases, Pollari [Member] | PM USA [Member]        
Loss Contingencies [Line Items]        
Number of favorable verdicts 1      
Subsequent Event [Member] | Engle Progeny Cases, Gloger, Rintoul and Duignam [Member] | PM USA [Member]        
Loss Contingencies [Line Items]        
Number of favorable verdicts 3      
Subsequent Event [Member] | Engle Progeny Cases, Freeman [Member] | PM USA [Member]        
Loss Contingencies [Line Items]        
Number of favorable verdicts 1      
XML 85 R60.htm IDEA: XBRL DOCUMENT v3.20.1
Contingencies (Schedule of Pending Cases) (Details)
 1 Months Ended
Apr. 27, 2020
case
lawsuit
claim
Mar. 31, 2018
case
Apr. 30, 2020
lawsuit
Apr. 22, 2019
case
Apr. 23, 2018
case
Individual Smoking and Health Cases [Member]          
Loss Contingencies [Line Items]          
Number of cases pending       98 102
ETS Smoking and Health Case, Flight Attendants [Member] | Pending Litigation [Member]          
Loss Contingencies [Line Items]          
Number of claims dismissed   923      
Health Care Cost Recovery Actions [Member]          
Loss Contingencies [Line Items]          
Number of cases pending       1 1
E-vapor Litigation [Member]          
Loss Contingencies [Line Items]          
Number of cases pending       2 3
Other Tabacco-Related Cases [Member]          
Loss Contingencies [Line Items]          
Number of cases pending       0 0
Loss contingency, number of inactive cases       2  
Subsequent Event [Member]          
Loss Contingencies [Line Items]          
Loss contingency, class action lawsuit | lawsuit     3    
Subsequent Event [Member] | Individual Smoking and Health Cases [Member]          
Loss Contingencies [Line Items]          
Number of cases pending 109        
Subsequent Event [Member] | Individual Smoking and Health Cases [Member] | Pending Litigation [Member] | Massachusetts [Member]          
Loss Contingencies [Line Items]          
Number of cases pending 22        
Subsequent Event [Member] | Individual Smoking and Health Cases [Member] | Pending Litigation [Member] | Florida [Member]          
Loss Contingencies [Line Items]          
Number of cases pending 46        
Subsequent Event [Member] | ETS Smoking and Health Case, Flight Attendants [Member] | Pending Litigation [Member]          
Loss Contingencies [Line Items]          
Number of cases 1,472        
Subsequent Event [Member] | Health Care Cost Recovery Actions [Member]          
Loss Contingencies [Line Items]          
Number of cases pending 0        
Subsequent Event [Member] | E-vapor Litigation [Member]          
Loss Contingencies [Line Items]          
Number of cases pending 202        
Loss contingency, class action lawsuit | lawsuit 24        
Number of cases set for trial | claim 0        
Subsequent Event [Member] | E-vapor Litigation [Member] | Pending Individual Lawsuits [Member]          
Loss Contingencies [Line Items]          
Number of cases pending | claim 170        
Subsequent Event [Member] | E-vapor Litigation [Member] | Pending Lawsuits Filed By State Or Local Governments [Member]          
Loss Contingencies [Line Items]          
Number of cases pending | claim 5        
Subsequent Event [Member] | E-vapor Litigation [Member] | Pending Lawsuit Filed By School District [Member]          
Loss Contingencies [Line Items]          
Number of cases pending | claim 3        
Subsequent Event [Member] | Other Tabacco-Related Cases [Member]          
Loss Contingencies [Line Items]          
Number of cases pending 4        
Loss contingency, number of inactive cases 2        
Loss contingency, number of cases tried in a single proceeding 1        
Loss contingency, number of inactive class action lawsuits 2        
PM USA [Member] | Subsequent Event [Member] | Engle Progeny Cases [Member]          
Loss Contingencies [Line Items]          
Number of cases set for trial 2        
PM USA [Member] | Subsequent Event [Member] | Individual Smoking and Health Cases [Member]          
Loss Contingencies [Line Items]          
Number of cases set for trial 0        
XML 86 R68.htm IDEA: XBRL DOCUMENT v3.20.1
Contingencies (Health Care Cost Recovery Litigation) (Details)
$ in Millions
 1 Months Ended 3 Months Ended
Nov. 30, 1998
USD ($)
state
Mar. 31, 2020
USD ($)
case
Mar. 31, 2019
USD ($)
manufacture
Apr. 22, 2019
case
Apr. 23, 2018
case
Health Care Cost Recovery Actions [Member]          
Loss Contingencies [Line Items]          
Number of cases pending | case       1 1
Number of states with settled litigation | state 46        
State settlement agreements annual payments $ 9,400        
State settlement agreements attorney fees annual cap $ 500        
Litigation settlement   $ 1,100 $ 900    
Threatened Litigation [Member] | Canada [Member] | Health Care Cost Recovery Actions [Member]          
Loss Contingencies [Line Items]          
Number of cases pending | case   10      
Canadian Tobacco Manufacturers [Member] | Canada [Member] | Smoking and Health Class Actions and Aggregated Claims Litigation [Member]          
Loss Contingencies [Line Items]          
Number of manufacturers | manufacture     3    
XML 87 R43.htm IDEA: XBRL DOCUMENT v3.20.1
Investments in Equity Securities (Investment in JUUL Narrative) (Details)
 1 Months Ended 12 Months Ended
Jan. 28, 2020
director
Dec. 31, 2018
USD ($)
Dec. 31, 2019
USD ($)
Mar. 31, 2020
USD ($)
director
Schedule of Equity Method Investments [Line Items]        
Equity securities without readily determinable fair value, upward price adjustment, cumulative amount | $       $ 0
JUUL [Member]        
Schedule of Equity Method Investments [Line Items]        
Payments to acquire equity securities | $   $ 12,800,000,000    
Equity securities, ownership percentage     35.00% 35.00%
Equity securities without readily determinable fair value, impairment loss, annual amount | $     $ 8,600,000,000  
Equity securities without readily determinable fair value, amount | $     $ 4,205,000,000 $ 4,205,000,000
Equity securities without readily determinable fair value, no litigation period 1 year      
Equity securities without readily determinable fair value, non-compete release trigger period 12 months      
Equity securities without readily determinable fair value, non-compete release trigger percentage of investment carrying value 10.00%      
Equity securities without readily determinable fair value, quantitative assessment adjustment, annual amount | $   $ 12,800,000,000    
Equity securities without readily determinable fair value, number of board members       7
Equity securities without readily determinable fair value, number of board members upon share conversion 9      
Equity securities without readily determinable fair value, number of independent board members upon share conversion 3      
Equity securities without readily determinable fair value, number of board members appointed by investor upon share conversion 1      
Equity securities without readily determinable fair value, number of board members appointed by investee stockholders upon share conversion 2      
Equity securities without readily determinable fair value, number of investor nominating committee designees upon share conversion 1      
Equity securities without readily determinable fair value, number of directors designated by investor upon share conversion 2      
Equity securities without readily determinable fair value, number of nominating committee directors designated by investee upon share conversion 3      
Equity securities without readily determinable fair value, number of oversight committee directors designated by investor upon share conversion 2      
Equity securities without readily determinable fair value, number of oversight committee chair directors designated by investor upon share conversion 1      
XML 88 R47.htm IDEA: XBRL DOCUMENT v3.20.1
Financial Instruments (Beginning and Ending Balances of Fixed-price Preemptive Rights and Warrants) (Details) - Fair Value, Inputs, Level 3 [Member] - Equity Contract [Member]
$ in Millions
 3 Months Ended
Mar. 31, 2020
USD ($)
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]  
Balance at begging of period $ 303
Pre-tax earnings (losses) recognized in net earnings (137)
Balance at end of period $ 166
XML 89 R79.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidating Financial Information (Condensed Consolidating Statements of Cash Flows) (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Cash Provided by (Used In) Operating Activities    
Net cash provided by (used in) operating activities $ 3,129 $ 2,289
Cash Provided by (Used in) Investing Activities    
Capital expenditures (52) (38)
Investment in Cronos 0 (1,831)
Investment in consolidated subsidiaries 0 0
Other, net 0 (81)
Net cash provided by (used in) investing activities (52) (1,950)
Cash Provided by (Used in) Financing Activities    
Proceeds from short-term borrowings 3,000 0
Repayment of short-term borrowings 0 (12,800)
Long-term debt issued 0 16,265
Long-term debt repaid (1,000) 0
Repurchases of common stock 0 (151)
Dividends paid on common stock (1,563) (1,502)
Changes in amounts due to/from Altria Group, Inc. and subsidiaries 0 0
Cash dividends paid to parent 0 0
Other, net (10) (129)
Net cash provided by (used in) financing activities 427 1,683
Cash, cash equivalents and restricted cash:    
Increase (decrease) 3,504 2,022
Balance at beginning of period 2,160 1,433
Balance at end of period 5,664 3,455
Reportable Legal Entities [Member] | Altria Group, Inc. [Member]    
Cash Provided by (Used In) Operating Activities    
Net cash provided by (used in) operating activities 1,515 1,642
Cash Provided by (Used in) Investing Activities    
Capital expenditures 0 0
Investment in Cronos   0
Investment in consolidated subsidiaries (1) (1,947)
Other, net 0 (3)
Net cash provided by (used in) investing activities (1) (1,950)
Cash Provided by (Used in) Financing Activities    
Proceeds from short-term borrowings 3,000  
Repayment of short-term borrowings   (12,800)
Long-term debt issued   16,265
Long-term debt repaid (1,000)  
Repurchases of common stock   (151)
Dividends paid on common stock (1,563) (1,502)
Changes in amounts due to/from Altria Group, Inc. and subsidiaries 1,584 657
Cash dividends paid to parent 0 0
Other, net (9) (120)
Net cash provided by (used in) financing activities 2,012 2,349
Cash, cash equivalents and restricted cash:    
Increase (decrease) 3,526 2,041
Balance at beginning of period 2,022 1,277
Balance at end of period 5,548 3,318
Reportable Legal Entities [Member] | PM USA [Member]    
Cash Provided by (Used In) Operating Activities    
Net cash provided by (used in) operating activities 3,351 2,520
Cash Provided by (Used in) Investing Activities    
Capital expenditures (15) (9)
Investment in Cronos   0
Investment in consolidated subsidiaries 0 0
Other, net 0 0
Net cash provided by (used in) investing activities (15) (9)
Cash Provided by (Used in) Financing Activities    
Proceeds from short-term borrowings 0  
Repayment of short-term borrowings   0
Long-term debt issued   0
Long-term debt repaid 0  
Repurchases of common stock   0
Dividends paid on common stock 0 0
Changes in amounts due to/from Altria Group, Inc. and subsidiaries (1,582) (771)
Cash dividends paid to parent (1,748) (1,737)
Other, net 0 0
Net cash provided by (used in) financing activities (3,330) (2,508)
Cash, cash equivalents and restricted cash:    
Increase (decrease) 6 3
Balance at beginning of period 43 100
Balance at end of period 49 103
Reportable Legal Entities [Member] | Non-Guarantor Subsidiaries [Member]    
Cash Provided by (Used In) Operating Activities    
Net cash provided by (used in) operating activities 437 166
Cash Provided by (Used in) Investing Activities    
Capital expenditures (37) (29)
Investment in Cronos   (1,831)
Investment in consolidated subsidiaries 0 0
Other, net 0 (78)
Net cash provided by (used in) investing activities (37) (1,938)
Cash Provided by (Used in) Financing Activities    
Proceeds from short-term borrowings 0  
Repayment of short-term borrowings   0
Long-term debt issued   0
Long-term debt repaid 0  
Repurchases of common stock   0
Dividends paid on common stock 0 0
Changes in amounts due to/from Altria Group, Inc. and subsidiaries (1) 2,061
Cash dividends paid to parent (426) (302)
Other, net (1) (9)
Net cash provided by (used in) financing activities (428) 1,750
Cash, cash equivalents and restricted cash:    
Increase (decrease) (28) (22)
Balance at beginning of period 95 56
Balance at end of period 67 34
Total Consolidating Adjustments [Member]    
Cash Provided by (Used In) Operating Activities    
Net cash provided by (used in) operating activities (2,174) (2,039)
Cash Provided by (Used in) Investing Activities    
Capital expenditures 0 0
Investment in Cronos   0
Investment in consolidated subsidiaries 1 1,947
Other, net 0 0
Net cash provided by (used in) investing activities 1 1,947
Cash Provided by (Used in) Financing Activities    
Proceeds from short-term borrowings 0  
Repayment of short-term borrowings   0
Long-term debt issued   0
Long-term debt repaid 0  
Repurchases of common stock   0
Dividends paid on common stock 0 0
Changes in amounts due to/from Altria Group, Inc. and subsidiaries (1) (1,947)
Cash dividends paid to parent 2,174 2,039
Other, net 0 0
Net cash provided by (used in) financing activities 2,173 92
Cash, cash equivalents and restricted cash:    
Increase (decrease) 0 0
Balance at beginning of period 0 0
Balance at end of period $ 0 $ 0
XML 90 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 91 R71.htm IDEA: XBRL DOCUMENT v3.20.1
Contingencies (Federal Government's Lawsuit) (Details) - Federal Governments Lawsuit [Member] - USD ($)
$ in Millions
 1 Months Ended 3 Months Ended 12 Months Ended
Aug. 31, 2006
Dec. 31, 2019
Dec. 31, 2014
Loss Contingencies [Line Items]      
Disclosure period 10 years    
Implementation of Corrective Communications [Member]      
Loss Contingencies [Line Items]      
Provision related to litigation recorded   $ 5 $ 31
XML 92 R75.htm IDEA: XBRL DOCUMENT v3.20.1
Contingencies (Antitrust Litigation) (Details) - lawsuit
Apr. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
JUUL [Member]      
Loss Contingencies [Line Items]      
Equity securities, ownership percentage   35.00% 35.00%
Subsequent Event [Member]      
Loss Contingencies [Line Items]      
Loss contingency, class action lawsuit 3    
XML 93 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.1 html 457 414 1 true 214 0 false 21 false false R1.htm 0001000 - Document - Cover Page Sheet http://www.altria.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1001000 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.altria.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 1001501 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.altria.com/role/CondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1003000 - Statement - Condensed Consolidated Statements of Earnings Sheet http://www.altria.com/role/CondensedConsolidatedStatementsOfEarnings Condensed Consolidated Statements of Earnings Statements 4 false false R5.htm 1004000 - Statement - Condensed Consolidated Statements of Comprehensive Earnings Sheet http://www.altria.com/role/CondensedConsolidatedStatementsOfComprehensiveEarnings Condensed Consolidated Statements of Comprehensive Earnings Statements 5 false false R6.htm 1004000 - Statement - Condensed Consolidated Statements of Stockholders' Equity Sheet http://www.altria.com/role/CondensedConsolidatedStatementsOfStockholdersEquity Condensed Consolidated Statements of Stockholders' Equity Statements 6 false false R7.htm 1004501 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Parenthetical) Sheet http://www.altria.com/role/CondensedConsolidatedStatementsOfStockholdersEquityParenthetical Condensed Consolidated Statements of Stockholders' Equity (Parenthetical) Statements 7 false false R8.htm 106000 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 8 false false R9.htm 2101100 - Disclosure - Background and Basis of Presentation Sheet http://www.altria.com/role/BackgroundAndBasisOfPresentation Background and Basis of Presentation Notes 9 false false R10.htm 2103100 - Disclosure - Revenues from Contracts with Customers Sheet http://www.altria.com/role/RevenuesFromContractsWithCustomers Revenues from Contracts with Customers Notes 10 false false R11.htm 2106100 - Disclosure - Asset Impairment, Exit and Implementation Costs Sheet http://www.altria.com/role/AssetImpairmentExitAndImplementationCosts Asset Impairment, Exit and Implementation Costs Notes 11 false false R12.htm 2108100 - Disclosure - Investments in Equity Securities Sheet http://www.altria.com/role/InvestmentsInEquitySecurities Investments in Equity Securities Notes 12 false false R13.htm 2109100 - Disclosure - Financial Instruments Sheet http://www.altria.com/role/FinancialInstruments Financial Instruments Notes 13 false false R14.htm 2112100 - Disclosure - Benefit Plans Sheet http://www.altria.com/role/BenefitPlans Benefit Plans Notes 14 false false R15.htm 2113100 - Disclosure - Earnings Per Share Sheet http://www.altria.com/role/EarningsPerShare Earnings Per Share Notes 15 false false R16.htm 2116100 - Disclosure - Other Comprehensive Earnings/Losses Sheet http://www.altria.com/role/OtherComprehensiveEarningsLosses Other Comprehensive Earnings/Losses Notes 16 false false R17.htm 2117100 - Disclosure - Segment Reporting Sheet http://www.altria.com/role/SegmentReporting Segment Reporting Notes 17 false false R18.htm 2118100 - Disclosure - Debt Sheet http://www.altria.com/role/Debt Debt Notes 18 false false R19.htm 2120100 - Disclosure - Contingencies Sheet http://www.altria.com/role/Contingencies Contingencies Notes 19 false false R20.htm 2121100 - Disclosure - Condensed Consolidating Financial Information Sheet http://www.altria.com/role/CondensedConsolidatingFinancialInformation Condensed Consolidating Financial Information Notes 20 false false R21.htm 2122100 - Disclosure - New Accounting Guidance Not Yet Adopted Sheet http://www.altria.com/role/NewAccountingGuidanceNotYetAdopted New Accounting Guidance Not Yet Adopted Notes 21 false false R22.htm 2201201 - Disclosure - Background and Basis of Presentation (Policies) Sheet http://www.altria.com/role/BackgroundAndBasisOfPresentationPolicies Background and Basis of Presentation (Policies) Policies http://www.altria.com/role/NewAccountingGuidanceNotYetAdopted 22 false false R23.htm 2301302 - Disclosure - Background and Basis of Presentation (Tables) Sheet http://www.altria.com/role/BackgroundAndBasisOfPresentationTables Background and Basis of Presentation (Tables) Tables http://www.altria.com/role/BackgroundAndBasisOfPresentation 23 false false R24.htm 2306301 - Disclosure - Asset Impairment, Exit and Implementation Costs (Tables) Sheet http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsTables Asset Impairment, Exit and Implementation Costs (Tables) Tables http://www.altria.com/role/AssetImpairmentExitAndImplementationCosts 24 false false R25.htm 2308301 - Disclosure - Investments in Equity Securities Investments in Equity Securities (Tables) Sheet http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentsInEquitySecuritiesTables Investments in Equity Securities Investments in Equity Securities (Tables) Tables 25 false false R26.htm 2309301 - Disclosure - Financial Instruments (Tables) Sheet http://www.altria.com/role/FinancialInstrumentsTables Financial Instruments (Tables) Tables http://www.altria.com/role/FinancialInstruments 26 false false R27.htm 2312301 - Disclosure - Benefit Plans (Tables) Sheet http://www.altria.com/role/BenefitPlansTables Benefit Plans (Tables) Tables http://www.altria.com/role/BenefitPlans 27 false false R28.htm 2313301 - Disclosure - Earnings Per Share (Tables) Sheet http://www.altria.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.altria.com/role/EarningsPerShare 28 false false R29.htm 2316301 - Disclosure - Other Comprehensive Earnings/Losses (Tables) Sheet http://www.altria.com/role/OtherComprehensiveEarningsLossesTables Other Comprehensive Earnings/Losses (Tables) Tables http://www.altria.com/role/OtherComprehensiveEarningsLosses 29 false false R30.htm 2317301 - Disclosure - Segment Reporting (Tables) Sheet http://www.altria.com/role/SegmentReportingTables Segment Reporting (Tables) Tables http://www.altria.com/role/SegmentReporting 30 false false R31.htm 2320301 - Disclosure - Contingencies (Tables) Sheet http://www.altria.com/role/ContingenciesTables Contingencies (Tables) Tables http://www.altria.com/role/Contingencies 31 false false R32.htm 2321301 - Disclosure - Condensed Consolidating Financial Information (Tables) Sheet http://www.altria.com/role/CondensedConsolidatingFinancialInformationTables Condensed Consolidating Financial Information (Tables) Tables http://www.altria.com/role/CondensedConsolidatingFinancialInformation 32 false false R33.htm 2322301 - Disclosure - New Accounting Guidance Not Yet Adopted (Tables) Sheet http://www.altria.com/role/NewAccountingGuidanceNotYetAdoptedTables New Accounting Guidance Not Yet Adopted (Tables) Tables http://www.altria.com/role/NewAccountingGuidanceNotYetAdopted 33 false false R34.htm 2401403 - Disclosure - Background and Basis of Presentation (Narrative) (Details) Sheet http://www.altria.com/role/BackgroundAndBasisOfPresentationNarrativeDetails Background and Basis of Presentation (Narrative) (Details) Details http://www.altria.com/role/BackgroundAndBasisOfPresentationTables 34 false false R35.htm 2401404 - Disclosure - Background and Basis of Presentation (Share Repurchase Table) (Details) Sheet http://www.altria.com/role/BackgroundAndBasisOfPresentationShareRepurchaseTableDetails Background and Basis of Presentation (Share Repurchase Table) (Details) Details http://www.altria.com/role/BackgroundAndBasisOfPresentationTables 35 false false R36.htm 2403401 - Disclosure - Revenues from Contracts with Customers (Narrative) (Details) Sheet http://www.altria.com/role/RevenuesFromContractsWithCustomersNarrativeDetails Revenues from Contracts with Customers (Narrative) (Details) Details http://www.altria.com/role/RevenuesFromContractsWithCustomers 36 false false R37.htm 2406402 - Disclosure - Asset Impairment, Exit and Implementation Costs (Pre-tax Asset Impairment, Exit and Implementation Costs) (Details) Sheet http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsPreTaxAssetImpairmentExitAndImplementationCostsDetails Asset Impairment, Exit and Implementation Costs (Pre-tax Asset Impairment, Exit and Implementation Costs) (Details) Details http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsTables 37 false false R38.htm 2406403 - Disclosure - Asset Impairment, Exit and Implementation Costs (Movement in Restructuring Liabilities) (Details) Sheet http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsMovementInRestructuringLiabilitiesDetails Asset Impairment, Exit and Implementation Costs (Movement in Restructuring Liabilities) (Details) Details http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsTables 38 false false R39.htm 2406404 - Disclosure - Asset Impairment, Exit and Implementation Costs (Narrative) (Details) Sheet http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsNarrativeDetails Asset Impairment, Exit and Implementation Costs (Narrative) (Details) Details http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsTables 39 false false R40.htm 2408402 - Disclosure - Investments in Equity Securities (Summary of Investments) (Details) Sheet http://www.altria.com/role/InvestmentsInEquitySecuritiesSummaryOfInvestmentsDetails Investments in Equity Securities (Summary of Investments) (Details) Details http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentsInEquitySecuritiesTables 40 false false R41.htm 2408403 - Disclosure - Investments in Equity Securities (Earnings in Equity Securities) (Details) Sheet http://www.altria.com/role/InvestmentsInEquitySecuritiesEarningsInEquitySecuritiesDetails Investments in Equity Securities (Earnings in Equity Securities) (Details) Details http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentsInEquitySecuritiesTables 41 false false R42.htm 2408404 - Disclosure - Investments in Equity Securities (Investment in ABI Narrative) (Details) Sheet http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInAbiNarrativeDetails Investments in Equity Securities (Investment in ABI Narrative) (Details) Details http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentsInEquitySecuritiesTables 42 false false R43.htm 2408405 - Disclosure - Investments in Equity Securities (Investment in JUUL Narrative) (Details) Sheet http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInJuulNarrativeDetails Investments in Equity Securities (Investment in JUUL Narrative) (Details) Details http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentsInEquitySecuritiesTables 43 false false R44.htm 2408406 - Disclosure - Investments in Equity Securities (Investment in Cronos Narrative) (Details) Sheet http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInCronosNarrativeDetails Investments in Equity Securities (Investment in Cronos Narrative) (Details) Details http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentsInEquitySecuritiesTables 44 false false R45.htm 2409402 - Disclosure - Financial Instruments (Narrative) (Details) Sheet http://www.altria.com/role/FinancialInstrumentsNarrativeDetails Financial Instruments (Narrative) (Details) Details http://www.altria.com/role/FinancialInstrumentsTables 45 false false R46.htm 2409403 - Disclosure - Financial Instruments (Fair Value Using Black-Scholes Option-Pricing Model) (Details) Sheet http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails Financial Instruments (Fair Value Using Black-Scholes Option-Pricing Model) (Details) Details http://www.altria.com/role/FinancialInstrumentsTables 46 false false R47.htm 2409404 - Disclosure - Financial Instruments (Beginning and Ending Balances of Fixed-price Preemptive Rights and Warrants) (Details) Sheet http://www.altria.com/role/FinancialInstrumentsBeginningAndEndingBalancesOfFixedPricePreemptiveRightsAndWarrantsDetails Financial Instruments (Beginning and Ending Balances of Fixed-price Preemptive Rights and Warrants) (Details) Details http://www.altria.com/role/FinancialInstrumentsTables 47 false false R48.htm 2409405 - Disclosure - Financial Instruments (Fair Value Derivative Financial Instruments) (Details) Sheet http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails Financial Instruments (Fair Value Derivative Financial Instruments) (Details) Details http://www.altria.com/role/FinancialInstrumentsTables 48 false false R49.htm 2409406 - Disclosure - Financial Instruments (Pre-tax Unrealized Gains (Losses)) (Details) Sheet http://www.altria.com/role/FinancialInstrumentsPreTaxUnrealizedGainsLossesDetails Financial Instruments (Pre-tax Unrealized Gains (Losses)) (Details) Details http://www.altria.com/role/FinancialInstrumentsTables 49 false false R50.htm 2409407 - Disclosure - Financial Instruments (Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses) (Details) Sheet http://www.altria.com/role/FinancialInstrumentsEffectsOfNetInvestmentHedgesOnAccumulatedOtherComprehensiveLossesDetails Financial Instruments (Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses) (Details) Details http://www.altria.com/role/FinancialInstrumentsTables 50 false false R51.htm 2412402 - Disclosure - Benefit Plans (Schedule Of Components Of Net Periodic Benefit Cost (Income)) (Details) Sheet http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails Benefit Plans (Schedule Of Components Of Net Periodic Benefit Cost (Income)) (Details) Details http://www.altria.com/role/BenefitPlansTables 51 false false R52.htm 2412403 - Disclosure - Benefit Plans (Narrative) (Details) Sheet http://www.altria.com/role/BenefitPlansNarrativeDetails Benefit Plans (Narrative) (Details) Details http://www.altria.com/role/BenefitPlansTables 52 false false R53.htm 2413402 - Disclosure - Earnings Per Share (Basic and Diluted Earnings Per Share) (Details) Sheet http://www.altria.com/role/EarningsPerShareBasicAndDilutedEarningsPerShareDetails Earnings Per Share (Basic and Diluted Earnings Per Share) (Details) Details http://www.altria.com/role/EarningsPerShareTables 53 false false R54.htm 2416402 - Disclosure - Other Comprehensive Earnings/Losses (Changes in Each Component of Accumulated Other Comprehensive Losses) (Details) Sheet http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesInEachComponentOfAccumulatedOtherComprehensiveLossesDetails Other Comprehensive Earnings/Losses (Changes in Each Component of Accumulated Other Comprehensive Losses) (Details) Details http://www.altria.com/role/OtherComprehensiveEarningsLossesTables 54 false false R55.htm 2416403 - Disclosure - Other Comprehensive Earnings/Losses (Reclassifications) (Details) Sheet http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails Other Comprehensive Earnings/Losses (Reclassifications) (Details) Details http://www.altria.com/role/OtherComprehensiveEarningsLossesTables 55 false false R56.htm 2417402 - Disclosure - Segment Reporting (Segment Data Schedule) (Details) Sheet http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails Segment Reporting (Segment Data Schedule) (Details) Details http://www.altria.com/role/SegmentReportingTables 56 false false R57.htm 2417403 - Disclosure - Segment Reporting (Schedule of Tobacco and Health Litigation Items) (Details) Sheet http://www.altria.com/role/SegmentReportingScheduleOfTobaccoAndHealthLitigationItemsDetails Segment Reporting (Schedule of Tobacco and Health Litigation Items) (Details) Details http://www.altria.com/role/SegmentReportingTables 57 false false R58.htm 2418401 - Disclosure - Debt (Narrative) (Details) Sheet http://www.altria.com/role/DebtNarrativeDetails Debt (Narrative) (Details) Details http://www.altria.com/role/Debt 58 false false R59.htm 2420402 - Disclosure - Contingencies (General Information) (Details) Sheet http://www.altria.com/role/ContingenciesGeneralInformationDetails Contingencies (General Information) (Details) Details http://www.altria.com/role/ContingenciesTables 59 false false R60.htm 2420403 - Disclosure - Contingencies (Schedule of Pending Cases) (Details) Sheet http://www.altria.com/role/ContingenciesScheduleOfPendingCasesDetails Contingencies (Schedule of Pending Cases) (Details) Details http://www.altria.com/role/ContingenciesTables 60 false false R61.htm 2420404 - Disclosure - Contingencies (Overview of Altria and/or PM USA Tobacco-Related Litigation Narrative) (Details) Sheet http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails Contingencies (Overview of Altria and/or PM USA Tobacco-Related Litigation Narrative) (Details) Details http://www.altria.com/role/ContingenciesTables 61 false false R62.htm 2420405 - Disclosure - Contingencies (Judgments Paid and Provisions for Tobacco and Health Litigation) (Details) Sheet http://www.altria.com/role/ContingenciesJudgmentsPaidAndProvisionsForTobaccoAndHealthLitigationDetails Contingencies (Judgments Paid and Provisions for Tobacco and Health Litigation) (Details) Details http://www.altria.com/role/ContingenciesTables 62 false false R63.htm 2420406 - Disclosure - Contingencies (Non-Engle Progeny Litigation) (Details) Sheet http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails Contingencies (Non-Engle Progeny Litigation) (Details) Details http://www.altria.com/role/ContingenciesTables 63 false false R64.htm 2420407 - Disclosure - Contingencies (Engle Class Action And Engle Progeny Trial Results) (Details) Sheet http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails Contingencies (Engle Class Action And Engle Progeny Trial Results) (Details) Details http://www.altria.com/role/ContingenciesTables 64 false false R65.htm 2420408 - Disclosure - Contingencies (Engle Progeny Cases Trial Results - Pending and Concluded) (Details) Sheet http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails Contingencies (Engle Progeny Cases Trial Results - Pending and Concluded) (Details) Details http://www.altria.com/role/ContingenciesTables 65 false false R66.htm 2420409 - Disclosure - Contingencies (Florida Bond Statute) (Details) Sheet http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails Contingencies (Florida Bond Statute) (Details) Details http://www.altria.com/role/ContingenciesTables 66 false false R67.htm 2420410 - Disclosure - Contingencies (Other Smoking and Health Class Actions) (Details) Sheet http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails Contingencies (Other Smoking and Health Class Actions) (Details) Details http://www.altria.com/role/ContingenciesTables 67 false false R68.htm 2420411 - Disclosure - Contingencies (Health Care Cost Recovery Litigation) (Details) Sheet http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails Contingencies (Health Care Cost Recovery Litigation) (Details) Details http://www.altria.com/role/ContingenciesTables 68 false false R69.htm 2420412 - Disclosure - Contingencies (NPM Adjustment Disputes - Settlement with 20 States and Territories and Settlement with New York) (Details) Sheet http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails Contingencies (NPM Adjustment Disputes - Settlement with 20 States and Territories and Settlement with New York) (Details) Details http://www.altria.com/role/ContingenciesTables 69 false false R70.htm 2420413 - Disclosure - Contingencies (Other Disputes Under the State Settlement Agreements) (Details) Sheet http://www.altria.com/role/ContingenciesOtherDisputesUnderStateSettlementAgreementsDetails Contingencies (Other Disputes Under the State Settlement Agreements) (Details) Details http://www.altria.com/role/ContingenciesTables 70 false false R71.htm 2420414 - Disclosure - Contingencies (Federal Government's Lawsuit) (Details) Sheet http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails Contingencies (Federal Government's Lawsuit) (Details) Details http://www.altria.com/role/ContingenciesTables 71 false false R72.htm 2420415 - Disclosure - Contingencies (E-vapor Product Litigation) (Details) Sheet http://www.altria.com/role/ContingenciesEVaporProductLitigationDetails Contingencies (E-vapor Product Litigation) (Details) Details http://www.altria.com/role/ContingenciesTables 72 false false R73.htm 2420416 - Disclosure - Contingencies (Lights/Ultra Lights Cases) (Details) Sheet http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails Contingencies (Lights/Ultra Lights Cases) (Details) Details http://www.altria.com/role/ContingenciesTables 73 false false R74.htm 2420417 - Disclosure - Contingencies (UST Litigations Narrative) (Details) Sheet http://www.altria.com/role/ContingenciesUstLitigationsNarrativeDetails Contingencies (UST Litigations Narrative) (Details) Details http://www.altria.com/role/ContingenciesTables 74 false false R75.htm 2420418 - Disclosure - Contingencies (Antitrust Litigation) (Details) Sheet http://www.altria.com/role/ContingenciesAntitrustLitigationDetails Contingencies (Antitrust Litigation) (Details) Details http://www.altria.com/role/ContingenciesTables 75 false false R76.htm 2420419 - Disclosure - Contingencies (Guarantees and Other Similar Matters Narrative) (Details) Sheet http://www.altria.com/role/ContingenciesGuaranteesAndOtherSimilarMattersNarrativeDetails Contingencies (Guarantees and Other Similar Matters Narrative) (Details) Details http://www.altria.com/role/ContingenciesTables 76 false false R77.htm 2421402 - Disclosure - Condensed Consolidating Financial Information (Condensed Consolidating Balance Sheets) (Details) Sheet http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails Condensed Consolidating Financial Information (Condensed Consolidating Balance Sheets) (Details) Details http://www.altria.com/role/CondensedConsolidatingFinancialInformationTables 77 false false R78.htm 2421403 - Disclosure - Condensed Consolidating Financial Information (Condensed Consolidating Statements of Earnings and Comprehensive Earnings) (Details) Sheet http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfEarningsAndComprehensiveEarningsDetails Condensed Consolidating Financial Information (Condensed Consolidating Statements of Earnings and Comprehensive Earnings) (Details) Details http://www.altria.com/role/CondensedConsolidatingFinancialInformationTables 78 false false R79.htm 2421404 - Disclosure - Condensed Consolidating Financial Information (Condensed Consolidating Statements of Cash Flows) (Details) Sheet http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails Condensed Consolidating Financial Information (Condensed Consolidating Statements of Cash Flows) (Details) Details http://www.altria.com/role/CondensedConsolidatingFinancialInformationTables 79 false false R9999.htm Uncategorized Items - a2020form10qq12020.htm Sheet http://xbrl.sec.gov/role/uncategorizedFacts Uncategorized Items - a2020form10qq12020.htm Cover 80 false false All Reports Book All Reports a2020form10qq12020.htm exhibit101restrictedst.htm exhibit102performacest.htm exhibit311q12020.htm exhibit312q12020.htm exhibit321q12020.htm exhibit322q12020.htm exhibit991q12020.htm exhibit992q12020.htm mo-20200331.xsd mo-20200331_cal.xml mo-20200331_def.xml mo-20200331_lab.xml mo-20200331_pre.xml http://fasb.org/srt/2019-01-31 http://xbrl.sec.gov/stpr/2018-01-31 http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/us-gaap/2019-01-31 http://xbrl.sec.gov/country/2017-01-31 true true XML 94 R3.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Mar. 31, 2020
Dec. 31, 2019
Statement of Financial Position [Abstract]    
Common stock, par value (usd per share) $ 0.3333 $ 0.3333
Common stock, shares issued (shares) 2,805,961,317 2,805,961,317
Shares repurchased (shares) 947,593,259 947,979,763
XML 95 R56.htm IDEA: XBRL DOCUMENT v3.20.1
Segment Reporting (Segment Data Schedule) (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Segment Reporting Information [Line Items]    
Net revenues $ 6,359 $ 5,628
Operating income 2,336 2,238
Corporate asset impairment and exit costs   (52)
Interest and other debt expense, net (275) (384)
Net periodic benefit income, excluding service cost 27 1
Earnings from equity investments 157 86
Loss on Cronos-related financial instruments (137) (425)
Earnings (losses) before income taxes and equity earnings of subsidiaries 2,108 1,516
Smokeable Products Segment [Member]    
Segment Reporting Information [Line Items]    
Net revenues 5,606 4,935
Oral Tobacco Segment [Member]    
Segment Reporting Information [Line Items]    
Net revenues 601 540
Wine Segment [Member]    
Segment Reporting Information [Line Items]    
Net revenues 146 151
All Other [Member]    
Segment Reporting Information [Line Items]    
Net revenues 6 2
Operating Segments [Member] | Smokeable Products Segment [Member]    
Segment Reporting Information [Line Items]    
Operating income 2,370 1,932
Operating Segments [Member] | Oral Tobacco Segment [Member]    
Segment Reporting Information [Line Items]    
Operating income 414 358
Operating Segments [Member] | Wine Segment [Member]    
Segment Reporting Information [Line Items]    
Operating income (379) 15
Operating Segments [Member] | All Other [Member]    
Segment Reporting Information [Line Items]    
Operating income (5) (12)
Segment Reconciling Items [Member]    
Segment Reporting Information [Line Items]    
Amortization of intangibles (19) (8)
General corporate [Member]    
Segment Reporting Information [Line Items]    
General corporate expenses (45) (46)
Corporate asset impairment and exit costs $ 0 $ (1)
XML 96 R52.htm IDEA: XBRL DOCUMENT v3.20.1
Benefit Plans (Narrative) (Details)
 3 Months Ended
Mar. 31, 2020
USD ($)
Pension [Member]  
Defined Benefit Plan Disclosure [Line Items]  
Defined benefit plan, plan assets, contributions by employer $ 4,000,000
Pension [Member] | Maximum [Member]  
Defined Benefit Plan Disclosure [Line Items]  
Anticipated additional employer contributions 25,000,000
Postretirement [Member]  
Defined Benefit Plan Disclosure [Line Items]  
Defined benefit plan, plan assets, contributions by employer 0
Postretirement [Member] | Maximum [Member]  
Defined Benefit Plan Disclosure [Line Items]  
Anticipated additional employer contributions $ 60,000,000
XML 97 R7.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Stockholders' Equity (Parenthetical) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Statement of Stockholders' Equity [Abstract]    
Net earnings attributable to noncontrolling interests $ 1 $ 1
Dividends declared (usd per share) $ 0.84 $ 0.80
XML 98 R33.htm IDEA: XBRL DOCUMENT v3.20.1
New Accounting Guidance Not Yet Adopted (Tables)
 3 Months Ended
Mar. 31, 2020
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]  
Recent Accounting Guidance Not Yet Adopted

The following table provides a description of issued accounting guidance applicable to, but not yet adopted by, Altria:
Standards
Description
Effective Date for Public Entity
Effect on Financial Statements
ASU 2019-12 Simplifying the Accounting for Income Taxes (Topic 740)
The guidance removes certain exceptions for investments, intraperiod allocations and interim calculations, and adds guidance to reduce complexity in accounting for income taxes.
The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early application is permitted, including adoption in any interim period.
Altria is in the process of evaluating the impact of this guidance on its consolidated financial statements and related disclosures.
ASU 2020-01 Clarifying the Interactions between Topic 321, Topic 323, and Topic 815
The guidance provides clarification of the interaction of rules for equity securities, the equity method of accounting, and forward contracts and purchase options on certain types of securities.
The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early application is permitted, including adoption in any interim period.
Altria is in the process of evaluating the impact of this guidance on its consolidated financial statements and related disclosures.
JSON 99 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "a2020form10qq12020.htm": { "axisCustom": 0, "axisStandard": 34, "contextCount": 457, "dts": { "calculationLink": { "local": [ "mo-20200331_cal.xml" ] }, "definitionLink": { "local": [ "mo-20200331_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "a2020form10qq12020.htm" ] }, "labelLink": { "local": [ "mo-20200331_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-doc-2019-01-31.xml", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "mo-20200331_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-ref-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-ref-2019-01-31.xml" ] }, "schema": { "local": [ "mo-20200331.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd", "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-parts-codification-2019-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 701, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2019-01-31": 33, "http://www.altria.com/20200331": 51, "http://xbrl.sec.gov/dei/2019-01-31": 5, "total": 89 }, "keyCustom": 106, "keyStandard": 308, "memberCustom": 121, "memberStandard": 89, "nsprefix": "mo", "nsuri": "http://www.altria.com/20200331", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001000 - Document - Cover Page", "role": "http://www.altria.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2103100 - Disclosure - Revenues from Contracts with Customers", "role": "http://www.altria.com/role/RevenuesFromContractsWithCustomers", "shortName": "Revenues from Contracts with Customers", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2106100 - Disclosure - Asset Impairment, Exit and Implementation Costs", "role": "http://www.altria.com/role/AssetImpairmentExitAndImplementationCosts", "shortName": "Asset Impairment, Exit and Implementation Costs", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2108100 - Disclosure - Investments in Equity Securities", "role": "http://www.altria.com/role/InvestmentsInEquitySecurities", "shortName": "Investments in Equity Securities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2109100 - Disclosure - Financial Instruments", "role": "http://www.altria.com/role/FinancialInstruments", "shortName": "Financial Instruments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2112100 - Disclosure - Benefit Plans", "role": "http://www.altria.com/role/BenefitPlans", "shortName": "Benefit Plans", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2113100 - Disclosure - Earnings Per Share", "role": "http://www.altria.com/role/EarningsPerShare", "shortName": "Earnings Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2116100 - Disclosure - Other Comprehensive Earnings/Losses", "role": "http://www.altria.com/role/OtherComprehensiveEarningsLosses", "shortName": "Other Comprehensive Earnings/Losses", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2117100 - Disclosure - Segment Reporting", "role": "http://www.altria.com/role/SegmentReporting", "shortName": "Segment Reporting", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2118100 - Disclosure - Debt", "role": "http://www.altria.com/role/Debt", "shortName": "Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LegalMattersAndContingenciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2120100 - Disclosure - Contingencies", "role": "http://www.altria.com/role/Contingencies", "shortName": "Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LegalMattersAndContingenciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "srt:ScheduleOfCondensedBalanceSheetTableTextBlock", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FI2020Q1", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1001000 - Statement - Condensed Consolidated Balance Sheets", "role": "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": null }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "srt:CondensedFinancialStatementsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2121100 - Disclosure - Condensed Consolidating Financial Information", "role": "http://www.altria.com/role/CondensedConsolidatingFinancialInformation", "shortName": "Condensed Consolidating Financial Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "srt:CondensedFinancialStatementsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2122100 - Disclosure - New Accounting Guidance Not Yet Adopted", "role": "http://www.altria.com/role/NewAccountingGuidanceNotYetAdopted", "shortName": "New Accounting Guidance Not Yet Adopted", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2201201 - Disclosure - Background and Basis of Presentation (Policies)", "role": "http://www.altria.com/role/BackgroundAndBasisOfPresentationPolicies", "shortName": "Background and Basis of Presentation (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2301302 - Disclosure - Background and Basis of Presentation (Tables)", "role": "http://www.altria.com/role/BackgroundAndBasisOfPresentationTables", "shortName": "Background and Basis of Presentation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2306301 - Disclosure - Asset Impairment, Exit and Implementation Costs (Tables)", "role": "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsTables", "shortName": "Asset Impairment, Exit and Implementation Costs (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2308301 - Disclosure - Investments in Equity Securities Investments in Equity Securities (Tables)", "role": "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentsInEquitySecuritiesTables", "shortName": "Investments in Equity Securities Investments in Equity Securities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2309301 - Disclosure - Financial Instruments (Tables)", "role": "http://www.altria.com/role/FinancialInstrumentsTables", "shortName": "Financial Instruments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2312301 - Disclosure - Benefit Plans (Tables)", "role": "http://www.altria.com/role/BenefitPlansTables", "shortName": "Benefit Plans (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2313301 - Disclosure - Earnings Per Share (Tables)", "role": "http://www.altria.com/role/EarningsPerShareTables", "shortName": "Earnings Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2316301 - Disclosure - Other Comprehensive Earnings/Losses (Tables)", "role": "http://www.altria.com/role/OtherComprehensiveEarningsLossesTables", "shortName": "Other Comprehensive Earnings/Losses (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": null, "groupType": "statement", "isDefault": "false", "longName": "1001501 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "role": "http://www.altria.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R30": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2317301 - Disclosure - Segment Reporting (Tables)", "role": "http://www.altria.com/role/SegmentReportingTables", "shortName": "Segment Reporting (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2320301 - Disclosure - Contingencies (Tables)", "role": "http://www.altria.com/role/ContingenciesTables", "shortName": "Contingencies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfCondensedBalanceSheetTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2321301 - Disclosure - Condensed Consolidating Financial Information (Tables)", "role": "http://www.altria.com/role/CondensedConsolidatingFinancialInformationTables", "shortName": "Condensed Consolidating Financial Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfCondensedBalanceSheetTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2322301 - Disclosure - New Accounting Guidance Not Yet Adopted (Tables)", "role": "http://www.altria.com/role/NewAccountingGuidanceNotYetAdoptedTables", "shortName": "New Accounting Guidance Not Yet Adopted (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FI2020Q1_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mo_ABInBevMember", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2401403 - Disclosure - Background and Basis of Presentation (Narrative) (Details)", "role": "http://www.altria.com/role/BackgroundAndBasisOfPresentationNarrativeDetails", "shortName": "Background and Basis of Presentation (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "I2018Q2May_us-gaap_ShareRepurchaseProgramAxis_mo_January2018ShareRepurchaseProgramMember", "decimals": "INF", "lang": null, "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2019Q1YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:TreasuryStockValueAcquiredCostMethod", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2401404 - Disclosure - Background and Basis of Presentation (Share Repurchase Table) (Details)", "role": "http://www.altria.com/role/BackgroundAndBasisOfPresentationShareRepurchaseTableDetails", "shortName": "Background and Basis of Presentation (Share Repurchase Table) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfTreasuryStockByClassTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2019Q1YTD_us-gaap_ShareRepurchaseProgramAxis_mo_January2018ShareRepurchaseProgramMember", "decimals": "-6", "lang": null, "name": "us-gaap:TreasuryStockValueAcquiredCostMethod", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FI2020Q1", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2403401 - Disclosure - Revenues from Contracts with Customers (Narrative) (Details)", "role": "http://www.altria.com/role/RevenuesFromContractsWithCustomersNarrativeDetails", "shortName": "Revenues from Contracts with Customers (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FI2020Q1", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "first": true, "lang": null, "name": "mo:AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2406402 - Disclosure - Asset Impairment, Exit and Implementation Costs (Pre-tax Asset Impairment, Exit and Implementation Costs) (Details)", "role": "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsPreTaxAssetImpairmentExitAndImplementationCostsDetails", "shortName": "Asset Impairment, Exit and Implementation Costs (Pre-tax Asset Impairment, Exit and Implementation Costs) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2019Q1YTD", "decimals": "-6", "lang": null, "name": "mo:NetPeriodicDefinedBenefitsIncomeReversalofIncomeExcludingServiceCostComponentAssetImpairmentAndBusinessExitCosts", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:RestructuringReserve", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2406403 - Disclosure - Asset Impairment, Exit and Implementation Costs (Movement in Restructuring Liabilities) (Details)", "role": "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsMovementInRestructuringLiabilitiesDetails", "shortName": "Asset Impairment, Exit and Implementation Costs (Movement in Restructuring Liabilities) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:RestructuringReserve", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:RestructuringCharges", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2406404 - Disclosure - Asset Impairment, Exit and Implementation Costs (Narrative) (Details)", "role": "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsNarrativeDetails", "shortName": "Asset Impairment, Exit and Implementation Costs (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD_us-gaap_RestructuringPlanAxis_mo_WineBusinessStrategicResetMember", "decimals": "-6", "lang": null, "name": "us-gaap:RestructuringCharges", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003000 - Statement - Condensed Consolidated Statements of Earnings", "role": "http://www.altria.com/role/CondensedConsolidatedStatementsOfEarnings", "shortName": "Condensed Consolidated Statements of Earnings", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": "2", "lang": null, "name": "us-gaap:EarningsPerShareBasicAndDiluted", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "us-gaap:InvestmentTableTextBlock", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FI2020Q1", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:Investments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408402 - Disclosure - Investments in Equity Securities (Summary of Investments) (Details)", "role": "http://www.altria.com/role/InvestmentsInEquitySecuritiesSummaryOfInvestmentsDetails", "shortName": "Investments in Equity Securities (Summary of Investments) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "us-gaap:InvestmentTableTextBlock", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FI2020Q1", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:Investments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromEquityMethodInvestments", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408403 - Disclosure - Investments in Equity Securities (Earnings in Equity Securities) (Details)", "role": "http://www.altria.com/role/InvestmentsInEquitySecuritiesEarningsInEquitySecuritiesDetails", "shortName": "Investments in Equity Securities (Earnings in Equity Securities) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:EquityMethodInvestmentsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mo_ABInBevMember", "decimals": "-6", "lang": null, "name": "us-gaap:IncomeLossFromEquityMethodInvestments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FI2020Q1_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mo_ABInBevMember", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408404 - Disclosure - Investments in Equity Securities (Investment in ABI Narrative) (Details)", "role": "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInAbiNarrativeDetails", "shortName": "Investments in Equity Securities (Investment in ABI Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FI2020Q1_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mo_ABInBevMember", "decimals": "-6", "lang": null, "name": "mo:EquityMethodInvestmentNumberofSharesOwnedRestricted", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "span", "ix:continuation", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FI2020Q1", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408405 - Disclosure - Investments in Equity Securities (Investment in JUUL Narrative) (Details)", "role": "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInJuulNarrativeDetails", "shortName": "Investments in Equity Securities (Investment in JUUL Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "ix:continuation", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FI2020Q1", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FI2019Q1_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mo_CronosGroupInc.Member", "decimals": "-5", "first": true, "lang": null, "name": "mo:EquityMethodInvestmentNumberofSharesOwnedCommon", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408406 - Disclosure - Investments in Equity Securities (Investment in Cronos Narrative) (Details)", "role": "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInCronosNarrativeDetails", "shortName": "Investments in Equity Securities (Investment in Cronos Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FI2019Q1_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mo_CronosGroupInc.Member", "decimals": "-5", "first": true, "lang": null, "name": "mo:EquityMethodInvestmentNumberofSharesOwnedCommon", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FI2020Q1", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShortTermBorrowings", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2409402 - Disclosure - Financial Instruments (Narrative) (Details)", "role": "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails", "shortName": "Financial Instruments (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "I2019Q2March07_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForwardContractsMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember", "decimals": "-8", "lang": null, "name": "us-gaap:DerivativeAssetNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FI2020Q1_us-gaap_DerivativeInstrumentRiskAxis_mo_EquityContractPreemptiveRIghtsMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputSharePriceMember", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:DerivativeAssetMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2409403 - Disclosure - Financial Instruments (Fair Value Using Black-Scholes Option-Pricing Model) (Details)", "role": "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails", "shortName": "Financial Instruments (Fair Value Using Black-Scholes Option-Pricing Model) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FI2020Q1_us-gaap_DerivativeInstrumentRiskAxis_mo_EquityContractPreemptiveRIghtsMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputSharePriceMember", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:DerivativeAssetMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_EquityContractMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2409404 - Disclosure - Financial Instruments (Beginning and Ending Balances of Fixed-price Preemptive Rights and Warrants) (Details)", "role": "http://www.altria.com/role/FinancialInstrumentsBeginningAndEndingBalancesOfFixedPricePreemptiveRightsAndWarrantsDetails", "shortName": "Financial Instruments (Beginning and Ending Balances of Fixed-price Preemptive Rights and Warrants) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_EquityContractMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FI2020Q1_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_NetInvestmentHedgingMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2409405 - Disclosure - Financial Instruments (Fair Value Derivative Financial Instruments) (Details)", "role": "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails", "shortName": "Financial Instruments (Fair Value Derivative Financial Instruments) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FI2020Q1_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_NetInvestmentHedgingMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:UnrealizedGainLossOnDerivatives", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2409406 - Disclosure - Financial Instruments (Pre-tax Unrealized Gains (Losses)) (Details)", "role": "http://www.altria.com/role/FinancialInstrumentsPreTaxUnrealizedGainsLossesDetails", "shortName": "Financial Instruments (Pre-tax Unrealized Gains (Losses)) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:UnrealizedGainLossOnDerivatives", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "srt:ScheduleOfCondensedIncomeStatementTableTextBlock", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004000 - Statement - Condensed Consolidated Statements of Comprehensive Earnings", "role": "http://www.altria.com/role/CondensedConsolidatedStatementsOfComprehensiveEarnings", "shortName": "Condensed Consolidated Statements of Comprehensive Earnings", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_NetInvestmentHedgingMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2409407 - Disclosure - Financial Instruments (Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses) (Details)", "role": "http://www.altria.com/role/FinancialInstrumentsEffectsOfNetInvestmentHedgesOnAccumulatedOtherComprehensiveLossesDetails", "shortName": "Financial Instruments (Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_NetInvestmentHedgingMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanServiceCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2412402 - Disclosure - Benefit Plans (Schedule Of Components Of Net Periodic Benefit Cost (Income)) (Details)", "role": "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails", "shortName": "Benefit Plans (Schedule Of Components Of Net Periodic Benefit Cost (Income)) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanServiceCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2412403 - Disclosure - Benefit Plans (Narrative) (Details)", "role": "http://www.altria.com/role/BenefitPlansNarrativeDetails", "shortName": "Benefit Plans (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "srt:ScheduleOfCondensedIncomeStatementTableTextBlock", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2413402 - Disclosure - Earnings Per Share (Basic and Diluted Earnings Per Share) (Details)", "role": "http://www.altria.com/role/EarningsPerShareBasicAndDilutedEarningsPerShareDetails", "shortName": "Earnings Per Share (Basic and Diluted Earnings Per Share) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "lang": null, "name": "mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2416402 - Disclosure - Other Comprehensive Earnings/Losses (Changes in Each Component of Accumulated Other Comprehensive Losses) (Details)", "role": "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesInEachComponentOfAccumulatedOtherComprehensiveLossesDetails", "shortName": "Other Comprehensive Earnings/Losses (Changes in Each Component of Accumulated Other Comprehensive Losses) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember", "decimals": "-6", "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2416403 - Disclosure - Other Comprehensive Earnings/Losses (Reclassifications) (Details)", "role": "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails", "shortName": "Other Comprehensive Earnings/Losses (Reclassifications) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember", "decimals": "-6", "lang": null, "name": "us-gaap:IncomeLossFromEquityMethodInvestments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2417402 - Disclosure - Segment Reporting (Segment Data Schedule) (Details)", "role": "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails", "shortName": "Segment Reporting (Segment Data Schedule) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD_us-gaap_StatementBusinessSegmentsAxis_mo_SmokeableProductsSegmentMember", "decimals": "-6", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "mo:ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD_srt_LitigationCaseAxis_mo_TobaccoandHealthLitigationCasesMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:LossContingencyAccrualProvision", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2417403 - Disclosure - Segment Reporting (Schedule of Tobacco and Health Litigation Items) (Details)", "role": "http://www.altria.com/role/SegmentReportingScheduleOfTobaccoAndHealthLitigationItemsDetails", "shortName": "Segment Reporting (Schedule of Tobacco and Health Litigation Items) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "mo:ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD_srt_LitigationCaseAxis_mo_TobaccoandHealthLitigationCasesMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:LossContingencyAccrualProvision", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FI2020Q1", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShortTermBorrowings", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2418401 - Disclosure - Debt (Narrative) (Details)", "role": "http://www.altria.com/role/DebtNarrativeDetails", "shortName": "Debt (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FI2019Q4", "decimals": "INF", "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FI2020Q1", "decimals": "INF", "first": true, "lang": null, "name": "mo:LossContingencyNumberofStatesThatCapBondorRequireNoBond", "reportCount": 1, "unique": true, "unitRef": "state", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420402 - Disclosure - Contingencies (General Information) (Details)", "role": "http://www.altria.com/role/ContingenciesGeneralInformationDetails", "shortName": "Contingencies (General Information) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FI2020Q1", "decimals": "INF", "first": true, "lang": null, "name": "mo:LossContingencyNumberofStatesThatCapBondorRequireNoBond", "reportCount": 1, "unique": true, "unitRef": "state", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FI2018Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004000 - Statement - Condensed Consolidated Statements of Stockholders' Equity", "role": "http://www.altria.com/role/CondensedConsolidatedStatementsOfStockholdersEquity", "shortName": "Condensed Consolidated Statements of Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember", "decimals": "-6", "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "I2019Q2April22_srt_LitigationCaseAxis_mo_IndividualSmokingAndHealthCasesMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:LossContingencyPendingClaimsNumber", "reportCount": 1, "unitRef": "case", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420403 - Disclosure - Contingencies (Schedule of Pending Cases) (Details)", "role": "http://www.altria.com/role/ContingenciesScheduleOfPendingCasesDetails", "shortName": "Contingencies (Schedule of Pending Cases) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "D2018Q1March2018_srt_LitigationCaseAxis_mo_ETSSmokingandHealthCaseFlightAttendantsMember_us-gaap_LitigationStatusAxis_us-gaap_PendingLitigationMember", "decimals": "INF", "lang": null, "name": "us-gaap:LossContingencyClaimsDismissedNumber", "reportCount": 1, "unique": true, "unitRef": "case", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "I2019Q2April22_srt_LitigationCaseAxis_mo_OtherTabaccoRelatedCasesMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:LossContingencyPendingClaimsNumber", "reportCount": 1, "unitRef": "case", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420404 - Disclosure - Contingencies (Overview of Altria and/or PM USA Tobacco-Related Litigation Narrative) (Details)", "role": "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails", "shortName": "Contingencies (Overview of Altria and/or PM USA Tobacco-Related Litigation Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "D2020Q2Jan01April27_dei_LegalEntityAxis_mo_PhilipMorrisUSAMember_srt_LitigationCaseAxis_mo_NonEngleProgenyCasesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember", "decimals": "INF", "lang": null, "name": "mo:LossContingencyClaimsDecided", "reportCount": 1, "unique": true, "unitRef": "case", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:LossContingencyAccrualAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420405 - Disclosure - Contingencies (Judgments Paid and Provisions for Tobacco and Health Litigation) (Details)", "role": "http://www.altria.com/role/ContingenciesJudgmentsPaidAndProvisionsForTobaccoAndHealthLitigationDetails", "shortName": "Contingencies (Judgments Paid and Provisions for Tobacco and Health Litigation) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:LossContingencyAccrualAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "I2020Q1Feb29_srt_LitigationCaseAxis_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember", "decimals": "-6", "first": true, "lang": null, "name": "mo:LossContingencyCompensatoryDamagesAwardedValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420406 - Disclosure - Contingencies (Non-Engle Progeny Litigation) (Details)", "role": "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails", "shortName": "Contingencies (Non-Engle Progeny Litigation) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "I2020Q1Feb29_srt_LitigationCaseAxis_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember", "decimals": "-6", "first": true, "lang": null, "name": "mo:LossContingencyCompensatoryDamagesAwardedValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "I2000Q3Jul31_srt_LitigationCaseAxis_mo_EngleProgenyCasesMember", "decimals": "-9", "first": true, "lang": null, "name": "mo:LossContingencyPunitiveDamagesAwardedValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420407 - Disclosure - Contingencies (Engle Class Action And Engle Progeny Trial Results) (Details)", "role": "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails", "shortName": "Contingencies (Engle Class Action And Engle Progeny Trial Results) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "I2000Q3Jul31_srt_LitigationCaseAxis_mo_EngleProgenyCasesMember", "decimals": "-9", "first": true, "lang": null, "name": "mo:LossContingencyPunitiveDamagesAwardedValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1QTD_dei_LegalEntityAxis_mo_PhilipMorrisUSAMember", "decimals": "-6", "first": true, "lang": null, "name": "mo:PreTaxChargesGainIncludedinNetEarning", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420408 - Disclosure - Contingencies (Engle Progeny Cases Trial Results - Pending and Concluded) (Details)", "role": "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails", "shortName": "Contingencies (Engle Progeny Cases Trial Results - Pending and Concluded) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1QTD_dei_LegalEntityAxis_mo_PhilipMorrisUSAMember", "decimals": "-6", "first": true, "lang": null, "name": "mo:PreTaxChargesGainIncludedinNetEarning", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "I2009Q2Jun30_srt_LitigationCaseAxis_mo_EngleProgenyCasesStateMember_srt_StatementGeographicalAxis_stpr_FL", "decimals": "-6", "first": true, "lang": null, "name": "mo:MaximumBondForAllDefendants", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420409 - Disclosure - Contingencies (Florida Bond Statute) (Details)", "role": "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails", "shortName": "Contingencies (Florida Bond Statute) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "I2009Q2Jun30_srt_LitigationCaseAxis_mo_EngleProgenyCasesStateMember_srt_StatementGeographicalAxis_stpr_FL", "decimals": "-6", "first": true, "lang": null, "name": "mo:MaximumBondForAllDefendants", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "D2020Q1March31_dei_LegalEntityAxis_mo_PhilipMorrisUSAMember_srt_LitigationCaseAxis_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember", "decimals": "INF", "first": true, "lang": null, "name": "mo:LossContingencyClassNotCertifiedNumber", "reportCount": 1, "unique": true, "unitRef": "case", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420410 - Disclosure - Contingencies (Other Smoking and Health Class Actions) (Details)", "role": "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails", "shortName": "Contingencies (Other Smoking and Health Class Actions) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "D2020Q1March31_dei_LegalEntityAxis_mo_PhilipMorrisUSAMember_srt_LitigationCaseAxis_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember", "decimals": "INF", "first": true, "lang": null, "name": "mo:LossContingencyClassNotCertifiedNumber", "reportCount": 1, "unique": true, "unitRef": "case", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "I2019Q2April22_srt_LitigationCaseAxis_mo_HealthCareCostRecoveryActionsMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:LossContingencyPendingClaimsNumber", "reportCount": 1, "unitRef": "case", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420411 - Disclosure - Contingencies (Health Care Cost Recovery Litigation) (Details)", "role": "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails", "shortName": "Contingencies (Health Care Cost Recovery Litigation) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "D1998Q4Nov_srt_LitigationCaseAxis_mo_HealthCareCostRecoveryActionsMember", "decimals": "-8", "lang": null, "name": "mo:LitigationSettlementAnnualPaymentAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "D1998Q4Nov_srt_LitigationCaseAxis_mo_HealthCareCostRecoveryActionsMember", "decimals": "INF", "first": true, "lang": null, "name": "mo:LossContingencyNumberofStateswithSettledLitigation", "reportCount": 1, "unitRef": "state", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420412 - Disclosure - Contingencies (NPM Adjustment Disputes - Settlement with 20 States and Territories and Settlement with New York) (Details)", "role": "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails", "shortName": "Contingencies (NPM Adjustment Disputes - Settlement with 20 States and Territories and Settlement with New York) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2019Q1QTD_dei_LegalEntityAxis_mo_PhilipMorrisUSAMember_srt_LitigationCaseAxis_mo_HealthCareCostRecoveryActionsMember", "decimals": "-6", "lang": null, "name": "mo:LossContingencyReductionToCostOfSales", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "span", "div", "link:footnote", "td", "tr", "table", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004501 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Parenthetical)", "role": "http://www.altria.com/role/CondensedConsolidatedStatementsOfStockholdersEquityParenthetical", "shortName": "Condensed Consolidated Statements of Stockholders' Equity (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "link:footnote", "td", "tr", "table", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "D2018Q3Aug_dei_LegalEntityAxis_mo_PhilipMorrisUSAMember_srt_LitigationCaseAxis_mo_OtherDisputesUndertheStateSettlementAgreementsMember", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LitigationSettlementAmountAwardedFromOtherParty", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420413 - Disclosure - Contingencies (Other Disputes Under the State Settlement Agreements) (Details)", "role": "http://www.altria.com/role/ContingenciesOtherDisputesUnderStateSettlementAgreementsDetails", "shortName": "Contingencies (Other Disputes Under the State Settlement Agreements) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "D2018Q3Aug_dei_LegalEntityAxis_mo_PhilipMorrisUSAMember_srt_LitigationCaseAxis_mo_OtherDisputesUndertheStateSettlementAgreementsMember", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LitigationSettlementAmountAwardedFromOtherParty", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "D2006Q2_srt_LitigationCaseAxis_mo_FederalGovernmentsLawsuitMember", "decimals": null, "first": true, "lang": "en-US", "name": "mo:FederalTradeCommissionDisclosurePeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420414 - Disclosure - Contingencies (Federal Government's Lawsuit) (Details)", "role": "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails", "shortName": "Contingencies (Federal Government's Lawsuit) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "D2006Q2_srt_LitigationCaseAxis_mo_FederalGovernmentsLawsuitMember", "decimals": null, "first": true, "lang": "en-US", "name": "mo:FederalTradeCommissionDisclosurePeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "I2019Q2April22_srt_LitigationCaseAxis_mo_EvaporLitigationMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:LossContingencyPendingClaimsNumber", "reportCount": 1, "unitRef": "case", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420415 - Disclosure - Contingencies (E-vapor Product Litigation) (Details)", "role": "http://www.altria.com/role/ContingenciesEVaporProductLitigationDetails", "shortName": "Contingencies (E-vapor Product Litigation) (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R73": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "I2020Q2April27_srt_LitigationCaseAxis_mo_LightsUltraLightsClassActionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:LossContingencyPendingClaimsNumber", "reportCount": 1, "unique": true, "unitRef": "case", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420416 - Disclosure - Contingencies (Lights/Ultra Lights Cases) (Details)", "role": "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails", "shortName": "Contingencies (Lights/Ultra Lights Cases) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "I2020Q2April27_srt_LitigationCaseAxis_mo_LightsUltraLightsClassActionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:LossContingencyPendingClaimsNumber", "reportCount": 1, "unique": true, "unitRef": "case", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2019Q4QTD", "decimals": "INF", "first": true, "lang": null, "name": "mo:LossContingencyNumberOfShareholdersFilingClassActionLawsuits", "reportCount": 1, "unique": true, "unitRef": "shareholder", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420417 - Disclosure - Contingencies (UST Litigations Narrative) (Details)", "role": "http://www.altria.com/role/ContingenciesUstLitigationsNarrativeDetails", "shortName": "Contingencies (UST Litigations Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2019Q4QTD", "decimals": "INF", "first": true, "lang": null, "name": "mo:LossContingencyNumberOfShareholdersFilingClassActionLawsuits", "reportCount": 1, "unique": true, "unitRef": "shareholder", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FI2020Q1_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mo_JUULMember", "decimals": "2", "first": true, "lang": null, "name": "mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420418 - Disclosure - Contingencies (Antitrust Litigation) (Details)", "role": "http://www.altria.com/role/ContingenciesAntitrustLitigationDetails", "shortName": "Contingencies (Antitrust Litigation) (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R76": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FI2020Q1", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:GuaranteeObligationsMaximumExposure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420419 - Disclosure - Contingencies (Guarantees and Other Similar Matters Narrative) (Details)", "role": "http://www.altria.com/role/ContingenciesGuaranteesAndOtherSimilarMattersNarrativeDetails", "shortName": "Contingencies (Guarantees and Other Similar Matters Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FI2020Q1", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:GuaranteeObligationsMaximumExposure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "srt:ScheduleOfCondensedBalanceSheetTableTextBlock", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FI2020Q1", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2421402 - Disclosure - Condensed Consolidating Financial Information (Condensed Consolidating Balance Sheets) (Details)", "role": "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails", "shortName": "Condensed Consolidating Financial Information (Condensed Consolidating Balance Sheets) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "srt:ScheduleOfCondensedBalanceSheetTableTextBlock", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FI2020Q1", "decimals": "-6", "lang": null, "name": "us-gaap:DueFromAffiliateCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2421403 - Disclosure - Condensed Consolidating Financial Information (Condensed Consolidating Statements of Earnings and Comprehensive Earnings) (Details)", "role": "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfEarningsAndComprehensiveEarningsDetails", "shortName": "Condensed Consolidating Financial Information (Condensed Consolidating Statements of Earnings and Comprehensive Earnings) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "srt:ScheduleOfCondensedIncomeStatementTableTextBlock", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "lang": null, "name": "us-gaap:IncomeLossFromSubsidiariesNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "srt:ScheduleOfCondensedCashFlowStatementTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2421404 - Disclosure - Condensed Consolidating Financial Information (Condensed Consolidating Statements of Cash Flows) (Details)", "role": "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails", "shortName": "Condensed Consolidating Financial Information (Condensed Consolidating Statements of Cash Flows) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "srt:ScheduleOfCondensedCashFlowStatementTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "lang": null, "name": "mo:InvestmentsinConsolidatedSubsidiaries", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "srt:ScheduleOfCondensedIncomeStatementTableTextBlock", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "106000 - Statement - Condensed Consolidated Statements of Cash Flows", "role": "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows", "shortName": "Condensed Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "lang": null, "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2101100 - Disclosure - Background and Basis of Presentation", "role": "http://www.altria.com/role/BackgroundAndBasisOfPresentation", "shortName": "Background and Basis of Presentation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9999": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FI2020Q1", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:RestrictedCashNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "", "isDefault": "false", "longName": "Uncategorized Items - a2020form10qq12020.htm", "role": "http://xbrl.sec.gov/role/uncategorizedFacts", "shortName": "Uncategorized Items - a2020form10qq12020.htm", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "a2020form10qq12020.htm", "contextRef": "FI2020Q1", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:RestrictedCashNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } } }, "segmentCount": 214, "tag": { "country_CA": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "CANADA", "terseLabel": "Canada [Member]" } } }, "localname": "CA", "nsuri": "http://xbrl.sec.gov/country/2017-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails", "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails", "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails" ], "xbrltype": "domainItemType" }, "country_PR": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "PUERTO RICO", "terseLabel": "Puerto Rico [Member]" } } }, "localname": "PR", "nsuri": "http://xbrl.sec.gov/country/2017-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.altria.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.altria.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.altria.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.altria.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.altria.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.altria.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r409" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.altria.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r410" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.altria.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.altria.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntitiesTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Container to assemble all relevant information about each entity associated with the document instance", "label": "Entities [Table]", "terseLabel": "Entities [Table]" } } }, "localname": "EntitiesTable", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.altria.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.altria.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.altria.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.altria.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.altria.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r411" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.altria.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.altria.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.altria.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]", "terseLabel": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.altria.com/role/BackgroundAndBasisOfPresentationNarrativeDetails", "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails", "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails", "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails", "http://www.altria.com/role/ContingenciesJudgmentsPaidAndProvisionsForTobaccoAndHealthLitigationDetails", "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails", "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails", "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails", "http://www.altria.com/role/ContingenciesOtherDisputesUnderStateSettlementAgreementsDetails", "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails", "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails", "http://www.altria.com/role/ContingenciesScheduleOfPendingCasesDetails", "http://www.altria.com/role/SegmentReportingScheduleOfTobaccoAndHealthLitigationItemsDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r411" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.altria.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.altria.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r411" ], "lang": { "en-US": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.altria.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.altria.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Information [Line Items]", "terseLabel": "Entity Information [Line Items]" } } }, "localname": "EntityInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.altria.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r412" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.altria.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r411" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.altria.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r411" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.altria.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r411" ], "lang": { "en-US": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.altria.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r411" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.altria.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]", "terseLabel": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.altria.com/role/BackgroundAndBasisOfPresentationNarrativeDetails", "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails", "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails", "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails", "http://www.altria.com/role/ContingenciesJudgmentsPaidAndProvisionsForTobaccoAndHealthLitigationDetails", "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails", "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails", "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails", "http://www.altria.com/role/ContingenciesOtherDisputesUnderStateSettlementAgreementsDetails", "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails", "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails", "http://www.altria.com/role/ContingenciesScheduleOfPendingCasesDetails", "http://www.altria.com/role/SegmentReportingScheduleOfTobaccoAndHealthLitigationItemsDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.altria.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r407" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.altria.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r408" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.altria.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.altria.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "mo_ABInBevMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "AB InBev [Member]", "label": "AB InBev [Member]", "terseLabel": "ABI [Member]" } } }, "localname": "ABInBevMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/BackgroundAndBasisOfPresentationNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesEarningsInEquitySecuritiesDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInAbiNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesSummaryOfInvestmentsDetails" ], "xbrltype": "domainItemType" }, "mo_AccruedSettlementLiabilityCurrent": { "auth_ref": [], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accrued Settlement Liability, Current", "label": "Accrued Settlement Liability, Current", "terseLabel": "Settlement charges" } } }, "localname": "AccruedSettlementLiabilityCurrent", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Accumulated Equity Method Investments Attributable To Parent [Member]", "label": "Accumulated Equity Method Investments Attributable To Parent [Member]", "terseLabel": "ABI [Member]" } } }, "localname": "AccumulatedEquityMethodInvestmentsAttributableToParentMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesInEachComponentOfAccumulatedOtherComprehensiveLossesDetails" ], "xbrltype": "domainItemType" }, "mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Adjustment To Additional Paid In Capital, Share Based Compensation, Restricted And Deferred Stock Awards and the tax benefits associated with vestings of prior period restricted and deferred stock awards", "label": "Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition and Income Tax Effect, Net", "terseLabel": "Stock award activity" } } }, "localname": "AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "mo_AllowanceForSalesDiscountsGoods": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Allowance For Sales Discounts, Goods", "label": "Allowance For Sales Discounts, Goods", "terseLabel": "Allowance for sales discounts, goods" } } }, "localname": "AllowanceForSalesDiscountsGoods", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/RevenuesFromContractsWithCustomersNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "mo_AmountAwardedtoOtherParty": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount Awarded to Other Party", "label": "Amount Awarded to Other Party", "terseLabel": "Amount awarded to other party" } } }, "localname": "AmountAwardedtoOtherParty", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails" ], "xbrltype": "monetaryItemType" }, "mo_AssetImpairmentandBusinessExitCosts": { "auth_ref": [], "calculation": { "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsPreTaxAssetImpairmentExitAndImplementationCostsDetails": { "order": 1.0, "parentTag": "us-gaap_RestructuringCharges", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Asset Impairment and Business Exit Costs", "label": "Asset Impairment and Business Exit Costs", "negatedTerseLabel": "Corporate asset impairment and exit costs", "totalLabel": "Asset Impairment and Exit Costs" } } }, "localname": "AssetImpairmentandBusinessExitCosts", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsPreTaxAssetImpairmentExitAndImplementationCostsDetails", "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" ], "xbrltype": "monetaryItemType" }, "mo_AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit": { "auth_ref": [], "calculation": { "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsPreTaxAssetImpairmentExitAndImplementationCostsDetails": { "order": 1.0, "parentTag": "mo_RestructuringChargesIncludingNetPensionCostCredit", "weight": 1.0 }, "http://www.altria.com/role/CondensedConsolidatedStatementsOfEarnings": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Asset Impairment and Business Exit Costs, Excluding Net Pension Cost (Credit)", "label": "Asset Impairment and Business Exit Costs, Excluding Net Pension Cost (Credit)", "terseLabel": "Asset impairment and exit costs" } } }, "localname": "AssetImpairmentandBusinessExitCostsExcludingNetPensionCostCredit", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsPreTaxAssetImpairmentExitAndImplementationCostsDetails", "http://www.altria.com/role/CondensedConsolidatedStatementsOfEarnings", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfEarningsAndComprehensiveEarningsDetails" ], "xbrltype": "monetaryItemType" }, "mo_BritishColumbiaSaskatchewanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "British Columbia, Saskatchewan [Member]", "label": "British Columbia, Saskatchewan [Member]", "terseLabel": "British Columbia and Saskatchewan [Member]" } } }, "localname": "BritishColumbiaSaskatchewanMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails" ], "xbrltype": "domainItemType" }, "mo_CanadianTobaccoManufacturersMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Canadian Tobacco Manufacturers [Member]", "label": "Canadian Tobacco Manufacturers [Member]", "terseLabel": "Canadian Tobacco Manufacturers [Member]" } } }, "localname": "CanadianTobaccoManufacturersMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails", "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails" ], "xbrltype": "domainItemType" }, "mo_CommonStock0.3313ParValueMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Common Stock, 0.33 1/3 Par Value [Member]", "label": "Common Stock, 0.33 1/3 Par Value [Member]", "terseLabel": "Common Stock, $0.33 1/3 par value [Member]" } } }, "localname": "CommonStock0.3313ParValueMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "mo_CommonStock1.000NotesDue2023Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Common Stock, 1.000% Notes Due 2023 [Member]", "label": "Common Stock, 1.000% Notes Due 2023 [Member]", "terseLabel": "1.000% Notes due 2023 [Member]" } } }, "localname": "CommonStock1.000NotesDue2023Member", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "mo_CommonStock1.700NotesDue2025Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Common Stock, 1.700% Notes Due 2025 [Member]", "label": "Common Stock, 1.700% Notes Due 2025 [Member]", "terseLabel": "1.700% Notes due 2025 [Member]" } } }, "localname": "CommonStock1.700NotesDue2025Member", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "mo_CommonStock2.200NotesDue2027Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Common Stock, 2.200% Notes Due 2027 [Member]", "label": "Common Stock, 2.200% Notes Due 2027 [Member]", "terseLabel": "2.200% Notes due 2027 [Member]" } } }, "localname": "CommonStock2.200NotesDue2027Member", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "mo_CommonStock3.125NotesDue2031Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Common Stock, 3.125% Notes Due 2031 [Member]", "label": "Common Stock, 3.125% Notes Due 2031 [Member]", "terseLabel": "3.125% Notes due 2031 [Member]" } } }, "localname": "CommonStock3.125NotesDue2031Member", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "mo_CreditAgreementMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Credit Agreement [Member]", "label": "Credit Agreement [Member]", "terseLabel": "Credit Agreement [Member]" } } }, "localname": "CreditAgreementMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesGuaranteesAndOtherSimilarMattersNarrativeDetails" ], "xbrltype": "domainItemType" }, "mo_CronosGroupInc.Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cronos Group Inc. [Member]", "label": "Cronos Group Inc. [Member]", "terseLabel": "Cronos Group Inc. [Member]", "verboseLabel": "Cronos [Member]" } } }, "localname": "CronosGroupInc.Member", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/BackgroundAndBasisOfPresentationNarrativeDetails", "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesEarningsInEquitySecuritiesDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInCronosNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesSummaryOfInvestmentsDetails" ], "xbrltype": "domainItemType" }, "mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Consolidated EBITDA to Interest Expense Ratio", "label": "Debt Instrument, Consolidated EBITDA to Interest Expense Ratio", "terseLabel": "Debt instrument, consolidated EBITDA to interest expense ratio" } } }, "localname": "DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/DebtNarrativeDetails" ], "xbrltype": "pureItemType" }, "mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Covenant, Consolidated EBITDA to Interest Expense Ratio, Minimum", "label": "Debt Instrument, Covenant, Consolidated EBITDA to Interest Expense Ratio, Minimum", "terseLabel": "Debt instrument, covenant, consolidated EBITDA to interest expense ratio, minimum" } } }, "localname": "DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/DebtNarrativeDetails" ], "xbrltype": "pureItemType" }, "mo_DebtInstrumentExpectedRepaymentPeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Expected Repayment Period", "label": "Debt Instrument, Expected Repayment Period", "terseLabel": "Debt instrument, expected repayment period" } } }, "localname": "DebtInstrumentExpectedRepaymentPeriod", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/DebtNarrativeDetails" ], "xbrltype": "durationItemType" }, "mo_DebtInstrumentExtensionTerm": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Extension Term", "label": "Debt Instrument, Extension Term", "terseLabel": "Debt instrument, extension term" } } }, "localname": "DebtInstrumentExtensionTerm", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/DebtNarrativeDetails" ], "xbrltype": "durationItemType" }, "mo_DebtInstrumentNumberofExtensions": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Number of Extensions", "label": "Debt Instrument, Number of Extensions", "terseLabel": "Debt instrument, number of extensions" } } }, "localname": "DebtInstrumentNumberofExtensions", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/DebtNarrativeDetails" ], "xbrltype": "integerItemType" }, "mo_DerivativeInstrumentNumberOfSharesHedged": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Derivative Instrument, Number Of Shares Hedged", "label": "Derivative Instrument, Number Of Shares Hedged", "terseLabel": "Derivative instrument, number of shares hedged (in shares)" } } }, "localname": "DerivativeInstrumentNumberOfSharesHedged", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInAbiNarrativeDetails" ], "xbrltype": "sharesItemType" }, "mo_DerivativeInstrumentSharesHedgedPricePerShare": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Derivative Instrument, Shares Hedged, Price Per Share", "label": "Derivative Instrument, Shares Hedged, Price Per Share", "terseLabel": "Derivative instrument, shares hedged, price per share (in eur per share)" } } }, "localname": "DerivativeInstrumentSharesHedgedPricePerShare", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInAbiNarrativeDetails" ], "xbrltype": "perShareItemType" }, "mo_ETSSmokingandHealthCaseFlightAttendantsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "ETS Smoking and Health Case, Flight Attendants [Member]", "label": "ETS Smoking and Health Case, Flight Attendants [Member]", "terseLabel": "ETS Smoking and Health Case, Flight Attendants [Member]" } } }, "localname": "ETSSmokingandHealthCaseFlightAttendantsMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesScheduleOfPendingCasesDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesAlvarezdelRealMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, Alvarez del Real [Member]", "label": "Engle Progeny Cases, Alvarez del Real [Member]", "terseLabel": "Engle Progeny Cases, Alvarez del Real [Member]" } } }, "localname": "EngleProgenyCasesAlvarezdelRealMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesBergerMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, Berger [Member]", "label": "Engle Progeny Cases, Berger [Member]", "terseLabel": "Engle Progeny Cases, Berger [Member]" } } }, "localname": "EngleProgenyCasesBergerMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesBoatrightMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, Boatright [Member]", "label": "Engle Progeny Cases, Boatright [Member]", "terseLabel": "Engle Progeny Cases, Boatright [Member]" } } }, "localname": "EngleProgenyCasesBoatrightMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesBryantMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, Bryant [Member]", "label": "Engle Progeny Cases, Bryant [Member]", "terseLabel": "Engle Progeny Cases, Bryant [Member]" } } }, "localname": "EngleProgenyCasesBryantMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesChadwellMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, Chadwell [Member] [Member]", "label": "Engle Progeny Cases, Chadwell [Member]", "terseLabel": "Engle Progeny Cases, Chadwell [Member]" } } }, "localname": "EngleProgenyCasesChadwellMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesCooperMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, Cooper [Member]", "label": "Engle Progeny Cases, Cooper [Member]", "terseLabel": "Engle Progeny Cases, Cooper [Member]" } } }, "localname": "EngleProgenyCasesCooperMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesCuddiheeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, Cuddihee", "label": "Engle Progeny Cases, Cuddihee [Member]", "terseLabel": "Engle Progeny Cases, Cuddihee [Member]" } } }, "localname": "EngleProgenyCasesCuddiheeMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesD.BrownMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, D. Brown [Member]", "label": "Engle Progeny Cases, D. Brown [Member]", "terseLabel": "Engle Progeny Cases, D. Brown [Member]" } } }, "localname": "EngleProgenyCasesD.BrownMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesDanielsonMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, Danielson [Member]", "label": "Engle Progeny Cases, Danielson [Member]", "terseLabel": "Engle Progeny Cases, Danielson [Member]" } } }, "localname": "EngleProgenyCasesDanielsonMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesDuignanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, Duignan [Member]", "label": "Engle Progeny Cases, Duignan [Member]", "terseLabel": "Engle Progeny Cases, Duignan [Member]" } } }, "localname": "EngleProgenyCasesDuignanMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesFederalMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, Federal [Member]", "label": "Engle Progeny Cases, Federal [Member]", "terseLabel": "Engle Progeny Cases, Federal [Member]" } } }, "localname": "EngleProgenyCasesFederalMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesFreemanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, Freeman [Member]", "label": "Engle Progeny Cases, Freeman [Member]", "terseLabel": "Engle Progeny Cases, Freeman [Member]" } } }, "localname": "EngleProgenyCasesFreemanMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesFrogelMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, Frogel [Member]", "label": "Engle Progeny Cases, Frogel [Member]", "terseLabel": "Engle Progeny Cases, Frogel [Member]" } } }, "localname": "EngleProgenyCasesFrogelMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesGlogerMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, Gloger [Member]", "label": "Engle Progeny Cases, Gloger [Member]", "terseLabel": "Engle Progeny Cases, Gloger [Member]" } } }, "localname": "EngleProgenyCasesGlogerMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesGlogerRintoulandDuignamMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, Gloger, Rintoul and Duignam [Member]", "label": "Engle Progeny Cases, Gloger, Rintoul and Duignam [Member]", "terseLabel": "Engle Progeny Cases, Gloger, Rintoul and Duignam [Member]" } } }, "localname": "EngleProgenyCasesGlogerRintoulandDuignamMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesGoreMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, Gore [Member]", "label": "Engle Progeny Cases, Gore [Member]", "terseLabel": "Engle Progeny Cases, Gore [Member]" } } }, "localname": "EngleProgenyCasesGoreMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesHarrisMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, Harris [Member]", "label": "Engle Progeny Cases, Harris [Member]", "terseLabel": "Engle Progeny Cases, Harris [Member]" } } }, "localname": "EngleProgenyCasesHarrisMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesHollimanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, Holliman [Member]", "label": "Engle Progeny Cases, Holliman [Member]", "terseLabel": "Engle Progeny Cases, Holliman [Member]" } } }, "localname": "EngleProgenyCasesHollimanMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesJ.BrownMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, J. Brown [Member]", "label": "Engle Progeny Cases, J. Brown [Member]", "terseLabel": "Engle Progeny Cases, J. Brown [Member]" } } }, "localname": "EngleProgenyCasesJ.BrownMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesJordanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, Jordan [Member]", "label": "Engle Progeny Cases, Jordan [Member]", "terseLabel": "Engle Progeny Cases, Jordan [Member]" } } }, "localname": "EngleProgenyCasesJordanMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesKaplanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, Kaplan [Member]", "label": "Engle Progeny Cases, Kaplan [Member]", "terseLabel": "Engle Progeny Cases, Kaplan [Member]" } } }, "localname": "EngleProgenyCasesKaplanMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesKerrivanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, Kerrivan [Member]", "label": "Engle Progeny Cases, Kerrivan [Member]", "terseLabel": "Engle Progeny Cases, Kerrivan [Member]" } } }, "localname": "EngleProgenyCasesKerrivanMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesL.MartinMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, L. Martin [Member]", "label": "Engle Progeny Cases, L. Martin [Member]", "terseLabel": "Engle Progeny Cases, L. Martin [Member]" } } }, "localname": "EngleProgenyCasesL.MartinMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesLandiMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, Landi [Member]", "label": "Engle Progeny Cases, Landi [Member]", "terseLabel": "Engle Progeny Cases, Landi [Member]" } } }, "localname": "EngleProgenyCasesLandiMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesM.BrownMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, M. Brown [Member]", "label": "Engle Progeny Cases, M. Brown [Member]", "terseLabel": "Engle Progeny Cases, M. Brown [Member]" } } }, "localname": "EngleProgenyCasesM.BrownMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesMahfuzMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, Mahfuz [Member]", "label": "Engle Progeny Cases, Mahfuz [Member]", "terseLabel": "Engle Progeny Cases, Mahfuz [Member]" } } }, "localname": "EngleProgenyCasesMahfuzMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesMcCallMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, McCall [Member]", "label": "Engle Progeny Cases, McCall [Member]", "terseLabel": "Engle Progeny Cases, McCall [Member]" } } }, "localname": "EngleProgenyCasesMcCallMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesMcKeeverMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, McKeever [Member]", "label": "Engle Progeny Cases, McKeever [Member]", "terseLabel": "Engle Progeny Cases, McKeever [Member]" } } }, "localname": "EngleProgenyCasesMcKeeverMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases [Member]", "label": "Engle Progeny Cases [Member]", "terseLabel": "Engle Progeny Cases [Member]" } } }, "localname": "EngleProgenyCasesMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails", "http://www.altria.com/role/ContingenciesJudgmentsPaidAndProvisionsForTobaccoAndHealthLitigationDetails", "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails", "http://www.altria.com/role/ContingenciesScheduleOfPendingCasesDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesNaugleMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, Naugle [Member]", "label": "Engle Progeny Cases, Naugle [Member]", "terseLabel": "Engle Progeny Cases, Naugle [Member]" } } }, "localname": "EngleProgenyCasesNaugleMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesNeffMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, Neff [Member]", "label": "Engle Progeny Cases, Neff [Member]", "terseLabel": "Engle Progeny Cases, Neff [Member]" } } }, "localname": "EngleProgenyCasesNeffMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesPardueMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, Pardue [Member]", "label": "Engle Progeny Cases, Pardue [Member]", "terseLabel": "Engle Progeny Cases, Pardue [Member]" } } }, "localname": "EngleProgenyCasesPardueMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, Pearson, D Cohen, Collar, Chacon [Member] [Member]", "label": "Engle Progeny Cases, Pearson, D Cohen, Collar, Chacon [Member] [Member]", "terseLabel": "Engle Progeny Cases, D Cohen, Collar, Chacon [Member]" } } }, "localname": "EngleProgenyCasesPearsonDCohenCollarChaconMemberMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesPollariMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, Pollari [Member]", "label": "Engle Progeny Cases, Pollari [Member]", "terseLabel": "Engle Progeny Cases, Pollari [Member]" } } }, "localname": "EngleProgenyCasesPollariMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesR.DouglasMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, R. Douglas [Member]", "label": "Engle Progeny Cases, R. Douglas [Member]", "terseLabel": "Engle Progeny Cases, R. Douglas [Member]" } } }, "localname": "EngleProgenyCasesR.DouglasMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesReiderandBanksMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, Reider and Banks [Member]", "label": "Engle Progeny Cases, Reider and Banks [Member]", "terseLabel": "Engle Progeny Cases, Reider and Banks [Member]" } } }, "localname": "EngleProgenyCasesReiderandBanksMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesRintoulMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, Rintoul", "label": "Engle Progeny Cases, Rintoul [Member]", "terseLabel": "Engle Progeny Cases, Rintoul [Member]" } } }, "localname": "EngleProgenyCasesRintoulMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesS.MartinMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, S. Martin [Member]", "label": "Engle Progeny Cases, S. Martin [Member]", "terseLabel": "Engle Progeny Cases, S. Martin [Member]" } } }, "localname": "EngleProgenyCasesS.MartinMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesSantoroMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, Santoro [Member]", "label": "Engle Progeny Cases, Santoro [Member]", "terseLabel": "Engle Progeny Cases, Santoro [Member]" } } }, "localname": "EngleProgenyCasesSantoroMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesSearcyMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, Searcy [Member]", "label": "Engle Progeny Cases, Searcy [Member]", "terseLabel": "Engle Progeny Cases, Searcy [Member]" } } }, "localname": "EngleProgenyCasesSearcyMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesSommersMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, Sommers [Member]", "label": "Engle Progeny Cases, Sommers [Member]", "terseLabel": "Engle Progeny Cases, Sommers [Member]" } } }, "localname": "EngleProgenyCasesSommersMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesStateMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, State [Member]", "label": "Engle Progeny Cases, State [Member]", "terseLabel": "Engle Progeny Cases, State [Member]" } } }, "localname": "EngleProgenyCasesStateMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails", "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesTheisMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, Theis [Member]", "label": "Engle Progeny Cases, Theis [Member]", "terseLabel": "Engle Progeny Cases, Theis [Member]" } } }, "localname": "EngleProgenyCasesTheisMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesWallaceMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, Wallace [Member]", "label": "Engle Progeny Cases, Wallace [Member]", "terseLabel": "Engle Progeny Cases, Wallace [Member]" } } }, "localname": "EngleProgenyCasesWallaceMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesWeingartandHancockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, Weingart and Hancock [Member]", "label": "Engle Progeny Cases, Weingart and Hancock [Member]", "terseLabel": "Engle Progeny Cases, Weingart and Hancock [Member]" } } }, "localname": "EngleProgenyCasesWeingartandHancockMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails" ], "xbrltype": "domainItemType" }, "mo_EngleProgenyCasesZingaroMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Engle Progeny Cases, Zingaro [Member]", "label": "Engle Progeny Cases, Zingaro [Member]", "terseLabel": "Engle Progeny Cases, Zingaro [Member]" } } }, "localname": "EngleProgenyCasesZingaroMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "domainItemType" }, "mo_EquityContractPreemptiveRIghtsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equity Contract, Preemptive RIghts [Member]", "label": "Equity Contract, Preemptive RIghts [Member]", "terseLabel": "Fixed-price Preemptive Rights [Member]", "verboseLabel": "Equity Contract, Preemptive Rights [Member]" } } }, "localname": "EquityContractPreemptiveRIghtsMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails", "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails", "http://www.altria.com/role/FinancialInstrumentsPreTaxUnrealizedGainsLossesDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInCronosNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesSummaryOfInvestmentsDetails" ], "xbrltype": "domainItemType" }, "mo_EquityContractWarrantMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equity Contract, Warrant [Member]", "label": "Equity Contract, Warrant [Member]", "terseLabel": "Equity Contract, Warrant [Member]", "verboseLabel": "Cronos Warrant [Member]" } } }, "localname": "EquityContractWarrantMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails", "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails", "http://www.altria.com/role/FinancialInstrumentsPreTaxUnrealizedGainsLossesDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInCronosNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesSummaryOfInvestmentsDetails" ], "xbrltype": "domainItemType" }, "mo_EquityMethodInvestmentAggregateExercisePrice": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Equity Method Investment, Aggregate Exercise Price", "label": "Equity Method Investment, Aggregate Exercise Price", "terseLabel": "Equity method investment, aggregate exercise price" } } }, "localname": "EquityMethodInvestmentAggregateExercisePrice", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInCronosNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equity Method Investment, Difference Between Carrying Amount and Fair Value, Percentage", "label": "Equity Method Investment, Difference Between Carrying Amount and Fair Value, Percentage", "negatedTerseLabel": "Difference between carrying amount and fair value, percentage (approximately)", "terseLabel": "Equity method investment, difference between carrying amount and fair value, percentage (approximately)" } } }, "localname": "EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInAbiNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInCronosNarrativeDetails" ], "xbrltype": "percentItemType" }, "mo_EquityMethodInvestmentImpairment": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Equity Method Investment, Impairment", "label": "Equity Method Investment, Impairment", "terseLabel": "Equity method investment, impairment" } } }, "localname": "EquityMethodInvestmentImpairment", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInAbiNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "mo_EquityMethodInvestmentNumberofIndependentDirectorsNominated": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equity Method Investment, Number of Independent Directors Nominated", "label": "Equity Method Investment, Number of Independent Directors Nominated", "terseLabel": "Equity method investment, number of independent directors nominated" } } }, "localname": "EquityMethodInvestmentNumberofIndependentDirectorsNominated", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInCronosNarrativeDetails" ], "xbrltype": "integerItemType" }, "mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equity Method Investment, Number of Shares Eligible For Purchase", "label": "Equity Method Investment, Number of Shares Eligible For Purchase", "terseLabel": "Equity method investment, number of shares eligible for purchase (in shares)" } } }, "localname": "EquityMethodInvestmentNumberofSharesEligibleForPurchase", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInCronosNarrativeDetails" ], "xbrltype": "sharesItemType" }, "mo_EquityMethodInvestmentNumberofSharesOwnedCommon": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equity Method Investment, Number of Shares Owned, Common", "label": "Equity Method Investment, Number of Shares Owned, Common", "terseLabel": "Number of ordinary shares owned (in shares)", "verboseLabel": "Number of ordinary shares owned (approximately) (in shares)" } } }, "localname": "EquityMethodInvestmentNumberofSharesOwnedCommon", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInAbiNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInCronosNarrativeDetails" ], "xbrltype": "sharesItemType" }, "mo_EquityMethodInvestmentNumberofSharesOwnedRestricted": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equity Method Investment, Number of Shares Owned, Restricted", "label": "Equity Method Investment, Number of Shares Owned, Restricted", "terseLabel": "Number of restricted shares owned (in shares)" } } }, "localname": "EquityMethodInvestmentNumberofSharesOwnedRestricted", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInAbiNarrativeDetails" ], "xbrltype": "sharesItemType" }, "mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equity Method Investment, Percentage of Shares Eligible For Purchase", "label": "Equity Method Investment, Percentage of Shares Eligible For Purchase", "terseLabel": "Equity method investment, percentage of shares eligible for purchase" } } }, "localname": "EquityMethodInvestmentPercentageofSharesEligibleForPurchase", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInCronosNarrativeDetails" ], "xbrltype": "percentItemType" }, "mo_EquityMethodInvestmentPricePerShareIfExercised": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equity Method Investment, Price Per Share If Exercised", "label": "Equity Method Investment, Price Per Share If Exercised", "terseLabel": "Equity method investment, shares purchased, (CAD per share)" } } }, "localname": "EquityMethodInvestmentPricePerShareIfExercised", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInCronosNarrativeDetails" ], "xbrltype": "perShareItemType" }, "mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equity Method Investment, Warrant Exercised, Ownership Percentage", "label": "Equity Method Investment, Warrant Exercised, Ownership Percentage", "verboseLabel": "Equity method investment, warrant exercised, ownership percentage (approximately)" } } }, "localname": "EquityMethodInvestmentWarrantExercisedOwnershipPercentage", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInCronosNarrativeDetails" ], "xbrltype": "percentItemType" }, "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNoLitigationPeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equity Securities Without Readily Determinable Fair Value, No Litigation Period", "label": "Equity Securities Without Readily Determinable Fair Value, No Litigation Period", "terseLabel": "Equity securities without readily determinable fair value, no litigation period" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNoLitigationPeriod", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInJuulNarrativeDetails" ], "xbrltype": "durationItemType" }, "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equity Securities Without Readily Determinable Fair Value, Non-Compete Release Trigger Percentage Of Investment Carrying Value", "label": "Equity Securities Without Readily Determinable Fair Value, Non-Compete Release Trigger Percentage Of Investment Carrying Value", "terseLabel": "Equity securities without readily determinable fair value, non-compete release trigger percentage of investment carrying value" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInJuulNarrativeDetails" ], "xbrltype": "percentItemType" }, "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equity Securities Without Readily Determinable Fair Value, Non-Compete Release Trigger Period", "label": "Equity Securities Without Readily Determinable Fair Value, Non-Compete Release Trigger Period", "terseLabel": "Equity securities without readily determinable fair value, non-compete release trigger period" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPeriod", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInJuulNarrativeDetails" ], "xbrltype": "durationItemType" }, "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equity Securities Without Readily Determinable Fair Value, Number Of Board Members", "label": "Equity Securities Without Readily Determinable Fair Value, Number Of Board Members", "terseLabel": "Equity securities without readily determinable fair value, number of board members" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInJuulNarrativeDetails" ], "xbrltype": "integerItemType" }, "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Appointed By Investee Stockholders Upon Share Conversion", "label": "Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Appointed By Investee Stockholders Upon Share Conversion", "terseLabel": "Equity securities without readily determinable fair value, number of board members appointed by investee stockholders upon share conversion" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInJuulNarrativeDetails" ], "xbrltype": "integerItemType" }, "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Appointed By Investor Upon Share Conversion", "label": "Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Appointed By Investor Upon Share Conversion", "terseLabel": "Equity securities without readily determinable fair value, number of board members appointed by investor upon share conversion" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInJuulNarrativeDetails" ], "xbrltype": "integerItemType" }, "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Upon Share Conversion", "label": "Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Upon Share Conversion", "terseLabel": "Equity securities without readily determinable fair value, number of board members upon share conversion" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInJuulNarrativeDetails" ], "xbrltype": "integerItemType" }, "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equity Securities Without Readily Determinable Fair Value, Number Of Directors Designated By Investor Upon Share Conversion", "label": "Equity Securities Without Readily Determinable Fair Value, Number Of Directors Designated By Investor Upon Share Conversion", "terseLabel": "Equity securities without readily determinable fair value, number of directors designated by investor upon share conversion" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInJuulNarrativeDetails" ], "xbrltype": "integerItemType" }, "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equity Securities Without Readily Determinable Fair Value, Number Of Independent Board Members Upon Share Conversion", "label": "Equity Securities Without Readily Determinable Fair Value, Number Of Independent Board Members Upon Share Conversion", "terseLabel": "Equity securities without readily determinable fair value, number of independent board members upon share conversion" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInJuulNarrativeDetails" ], "xbrltype": "integerItemType" }, "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equity Securities Without Readily Determinable Fair Value, Number Of Investor Nominating Committee Designees Upon Share Conversion", "label": "Equity Securities Without Readily Determinable Fair Value, Number Of Investor Nominating Committee Designees Upon Share Conversion", "terseLabel": "Equity securities without readily determinable fair value, number of investor nominating committee designees upon share conversion" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInJuulNarrativeDetails" ], "xbrltype": "integerItemType" }, "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equity Securities Without Readily Determinable Fair Value, Number Of Nominating Committee Directors Designated By Investee Upon Share Conversion", "label": "Equity Securities Without Readily Determinable Fair Value, Number Of Nominating Committee Directors Designated By Investee Upon Share Conversion", "terseLabel": "Equity securities without readily determinable fair value, number of nominating committee directors designated by investee upon share conversion" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInJuulNarrativeDetails" ], "xbrltype": "integerItemType" }, "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equity Securities Without Readily Determinable Fair Value, Number Of Oversight Committee Chair Directors Designated By Investor Upon Share Conversion", "label": "Equity Securities Without Readily Determinable Fair Value, Number Of Oversight Committee Chair Directors Designated By Investor Upon Share Conversion", "terseLabel": "Equity securities without readily determinable fair value, number of oversight committee chair directors designated by investor upon share conversion" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInJuulNarrativeDetails" ], "xbrltype": "integerItemType" }, "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equity Securities Without Readily Determinable Fair Value, Number Of Oversight Committee Directors Designated By Investor Upon Share Conversion", "label": "Equity Securities Without Readily Determinable Fair Value, Number Of Oversight Committee Directors Designated By Investor Upon Share Conversion", "terseLabel": "Equity securities without readily determinable fair value, number of oversight committee directors designated by investor upon share conversion" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInJuulNarrativeDetails" ], "xbrltype": "integerItemType" }, "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equity Securities Without Readily Determinable Fair Value, Ownership Percentage", "label": "Equity Securities Without Readily Determinable Fair Value, Ownership Percentage", "terseLabel": "Equity securities, ownership percentage" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/BackgroundAndBasisOfPresentationNarrativeDetails", "http://www.altria.com/role/ContingenciesAntitrustLitigationDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInJuulNarrativeDetails" ], "xbrltype": "percentItemType" }, "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Equity Securities Without Readily Determinable Fair Value, Quantitative Assessment Adjustment, Annual Amount", "label": "Equity Securities Without Readily Determinable Fair Value, Quantitative Assessment Adjustment, Annual Amount", "terseLabel": "Equity securities without readily determinable fair value, quantitative assessment adjustment, annual amount" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInJuulNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "mo_EquitySecurityInvestments": { "auth_ref": [], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Equity Security Investments", "label": "Equity Security Investments", "verboseLabel": "Investments in equity securities" } } }, "localname": "EquitySecurityInvestments", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "mo_EvaporLitigationMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "E-vapor Litigation [Member]", "label": "E-vapor Litigation [Member]", "terseLabel": "E-vapor Litigation [Member]" } } }, "localname": "EvaporLitigationMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEVaporProductLitigationDetails", "http://www.altria.com/role/ContingenciesScheduleOfPendingCasesDetails" ], "xbrltype": "domainItemType" }, "mo_FederalGovernmentsLawsuitMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Federal Government's Lawsuit [Member]", "label": "Federal Governments Lawsuit [Member]", "terseLabel": "Federal Governments Lawsuit [Member]" } } }, "localname": "FederalGovernmentsLawsuitMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails" ], "xbrltype": "domainItemType" }, "mo_FederalTradeCommissionDisclosurePeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Federal Trade Commission, Disclosure Period", "label": "Federal Trade Commission, Disclosure Period", "terseLabel": "Disclosure period" } } }, "localname": "FederalTradeCommissionDisclosurePeriod", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails" ], "xbrltype": "durationItemType" }, "mo_ForeignCurrencyDenominatedDebtMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Foreign Currency Denominated Debt [Member]", "label": "Foreign Currency Denominated Debt [Member]", "terseLabel": "Foreign Currency Denominated Debt [Member]", "verboseLabel": "Foreign currency denominated debt [Member]" } } }, "localname": "ForeignCurrencyDenominatedDebtMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsEffectsOfNetInvestmentHedgesOnAccumulatedOtherComprehensiveLossesDetails", "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "mo_HealthCareCostRecoveryActions20032015NPMAdjustmentsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Health Care Cost Recovery Actions, 2003-2015 NPM Adjustments [Member]", "label": "Health Care Cost Recovery Actions, 2003-2015 NPM Adjustments [Member]", "terseLabel": "Health Care Cost Recovery Actions, 2003-2015 NPM Adjustments [Member]" } } }, "localname": "HealthCareCostRecoveryActions20032015NPMAdjustmentsMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "domainItemType" }, "mo_HealthCareCostRecoveryActions2003NPMAdjustmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Health Care Cost Recovery Actions, 2003 NPM Adjustment [Member]", "label": "Health Care Cost Recovery Actions, 2003 NPM Adjustment [Member]", "terseLabel": "Health Care Cost Recovery Actions, 2003 NPM Adjustment [Member]" } } }, "localname": "HealthCareCostRecoveryActions2003NPMAdjustmentMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "domainItemType" }, "mo_HealthCareCostRecoveryActions20042017Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Health Care Cost Recovery Actions, 2004-2017 [Member]", "label": "Health Care Cost Recovery Actions, 2004-2017 [Member]", "terseLabel": "Health Care Cost Recovery Actions, 2004-2017 [Member]" } } }, "localname": "HealthCareCostRecoveryActions20042017Member", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "domainItemType" }, "mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member]", "label": "Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member]", "terseLabel": "Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member]" } } }, "localname": "HealthCareCostRecoveryActions2004NPMAdjustmentMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "domainItemType" }, "mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Health Care Cost Recovery Actions, 2005 NPM Adjustment [Member]", "label": "Health Care Cost Recovery Actions, 2005 NPM Adjustment [Member]", "terseLabel": "Health Care Cost Recovery Actions, 2005 NPM Adjustment [Member]" } } }, "localname": "HealthCareCostRecoveryActions2005NPMAdjustmentMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "domainItemType" }, "mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Health Care Cost Recovery Actions, 2006 NPM Adjustment [Member]", "label": "Health Care Cost Recovery Actions, 2006 NPM Adjustment [Member]", "terseLabel": "Health Care Cost Recovery Actions, 2006 NPM Adjustment [Member]" } } }, "localname": "HealthCareCostRecoveryActions2006NPMAdjustmentMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "domainItemType" }, "mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Health Care Cost Recovery Actions, 2007 NPM Adjustment [Member]", "label": "Health Care Cost Recovery Actions, 2007 NPM Adjustment [Member]", "terseLabel": "Health Care Cost Recovery Actions, 2007 NPM Adjustment [Member]" } } }, "localname": "HealthCareCostRecoveryActions2007NPMAdjustmentMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "domainItemType" }, "mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Health Care Cost Recovery Actions, 2008 NPM Adjustment [Member]", "label": "Health Care Cost Recovery Actions, 2008 NPM Adjustment [Member]", "terseLabel": "Health Care Cost Recovery Actions, 2008 NPM Adjustment [Member]" } } }, "localname": "HealthCareCostRecoveryActions2008NPMAdjustmentMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "domainItemType" }, "mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Health Care Cost Recovery Actions, 2009 NPM Adjustment [Member]", "label": "Health Care Cost Recovery Actions, 2009 NPM Adjustment [Member]", "terseLabel": "Health Care Cost Recovery Actions, 2009 NPM Adjustment [Member]" } } }, "localname": "HealthCareCostRecoveryActions2009NPMAdjustmentMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "domainItemType" }, "mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Health Care Cost Recovery Actions, 2010 NPM Adjustment [Member]", "label": "Health Care Cost Recovery Actions, 2010 NPM Adjustment [Member]", "terseLabel": "Health Care Cost Recovery Actions, 2010 NPM Adjustment [Member]" } } }, "localname": "HealthCareCostRecoveryActions2010NPMAdjustmentMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "domainItemType" }, "mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Health Care Cost Recovery Actions, 2011 NPM Adjustment [Member]", "label": "Health Care Cost Recovery Actions, 2011 NPM Adjustment [Member]", "terseLabel": "Health Care Cost Recovery Actions, 2011 NPM Adjustment [Member]" } } }, "localname": "HealthCareCostRecoveryActions2011NPMAdjustmentMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "domainItemType" }, "mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Health Care Cost Recovery Actions, 2012 NPM Adjustment [Member]", "label": "Health Care Cost Recovery Actions, 2012 NPM Adjustment [Member]", "terseLabel": "Health Care Cost Recovery Actions, 2012 NPM Adjustment [Member]" } } }, "localname": "HealthCareCostRecoveryActions2012NPMAdjustmentMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "domainItemType" }, "mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Health Care Cost Recovery Actions, 2013 NPM Adjustment [Member]", "label": "Health Care Cost Recovery Actions, 2013 NPM Adjustment [Member]", "terseLabel": "Health Care Cost Recovery Actions, 2013 NPM Adjustment [Member]" } } }, "localname": "HealthCareCostRecoveryActions2013NPMAdjustmentMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "domainItemType" }, "mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Health Care Cost Recovery Actions, 2014 NPM Adjustment [Member]", "label": "Health Care Cost Recovery Actions, 2014 NPM Adjustment [Member]", "terseLabel": "Health Care Cost Recovery Actions, 2014 NPM Adjustment [Member]" } } }, "localname": "HealthCareCostRecoveryActions2014NPMAdjustmentMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "domainItemType" }, "mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Health Care Cost Recovery Actions, 2015 NPM Adjustments [Member]", "label": "Health Care Cost Recovery Actions, 2015 NPM Adjustments [Member]", "terseLabel": "Health Care Cost Recovery Actions, 2015 NPM Adjustments [Member]" } } }, "localname": "HealthCareCostRecoveryActions2015NPMAdjustmentsMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "domainItemType" }, "mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member]", "label": "Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member] [Member]", "terseLabel": "Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member]" } } }, "localname": "HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "domainItemType" }, "mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Health Care Cost Recovery Actions, 2017 NPM Adjustments [Member]", "label": "Health Care Cost Recovery Actions, 2017 NPM Adjustments [Member]", "terseLabel": "Health Care Cost Recovery Actions, 2017 NPM Adjustments [Member]" } } }, "localname": "HealthCareCostRecoveryActions2017NPMAdjustmentsMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "domainItemType" }, "mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Health Care Cost Recovery Actions, 2018 NPM Adjustments [Member]", "label": "Health Care Cost Recovery Actions, 2018 NPM Adjustments [Member]", "terseLabel": "Health Care Cost Recovery Actions, 2018 NPM Adjustments [Member]" } } }, "localname": "HealthCareCostRecoveryActions2018NPMAdjustmentsMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "domainItemType" }, "mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Health Care Cost Recovery Actions, 2019 NPM Adjustments [Member]", "label": "Health Care Cost Recovery Actions, 2019 NPM Adjustments [Member]", "terseLabel": "Health Care Cost Recovery Actions, 2019 NPM Adjustments [Member]" } } }, "localname": "HealthCareCostRecoveryActions2019NPMAdjustmentsMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "domainItemType" }, "mo_HealthCareCostRecoveryActionsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Health Care Cost Recovery Actions [Member]", "label": "Health Care Cost Recovery Actions [Member]", "terseLabel": "Health Care Cost Recovery Actions [Member]" } } }, "localname": "HealthCareCostRecoveryActionsMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails", "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails", "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails", "http://www.altria.com/role/ContingenciesScheduleOfPendingCasesDetails" ], "xbrltype": "domainItemType" }, "mo_HealthCareCostRecoveryActionsTransitionYears20042017Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Health Care Cost Recovery Actions, Transition Years 2004-2017 [Member]", "label": "Health Care Cost Recovery Actions, Transition Years 2004-2017 [Member]", "terseLabel": "Health Care Cost Recovery Actions, Transition Years 2004-2017 [Member]" } } }, "localname": "HealthCareCostRecoveryActionsTransitionYears20042017Member", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "domainItemType" }, "mo_HelixInnovationsLLCMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Helix Innovations LLC [Member]", "label": "Helix Innovations LLC [Member]", "terseLabel": "Helix Innovations LLC [Member]" } } }, "localname": "HelixInnovationsLLCMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/BackgroundAndBasisOfPresentationNarrativeDetails" ], "xbrltype": "domainItemType" }, "mo_ImplementationofCorrectiveCommunicationsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Implementation of Corrective Communications [Member]", "label": "Implementation of Corrective Communications [Member]", "terseLabel": "Implementation of Corrective Communications [Member]" } } }, "localname": "ImplementationofCorrectiveCommunicationsMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails" ], "xbrltype": "domainItemType" }, "mo_IncreaseDecreaseInSettlementPayable": { "auth_ref": [], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The net change during the period in Settlement payable.", "label": "Increase (Decrease) In Settlement Payable", "terseLabel": "Accrued settlement charges" } } }, "localname": "IncreaseDecreaseInSettlementPayable", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "mo_IndividualSmokingAndHealthCasesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Individual Smoking and Health Cases [Member]", "label": "Individual Smoking And Health Cases [Member]", "terseLabel": "Individual Smoking and Health Cases [Member]" } } }, "localname": "IndividualSmokingAndHealthCasesMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails", "http://www.altria.com/role/ContingenciesScheduleOfPendingCasesDetails" ], "xbrltype": "domainItemType" }, "mo_InterestExpenseRelatedToLitigationMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest Expense Related To Litigation [Member]", "label": "Interest Expense Related To Litigation [Member]", "terseLabel": "Interest Expense Related to Litigation [Member]" } } }, "localname": "InterestExpenseRelatedToLitigationMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesJudgmentsPaidAndProvisionsForTobaccoAndHealthLitigationDetails" ], "xbrltype": "domainItemType" }, "mo_InventoryRawMaterialsPlantMaterialNetofReserves": { "auth_ref": [], "calculation": { "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount as of the balance sheet date of products consisting of plant matter that is not used in the growth of plant goods", "label": "Inventory, Raw Materials, Plant Material, Net of Reserves", "terseLabel": "Leaf tobacco" } } }, "localname": "InventoryRawMaterialsPlantMaterialNetofReserves", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "mo_InventoryWriteOffMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Inventory Write-Off [Member]", "label": "Inventory Write-Off [Member]", "terseLabel": "Inventory Write-Off [Member]" } } }, "localname": "InventoryWriteOffMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsNarrativeDetails" ], "xbrltype": "domainItemType" }, "mo_InvestmentinConsolidatedSubsidiaries": { "auth_ref": [], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Investment in Consolidated Subsidiaries", "label": "Investment in Consolidated Subsidiaries", "terseLabel": "Investment in consolidated subsidiaries" } } }, "localname": "InvestmentinConsolidatedSubsidiaries", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "mo_InvestmentsInEquitySecuritiesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Investments In Equity Securities [Member]", "label": "Investments In Equity Securities [Member]", "terseLabel": "Investments In Equity Securities [Member]" } } }, "localname": "InvestmentsInEquitySecuritiesMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "mo_InvestmentsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "[Line Items] for Investments [Table]", "label": "Investments [Line Items]", "terseLabel": "Investments [Line Items]" } } }, "localname": "InvestmentsLineItems", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInCronosNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesSummaryOfInvestmentsDetails" ], "xbrltype": "stringItemType" }, "mo_InvestmentsTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Investments [Table]", "label": "Investments [Table]", "terseLabel": "Investments [Table]" } } }, "localname": "InvestmentsTable", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInCronosNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesSummaryOfInvestmentsDetails" ], "xbrltype": "stringItemType" }, "mo_InvestmentsinConsolidatedSubsidiaries": { "auth_ref": [], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Investments in Consolidated Subsidiaries", "label": "Investments in Consolidated Subsidiaries", "negatedTerseLabel": "Investment in consolidated subsidiaries" } } }, "localname": "InvestmentsinConsolidatedSubsidiaries", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "mo_JUULMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "JUUL [Member]", "label": "JUUL [Member]", "terseLabel": "JUUL [Member]" } } }, "localname": "JUULMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/BackgroundAndBasisOfPresentationNarrativeDetails", "http://www.altria.com/role/ContingenciesAntitrustLitigationDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInAbiNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInJuulNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesSummaryOfInvestmentsDetails" ], "xbrltype": "domainItemType" }, "mo_January2018ShareRepurchaseProgramMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "January 2018 Share Repurchase Program [Member]", "label": "January 2018 Share Repurchase Program [Member]", "terseLabel": "January 2018 Share Repurchase Program [Member]" } } }, "localname": "January2018ShareRepurchaseProgramMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/BackgroundAndBasisOfPresentationNarrativeDetails", "http://www.altria.com/role/BackgroundAndBasisOfPresentationShareRepurchaseTableDetails" ], "xbrltype": "domainItemType" }, "mo_July2019ShareRepurchaseProgramMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "July 2019 Share Repurchase Program [Member]", "label": "July 2019 Share Repurchase Program [Member]", "terseLabel": "July 2019 Share Repurchase Program [Member]" } } }, "localname": "July2019ShareRepurchaseProgramMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/BackgroundAndBasisOfPresentationNarrativeDetails" ], "xbrltype": "domainItemType" }, "mo_LightsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Lights [Member]", "label": "Lights [Member]", "terseLabel": "Lights [Member]" } } }, "localname": "LightsMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails" ], "xbrltype": "domainItemType" }, "mo_LightsUltraLightsClassActionsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Lights/Ultra Lights Class Actions\n[Member]", "label": "Lights Ultra Lights Class Actions [Member]", "terseLabel": "Lights Ultra Lights Class Actions [Member]" } } }, "localname": "LightsUltraLightsClassActionsMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails" ], "xbrltype": "domainItemType" }, "mo_LitigationCasesResultsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Litigation Cases Results [Member]", "label": "Litigation Cases Results [Member]", "terseLabel": "Litigation Cases Results [Member]" } } }, "localname": "LitigationCasesResultsMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesJudgmentsPaidAndProvisionsForTobaccoAndHealthLitigationDetails" ], "xbrltype": "domainItemType" }, "mo_LitigationEscrowDeposit": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Litigation Escrow Deposit", "label": "Litigation Escrow Deposit", "terseLabel": "Security posted for appeal of judgments" } } }, "localname": "LitigationEscrowDeposit", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesJudgmentsPaidAndProvisionsForTobaccoAndHealthLitigationDetails" ], "xbrltype": "monetaryItemType" }, "mo_LitigationSettlementAnnualLegalFeesPayableMaximum": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Litigation Settlement, Annual Legal Fees Payable, Maximum", "label": "Litigation Settlement, Annual Legal Fees Payable, Maximum", "terseLabel": "State settlement agreements attorney fees annual cap" } } }, "localname": "LitigationSettlementAnnualLegalFeesPayableMaximum", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails" ], "xbrltype": "monetaryItemType" }, "mo_LitigationSettlementAnnualPaymentAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Litigation Settlement, Annual Payment Amount", "label": "Litigation Settlement, Annual Payment Amount", "terseLabel": "State settlement agreements annual payments" } } }, "localname": "LitigationSettlementAnnualPaymentAmount", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails" ], "xbrltype": "monetaryItemType" }, "mo_LitigationSettlementEstimateofPossibleGain": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Litigation Settlement, Estimate of Possible Gain", "label": "Litigation Settlement, Estimate of Possible Gain", "terseLabel": "Estimate of possible gain" } } }, "localname": "LitigationSettlementEstimateofPossibleGain", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "monetaryItemType" }, "mo_LossContingencyClaimsDecided": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Claims Decided", "label": "Loss Contingency, Claims Decided", "terseLabel": "Number of verdicts returned" } } }, "localname": "LossContingencyClaimsDecided", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails", "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails" ], "xbrltype": "integerItemType" }, "mo_LossContingencyClaimsDecidedFavorableNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Claims Decided Favorable, Number", "label": "Loss Contingency, Claims Decided Favorable, Number", "terseLabel": "Number of favorable verdicts" } } }, "localname": "LossContingencyClaimsDecidedFavorableNumber", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails", "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails" ], "xbrltype": "integerItemType" }, "mo_LossContingencyClaimsDecidedUnfavorableNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Claims Decided Unfavorable, Number", "label": "Loss Contingency, Claims Decided Unfavorable, Number", "terseLabel": "Number of unfavorable verdicts" } } }, "localname": "LossContingencyClaimsDecidedUnfavorableNumber", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails", "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails" ], "xbrltype": "integerItemType" }, "mo_LossContingencyClaimsNotCertifiedNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Claims Not Certified, Number", "label": "Loss Contingency, Claims Not Certified, Number", "terseLabel": "Claims not certified, number" } } }, "localname": "LossContingencyClaimsNotCertifiedNumber", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails" ], "xbrltype": "integerItemType" }, "mo_LossContingencyClaimsResolvedNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Claims Resolved, Number", "label": "Loss Contingency, Claims Resolved, Number", "terseLabel": "Number of claims resolved" } } }, "localname": "LossContingencyClaimsResolvedNumber", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails" ], "xbrltype": "integerItemType" }, "mo_LossContingencyClassActionLawsuit": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Class Action Lawsuit", "label": "Loss Contingency, Class Action Lawsuit", "terseLabel": "Loss contingency, class action lawsuit" } } }, "localname": "LossContingencyClassActionLawsuit", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesAntitrustLitigationDetails", "http://www.altria.com/role/ContingenciesScheduleOfPendingCasesDetails" ], "xbrltype": "integerItemType" }, "mo_LossContingencyClassNotCertifiedNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Class Not Certified, Number", "label": "Loss Contingency, Class Not Certified, Number", "terseLabel": "Class not certified" } } }, "localname": "LossContingencyClassNotCertifiedNumber", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails" ], "xbrltype": "integerItemType" }, "mo_LossContingencyCompensatoryDamagesAwardedAllocationPercentage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Compensatory Damages Awarded, Allocation Percentage", "label": "Loss Contingency, Compensatory Damages Awarded, Allocation Percentage", "terseLabel": "Compensatory damages award, allocation percentage" } } }, "localname": "LossContingencyCompensatoryDamagesAwardedAllocationPercentage", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails" ], "xbrltype": "percentItemType" }, "mo_LossContingencyCompensatoryDamagesAwardedValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Compensatory Damages Awarded, Value", "label": "Loss Contingency, Compensatory Damages Awarded, Value", "terseLabel": "Compensatory damages awarded" } } }, "localname": "LossContingencyCompensatoryDamagesAwardedValue", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails", "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails" ], "xbrltype": "monetaryItemType" }, "mo_LossContingencyNumberOfCases": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Number Of Cases", "label": "Loss Contingency, Number Of Cases", "verboseLabel": "Number of cases" } } }, "localname": "LossContingencyNumberOfCases", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesScheduleOfPendingCasesDetails" ], "xbrltype": "integerItemType" }, "mo_LossContingencyNumberOfCasesTriedinASingleProceeding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Number Of Cases Tried in A Single Proceeding", "label": "Loss Contingency, Number Of Cases Tried in A Single Proceeding", "terseLabel": "Loss contingency, number of cases tried in a single proceeding" } } }, "localname": "LossContingencyNumberOfCasesTriedinASingleProceeding", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesScheduleOfPendingCasesDetails" ], "xbrltype": "integerItemType" }, "mo_LossContingencyNumberOfDisputesOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Number Of Disputes Outstanding", "label": "Loss Contingency, Number Of Disputes Outstanding", "terseLabel": "Loss contingency, number of disputes outstanding" } } }, "localname": "LossContingencyNumberOfDisputesOutstanding", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "integerItemType" }, "mo_LossContingencyNumberOfInactiveCases": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Number Of Inactive Cases", "label": "Loss Contingency, Number Of Inactive Cases", "terseLabel": "Loss contingency, number of inactive cases" } } }, "localname": "LossContingencyNumberOfInactiveCases", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails", "http://www.altria.com/role/ContingenciesScheduleOfPendingCasesDetails" ], "xbrltype": "integerItemType" }, "mo_LossContingencyNumberOfInactiveClassActionLawsuits": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Number Of Inactive Class Action Lawsuits", "label": "Loss Contingency, Number Of Inactive Class Action Lawsuits", "terseLabel": "Loss contingency, number of inactive class action lawsuits" } } }, "localname": "LossContingencyNumberOfInactiveClassActionLawsuits", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesScheduleOfPendingCasesDetails" ], "xbrltype": "integerItemType" }, "mo_LossContingencyNumberOfPreTrialResolutionCases": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Number Of Pre-Trial Resolution Cases", "label": "Loss Contingency, Number Of Pre-Trial Resolution Cases", "terseLabel": "Loss contingency, number of pre-trial resolution cases" } } }, "localname": "LossContingencyNumberOfPreTrialResolutionCases", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesJudgmentsPaidAndProvisionsForTobaccoAndHealthLitigationDetails" ], "xbrltype": "integerItemType" }, "mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Number Of Shareholders Filing Class Action Lawsuits", "label": "Loss Contingency, Number Of Shareholders Filing Class Action Lawsuits", "terseLabel": "Loss contingency, number of shareholders filing class action lawsuits" } } }, "localname": "LossContingencyNumberOfShareholdersFilingClassActionLawsuits", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesUstLitigationsNarrativeDetails" ], "xbrltype": "integerItemType" }, "mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Number of Additional States Extended with Settled Litigation", "label": "Loss Contingency, Number of Additional States Extended with Settled Litigation", "terseLabel": "Loss contingency, number of additional states extended with settled litigation" } } }, "localname": "LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "integerItemType" }, "mo_LossContingencyNumberofAdditionalStateswithSettledLitigation": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Number of Additional States with Settled Litigation", "label": "Loss Contingency, Number of Additional States with Settled Litigation", "terseLabel": "Loss contingency, number of additional states added" } } }, "localname": "LossContingencyNumberofAdditionalStateswithSettledLitigation", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "integerItemType" }, "mo_LossContingencyNumberofCasesSetforTrial": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Number of Cases Set for Trial", "label": "Loss Contingency, Number of Cases Set for Trial", "terseLabel": "Number of cases set for trial" } } }, "localname": "LossContingencyNumberofCasesSetforTrial", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEVaporProductLitigationDetails", "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails", "http://www.altria.com/role/ContingenciesScheduleOfPendingCasesDetails" ], "xbrltype": "integerItemType" }, "mo_LossContingencyNumberofManufacturers": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Number of Manufacturers", "label": "Loss Contingency, Number of Manufacturers", "terseLabel": "Number of manufacturers" } } }, "localname": "LossContingencyNumberofManufacturers", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails", "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails" ], "xbrltype": "integerItemType" }, "mo_LossContingencyNumberofSettlementDevelopments": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Number of Settlement Developments", "label": "Loss Contingency, Number of Settlement Developments", "terseLabel": "Loss contingency, number of settlement developments" } } }, "localname": "LossContingencyNumberofSettlementDevelopments", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "integerItemType" }, "mo_LossContingencyNumberofStates": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Number of States", "label": "Loss Contingency, Number of States", "terseLabel": "Loss contingency, number of states" } } }, "localname": "LossContingencyNumberofStates", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "integerItemType" }, "mo_LossContingencyNumberofStatesRemaining": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Number of States Remaining", "label": "Loss Contingency, Number of States Remaining", "terseLabel": "Loss contingency, number of states remaining" } } }, "localname": "LossContingencyNumberofStatesRemaining", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "integerItemType" }, "mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Number of States That Cap Bond or Require No Bond", "label": "Loss Contingency, Number of States That Cap Bond or Require No Bond", "terseLabel": "Number of states that cap bond or require no bond" } } }, "localname": "LossContingencyNumberofStatesThatCapBondorRequireNoBond", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesGeneralInformationDetails" ], "xbrltype": "integerItemType" }, "mo_LossContingencyNumberofStatesWithoutDefense": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Number of States Without Defense", "label": "Loss Contingency, Number of States Without Defense", "terseLabel": "Number of states without defense" } } }, "localname": "LossContingencyNumberofStatesWithoutDefense", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "integerItemType" }, "mo_LossContingencyNumberofStateswithSettledLitigation": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Number of States with Settled Litigation", "label": "Loss Contingency, Number of States with Settled Litigation", "terseLabel": "Number of states with settled litigation" } } }, "localname": "LossContingencyNumberofStateswithSettledLitigation", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails", "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "integerItemType" }, "mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Number of States with Settled Litigation, Settlement One", "label": "Loss Contingency, Number of States with Settled Litigation, Settlement One", "terseLabel": "Loss contingency, number of states with settled litigation including New York, subsequent expansion" } } }, "localname": "LossContingencyNumberofStateswithSettledLitigationSettlementOne", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "integerItemType" }, "mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Period for Decertified Class Members to File Individual Actions Against Defendants", "label": "Loss Contingency, Period for Decertified Class Members to File Individual Actions Against Defendants", "terseLabel": "Period for decertified class members could file individual actions" } } }, "localname": "LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails" ], "xbrltype": "durationItemType" }, "mo_LossContingencyProceedsfromLegalSettlements": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Loss Contingency, \u200bProceeds from Legal Settlements", "label": "Loss Contingency, \u200bProceeds from Legal Settlements", "terseLabel": "\u200bProceeds from legal settlements" } } }, "localname": "LossContingencyProceedsfromLegalSettlements", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "monetaryItemType" }, "mo_LossContingencyPunitiveDamagesAwardedValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Punitive Damages Awarded, Value", "label": "Loss Contingency, Punitive Damages Awarded, Value", "terseLabel": "Punitive damages awarded" } } }, "localname": "LossContingencyPunitiveDamagesAwardedValue", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails", "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails", "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails" ], "xbrltype": "monetaryItemType" }, "mo_LossContingencyReductionToCostOfSales": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Reduction To Cost Of Sales", "label": "Loss Contingency, Reduction To Cost Of Sales", "terseLabel": "Loss contingency, reduction to cost of sales" } } }, "localname": "LossContingencyReductionToCostOfSales", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "monetaryItemType" }, "mo_LossContingencySettlementAgreementPaymentPeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Settlement Agreement, Payment Period", "label": "Loss Contingency, Settlement Agreement, Payment Period", "terseLabel": "Loss contingency, settlement agreement, payment period" } } }, "localname": "LossContingencySettlementAgreementPaymentPeriod", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "durationItemType" }, "mo_LossContingencySettlementAgreementsNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Settlement Agreements, Number", "label": "Loss Contingency, Settlement Agreements, Number", "terseLabel": "Settlement agreements, number" } } }, "localname": "LossContingencySettlementAgreementsNumber", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "integerItemType" }, "mo_LossContingencyStateCourtsNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency, State Courts, Number", "label": "Loss Contingency, State Courts, Number", "terseLabel": "Number of state courts" } } }, "localname": "LossContingencyStateCourtsNumber", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails" ], "xbrltype": "integerItemType" }, "mo_LossContingencyUnfavorableVerdictsPendingReversed": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Unfavorable Verdicts Pending/Reversed", "label": "Loss Contingency, Unfavorable Verdicts Pending/Reversed", "terseLabel": "Number of claims with unfavorable verdicts pending/reversed" } } }, "localname": "LossContingencyUnfavorableVerdictsPendingReversed", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails" ], "xbrltype": "integerItemType" }, "mo_LossContingencyVerdictReversedNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Verdict Reversed, Number", "label": "Loss Contingency, Verdict Reversed, Number", "terseLabel": "Number of verdicts reversed" } } }, "localname": "LossContingencyVerdictReversedNumber", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails", "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails" ], "xbrltype": "integerItemType" }, "mo_LossContingencyVerdictsUpheld": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Verdicts Upheld", "label": "Loss Contingency, Verdicts Upheld", "terseLabel": "Number of verdicts upheld" } } }, "localname": "LossContingencyVerdictsUpheld", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails" ], "xbrltype": "integerItemType" }, "mo_LossContingencyZeroDamagesVerdictModified": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Zero Damages Verdict Modified", "label": "Loss Contingency, Zero Damages Verdict Modified", "terseLabel": "Zero damages verdict modified" } } }, "localname": "LossContingencyZeroDamagesVerdictModified", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails" ], "xbrltype": "integerItemType" }, "mo_LossContingencyZeroDamagesVerdicts": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loss Contingency, Zero Damages Verdicts", "label": "Loss Contingency, Zero Damages Verdicts", "terseLabel": "Zero damages verdicts" } } }, "localname": "LossContingencyZeroDamagesVerdicts", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails" ], "xbrltype": "integerItemType" }, "mo_MarketingAdministrationandResearchCosts": { "auth_ref": [], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfEarnings": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as research and development costs and all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. Research and development costs represent the aggregate costs incurred during an accounting period to research and develop new products/technologies when the technological feasibility has not been reached. General and administrative expenses include salaries of nonsales personnel, rent, utilities, communication, etc.", "label": "Marketing, Administration and Research Costs", "terseLabel": "Marketing, administration and research costs" } } }, "localname": "MarketingAdministrationandResearchCosts", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfEarnings", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfEarningsAndComprehensiveEarningsDetails" ], "xbrltype": "monetaryItemType" }, "mo_MarylandMissouriNewMexicoandPennsylvaniaMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Maryland, Missouri, New Mexico and Pennsylvania [Member]", "label": "Maryland, Missouri, New Mexico and Pennsylvania [Member]", "terseLabel": "Maryland, Missouri, New Mexico and Pennsylvania [Member]" } } }, "localname": "MarylandMissouriNewMexicoandPennsylvaniaMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "domainItemType" }, "mo_MaximumBondForAllDefendants": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Maximum Bond For All Defendants", "label": "Maximum Bond For All Defendants", "terseLabel": "Maximum bond for all defendants" } } }, "localname": "MaximumBondForAllDefendants", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails" ], "xbrltype": "monetaryItemType" }, "mo_MeasurementInputWeightedAverageExpectedTermMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Measurement Input, Weighted Average Expected Term [Member]", "label": "Measurement Input, Weighted Average Expected Term [Member]", "terseLabel": "Weighted Average Expected Term [Member]" } } }, "localname": "MeasurementInputWeightedAverageExpectedTermMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails" ], "xbrltype": "domainItemType" }, "mo_NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted": { "auth_ref": [], "calculation": { "http://www.altria.com/role/EarningsPerShareBasicAndDilutedEarningsPerShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Net Income (Loss) Available to Common Stockholders, Basic and Diluted", "label": "Net Income (Loss) Available to Common Stockholders, Basic and Diluted", "totalLabel": "Earnings for basic and diluted EPS" } } }, "localname": "NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/EarningsPerShareBasicAndDilutedEarningsPerShareDetails" ], "xbrltype": "monetaryItemType" }, "mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts": { "auth_ref": [], "calculation": { "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsPreTaxAssetImpairmentExitAndImplementationCostsDetails": { "order": 2.0, "parentTag": "mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentRestructuringCharges", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component, Implementation Costs", "label": "Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component, Implementation Costs", "terseLabel": "Plus amounts included in net period benefit income, excluding service cost, Implementation Costs" } } }, "localname": "NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentImplementationCosts", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsPreTaxAssetImpairmentExitAndImplementationCostsDetails" ], "xbrltype": "monetaryItemType" }, "mo_NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentRestructuringCharges": { "auth_ref": [], "calculation": { "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsPreTaxAssetImpairmentExitAndImplementationCostsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsPreTaxAssetImpairmentExitAndImplementationCostsDetailsCalc2": { "order": 2.0, "parentTag": "us-gaap_RestructuringCharges", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component, Restructuring Charges", "label": "Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component, Restructuring Charges", "totalLabel": "Plus amounts included in net periodic benefit income, excluding service cost, Total" } } }, "localname": "NetPeriodicDefinedBenefitsExpenseReversalofExpenseExcludingServiceCostComponentRestructuringCharges", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsPreTaxAssetImpairmentExitAndImplementationCostsDetails" ], "xbrltype": "monetaryItemType" }, "mo_NetPeriodicDefinedBenefitsIncomeReversalofIncomeExcludingServiceCostComponentAssetImpairmentAndBusinessExitCosts": { "auth_ref": [], "calculation": { "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsPreTaxAssetImpairmentExitAndImplementationCostsDetails": { "order": 2.0, "parentTag": "mo_AssetImpairmentandBusinessExitCosts", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Net Periodic Defined Benefits Income (Reversal of Income), Excluding Service Cost Component, Asset Impairment And Business Exit Costs", "label": "Net Periodic Defined Benefits Income (Reversal of Income), Excluding Service Cost Component, Asset Impairment And Business Exit Costs", "terseLabel": "Plus amounts included in net periodic benefit income, excluding service cost, Asset Impairment and Exit Costs" } } }, "localname": "NetPeriodicDefinedBenefitsIncomeReversalofIncomeExcludingServiceCostComponentAssetImpairmentAndBusinessExitCosts", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsPreTaxAssetImpairmentExitAndImplementationCostsDetails" ], "xbrltype": "monetaryItemType" }, "mo_NonEngleProgenyCasesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Non Engle Progeny Cases [Member]", "label": "Non Engle Progeny Cases [Member]", "terseLabel": "Non Engle Progeny Cases [Member]" } } }, "localname": "NonEngleProgenyCasesMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails" ], "xbrltype": "domainItemType" }, "mo_NonEngleProgenySmokingAndHealthCasePrincipeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Non-Engle Progeny Smoking And Health Case, Principe", "label": "Non-Engle Progeny Smoking And Health Case, Principe [Member]", "terseLabel": "Non-Engle Progeny Smoking And Health Case, Principe [Member]" } } }, "localname": "NonEngleProgenySmokingAndHealthCasePrincipeMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails" ], "xbrltype": "domainItemType" }, "mo_NonEngleProgenySmokingandHealthCaseGentileMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Non-Engle Progeny Smoking and Health Case, Gentile", "label": "Non-Engle Progeny Smoking and Health Case, Gentile [Member]", "terseLabel": "Non-Engle Progeny Smoking and Health Case, Gentile [Member]" } } }, "localname": "NonEngleProgenySmokingandHealthCaseGentileMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails" ], "xbrltype": "domainItemType" }, "mo_NonEngleProgenySmokingandHealthCaseGreeneMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Non-Engle Progeny Smoking and Health Case, Greene [Member]", "label": "Non-Engle Progeny Smoking and Health Case, Greene [Member]", "terseLabel": "Non-Engle Progeny Smoking and Health Case, Greene [Member]" } } }, "localname": "NonEngleProgenySmokingandHealthCaseGreeneMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails" ], "xbrltype": "domainItemType" }, "mo_NonEngleProgenySmokingandHealthCaseLaramieMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Non-Engle Progeny Smoking and Health Case, Laramie [Member] [Member]", "label": "Non-Engle Progeny Smoking and Health Case, Laramie [Member]", "terseLabel": "Non-Engle Progeny Smoking and Health Case, Laramie [Member]" } } }, "localname": "NonEngleProgenySmokingandHealthCaseLaramieMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails" ], "xbrltype": "domainItemType" }, "mo_NumberofDirectorsNominated": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of Directors Nominated", "label": "Number of Directors Nominated", "terseLabel": "Number of directors nominated" } } }, "localname": "NumberofDirectorsNominated", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInCronosNarrativeDetails" ], "xbrltype": "integerItemType" }, "mo_NumberofMembersOntheBoardofDirectors": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of Members On the Board of Directors", "label": "Number of Members On the Board of Directors", "terseLabel": "Number of members on the Board of Directors" } } }, "localname": "NumberofMembersOntheBoardofDirectors", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInCronosNarrativeDetails" ], "xbrltype": "integerItemType" }, "mo_OralTobaccoSegmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Oral Tobacco Segment [Member]", "label": "Oral Tobacco Segment [Member]", "verboseLabel": "Oral Tobacco Segment [Member]" } } }, "localname": "OralTobaccoSegmentMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsPreTaxAssetImpairmentExitAndImplementationCostsDetails", "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" ], "xbrltype": "domainItemType" }, "mo_OtherAccruedLiabilitiesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Other Accrued Liabilities [Member]", "label": "Other Accrued Liabilities [Member]", "terseLabel": "Other Accrued Liabilities [Member]" } } }, "localname": "OtherAccruedLiabilitiesMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "mo_OtherComprehensiveIncomeLossFromEquityMethodInvestmentAdjustmentNetOfTax": { "auth_ref": [], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfComprehensiveEarnings": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Other Comprehensive Income (Loss) From Equity Method Investment, Adjustment", "label": "Other Comprehensive Income (Loss) From Equity Method Investment, Adjustment, Net Of Tax", "terseLabel": "ABI" } } }, "localname": "OtherComprehensiveIncomeLossFromEquityMethodInvestmentAdjustmentNetOfTax", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfComprehensiveEarnings" ], "xbrltype": "monetaryItemType" }, "mo_OtherDisputesUndertheStateSettlementAgreementsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Other Disputes Under the State Settlement Agreements [Member]", "label": "Other Disputes Under the State Settlement Agreements [Member]", "terseLabel": "Other Disputes Under the State Settlement Agreements [Member]" } } }, "localname": "OtherDisputesUndertheStateSettlementAgreementsMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesOtherDisputesUnderStateSettlementAgreementsDetails" ], "xbrltype": "domainItemType" }, "mo_OtherInventoryRawMaterialsNetofReserves": { "auth_ref": [], "calculation": { "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Other Inventory, Raw Materials, Net of Reserves", "label": "Other Inventory, Raw Materials, Net of Reserves", "terseLabel": "Other raw materials" } } }, "localname": "OtherInventoryRawMaterialsNetofReserves", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "mo_OtherRestructuringCostsIncludingNetPensionCostCredit": { "auth_ref": [], "calculation": { "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsPreTaxAssetImpairmentExitAndImplementationCostsDetails": { "order": 2.0, "parentTag": "mo_RestructuringChargesIncludingNetPensionCostCredit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Other Restructuring Costs, Including Net Pension Cost (Credit)", "label": "Other Restructuring Costs, Including Net Pension Cost (Credit)", "terseLabel": "Total, Implementation Costs" } } }, "localname": "OtherRestructuringCostsIncludingNetPensionCostCredit", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsPreTaxAssetImpairmentExitAndImplementationCostsDetails" ], "xbrltype": "monetaryItemType" }, "mo_OtherTabaccoRelatedCasesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Other Tabacco-Related Cases [Member]", "label": "Other Tabacco-Related Cases [Member]", "terseLabel": "Other Tabacco-Related Cases [Member]" } } }, "localname": "OtherTabaccoRelatedCasesMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails", "http://www.altria.com/role/ContingenciesScheduleOfPendingCasesDetails" ], "xbrltype": "domainItemType" }, "mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted": { "auth_ref": [], "calculation": { "http://www.altria.com/role/EarningsPerShareBasicAndDilutedEarningsPerShareDetails": { "order": 2.0, "parentTag": "mo_NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Participating Securities, Distributed and Undistributed Earnings (Loss), Basic and Diluted", "label": "Participating Securities, Distributed and Undistributed Earnings (Loss), Basic and Diluted", "negatedLabel": "Less: Distributed and undistributed earnings attributable to share-based awards" } } }, "localname": "ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/EarningsPerShareBasicAndDilutedEarningsPerShareDetails" ], "xbrltype": "monetaryItemType" }, "mo_PaymentsToAcquireEquityMethodInvestmentsAndDerivativeInstrumentsInvestingActivities": { "auth_ref": [], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Payments To Acquire Equity Method Investments And Derivative Instruments, Investing Activities", "label": "Payments To Acquire Equity Method Investments And Derivative Instruments, Investing Activities", "negatedTerseLabel": "Investment in Cronos" } } }, "localname": "PaymentsToAcquireEquityMethodInvestmentsAndDerivativeInstrumentsInvestingActivities", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "mo_PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Payments to Acquire Equity Method Investments and Derivative Instruments, Investing", "label": "Payments to Acquire Equity Method Investments and Derivative Instruments, Investing", "terseLabel": "Equity method investments, purchase price" } } }, "localname": "PaymentstoAcquireEquityMethodInvestmentsandDerivativeInstrumentsInvesting", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInCronosNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Payments to Acquire Equity Securities Without Readily Determinable Fair Value", "label": "Payments to Acquire Equity Securities Without Readily Determinable Fair Value", "terseLabel": "Payments to acquire equity securities" } } }, "localname": "PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInJuulNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "mo_PendingIndividualLawsuitsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Pending Individual Lawsuits [Member]", "label": "Pending Individual Lawsuits [Member]", "terseLabel": "Pending Individual Lawsuits [Member]" } } }, "localname": "PendingIndividualLawsuitsMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEVaporProductLitigationDetails", "http://www.altria.com/role/ContingenciesScheduleOfPendingCasesDetails", "http://www.altria.com/role/ContingenciesUstLitigationsNarrativeDetails" ], "xbrltype": "domainItemType" }, "mo_PendingLawsuitFiledBySchoolDistrictMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Pending Lawsuit Filed By School District [Member]", "label": "Pending Lawsuit Filed By School District [Member]", "terseLabel": "Pending Lawsuit Filed By School District [Member]" } } }, "localname": "PendingLawsuitFiledBySchoolDistrictMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesScheduleOfPendingCasesDetails" ], "xbrltype": "domainItemType" }, "mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Pending Lawsuits Filed By State Or Local Governments [Member]", "label": "Pending Lawsuits Filed By State Or Local Governments [Member]", "terseLabel": "Pending Lawsuits Filed By State Or Local Governments [Member]" } } }, "localname": "PendingLawsuitsFiledByStateOrLocalGovernmentsMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesScheduleOfPendingCasesDetails" ], "xbrltype": "domainItemType" }, "mo_PhilipMorrisUSAMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Philip Morris USA [Member]", "label": "Philip Morris USA [Member]", "terseLabel": "PM USA [Member]" } } }, "localname": "PhilipMorrisUSAMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails", "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails", "http://www.altria.com/role/ContingenciesJudgmentsPaidAndProvisionsForTobaccoAndHealthLitigationDetails", "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails", "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails", "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails", "http://www.altria.com/role/ContingenciesOtherDisputesUnderStateSettlementAgreementsDetails", "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails", "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails", "http://www.altria.com/role/ContingenciesScheduleOfPendingCasesDetails", "http://www.altria.com/role/SegmentReportingScheduleOfTobaccoAndHealthLitigationItemsDetails" ], "xbrltype": "domainItemType" }, "mo_PhilipMorrisUSAandAltriaGroupMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Philip Morris USA and Altria Group [Member]", "label": "Philip Morris USA and Altria Group [Member]", "terseLabel": "Philip Morris USA and Altria Group [Member]" } } }, "localname": "PhilipMorrisUSAandAltriaGroupMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails", "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails" ], "xbrltype": "domainItemType" }, "mo_PreTaxChargesGainIncludedinNetEarning": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Pre-Tax Charges (Gain) Included in Net Earning", "label": "Pre-Tax Charges (Gain) Included in Net Earning", "terseLabel": "Pre-tax charges (gain) included in net earning" } } }, "localname": "PreTaxChargesGainIncludedinNetEarning", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "monetaryItemType" }, "mo_PreTrialResolutionMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Pre-Trial Resolution [Member]", "label": "Pre-Trial Resolution [Member]", "terseLabel": "Pre-Trial Resolution [Member]" } } }, "localname": "PreTrialResolutionMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesJudgmentsPaidAndProvisionsForTobaccoAndHealthLitigationDetails" ], "xbrltype": "domainItemType" }, "mo_RestructuringChargesIncludingNetPensionCostCredit": { "auth_ref": [], "calculation": { "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsPreTaxAssetImpairmentExitAndImplementationCostsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsPreTaxAssetImpairmentExitAndImplementationCostsDetailsCalc2": { "order": 1.0, "parentTag": "us-gaap_RestructuringCharges", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Restructuring Charges, Including Net Pension Cost (Credit)", "label": "Restructuring Charges, Including Net Pension Cost (Credit)", "totalLabel": "Total restructuring" } } }, "localname": "RestructuringChargesIncludingNetPensionCostCredit", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsPreTaxAssetImpairmentExitAndImplementationCostsDetails" ], "xbrltype": "monetaryItemType" }, "mo_RevolvingCreditFacilityDueAugust2023Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Revolving Credit Facility Due August 2023 [Member]", "label": "Revolving Credit Facility Due August 2023 [Member]", "terseLabel": "Revolving Credit Facility Due August 2023 [Member]" } } }, "localname": "RevolvingCreditFacilityDueAugust2023Member", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "[Line Items] for Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]", "label": "Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]", "terseLabel": "Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]" } } }, "localname": "ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/SegmentReportingScheduleOfTobaccoAndHealthLitigationItemsDetails" ], "xbrltype": "stringItemType" }, "mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]", "label": "Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]", "terseLabel": "Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]" } } }, "localname": "ScheduleofPretaxTobaccoandHealthLitigationChargesTable", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/SegmentReportingScheduleOfTobaccoAndHealthLitigationItemsDetails" ], "xbrltype": "stringItemType" }, "mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "[Table Text Block] for Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]", "label": "Schedule of Pre-tax Tobacco and Health Litigation Charges [Table Text Block]", "terseLabel": "Schedule of Pre-tax Tobacco and Health Litigation Items" } } }, "localname": "ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/SegmentReportingTables" ], "xbrltype": "textBlockItemType" }, "mo_SmokeableProductsSegmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Smokeable Products Segment [Member]", "label": "Smokeable Products Segment [Member]", "terseLabel": "Smokeable Products Segment [Member]" } } }, "localname": "SmokeableProductsSegmentMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsPreTaxAssetImpairmentExitAndImplementationCostsDetails", "http://www.altria.com/role/SegmentReportingScheduleOfTobaccoAndHealthLitigationItemsDetails", "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" ], "xbrltype": "domainItemType" }, "mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Smoking and Health Class Actions and Aggregated Claims Litigation\n[Member]", "label": "Smoking And Health Class Actions And Aggregated Claims Litigation [Member]", "terseLabel": "Smoking and Health Class Actions and Aggregated Claims Litigation [Member]" } } }, "localname": "SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails", "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails", "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails" ], "xbrltype": "domainItemType" }, "mo_StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Stock Repurchase Program, Rescinded Authorized Repurchase Amount", "label": "Stock Repurchase Program, Rescinded Authorized Repurchase Amount", "terseLabel": "Stock repurchase program, remaining authorized repurchase amount" } } }, "localname": "StockRepurchaseProgramRescindedAuthorizedRepurchaseAmount", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/BackgroundAndBasisOfPresentationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "mo_TobaccoandHealthJudgmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tobacco and Health Judgment [Member]", "label": "Tobacco and Health Judgment [Member]", "terseLabel": "Tobacco and Health Judgment [Member]" } } }, "localname": "TobaccoandHealthJudgmentMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesJudgmentsPaidAndProvisionsForTobaccoAndHealthLitigationDetails" ], "xbrltype": "domainItemType" }, "mo_TobaccoandHealthLitigationCasesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tobacco and Health Litigation Cases [Member]", "label": "Tobacco and Health Litigation Cases [Member]", "terseLabel": "Tobacco and Health Litigation Cases [Member]" } } }, "localname": "TobaccoandHealthLitigationCasesMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/SegmentReportingScheduleOfTobaccoAndHealthLitigationItemsDetails" ], "xbrltype": "domainItemType" }, "mo_USTLitigationMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "UST Litigation [Member]", "label": "UST Litigation [Member]", "terseLabel": "UST Litigation [Member]" } } }, "localname": "USTLitigationMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/ContingenciesUstLitigationsNarrativeDetails" ], "xbrltype": "domainItemType" }, "mo_WineBusinessStrategicResetMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Wine Business Strategic Reset [Member]", "label": "Wine Business Strategic Reset [Member]", "terseLabel": "Wine Business Strategic Reset [Member]" } } }, "localname": "WineBusinessStrategicResetMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsNarrativeDetails" ], "xbrltype": "domainItemType" }, "mo_WineSegmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Wine Segment [Member]", "label": "Wine Segment [Member]", "terseLabel": "Wine Segment [Member]" } } }, "localname": "WineSegmentMember", "nsuri": "http://www.altria.com/20200331", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsPreTaxAssetImpairmentExitAndImplementationCostsDetails", "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" ], "xbrltype": "domainItemType" }, "srt_CondensedBalanceSheetStatementTable": { "auth_ref": [ "r118", "r289", "r417" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations.", "label": "Condensed Balance Sheet Statement [Table]", "terseLabel": "Condensed Balance Sheet Statement [Table]" } } }, "localname": "CondensedBalanceSheetStatementTable", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "stringItemType" }, "srt_CondensedBalanceSheetStatementsCaptionsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Condensed Balance Sheet Statements, Captions [Line Items]", "terseLabel": "Condensed Balance Sheet Statements, Captions [Line Items]" } } }, "localname": "CondensedBalanceSheetStatementsCaptionsLineItems", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "stringItemType" }, "srt_CondensedCashFlowStatementTable": { "auth_ref": [ "r118", "r289", "r418" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations.", "label": "Condensed Cash Flow Statement [Table]", "terseLabel": "Condensed Cash Flow Statement [Table]" } } }, "localname": "CondensedCashFlowStatementTable", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails" ], "xbrltype": "stringItemType" }, "srt_CondensedCashFlowStatementsCaptionsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Condensed Cash Flow Statements, Captions [Line Items]", "terseLabel": "Condensed Cash Flow Statements, Captions [Line Items]" } } }, "localname": "CondensedCashFlowStatementsCaptionsLineItems", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails" ], "xbrltype": "stringItemType" }, "srt_CondensedFinancialStatementsTextBlock": { "auth_ref": [ "r118", "r418", "r419", "r422", "r423", "r424" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for condensed financial statements.", "label": "Condensed Financial Statements [Text Block]", "terseLabel": "Condensed Consolidating Financial Information" } } }, "localname": "CondensedFinancialStatementsTextBlock", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatingFinancialInformation" ], "xbrltype": "textBlockItemType" }, "srt_CondensedIncomeStatementTable": { "auth_ref": [ "r118", "r289", "r418" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about condensed income statement including, but not limited to, income statements of consolidated entities and consolidation eliminations.", "label": "Condensed Income Statement [Table]", "terseLabel": "Condensed Income Statement [Table]" } } }, "localname": "CondensedIncomeStatementTable", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfEarningsAndComprehensiveEarningsDetails" ], "xbrltype": "stringItemType" }, "srt_CondensedIncomeStatementsCaptionsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Condensed Income Statements, Captions [Line Items]", "terseLabel": "Condensed Income Statements, Captions [Line Items]" } } }, "localname": "CondensedIncomeStatementsCaptionsLineItems", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfEarningsAndComprehensiveEarningsDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r406", "r415" ], "lang": { "en-US": { "role": { "documentation": "Information by consolidated entity or group of entities.", "label": "Consolidated Entities [Axis]", "terseLabel": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfEarningsAndComprehensiveEarningsDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Entity or group of entities consolidated into reporting entity.", "label": "Consolidated Entities [Domain]", "terseLabel": "Consolidated Entities [Domain]" } } }, "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfEarningsAndComprehensiveEarningsDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidationEliminationsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Eliminating entries used in consolidating a parent entity and its subsidiaries.", "label": "Consolidation, Eliminations [Member]", "terseLabel": "Total Consolidating Adjustments [Member]" } } }, "localname": "ConsolidationEliminationsMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfEarningsAndComprehensiveEarningsDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r137", "r146" ], "lang": { "en-US": { "role": { "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.", "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsPreTaxAssetImpairmentExitAndImplementationCostsDetails", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfEarningsAndComprehensiveEarningsDetails", "http://www.altria.com/role/SegmentReportingScheduleOfTobaccoAndHealthLitigationItemsDetails", "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.", "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsPreTaxAssetImpairmentExitAndImplementationCostsDetails", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfEarningsAndComprehensiveEarningsDetails", "http://www.altria.com/role/SegmentReportingScheduleOfTobaccoAndHealthLitigationItemsDetails", "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" ], "xbrltype": "domainItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of investment, including named security. Excludes consolidated entity.", "label": "Investment, Name [Domain]", "terseLabel": "Investment, Name [Domain]", "verboseLabel": "Investment, Name [Domain]" } } }, "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.altria.com/role/BackgroundAndBasisOfPresentationNarrativeDetails", "http://www.altria.com/role/ContingenciesAntitrustLitigationDetails", "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesEarningsInEquitySecuritiesDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInAbiNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInCronosNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInJuulNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesSummaryOfInvestmentsDetails" ], "xbrltype": "domainItemType" }, "srt_GuarantorSubsidiariesMember": { "auth_ref": [ "r218", "r420" ], "lang": { "en-US": { "role": { "documentation": "Entity owned or controlled by another entity which has guaranteed the issue of securities by another subsidiary of the parent or has guaranteed the issue of securities by the parent.", "label": "Guarantor Subsidiaries [Member]", "terseLabel": "PM USA [Member]", "verboseLabel": "PM USA [Member]" } } }, "localname": "GuarantorSubsidiariesMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfEarningsAndComprehensiveEarningsDetails" ], "xbrltype": "domainItemType" }, "srt_LitigationCaseAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of judicial proceeding, alternative dispute resolution or claim.", "label": "Litigation Case [Axis]", "terseLabel": "Litigation Case [Axis]" } } }, "localname": "LitigationCaseAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesEVaporProductLitigationDetails", "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails", "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails", "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails", "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails", "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails", "http://www.altria.com/role/ContingenciesJudgmentsPaidAndProvisionsForTobaccoAndHealthLitigationDetails", "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails", "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails", "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails", "http://www.altria.com/role/ContingenciesOtherDisputesUnderStateSettlementAgreementsDetails", "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails", "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails", "http://www.altria.com/role/ContingenciesScheduleOfPendingCasesDetails", "http://www.altria.com/role/ContingenciesUstLitigationsNarrativeDetails", "http://www.altria.com/role/SegmentReportingScheduleOfTobaccoAndHealthLitigationItemsDetails" ], "xbrltype": "stringItemType" }, "srt_LitigationCaseTypeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Judicial proceeding, alternative dispute resolution or claim. For example, but not limited to, name of case, category of litigation, or other differentiating information.", "label": "Litigation Case [Domain]", "terseLabel": "Litigation Case [Domain]", "verboseLabel": "Litigation Case [Domain]" } } }, "localname": "LitigationCaseTypeDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesEVaporProductLitigationDetails", "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails", "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails", "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails", "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails", "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails", "http://www.altria.com/role/ContingenciesJudgmentsPaidAndProvisionsForTobaccoAndHealthLitigationDetails", "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails", "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails", "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails", "http://www.altria.com/role/ContingenciesOtherDisputesUnderStateSettlementAgreementsDetails", "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails", "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails", "http://www.altria.com/role/ContingenciesScheduleOfPendingCasesDetails", "http://www.altria.com/role/ContingenciesUstLitigationsNarrativeDetails", "http://www.altria.com/role/SegmentReportingScheduleOfTobaccoAndHealthLitigationItemsDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum [Member]", "terseLabel": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.altria.com/role/BenefitPlansNarrativeDetails", "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum [Member]", "terseLabel": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails" ], "xbrltype": "domainItemType" }, "srt_NonGuarantorSubsidiariesMember": { "auth_ref": [ "r219", "r421" ], "lang": { "en-US": { "role": { "documentation": "Entity owned or controlled by another entity which has not guaranteed the issue of securities by another subsidiary of the parent or has not guaranteed the issue of securities by the parent.", "label": "Non-Guarantor Subsidiaries [Member]", "terseLabel": "Non-Guarantor Subsidiaries [Member]" } } }, "localname": "NonGuarantorSubsidiariesMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfEarningsAndComprehensiveEarningsDetails" ], "xbrltype": "domainItemType" }, "srt_OwnershipAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.", "label": "Ownership [Axis]", "terseLabel": "Ownership [Axis]" } } }, "localname": "OwnershipAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.altria.com/role/BackgroundAndBasisOfPresentationNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_OwnershipDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.", "label": "Ownership [Domain]", "terseLabel": "Ownership [Domain]" } } }, "localname": "OwnershipDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.altria.com/role/BackgroundAndBasisOfPresentationNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ParentCompanyMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The registrant that controls, directly or indirectly, another entity (or entities). The usual condition for control is ownership of a majority (over 50%) of the outstanding voting stock. The power to control may also exist with a lesser percentage of ownership, for example, by contract, lease, agreement with other stockholders or by court decree.", "label": "Parent Company [Member]", "terseLabel": "Altria Group, Inc. [Member]" } } }, "localname": "ParentCompanyMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfEarningsAndComprehensiveEarningsDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.altria.com/role/BenefitPlansNarrativeDetails", "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.altria.com/role/BenefitPlansNarrativeDetails", "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails" ], "xbrltype": "domainItemType" }, "srt_ReportableLegalEntitiesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Legal entities of the consolidated entity reporting separate financial information in the entity's financial statements.", "label": "Reportable Legal Entities [Member]", "terseLabel": "Reportable Legal Entities [Member]" } } }, "localname": "ReportableLegalEntitiesMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfEarningsAndComprehensiveEarningsDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [ "r413" ], "lang": { "en-US": { "role": { "documentation": "Information reported for future period.", "label": "Forecast [Member]", "terseLabel": "Forecast [Member]" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.", "label": "Scenario [Domain]", "terseLabel": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfCondensedBalanceSheetTableTextBlock": { "auth_ref": [ "r425" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations.", "label": "Condensed Balance Sheet [Table Text Block]", "terseLabel": "Condensed Consolidating Balance Sheet" } } }, "localname": "ScheduleOfCondensedBalanceSheetTableTextBlock", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatingFinancialInformationTables" ], "xbrltype": "textBlockItemType" }, "srt_ScheduleOfCondensedCashFlowStatementTableTextBlock": { "auth_ref": [ "r425" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations.", "label": "Condensed Cash Flow Statement [Table Text Block]", "verboseLabel": "Condensed Consolidating Statements of Cash Flows" } } }, "localname": "ScheduleOfCondensedCashFlowStatementTableTextBlock", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatingFinancialInformationTables" ], "xbrltype": "textBlockItemType" }, "srt_ScheduleOfCondensedIncomeStatementTableTextBlock": { "auth_ref": [ "r425" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations.", "label": "Condensed Income Statement [Table Text Block]", "verboseLabel": "Condensed Consolidating Statements of Earnings and Comprehensive Earnings" } } }, "localname": "ScheduleOfCondensedIncomeStatementTableTextBlock", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatingFinancialInformationTables" ], "xbrltype": "textBlockItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r161" ], "lang": { "en-US": { "role": { "documentation": "Information by name of investment, including named security. Excludes consolidated entity.", "label": "Investment, Name [Axis]", "terseLabel": "Investment, Name [Axis]", "verboseLabel": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.altria.com/role/BackgroundAndBasisOfPresentationNarrativeDetails", "http://www.altria.com/role/ContingenciesAntitrustLitigationDetails", "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesEarningsInEquitySecuritiesDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInAbiNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInCronosNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInJuulNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesSummaryOfInvestmentsDetails" ], "xbrltype": "stringItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Geographical area.", "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails", "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails", "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails", "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails", "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails", "http://www.altria.com/role/ContingenciesScheduleOfPendingCasesDetails", "http://www.altria.com/role/ContingenciesUstLitigationsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r149", "r241", "r243", "r399", "r403", "r405", "r414", "r416" ], "lang": { "en-US": { "role": { "documentation": "Information by geographical components.", "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails", "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails", "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails", "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails", "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails", "http://www.altria.com/role/ContingenciesScheduleOfPendingCasesDetails", "http://www.altria.com/role/ContingenciesUstLitigationsNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r205", "r357" ], "lang": { "en-US": { "role": { "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.", "label": "Scenario [Axis]", "terseLabel": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsNarrativeDetails" ], "xbrltype": "stringItemType" }, "stpr_AK": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "ALASKA", "terseLabel": "Alaska [Member]" } } }, "localname": "AK", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails" ], "xbrltype": "domainItemType" }, "stpr_AR": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "ARKANSAS", "terseLabel": "Arkansas [Member]" } } }, "localname": "AR", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails" ], "xbrltype": "domainItemType" }, "stpr_CA": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "CALIFORNIA", "terseLabel": "California [Member]" } } }, "localname": "CA", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails", "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails", "http://www.altria.com/role/ContingenciesUstLitigationsNarrativeDetails" ], "xbrltype": "domainItemType" }, "stpr_CT": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "CONNECTICUT", "terseLabel": "Connecticut [Member]" } } }, "localname": "CT", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails" ], "xbrltype": "domainItemType" }, "stpr_DC": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "DISTRICT OF COLUMBIA", "terseLabel": "District of Columbia [Member]" } } }, "localname": "DC", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails" ], "xbrltype": "domainItemType" }, "stpr_DE": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "DELAWARE", "terseLabel": "Delaware [Member]" } } }, "localname": "DE", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails" ], "xbrltype": "domainItemType" }, "stpr_FL": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "FLORIDA", "terseLabel": "Florida [Member]" } } }, "localname": "FL", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails", "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails", "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails", "http://www.altria.com/role/ContingenciesScheduleOfPendingCasesDetails" ], "xbrltype": "domainItemType" }, "stpr_IA": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "IOWA", "terseLabel": "Iowa [Member]" } } }, "localname": "IA", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails" ], "xbrltype": "domainItemType" }, "stpr_IL": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "ILLINOIS", "terseLabel": "Illinois [Member]" } } }, "localname": "IL", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails" ], "xbrltype": "domainItemType" }, "stpr_KS": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "KANSAS", "terseLabel": "Kansas [Member]" } } }, "localname": "KS", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails" ], "xbrltype": "domainItemType" }, "stpr_LA": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "LOUISIANA", "terseLabel": "Louisiana [Member]" } } }, "localname": "LA", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails", "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails" ], "xbrltype": "domainItemType" }, "stpr_MA": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "MASSACHUSETTS", "verboseLabel": "Massachusetts [Member]" } } }, "localname": "MA", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails", "http://www.altria.com/role/ContingenciesScheduleOfPendingCasesDetails" ], "xbrltype": "domainItemType" }, "stpr_MD": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "MARYLAND", "terseLabel": "Maryland [Member]" } } }, "localname": "MD", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails" ], "xbrltype": "domainItemType" }, "stpr_MI": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "MICHIGAN", "terseLabel": "Michigan [Member]" } } }, "localname": "MI", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails" ], "xbrltype": "domainItemType" }, "stpr_MN": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "MINNESOTA", "terseLabel": "Minnesota [Member]" } } }, "localname": "MN", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails" ], "xbrltype": "domainItemType" }, "stpr_MO": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "MISSOURI", "terseLabel": "Missouri [Member]" } } }, "localname": "MO", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails" ], "xbrltype": "domainItemType" }, "stpr_MS": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "MISSISSIPPI", "terseLabel": "Mississippi [Member]" } } }, "localname": "MS", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails" ], "xbrltype": "domainItemType" }, "stpr_NH": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "NEW HAMPSHIRE", "terseLabel": "New Hampshire [Member]" } } }, "localname": "NH", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails" ], "xbrltype": "domainItemType" }, "stpr_NJ": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "NEW JERSEY", "terseLabel": "New Jersey [Member]" } } }, "localname": "NJ", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails", "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails" ], "xbrltype": "domainItemType" }, "stpr_NV": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "NEVADA", "terseLabel": "Nevada [Member]" } } }, "localname": "NV", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails" ], "xbrltype": "domainItemType" }, "stpr_NY": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "NEW YORK", "terseLabel": "New York [Member]" } } }, "localname": "NY", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails", "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails", "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails" ], "xbrltype": "domainItemType" }, "stpr_OH": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "OHIO", "terseLabel": "Ohio [Member]" } } }, "localname": "OH", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails", "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails" ], "xbrltype": "domainItemType" }, "stpr_OK": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "OKLAHOMA", "terseLabel": "Oklahoma [Member]" } } }, "localname": "OK", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails" ], "xbrltype": "domainItemType" }, "stpr_OR": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "OREGON", "terseLabel": "Oregon [Member]" } } }, "localname": "OR", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails" ], "xbrltype": "domainItemType" }, "stpr_PA": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "PENNSYLVANIA", "terseLabel": "Pennsylvania [Member]" } } }, "localname": "PA", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails", "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails" ], "xbrltype": "domainItemType" }, "stpr_RI": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "RHODE ISLAND", "terseLabel": "Rhode Island [Member]" } } }, "localname": "RI", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails" ], "xbrltype": "domainItemType" }, "stpr_SC": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "SOUTH CAROLINA", "terseLabel": "South Carolina [Member]" } } }, "localname": "SC", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails" ], "xbrltype": "domainItemType" }, "stpr_TN": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "TENNESSEE", "terseLabel": "Tennessee [Member]" } } }, "localname": "TN", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails" ], "xbrltype": "domainItemType" }, "stpr_TX": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "TEXAS", "terseLabel": "Texas [Member]" } } }, "localname": "TX", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails" ], "xbrltype": "domainItemType" }, "stpr_WI": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "WISCONSIN", "terseLabel": "Wisconsin [Member]" } } }, "localname": "WI", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails" ], "xbrltype": "domainItemType" }, "stpr_WV": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "WEST VIRGINIA", "terseLabel": "West Virginia [Member]" } } }, "localname": "WV", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]", "terseLabel": "Accumulated Other Comprehensive Income [Roll Forward]" } } }, "localname": "AOCIAttributableToParentNetOfTaxRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesInEachComponentOfAccumulatedOtherComprehensiveLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r40" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "verboseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesCurrent": { "auth_ref": [ "r18", "r368", "r383" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails": { "order": 8.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.", "label": "Accrued Income Taxes, Current", "terseLabel": "Income taxes" } } }, "localname": "AccruedIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Accrued Liabilities, Current [Abstract]", "terseLabel": "Accrued liabilities:" } } }, "localname": "AccruedLiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccruedMarketingCostsCurrent": { "auth_ref": [], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services. Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Marketing Costs, Current", "terseLabel": "Marketing" } } }, "localname": "AccruedMarketingCostsCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "auth_ref": [ "r64", "r71", "r73", "r264", "r298" ], "lang": { "en-US": { "role": { "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "terseLabel": "Benefit Plans [Member]" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesInEachComponentOfAccumulatedOtherComprehensiveLossesDetails", "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember": { "auth_ref": [ "r66", "r71", "r73", "r263", "r298" ], "lang": { "en-US": { "role": { "documentation": "Accumulated other comprehensive (income) loss related to prior service cost (credit) component of defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent [Member]", "terseLabel": "Prior service cost/credit [Member]" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember": { "auth_ref": [ "r63", "r71", "r73", "r263", "r298" ], "lang": { "en-US": { "role": { "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]", "terseLabel": "Net loss [Member]" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r38", "r186" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "terseLabel": "Less accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesInEachComponentOfAccumulatedOtherComprehensiveLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r68", "r70", "r71" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "verboseLabel": "Accumulated other comprehensive losses" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesInEachComponentOfAccumulatedOtherComprehensiveLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r67", "r71", "r73", "r298" ], "lang": { "en-US": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "verboseLabel": "Accumulated Other Comprehensive Losses [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfStockholdersEquity", "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesInEachComponentOfAccumulatedOtherComprehensiveLossesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r61", "r71", "r73", "r298" ], "lang": { "en-US": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "terseLabel": "Currency Translation Adjustments and Other [Member]" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesInEachComponentOfAccumulatedOtherComprehensiveLossesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r27" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid in Capital, Common Stock", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net earnings to operating cash flows:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllOtherSegmentsMember": { "auth_ref": [ "r130", "r131", "r132", "r133", "r134", "r135" ], "lang": { "en-US": { "role": { "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items.", "label": "Other Segments [Member]", "terseLabel": "All Other [Member]" } } }, "localname": "AllOtherSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsPreTaxAssetImpairmentExitAndImplementationCostsDetails", "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r107", "r182", "r184" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "negatedLabel": "Amortization of intangibles" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r141", "r366", "r382" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets [Abstract]", "verboseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r4", "r5", "r57" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets [Member]", "terseLabel": "Assets [Member]" } } }, "localname": "AssetsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesJudgmentsPaidAndProvisionsForTobaccoAndHealthLitigationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesJudgmentsPaidAndProvisionsForTobaccoAndHealthLitigationDetails", "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r311", "r316" ], "lang": { "en-US": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesJudgmentsPaidAndProvisionsForTobaccoAndHealthLitigationDetails", "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r286", "r287", "r288" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "terseLabel": "Business Combination, Consideration Transferred" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/BackgroundAndBasisOfPresentationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CarryingReportedAmountFairValueDisclosureMember": { "auth_ref": [ "r344", "r345" ], "lang": { "en-US": { "role": { "documentation": "Measured as reported on the statement of financial position (balance sheet).", "label": "Reported Value Measurement [Member]", "terseLabel": "Reported Value Measurement [Member]" } } }, "localname": "CarryingReportedAmountFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r2", "r35", "r109" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 }, "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]", "terseLabel": "Cash, cash equivalents and restricted cash:" } } }, "localname": "CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r102", "r109", "r110" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Balance at end of period", "periodStartLabel": "Balance at beginning of period", "totalLabel": "Cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r102", "r347" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Increase (decrease)" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries": { "auth_ref": [ "r119" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "This element represents disclosure of the aggregate cash dividends paid to the entity by consolidated subsidiaries.", "label": "SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Consolidated Subsidiaries", "terseLabel": "Cash dividends paid to parent" } } }, "localname": "CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfTreasuryStockTable": { "auth_ref": [ "r233", "r234", "r235", "r236" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.", "label": "Class of Treasury Stock [Table]", "terseLabel": "Class of Treasury Stock [Table]" } } }, "localname": "ClassOfTreasuryStockTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/BackgroundAndBasisOfPresentationNarrativeDetails", "http://www.altria.com/role/BackgroundAndBasisOfPresentationShareRepurchaseTableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r50", "r204", "r374", "r392" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Contingencies", "verboseLabel": "Contingencies (Note 11)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommonStockDividendsPerShareDeclared": { "auth_ref": [ "r232" ], "lang": { "en-US": { "role": { "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.", "label": "Common Stock, Dividends, Per Share, Declared", "verboseLabel": "Dividends declared (usd per share)" } } }, "localname": "CommonStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfStockholdersEquityParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfStockholdersEquity", "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInCronosNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesSummaryOfInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r25" ], "lang": { "en-US": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (usd per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r25" ], "lang": { "en-US": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued (shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r25" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, par value $0.33 1/3 per share (2,805,961,317 shares issued)", "verboseLabel": "Common stock" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Retirement Benefits [Abstract]" } } }, "localname": "CompensationAndRetirementDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r76", "r78", "r79" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfComprehensiveEarnings": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive earnings attributable to Altria" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfComprehensiveEarnings", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfEarningsAndComprehensiveEarningsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r76", "r78", "r293", "r294", "r301" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfComprehensiveEarnings": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "negatedLabel": "Comprehensive earnings attributable to noncontrolling interests", "negatedTerseLabel": "Comprehensive (earnings) losses attributable to noncontrolling interests" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfComprehensiveEarnings", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfEarningsAndComprehensiveEarningsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r76", "r78", "r292", "r301" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfComprehensiveEarnings": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Comprehensive earnings" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfComprehensiveEarnings", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfEarningsAndComprehensiveEarningsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "auth_ref": [ "r89" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.", "label": "Comprehensive Income (Loss) Note [Text Block]", "terseLabel": "Other Comprehensive Earnings/Losses" } } }, "localname": "ComprehensiveIncomeNoteTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/OtherComprehensiveEarningsLosses" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r237", "r238", "r242" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract with Customer, Liability", "terseLabel": "Deferred revenue" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/RevenuesFromContractsWithCustomersNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CorporateNonSegmentMember": { "auth_ref": [ "r148" ], "lang": { "en-US": { "role": { "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.", "label": "Corporate, Non-Segment [Member]", "terseLabel": "Corporate, Non-Segment [Member]", "verboseLabel": "General corporate [Member]" } } }, "localname": "CorporateNonSegmentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsPreTaxAssetImpairmentExitAndImplementationCostsDetails", "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r87" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfEarnings": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Cost of sales" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfEarnings", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfEarningsAndComprehensiveEarningsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]", "terseLabel": "Cost of Sales [Member]" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesGuaranteesAndOtherSimilarMattersNarrativeDetails", "http://www.altria.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesGuaranteesAndOtherSimilarMattersNarrativeDetails", "http://www.altria.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r221" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Debt" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/Debt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r17", "r18", "r19", "r367", "r369", "r380" ], "lang": { "en-US": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesGuaranteesAndOtherSimilarMattersNarrativeDetails", "http://www.altria.com/role/DebtNarrativeDetails", "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Debt instrument, basis spread on variable rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r350", "r351" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Face amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFairValue": { "auth_ref": [ "r343" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.", "label": "Debt Instrument, Fair Value Disclosure", "terseLabel": "Debt instrument, fair value disclosure" } } }, "localname": "DebtInstrumentFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "auth_ref": [ "r47", "r350" ], "lang": { "en-US": { "role": { "documentation": "The average effective interest rate during the reporting period.", "label": "Debt Instrument, Interest Rate During Period", "terseLabel": "Debt instrument, interest rate during period" } } }, "localname": "DebtInstrumentInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r48" ], "lang": { "en-US": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesGuaranteesAndOtherSimilarMattersNarrativeDetails", "http://www.altria.com/role/DebtNarrativeDetails", "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r48", "r115", "r228", "r229", "r230", "r231", "r349", "r350", "r351", "r379" ], "lang": { "en-US": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument, Term", "terseLabel": "Debt instrument, term" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/DebtNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r107", "r112", "r282", "r283" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "terseLabel": "Deferred income tax provision (benefit)" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r280", "r281" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities, Net", "terseLabel": "Deferred income taxes", "verboseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesInvestments": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from investments (excludes investments in subsidiaries and equity method investments).", "label": "Deferred Tax Liabilities, Investments", "terseLabel": "Payments for deferred tax liability" } } }, "localname": "DeferredTaxLiabilitiesInvestments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInCronosNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent": { "auth_ref": [ "r21", "r247", "r248", "r253" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.", "label": "Liability, Defined Benefit Pension Plan, Noncurrent", "terseLabel": "Accrued pension costs" } } }, "localname": "DefinedBenefitPensionPlanLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": { "auth_ref": [ "r260", "r273", "r277" ], "calculation": { "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails": { "order": 4.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.", "label": "Defined Benefit Plan, Amortization of Gain (Loss)", "negatedLabel": "Net loss" } } }, "localname": "DefinedBenefitPlanAmortizationOfGainsLosses", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": { "auth_ref": [ "r261", "r274", "r277" ], "calculation": { "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails": { "order": 5.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.", "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)", "verboseLabel": "Prior service cost (credit)" } } }, "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanContributionsByEmployer": { "auth_ref": [ "r252", "r254", "r255", "r276", "r277" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.", "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer", "terseLabel": "Defined benefit plan, plan assets, contributions by employer" } } }, "localname": "DefinedBenefitPlanContributionsByEmployer", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/BenefitPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plan Disclosure [Line Items]", "terseLabel": "Defined Benefit Plan Disclosure [Line Items]" } } }, "localname": "DefinedBenefitPlanDisclosureLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/BenefitPlansNarrativeDetails", "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear": { "auth_ref": [ "r276" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of contributions expected to be received by defined benefit plan from employer in fiscal year. Excludes contributions paid by employer in current fiscal year.", "label": "Defined Benefit Plan, Expected Future Employer Contributions, Remainder of Fiscal Year", "terseLabel": "Anticipated additional employer contributions" } } }, "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/BenefitPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": { "auth_ref": [ "r259", "r272", "r277" ], "calculation": { "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails": { "order": 3.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.", "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets", "negatedLabel": "Expected return on plan assets" } } }, "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanInterestCost": { "auth_ref": [ "r251", "r258", "r271", "r277" ], "calculation": { "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails": { "order": 2.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.", "label": "Defined Benefit Plan, Interest Cost", "terseLabel": "Interest cost" } } }, "localname": "DefinedBenefitPlanInterestCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "auth_ref": [ "r256", "r269", "r277" ], "calculation": { "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)", "totalLabel": "Net periodic benefit (income) cost" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]", "terseLabel": "Amortization:" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCostAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1": { "auth_ref": [ "r262", "r275" ], "calculation": { "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails": { "order": 6.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from settlement and curtailment.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment", "negatedLabel": "Curtailment" } } }, "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanServiceCost": { "auth_ref": [ "r250", "r257", "r270", "r277" ], "calculation": { "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails": { "order": 1.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.", "label": "Defined Benefit Plan, Service Cost", "verboseLabel": "Service cost" } } }, "localname": "DefinedBenefitPlanServiceCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r107", "r138" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetMeasurementInput": { "auth_ref": [ "r337" ], "lang": { "en-US": { "role": { "documentation": "Value of input used to measure derivative asset.", "label": "Derivative Asset, Measurement Input", "terseLabel": "Derivative asset, measurement input" } } }, "localname": "DerivativeAssetMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails" ], "xbrltype": "decimalItemType" }, "us-gaap_DerivativeAssetNotionalAmount": { "auth_ref": [ "r304", "r305", "r307" ], "lang": { "en-US": { "role": { "documentation": "Nominal or face amount used to calculate payments on the derivative asset.", "label": "Derivative Asset, Notional Amount", "terseLabel": "Derivative asset, notional amount" } } }, "localname": "DerivativeAssetNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsBeginningAndEndingBalancesOfFixedPricePreemptiveRightsAndWarrantsDetails", "http://www.altria.com/role/FinancialInstrumentsEffectsOfNetInvestmentHedgesOnAccumulatedOtherComprehensiveLossesDetails", "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails", "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails", "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails", "http://www.altria.com/role/FinancialInstrumentsPreTaxUnrealizedGainsLossesDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInCronosNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesSummaryOfInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeFairValueOfDerivativeAsset": { "auth_ref": [ "r58", "r59", "r314", "r362" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.", "label": "Derivative Asset, Fair Value, Gross Asset", "terseLabel": "Fair Value of Assets", "verboseLabel": "Derivative asset, fair value, gross asset" } } }, "localname": "DerivativeFairValueOfDerivativeAsset", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesSummaryOfInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueOfDerivativeLiability": { "auth_ref": [ "r58", "r59", "r314", "r362" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.", "label": "Derivative Liability, Fair Value, Gross Liability", "terseLabel": "Fair Value of Liabilities" } } }, "localname": "DerivativeFairValueOfDerivativeLiability", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "auth_ref": [ "r313" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.altria.com/role/CondensedConsolidatedStatementsOfEarnings": { "order": 5.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.", "label": "Derivative, Gain (Loss) on Derivative, Net", "negatedLabel": "Loss on Cronos-related financial instruments", "negatedTerseLabel": "Loss on Cronos-related financial instruments", "netLabel": "Derivative, gain (loss) on derivative, net", "terseLabel": "Loss on Cronos-related financial instruments" } } }, "localname": "DerivativeGainLossOnDerivativeNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.altria.com/role/CondensedConsolidatedStatementsOfEarnings", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfEarningsAndComprehensiveEarningsDetails", "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails", "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r312", "r315", "r320", "r326" ], "lang": { "en-US": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsBeginningAndEndingBalancesOfFixedPricePreemptiveRightsAndWarrantsDetails", "http://www.altria.com/role/FinancialInstrumentsEffectsOfNetInvestmentHedgesOnAccumulatedOtherComprehensiveLossesDetails", "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails", "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails", "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails", "http://www.altria.com/role/FinancialInstrumentsPreTaxUnrealizedGainsLossesDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInCronosNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesSummaryOfInvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r333" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "terseLabel": "Financial Instruments" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "auth_ref": [ "r309", "r312", "r320" ], "lang": { "en-US": { "role": { "documentation": "Information by type of hedging relationship.", "label": "Hedging Relationship [Axis]", "terseLabel": "Hedging Relationship [Axis]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsEffectsOfNetInvestmentHedgesOnAccumulatedOtherComprehensiveLossesDetails", "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails", "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "auth_ref": [ "r309", "r312", "r320", "r326", "r327", "r330", "r332" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table]", "terseLabel": "Derivative Instruments, Gain (Loss) [Table]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsEffectsOfNetInvestmentHedgesOnAccumulatedOtherComprehensiveLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments, Gain (Loss) [Line Items]", "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]" } } }, "localname": "DerivativeInstrumentsGainLossLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsEffectsOfNetInvestmentHedgesOnAccumulatedOtherComprehensiveLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative [Line Items]", "terseLabel": "Derivative [Line Items]" } } }, "localname": "DerivativeLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsBeginningAndEndingBalancesOfFixedPricePreemptiveRightsAndWarrantsDetails", "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails", "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails", "http://www.altria.com/role/FinancialInstrumentsPreTaxUnrealizedGainsLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeNotionalAmount": { "auth_ref": [ "r305", "r307" ], "lang": { "en-US": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Derivative, Notional Amount", "terseLabel": "Derivative, notional amount" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeTable": { "auth_ref": [ "r117", "r303", "r306", "r307", "r309", "r310", "r317", "r320", "r328", "r329", "r332" ], "lang": { "en-US": { "role": { "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Derivative [Table]", "terseLabel": "Derivative [Table]" } } }, "localname": "DerivativeTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsBeginningAndEndingBalancesOfFixedPricePreemptiveRightsAndWarrantsDetails", "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails", "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails", "http://www.altria.com/role/FinancialInstrumentsPreTaxUnrealizedGainsLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativesFairValueLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivatives, Fair Value [Line Items]", "terseLabel": "Derivatives, Fair Value [Line Items]" } } }, "localname": "DerivativesFairValueLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted": { "auth_ref": [ "r123" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for a new accounting pronouncement that has been issued but not yet adopted.", "label": "Description of New Accounting Pronouncements Not yet Adopted [Text Block]", "terseLabel": "New Accounting Guidance Not Yet Adopted" } } }, "localname": "DescriptionOfNewAccountingPronouncementsNotYetAdopted", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/NewAccountingGuidanceNotYetAdopted" ], "xbrltype": "textBlockItemType" }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "auth_ref": [ "r309" ], "lang": { "en-US": { "role": { "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Designated as Hedging Instrument [Member]", "terseLabel": "Designated as Hedging Instrument [Member]" } } }, "localname": "DesignatedAsHedgingInstrumentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DividendsCommonStockCash": { "auth_ref": [ "r232" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.", "label": "Dividends, Common Stock, Cash", "negatedTerseLabel": "Cash dividends declared" } } }, "localname": "DividendsCommonStockCash", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPayableCurrent": { "auth_ref": [ "r8", "r45" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Dividends Payable, Current", "terseLabel": "Dividends payable" } } }, "localname": "DividendsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueFromAffiliateCurrent": { "auth_ref": [ "r53", "r116", "r352", "r353", "r354", "r355" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of receivables due from an entity that is affiliated with the reporting entity by means of direct or indirect ownership, due within 1 year (or 1 business cycle).", "label": "Due from Affiliate, Current", "terseLabel": "Due from Altria Group, Inc. and subsidiaries" } } }, "localname": "DueFromAffiliateCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueFromAffiliateNoncurrent": { "auth_ref": [ "r11", "r113", "r352", "r353", "r354", "r355", "r365", "r381", "r401" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of receivables due from an entity that is affiliated with the reporting entity by means of direct or indirect ownership, due after 1 year (or 1 business cycle).", "label": "Due from Affiliate, Noncurrent", "terseLabel": "Due from Altria Group, Inc. and subsidiaries" } } }, "localname": "DueFromAffiliateNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToAffiliateCurrent": { "auth_ref": [ "r15", "r114", "r352", "r400" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Due to Affiliate, Current", "terseLabel": "Due to Altria Group, Inc. and subsidiaries" } } }, "localname": "DueToAffiliateCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToAffiliateNoncurrent": { "auth_ref": [ "r20", "r114", "r352", "r354", "r400" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails": { "order": 7.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of receivables owed to an entity that is affiliated with the reporting entity by means of direct or indirect ownership, which are usually due after one year (or one business cycle, if longer).", "label": "Due to Affiliate, Noncurrent", "verboseLabel": "Due to Altria Group, Inc. and subsidiaries" } } }, "localname": "DueToAffiliateNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Per share data:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfEarnings" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [ "r124" ], "lang": { "en-US": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Basic and Diluted", "terseLabel": "Basic and diluted earnings per share attributable to Altria (in usd per share)" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfEarnings" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r126" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Earnings Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/EarningsPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityClassOfTreasuryStockLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Equity, Class of Treasury Stock [Line Items]", "terseLabel": "Equity, Class of Treasury Stock [Line Items]" } } }, "localname": "EquityClassOfTreasuryStockLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/BackgroundAndBasisOfPresentationNarrativeDetails", "http://www.altria.com/role/BackgroundAndBasisOfPresentationShareRepurchaseTableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r227" ], "lang": { "en-US": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfStockholdersEquity", "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesInEachComponentOfAccumulatedOtherComprehensiveLossesDetails", "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityContractMember": { "auth_ref": [ "r254", "r325" ], "lang": { "en-US": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to share prices.", "label": "Equity Contract [Member]", "terseLabel": "Equity Contract [Member]" } } }, "localname": "EquityContractMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsBeginningAndEndingBalancesOfFixedPricePreemptiveRightsAndWarrantsDetails", "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment": { "auth_ref": [ "r159" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.", "label": "Equity Method Investment, Other than Temporary Impairment", "terseLabel": "Equity method investment, impairment" } } }, "localname": "EquityMethodInvestmentOtherThanTemporaryImpairment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInCronosNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r161" ], "lang": { "en-US": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Equity method investment, ownership percentage", "verboseLabel": "Ownership percentage (approximately)" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/BackgroundAndBasisOfPresentationNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInAbiNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInCronosNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r36", "r142", "r160" ], "calculation": { "http://www.altria.com/role/InvestmentsInEquitySecuritiesSummaryOfInvestmentsDetails": { "order": 2.0, "parentTag": "us-gaap_Investments", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity Method Investments", "terseLabel": "Equity method investments", "verboseLabel": "Investments in equity securities" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInAbiNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInCronosNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesSummaryOfInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestmentsFairValueDisclosure": { "auth_ref": [ "r158" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of investments accounted under the equity method.", "label": "Equity Method Investments, Fair Value Disclosure", "terseLabel": "Fair value of equity investment" } } }, "localname": "EquityMethodInvestmentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInAbiNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInCronosNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestmentsPolicy": { "auth_ref": [ "r36", "r101", "r111", "r162", "r346" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.", "label": "Equity Method Investments [Policy Text Block]", "terseLabel": "Equity Method Investments" } } }, "localname": "EquityMethodInvestmentsPolicy", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/BackgroundAndBasisOfPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityMethodInvestmentsTextBlock": { "auth_ref": [ "r164" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.", "label": "Equity Method Investments [Table Text Block]", "terseLabel": "Equity Method Investments" } } }, "localname": "EquityMethodInvestmentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentsInEquitySecuritiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": { "auth_ref": [ "r153" ], "calculation": { "http://www.altria.com/role/InvestmentsInEquitySecuritiesSummaryOfInvestmentsDetails": { "order": 1.0, "parentTag": "us-gaap_Investments", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of investment in equity security without readily determinable fair value.", "label": "Equity Securities without Readily Determinable Fair Value, Amount", "verboseLabel": "Equity securities without readily determinable fair value, amount" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInJuulNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesSummaryOfInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount": { "auth_ref": [ "r154" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of impairment loss on investment in equity security without readily determinable fair value.", "label": "Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount", "terseLabel": "Equity securities without readily determinable fair value, impairment loss, annual amount" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInJuulNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock": { "auth_ref": [ "r156" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for investment in equity security without readily determinable fair value, which does not qualify for practical expedient to estimate fair value using net asset value per share. Includes, but is not limited to, information considered for determining upward and downward adjustment from observable price change.", "label": "Equity Securities without Readily Determinable Fair Value [Policy Text Block]", "terseLabel": "Equity Securities Without Readily Determinable Fair Value" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/BackgroundAndBasisOfPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount": { "auth_ref": [ "r155" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cumulative gain from upward price adjustment on investment in equity security without readily determinable fair value.", "label": "Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount", "terseLabel": "Equity securities without readily determinable fair value, upward price adjustment, cumulative amount" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInJuulNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EstimateOfFairValueFairValueDisclosureMember": { "auth_ref": [ "r343" ], "lang": { "en-US": { "role": { "documentation": "Measured as an estimate of fair value.", "label": "Estimate of Fair Value Measurement [Member]", "terseLabel": "Estimate of Fair Value Measurement [Member]" } } }, "localname": "EstimateOfFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ExciseAndSalesTaxes": { "auth_ref": [ "r81" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfEarnings": { "order": 3.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of excise and sales taxes included in sales and revenues, which are then deducted as a cost of sales. Includes excise taxes, which are applied to specific types of transactions or items (such as gasoline or alcohol); and sales, use and value added taxes, which are applied to a broad class of revenue-producing transactions involving a wide range of goods and services.", "label": "Excise and Sales Taxes", "terseLabel": "Excise taxes on products" } } }, "localname": "ExciseAndSalesTaxes", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfEarnings", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfEarningsAndComprehensiveEarningsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [ "r336" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]", "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r254", "r255", "r277", "r335", "r358" ], "lang": { "en-US": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsBeginningAndEndingBalancesOfFixedPricePreemptiveRightsAndWarrantsDetails", "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInAbiNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInCronosNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementBasisAxis": { "auth_ref": [ "r334", "r341" ], "lang": { "en-US": { "role": { "documentation": "Information by measurement basis.", "label": "Measurement Basis [Axis]", "terseLabel": "Measurement Basis [Axis]" } } }, "localname": "FairValueByMeasurementBasisAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosureItemAmountsDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.", "label": "Fair Value Measurement [Domain]", "terseLabel": "Fair Value Measurement [Domain]" } } }, "localname": "FairValueDisclosureItemAmountsDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r254", "r255", "r277", "r335", "r359" ], "lang": { "en-US": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Fair Value, Inputs, Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInAbiNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInCronosNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r254", "r255", "r277", "r335", "r360" ], "lang": { "en-US": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Fair Value, Inputs, Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r254", "r255", "r277", "r335", "r361" ], "lang": { "en-US": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Fair Value, Inputs, Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsBeginningAndEndingBalancesOfFixedPricePreemptiveRightsAndWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsBeginningAndEndingBalancesOfFixedPricePreemptiveRightsAndWarrantsDetails", "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInAbiNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInCronosNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]", "terseLabel": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsBeginningAndEndingBalancesOfFixedPricePreemptiveRightsAndWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock": { "auth_ref": [ "r338", "r340" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings": { "auth_ref": [ "r339", "r340" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of gain (loss) recognized in income from derivative asset (liability) after deduction of derivative liability (asset), measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Earnings", "terseLabel": "Pre-tax earnings (losses) recognized in net earnings" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsBeginningAndEndingBalancesOfFixedPricePreemptiveRightsAndWarrantsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs": { "auth_ref": [ "r334", "r340" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value of financial instrument classified as derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs", "periodEndLabel": "Balance at end of period", "periodStartLabel": "Balance at begging of period" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsBeginningAndEndingBalancesOfFixedPricePreemptiveRightsAndWarrantsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": { "auth_ref": [ "r311", "r317", "r330" ], "lang": { "en-US": { "role": { "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]", "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]" } } }, "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r167", "r168", "r169", "r170", "r171", "r172", "r173", "r174", "r175" ], "lang": { "en-US": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]", "terseLabel": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInCronosNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesSummaryOfInvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ForeignExchangeContractMember": { "auth_ref": [ "r254", "r324" ], "lang": { "en-US": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.", "label": "Foreign Exchange Contract [Member]", "terseLabel": "Foreign currency contracts [Member]" } } }, "localname": "ForeignExchangeContractMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsEffectsOfNetInvestmentHedgesOnAccumulatedOtherComprehensiveLossesDetails", "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails", "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForwardContractsMember": { "auth_ref": [ "r323" ], "lang": { "en-US": { "role": { "documentation": "Contracts negotiated between two parties to purchase and sell a specific quantity of a financial instrument, foreign currency, or commodity at a price specified at origination of the contract, with delivery and settlement at a specified future date.", "label": "Forward Contracts [Member]", "terseLabel": "Forward Contracts [Member]" } } }, "localname": "ForwardContractsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r88" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "negatedTerseLabel": "General corporate expenses" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r178", "r179" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r85" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfEarnings": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfEarnings", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfEarningsAndComprehensiveEarningsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GuaranteeObligationsMaximumExposure": { "auth_ref": [ "r216" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.", "label": "Guarantor Obligations, Maximum Exposure, Undiscounted", "terseLabel": "Contingent liability related to performance surety bonds" } } }, "localname": "GuaranteeObligationsMaximumExposure", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesGuaranteesAndOtherSimilarMattersNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgingDesignationAxis": { "auth_ref": [ "r309", "r327" ], "lang": { "en-US": { "role": { "documentation": "Information by designation of purpose of derivative instrument.", "label": "Hedging Designation [Axis]", "terseLabel": "Hedging Designation [Axis]" } } }, "localname": "HedgingDesignationAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails", "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HedgingDesignationDomain": { "auth_ref": [ "r309" ], "lang": { "en-US": { "role": { "documentation": "Designation of purpose of derivative instrument.", "label": "Hedging Designation [Domain]", "terseLabel": "Hedging Designation [Domain]" } } }, "localname": "HedgingDesignationDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails", "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_HedgingRelationshipDomain": { "auth_ref": [ "r309" ], "lang": { "en-US": { "role": { "documentation": "Nature or intent of a hedge.", "label": "Hedging Relationship [Domain]", "terseLabel": "Hedging Relationship [Domain]" } } }, "localname": "HedgingRelationshipDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsEffectsOfNetInvestmentHedgesOnAccumulatedOtherComprehensiveLossesDetails", "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails", "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r82", "r121", "r364", "r376", "r397" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfEarnings": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfEarningsAndComprehensiveEarningsDetails": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Earnings (losses) before income taxes and equity earnings of subsidiaries" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfEarnings", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfEarningsAndComprehensiveEarningsDetails", "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r83", "r107", "r139", "r160", "r375", "r395" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.altria.com/role/CondensedConsolidatedStatementsOfEarnings": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Income (Loss) from Equity Method Investments", "negatedLabel": "ABI", "negatedTerseLabel": "Earnings from equity investments", "terseLabel": "Earnings from equity investments" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.altria.com/role/CondensedConsolidatedStatementsOfEarnings", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfEarningsAndComprehensiveEarningsDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesEarningsInEquitySecuritiesDetails", "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails", "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromSubsidiariesNetOfTax": { "auth_ref": [], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfEarningsAndComprehensiveEarningsDetails": { "order": 3.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of income (loss) of subsidiary attributable to the parent entity.", "label": "Income (Loss) from Subsidiaries, Net of Tax", "terseLabel": "Equity earnings of subsidiaries" } } }, "localname": "IncomeLossFromSubsidiariesNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfEarningsAndComprehensiveEarningsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r188" ], "lang": { "en-US": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r112", "r140", "r285" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfEarningsAndComprehensiveEarningsDetails": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Provision for income taxes", "verboseLabel": "Provision (benefit) for income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfEarnings", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfEarningsAndComprehensiveEarningsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r106" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": { "auth_ref": [ "r106" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.", "label": "Increase (Decrease) in Income Taxes Payable", "verboseLabel": "Income taxes" } } }, "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r106" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "verboseLabel": "Cash effects of changes:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet": { "auth_ref": [], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in noncurrent operating assets after deduction of noncurrent operating liabilities classified as other.", "label": "Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net", "negatedLabel": "Accrued liabilities and other current assets" } } }, "localname": "IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": { "auth_ref": [ "r106" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.", "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net", "negatedLabel": "Other, net" } } }, "localname": "IncreaseDecreaseInOtherOperatingCapitalNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations": { "auth_ref": [ "r106" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in obligation for pension and other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Increase (Decrease) in Obligation, Pension and Other Postretirement Benefits", "terseLabel": "Pension provisions and postretirement, net" } } }, "localname": "IncreaseDecreaseInPensionAndPostretirementObligations", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInReceivables": { "auth_ref": [ "r106" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Receivables", "negatedLabel": "Receivables" } } }, "localname": "IncreaseDecreaseInReceivables", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r181", "r183" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "verboseLabel": "Other intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r378" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfEarnings": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest Income (Expense), Net", "negatedNetLabel": "Interest and other debt expense (income), net", "negatedTerseLabel": "Interest and other debt expense, net", "terseLabel": "Interest and other debt expense, net" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfEarnings", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfEarningsAndComprehensiveEarningsDetails", "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r8", "r9", "r45" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Interest Payable, Current", "terseLabel": "Interest payable, short-term borrowings" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrentAndNoncurrent": { "auth_ref": [ "r373", "r394" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables.", "label": "Interest Payable", "terseLabel": "Accrued interest on long-term debt" } } }, "localname": "InterestPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [ "r33", "r177" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.", "label": "Inventory, Finished Goods, Net of Reserves", "terseLabel": "Finished product" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r3", "r55", "r176" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "totalLabel": "Inventory, net" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNetAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Inventory, Net [Abstract]", "verboseLabel": "Inventories:" } } }, "localname": "InventoryNetAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "auth_ref": [ "r34", "r177" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.", "label": "Inventory, Work in Process, Net of Reserves", "terseLabel": "Work in process" } } }, "localname": "InventoryWorkInProcessNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentTableTextBlock": { "auth_ref": [ "r152", "r157", "r165", "r166" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of investment.", "label": "Investment [Table Text Block]", "terseLabel": "Investment" } } }, "localname": "InvestmentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentsInEquitySecuritiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentTextBlock": { "auth_ref": [ "r152", "r157", "r165", "r166" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for investment.", "label": "Investment [Text Block]", "terseLabel": "Investments in Equity Securities" } } }, "localname": "InvestmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecurities" ], "xbrltype": "textBlockItemType" }, "us-gaap_Investments": { "auth_ref": [ "r393" ], "calculation": { "http://www.altria.com/role/InvestmentsInEquitySecuritiesSummaryOfInvestmentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.", "label": "Investments", "totalLabel": "Investments" } } }, "localname": "Investments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesSummaryOfInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Investments [Abstract]" } } }, "localname": "InvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_LegalMattersAndContingenciesTextBlock": { "auth_ref": [ "r213" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.", "label": "Legal Matters and Contingencies [Text Block]", "terseLabel": "Contingencies" } } }, "localname": "LegalMattersAndContingenciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/Contingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LetterOfCreditMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).", "label": "Letter of Credit [Member]", "terseLabel": "Letter of Credit [Member]" } } }, "localname": "LetterOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesGuaranteesAndOtherSimilarMattersNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r44" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 }, "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities [Abstract]", "verboseLabel": "Liabilities" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r31", "r372", "r389" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Stockholders\u2019 Equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r46" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r41" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Credit line available under the agreement" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesGuaranteesAndOtherSimilarMattersNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Line of Credit [Member]", "terseLabel": "Line of Credit [Member]" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LitigationSettlementAmountAwardedFromOtherParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount awarded from other party in judgment or settlement of litigation.", "label": "Litigation Settlement, Amount Awarded from Other Party", "terseLabel": "Loss contingency, credits to offset payments", "verboseLabel": "Amount ordered to be paid from other party" } } }, "localname": "LitigationSettlementAmountAwardedFromOtherParty", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails", "http://www.altria.com/role/ContingenciesOtherDisputesUnderStateSettlementAgreementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LitigationSettlementAmountAwardedToOtherParty": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount awarded to other party in judgment or settlement of litigation.", "label": "Litigation Settlement, Amount Awarded to Other Party", "terseLabel": "Litigation settlement" } } }, "localname": "LitigationSettlementAmountAwardedToOtherParty", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LitigationSettlementInterest": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Interest expense (income) directly attributable to an award in settlement of litigation.", "label": "Litigation Settlement Interest", "netLabel": "Litigation settlement interest expense (income)" } } }, "localname": "LitigationSettlementInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesJudgmentsPaidAndProvisionsForTobaccoAndHealthLitigationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LitigationStatusAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by status of pending, threatened, or settled litigation.", "label": "Litigation Status [Axis]", "terseLabel": "Litigation Status [Axis]" } } }, "localname": "LitigationStatusAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesEVaporProductLitigationDetails", "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails", "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails", "http://www.altria.com/role/ContingenciesJudgmentsPaidAndProvisionsForTobaccoAndHealthLitigationDetails", "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails", "http://www.altria.com/role/ContingenciesScheduleOfPendingCasesDetails", "http://www.altria.com/role/ContingenciesUstLitigationsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LitigationStatusDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Status of pending, threatened, or settled litigation.", "label": "Litigation Status [Domain]", "terseLabel": "Litigation Status [Domain]" } } }, "localname": "LitigationStatusDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesEVaporProductLitigationDetails", "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails", "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails", "http://www.altria.com/role/ContingenciesJudgmentsPaidAndProvisionsForTobaccoAndHealthLitigationDetails", "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails", "http://www.altria.com/role/ContingenciesScheduleOfPendingCasesDetails", "http://www.altria.com/role/ContingenciesUstLitigationsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LondonInterbankOfferedRateLIBORMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.", "label": "London Interbank Offered Rate (LIBOR) [Member]", "terseLabel": "London Interbank Offered Rate (LIBOR) [Member]" } } }, "localname": "LondonInterbankOfferedRateLIBORMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r19", "r220", "r369", "r385" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt", "terseLabel": "Long-term debt" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [ "r43" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Current Maturities", "terseLabel": "Current portion of long-term debt" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.", "label": "Long-term Debt, Fair Value", "terseLabel": "Long-term debt, fair value" } } }, "localname": "LongTermDebtFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r48" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Excluding Current Maturities", "verboseLabel": "Long-term debt" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r48" ], "lang": { "en-US": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesGuaranteesAndOtherSimilarMattersNarrativeDetails", "http://www.altria.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r48", "r217" ], "lang": { "en-US": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesGuaranteesAndOtherSimilarMattersNarrativeDetails", "http://www.altria.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongtermPurchaseCommitmentPeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Period covered by the long-term purchase commitment, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Long-term Purchase Commitment, Period", "terseLabel": "Fulfillment term" } } }, "localname": "LongtermPurchaseCommitmentPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LossContingenciesByNatureOfContingencyAxis": { "auth_ref": [ "r204", "r205", "r206", "r208", "r209", "r210", "r212", "r214", "r215" ], "lang": { "en-US": { "role": { "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.", "label": "Loss Contingency Nature [Axis]", "terseLabel": "Loss Contingency Nature [Axis]" } } }, "localname": "LossContingenciesByNatureOfContingencyAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails", "http://www.altria.com/role/ContingenciesJudgmentsPaidAndProvisionsForTobaccoAndHealthLitigationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]", "terseLabel": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesAntitrustLitigationDetails", "http://www.altria.com/role/ContingenciesEVaporProductLitigationDetails", "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails", "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails", "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails", "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails", "http://www.altria.com/role/ContingenciesGuaranteesAndOtherSimilarMattersNarrativeDetails", "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails", "http://www.altria.com/role/ContingenciesJudgmentsPaidAndProvisionsForTobaccoAndHealthLitigationDetails", "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails", "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails", "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails", "http://www.altria.com/role/ContingenciesOtherDisputesUnderStateSettlementAgreementsDetails", "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails", "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails", "http://www.altria.com/role/ContingenciesScheduleOfPendingCasesDetails", "http://www.altria.com/role/ContingenciesUstLitigationsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r204", "r205", "r206", "r208", "r209", "r210", "r212", "r214", "r215" ], "lang": { "en-US": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]", "terseLabel": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesAntitrustLitigationDetails", "http://www.altria.com/role/ContingenciesEVaporProductLitigationDetails", "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails", "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails", "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails", "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails", "http://www.altria.com/role/ContingenciesGuaranteesAndOtherSimilarMattersNarrativeDetails", "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails", "http://www.altria.com/role/ContingenciesJudgmentsPaidAndProvisionsForTobaccoAndHealthLitigationDetails", "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails", "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails", "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails", "http://www.altria.com/role/ContingenciesOtherDisputesUnderStateSettlementAgreementsDetails", "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails", "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails", "http://www.altria.com/role/ContingenciesScheduleOfPendingCasesDetails", "http://www.altria.com/role/ContingenciesUstLitigationsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyAccrualAtCarryingValue": { "auth_ref": [ "r204" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of loss contingency liability.", "label": "Loss Contingency Accrual", "periodEndLabel": "Accrued liability for tobacco and health litigation items at end of period", "periodStartLabel": "Accrued liability for tobacco and health litigation items at beginning of period" } } }, "localname": "LossContingencyAccrualAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesJudgmentsPaidAndProvisionsForTobaccoAndHealthLitigationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyAccrualPayments": { "auth_ref": [ "r204" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow reducing loss contingency liability.", "label": "Loss Contingency Accrual, Payments", "negatedTerseLabel": "Payments" } } }, "localname": "LossContingencyAccrualPayments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesJudgmentsPaidAndProvisionsForTobaccoAndHealthLitigationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyAccrualProvision": { "auth_ref": [ "r204" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.", "label": "Loss Contingency Accrual, Provision", "terseLabel": "Provision related to litigation recorded" } } }, "localname": "LossContingencyAccrualProvision", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails", "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails", "http://www.altria.com/role/ContingenciesJudgmentsPaidAndProvisionsForTobaccoAndHealthLitigationDetails", "http://www.altria.com/role/SegmentReportingScheduleOfTobaccoAndHealthLitigationItemsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyAccrualRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Loss Contingency Accrual [Roll Forward]", "terseLabel": "Loss Contingency Accrual [Roll Forward]" } } }, "localname": "LossContingencyAccrualRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesJudgmentsPaidAndProvisionsForTobaccoAndHealthLitigationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyClaimsDismissedNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of claims dismissed.", "label": "Loss Contingency, Claims Dismissed, Number", "terseLabel": "Number of claims dismissed" } } }, "localname": "LossContingencyClaimsDismissedNumber", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesScheduleOfPendingCasesDetails" ], "xbrltype": "integerItemType" }, "us-gaap_LossContingencyDamagesAwardedValue": { "auth_ref": [ "r204", "r207", "r211" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of damages awarded to the plaintiff in the legal matter.", "label": "Loss Contingency, Damages Awarded, Value", "terseLabel": "Damages awarded, value" } } }, "localname": "LossContingencyDamagesAwardedValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails", "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyDamagesPaidValue": { "auth_ref": [ "r204", "r207", "r211" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of damages paid to the plaintiff in the legal matter.", "label": "Loss Contingency, Damages Paid, Value", "terseLabel": "Judgments paid (approximately)" } } }, "localname": "LossContingencyDamagesPaidValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesJudgmentsPaidAndProvisionsForTobaccoAndHealthLitigationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyNatureDomain": { "auth_ref": [ "r204", "r205", "r206", "r208", "r209", "r210", "r212", "r214", "r215" ], "lang": { "en-US": { "role": { "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.", "label": "Loss Contingency, Nature [Domain]", "terseLabel": "Loss Contingency, Nature [Domain]" } } }, "localname": "LossContingencyNatureDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails", "http://www.altria.com/role/ContingenciesJudgmentsPaidAndProvisionsForTobaccoAndHealthLitigationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingencyNumberOfPlaintiffs": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of plaintiffs that have filed claims pertaining to a loss contingency.", "label": "Loss Contingency, Number of Plaintiffs", "terseLabel": "Number of plaintiffs" } } }, "localname": "LossContingencyNumberOfPlaintiffs", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails" ], "xbrltype": "integerItemType" }, "us-gaap_LossContingencyPendingClaimsNumber": { "auth_ref": [ "r207" ], "lang": { "en-US": { "role": { "documentation": "Number of pending claims pertaining to a loss contingency.", "label": "Loss Contingency, Pending Claims, Number", "terseLabel": "Claims filed, number", "verboseLabel": "Number of cases pending" } } }, "localname": "LossContingencyPendingClaimsNumber", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesEVaporProductLitigationDetails", "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails", "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails", "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails", "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails", "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails", "http://www.altria.com/role/ContingenciesScheduleOfPendingCasesDetails", "http://www.altria.com/role/ContingenciesUstLitigationsNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_MaterialReconcilingItemsMember": { "auth_ref": [ "r144", "r145" ], "lang": { "en-US": { "role": { "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity.", "label": "Segment Reconciling Items [Member]", "terseLabel": "Segment Reconciling Items [Member]" } } }, "localname": "MaterialReconcilingItemsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/SegmentReportingScheduleOfTobaccoAndHealthLitigationItemsDetails", "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedDividendRateMember": { "auth_ref": [ "r336" ], "lang": { "en-US": { "role": { "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.", "label": "Measurement Input, Expected Dividend Rate [Member]", "terseLabel": "Expected Dividend Yield [Member]" } } }, "localname": "MeasurementInputExpectedDividendRateMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedTermMember": { "auth_ref": [ "r336" ], "lang": { "en-US": { "role": { "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.", "label": "Measurement Input, Expected Term [Member]", "terseLabel": "Expected Life [Member]" } } }, "localname": "MeasurementInputExpectedTermMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputPriceVolatilityMember": { "auth_ref": [ "r336" ], "lang": { "en-US": { "role": { "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.", "label": "Measurement Input, Price Volatility [Member]", "terseLabel": "Expected Volatility [Member]" } } }, "localname": "MeasurementInputPriceVolatilityMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "auth_ref": [ "r336" ], "lang": { "en-US": { "role": { "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.", "label": "Measurement Input, Risk Free Interest Rate [Member]", "verboseLabel": "Risk Free Interest Rate [Member]" } } }, "localname": "MeasurementInputRiskFreeInterestRateMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputSharePriceMember": { "auth_ref": [ "r336" ], "lang": { "en-US": { "role": { "documentation": "Measurement input using share price of saleable stock.", "label": "Measurement Input, Share Price [Member]", "terseLabel": "Share price [Member]" } } }, "localname": "MeasurementInputSharePriceMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r336" ], "lang": { "en-US": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]", "terseLabel": "Measurement Input Type [Axis]" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Domain]", "terseLabel": "Measurement Input Type [Domain]" } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsFairValueUsingBlackScholesOptionPricingModelDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r54", "r371", "r388" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "terseLabel": "Noncontrolling interests" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.", "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners", "terseLabel": "Noncontrolling interest, ownership percentage by noncontrolling owners" } } }, "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/BackgroundAndBasisOfPresentationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.", "label": "Noncontrolling Interest, Ownership Percentage by Parent", "terseLabel": "Noncontrolling interest, ownership percentage by parent" } } }, "localname": "MinorityInterestOwnershipPercentageByParent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/BackgroundAndBasisOfPresentationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r102" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 }, "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash Provided by (Used in) Financing Activities", "verboseLabel": "Cash Provided by (Used in) Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r102" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 }, "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash Provided by (Used in) Investing Activities", "verboseLabel": "Cash Provided by (Used in) Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r102", "r105", "r108" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "terseLabel": "Net cash provided by (used in) operating activities", "totalLabel": "Net cash provided by (used in) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash Provided by (Used In) Operating Activities", "verboseLabel": "Cash Provided by (Used in) Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r74", "r77", "r84", "r108", "r125", "r377", "r396" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfEarnings": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.altria.com/role/EarningsPerShareBasicAndDilutedEarningsPerShareDetails": { "order": 1.0, "parentTag": "mo_NetIncomeLossAvailabletoCommonStockholdersBasicandDiluted", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "totalLabel": "Net earnings attributable to Altria", "verboseLabel": "Net earnings attributable to Altria" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfEarnings", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfEarningsAndComprehensiveEarningsDetails", "http://www.altria.com/role/EarningsPerShareBasicAndDilutedEarningsPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r74", "r77", "r296", "r300" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfEarnings": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "negatedTerseLabel": "Net (earnings) losses attributable to noncontrolling interests" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfEarnings", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfEarningsAndComprehensiveEarningsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest": { "auth_ref": [ "r86" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.", "label": "Net Income (Loss) Attributable to Redeemable Noncontrolling Interest", "terseLabel": "Net earnings attributable to noncontrolling interests" } } }, "localname": "NetIncomeLossAttributableToRedeemableNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfStockholdersEquityParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest": { "auth_ref": [ "r224", "r296", "r297" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.", "label": "Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest", "terseLabel": "Net earnings" } } }, "localname": "NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentHedgingMember": { "auth_ref": [ "r308" ], "lang": { "en-US": { "role": { "documentation": "Hedges of a net investment in a foreign operation.", "label": "Net Investment Hedging [Member]", "terseLabel": "Net Investment Hedging [Member]" } } }, "localname": "NetInvestmentHedgingMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsEffectsOfNetInvestmentHedgesOnAccumulatedOtherComprehensiveLossesDetails", "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails", "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent": { "auth_ref": [ "r249" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfEarnings": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expense (reversal of expense) for net periodic benefit cost components, excluding service cost component, of defined benefit plan. Amount includes, but is not limited to, interest cost, expected (return) loss on plan asset, amortization of prior service cost (credit), amortization of (gain) loss, amortization of transition (asset) obligation, settlement (gain) loss, curtailment (gain) loss and certain termination benefits.", "label": "Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component", "negatedLabel": "Net periodic benefit income, excluding service cost", "netLabel": "Net periodic benefit (income) cost, excluding service cost", "terseLabel": "Net periodic benefit income, excluding service cost" } } }, "localname": "NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfEarnings", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfEarningsAndComprehensiveEarningsDetails", "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails", "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]" } } }, "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "New Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/BackgroundAndBasisOfPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r290" ], "lang": { "en-US": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Non-controlling Interests [Member]" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_NondesignatedMember": { "auth_ref": [ "r309" ], "lang": { "en-US": { "role": { "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Not Designated as Hedging Instrument [Member]", "terseLabel": "Not Designated as Hedging Instrument [Member]" } } }, "localname": "NondesignatedMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails", "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfEarnings": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating income (expense)", "verboseLabel": "Operating income" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfEarnings", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfEarningsAndComprehensiveEarningsDetails", "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r137", "r146" ], "lang": { "en-US": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating Segments [Member]" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsPreTaxAssetImpairmentExitAndImplementationCostsDetails", "http://www.altria.com/role/SegmentReportingScheduleOfTobaccoAndHealthLitigationItemsDetails", "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r1", "r302" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "Background and Basis of Presentation" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/BackgroundAndBasisOfPresentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r7", "r8", "r9", "r45" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Current", "verboseLabel": "Other" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r56" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsMember": { "auth_ref": [ "r311", "r330" ], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing other assets.", "label": "Other Assets [Member]", "terseLabel": "Other Assets [Member]" } } }, "localname": "OtherAssetsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r39" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "verboseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": { "auth_ref": [ "r71" ], "calculation": { "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesInEachComponentOfAccumulatedOtherComprehensiveLossesDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax", "terseLabel": "Other comprehensive earnings (losses) before reclassifications" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesInEachComponentOfAccumulatedOtherComprehensiveLossesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": { "auth_ref": [ "r71", "r80" ], "calculation": { "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesInEachComponentOfAccumulatedOtherComprehensiveLossesDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax", "totalLabel": "Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesInEachComponentOfAccumulatedOtherComprehensiveLossesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": { "auth_ref": [ "r69", "r284" ], "calculation": { "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesInEachComponentOfAccumulatedOtherComprehensiveLossesDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax", "negatedLabel": "Deferred income taxes" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesInEachComponentOfAccumulatedOtherComprehensiveLossesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax": { "auth_ref": [ "r62", "r68", "r319", "r322", "r331" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, before tax and adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.", "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax", "terseLabel": "Gain (Loss) Recognized in Net Earnings" } } }, "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsEffectsOfNetInvestmentHedgesOnAccumulatedOtherComprehensiveLossesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r60", "r348" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfComprehensiveEarnings": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "terseLabel": "Currency translation adjustments and other" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfComprehensiveEarnings" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": { "auth_ref": [ "r321" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.", "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax", "terseLabel": "Gain (Loss) Recognized in Accumulated Other Comprehensive Losses" } } }, "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsEffectsOfNetInvestmentHedgesOnAccumulatedOtherComprehensiveLossesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r75", "r78", "r80", "r227" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfComprehensiveEarnings": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesInEachComponentOfAccumulatedOtherComprehensiveLossesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Other comprehensive earnings (losses), net of deferred income taxes", "totalLabel": "Other comprehensive earnings (losses), net of deferred income taxes", "verboseLabel": "Other comprehensive earnings (losses), net of deferred income taxes" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfComprehensiveEarnings", "http://www.altria.com/role/CondensedConsolidatedStatementsOfStockholdersEquity", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfEarningsAndComprehensiveEarningsDetails", "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesInEachComponentOfAccumulatedOtherComprehensiveLossesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]", "verboseLabel": "Other comprehensive earnings (losses), net of deferred income taxes:" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfComprehensiveEarnings" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "auth_ref": [ "r65", "r68" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfComprehensiveEarnings": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax", "negatedTerseLabel": "Benefit plans" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfComprehensiveEarnings" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCurrentAssetsMember": { "auth_ref": [ "r311", "r330" ], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing other current assets.", "label": "Other Current Assets [Member]", "terseLabel": "Other Current Assets [Member]" } } }, "localname": "OtherCurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesMember": { "auth_ref": [ "r311", "r330" ], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing other liabilities.", "label": "Other Liabilities [Member]", "terseLabel": "Other Liabilities [Member]" } } }, "localname": "OtherLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsFairValueDerivativeFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r49" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails": { "order": 6.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": { "auth_ref": [ "r246", "r265", "r266", "r278" ], "lang": { "en-US": { "role": { "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.", "label": "Other Postretirement Benefits Plan [Member]", "verboseLabel": "Postretirement [Member]" } } }, "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/BenefitPlansNarrativeDetails", "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent": { "auth_ref": [ "r21", "r247", "r248", "r253" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails": { "order": 5.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit other postretirement plan, classified as noncurrent. Excludes pension plan.", "label": "Liability, Other Postretirement Defined Benefit Plan, Noncurrent", "terseLabel": "Accrued postretirement health care costs" } } }, "localname": "OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherRestructuringCosts": { "auth_ref": [ "r107", "r190", "r196", "r201" ], "calculation": { "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsPreTaxAssetImpairmentExitAndImplementationCostsDetails": { "order": 2.0, "parentTag": "us-gaap_RestructuringCharges", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.", "label": "Other Restructuring Costs", "totalLabel": "Implementation Costs" } } }, "localname": "OtherRestructuringCosts", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsPreTaxAssetImpairmentExitAndImplementationCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForDerivativeInstrumentInvestingActivities": { "auth_ref": [ "r93" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow for derivative instruments during the period, which are classified as investing activities, excluding those designated as hedging instruments.", "label": "Payments for Derivative Instrument, Investing Activities", "terseLabel": "Payments for derivative instrument, investing activities" } } }, "localname": "PaymentsForDerivativeInstrumentInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInCronosNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "auth_ref": [ "r90", "r93", "r118" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.", "label": "Payments for (Proceeds from) Other Investing Activities", "negatedTerseLabel": "Other, net" } } }, "localname": "PaymentsForProceedsFromOtherInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r96" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Repurchases of common stock" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRestructuring": { "auth_ref": [ "r99", "r192" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.", "label": "Payments for Restructuring", "negatedLabel": "Cash spent" } } }, "localname": "PaymentsForRestructuring", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsMovementInRestructuringLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsCommonStock": { "auth_ref": [ "r96" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.", "label": "Payments of Ordinary Dividends, Common Stock", "negatedLabel": "Dividends paid on common stock" } } }, "localname": "PaymentsOfDividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireEquityMethodInvestments": { "auth_ref": [ "r91" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.", "label": "Payments to Acquire Equity Method Investments", "terseLabel": "Payments to acquire equity method investments" } } }, "localname": "PaymentsToAcquireEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInCronosNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r92" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedTerseLabel": "Capital expenditures" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PendingLitigationMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.", "label": "Pending Litigation [Member]", "terseLabel": "Pending Litigation [Member]" } } }, "localname": "PendingLitigationMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails", "http://www.altria.com/role/ContingenciesJudgmentsPaidAndProvisionsForTobaccoAndHealthLitigationDetails", "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails", "http://www.altria.com/role/ContingenciesScheduleOfPendingCasesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitContributions": { "auth_ref": [ "r104" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow for pension and other postretirement benefits. Includes, but is not limited to, employer contribution to fund plan asset and payment to retiree.", "label": "Payment for Pension and Other Postretirement Benefits", "negatedLabel": "Pension plan contributions" } } }, "localname": "PensionAndOtherPostretirementBenefitContributions", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "auth_ref": [ "r279" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for pension and other postretirement benefits.", "label": "Pension and Other Postretirement Benefits Disclosure [Text Block]", "terseLabel": "Benefit Plans" } } }, "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/BenefitPlans" ], "xbrltype": "textBlockItemType" }, "us-gaap_PensionPlansDefinedBenefitMember": { "auth_ref": [ "r245", "r265", "r266", "r278" ], "lang": { "en-US": { "role": { "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.", "label": "Pension Plan [Member]", "terseLabel": "Pension [Member]", "verboseLabel": "Pension [Member]" } } }, "localname": "PensionPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/BenefitPlansNarrativeDetails", "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "auth_ref": [ "r342" ], "lang": { "en-US": { "role": { "documentation": "Measured at fair value for financial reporting purposes.", "label": "Portion at Fair Value Measurement [Member]", "terseLabel": "Portion at Fair Value Measurement [Member]" } } }, "localname": "PortionAtFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [ "r94" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.", "label": "Proceeds from Issuance of Long-term Debt", "terseLabel": "Long-term debt issued" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLegalSettlements": { "auth_ref": [ "r103" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Cash received for the settlement of litigation during the current period.", "label": "Proceeds from Legal Settlements", "terseLabel": "Payments received from litigation settlement" } } }, "localname": "ProceedsFromLegalSettlements", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "auth_ref": [ "r95", "r98", "r118" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.", "label": "Proceeds from (Payments for) Other Financing Activities", "terseLabel": "Other, net" } } }, "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt": { "auth_ref": [ "r118" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts.", "label": "Proceeds from (Repayments of) Related Party Debt", "terseLabel": "Changes in amounts due to/from Altria Group, Inc. and subsidiaries" } } }, "localname": "ProceedsFromRepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromShortTermDebt": { "auth_ref": [ "r94" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.", "label": "Proceeds from Short-term Debt", "terseLabel": "Proceeds from short-term borrowings", "verboseLabel": "Proceeds from short-term borrowings" } } }, "localname": "ProceedsFromShortTermDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r74", "r77", "r100", "r141", "r147", "r292", "r295", "r297", "r300", "r301" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.altria.com/role/CondensedConsolidatedStatementsOfComprehensiveEarnings": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://www.altria.com/role/CondensedConsolidatedStatementsOfEarnings": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 }, "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfEarningsAndComprehensiveEarningsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "negatedLabel": "Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings", "terseLabel": "Net earnings", "totalLabel": "Net earnings", "verboseLabel": "Net earnings" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.altria.com/role/CondensedConsolidatedStatementsOfComprehensiveEarnings", "http://www.altria.com/role/CondensedConsolidatedStatementsOfEarnings", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfEarningsAndComprehensiveEarningsDetails", "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r37", "r185" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "verboseLabel": "Property, plant and equipment, at cost" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r12", "r13", "r187", "r391" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "totalLabel": "Property, plant and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PurchaseCommitmentMember": { "auth_ref": [ "r22", "r370", "r386" ], "lang": { "en-US": { "role": { "documentation": "Purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier. Excludes long-term commitments.", "label": "Purchase Commitment [Member]", "terseLabel": "Purchase Commitment [Member]" } } }, "localname": "PurchaseCommitmentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReceivablesNetCurrent": { "auth_ref": [ "r26", "r32", "r390", "r402" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.", "label": "Receivables, Net, Current", "terseLabel": "Receivables" } } }, "localname": "ReceivablesNetCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails", "http://www.altria.com/role/RevenuesFromContractsWithCustomersNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]", "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]" } } }, "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": { "auth_ref": [ "r71", "r73" ], "calculation": { "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesInEachComponentOfAccumulatedOtherComprehensiveLossesDetails": { "order": 1.0, "parentTag": "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax", "negatedLabel": "Amounts reclassified to net earnings" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesInEachComponentOfAccumulatedOtherComprehensiveLossesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": { "auth_ref": [ "r71", "r73", "r80" ], "calculation": { "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesInEachComponentOfAccumulatedOtherComprehensiveLossesDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax", "negatedTotalLabel": "Amounts reclassified to net earnings, net of deferred income taxes" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesInEachComponentOfAccumulatedOtherComprehensiveLossesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAociCurrentPeriodTax": { "auth_ref": [ "r69", "r72", "r284" ], "calculation": { "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesInEachComponentOfAccumulatedOtherComprehensiveLossesDetails": { "order": 2.0, "parentTag": "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).", "label": "Reclassification from AOCI, Current Period, Tax", "terseLabel": "Deferred income taxes" } } }, "localname": "ReclassificationFromAociCurrentPeriodTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesInEachComponentOfAccumulatedOtherComprehensiveLossesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Axis]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Item reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Domain]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Member]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/OtherComprehensiveEarningsLossesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": { "auth_ref": [ "r222", "r223", "r225", "r226" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.", "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount", "terseLabel": "Redeemable noncontrolling interest" } } }, "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails", "http://www.altria.com/role/ContingenciesGuaranteesAndOtherSimilarMattersNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r97" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "Repayments of Long-term Debt", "negatedTerseLabel": "Long-term debt repaid", "terseLabel": "Long-term debt repaid" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails", "http://www.altria.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfShortTermDebt": { "auth_ref": [ "r97" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.", "label": "Repayments of Short-term Debt", "negatedTerseLabel": "Repayment of short-term borrowings" } } }, "localname": "RepaymentsOfShortTermDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashCurrent": { "auth_ref": [ "r2", "r10", "r110" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash, Current", "terseLabel": "Restricted cash included in other current assets" } } }, "localname": "RestrictedCashCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashNoncurrent": { "auth_ref": [ "r6", "r14", "r110", "r404" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash, Noncurrent", "terseLabel": "Restricted cash included in other assets" } } }, "localname": "RestrictedCashNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Restructuring and Related Activities [Abstract]" } } }, "localname": "RestructuringAndRelatedActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "auth_ref": [ "r203" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.", "label": "Restructuring and Related Activities Disclosure [Text Block]", "terseLabel": "Asset Impairment, Exit and Implementation Costs" } } }, "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCosts" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestructuringAndRelatedCostIncurredCost": { "auth_ref": [ "r191", "r193", "r199", "r202" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.", "label": "Restructuring and Related Cost, Incurred Cost", "terseLabel": "Charges" } } }, "localname": "RestructuringAndRelatedCostIncurredCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsMovementInRestructuringLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringCharges": { "auth_ref": [ "r107", "r190", "r196", "r201" ], "calculation": { "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsPreTaxAssetImpairmentExitAndImplementationCostsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsPreTaxAssetImpairmentExitAndImplementationCostsDetailsCalc2": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.", "label": "Restructuring Charges", "terseLabel": "Restructuring charges", "totalLabel": "Total" } } }, "localname": "RestructuringCharges", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsNarrativeDetails", "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsPreTaxAssetImpairmentExitAndImplementationCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringCostAndReserveAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of restructuring cost.", "label": "Restructuring Type [Axis]", "terseLabel": "Restructuring Type [Axis]" } } }, "localname": "RestructuringCostAndReserveAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringCostAndReserveLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Restructuring Cost and Reserve [Line Items]", "terseLabel": "Restructuring Cost and Reserve [Line Items]" } } }, "localname": "RestructuringCostAndReserveLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsNarrativeDetails", "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsPreTaxAssetImpairmentExitAndImplementationCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringCosts": { "auth_ref": [ "r107" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.", "label": "Restructuring Costs", "terseLabel": "Asset impairment and exit costs, net of cash paid" } } }, "localname": "RestructuringCosts", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringPlanAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by individual restructuring plan.", "label": "Restructuring Plan [Axis]", "terseLabel": "Restructuring Plan [Axis]" } } }, "localname": "RestructuringPlanAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringPlanDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identification of the individual restructuring plans.", "label": "Restructuring Plan [Domain]", "terseLabel": "Restructuring Plan [Domain]" } } }, "localname": "RestructuringPlanDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringReserve": { "auth_ref": [ "r192", "r197" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.", "label": "Restructuring Reserve", "periodEndLabel": "Restructuring reserve, end of period", "periodStartLabel": "Restructuring reserve, beginning of period" } } }, "localname": "RestructuringReserve", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsMovementInRestructuringLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Restructuring Reserve [Roll Forward]", "terseLabel": "Restructuring Reserve [Roll Forward]" } } }, "localname": "RestructuringReserveRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsMovementInRestructuringLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r28", "r232", "r387" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "verboseLabel": "Earnings reinvested in the business" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Earnings Reinvested in the Business [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanTypeAxis": { "auth_ref": [ "r245", "r246", "r265", "r266", "r278" ], "lang": { "en-US": { "role": { "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Axis]", "terseLabel": "Retirement Plan Type [Axis]" } } }, "localname": "RetirementPlanTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/BenefitPlansNarrativeDetails", "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanTypeDomain": { "auth_ref": [ "r245", "r246", "r265", "r266", "r278" ], "lang": { "en-US": { "role": { "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Domain]", "terseLabel": "Retirement Plan Type [Domain]" } } }, "localname": "RetirementPlanTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/BenefitPlansNarrativeDetails", "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r240", "r241" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedStatementsOfEarnings": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "verboseLabel": "Net revenues" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfEarnings", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingStatementsOfEarningsAndComprehensiveEarningsDetails", "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r244" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Revenues from Contracts with Customers" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/RevenuesFromContractsWithCustomers" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenuePerformanceObligationDescriptionOfTiming": { "auth_ref": [ "r239" ], "lang": { "en-US": { "role": { "documentation": "Description of timing for satisfying performance obligation in contract with customer. Includes, but is not limited to, as services are rendered, and upon shipment, delivery or completion of service.", "label": "Revenue, Performance Obligation, Description of Timing", "terseLabel": "Expected period for satisfaction of performance obligation" } } }, "localname": "RevenuePerformanceObligationDescriptionOfTiming", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/RevenuesFromContractsWithCustomersNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility [Member]" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesGuaranteesAndOtherSimilarMattersNarrativeDetails", "http://www.altria.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r71" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/OtherComprehensiveEarningsLossesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "auth_ref": [ "r265", "r266", "r267", "r268", "r277" ], "lang": { "en-US": { "role": { "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Defined Benefit Plans Disclosures [Table]", "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/BenefitPlansNarrativeDetails", "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": { "auth_ref": [ "r312", "r320", "r327" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table Text Block]", "terseLabel": "Pre-tax Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses" } } }, "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r125" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Earnings Per Share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule of Equity Method Investments [Line Items]", "terseLabel": "Schedule of Equity Method Investments [Line Items]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesEarningsInEquitySecuritiesDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInAbiNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInJuulNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsTable": { "auth_ref": [ "r163" ], "lang": { "en-US": { "role": { "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.", "label": "Schedule of Equity Method Investments [Table]", "terseLabel": "Schedule of Equity Method Investments [Table]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesEarningsInEquitySecuritiesDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInAbiNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInJuulNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock": { "auth_ref": [ "r204", "r205", "r206", "r208", "r209", "r210", "r212", "r214", "r215" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the loss contingencies that were reported in the period or disclosed as of the balance sheet date.", "label": "Schedule of Loss Contingencies by Contingency [Table Text Block]", "terseLabel": "Schedule of Contingencies" } } }, "localname": "ScheduleOfLossContingenciesByContingencyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": { "auth_ref": [ "r256" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.", "label": "Schedule of Net Benefit Costs [Table Text Block]", "terseLabel": "Schedule of Net Periodic Benefit (Income) Cost" } } }, "localname": "ScheduleOfNetBenefitCostsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/BenefitPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "auth_ref": [ "r318" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure for net investment hedges of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.", "label": "Schedule of Net Investment Hedges, Statements of Financial Performance and Financial Position, Location [Table Text Block]", "terseLabel": "Schedule of Derivative Liabilities at Fair Value" } } }, "localname": "ScheduleOfNetInvestmentHedgesStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "auth_ref": [ "r120", "r122", "r127", "r128", "r129" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.", "label": "Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]", "terseLabel": "Recent Accounting Guidance Not Yet Adopted" } } }, "localname": "ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/NewAccountingGuidanceNotYetAdoptedTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "auth_ref": [ "r194", "r195", "r198" ], "lang": { "en-US": { "role": { "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.", "label": "Schedule of Restructuring and Related Costs [Table]", "terseLabel": "Schedule of Restructuring and Related Costs [Table]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsNarrativeDetails", "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsPreTaxAssetImpairmentExitAndImplementationCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": { "auth_ref": [ "r194", "r195", "r198" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.", "label": "Restructuring and Related Costs [Table Text Block]", "terseLabel": "Restructuring and Related Costs" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": { "auth_ref": [ "r192", "r200" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.", "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]", "terseLabel": "Schedule of Restructuring Reserve by Type of Cost" } } }, "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r136", "r141", "r143", "r144", "r180" ], "lang": { "en-US": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r136", "r141", "r143", "r144", "r180" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Schedule of Segment Reporting Information, by Segment" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/SegmentReportingTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": { "auth_ref": [ "r233", "r234", "r235", "r236" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.", "label": "Class of Treasury Stock [Table Text Block]", "terseLabel": "Schedule of Share Repurchase Activity" } } }, "localname": "ScheduleOfTreasuryStockByClassTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/BackgroundAndBasisOfPresentationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]", "verboseLabel": "Reporting Segment [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsPreTaxAssetImpairmentExitAndImplementationCostsDetails", "http://www.altria.com/role/SegmentReportingScheduleOfTobaccoAndHealthLitigationItemsDetails", "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r150" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Segment Reporting" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/SegmentReporting" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SeniorNotesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.", "label": "Senior Notes [Member]", "terseLabel": "Senior Notes [Member]" } } }, "localname": "SeniorNotesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SettledLitigationMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Agreement reached between parties in a litigation that occurs without judicial intervention, supervision or approval.", "label": "Settled Litigation [Member]", "terseLabel": "Settled Litigation [Member]" } } }, "localname": "SettledLitigationMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails", "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareRepurchaseProgramAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by share repurchase program.", "label": "Share Repurchase Program [Axis]", "terseLabel": "Share Repurchase Program [Axis]" } } }, "localname": "ShareRepurchaseProgramAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/BackgroundAndBasisOfPresentationNarrativeDetails", "http://www.altria.com/role/BackgroundAndBasisOfPresentationShareRepurchaseTableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareRepurchaseProgramDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the share repurchase program.", "label": "Share Repurchase Program [Domain]", "terseLabel": "Share Repurchase Program [Domain]" } } }, "localname": "ShareRepurchaseProgramDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/BackgroundAndBasisOfPresentationNarrativeDetails", "http://www.altria.com/role/BackgroundAndBasisOfPresentationShareRepurchaseTableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShortTermBorrowings": { "auth_ref": [ "r16", "r367", "r384" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails": { "order": 9.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.", "label": "Short-term Debt", "terseLabel": "Short-term borrowings", "verboseLabel": "Short-term borrowings" } } }, "localname": "ShortTermBorrowings", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails", "http://www.altria.com/role/DebtNarrativeDetails", "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShortTermDebtTypeAxis": { "auth_ref": [ "r42" ], "lang": { "en-US": { "role": { "documentation": "Information by type of short-term debt arrangement.", "label": "Short-term Debt, Type [Axis]", "terseLabel": "Short-term Debt, Type [Axis]" } } }, "localname": "ShortTermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeDomain": { "auth_ref": [ "r40" ], "lang": { "en-US": { "role": { "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.", "label": "Short-term Debt, Type [Domain]", "terseLabel": "Short-term Debt, Type [Domain]" } } }, "localname": "ShortTermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r0", "r141", "r180", "r189", "r193", "r202", "r398" ], "lang": { "en-US": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsPreTaxAssetImpairmentExitAndImplementationCostsDetails", "http://www.altria.com/role/SegmentReportingScheduleOfTobaccoAndHealthLitigationItemsDetails", "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r23", "r24", "r25", "r227" ], "lang": { "en-US": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r52", "r227" ], "lang": { "en-US": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]", "verboseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfStockholdersEquity", "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesInEachComponentOfAccumulatedOtherComprehensiveLossesDetails", "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of stock repurchase plan authorized.", "label": "Stock Repurchase Program, Authorized Amount", "verboseLabel": "Planned share repurchase program" } } }, "localname": "StockRepurchaseProgramAuthorizedAmount1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/BackgroundAndBasisOfPresentationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r25", "r29", "r30", "r151" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total stockholders\u2019 equity attributable to Altria" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r290", "r291", "r299" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total stockholders\u2019 equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatedStatementsOfStockholdersEquity", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails", "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesInEachComponentOfAccumulatedOtherComprehensiveLossesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]", "terseLabel": "Stockholders\u2019 Equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/BackgroundAndBasisOfPresentationNarrativeDetails", "http://www.altria.com/role/ContingenciesAntitrustLitigationDetails", "http://www.altria.com/role/ContingenciesEVaporProductLitigationDetails", "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails", "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails", "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails", "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails", "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails", "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails", "http://www.altria.com/role/ContingenciesScheduleOfPendingCasesDetails", "http://www.altria.com/role/ContingenciesUstLitigationsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r356" ], "lang": { "en-US": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/BackgroundAndBasisOfPresentationNarrativeDetails", "http://www.altria.com/role/ContingenciesAntitrustLitigationDetails", "http://www.altria.com/role/ContingenciesEVaporProductLitigationDetails", "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails", "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails", "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails", "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails", "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails", "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails", "http://www.altria.com/role/ContingenciesScheduleOfPendingCasesDetails", "http://www.altria.com/role/ContingenciesUstLitigationsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r356" ], "lang": { "en-US": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/BackgroundAndBasisOfPresentationNarrativeDetails", "http://www.altria.com/role/ContingenciesAntitrustLitigationDetails", "http://www.altria.com/role/ContingenciesEVaporProductLitigationDetails", "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails", "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingAndConcludedDetails", "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails", "http://www.altria.com/role/ContingenciesNpmAdjustmentDisputesSettlementWith20StatesAndTerritoriesAndSettlementWithNewYorkDetails", "http://www.altria.com/role/ContingenciesOtherSmokingAndHealthClassActionsDetails", "http://www.altria.com/role/ContingenciesOverviewOfAltriaAndOrPmUsaTobaccoRelatedLitigationNarrativeDetails", "http://www.altria.com/role/ContingenciesScheduleOfPendingCasesDetails", "http://www.altria.com/role/ContingenciesUstLitigationsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ThreatenedLitigationMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Risk of loss associated with the outcome of threatened litigation against the entity.", "label": "Threatened Litigation [Member]", "terseLabel": "Threatened Litigation [Member]" } } }, "localname": "ThreatenedLitigationMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r363" ], "lang": { "en-US": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]", "terseLabel": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/InvestmentsInEquitySecuritiesInvestmentInCronosNarrativeDetails", "http://www.altria.com/role/InvestmentsInEquitySecuritiesSummaryOfInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockAcquiredAverageCostPerShare": { "auth_ref": [ "r233" ], "lang": { "en-US": { "role": { "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.", "label": "Treasury Stock Acquired, Average Cost Per Share", "terseLabel": "Average price of repurchased shares, per share (usd per share)", "verboseLabel": "Average price per share of shares repurchased (usd per share)" } } }, "localname": "TreasuryStockAcquiredAverageCostPerShare", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/BackgroundAndBasisOfPresentationNarrativeDetails", "http://www.altria.com/role/BackgroundAndBasisOfPresentationShareRepurchaseTableDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [ "r51", "r233" ], "lang": { "en-US": { "role": { "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Treasury Stock [Member]", "terseLabel": "Cost of Repurchased Stock [Member]" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockShares": { "auth_ref": [ "r51", "r233" ], "lang": { "en-US": { "role": { "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.", "label": "Treasury Stock, Shares", "terseLabel": "Shares repurchased (shares)" } } }, "localname": "TreasuryStockShares", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockSharesAcquired": { "auth_ref": [ "r25", "r227", "r232" ], "lang": { "en-US": { "role": { "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.", "label": "Treasury Stock, Shares, Acquired", "terseLabel": "Repurchase of common stock (shares)", "verboseLabel": "Total number of shares repurchased (shares)" } } }, "localname": "TreasuryStockSharesAcquired", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/BackgroundAndBasisOfPresentationNarrativeDetails", "http://www.altria.com/role/BackgroundAndBasisOfPresentationShareRepurchaseTableDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r51", "r233", "r236" ], "calculation": { "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedLabel": "Cost of repurchased stock (947,593,259 shares at March 31, 2020 and 947,979,763 shares at December 31, 2019)", "negatedTerseLabel": "Cost of repurchased stock" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/CondensedConsolidatedBalanceSheets", "http://www.altria.com/role/CondensedConsolidatingFinancialInformationCondensedConsolidatingBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "auth_ref": [ "r227", "r232", "r233" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.", "label": "Treasury Stock, Value, Acquired, Cost Method", "negatedTerseLabel": "Repurchases of common stock", "terseLabel": "Aggregate cost of shares repurchased" } } }, "localname": "TreasuryStockValueAcquiredCostMethod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/BackgroundAndBasisOfPresentationShareRepurchaseTableDetails", "http://www.altria.com/role/CondensedConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfRestructuringDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identification of the types of restructuring costs.", "label": "Type of Restructuring [Domain]", "terseLabel": "Type of Restructuring [Domain]" } } }, "localname": "TypeOfRestructuringDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/AssetImpairmentExitAndImplementationCostsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnrealizedGainLossOnDerivatives": { "auth_ref": [ "r107" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.", "label": "Unrealized Gain (Loss) on Derivatives", "terseLabel": "Unrealized gain (loss) on derivatives" } } }, "localname": "UnrealizedGainLossOnDerivatives", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/FinancialInstrumentsPreTaxUnrealizedGainsLossesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted", "terseLabel": "Weighted-average shares for basic and diluted EPS (in shares)" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.altria.com/role/EarningsPerShareBasicAndDilutedEarningsPerShareDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 21 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r1": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3000-108585" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "21D", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=SL94080555-108585" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(11))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=SL98516268-108586" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(e),(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(n)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(b))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794" }, "r123": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "http://asc.fasb.org/topic&trid=2122394" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r126": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e725-108305" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e765-108305" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.10-01.(b)(6))", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=27015980&loc=d3e46468-122699" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8615-108599" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8654-108599" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8657-108599" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8660-108599" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8663-108599" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8672-108599" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8721-108599" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8924-108599" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8475-108599" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19)(a)(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r152": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "http://asc.fasb.org/topic&trid=2196928" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=116654751&loc=SL75117539-209714" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=116654751&loc=SL75117539-209714" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=116654751&loc=SL75117539-209714" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=116654751&loc=SL75117539-209714" }, "r157": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "321", "URI": "http://asc.fasb.org/topic&trid=75115024" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=117311354&loc=d3e32014-111567" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=118954474&loc=d3e32787-111569" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(b)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r165": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "323", "URI": "http://asc.fasb.org/topic&trid=2196965" }, "r166": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "325", "URI": "http://asc.fasb.org/topic&trid=2197064" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919244-210447" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919253-210447" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919258-210447" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919230-210447" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922888-210455" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922895-210455" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922900-210455" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=118942371&loc=SL82922954-210456" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116846819&loc=d3e3927-108312" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=77989000&loc=SL49117168-202975" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.3)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.3)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4(b))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r203": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "420", "URI": "http://asc.fasb.org/topic&trid=2175745" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14326-108349" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14615-108349" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14394-108349" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14435-108349" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14435-108349" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14453-108349" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14472-108349" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14557-108349" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14557-108349" }, "r213": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=118943654&loc=d3e12021-110248" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=118943654&loc=d3e12053-110248" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=118943654&loc=d3e12069-110248" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-10(d)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=116634808&loc=d3e168853-122756" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-10(d)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=116634808&loc=d3e168853-122756" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(25))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870" }, "r221": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(12)(c)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(16)(c)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(3)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "14", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "15", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130531-203044" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130532-203044" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130554-203045" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130543-203045" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046" }, "r244": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1703-114919" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1731-114919" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=SL108413299-114919" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i),(j)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(j)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2410-114920" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2439-114920" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942" }, "r279": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "http://asc.fasb.org/topic&trid=2235017" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e31931-109318" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e39076-109324" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=d3e5283-111683" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613674-111683" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4590271-111686" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591551-111686" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591552-111686" }, "r302": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579240-113959" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5580258-113959" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(iii)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41638-113959" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "4CCC", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL109998896-113959" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "4CCC", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL109998896-113959" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624181-113959" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41641-113959" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41678-113959" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=116861445&loc=SL5629052-113961" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109974929&loc=SL110061190-113977" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109977999&loc=d3e76258-113986" }, "r333": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "http://asc.fasb.org/topic&trid=2229140" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=d3e13220-108610" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13433-108611" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13467-108611" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13476-108611" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b,c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=6918054&loc=d3e56071-112765" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=SL51823488-111719" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(3))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(17))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(5))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1(h))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=6488278&loc=d3e603758-122996" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-06(3)(a)(3))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=6488278&loc=d3e604059-122996" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-06(3))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=6488278&loc=d3e604059-122996" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=6589523&loc=d3e617274-123014" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=116631420&loc=SL116631458-115580" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=6590653&loc=d3e638233-123024" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=6590653&loc=d3e638233-123024" }, "r407": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r408": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r409": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-13" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r410": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1-" }, "r411": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r412": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r413": { "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "11", "Subsection": "03" }, "r414": { "Footnote": "2", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r415": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r416": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "29" }, "r417": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "12", "Subsection": "04" }, "r418": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "a", "Publisher": "SEC", "Section": "12", "Subsection": "04" }, "r419": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "c", "Publisher": "SEC", "Section": "3", "Subparagraph": "4", "Subsection": "10" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r420": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "d", "Publisher": "SEC", "Section": "3", "Subparagraph": "(4)(iii)", "Subsection": "10" }, "r421": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "d", "Publisher": "SEC", "Section": "3", "Subparagraph": "(4)(iv)", "Subsection": "10" }, "r422": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "d", "Publisher": "SEC", "Section": "3", "Subparagraph": "4", "Subsection": "10" }, "r423": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "e", "Publisher": "SEC", "Section": "3", "Subparagraph": "4", "Subsection": "10" }, "r424": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "f", "Publisher": "SEC", "Section": "3", "Subparagraph": "4", "Subsection": "10" }, "r425": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "i", "Publisher": "SEC", "Section": "3", "Subsection": "10" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6801-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3(a)(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6812-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(dd)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i),(j),(k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i-k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e637-108580" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e640-108580" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6911-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e681-108580" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669686-108580" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "17A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724391-108580" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "17B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724394-108580" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e557-108580" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6935-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118951672&loc=d3e1436-108581" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.19)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r89": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "220", "URI": "http://asc.fasb.org/topic&trid=2134417" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e7018-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3367-108585" } }, "version": "2.1" } XML 100 R37.htm IDEA: XBRL DOCUMENT v3.20.1
Asset Impairment, Exit and Implementation Costs (Pre-tax Asset Impairment, Exit and Implementation Costs) (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Restructuring Cost and Reserve [Line Items]    
Asset impairment and exit costs $ 0 $ 40
Plus amounts included in net periodic benefit income, excluding service cost, Asset Impairment and Exit Costs   12
Asset Impairment and Exit Costs   52
Total, Implementation Costs 392 9
Plus amounts included in net period benefit income, excluding service cost, Implementation Costs 0 0
Implementation Costs 392 9
Total restructuring 392 49
Plus amounts included in net periodic benefit income, excluding service cost, Total 0 12
Total 392 61
Operating Segments [Member] | Smokeable Products Segment [Member]    
Restructuring Cost and Reserve [Line Items]    
Asset impairment and exit costs   36
Total, Implementation Costs 0 8
Total restructuring 0 44
Operating Segments [Member] | Oral Tobacco Segment [Member]    
Restructuring Cost and Reserve [Line Items]    
Asset impairment and exit costs   8
Total, Implementation Costs 0 1
Total restructuring 0 9
Operating Segments [Member] | Wine Segment [Member]    
Restructuring Cost and Reserve [Line Items]    
Asset impairment and exit costs   0
Total, Implementation Costs 392 0
Total restructuring 392 0
Operating Segments [Member] | All Other [Member]    
Restructuring Cost and Reserve [Line Items]    
Asset impairment and exit costs   (5)
Total, Implementation Costs 0 0
Total restructuring 0 (5)
Corporate, Non-Segment [Member]    
Restructuring Cost and Reserve [Line Items]    
Asset impairment and exit costs   1
Asset Impairment and Exit Costs 0 1
Total, Implementation Costs 0 0
Total restructuring $ 0 $ 1
XML 101 R14.htm IDEA: XBRL DOCUMENT v3.20.1
Benefit Plans
 3 Months Ended
Mar. 31, 2020
Retirement Benefits [Abstract]  
Benefit Plans Benefit Plans:

Components of Net Periodic Benefit (Income) Cost

Net periodic benefit (income) cost consisted of the following: 
 
For the Three Months Ended March 31,
 
Pension
 
Postretirement
 
2020
 
2019
 
2020
 
2019
 
(in millions)
Service cost
$
19

 
$
17

 
$
4

 
$
4

Interest cost
63

 
77

 
15

 
20

Expected return on plan assets
(126
)
 
(145
)
 
(3
)
 
(4
)
Amortization:
 
 
 
 
 
 
 
Net loss
27

 
42

 
3

 
3

Prior service cost (credit)
1

 
1

 
(7
)
 
(7
)
Curtailment
—

 
7

 
—

 
5

Net periodic benefit (income) cost
$
(16
)
 
$
(1
)
 
$
12

 
$
21



Curtailment costs shown in the table above were related to the cost reduction program discussed in Note 3. Asset Impairment, Exit and Implementation Costs.

Employer Contributions

Altria makes contributions to the pension plans to the extent that the contributions are tax deductible and pays benefits that relate to plans for salaried employees that cannot be funded under Internal Revenue Service regulations. Altria made employer contributions of $4 million to its pension plans during the three months ended March 31, 2020. Currently, Altria anticipates making additional employer contributions to its pension plans during the remainder of 2020 of up to approximately $25 million based on current tax law. Altria did not make any employer contributions to its postretirement plans during the three months ended March 31, 2020. Currently, Altria anticipates making employer contributions to its postretirement plans of up to approximately $60 million in 2020. However, these estimates may be subject to change as a result of changes in tax and other benefit laws, as well as asset performance significantly above or below the assumed long-term rate of return on assets, changes in interest rates or other considerations.
XML 102 R10.htm IDEA: XBRL DOCUMENT v3.20.1
Revenues from Contracts with Customers
 3 Months Ended
Mar. 31, 2020
Revenue from Contract with Customer [Abstract]  
Revenues from Contracts with Customers Revenues from Contracts with Customers:

Altria disaggregates net revenues based on product type. For further discussion, see Note 9. Segment Reporting.

Altria’s businesses offer cash discounts to customers for prompt payment and calculate cash discounts as a percentage of the list price based on historical experience and agreed-upon payment terms. Altria’s businesses record an allowance for cash discounts, which is included as a contra-asset against receivables on Altria’s condensed consolidated balance sheets. Cash discounts at March 31, 2020 and December 31, 2019 were de minimis, and there were no differences between amounts recorded as an allowance for cash discounts and cash discounts subsequently given to customers.

Altria’s businesses that receive payments in advance of product shipment record such payments as deferred revenue. These payments are included in other accrued liabilities on Altria’s condensed consolidated balance sheets until control of such products is obtained by the customer. Deferred revenue was $219 million and $362 million at March 31, 2020 and December 31, 2019, respectively. When cash is received in advance of product shipment, Altria’s businesses satisfy their performance
obligations within three days of receiving payment. At March 31, 2020 and December 31, 2019, there were no differences between amounts recorded as deferred revenue and amounts subsequently recognized as revenue.

Receivables, which primarily reflect sales of wine produced and/or distributed by Ste. Michelle, were $147 million and $152 million at March 31, 2020 and December 31, 2019, respectively. At March 31, 2020 and December 31, 2019, there were no expected differences between amounts recorded and subsequently received, and Altria’s businesses did not record an allowance for doubtful accounts against these receivables.

Altria’s businesses record an allowance for returned goods, which is included in other accrued liabilities on Altria’s condensed consolidated balance sheets. While all of Altria’s tobacco operating companies sell tobacco products with dates relative to freshness as printed on product packaging, it is USSTC’s policy to accept authorized sales returns from its customers for products that have passed such dates due to the limited shelf life of USSTC’s MST and snus products. Altria’s businesses record estimated sales returns, which are based principally on historical volume and return rates, as a reduction to revenues. Actual sales returns will differ from estimated sales returns to the extent actual results differ from estimated assumptions. Altria’s businesses reflect differences between actual and estimated sales returns in the period in which the actual amounts become known. These differences, if any, have not had a material impact on Altria’s condensed consolidated financial statements. All returned goods are destroyed upon return and not included in inventory. Consequently, Altria’s businesses do not record an asset for their right to recover goods from customers upon return.

Sales incentives include variable payments related to goods sold by Altria’s businesses. Altria’s businesses include estimates of variable consideration as a reduction to revenues upon shipment of goods to customers. The sales incentives that require significant estimates and judgments are as follows:

Price promotion payments- Altria’s businesses make price promotion payments, substantially all of which are made to their retail partners, to incent the promotion of certain product offerings in select geographic areas.

Wholesale and retail participation payments- Altria’s businesses make payments to their wholesale and retail partners to incent merchandising and sharing of sales data in accordance with each business’s trade agreements.

These estimates primarily include estimated wholesale to retail sales volume and historical acceptance rates. Actual payments will differ from estimated payments to the extent actual results differ from estimated assumptions. Differences between actual and estimated payments are reflected in the period such information becomes available. These differences, if any, have not had a material impact on Altria’s condensed consolidated financial statements.
XML 103 R18.htm IDEA: XBRL DOCUMENT v3.20.1
Debt
 3 Months Ended
Mar. 31, 2020
Debt Disclosure [Abstract]  
Debt Debt:

Short-term Borrowings and Borrowing Arrangements

Altria had $3.0 billion and no short-term borrowings at March 31, 2020 and December 31, 2019, respectively.

At March 31, 2020, Altria had a senior unsecured 5-year revolving credit agreement, dated August 1, 2018 (as amended, the “Credit Agreement”), that provides for borrowings up to an aggregate principal amount of $3.0 billion.

On March 23, 2020, Altria provided notice to JPMorgan Chase Bank, N.A., as administrative agent under the Credit Agreement, to borrow the entire available amount ($3.0 billion) under the Credit Agreement and, as of March 31, 2020, $3.0 billion was outstanding under the Credit Agreement. Altria typically accesses the commercial paper market early in the second quarter to help fund payments related to the 1998 Master Settlement Agreement (the “MSA”) and shareholder dividends. In light of the current uncertainty in the global capital markets, including the commercial paper markets, resulting from the COVID-19 pandemic, Altria elected to borrow the entire amount available under the Credit Agreement as a precautionary measure to increase its cash position and preserve financial flexibility. Altria used a portion of the proceeds from the borrowing under the Credit Agreement to help fund these payments and for other general corporate purposes.

All borrowings under the Credit Agreement mature on August 1, 2023, unless extended pursuant to the terms of the Credit Agreement. The Credit Agreement includes an option, subject to certain conditions, for Altria to extend the expiration date for two additional one-year periods. Altria may repay the borrowings under the Credit Agreement at any time without penalty. Altria has the intent and ability to repay the entire outstanding balance under the Credit Agreement within one year and believes it has adequate liquidity and access to financial resources to meet its anticipated obligations in the foreseeable future. As a result, Altria has classified the full amount of the borrowings as a current liability on its condensed consolidated balance sheet at March 31, 2020. Interest on the outstanding borrowings at March 31, 2020 was based on the three-month London Interbank Offered Rate (“LIBOR”) plus an applicable percentage based on the higher of the ratings of Altria’s long-term senior unsecured debt from Moody’s Investors Service, Inc. and Standard & Poor’s Ratings Services. The applicable percentage based on Altria’s long-term senior unsecured debt ratings at March 31, 2020 for borrowings under the Credit Agreement was 1.0%. At March 31, 2020, the interest rate for Altria’s current borrowings under the Credit Agreement was 2.23%. The Credit Agreement does not include any other rating triggers or any provisions that could require the posting of collateral.

The Credit Agreement includes various covenants, one of which requires Altria to maintain a ratio of consolidated earnings before interest, taxes, depreciation and amortization (“EBITDA”) to Consolidated Interest Expense of not less than 4.0 to 1.0, calculated as of the end of the applicable quarter on a rolling four quarters basis. At March 31, 2020, the ratio of consolidated EBITDA to Consolidated Interest Expense, calculated in accordance with the Credit Agreement, was 9.0 to 1.0. At March 31, 2020, Altria was in compliance with its covenants in the Credit Agreement. The terms “Consolidated EBITDA” and “Consolidated Interest Expense,” each as defined in the Credit Agreement, include certain adjustments.

At March 31, 2020, accrued interest on short-term borrowings under the Credit Agreement of $1 million was included in other accrued liabilities on Altria’s condensed consolidated balance sheet.

Any commercial paper issued by Altria and borrowings under the Credit Agreement are guaranteed by PM USA as further discussed in Note 12. Condensed Consolidating Financial Information.

For discussion of the fair value of Altria’s short-term borrowings, see Note 5. Financial Instruments.

Long-term Debt

During the first quarter of 2020, Altria repaid in full at maturity senior unsecured notes in the aggregate principal amount of $1,000 million.

At March 31, 2020 and December 31, 2019, accrued interest on long-term debt of $270 million and $470 million, respectively, was included in other accrued liabilities on Altria’s condensed consolidated balance sheets.

Altria designated its Euro denominated senior unsecured notes as a net investment hedge of its investment in ABI.

For discussion of Altria’s net investment hedge and the fair value of Altria’s long-term debt, see Note 5. Financial Instruments.